<DOC>
<DOCNO> FR940112-0-00001 </DOCNO>
<PARENT> FR940112-0-00001 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4700 -->

<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Rules and Regulations

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 8
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00002 </DOCNO>
<PARENT> FR940112-0-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF JUSTICE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Immigration and Naturalization Service</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO> 8 CFR Part 238</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[INS No. 1640&hyph;93]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 1115&hyph;AC24</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Contracts With Transportation Lines; Signatory Authority
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Immigration and Naturalization Service, Justice.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This final rule amends agency regulations by adding the names of airlines who have entered into agreements with the
Immigration and Naturalization Service (Service) under the purview of the Immigration and Nationality Act (the
Act). This rule is necessary so that air carriers who become signatory to preinspection or transit without visa (TWOV)
agreements with the Services are listed in agency regulations. This rule also adds Aruba and Paradise Island, Bahamas
to the list of preinspection stations.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This rule is effective January 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Una Brien, Assistant Chief Inspector, Inspections Division, Immigration and Naturalization Service, 425 I Street,
NW., room 7228, Washington, DC 20536, telephone (202) 514&hyph;2681.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Under the current regulations, air carriers are required to enter into contracts with the Service in order to participate
in the preinspection and Transit Without Visa (TWOV) programs. Contracts have been signed using Forms I&hyph;425
(Agreement for Preinspection) and I&hyph;426 (Immediate and Continuous Transit Agreement) under the purview of
section 238 of the Immigration and Nationality Act. Accordingly, &sect;&sect;238.3 and 238.4 of title 8 of the Code
of Federal Regulations are being amended to include these carriers.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Service's implementation of this rule as a final rule is based upon the ``good cause'' exception found at 5 U.S.C.
553(b)(B) and (d)(3). The reasons for immediate implementation of this final rule are as follows: A notice and comment
period for a proposed rule is unnecessary because this regulation merely updates the listing of carriers and preinspection
stations signatory with the agency. Moreover, it imposes a benefit rather than a burden or penalty of any kind to applicable
persons.
<!-- PJG 0012 frnewline -->
In accordance with 5 U.S.C. 605(b), the Commissioner of the Immigration and Naturalization Service certifies that
this rule does not have a significant adverse economic impact on a substantial number of small entities. It is anticipated
that this rule will not have a significant adverse economic impact since this rule merely amends agency regulations
by adding to the list of airline carriers and preinspection stations. This rule is not significant within the meaning
of section 3(f) of Executive Order 12866, nor does this rule have Federalism implications warranting the preparation
of a Federalism Assessment in accordance with Executive Order 12612.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 8 CFR Part 238
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Administrative practice and procedures, Air carriers, Aliens, Government contracts, Travel.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, part 238 of chapter I of title 8 of the Code of Federal Regulations is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 238_CONTRACTS WITH TRANSPORTATION LINES
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 238 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 8 U.S.C. 1103, 1228; 8 CFR part 2.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;238.3, paragraph (a) is revised to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00003 </DOCNO>
<PARENT> FR940112-0-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;238.3 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Aliens in immediate and continuous transit.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form I&hyph;426 agreements. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A transportation line bringing aliens to the United States pursuant to &sect;212.1(f)(1) of this chapter shall enter
into an agreement on Form I&hyph;426. Such an agreement shall be negotiated directly by the Service's Headquarters
Inspections Office and the head offices of the transportation lines.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. In &sect;238.3, paragraph (b) is amended by adding the following airline carriers, in alphabetical sequence,
to the list of signatory lines to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;238.3 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Aliens in immediate and continuous transit.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Aerolineas Centrales De Colombia (ACES).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Aeroposta, S.A.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Air Aruba.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
AirBC Limited.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Air Belgium.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Air Columbus.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Air Gambia Limited.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Alliance Air.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Asiana Air.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Atlantic Air BVI.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Aviateca, S.A.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Balkan Bulgarian.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Dominair.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Eva Air.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Florida Air, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
J. D. Valenciana De Aviacion.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
KIWI International Airlines.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Leisure International Airways.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Nicaraguense De Aviacion S.A. (NICA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Polynesian Airlines.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
SAETA.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Transbrasil Airlines.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Translift Airways.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Transworld Express.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Turkish Airlines.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
VASP Brazilian (Viacao Aerea Sao Paulo S.A.).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;238.3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. In &sect;238.3, paragraph (b) is amended by removing ``Aerovias Venezolanas, S.A. (AVENSA)'' and ``Avensa Airlines''
from the list of carriers.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00004 </DOCNO>
<PARENT> FR940112-0-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Section 238.4 is amended by adding the following preinspection stations and airline carriers in alphabetical
sequence within each location, to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;238.4 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Preinspection outside the United States. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Aruba
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Air Aruba.
<!-- PJG 0012 frnewline -->
Airmark Aviation, Inc. 
<!-- PJG 0012 frnewline -->
ALM Antillean Airlines. 
<!-- PJG 0012 frnewline -->
American Airlines, Inc. 
<!-- PJG 0012 frnewline -->
Jet Fleet Corporation. 
<!-- PJG 0012 frnewline -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->
Rich International Airways, Inc. 
<!-- PJG 0012 frnewline -->
Servicious Avensa S.A. (SERVIVENSA). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Bermuda 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=13 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Northwest Airlines, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Calgary 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Edmonton 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Freeport 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Trinity Air Bahamas 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Montreal 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Comair, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Nassau 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Trinity Air Bahamas 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Paradise Island 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Paradise Island Airlines, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Toronto 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Atlantic Coast Airlines dba United Express 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Conifair Aviation Inc. dba Royal Airlines 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Shannon 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Aeroflot 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Translift Airways Limited 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Vancouver 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Victoria 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
At Winnipeg 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Miami Air International, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Doris Meissner, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Commissioner, Immigration and Naturalization Service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;754 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;10&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00005 </DOCNO>
<PARENT> FR940112-0-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NUCLEAR REGULATORY COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>10 CFR Parts 30, 40, 50, 70, 72 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>RIN 3150&hyph;AE16</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Self-Guarantee as an Additional Financial Assurance Mechanism; Correction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Nuclear Regulatory Commission. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule, correction. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This document corrects a final rule that appeared in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on December 29, 1993 (58 FR 68726), that amended NRC regulations for decommissioning licensed facilities to allow
certain non-electric utility licensees to use self-guarantee as a means of financial assurance. This action is necessary
to correct the designation of an appendix in the final rule.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
January 28, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Clark Prichard, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington DC 20555,
telephone (301) 492&hyph;3734.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 30_[AMENDED] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. On page 68730, in the first column, in the last line of &sect;30.8(b) the reference to ``appendix A and B'' should
be changed to read ``appendix A and C''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. On page 68730, in the first column, in the 20th line of &sect;30.35(f)(2), the reference to ``appendix B'' should
be changed to read ``appendix C''.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. On page 68730, in amendatory instruction number 4, the reference to ``appendix B'' should be changed to read ``appendix
C''.
<!-- PJG 0012 frnewline -->
4. On page 68730, in the first line of the second column, ``Appendix B'' should be changed to read ``Appendix C''.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 40_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
5. On page 68731, in the first column, in the 20th line of &sect;40.36(e)(2), the reference to ``appendix B'' should
be changed to read ``appendix C''.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 50_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
6. On page 68731, in &sect;50.75(e)(2)(iii), in the third column, in the sixth line, the reference to ``appendix B''
should be changed to read ``appendix C''.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 70_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
7. On page 68731, in &sect;70.25(f)(2), in the last line of the third column, the reference to ``appendix B'' should
be changed to read ``appendix C''.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 72_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
8. On page 68732, in &sect;72.30(c)(2), in the second column, in the 12th line, the reference to ``appendix B'' should
be changed to read ``appendix C''.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->
Dated at Bethesda, Maryland, this 6th day of January 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->
For the Nuclear Regulatory Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=2 -->
David L. Meyer, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=2 -->
Chief, Rules Review and Directives Branch, Division of Freedom of Information and Publications Services, Office
of Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=2 -->
[FR Doc. 94&hyph;702 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=2 -->
BILLING CODE 7590&hyph;01&hyph;P&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00006 </DOCNO>
<PARENT> FR940112-0-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=2 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=2 -->
Federal Aviation Administration 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->

<CFRNO>14 CFR Part 71 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=2 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;20]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
Alteration of Jet Route J&hyph;171; CO 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This action revokes a portion of Jet Route J&hyph;171 from Hugo, CO, to Kiowa, CO, because the Kiowa, CO, Very High Frequency
Omnidirectional Range/Tactical Navigation (VORTAC) facility will be decommissioned after the new Denver International
Airport becomes operational. This action supports the new Denver International Airport airspace realignment.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
0901 U.T.C., March 9, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Norman W. Thomas, Airspace and Obstruction Evaluation Branch (ATP&hyph;240), Airspace-Rules and Aeronautical
Information Division, Air Traffic Rules and Procedures Service, Federal Aviation Administration, 800 Independence
Avenue, SW., Washington, DC 20591; telephone: (202) 267&hyph;9230. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->
History 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
On August 6, 1993, the FAA proposed to amend part 71 of the Federal Aviation Regulations (14 CFR part 71) to remove that
portion of Jet Route J&hyph;171 from Hugo, CO, to Kiowa, CO (58 FR 42038). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested parties were invited to participate in this rulemaking proceeding by submitting written comments on
the proposal to the FAA. No comments objecting to the proposal were received. Except for editorial changes, this amendment
is the same as that proposed in the notice. Jet routes are published in paragraph 2004 of FAA Order 7400.9A dated June
17, 1993, and effective September 16, 1993, which is incorporated by reference in 14 CFR 71.1 (58 FR 36298; July 6, 1993).
The jet route listed in this document will be published subsequently in the Order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Rule 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
This amendment to part 71 of the Federal Aviation Regulations revokes a portion of Jet Route J&hyph;171 from Hugo,
CO, to Kiowa, CO. The Kiowa, CO, VORTAC will be decommissioned after the new Denver International Airport becomes
operational. This accommodates the new Denver International Airport airspace realignment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore; (1) Is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic procedures and
air navigation, it is certified that this rule will not have a significant economic impact on a substantial number
of small entities under the criteria of the Regulatory Flexibility Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporation by reference, Navigation (air). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Adoption of the Amendment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of foregoing, the Federal Aviation Administration amends 14 CFR part 71, as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 2004_Jet Routes 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
J&hyph;171 [Revised] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
From Tobe, CO, to Hugo, CO. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on January 3, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Harold W. Becker, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Airspace-Rules and Aeronautical Information Division. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;783 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00007 </DOCNO>
<PARENT> FR940112-0-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ASO&hyph;11]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Designation of Class E Airspace, Dunnellon, FL
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This action establishes Class E airspace at Dunnellon, Florida. A Standard Instrument Approach Procedure (SIAP)
for Runway 23 at the Dunnellon Airport has been developed and controlled airspace extending upward from 700 feet above
the surface of the earth is needed to contain instrument flight rules (IFR) operations when using this SIAP.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 0901 u.t.c., March 3, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Armando Castro, Airspace Section, System Management Branch, Air Traffic Division, Federal Aviation Administration,
P.O. Box 20636, Atlanta, Georgia 30320; telephone (404) 305&hyph;5588.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
History
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
On June 23, 1993, the FAA proposed to amend part 71 of the Federal Aviation Regulations (14 CFR part 71) to establish
Class E airspace at Dunnellon, Florida, to accommodate a Runway 23 instrument approach procedure to the Dunnellon
Airport, Dunnellon, Florida (58 FR 41211). The proposal was to add controlled airspace extending upward from 700
feet above the surface to contain IFR operations in controlled airspace during portions of the terminal operation,
while transiting between the en route and terminal environments, and to change the operating status of the airport
from visual flight rules (VFR) operations to include IFR operations concurrent with publication of the SIAP. Interested
parties were invited to participate in this rulemaking proceeding by submitting written comments on the proposal
to the FAA. No comments objecting to the proposal were received.
<!-- PJG 0012 frnewline -->
Airspace Reclassificaiton, in effect as of September 16, 1993, has discontinued the use of the term ``transition
area'' and has replaced it with the designation ``Class E airspace'' for airspace extending upward from 700 feet above
the surface. The coorindates for this airspace docket are based on North American Datum 83. Designation for Class
E airspace extending upward from 700 feet or more above the surface of the earth are published in paragraph 6005 of FAA
Order 7400.9A dated June 17, 1993, and effective September 16, 1993, which is incorporated by reference in 14 CFR 71.1
(58 FR 36298, July 6, 1993). The Class E airspace designation listed in this document will be published subsequently
in the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Rule
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
This amendment to part 71 of the Federal Aviation Regulations establishes Class E airspace at Dunnellon, Florida,
to accommodate a Runway 23 SIAP based on the Ocala Very High Frequency Omnidirectional Range/Tactical Air Navigation
facility (VORTAC) to the Dunnellon Airport. Controlled airspace extending upward from 700 feet above the surface
is needed to contain aircraft executing the approach.
<!-- PJG 0012 frnewline -->
Aeronautical maps and charts will reflect the defined area which will enable pilots to circumnavigate the area in
order to comply with applicable VFR requirements.
<!-- PJG 0012 frnewline -->
In addition, the operating status of the Dunnellon Airport is changed from VFR operations to include IFR operations
concurrent with the publication of the SIAP.
<!-- PJG 0012 frnewline -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore: (1) Is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic procedures and
air navigation, it is certified that this rule will not have a significant economic impact on a substantial number
of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporated by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Adoption of the Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration amends 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963, Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designation
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=3 -->
Paragraph 6005_Class E Airspace Areas Extending Upward From 700 Feet or More Above the Surface of the Earth
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=3 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=3 -->
ASO FL E5 Dunnellon, FL [New]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Dunnellon Airport, FL
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=3 -->
(lat. 29
<!-- PJG 0017 degreeslatlong -->
&cir;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;45
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 82
<!-- PJG 0017 degreeslatlong -->
&cir;22
<!-- PJG 0020 minuteslatlong -->
&rsquo;38
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
That airspace extending upward from 700 feet above the surface within a 6.4-mile radius of Dunnellon Airport, excluding
that portion that coincides with the Ocala, FL, Class E airspace.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=3 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Issued in College Park, Georgia, on December 28, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->
Stephen P. Alogna,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=3 -->
Acting Manager, Air Traffic Division, Southern Region.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=3 -->
[FR Doc. 94&hyph;777 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=3 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00008 </DOCNO>
<PARENT> FR940112-0-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=3 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=3 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;21]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=3 -->
Amendment of Class E Airspace; Blanding, UT
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This action amends the Blanding, Utah, Class E airspace. Controlled airspace extending from 700 feet above ground
level (AGL) is necessary for a new instrument approach procedure and missed approach holding pattern at Blanding
Municipal Airport, Blanding, Utah. Airspace reclassification, in effect as of September 16, 1993, has discontinued
the use of the term ``transition area,'' replacing it with the designation ``Class E airspace.'' The airspace will
be depicted on aeronautical charts for pilot reference.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
0901 u.t.c., February 15, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
James E. Riley, ANM&hyph;537, Federal Aviation Administration, Docket No. 93&hyph;ANM&hyph;21, 1601 Lind Avenue
SW., Renton, Washington 98055&hyph;4056, Telephone: (206) 227&hyph;2537.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->
History
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
On October 1, 1993, the FAA proposed to amend part 71 of the Federal Aviation Regulations (14 CFR part 71) by amending
the Blanding, Utah, Class E Airspace (58 FR 51256). Interested parties were invited to participate in this rulemaking
proceeding by submitting written comments on the proposal to the FAA. No comments objecting to the proposal were received.
<!-- PJG 0012 frnewline -->
Airspace reclassification, in effect as of September 16, 1993, has discontinued the use of the term ``transition
area,'' and airspace extending upward from 700 feet or more above the surface of the earth is now Class E airspace. Class
E airspace designations for airspace areas extending 700 feet or more above the surface of the earth are published
in paragraph 6005 of FAA Order 7400.9A dated June 17, 1993, and effective September 16, 1993, which is incorporated
by reference in 14 CFR 71.1 (58 FR 36298; July 6, 1993). The Class E airspace designation listed in this document will
be published subsequently in the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Rule
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
This amendment to part 71 of the Federal Aviation Regulations amends the Class E airspace at Blanding, Utah, to provide
controlled airspace for aircraft executing a new instrument approach procedure and missed approach holding pattern
at Blanding Municipal Airport, Blanding, Utah.
<!-- PJG 0012 frnewline -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore: (1) Is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic procedures and
air navigation, it is certified that this rule will not have a significant economic impact on a substantial number
of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Adoption of the Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration amends 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 6005_Class E Airspace Areas Extending Upward From 700 Feet or More Above the Surface of the Earth
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM UT E5 Blanding, UT [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Blanding Municipal Airport, UT
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 37
<!-- PJG 0017 degreeslatlong -->
&cir;34
<!-- PJG 0020 minuteslatlong -->
&rsquo;59
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 109
<!-- PJG 0017 degreeslatlong -->
&cir;29
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Blanding NDB
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 37
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 109
<!-- PJG 0017 degreeslatlong -->
&cir;29
<!-- PJG 0020 minuteslatlong -->
&rsquo;34
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Dove Creek VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 37
<!-- PJG 0017 degreeslatlong -->
&cir;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;32
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 108
<!-- PJG 0017 degreeslatlong -->
&cir;55
<!-- PJG 0020 minuteslatlong -->
&rsquo;53
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from 700 feet above the surface within a 5.3-mile radius of the Blanding Municipal
Airport, and within 5 miles east and 3.1 miles west of the 188 degree bearing from the Blanding NDB extending from the
5.3-mile radius to 10.1 miles south of the NDB; that airspace extending upward from 1,200 feet above the surface within
8.3 miles east and 5 miles west of the 188 and 008 degree bearings from the Blanding NDB extending from 16.1 miles south
to 6.1 miles north of the NDB, and within 4.3 miles each side of a direct line between the Blanding NDB and the Dove Creek
VORTAC.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Seattle, Washington, on December 16, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Temple H. Johnson, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Air Traffic Division, Northwest Mountain Region.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;781 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00009 </DOCNO>
<PARENT> FR940112-0-00006 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;29]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Amendment of Class E Airspace; Moab, UT
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This action amends the Moab, Utah, Class E airspace. Controlled airspace extending from 700 feet above ground level
(AGL) is necessary for a new instrument approach procedure at Canyonlands Field Airport, Moab, Utah. The airspace
will be depicted on aeronautical chats for pilot reference.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 0901 u.t.c., February 15, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 James E. Riley, ANM&hyph;537, Federal Aviation Administration, Docket No. 93&hyph;ANM&hyph;29, 1601 Lind Avenue
SW., Renton, Washington 98055&hyph;4056, Telephone: (206) 227&hyph;2537.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
History
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
On October 1, 1993, the FAA proposed to amend part 71 of the Federal Aviation Regulations (14 CFR part 71) by amending
the Moab, Utah, Class E airspace (58 FR 51257). Interested parties were invited to participate in this rulemaking
proceeding by submitting written comments on the proposal to the FAA. No comments objecting to the proposal were received.
<!-- PJG 0012 frnewline -->
Class E airspace designations for airspace areas extending 700 feet or more above the surface of the earth are published
in Paragraph 6005 of FAA Order 7400.9A dated June 17, 1993, and effective September 16, 1993, which is incorporated
by reference in 14 CFR 71.1 (58 FR 36298; July 6, 1993). The Class E airspace designation listed in this document will
be published subsequently in the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Rule
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
This amendment to part 71 of the Federal Aviation Regulations amends the Class E airspace at Moab, Utah, to provide
controlled airspace for aircraft executing a new instrument approach procedure at Canyonlands Field Airport, Moab,
Utah.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore: (1) Is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. Since this is a routine matter that will only effect air traffic procedures and
air navigation, it is certified that this rule will not have a significant economic impact on a substantial number
of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Adoption of the Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration amends 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 6005_Class E Airspace Areas Extending Upward From 700 Feet or More Above the Surface of the Earth
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM UT E5 Moab, UT [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Canyonlands Field Airport, UT
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 38
<!-- PJG 0017 degreeslatlong -->
&cir;45
<!-- PJG 0020 minuteslatlong -->
&rsquo;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 109
<!-- PJG 0017 degreeslatlong -->
&cir;45
<!-- PJG 0020 minuteslatlong -->
&rsquo;17
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Moab VOR/DME
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 38
<!-- PJG 0017 degreeslatlong -->
&cir;45
<!-- PJG 0020 minuteslatlong -->
&rsquo;22
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 109
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;58
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from 700 feet above the surface within an 8.7-mile radius of the Canyonlands Field
Airport, and within 6.1 miles northeast and 8.7 miles southwest of the Moab VOR/DME 301
<!-- PJG 0017 degreeslatlong -->
&cir; radial extending from the 8.7-mile radius to 16.1 miles northwest of the airport and within 2 miles each side
of the 040
<!-- PJG 0017 degreeslatlong -->
&cir; bearing from Canyonlands Field Airport extending from the 8.7-mile radius to 10 miles northeast of the airport;
that airspace extending upward from 1,200 feet above the surface bounded on the north by V&hyph;134, on the east by
V&hyph;391, on the south by V&hyph;244, and on the west by V&hyph;208, excluding the Price Carbon County Airport,
Utah, and the Grand Junction, Walker Field, Co. Class E Airspace Areas and all Federal Airways.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Seattle, Washington, on December 16, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Temple H. Johnson, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=3 -->
Manager, Air Traffic Division, Northwest Mountain Region.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;780 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00010 </DOCNO>
<PARENT> FR940112-0-00007 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;10]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Modification of Class D Airspace; Seattle, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This rule amends the Class D airspace for Seattle-Tacoma International Airport, Boeing Field Airport, and Renton
Municipal Airport. These changes are necessary to reflect the actual airspace delegated to each airport traffic
control tower and show this airspace on appropriate aeronautical charts for pilots' use.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
0901 UTC, March 3, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Robert L. Brown, ANM&hyph;535, Federal Aviation Administration, Docket No. 93&hyph;ANM&hyph;10, 1601 Lind Avenue
SW., Renton, Washington 98055&hyph;4056, Telephone: (206) 227&hyph;2535.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
History
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On August 17, 1993, the FAA proposed to amend part 71 of the Federal Aviation Regulations (14 CFR part 71) to amend the
Class D airspace for Seattle-Tacoma International Airport, Boeing Field Airport, and Renton Municipal Airport,
Washington (58 FR 43573).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interested parties were invited to participate in this rulemaking proceeding by submitting written comments on
the proposal to the FAA. No comments objecting to the proposal were received. This amendment is the same as that proposed
in the notice, except some coordinates of the airspace descriptions have been changed slightly to delete a small amount
of Class D airspace south of Boeing Field which was found to be unnecessary. The coordinates in the proposal were North
American Datum 27; however, these coordinates have been updated to North American Datum 83. Class D airspace areas
are published in paragraph 5000 of FAA Order 7400.9A dated June 17, 1993, and effective September 16, 1993, which is
incorporated by reference in 14 CFR 71.1 (58 FR 36298; July 6, 1993). The Class D airspace designation listed in this
document will be published subsequently in the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Rule
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment to part 71 of the Federal Aviation Regulations amends the Class D airspace for Seattle-Tacoma International
Airport, Boeing Field Airport, and Renton Municipal Airport, Washington. These changes are necessary to reflect
the actual airspace delegated to each airport traffic control tower and to show this airspace on appropriate aeronautical
charts for pilots' use.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore: (1) Is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic procedures and
air navigation, it is certified that this rule will not have a significant economic impact on a substantial number
of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Adoption of the Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Federal Aviation Administration amends 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 5000_General
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM WA D Seattle-Tacoma International Airport, WA (Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Seattle_Tacoma International Airport, WA
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;56
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, Long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;34
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Seattle, Boeing Field/King County International Airport, WA
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00011 </DOCNO>
<PARENT> FR940112-0-00007 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to but not including 3,000 feet MSL beginning at lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;22
<!-- PJG 0020 minuteslatlong -->
&rsquo;37
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;53
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., clockwise along the 5-mile radius of the Seattle-Tacoma International Airport to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;29
<!-- PJG 0020 minuteslatlong -->
&rsquo;38
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;24
<!-- PJG 0020 minuteslatlong -->
&rsquo;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence clockwise along the 5-mile radius of Boeing Field/King County International Airport to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence east along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence southeast along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;51
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence south along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence south along a line to the point of beginning excluding that airspace within the Seattle, Washington,
Class B airspace area.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM WA D Seattle, Boeing Field/King County International Airport, WA [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Seattle, Boeing Field/King County International Airport, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Seattle VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;35
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 2,500 feet MSL beginning at lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., clockwise along the 5-mile radius of Boeing Field/King County International Airport to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;34
<!-- PJG 0020 minuteslatlong -->
&rsquo;32
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;11
<!-- PJG 0020 minuteslatlong -->
&rsquo;57
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence southwest along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;33
<!-- PJG 0020 minuteslatlong -->
&rsquo;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence southwest along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;15
<!-- PJG 0020 minuteslatlong -->
&rsquo;32
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence southeast along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;33
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence south along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;28
<!-- PJG 0020 minuteslatlong -->
&rsquo;09
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;33
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence southeast along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;27
<!-- PJG 0020 minuteslatlong -->
&rsquo;45
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;58
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence south along a line to the intersection with a Seattle VORTAC 097 bearing at lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;36
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;19
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence west along the Seattle VORTAC 097 bearing to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence north along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;51
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence northwest along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence west along a line to the point of beginning excluding that airspace within the Seattle, Washington,
Class B airspace area.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM WA D Renton, WA [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;29
<!-- PJG 0020 minuteslatlong -->
&rsquo;35
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;57
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Seattle, Boeing Field/King County International Airport, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Seattle VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;35
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 2,500 feet MSL beginning at the intersection of a
5-mile radius of Boeing Field/King County International Airport and a 5-mile radius of Renton Municipal Airport
at lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;34
<!-- PJG 0020 minuteslatlong -->
&rsquo;32
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;11
<!-- PJG 0020 minuteslatlong -->
&rsquo;57
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence clockwise along the 5-mile radius of Renton Municipal Airport to the intersection with a Seattle
VORTAC 097 bearing at lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;20
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;09
<!-- PJG 0020 minuteslatlong -->
&rsquo;05
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence west along the Seattle VORTAC 097 bearing to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;36
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;19
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence north along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;27
<!-- PJG 0020 minuteslatlong -->
&rsquo;45
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;58
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence northwest along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;28
<!-- PJG 0020 minuteslatlong -->
&rsquo;09
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;33
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence north along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;33
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence northwest along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;15
<!-- PJG 0020 minuteslatlong -->
&rsquo;32
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence northeast along a line to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;33
<!-- PJG 0020 minuteslatlong -->
&rsquo;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., thence northeast along a line to the point of beginning.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Seattle, Washington, on December 14, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Helen M. Parke,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Manager, Air Traffic Division, Northwest Mountain Region.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;785 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00012 </DOCNO>
<PARENT> FR940112-0-00008 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;40]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Revocation of Jet Route J&hyph;201
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This action revokes Jet Route J&hyph;201 located between the Myton, UT, Very High Frequency Omnidirectional Range/Tactical
Air Navigation (VORTAC) facility and the Scottsbluff, NE, VORTAC. This jet route failed to meet the necessary criteria
required for extended service volume protection during the latest flight check. The FAA has issued several notices
to airmen (NOTAM) stating that J&hyph;201 is canceled and flight is not authorized. These NOTAM's will be canceled
once this final rule becomes effective on March 3, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
0901 u.t.c., March 3, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Norman W. Thomas, Airspace and Obstruction Evaluation Branch (ATP&hyph;240), Airspace-Rules and Aeronautical
Information Division, Air Traffic Rules and Procedures Service, Federal Aviation Administration, 800 Independence
Avenue, SW., Washington, DC 20591; telephone: (202) 267&hyph;9230.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Rule
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment to part 71 of the Federal Aviation Regulations revokes J&hyph;201 between the Myton, UT, VORTAC and
the Scottsbluff, NE, VORTAC. During the latest flight check, this jet route failed to meet the necessary criteria
required for extended service volume protection. The FAA has issued several NOTAM's stating that J&hyph;201 is canceled
and flight is not authorized. These NOTAM's will be canceled once this final rule becomes effective on March 3, 1994.
I find that notice and public procedure under 5 U.S.C. 553(b) are unnecessary because this is a minor technical amendment
in which the public is not particularly interested. Jet routes are published in Paragraph 2004 of FAA Order 7400.9A
dated June 17, 1993, and effective September 16, 1993, which is incorporated by reference in 14 CFR 71.1 (58 FR 36298;
July 6, 1993). The jet route listed in this document will be removed subsequently from the Order.
<!-- PJG 0012 frnewline -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore_(1) is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic procedures and
air navigation, it is certified that this rule will not have a significant economic impact on a substantial number
of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Adoption of the Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Federal Aviation Administration amends 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 2004_Jet Routes
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
J&hyph;201&blank;[Removed]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Harold W. Becker,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Airspace-Rules and Aeronautical Information Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;790 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00013 </DOCNO>
<PARENT> FR940112-0-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 97</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 27567; Amdt. No. 1580]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Standard Instrument Approach Procedures: Miscellaneous Amendments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This amendment establishes, amends, suspends, or revokes Standard Instrument Approach Procedures (SIAPs) for
operations at certain airports. These regulatory actions are needed because of changes occurring in the National
Airspace System, such as the commissioning of new navigational facilities, addition of new obstacles, or changes
in air traffic requirements. These changes are designed to provide safe and efficient use of the navigable airspace
and to promote safe flight operations under instrument flight rules at the affected airports.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Effective:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 An effective date for each SIAP is specified in the amendatory provisions.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Incorporation by reference-approved by the Director of the Federal Register on December 31, 1980, and reapproved
as of January 1, 1982.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Availability of matter incorporated by reference in the amendment is as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
For Examination
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. FAA Rules Docket, FAA Headquarters Building, 800 Independence Avenue, SW., Washington, DC 20591;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The FAA Regional Office of the region in which affected airport is located; or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The Flight Inspection Field Office which originated the SIAP. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
For Purchase
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individual SIAP copies may be obtained from:
<!-- PJG 0012 frnewline -->
1. FAA Public Inquiry Center (APA&hyph;200), FAA Headquarters Building, 800 Independence Avenue, SW., Washington,
DC 20591; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The FAA Regional Office of the region in which the affected airport is located.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
By Subscription
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Copies of all SIAPs, mailed once every 2 weeks, are for sale by the Superintendent of Documents, US Government Printing
Office, Washington, DC 20402.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Paul J. Best, Flight Procedures Standards Branch (AFS&hyph;420), Technical Programs Division, Flight Standards
Service, Federal Aviation Administration, 800 Independence Avenue, SW., Washington, DC 20591; telephone (202)
267&hyph;8277.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This amendment to part 91 of the Federal Aviation Regulations (14 CFR part 97) establishes, amends, suspends, or revokes
Standard Instrument Approach Procedures (SIAPs). The complete regulatory description on each SIAP is contained
in the appropriate FAA Form 8260 and the National Flight Data Center (FDC)/Permanent (P) Notices to Airmen (NOTAM)
which are incorporated by reference in the amendment under 5 U.S.C. 552(a), 1 CFR part 51, and &sect;97.20 of the Federal
Aviations Regulations (FAR). Materials incorporated by reference are available for examination or purchase as
stated above.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The large number of SIAPs, their complex nature, and the need for a special format make their verbatim publication
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 expensive and impractical. Further, airmen do not use the regulatory text of the SIAP's, but refer to their graphic
depiction of charts printed by publishers of aeronautical materials. Thus, the advantages of incorporation by reference
are realized and publication of the compete description of each SIAP contained in FAA form documents is unnecessary.
The Provisions of this amendment state the affected CFR (and FAR) sections, with the types and effective dates of the
SIAPs. This amendment also identifies the airport, its location, the procedure identification and the amendment
number.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Rule
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment to part 97 of the Federal Aviation Regulations (14 CFR part 97) establishes, amends, suspends, or revokes
SIAPs. For safety and timeliness of change considerations, this amendment incorporates only specific changes contained
in the content of the following FDC/P NOTAM for each SIAP. The SIAP information in some previously designated FDC/Temporary
(FDC/T) NOTAMs is of such duration as to be permanent. With conversion to FDC/P NOTAMs, the respective FDC/T NOTAMs
have been cancelled. The FDC/P NOTAMs for the SIAPs contained in this amendment are based on the criteria contained
in the U.S. Standard for Terminal Instrument Approach Procedures (TERPs). In developing these chart changes to SIAPs
by FDC/P NOTAMs, the TERPs criteria were applied to only these specific conditions existing at the affected airports.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This amendment to part 97 contains separate SIAPs which have compliance dates stated as effective dates based on related
changes in the National Airspace System or the application of new or revised criteria. All SIAP amendments in this
rule have been previously issued by the FAA in a National Flight Data Center (FDC) Notice Airmen (NOTAM) as an emergency
action of immediate flight safety relating directly to published aeronautical charts. The circumstances which
created the need for all these SIAP amendments requires making them effective in less than 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further, the SIAPs contained in this amendment are based on the criteria contained in the US Standard for Terminal
Instrument Approach Procedures (TERPs). Because of the close and immediate relationship between these SIAPs and
safety in air commerce, I find that notice and public procedure before adopting these SIAPs are unnecessary, impracticable,
and contrary to the public interest and, where applicable, that good cause exists for making these SIAPs effective
in less than 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore_(1) is not a significant
regulatory action under Executive Order 12866, is not a ``significant rule'' under DOT Regulatory Policies and Procedures
(44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as the anticipated
impact is so minimal. For the same reason, the FAA certifies that this amendment will not have a significant economic
impact on a substantial number of small entities under the criteria of the Regulatory Flexibility Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Part 97
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Air Traffic Control Approaches, Standard Instrument, Incorporation by reference (1) navigation. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on December 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Thomas C. Accardi,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Flight Standards Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Adoption of the Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, pursuant to the authority delegated to me, part 97 of the Federal Aviation Regulations (14 CFR, part
97) is amended by establishing, amending, suspending, or revoking Standard Instrument Approach Procedures, effective
at 0901 UTC on the dates specified, as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 97_STANDARD INSTRUMENT APPROACH PROCEDURES
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 97 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. App. 1348, 1354(a), 1421 and 1510; 49 U.S.C. 106(g) (revised Pub. L. 97&hyph;449, January 12, 1983); and
14 CFR 11.49(b)(2).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Part 97 is amended to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;&sect;97.23, 97.25, 97.27, 97.29, 97.31, 97.33 and 97.35 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00014 </DOCNO>
<PARENT> FR940112-0-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By amending: &sect;97.23 VOR, VOR/DME, VOR OR TACAN, and VOR/DME or TACAN; &sect;97.25 LOC, LOC/DME, LDA, LDA/DME,
SDF, SDF/DME; &sect;97.27 NDB, NDB/DME; &sect;97.29 ILS, ILS/DME, ISMLS, MLS, MLS/DME, MLS/RNAV; &sect;97.31
RADAR SIAPs; &sect;97.33 RNAV SIAPs; AND &sect;97.35 COPTER SIAPs, identified as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 6,L2,tp0,i1,10,xls28,r50,r50,10,xs120 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Effective
<!-- PJG 007 0150 intable -->
1State
<!-- PJG 007 0150 intable -->
1City
<!-- PJG 007 0150 intable -->
1Airport
<!-- PJG 007 0150 intable -->
1FDC No.
<!-- PJG 007 0150 intable -->
1SIAP
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
12/12/93
<!-- PJG 007 0104 intable -->
FL
<!-- PJG 007 0104 intable -->
Jacksonville
<!-- PJG 007 0104 intable -->
Craig Muni
<!-- PJG 007 0104 intable -->
3/6787
<!-- PJG 007 0104 intable -->
ILS RWY 32 AMDT 2A...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/14/93
<!-- PJG 007 0104 intable -->
AR
<!-- PJG 007 0104 intable -->
Fort Smith
<!-- PJG 007 0104 intable -->
Fort Smith Regional
<!-- PJG 007 0104 intable -->
3/6660
<!-- PJG 007 0104 intable -->
VOR OR TACAN RWY 25 AMDT 20...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/17/93
<!-- PJG 007 0104 intable -->
LA
<!-- PJG 007 0104 intable -->
New Orleans
<!-- PJG 007 0104 intable -->
New Orleans Intl/Moisant Fld
<!-- PJG 007 0104 intable -->
3/6685
<!-- PJG 007 0104 intable -->
ILS RWY 10 AMDT 1...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/17/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
Cortland
<!-- PJG 007 0104 intable -->
Cortland County-Chase Fld. Cortland
<!-- PJG 007 0104 intable -->
3/6674
<!-- PJG 007 0104 intable -->
VOR A ORIG...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/21/93
<!-- PJG 007 0104 intable -->
CA
<!-- PJG 007 0104 intable -->
Redding
<!-- PJG 007 0104 intable -->
Redding Muni
<!-- PJG 007 0104 intable -->
3/6728
<!-- PJG 007 0104 intable -->
VOR RWY 34 AMDT 10A...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/21/93
<!-- PJG 007 0104 intable -->
ND
<!-- PJG 007 0104 intable -->
Bowman
<!-- PJG 007 0104 intable -->
Bowman Muni
<!-- PJG 007 0104 intable -->
3/6709
<!-- PJG 007 0104 intable -->
NDB RWY 29 AMDT 2...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/21/93
<!-- PJG 007 0104 intable -->
WA
<!-- PJG 007 0104 intable -->
Lawrenceburg
<!-- PJG 007 0104 intable -->
Lawrenceburg Muni
<!-- PJG 007 0104 intable -->
3/6768
<!-- PJG 007 0104 intable -->
NDB RWY 17 AMDT 3...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
WA
<!-- PJG 007 0104 intable -->
Friday Harbor
<!-- PJG 007 0104 intable -->
Friday Harbor
<!-- PJG 007 0104 intable -->
3/6718
<!-- PJG 007 0104 intable -->
RADAR&hyph;1 AMDT 1...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/22/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
Allentown
<!-- PJG 007 0104 intable -->
Allentown-Bethlehem-Easton
<!-- PJG 007 0104 intable -->
3/6749
<!-- PJG 007 0104 intable -->
ILS RWY 13 AMDT 5...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/22/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
Hazleton
<!-- PJG 007 0104 intable -->
Hazleton Muni
<!-- PJG 007 0104 intable -->
3/6755
<!-- PJG 007 0104 intable -->
VOR RWY 28 AMDT 8...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/22/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
Johnstown
<!-- PJG 007 0104 intable -->
Johnstown-Cambria Co
<!-- PJG 007 0104 intable -->
3/6680
<!-- PJG 007 0104 intable -->
ILS RWY 33 AMDT 2A...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/22/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
St Marys
<!-- PJG 007 0104 intable -->
St Marys Muni
<!-- PJG 007 0104 intable -->
3/6741
<!-- PJG 007 0104 intable -->
RNAV RWY 10 AMDT 5...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
FL
<!-- PJG 007 0104 intable -->
Jacksonville
<!-- PJG 007 0104 intable -->
Jacksonville Intl
<!-- PJG 007 0104 intable -->
3/6785
<!-- PJG 007 0104 intable -->
LOC BC RWY 31 AMDT 8A...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
MS
<!-- PJG 007 0104 intable -->
Philadelphia
<!-- PJG 007 0104 intable -->
Philadelphia Muni
<!-- PJG 007 0104 intable -->
3/6765
<!-- PJG 007 0104 intable -->
NDB RWY 18 AMDT ORIG...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
MS
<!-- PJG 007 0104 intable -->
Ripley
<!-- PJG 007 0104 intable -->
Ripley
<!-- PJG 007 0104 intable -->
3/6766
<!-- PJG 007 0104 intable -->
VOR/DME&hyph;A AMDT 1...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
NC
<!-- PJG 007 0104 intable -->
Asheville
<!-- PJG 007 0104 intable -->
Asheville Regional
<!-- PJG 007 0104 intable -->
3/6791
<!-- PJG 007 0104 intable -->
ILS RWY 34 AMDT 23...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
NC
<!-- PJG 007 0104 intable -->
Edenton
<!-- PJG 007 0104 intable -->
Edenton Muni
<!-- PJG 007 0104 intable -->
3/6772
<!-- PJG 007 0104 intable -->
NDB RWY 5 AMDT 4...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
NC
<!-- PJG 007 0104 intable -->
Edenton
<!-- PJG 007 0104 intable -->
Edenton Muni
<!-- PJG 007 0104 intable -->
3/6773
<!-- PJG 007 0104 intable -->
NDB RWY 19 AMDT 5...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
NC
<!-- PJG 007 0104 intable -->
Mt Airy
<!-- PJG 007 0104 intable -->
Surry County
<!-- PJG 007 0104 intable -->
3/6790
<!-- PJG 007 0104 intable -->
NDB&hyph;A AMDT 2...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
NC
<!-- PJG 007 0104 intable -->
New Bern
<!-- PJG 007 0104 intable -->
Craven County Regional
<!-- PJG 007 0104 intable -->
3/6770
<!-- PJG 007 0104 intable -->
VOR RWY 22, AMDT 1A...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
NC
<!-- PJG 007 0104 intable -->
Oxford
<!-- PJG 007 0104 intable -->
Henderson-Oxford
<!-- PJG 007 0104 intable -->
3/6771
<!-- PJG 007 0104 intable -->
NDB RWY 6 AMDT 1...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
Coatesville
<!-- PJG 007 0104 intable -->
Chester Co G. O. Carlson
<!-- PJG 007 0104 intable -->
3/6756
<!-- PJG 007 0104 intable -->
VOR RWY 29 AMDT 5...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
Easton
<!-- PJG 007 0104 intable -->
Easton
<!-- PJG 007 0104 intable -->
3/6776
<!-- PJG 007 0104 intable -->
VOR/DME&hyph;D ORIG
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
PA
<!-- PJG 007 0104 intable -->
Latrobe
<!-- PJG 007 0104 intable -->
Westmoreland County
<!-- PJG 007 0104 intable -->
3/6762
<!-- PJG 007 0104 intable -->
RNAV RWY 5 AMDT 1...
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12/23/93
<!-- PJG 007 0104 intable -->
TN
<!-- PJG 007 0104 intable -->
Philadelphia
<!-- PJG 007 0104 intable -->
Northeast Philadelphia
<!-- PJG 007 0104 intable -->
3/6778
<!-- PJG 007 0104 intable -->
LOC BC RWY 6 AMDT 6...
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;778 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00015 </DOCNO>
<PARENT> FR940112-0-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 97</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 27566; Amdt. No. 1579]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Standard Instrument Approach Procedures; Miscellaneous Amendments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This amendment establishes, amends, suspends, or revokes Standard Instrument Approach Procedures (SIAPs) for
operations at certain airports. These regulatory actions are needed because of the adoption of new or revised criteria,
or because of changes occurring in the National Airspace System, such as the commissioning of new navigational facilities,
addition of new obstacles, or changes in air traffic requirements. These changes are designed to provide safe and
efficient use of the navigable airspace and to promote safe flight operations under instrument flight rules at the
affected airports.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Effective:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 An effective date for each SIAP is specified in the amendatory provisions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Incorporation by reference_approved by the Director of the Federal Register on December 31, 1980, and reapproved
as of January 1, 1982.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Availability of matters incorporated by reference in the amendment is as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
For Examination_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1. FAA Rules Docket, FAA Headquarters Building, 800 Independence Avenue SW., Washington, DC 20591;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The FAA Regional Office of the region in which the affected airport is located; or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The Flight Inspection Field Office which originated the SIAP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
For Purchase_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individual SIAP copies may be obtained from:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1. FAA Public Inquiry Center (APA&hyph;200), FAA Headquarters Building, 800 Independence Avenue SW., Washington,
DC 20591; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The FAA Regional Office of the region in which the affected airport is located.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
By Subscription_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Copies of all SIAPs, mailed once every 2 weeks, are for sale by the Superintendent of Documents, U.S. Government Printing
Office, Washington, DC 20402.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Paul J. Best, Flight Procedures Standards Branch (AFS&hyph;420), Technical Programs Division, Flight Standards
Service, Federal Aviation Administration, 800 Independence Avenue SW., Washington, DC 20591; telephone (202)
267&hyph;8277.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00016 </DOCNO>
<PARENT> FR940112-0-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This amendment to part 97 of the Federal Aviation Regulations (14 CFR part 97) establishes, amends, suspends, or revokes
Standard Instrument Approach Procedures (SIAPs). The complete regulatory description of each SIAP is contained
in official FAA form documents which are incorporated by reference in this amendment under 5 U.S.C. 552(a), 1 CFR part
51, and &sect;97.20 of the Federal Aviation Regulations (FAR). The applicable FAA Forms are identified as FAA Forms
8260&hyph;3, 8260&hyph;4, and 8260&hyph;5. Materials incorporated by reference are available for examination
or purchase as stated above.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The large number of SIAPs, their complex nature, and the need for a special format make their verbatim publication
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 expensive and impractical. Further, airmen do not use the regulatory text of the SIAPs, but refer to their graphic
depiction on charts printed by publishers of aeronautical materials. Thus, the advantages of incorporation by reference
are realized and publication of the complete description of each SIAP contained in FAA form documents is unnecessary.
The provisions of this amendment state the affected CFR (and FAR) sections, with the types and effective dates of the
SIAPs. This amendment also identifies the airport, its location, the procedure identification and the amendment
number.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This amendment to part 97 is effective upon publication of each separate SIAP as contained in the transmittal. Some
SIAP amendments may have been previously issued by the FAA in a National Flight Data Center (FDC) Notice to Airmen (NOTAM)
as an emergency action of immediate flight safety relating directly to published aeronautical charts. The circumstances
which created the need for some SIAP amendments may require making them effective in less than 30 days. For the remaining
SIAPs, an effective date at least 30 days after publication is provided.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further, the SIAPs contained in this amendment are based on the criteria contained in the U.S. Standard for Terminal
Instrument Approach Procedures (TERPs). In developing these SIAPs, the TERPs criteria were applied to the conditions
existing or anticipated at the affective airports. Because of the close and immediate relationship between these
SIAPs and safety in air commerce, I find that notice and public procedure before adopting these SIAPs are unnecessary,
impracticable, and contrary to the public interest and, where applicable, that good cause exists for making some
SIAPs effective in less than 30 days.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA has determined that this regulation only involves an established body of technical regulations for which
frequent and routine amendments are necessary to keep them operationally current. It, therefore_(1) is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. For the same reason, the FAA certifies that this amendment will not have a significant
economic impact on a substantial number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Part 97
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Air traffic control, Airports, Incorporation by reference, Navigation (Air), Standard instrument approaches,
Weather.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on December 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Thomas C. Accardi,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Flight Standards Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Adoption of the Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, pursuant to the authority delegated to me, part 97 of the Federal Aviation Regulations (14 CFR part 97)
is amended by establishing, amending, suspending, or revoking Standard Instrument Approach Procedures, effective
at 0901 UTC on the dates specified, as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 97_STANDARD INSTRUMENT APPROACH PROCEDURES
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 97 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. App. 1348, 1354(a), 1421 and 1510; 49 U.S.C. 106(g) (Revised Pub. L. 97&hyph;449, January 12, 1983); and
14 CFR 11.49(b)(2).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Part 97 is amended to read as follows:
<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00017 </DOCNO>
<PARENT> FR940112-0-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;&sect;97.23, 97.25, 97.27, 97.29, 97.31, 97.33 and 97.35 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By amending: &sect;97.23 VOR, VOR/DME, VOR or TACAN, and VOR/DME or TACAN; &sect;97.25 LOC, LOC/DME, LDA, LDA/DME,
SDF, SDF/DME; &sect;97.27 NDB, NDB/DME; &sect;97.29 ILS, ILS/DME, ISMLS, MLS, MLS/DME, MLS/RNAV; &sect;97.31
RADAR SIAPs; &sect;97.33 RNAV SIAPs; and &sect;97.35 COPTER SIAPs, identified as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
*&blank;*&blank;* Effective March 3, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Bunnell, Fl, Flager County, VOR&hyph;A, Orig. 
<!-- PJG 0012 frnewline -->
Bunnell, Fl, Flager County, VOR/DME&hyph;A, Amdt. 1, CANCELLED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
*&blank;*&blank;* Effective February 3, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Fullerton, CA, Fullerton Muni, VOR&hyph;A, Amdt. 6 
<!-- PJG 0012 frnewline -->
San Francisco, CA, San Francisco Intl, LDA/DME RWY 28R, Amdt. 3 
<!-- PJG 0012 frnewline -->
San Francisco, CA, San Francisco Intl, ILS RWY 28L, Amdt. 20 
<!-- PJG 0012 frnewline -->
San Francisco, CA, San Francisco Intl, BAY ILS/DME RWY 28L, Orig. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Point Lookout, MO, M. Graham Clark, NDB RWY 29, Amdt. 7
<!-- PJG 0012 frnewline -->
Point Lookout, MO, M. Graham Clark, VOR/DME RNAV RWY 29, Amdt. 2 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Circleville, OH, Pickaway County Memorial, NDB RWY 19, Orig. 
<!-- PJG 0012 frnewline -->
Pittsburgh, PA, Pittsburgh International, Converging ILS RWY 28R, Amdt. 1 
<!-- PJG 0012 frnewline -->
Pittsburgh, PA, Pittsburgh International, ILS RWY 28L, Amdt. 5 
<!-- PJG 0012 frnewline -->
Pittsburgh, PA, Pittsburgh International, ILS RWY 28R, Amdt. 6 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
*&blank;*&blank;* Effective December 23, 1993 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Fort Huachuca-Sierra Vista, AZ, AAF/Sierra Vista Muni, VOR RWY 26, Amdt. 2 
<!-- PJG 0012 frnewline -->
Fort Huachuca-Sierra Vista, AZ, AAF/Sierra Vista Muni, NDB RWY 26, Amdt. 2 
<!-- PJG 0012 frnewline -->
Fort Huachuca/Sierra Vista, AZ, Libby AAF/Sierra Vista Muni, ILS RWY 26, Amdt. 1 
<!-- PJG 0012 frnewline -->
Fort Huchauca/Sierra Vista, AZ, Libby AAF/Sierra Vista Muni, RADAR&hyph;1, Amdt. 4
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;779 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00018 </DOCNO>
<PARENT> FR940112-0-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL TRADE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>16 CFR Part 305</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 3084&hyph;AA26</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Rule Concerning Disclosures of Energy Consumption and Water Use Information About Certain Home Appliances and Other
Products Required Under the Energy Policy and Conservation Act
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Under the Energy and Water Use Rule, each required label on a covered appliance must show a range, or scale, indicating
the range of energy costs or efficiencies for all models of a size or capacity comparable to the labeled model. This
notice publishes the new range figures, which, under &sect;&sect;305.10, 305.11 and 305.14 of the rule, must be used
on labels on refrigerators, refrigerator-freezers, and freezers manufactured on and after April 12, 1994, and in
advertising of refrigerators, refrigerator-freezers, and freezers in catalogs printed after April 12, 1994. Properly
labeled refrigerators, refrigerator-freezers, and freezers manufactured prior to the effective date need not
be relabeled. Catalogs printed prior to the effective date in accordance with 16 CFR 305.14 need not be revised.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
April 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0172 columnbreak -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
James Mills, Attorney, 202&hyph;326&hyph;3035, Division of Enforcement, Federal Trade Commission, Washington,
DC 20580.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On November 19, 1979, the Commission issued a final rule,
<FOOTCITE>1</FOOTCITE>
 pursuant to section 324 of the Energy Policy and Conservation Act of 1975,
<FOOTCITE>2</FOOTCITE>
 covering certain appliance categories, including refrigerators, refrigerator-freezers, and freezers. The rule
requires that energy costs and related information be disclosed on labels and in retail sales catalogs for all refrigerators,
refrigerator-freezers and freezers presently manufactured. Certain point-of-sale promotional materials must
disclose the availability of energy usage information. If a refrigerator, refrigerator-freezer or freezer is advertised
in a catalog from which it may be purchased by cash, charge account or credit terms, then the range of estimated annual
energy costs for the product must be included on each page of the catalog that lists the product. The required disclosures
and all claims concerning energy consumption made in writing or in broadcast advertisements must be based on the results
of test procedures developed by the Department of Energy, which are referenced in the rule. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
44 FR 66466. On December 10, 1987 (52 FR 46888), the Commission amended the Appliance Labeling Rule by extending coverage
to include central air conditioners and heat pumps. On October 25, 1993 (58 FR 54955), the Commission extended the
Rule's coverage to include certain plumbing products (showerheads, faucets, water closets and urinals). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
42 U.S.C. 6294. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 305.8(b) of the rule requires manufacturers, after filing an initial report, to report estimated annual
operating cost or energy efficiency annually by specified dates for each product type.
<FOOTCITE>3</FOOTCITE>
 Because the costs for the various types of energy change yearly, and because manufacturers regularly add new models
to their lines, improve existing models and drop others, the data base from which the ranges of comparability are calculated
is constantly changing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Reports for refrigerators, refrigerator-freezers and freezers are due by August 1.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To keep the required information in line with these changes, the Commission is empowered, under &sect;305.10 of the
rule, to publish new ranges (but not more often than annually) if an analysis of the new data indicates that the upper
or lower limits of the ranges have changed by more than 15%. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The new figures for the estimated annual costs of operation for refrigerators, refrigerator-freezers, and freezers,
which were calculated using the 1993 representative average energy cost for electricity (8.30 cents per kilowatt-hour)
published by DOE on January 5, 1993,
<FOOTCITE>4</FOOTCITE>
 have been submitted and have been analyzed by the Commission. New ranges based upon them are herewith published.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
58 FR 345. The Commission published these figures on January 25, 1993, at 58 FR 5925. The cost for electricity was published
as 8.30 cents per kilowatt-hour; for natural gas: 59.46 cents per therm; for propane: 73 cents per gallon; for No. 2
heating oil: $1.00 per gallon. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00019 </DOCNO>
<PARENT> FR940112-0-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Commission amends Appendices A&hyph;1, A&hyph;2 and B of its of its Energy
and Water Use Rule as follows effective beginning April 12, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 16 CFR Part 305
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Advertising, Energy conservation, Household appliances, Labeling, Reporting and recordkeeping requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, 16 CFR part 305 is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 305_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 305 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
42 U.S.C. 6294.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In appendices A1, A2 and B, Paragraph 1 of each and the introductory text in Paragraph 2 of each are revised to read
as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix A1 to Part 305_Refrigerators
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Range Information:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,tp0,i1,s40,8,8 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Manufacturer's rated total refrigerated volume in cubic feet 
<!-- PJG 007 0150 intable -->
1Ranges of estimated yearly energy costs
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Low 
<!-- PJG 007 0150 intable -->
2High
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Less than 2.5 
<!-- PJG 007 0104 intable -->
$21 
<!-- PJG 007 0104 intable -->
$30
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2.5 to 4.4 
<!-- PJG 007 0104 intable -->
5 
<!-- PJG 007 0104 intable -->
35
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4.5 to 6.4 
<!-- PJG 007 0104 intable -->
22 
<!-- PJG 007 0104 intable -->
34
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6.5 to 8.4 
<!-- PJG 007 0104 intable -->
31 
<!-- PJG 007 0104 intable -->
35
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8.5 to 10.4 
<!-- PJG 007 0104 intable -->
9 
<!-- PJG 007 0104 intable -->
37
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10.5 to 12.4 
<!-- PJG 007 0104 intable -->
38 
<!-- PJG 007 0104 intable -->
43
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12.5 to 14.4 
<!-- PJG 007 0104 intable -->
41 
<!-- PJG 007 0104 intable -->
46
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
14.5 to 16.4 
<!-- PJG 007 0104 intable -->
19 
<!-- PJG 007 0104 intable -->
19
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
16.5 and over 
<!-- PJG 007 0104 intable -->
37 
<!-- PJG 007 0104 intable -->
38
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
2. Yearly Cost Information: Estimates on the scale are based on a national average electric rate of 8.30&cent; per
kilowatt hour.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00020 </DOCNO>
<PARENT> FR940112-0-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix A2 to Part 305_Refrigerator-Freezers
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Range Information:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,tp0,i1,s40,8,8 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Manufacturer's rated total refrigerated volume in cubic feet 
<!-- PJG 007 0150 intable -->
1Ranges of estimated yearly energy costs 
<!-- PJG 007 0150 intable -->
2Low 
<!-- PJG 007 0150 intable -->
2High
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Less than 10.5 
<!-- PJG 007 0104 intable -->
$17 
<!-- PJG 007 0104 intable -->
58
<!-- PJG 0012 frnewline -->
10.5 to 12.4 
<!-- PJG 007 0104 intable -->
43 
<!-- PJG 007 0104 intable -->
65
<!-- PJG 0012 frnewline -->
12.5 to 14.4 
<!-- PJG 007 0104 intable -->
25 
<!-- PJG 007 0104 intable -->
71
<!-- PJG 0012 frnewline -->
14.5 to 16.4 
<!-- PJG 007 0104 intable -->
31 
<!-- PJG 007 0104 intable -->
73
<!-- PJG 0012 frnewline -->
16.5 to 18.4 
<!-- PJG 007 0104 intable -->
47 
<!-- PJG 007 0104 intable -->
87
<!-- PJG 0012 frnewline -->
18.5 to 20.4 
<!-- PJG 007 0104 intable -->
50 
<!-- PJG 007 0104 intable -->
108
<!-- PJG 0012 frnewline -->
20.5 to 22.4 
<!-- PJG 007 0104 intable -->
52 
<!-- PJG 007 0104 intable -->
106
<!-- PJG 0012 frnewline -->
22.5 to 24.4 
<!-- PJG 007 0104 intable -->
60 
<!-- PJG 007 0104 intable -->
122
<!-- PJG 0012 frnewline -->
24.5 to 26.4 
<!-- PJG 007 0104 intable -->
61 
<!-- PJG 007 0104 intable -->
116
<!-- PJG 0012 frnewline -->
26.5 to 28.4 
<!-- PJG 007 0104 intable -->
71 
<!-- PJG 007 0104 intable -->
129
<!-- PJG 0012 frnewline -->
28.5 and over 
<!-- PJG 007 0104 intable -->
73 
<!-- PJG 007 0104 intable -->
122
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
2. Yearly Cost Information: Estimates on the scale are based on a national average electric rate of 8.30
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=7 f=2 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 per kilowatt hour.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00021 </DOCNO>
<PARENT> FR940112-0-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix B to Part 305_Freezers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Range Information
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,tp0,i1,s25,8,8 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Manufacturer's rated total refrigerated volume in cubic feet
<!-- PJG 007 0150 intable -->
1Ranges of estimated yearly energy costs
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Low
<!-- PJG 007 0150 intable -->
2High
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Less than 5.5
<!-- PJG 007 0104 intable -->
$14
<!-- PJG 007 0104 intable -->
$42
<!-- PJG 0012 frnewline -->
5.5 to 7.4
<!-- PJG 007 0104 intable -->
23
<!-- PJG 007 0104 intable -->
34
<!-- PJG 0012 frnewline -->
7.5 to 9.4
<!-- PJG 007 0104 intable -->
25
<!-- PJG 007 0104 intable -->
46
<!-- PJG 0012 frnewline -->
9.5 to 11.4
<!-- PJG 007 0104 intable -->
29
<!-- PJG 007 0104 intable -->
52
<!-- PJG 0012 frnewline -->
11.5 to 13.4
<!-- PJG 007 0104 intable -->
32
<!-- PJG 007 0104 intable -->
80
<!-- PJG 0012 frnewline -->
13.5 to 15.4
<!-- PJG 007 0104 intable -->
35
<!-- PJG 007 0104 intable -->
83
<!-- PJG 0012 frnewline -->
15.5 to 17.4
<!-- PJG 007 0104 intable -->
44
<!-- PJG 007 0104 intable -->
72
<!-- PJG 0012 frnewline -->
17.5 to 19.4
<!-- PJG 007 0104 intable -->
39
<!-- PJG 007 0104 intable -->
92
<!-- PJG 0012 frnewline -->
19.5 to 21.4
<!-- PJG 007 0104 intable -->
42
<!-- PJG 007 0104 intable -->
74
<!-- PJG 0012 frnewline -->
21.5 to 23.4
<!-- PJG 007 0104 intable -->
45
<!-- PJG 007 0104 intable -->
46
<!-- PJG 0012 frnewline -->
23.5 to 25.4
<!-- PJG 007 0104 intable -->
47
<!-- PJG 007 0104 intable -->
47
<!-- PJG 0012 frnewline -->
25.5 to 27.4
<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 0012 frnewline -->
27.5 to 29.4
<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 0012 frnewline -->
29.5 and over
<!-- PJG 007 0104 intable -->
140
<!-- PJG 007 0104 intable -->
223
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
1No data submitted.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
2. Yearly Cost Information: Estimates on the scale are based on a national average electric rate of 8.30
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=7 f=2 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 per kilowatt hour.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By direction of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;747 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00022 </DOCNO>
<PARENT> FR940112-0-00012 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>16 CFR Part 305</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 3084&hyph;AA26</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Rule Concerning Disclosures of Energy Consumption and Water Use Information About Certain Home Appliances and Other
Products Required Under the Energy Policy and Conservation Act
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Under the Energy and Water Use Rule, each required label on a covered appliance must show a range, or scale, indicating
the range of energy costs or efficiencies for all models of a size or capacity comparable to the labeled model. This
notice publishes the new range figures, which, under &sect;&sect;305.10, 305.11 and 305.14 of the rule must be used
on labels on dishwashers manufactured on and after April 12, 1994, and in advertising of dishwashers beginning April
12, 1994. Properly labeled dishwashers manufactured prior to the effective date need not be relabeled. Catalogs
printed prior to the effective date in accordance with 16 CFR 305.14 need not be revised.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
April 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
James Mills, Attorney, 202&hyph;326&hyph;3035, Division of Enforcement, Federal Trade Commission, Washington,
DC 20580.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Section 324 of the Energy Policy and Conservation Act of 1975 (EPCA)
<FOOTCITE>1</FOOTCITE>
 requires the Federal Trade Commission to consider labeling rules for the disclosure of estimated annual energy cost
or alternative energy consumption information for at least thirteen categories of appliances. Dishwashers are
included as one of the categories. Before these labeling requirements may be prescribed, the statute requires the
Department of Energy (``DOE'') to develop test procedures that measure how much energy the appliances use. In addition,
DOE is required to determine the representative average cost a customer pays for the different types of energy available.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
42 U.S.C. 6294.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On November 19, 1979, the Commission issued a final rule
<FOOTCITE>2</FOOTCITE>
 covering seven of the thirteen appliance categories, including dishwashers. The rule requires that energy costs
and related information be disclosed on labels and in retail sales catalogs for all dishwashers presently manufactured.
Certain point-of-sale promotional materials must disclose the availability of energy usage information. If a dishwasher
is advertised in a catalog from which it may be purchased by cash, charge account or credit terms, then on each page of
the catalog that lists the product shall be included the range of estimated annual energy costs for the product. The
required disclosures and all claims concerning energy consumption made in writing or in broadcast advertisements
must be based on the results of the DOE test procedures.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
44 FR 66466. On December 10, 1987 (52 FR 46888), the Commission amended the Appliance Labeling Rule by extending coverage
to include central air conditioners and heat pumps. On October 25, 1993 (58 FR 54955), the Commission extended the
Rule's coverage to include certain plumbing products (showerheads, faucets, water closets and urinals).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 305.8(b) of the rule requires manufacturers, after filing an initial report, to report annually by specified
dates for each product type.
<FOOTCITE>3</FOOTCITE>
 The data submitted by manufacturers are based, in part, on the representative average unit cost of the type of energy
used to run the appliances tested. According to &sect;305.9 of the rule, these average energy costs, which are provided
by DOE, will be periodically revised by the Commission, but not more often than annually. Because the costs for the
various types of energy change yearly, and because manufacturers regularly add new models to their lines, improve
existing models and drop others, the data base from which the ranges of comparability are calculated is constantly
changing. To keep the required information in line with these changes, the Commission is empowered, under &sect;305.10
of the rule, to publish new ranges (but not more often than annually) if an analysis of the new data indicates that the
upper or lower limits of the ranges have changed by more than 15%.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Reports for dishwashers are due by June 1.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The new figures for the estimated annual costs of operation for dishwashers, which were calculated using the 1993
representative average energy costs published by DOE on January 5, 1993,
<FOOTCITE>4</FOOTCITE>
 have been submitted and have been analyzed by the Commission. New ranges based upon them are herewith published. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
58 FR 345. The Commission published these figures on January 25, 1993, at 58 FR 5925. The cost for electricity was published
as 8.30 cents per kilowatt-hour; for natural gas: 59.46 cents per therm; for propane: 73 cents per gallon; for No. 2
heating oil: $1.00 per gallon.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Commission amends appendix C of its Energy and Water Use Rule by publishing
the following ranges of comparability for use in the labeling and advertising of dishwashers beginning April 12,
1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 16 CFR Part 305
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Advertising, Energy conservation, Household appliances, Labeling, Reporting and recordkeeping requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, 16 CFR part 305 is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 305_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 305 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 42 U.S.C. 6294.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In appendix C, Paragraph 1 and the introductory text in Paragraph 2 are revised to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendices to Part 305
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Appendix C to Part 305_Dishwashers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
1. Range Information:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 ``Compact'' includes countertop dishwasher models with a capacity of fewer than eight (8) place settings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
``Standard'' includes portable or built-in dishwasher models with a capacity of eight (8) or more place settings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Place settings shall conform to AHAM Specification DW&hyph;1 for chinaware, flatware and serving pieces. Load patterns
shall conform to the operating normal for the model being tested. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 5,L2,tp0,i1,s100,6,6,6,6  -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Ranges of comparability
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Ranges of estimated yearly energy costs
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Electrically heated water
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
3Low
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
3High
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
2Natural gas heated water
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
3Low
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
3High
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Compact
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
(1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
$39.00
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
$89.00
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
$21.00
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
$47.00
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
1No data submitted.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
2. Yearly Cost Information:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Estimates on the scales are based on national average electric rate of 8.30&cent; per kilowatt hour, a national average
natural gas rate of 59.46&cent; per therm, and 6.2 loads of dishes per week.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;748 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00023 </DOCNO>
<PARENT> FR940112-0-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF ENERGY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Energy Regulatory Commission</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>18 CFR Part 385 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RM94&hyph;8&hyph;000] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Revision of the Regulations Governing 
<!-- PJG 0012 frnewline -->
Commission Review of Department of Energy Remedial Orders 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued January 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Energy Regulatory Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Federal Energy Regulatory Commission (Commission) is revising its regulations governing Commission review
of contested Department of Energy remedial orders. The Commission is removing as not necessary the requirement that
the presiding officer submit a revised proposed order to the Commission at the same time as he or she certifies and files
with the Secretary the record in the proceeding and copies of written comments by the parties. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The final rule is effective on January 4, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Julia Lake White, Office of the General Counsel, Federal Energy Regulatory Commission, 825 North Capitol Street,
NE., Washington, DC 20426, (202) 208&hyph;0457.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In addition to publishing the full text of this document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, the Commission also provides all interested persons an opportunity to inspect or copy the contents of this document
during normal business hours in room 3104, 941 North Capitol Street NE., Washington, DC 20426.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission Issuance Posting System (CIPS), an electronic bulletin board service, provides access to the texts
of formal documents issued by the Commission. CIPS is available at no charge to the user and may be accessed using a personal
computer with a modem by dialing (202) 208&hyph;1397. To access CIPS, set your communications software to use 300,
1200, or 2400 bps, full duplex, no parity, 8 data bits, and 1 stop bit. CIPS can also be accessed at 9600 bps by dialing
(202) 208&hyph;1781. The full text of this document will be available on CIPS for 30 days from the date of issuance.
The complete text on diskette in Wordperfect format may also be purchased from the Commission's copy contractor,
La Dorn Systems Corporation, also located in room 3104, 941 North Capitol Street NE., Washington, DC 20426. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Energy Regulatory Commission (Commission) is revising its regulations in part 385 governing Commission
review of contested Department of Energy (DOE) remedial orders. The Commission is removing the requirement that
the presiding officer submit a revised proposed order to the Commission at the same time as he or she certifies and files
with the Secretary the record in the proceeding and copies of written comments by the parties. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Background and Discussion 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission reviews contested DOE remedial orders pursuant to section 503(c) of the Department of Energy Organization
Act (DOE Act).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Under the current Rules of Practice and Procedure, the Commission Administrative Law Judge (ALJ) who presides over
a remedial order proceeding issues a public decision and proposed order following the hearing in the matter. The parties
then have an opportunity to file comments and reply comments. The ALJ receives the comments and certifies the record
to the Commission. In addition, the Judge also submits to the Commission a nonpublic ``revised proposed order.''
The revised proposed order is not part of the record of the proceeding. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See 42 U.S.C. 7193(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00024 </DOCNO>
<PARENT> FR940112-0-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission is eliminating the requirement in 
<!-- PJG 0012 frnewline -->
&sect;385.913(d) of the Commission's regulations that ALJs submit a revised proposed order. This action will expedite
the appeal process by removing an unnecessary, duplicative step in remedial order proceedings. Since the Commission
now finds that revised proposed orders are not necessary, draft orders that have already been submitted by ALJs to
the Commission in pending and recently completed remedial order cases will be placed in the public docket of each proceeding.
Parties do not have any additional procedural rights or opportunities by virtue of the inclusion of these draft orders
in the public docket. Under the Commission's Rules of Practice and Procedure in remedial order cases, the parties
already enjoy ample opportunities to present their positions fully before the Commission.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Apart from the procedural opportunities available to parties before DOE, once a matter is appealed to the Commission,
the petitioner files a detailed answer to the RO; the petitioner, DOE and intervenors may seek discovery and permission
to raise new facts or issues not raised before DOE. The parties then have an opportunity to file briefs (Rule 906); to
obtain a hearing including an opportunity for the submission of oral or documentary evidence and oral argument (and
to ask the ALJ's permission for cross-examination) (Rule 909); and to file with the ALJ proposed findings of fact and
conclusions of law and replies to these pleadings. Finally, after the ALJ has issued a decision and proposed order,
the parties may file written comments and reply comments on the ALJ's decision. (Rule 913) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Regulatory Flexibility Certification 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Regulatory Flexibility Act of 1980 (RFA)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 generally requires a description and analysis of final rules that will have a significant economic impact on a substantial
number of small entities.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Pursuant to section 605(b) of the RFA, the Commission hereby certifies that this rule will not have a significant economic
impact on a substantial number of small entities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5 U.S.C. 601&hyph;602. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section 601(c) of the RFA defines a ``small entity'' as a 
<!-- PJG 0012 frnewline -->
small business, a small not-for-profit enterprise, or a small governmental jurisdiction. A ``small business''
is defined by reference to section 3 of the Small Business Act as an enterprise which is ``independently owned and 
<!-- PJG 0012 frnewline -->
operated and which is not dominant in its field of operation.'' 15 U.S.C. 632(a). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Environmental Statement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Issuance of this rule will not represent a major federal action having a significant adverse effect on the human environment
under the Commission's regulations implementing the National Environmental Policy Act.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This rule is procedural and falls within the categorical exemptions provided in the Commission's regulations. Neither
an environmental impact statement nor an environmental assessment is required.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See Order No. 486, 52 FR 47897 (Dec. 17, 1987), FERC 
<!-- PJG 0012 frnewline -->
Stats. &amp; Regs., Regulations Preambles 1986&hyph;1990, 
<!-- PJG 0012 frnewline -->
&para;30,783 (Dec. 10, 1987) (codified at 18 CFR part 380). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See 18 CFR 380.4(a)(1). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Information Collection Statement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Office of Management and Budget (OMB) regulations require that OMB approve certain information collection requirements
imposed by agency rule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This rule contains no information collection requirements and is not subject to OMB approval. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5 CFR part 1320. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VI. Administrative Findings and Effective Date 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This final rule is a rule of agency organization and procedure that does not alter any substantive rights or interests,
but merely deletes a nonpublic, revised proposed order in remedial order proceedings that is unnecessary and duplicative
in Commission deliberations. Prior notice and comment under section 4 of the Administrative Procedure Act are therefore

<!-- PJG 0012 frnewline -->
unnecessary.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The Commission finds good cause to make this rule effective immediately upon issuance. This rule, therefore, is effective
January 4, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5 U.S.C. 553(b). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 18 CFR Part 385 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Administrative practice and procedure, Electric power, 
<!-- PJG 0012 frnewline -->
Penalties, Pipelines, Reporting and recordkeeping requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Commission is amending part 385, chapter I, title 18, Code of Federal Regulations,
as set forth below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 385_RULES OF PRACTICE AND PROCEDURE 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 385 continues to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 5 U.S.C. 551&hyph;557; 15 U.S.C. 717&hyph;717w, 3301&hyph;3432; 16 U.S.C. 791a&hyph;825r, 2601&hyph;2645; 31
U.S.C. 9701; 42 U.S.C. 7101&hyph;7352; 49 U.S.C. 1&hyph;27.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;385.913, paragraph (d) is revised to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;385.913
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Proposed order (Rule 913). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
 * * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) The presiding officer will certify and file with the Secretary of the Commission a copy of the record in the proceedings
and copies of the written and reply comments filed pursuant to paragraphs (b) and (c) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
 * * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;681 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00025 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Social Security Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>20 CFR Parts 404 and 416 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 0960&hyph;AC88 </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Federal Old-Age, Survivors, and Disability Insurance and Supplemental Security Income for the Aged, Blind, and
Disabled; Standards Applicable in Certain Determinations of Good Cause, Fault, and Good Faith 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Social Security Administration, HHS. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 These final regulations amend the existing 
<!-- PJG 0012 frnewline -->
regulations to reflect the provisions of section 10305 of the Omnibus Budget Reconciliation Act of 1989 (OBRA 1989).

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 10305 requires that the Secretary of Health and Human Services (the Secretary), in making certain determinations
of good cause, without fault, and good faith under title II of the Social Security Act (the Act), take into account any
physical, mental, educational, or linguistic limitations (including any lack of facility with the English language)
the individual has. 
<!-- PJG 0012 frnewline -->
In addition, section 10305 amended title XVI of the Act to require that the Secretary take these limitations into account
in determining with respect to an individual's eligibility for title XVI benefits, whether the individual acted
in good faith or was without fault, and in determining fraud, deception, or intent. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 These final regulations are effective January 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Philip Berge, Legal Assistant, 3&hyph;B&hyph;1 Operations Building, 6401 Security Boulevard, Baltimore, MD 21235
(410) 965&hyph;1769. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On October 30, 1991, we published a notice of proposed rulemaking (NPRM) at 56 FR 55848. We received comments from a
nonprofit public interest law center and a national nonprofit organization. Both organizations represent people
who are hearing impaired and both strongly supported the proposed rule and urged its adoption. The final rule, with
the exception of several technical changes we have made and which we discuss below, is the same as the NPRM. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Sections 10305 (a), (b), (c), and (d) of OBRA 1989 amended sections 203(l), 204(b), 223(f), and 223(g)(2)(B) of title
II of the Act, respectively, to require that the Secretary, in making certain determinations and decisions of good
cause, fault, and good faith under the respective sections of the Act, take into account any physical, mental, educational,
or linguistic limitations (including any lack of facility with the English language) the individual has. In addition,
section 10305(e) of OBRA 1989 amended section 1631(c)(1) of title XVI of the Act to require that the Secretary take
these limitations into account in determining with respect to the eligibility of an individual for benefits under
title XVI, whether the individual acted in good faith or was without fault, and in determining fraud, deception, or
intent. The Conference Committee Report on OBRA 1989 indicates that the Congress intended that the amendment to section
1631(c)(1) of the Act would apply to provisions of title XVI that are similar to the title II provisions amended by sections
10305 (a) through (d). (H.R. Rep. No. 386, 101st Cong., 1st Sess. 708 (1989).) The amendments made by section 10305
are effective for determinations or decisions made after June 30, 1990. 
<!-- PJG 0012 frnewline -->
Generally, it has been our policy to take into account the limitations described in section 10305 in making determinations
or decisions of good cause, without fault, or good faith (or determinations or decisions concerning fraudulent or
similar intent) with respect to the rights and duties of applicants and beneficiaries under the title II and title
XVI programs. However, our existing regulations were not explicit in this respect. Therefore, we are revising our
regulations under the title II and title XVI programs to reflect explicitly the amendments to the Act made by section
10305 of OBRA 1989. The changes to the regulations make it clear that we will take into account any physical, mental,
educational, or linguistic limitations of an individual (including any lack of facility with the English language)
in making a determination of good cause, without fault, or good faith, as appropriate, under section 203(l), 204(b),
223(f), or 223(g)(2)(B) of the Act (as required by the amendments made by sections 10305 (a) through (d)), and in determining
with respect to an individual's eligibility for benefits under title XVI of the Act, whether such individual acted
in good faith or was without fault, and in determining fraud, deception, or intent (as required under the amendment
made to section 1631(c)(1) of the Act by section 10305(e)). Also, in keeping with the intent of Congress and in the interest
of consistency, we are amending certain provisions of the title II regulations to provide expressly for the consideration
of the limitations described in section 10305 in making certain determinations and decisions under the title II program
which relate to good cause or fraudulent intent and which are not covered expressly by the amendments under sections
10305 (a) through (d) of OBRA 1989. The changes we are making are discussed below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00026 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
&bull;Good Cause for Failure to Make Timely Reports 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Generally, in certain cases described in section 203 of the Act, a title II beneficiary who (1) Works for more than 45
hours during a month in noncovered employment outside the United States, (2) ceases to have a child in his or her care,
or (3) has earnings in excess of the annual exempt amount under the earnings test, is subject to a penalty (in the form
of benefit deductions) if he or she fails to report these facts to us within a specified time. However, under section
203(l) of the Act, a penalty does not apply if the individual can demonstrate to the satisfaction of the Secretary that
he or she has good cause for failing to make a timely report. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 10305(a) of OBRA 1989 amended section 203(l) to provide that the Secretary, in making determinations and
decisions of good cause, must take into account any physical, mental, educational, or linguistic limitations (including
any lack of facility with the English language) the individual has. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 404.454 is the regulation which implements section 203(l). Accordingly, we are amending &sect;404.454(a)
to provide that in making determinations and decisions of good cause for failure to make timely reports, we will take
into account any physical, mental, educational, or linguistic limitations (including any lack of facility with
the English language) the individual has. In addition, we are adding a new paragraph, (a)(9), to &sect;404.454 to
illustrate that good cause may be found where failure to file a timely report was due, for example, to a failure on the
part of the individual to understand reporting responsibilities due to his or her physical, mental, educational,
or linguistic limitation(s). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under section 1631(e)(2) of the Act, an individual who is required under rules prescribed by the Secretary to make
a timely report of circumstances affecting eligibility for, or the amount of, title XVI benefits is subject to a penalty
(in the form of benefit deductions) if the individual fails to make the required report on time. However, the penalty
under section 1631(e)(2) does not apply if the individual is without fault or has good cause for not reporting timely.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 416.732 of our current regulations explains how we determine whether an individual has good cause for failure
to make a timely report for purposes of section 1631(e)(2). We are adding a new paragraph to &sect;416.732 to provide
that we will take into account any physical, mental, educational, or linguistic limitations (including any lack
of facility with the English language) the individual has in making determinations and decisions of good cause for
failure to make timely reports. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00027 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
&bull;Fraudulent Behavior or Failure To Cooperate or To Take 
<!-- PJG 0012 frnewline -->
Any Required Action in Disability Determinations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under sections 223(f) and 1614(a)(4) of the Act, title II or 
<!-- PJG 0012 frnewline -->
title XVI disability benefits may be terminated if a prior 
<!-- PJG 0012 frnewline -->
favorable determination of disability was fraudulently obtained 
<!-- PJG 0012 frnewline -->
or if the beneficiary fails, without good cause, to cooperate 
<!-- PJG 0012 frnewline -->
with the Secretary in reviewing his or her entitlement or to 
<!-- PJG 0012 frnewline -->
follow prescribed treatment which is expected to restore his or 
<!-- PJG 0012 frnewline -->
her ability to work. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 10305(c) of OBRA 1989 amended section 223(f) of the 
<!-- PJG 0012 frnewline -->
Act to provide that in making, for purposes of section 223(f), 
<!-- PJG 0012 frnewline -->
any determination or decision relating to fraudulent behavior by 
<!-- PJG 0012 frnewline -->
any individual or failure by any individual without good cause to 
<!-- PJG 0012 frnewline -->
cooperate or to take any required action, the Secretary shall 
<!-- PJG 0012 frnewline -->
take into account any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) the individual may have. In addition, with 
<!-- PJG 0012 frnewline -->
respect to making similar determinations and decisions for 
<!-- PJG 0012 frnewline -->
purposes of section 1614(a)(4) of the Act, section 1631(c)(1) of 
<!-- PJG 0012 frnewline -->
title XVI of the Act, as amended by OBRA 1989, requires the 
<!-- PJG 0012 frnewline -->
Secretary to take these limitations into account in determining 
<!-- PJG 0012 frnewline -->
whether an individual acted in good faith or was at fault, and in 
<!-- PJG 0012 frnewline -->
determining fraud, deception, or intent. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sections 404.1518, 404.1530, 404.1579, 404.1594, 416.918, 
<!-- PJG 0012 frnewline -->
416.930, 416.994 and 416.994a reflect the pertinent provisions of 
<!-- PJG 0012 frnewline -->
sections 223(f) and 1614(a)(4) of the Act. We are making the 
<!-- PJG 0012 frnewline -->
following changes in these regulations: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Amend &sect;&sect;404.1518 and 416.918 to provide that we will take 
<!-- PJG 0012 frnewline -->
into account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) the individual has when determining if the individual 
<!-- PJG 0012 frnewline -->
has a good reason for failing to attend a consultative 
<!-- PJG 0012 frnewline -->
examination which we have arranged for the individual. These 
<!-- PJG 0012 frnewline -->
specific amendments were not included in the NPRM. Current 
<!-- PJG 0012 frnewline -->
&sect;&sect;404.1518 and 416.918 provide that we may determine that an 
<!-- PJG 0012 frnewline -->
individual who is applying for benefits based on disability or 
<!-- PJG 0012 frnewline -->
blindness is not disabled or blind, or that an individual who is 
<!-- PJG 0012 frnewline -->
entitled to or eligible for benefits based on disability or 
<!-- PJG 0012 frnewline -->
blindness is no longer disabled or blind, if we find that the 
<!-- PJG 0012 frnewline -->
individual failed or refused to attend a consultative examination 
<!-- PJG 0012 frnewline -->
without a good reason. While &sect;&sect;404.1518 and 416.918 provide 
<!-- PJG 0012 frnewline -->
rules for determining whether an individual has a good reason for 
<!-- PJG 0012 frnewline -->
such failure or refusal and, thus, are within the scope of the 
<!-- PJG 0012 frnewline -->
amendments to sections 223(f) and 1631(c)(1) of the Act, we 
<!-- PJG 0012 frnewline -->
inadvertently failed to include these regulations when we 
<!-- PJG 0012 frnewline -->
developed the proposed regulations to implement section 10305 of 
<!-- PJG 0012 frnewline -->
OBRA 1989. We are amending &sect;&sect;404.1518(a) and 416.918(a) in the 
<!-- PJG 0012 frnewline -->
final rule to make it clear that we will consider an individual's 
<!-- PJG 0012 frnewline -->
physical, mental, educational, and linguistic limitations 
<!-- PJG 0012 frnewline -->
(including any lack of facility with the English language) in 
<!-- PJG 0012 frnewline -->
determining whether the individual has a good reason for failing 
<!-- PJG 0012 frnewline -->
to attend a consultative examination. In connection with this 
<!-- PJG 0012 frnewline -->
change, we also are making related changes, which were not in the 
<!-- PJG 0012 frnewline -->
NPRM, to &sect;&sect;404.1579(e)(2), 404.1586(d), 404.1594(e)(2), 
<!-- PJG 0012 frnewline -->
416.986(c), 416.994(b)(4)(ii) and 416.994a(g)(2) to include in 
<!-- PJG 0012 frnewline -->
these sections a cross-reference to &sect;404.1518 or &sect;416.918, as 
<!-- PJG 0012 frnewline -->
appropriate, to clarify that &sect;&sect;404.1518 and 416.918 provide the 
<!-- PJG 0012 frnewline -->
rules for determining whether an individual has a good reason for 
<!-- PJG 0012 frnewline -->
not attending a consultative examination. Current 
<!-- PJG 0012 frnewline -->
&sect;416.994a(g)(2) already contains such a cross-reference. 
<!-- PJG 0012 frnewline -->
&bull;Amend &sect;&sect;404.1530(c) and 416.930(c) to provide that we will 
<!-- PJG 0012 frnewline -->
take into account any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) the individual has when deciding if the 
<!-- PJG 0012 frnewline -->
individual has acceptable reasons for failure to follow 
<!-- PJG 0012 frnewline -->
prescribed treatment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Amend &sect;&sect;404.1579 (e)(1) and (e)(2), 404.1594 (e)(1) and 
<!-- PJG 0012 frnewline -->
(e)(2), 416.994 (b)(4)(i) and (b)(4)(ii) and 416.994a (g)(1) and 
<!-- PJG 0012 frnewline -->
(g)(2) to indicate that we will take into account any physical, 
<!-- PJG 0012 frnewline -->
mental, educational, or linguistic limitations (including any 
<!-- PJG 0012 frnewline -->
lack of facility with the English language) the individual has in 
<!-- PJG 0012 frnewline -->
determining whether a prior favorable determination or decision 
<!-- PJG 0012 frnewline -->
was fraudulently obtained or in determining whether an individual 
<!-- PJG 0012 frnewline -->
has good cause for failure to supply evidence we ask for or to go 
<!-- PJG 0012 frnewline -->
for a physical or mental examination. The amendments to these 
<!-- PJG 0012 frnewline -->
sections of the regulations include certain technical changes 
<!-- PJG 0012 frnewline -->
that were not reflected in the NPRM. For the final rule, we are 
<!-- PJG 0012 frnewline -->
adding the phrase ``or decision'' to &sect;&sect;404.1579(e)(1), 
<!-- PJG 0012 frnewline -->
404.1594(e)(1), 416.994(b)(4)(i) and 416.994a(g)(1) to clarify 
<!-- PJG 0012 frnewline -->
that these provisions apply not only to determinations we make, 
<!-- PJG 0012 frnewline -->
but also to decisions we make. Section 416.994a(g)(1) already 
<!-- PJG 0012 frnewline -->
contains this language. Also, as discussed above, 
<!-- PJG 0012 frnewline -->
&sect;&sect;404.1579(e)(2), 404.1586(d), 404.1594(e)(2), 416.986(c), 
<!-- PJG 0012 frnewline -->
416.994(b)(4)(ii) and 416.994a(g)(2) of the final rule include a 
<!-- PJG 0012 frnewline -->
cross-reference to &sect;404.1518 or &sect;416.918, as appropriate, which 
<!-- PJG 0012 frnewline -->
provides rules for determining whether an individual has good 
<!-- PJG 0012 frnewline -->
cause for failing to attend a consultative examination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00028 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Consistent with the NPRM, the final changes to 
<!-- PJG 0012 frnewline -->
&sect;&sect;404.1579(e)(2), 404.1594(e)(2), 416.994(b)(4)(ii) and 
<!-- PJG 0012 frnewline -->
416.994a(g)(2) also explain that we will consider the factors 
<!-- PJG 0012 frnewline -->
described in &sect;&sect;404.911 and 416.1411 for purposes of determining 
<!-- PJG 0012 frnewline -->
generally whether an individual has good cause for failure to 
<!-- PJG 0012 frnewline -->
cooperate in a review of his or her entitlement to benefits based 
<!-- PJG 0012 frnewline -->
on disability. (Current &sect;&sect;404.911 and 416.1411 explain the 
<!-- PJG 0012 frnewline -->
factors we consider in determining whether an individual has good 
<!-- PJG 0012 frnewline -->
cause for missing a deadline to request review of a determination 
<!-- PJG 0012 frnewline -->
or decision under our administrative review process. As 
<!-- PJG 0012 frnewline -->
explained later in this preamble, we are amending &sect;&sect;404.911 and 
<!-- PJG 0012 frnewline -->
416.1411, which apply to title II and title XVI cases, 
<!-- PJG 0012 frnewline -->
respectively, to provide explicitly for the consideration of the 
<!-- PJG 0012 frnewline -->
limitations described in section 10305 of OBRA 1989 in 
<!-- PJG 0012 frnewline -->
determining whether an individual has good cause for missing a 
<!-- PJG 0012 frnewline -->
deadline to request review.) We are also revising 
<!-- PJG 0012 frnewline -->
&sect;&sect;404.1586(d) and 416.986(c) to clarify that we will 
<!-- PJG 0012 frnewline -->
consider the factors described in &sect;&sect;404.911 and 416.1411, 
<!-- PJG 0012 frnewline -->
respectively, for purposes of determining generally whether an 
<!-- PJG 0012 frnewline -->
individual has good cause for failure to cooperate in a review of 
<!-- PJG 0012 frnewline -->
his or her continuing entitlement to title II benefits, or 
<!-- PJG 0012 frnewline -->
continuing eligibility for title XVI benefits, based on 
<!-- PJG 0012 frnewline -->
blindness. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
&bull;Without Fault_Waiver of Adjustment or Recovery of 
<!-- PJG 0012 frnewline -->
Overpayments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under sections 204(b) and 1631(b)(1)(B) of the Act, 
<!-- PJG 0012 frnewline -->
recovery or adjustment of overpayments to a title II or title XVI 
<!-- PJG 0012 frnewline -->
beneficiary may be waived in situations where the individual is 
<!-- PJG 0012 frnewline -->
without fault in connection with the overpayment and recovery or 
<!-- PJG 0012 frnewline -->
adjustment would defeat the purposes of the program or would be 
<!-- PJG 0012 frnewline -->
against equity and good conscience or, with respect to the 
<!-- PJG 0012 frnewline -->
title XVI program, would impede efficient or effective 
<!-- PJG 0012 frnewline -->
administration of title XVI because of the small amount involved. 
<!-- PJG 0012 frnewline -->
Our existing regulations explain that in determining whether an 
<!-- PJG 0012 frnewline -->
individual was without fault, all pertinent factors surrounding 
<!-- PJG 0012 frnewline -->
the overpayment will be considered, including the individual's 
<!-- PJG 0012 frnewline -->
age, intelligence, education, and physical and mental 
<!-- PJG 0012 frnewline -->
capabilities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 10305(b) of OBRA 1989 amended section 204(b) of the 
<!-- PJG 0012 frnewline -->
Act to provide that the Secretary, in making determinations or 
<!-- PJG 0012 frnewline -->
decisions of ``without fault'' for purposes of section 204(b), must 
<!-- PJG 0012 frnewline -->
take into account any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) the individual has. In addition, the amendment 
<!-- PJG 0012 frnewline -->
to section 1631(c)(1) of the Act made by section 10305(e) of OBRA 
<!-- PJG 0012 frnewline -->
1989 provides that, for the purposes of the title XVI program, 
<!-- PJG 0012 frnewline -->
the Secretary must take these same limitations into account in 
<!-- PJG 0012 frnewline -->
determining, among other things, whether an individual is without 
<!-- PJG 0012 frnewline -->
fault. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We are making the following changes in our regulations which 
<!-- PJG 0012 frnewline -->
implement sections 204(b) and 1631(b)(1)(B) of the Act to reflect 
<!-- PJG 0012 frnewline -->
the pertinent amendments made by section 10305. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Amend &sect;404.507 to provide that in making 
<!-- PJG 0012 frnewline -->
determinations of without fault with respect to title II 
<!-- PJG 0012 frnewline -->
overpayments, we will take into account any physical, mental, 
<!-- PJG 0012 frnewline -->
educational, or linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) the individual has. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00029 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;Amend &sect;404.510 to provide that in determining whether an 
<!-- PJG 0012 frnewline -->
individual is without fault with respect to a title II deduction 
<!-- PJG 0012 frnewline -->
overpayment, we will consider all pertinent circumstances, 
<!-- PJG 0012 frnewline -->
including an individual's age and intelligence and any physical, 
<!-- PJG 0012 frnewline -->
mental, educational, or linguistic limitations of the individual 
<!-- PJG 0012 frnewline -->
(including any lack of facility with the English language). In 
<!-- PJG 0012 frnewline -->
addition, to eliminate any ambiguity with respect to the 
<!-- PJG 0012 frnewline -->
application of the amendment to section 204(b) of the Act made by 
<!-- PJG 0012 frnewline -->
section 10305(b) of OBRA 1989 in cases involving title II 
<!-- PJG 0012 frnewline -->
deduction overpayments, the changes to &sect;404.510 will: 
<!-- PJG 0012 frnewline -->
(1) clarify that the situations described in &sect;404.510 in which 
<!-- PJG 0012 frnewline -->
an individual will be considered without fault in connection with 
<!-- PJG 0012 frnewline -->
a deduction overpayment are not all-inclusive; and (2) eliminate 
<!-- PJG 0012 frnewline -->
the provision in paragraph (n) of &sect;404.510 which requires that 
<!-- PJG 0012 frnewline -->
for an individual to be considered without fault with respect to 
<!-- PJG 0012 frnewline -->
a deduction overpayment in certain circumstances described in 
<!-- PJG 0012 frnewline -->
paragraph (n), such individual must have made a bona fide attempt 
<!-- PJG 0012 frnewline -->
to restrict his or her annual earnings or otherwise comply with 
<!-- PJG 0012 frnewline -->
the deduction provisions of the Act. 
<!-- PJG 0012 frnewline -->
&bull;Amend &sect;404.511(b) to show that the Social Security 
<!-- PJG 0012 frnewline -->
Administration generally will not find an individual to be 
<!-- PJG 0012 frnewline -->
without fault when, after having been exonerated for a title II 
<!-- PJG 0012 frnewline -->
``deduction overpayment'' and after having been advised of the 
<!-- PJG 0012 frnewline -->
correct interpretation of the deduction provision, the individual 
<!-- PJG 0012 frnewline -->
incurs another ``deduction overpayment'' under the same 
<!-- PJG 0012 frnewline -->
circumstances as the first overpayment. The change to 
<!-- PJG 0012 frnewline -->
&sect;404.511(b) also explains that in determining ``without fault'' 
<!-- PJG 0012 frnewline -->
under such circumstances, however, any physical, mental, 
<!-- PJG 0012 frnewline -->
educational, or linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) the individual has will be 
<!-- PJG 0012 frnewline -->
taken into consideration. 
<!-- PJG 0012 frnewline -->
&bull;Amend &sect;416.552 to provide that we will take into account 
<!-- PJG 0012 frnewline -->
any physical, mental, educational, or linguistic limitations 
<!-- PJG 0012 frnewline -->
(including any lack of facility with the English language) the 
<!-- PJG 0012 frnewline -->
individual has in determining whether the individual is without 
<!-- PJG 0012 frnewline -->
fault for purposes of the waiver of adjustment or recovery of a 
<!-- PJG 0012 frnewline -->
title XVI overpayment. 
<!-- PJG 0012 frnewline -->
In general, under section 1631(b)(4) of the Act and the 
<!-- PJG 0012 frnewline -->
implementing regulation, &sect;416.556, if any title XVI overpayment 
<!-- PJG 0012 frnewline -->
is attributable solely to the ownership or possession by an 
<!-- PJG 0012 frnewline -->
individual (or by an individual and his or her spouse, if any) of 
<!-- PJG 0012 frnewline -->
countable resources having a value which exceeds, by $50 or less, 
<!-- PJG 0012 frnewline -->
the applicable limitation on resources specified in the Act and 
<!-- PJG 0012 frnewline -->
regulations, such individual (and spouse if any) will be deemed 
<!-- PJG 0012 frnewline -->
to have been without fault in connection with the overpayment, 
<!-- PJG 0012 frnewline -->
and waiver of adjustment or recovery will be made, unless the 
<!-- PJG 0012 frnewline -->
failure to report the value of the excess resources correctly and 
<!-- PJG 0012 frnewline -->
in a timely manner was willful and knowing. Based on the 
<!-- PJG 0012 frnewline -->
amendment to section 1631(c)(1) of the Act made by 
<!-- PJG 0012 frnewline -->
section 10305(e) of OBRA of 1989, we are amending &sect;416.556(b) to 
<!-- PJG 0012 frnewline -->
provide that in determining whether failure to report the excess 
<!-- PJG 0012 frnewline -->
resources correctly and in a timely manner was willful and 
<!-- PJG 0012 frnewline -->
knowing, and, thus, whether the individual was at fault, we will 
<!-- PJG 0012 frnewline -->
take into account any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) the individual has. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
&bull;Good Faith_Waiver of Recovery of Overpayments_Continuation 
<!-- PJG 0012 frnewline -->
of Disability Benefits Pending Appeal 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under sections 223(g) and 1631(a)(7) of the Act and the 
<!-- PJG 0012 frnewline -->
implementing regulations at &sect;&sect;404.1597a and 416.996, a title II 
<!-- PJG 0012 frnewline -->
or title XVI beneficiary receiving benefits based on disability 
<!-- PJG 0012 frnewline -->
whom the Secretary determines is no longer disabled based on 
<!-- PJG 0012 frnewline -->
medical factors has the option of having his or her benefits 
<!-- PJG 0012 frnewline -->
continued through a hearing before an administrative law judge 
<!-- PJG 0012 frnewline -->
(ALJ). Benefits paid during this period are considered 
<!-- PJG 0012 frnewline -->
overpayments if the beneficiary loses the appeal. However, if 
<!-- PJG 0012 frnewline -->
the beneficiary acted in good faith in pursuing the appeal, 
<!-- PJG 0012 frnewline -->
repayment can be waived (sections 223(g)(2)(B) and 
<!-- PJG 0012 frnewline -->
1631(a)(7)(B)(ii) of the Act and 404.1597a(j) and 416.996(g) of 
<!-- PJG 0012 frnewline -->
our regulations). Our regulations establish a presumption that 
<!-- PJG 0012 frnewline -->
appeals are made in good faith unless the beneficiary fails, 
<!-- PJG 0012 frnewline -->
without good cause, to cooperate during the appeal. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00030 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 10305(d) of OBRA 1989 amended section 223(g)(2)(B) 
<!-- PJG 0012 frnewline -->
of the Act to require that the Secretary take into account any 
<!-- PJG 0012 frnewline -->
physical, mental, educational, or linguistic limitations an 
<!-- PJG 0012 frnewline -->
individual may have (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) in determining whether an individual's appeal 
<!-- PJG 0012 frnewline -->
is made in good faith. 
<!-- PJG 0012 frnewline -->
Based on this amendment and the amendment to title XVI of 
<!-- PJG 0012 frnewline -->
the Act made by section 10305(e) of OBRA 1989, we are amending 
<!-- PJG 0012 frnewline -->
&sect;&sect;404.1597a(j)(3) and 416.996(g)(2) to provide that we will take 
<!-- PJG 0012 frnewline -->
into account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) the individual has in determining whether the 
<!-- PJG 0012 frnewline -->
individual acted in good faith in pursuing the appeal. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
&bull;Determinations of Good Cause or of Fraud or Similar 
<!-- PJG 0012 frnewline -->
Fault in Connection With the Administrative Review Process 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 10305(e) amended section 1631(c)(1) of the Act to 
<!-- PJG 0012 frnewline -->
provide that the Secretary shall specifically take into account 
<!-- PJG 0012 frnewline -->
any physical, mental, educational, or linguistic limitations of 
<!-- PJG 0012 frnewline -->
an individual (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) in determining, with respect to the eligibility of the 
<!-- PJG 0012 frnewline -->
individual for benefits under title XVI, whether the individual 
<!-- PJG 0012 frnewline -->
acted in good faith or was at fault, and in determining fraud, 
<!-- PJG 0012 frnewline -->
deception, or intent. 
<!-- PJG 0012 frnewline -->
The changes we are making in part 416 of the regulations in 
<!-- PJG 0012 frnewline -->
connection with the administrative review process are based on 
<!-- PJG 0012 frnewline -->
the amendment to section 1631(c)(1). We are making comparable 
<!-- PJG 0012 frnewline -->
changes in part 404 in the interest of consistency. 
<!-- PJG 0012 frnewline -->
Our current regulations provide that a determination or 
<!-- PJG 0012 frnewline -->
decision which we make about an individual's rights under title 
<!-- PJG 0012 frnewline -->
II or title XVI of the Act is generally final and binding unless 
<!-- PJG 0012 frnewline -->
the individual files a request for review of the determination or 
<!-- PJG 0012 frnewline -->
decision within a specified time period. However, the time 
<!-- PJG 0012 frnewline -->
period to request review will be extended if good cause can be 
<!-- PJG 0012 frnewline -->
established for missing the deadline to request review 
<!-- PJG 0012 frnewline -->
(&sect;&sect;404.911 and 416.1411). Also, under our regulations, we may 
<!-- PJG 0012 frnewline -->
reopen a determination or decision at any time if it was obtained 
<!-- PJG 0012 frnewline -->
by fraud or similar fault (&sect;&sect;404.988(c)(1) and 416.1488(c)), or, 
<!-- PJG 0012 frnewline -->
in title II cases, if certain other circumstances exist 
<!-- PJG 0012 frnewline -->
(&sect;404.988(c)). 
<!-- PJG 0012 frnewline -->
Under our regulations, a request for a hearing before an ALJ 
<!-- PJG 0012 frnewline -->
may be dismissed if neither the person requesting the hearing nor 
<!-- PJG 0012 frnewline -->
his or her designated representative appears at the time and 
<!-- PJG 0012 frnewline -->
place set for the hearing. However, if good cause for failure to 
<!-- PJG 0012 frnewline -->
appear can be established, the hearing request will not be 
<!-- PJG 0012 frnewline -->
dismissed (&sect;&sect;404.957(b) and 416.1457(b)). 
<!-- PJG 0012 frnewline -->
We are making the following changes to &sect;&sect;404.911, 404.936, 
<!-- PJG 0012 frnewline -->
404.957, 404.988, 416.1411, 416.1436, 416.1457, and 416.1488 to 
<!-- PJG 0012 frnewline -->
reflect the consideration of the factors described in section 
<!-- PJG 0012 frnewline -->
10305 of OBRA 1989. 
<!-- PJG 0012 frnewline -->
&bull;Amend &sect;&sect;404.911(a) and (b)(9) and 416.1411(a) and (b)(9) to 
<!-- PJG 0012 frnewline -->
provide that in determining whether an individual had good cause 
<!-- PJG 0012 frnewline -->
for missing a deadline to request review, we will take into 
<!-- PJG 0012 frnewline -->
account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations of the individual (including any lack of facility 
<!-- PJG 0012 frnewline -->
with the English language) which may have prevented the 
<!-- PJG 0012 frnewline -->
individual from filing a timely request or from understanding or 
<!-- PJG 0012 frnewline -->
knowing about the need to file a timely request for review. 
<!-- PJG 0012 frnewline -->
&bull;Amend &sect;&sect;404.936 and 416.1436 to further describe 
<!-- PJG 0012 frnewline -->
circumstances which an individual, who will not be represented at 
<!-- PJG 0012 frnewline -->
a hearing before an ALJ, may give for requesting a change in the 
<!-- PJG 0012 frnewline -->
time or place of the hearing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Amend &sect;&sect;404.957(b) and 416.1457(b) to require that in 
<!-- PJG 0012 frnewline -->
making determinations of whether an individual had good cause for 
<!-- PJG 0012 frnewline -->
failure to appear for a hearing before an ALJ, we will take into 
<!-- PJG 0012 frnewline -->
account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) the individual has. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00031 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&bull;Amend &sect;&sect;404.988(c)(1) and 416.1488(c) to indicate that in determining whether a determination
or decision was obtained by fraud or similar fault for the purposes of reopening, we will take into account any physical,
mental, educational, or linguistic limitations (including any lack of facility with the English language) the individual
has. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Good Cause for Refusal To Accept Rehabilitation Services 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under sections 222(b) and 1615(c) of the Act and the implementing regulations at &sect;&sect;404.422 and 416.1328,
deductions may be imposed against title II benefits, or title XVI benefits may be suspended, if a disabled or blind
beneficiary refuses without good cause to accept certain rehabilitation services. If good cause can be established
for the refusal, benefits will not be affected. The final regulations amend the pertinent regulations relating to
good cause for refusal of rehabilitation services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The change we are making in part 416 of the regulations is based on the amendment to section 1631(c)(1) of the Act. We
are making a comparable change in part 404 in the interest of consistency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sections 404.422 and 416.1715 of our regulations discuss how we determine whether an individual has good cause for
refusing rehabilitation services. We are amending &sect;&sect;404.422(e) and 416.1715(a) to provide that in making
good cause determinations concerning the refusal of rehabilitation services, we will take into account any physical,
mental, educational, or linguistic limitations (including any lack of facility with the English language) the individual
has. We are also making a technical correction in a cross-reference contained in &sect;416.2203 to indicate that
``good cause'' for refusal of vocational rehabilitation services is defined in &sect;416.1715. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Good Reason for Not Applying for Other Benefits 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 1611(e)(2) of the Act requires that SSI applicants and beneficiaries apply for other benefits for which they
may be eligible within 30 days from the date the individual receives our notice about any other benefits for which the
individual is likely to be eligible. Our existing regulations &sect;&sect;416.210(e) and 416.1330(a) provide
that individuals are not eligible for SSI benefits if they do not apply for the other benefits when told to do so. However,
both &sect;&sect;416.210(e) and 416.1330(a) provide that the individual will not be found ineligible for SSI benefits
if the individual had good reason (&sect;416.210(e)) or good cause (&sect;416.1330(a)) for not applying for the
other benefits within the 30-day period or taking other necessary steps to obtain them. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We are amending &sect;416.210(e)(2) to provide that we will take into account any physical, mental, educational,
or linguistic limitations (including any lack of facility with the English language) the individual has in determining
good reason or good cause for not filing for other benefits. Since &sect;416.1330(a) refers to &sect;416.210(e),
we are not amending &sect;416.1330(a). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00032 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Regulatory Procedures
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Regulatory Flexibility Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We certify that these regulations will not have a significant economic impact on a substantial number of small entities
because these rules will affect only individuals and States. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therefore, a regulatory flexibility analysis as provided in Public Law 96&hyph;354, the Regulatory Flexibility
Act, is not required. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Paperwork Reduction Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These regulations impose no new reporting or recordkeeping requirements requiring Office of Management and Budget
clearance.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance Program Nos. 93.802 through 93.805 Social Security; and 93.807 Supplemental
Security Income) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
20 CFR Part 404 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Administrative practice and procedure; Death benefits; Disability benefits; Old-age, Survivors, and Disability
insurance; Reporting and recordkeeping requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
20 CFR Part 416 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Administrative practice and procedure; Aged; Blind; Disability benefits; Public assistance programs; Reporting
and recordkeeping requirements; Supplemental Security Income (SSI).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 3, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Shirley Chater,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Commissioner of Social Security.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Approved: January 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna E. Shalala,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary of Health and Human Services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00033 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For the reasons set out in the preamble, subparts E, F, J, and P 
<!-- PJG 0012 frnewline -->
of part 404 and subparts B, E, G, I, N, Q and V of part 416 of 20 
<!-- PJG 0012 frnewline -->
CFR chapter III are amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 404_FEDERAL OLD-AGE, SURVIVORS AND DISABILITY 
<!-- PJG 0012 frnewline -->
INSURANCE (1950&hyph;&blank;&blank;) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for subpart E continues to 
<!-- PJG 0012 frnewline -->
read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 202, 203, 204 (a) and (e), 205(a), 
<!-- PJG 0012 frnewline -->
222(b), 223(e), 224, 227, and 1102 of the Social Security Act; 
<!-- PJG 0012 frnewline -->
42 U.S.C. 402, 403, 404 (a) and (e), 405(a), 422(b), 423(e), 424, 
<!-- PJG 0012 frnewline -->
427, and 1302. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 404.422 is amended by adding two new 
<!-- PJG 0012 frnewline -->
sentences immediately before the second sentence of the 
<!-- PJG 0012 frnewline -->
introductory text of paragraph (e) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.422 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Deductions because of refusal to accept rehabilitation 
<!-- PJG 0012 frnewline -->
services. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(e)&blank;*&blank;*&blank;* In determining whether an individual has good cause 
<!-- PJG 0012 frnewline -->
for refusing rehabilitation services, we will take into account 
<!-- PJG 0012 frnewline -->
any physical, mental, educational, or linguistic limitations 
<!-- PJG 0012 frnewline -->
(including any lack of facility with the English language) the 
<!-- PJG 0012 frnewline -->
individual may have which may have caused the individual to 
<!-- PJG 0012 frnewline -->
refuse such services. We also consider other factors that may 
<!-- PJG 0012 frnewline -->
have caused an individual to refuse such services. *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. Section 404.454 is amended by revising the third and 
<!-- PJG 0012 frnewline -->
fourth sentences of the introductory text of paragraph (a), by 
<!-- PJG 0012 frnewline -->
removing the word ``or'' that follows the semicolon at the end of 
<!-- PJG 0012 frnewline -->
paragraph (a)(7), by removing the period at the end of paragraph 
<!-- PJG 0012 frnewline -->
(a)(8) and replacing it with ``; or'', and by adding a new 
<!-- PJG 0012 frnewline -->
paragraph (a)(9) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.454 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Good cause for failure to make required reports. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
General
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. *&blank;*&blank;* The failure of the individual to submit 
<!-- PJG 0012 frnewline -->
evidence to establish good cause within a specified time may be 
<!-- PJG 0012 frnewline -->
considered a sufficient basis for a finding that good cause does 
<!-- PJG 0012 frnewline -->
not exist (see &sect;404.705). In determining whether good cause for 
<!-- PJG 0012 frnewline -->
failure to report timely has been established by the individual, 
<!-- PJG 0012 frnewline -->
consideration is given to whether the failure to report within 
<!-- PJG 0012 frnewline -->
the proper time limit was the result of untoward circumstances, 
<!-- PJG 0012 frnewline -->
misleading action of the Social Security Administration, 
<!-- PJG 0012 frnewline -->
confusion as to the requirements of the Act resulting from 
<!-- PJG 0012 frnewline -->
amendments to the Act or other legislation, or any physical, 
<!-- PJG 0012 frnewline -->
mental, educational, or linguistic limitations (including any 
<!-- PJG 0012 frnewline -->
lack of facility with the English language) the individual may 
<!-- PJG 0012 frnewline -->
have. *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(9) Failure of the individual to understand reporting 
<!-- PJG 0012 frnewline -->
responsibilities due to his or her physical, mental, educational, 
<!-- PJG 0012 frnewline -->
or linguistic limitation(s). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. The authority citation for subpart F continues to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 204(a)&hyph;(d), 205(a), and 1102 of the Social 
<!-- PJG 0012 frnewline -->
Security Act; 42 U.S.C. 404(a)&hyph;(d), 405(a), and 1302.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Section 404.507 is amended by revising the third sentence 
<!-- PJG 0012 frnewline -->
of the introductory text to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.507 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Fault. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*&blank;*&blank;* In determining whether an individual is at fault, the 
<!-- PJG 0012 frnewline -->
Social Security Administration will consider all pertinent 
<!-- PJG 0012 frnewline -->
circumstances, including the individual's age and intelligence, 
<!-- PJG 0012 frnewline -->
and any physical, mental, educational, or linguistic limitations 
<!-- PJG 0012 frnewline -->
(including any lack of facility with the English language) the 
<!-- PJG 0012 frnewline -->
individual has. *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. Section 404.510 is amended by revising the section 
<!-- PJG 0012 frnewline -->
heading, by removing the last sentence of paragraph (n) and by 
<!-- PJG 0012 frnewline -->
revising the introductory text of &sect;404.510 to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.510 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
When an individual is ``without fault'' in a deduction 
<!-- PJG 0012 frnewline -->
overpayment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In determining whether an individual is ``without fault'' with 
<!-- PJG 0012 frnewline -->
respect to a deduction overpayment, the Social Security 
<!-- PJG 0012 frnewline -->
Administration will consider all pertinent circumstances, 
<!-- PJG 0012 frnewline -->
including the individual's age and intelligence, and any 
<!-- PJG 0012 frnewline -->
physical, mental, educational, or linguistic limitations 
<!-- PJG 0012 frnewline -->
(including any lack of facility with the English language) the 
<!-- PJG 0012 frnewline -->
individual has. Except as provided in &sect;404.511 or elsewhere in 
<!-- PJG 0012 frnewline -->
this subpart F, situations in which an individual will be 
<!-- PJG 0012 frnewline -->
considered to be ``without fault'' with respect to a deduction 
<!-- PJG 0012 frnewline -->
overpayment include, but are not limited to, those that are 
<!-- PJG 0012 frnewline -->
described in this section. An individual will be considered 
<!-- PJG 0012 frnewline -->
``without fault'' in accepting a payment which is incorrect because 
<!-- PJG 0012 frnewline -->
he/she failed to report an event specified in sections 203 (b) and 
<!-- PJG 0012 frnewline -->
(c) of the Act, or an event specified in section 203(d) of the 
<!-- PJG 0012 frnewline -->
Act as in effect for monthly benefits for months after December 
<!-- PJG 0012 frnewline -->
1960, or because a deduction is required under section 203 (b), 
<!-- PJG 0012 frnewline -->
(c), (d), or section 222(b) of the Act, or payments were not 
<!-- PJG 0012 frnewline -->
withheld as required by section 202(t) or section 228 of the Act, 
<!-- PJG 0012 frnewline -->
if it is shown that such failure to report or acceptance of the 
<!-- PJG 0012 frnewline -->
overpayment was due to one of the following circumstances: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00034 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. Section 404.511 is amended by revising the section 
<!-- PJG 0012 frnewline -->
heading and by revising paragraph (b) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.511 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
When an individual is at ``fault'' in a deduction 
<!-- PJG 0012 frnewline -->
overpayment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Subsequent deduction overpayments.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The Social Security Administration generally will not find an 
<!-- PJG 0012 frnewline -->
individual to be without fault where, after having been 
<!-- PJG 0012 frnewline -->
exonerated for a ``deduction overpayment'' and after having been 
<!-- PJG 0012 frnewline -->
advised of the correct interpretation of the deduction provision, 
<!-- PJG 0012 frnewline -->
the individual incurs another ``deduction overpayment'' under the 
<!-- PJG 0012 frnewline -->
same circumstances as the first overpayment. However, in 
<!-- PJG 0012 frnewline -->
determining whether the individual is without fault, the Social 
<!-- PJG 0012 frnewline -->
Security Administration will consider all of the pertinent 
<!-- PJG 0012 frnewline -->
circumstances surrounding the prior and subsequent ``deduction 
<!-- PJG 0012 frnewline -->
overpayments,'' including any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) which the individual may have.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. The authority citation for subpart J of part 404 is revised 
<!-- PJG 0012 frnewline -->
to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Secs. 201(j), 205 (a), (b) and (d)&hyph;(h), 
<!-- PJG 0012 frnewline -->
221(d), and 1102 of the Social Security Act; 31 U.S.C. 3720A; 
<!-- PJG 0012 frnewline -->
42 U.S.C. 401(j), 405 (a), (b), and (d)&hyph;(h), 421(d), and 1302, 
<!-- PJG 0012 frnewline -->
sec. 5 of Pub. L. 97&hyph;455, 96 Stat. 2500; sec. 6 of Pub. L. 98&hyph;460, 
<!-- PJG 0012 frnewline -->
98 Stat. 1802. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
9. Section 404.911 is amended by removing the period after 
<!-- PJG 0012 frnewline -->
paragraph (a)(3) and replacing it with ``; and'', by adding a new 
<!-- PJG 0012 frnewline -->
paragraph (a)(4) after paragraph (a)(3), and by revising 
<!-- PJG 0012 frnewline -->
paragraph (b)(9) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.911 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Good cause for missing the deadline to request review. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Whether you had any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) which prevented you from filing a timely 
<!-- PJG 0012 frnewline -->
request or from understanding or knowing about the need to file a 
<!-- PJG 0012 frnewline -->
timely request for review. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(9) Unusual or unavoidable circumstances exist, including the 
<!-- PJG 0012 frnewline -->
circumstances described in paragraph (a)(4) of this section, 
<!-- PJG 0012 frnewline -->
which show that you could not have known of the need to file 
<!-- PJG 0012 frnewline -->
timely, or which prevented you from filing timely.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
10. Section 404.936 is amended by revising paragraph 
<!-- PJG 0012 frnewline -->
(d)(7) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.936 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Time and place for a hearing before an administrative 
<!-- PJG 0012 frnewline -->
law judge. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(7) You are unrepresented, and you are unable to respond to 
<!-- PJG 0012 frnewline -->
the notice of hearing because of any physical, mental, 
<!-- PJG 0012 frnewline -->
educational, or linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) which you may have.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
11. Section 404.957 is amended by redesignating paragraphs 
<!-- PJG 0012 frnewline -->
(b)(1) and (b)(2) as paragraphs (b)(1)(i) and (b)(1)(ii) and by 
<!-- PJG 0012 frnewline -->
adding a new paragraph (b)(2) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.957 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Dismissal of a request for a hearing before an 
<!-- PJG 0012 frnewline -->
administrative law judge. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) In determining good cause or good reason under this 
<!-- PJG 0012 frnewline -->
paragraph, we will consider any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) which you may have. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
12. Section 404.988 is amended by revising paragraph (c)(1) 
<!-- PJG 0012 frnewline -->
to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.988 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Conditions for reopening. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00035 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) It was obtained by fraud or similar fault (see 
<!-- PJG 0012 frnewline -->
&sect;416.1488(c) of this chapter for factors which we take into 
<!-- PJG 0012 frnewline -->
account in determining fraud or similar fault); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
13. The authority citation for subpart P is revised to read 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 202, 205(a), (b), and (d)&hyph;(h), 216(i), 
<!-- PJG 0012 frnewline -->
221(a) and (i), 222(c), 223, 225, and 1102 of the Social Security 
<!-- PJG 0012 frnewline -->
Act; 42 U.S.C. 402, 405(a), (b), and (d)&hyph;(h), 416(i), 421(a) and 
<!-- PJG 0012 frnewline -->
(i), 422(c), 423, 425, and 1302, sec. 505(a) of Pub. L. 96&hyph;265, 
<!-- PJG 0012 frnewline -->
94 Stat. 473; secs. 2(d)(2),5,6, and 15 of Pub L. 98&hyph;460, 96 
<!-- PJG 0012 frnewline -->
Stat. 1797, 1801, 1802, and 1808; sec. 10103 of Pub. L. 101&hyph;239, 
<!-- PJG 0012 frnewline -->
103 Stat. 2472.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
14. Section 404.1518 is amended by adding a new sentence at 
<!-- PJG 0012 frnewline -->
the end of paragraph (a) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.1518 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
If you do not appear at a consultative examination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) *&blank;*&blank;* We will consider your physical, mental, 
<!-- PJG 0012 frnewline -->
educational, and linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) when determining if you have 
<!-- PJG 0012 frnewline -->
a good reason for failing to attend a consultative examination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
15. Section 404.1530 is amended by revising the introductory 
<!-- PJG 0012 frnewline -->
text of paragraph (c) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.1530 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Need to follow prescribed treatment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Acceptable reasons for failure to follow prescribed 
<!-- PJG 0012 frnewline -->
treatment.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We will consider your physical, mental, educational, and 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) when determining if you have an acceptable 
<!-- PJG 0012 frnewline -->
reason for failure to follow prescribed treatment. The following 
<!-- PJG 0012 frnewline -->
are examples of a good reason for not following treatment: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00036 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
16. Section 404.1579 is amended by revising the section 
<!-- PJG 0012 frnewline -->
heading and by revising paragraphs (e)(1) and (e)(2) to read as 
<!-- PJG 0012 frnewline -->
follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.1579
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
How we will determine whether your disability 
<!-- PJG 0012 frnewline -->
continues or ends. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(e)&blank;*&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A prior determination or decision was fraudulently 
<!-- PJG 0012 frnewline -->
obtained
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. If we find that any prior favorable determination or 
<!-- PJG 0012 frnewline -->
decision was obtained by fraud, we may find that you are not 
<!-- PJG 0012 frnewline -->
disabled. In addition, we may reopen your claim under the rules 
<!-- PJG 0012 frnewline -->
in &sect;404.988. In determining whether a prior favorable 
<!-- PJG 0012 frnewline -->
determination or decision was fraudulently obtained, we will take 
<!-- PJG 0012 frnewline -->
into account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) which you may have had at the time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
You do not cooperate with us
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. If there is a question 
<!-- PJG 0012 frnewline -->
about whether you continue to be disabled and we ask you to give 
<!-- PJG 0012 frnewline -->
us medical or other evidence or to go for a physical or mental 
<!-- PJG 0012 frnewline -->
examination by a certain date, we will find that your disability 
<!-- PJG 0012 frnewline -->
has ended if you fail, without good cause, to do what we ask. 
<!-- PJG 0012 frnewline -->
Section 404.911 explains the factors we consider and how we will 
<!-- PJG 0012 frnewline -->
determine generally whether you have good cause for failure to 
<!-- PJG 0012 frnewline -->
cooperate. In addition, &sect;404.1518 discusses how we determine 
<!-- PJG 0012 frnewline -->
whether you have good cause for failing to attend a consultative 
<!-- PJG 0012 frnewline -->
examination. The month in which your disability ends will be the 
<!-- PJG 0012 frnewline -->
first month in which you failed to do what we asked. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
17. Section 404.1586 is amended by revising paragraph (d) to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.1586
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Why and when we will stop your cash benefits. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
If you do not cooperate with us
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->
If we ask you to give us medical or other evidence or to go for a 
<!-- PJG 0012 frnewline -->
medical examination by a certain date, we will find that your 
<!-- PJG 0012 frnewline -->
disability has ended if you fail, without good cause, to do what 
<!-- PJG 0012 frnewline -->
we ask. Section 404.911 explains the factors we consider and how 
<!-- PJG 0012 frnewline -->
we will determine generally whether you have good cause for 
<!-- PJG 0012 frnewline -->
failure to cooperate. In addition, &sect;404.1518 discusses how we 
<!-- PJG 0012 frnewline -->
determine whether you have good cause for failing to attend a 
<!-- PJG 0012 frnewline -->
consultative examination. The month in which your disability 
<!-- PJG 0012 frnewline -->
will be found to have ended will be the month in which you failed 
<!-- PJG 0012 frnewline -->
to do what we asked. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
18. Section 404.1594 is amended by revising the section 
<!-- PJG 0012 frnewline -->
heading and by revising paragraphs (e)(1) and (e)(2) to read as 
<!-- PJG 0012 frnewline -->
follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.1594
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
How we will determine whether your disability 
<!-- PJG 0012 frnewline -->
continues or ends. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(e)&blank;*&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A prior determination or decision was fraudulently 
<!-- PJG 0012 frnewline -->
obtained
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. If we find that any prior favorable determination or 
<!-- PJG 0012 frnewline -->
decision was obtained by fraud, we may find that you are not 
<!-- PJG 0012 frnewline -->
disabled. In addition, we may reopen your claim under the rules 
<!-- PJG 0012 frnewline -->
in &sect;404.988. In determining whether a prior favorable 
<!-- PJG 0012 frnewline -->
determination or decision was fraudulently obtained, we will take 
<!-- PJG 0012 frnewline -->
into account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) which you may have had at the time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00037 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
You do not cooperate with us
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. If there is a question 
<!-- PJG 0012 frnewline -->
about whether you continue to be disabled and we ask you to give 
<!-- PJG 0012 frnewline -->
us medical or other evidence or to go for a physical or mental 
<!-- PJG 0012 frnewline -->
examination by a certain date, we will find that your disability 
<!-- PJG 0012 frnewline -->
has ended if you fail, without good cause, to do what we ask. 
<!-- PJG 0012 frnewline -->
Section 404.911 explains the factors we consider and how we will 
<!-- PJG 0012 frnewline -->
determine generally whether you have good cause for failure to 
<!-- PJG 0012 frnewline -->
cooperate. In addition, &sect;404.1518 discusses how we determine 
<!-- PJG 0012 frnewline -->
whether you have good cause for failing to attend a consultative 
<!-- PJG 0012 frnewline -->
examination. The month in which your disability ends will be the 
<!-- PJG 0012 frnewline -->
first month in which you failed to do what we asked. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
19. Section 404.1597a is amended by adding a new sentence at 
<!-- PJG 0012 frnewline -->
the end of paragraph (j)(3) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;404.1597a
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Continued benefits pending appeal of a medical 
<!-- PJG 0012 frnewline -->
cessation determination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(j) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) *&blank;*&blank;*&blank;In determining whether an individual has good cause 
<!-- PJG 0012 frnewline -->
for failure to cooperate and, thus, whether an appeal was made in 
<!-- PJG 0012 frnewline -->
good faith, we will take into account any physical, mental, 
<!-- PJG 0012 frnewline -->
educational, or linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) the individual may have which 
<!-- PJG 0012 frnewline -->
may have caused the individual's failure to cooperate. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 416_SUPPLEMENTAL SECURITY INCOME FOR THE AGED, BLIND, AND 
<!-- PJG 0012 frnewline -->
DISABLED 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for subpart B continues to read as 
<!-- PJG 0012 frnewline -->
follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 1102, 1110(b), 1602, 1611, 1614, 1615(c), 
<!-- PJG 0012 frnewline -->
1619(a), 1631, and 1634, of the Social Security Act; 42 U.S.C. 
<!-- PJG 0012 frnewline -->
1302, 1310(b), 1381a, 1382, 1382c, 1382d(c), 1382h(a), 1383, and 
<!-- PJG 0012 frnewline -->
1383c; secs. 211 and 212 of Pub. L. 93&hyph;66, 87 Stat. 154 and 155; 
<!-- PJG 0012 frnewline -->
sec. 502(a) of Pub. L. 94&hyph;241, 90 Stat. 268; and sec. 2 of 
<!-- PJG 0012 frnewline -->
Pub. L. 99&hyph;643, 100 Stat. 3574. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 416.210 is amended by revising the introductory 
<!-- PJG 0012 frnewline -->
text of paragraph (e)(2) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.210
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
You do not apply for other benefits. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(e) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00038 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) We will not find you ineligible for SSI benefits if you 
<!-- PJG 0012 frnewline -->
have a good reason for not applying for the other benefits within 
<!-- PJG 0012 frnewline -->
the 30-day period or taking other necessary steps to obtain them. 
<!-- PJG 0012 frnewline -->
In determining whether a good reason exists, we will take into 
<!-- PJG 0012 frnewline -->
account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) which may have caused you to fail to apply for other 
<!-- PJG 0012 frnewline -->
benefits. You may have a good reason if, for example_ 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. The authority citation for subpart E is revised to read 
<!-- PJG 0012 frnewline -->
as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 1102, 1601, 1602, 1611(c), and 1631(a)&hyph;(d) and (g) of the Social Security Act; 42 U.S.C. 1302, 1381, 1381a,
1382(c), and 1383(a)&hyph;(d) and (g). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. Section 416.552 is amended by adding after the fifth 
<!-- PJG 0012 frnewline -->
sentence of the introductory text a new sentence to read as 
<!-- PJG 0012 frnewline -->
follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.552 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Waiver of adjustment or recovery_without fault. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 *&blank;*&blank;* In determining whether an individual is without fault 
<!-- PJG 0012 frnewline -->
based on a consideration of these factors, the Social Security 
<!-- PJG 0012 frnewline -->
Administration will take into account any physical, mental, 
<!-- PJG 0012 frnewline -->
educational, or linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) the individual may have. *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Section 416.556 is amended by revising paragraph (b) to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.556 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Waiver of adjustment or recovery_countable resources 
<!-- PJG 0012 frnewline -->
in excess of the limits prescribed in &sect;416.1205 by $50 or less. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) Failure to report the excess resources correctly and in a 
<!-- PJG 0012 frnewline -->
timely manner will be considered to be willful and knowing and 
<!-- PJG 0012 frnewline -->
the individual will be found to be at fault when the evidence 
<!-- PJG 0012 frnewline -->
clearly shows the individual (and spouse if any) was fully aware 
<!-- PJG 0012 frnewline -->
of the requirements of the law and of the excess resources and 
<!-- PJG 0012 frnewline -->
chose to conceal these resources. When an individual incurred a 
<!-- PJG 0012 frnewline -->
similar overpayment in the past and received an explanation and 
<!-- PJG 0012 frnewline -->
instructions at the time of the previous overpayment, we will 
<!-- PJG 0012 frnewline -->
generally find the individual to be at fault. However, in 
<!-- PJG 0012 frnewline -->
determining whether the individual is at fault, we will consider 
<!-- PJG 0012 frnewline -->
all aspects of the current and prior overpayment situations, and 
<!-- PJG 0012 frnewline -->
where we determine the individual is not at fault, we will waive 
<!-- PJG 0012 frnewline -->
adjustment or recovery of the subsequent overpayment. In making 
<!-- PJG 0012 frnewline -->
any determination or decision under this section concerning 
<!-- PJG 0012 frnewline -->
whether an individual is at fault, including a determination or 
<!-- PJG 0012 frnewline -->
decision of whether the failure to report the excess resources 
<!-- PJG 0012 frnewline -->
correctly and in a timely manner was willful and knowing, we will 
<!-- PJG 0012 frnewline -->
take into account any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) of the individual (and spouse if any). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. The authority citation for subpart G of part 416 
<!-- PJG 0012 frnewline -->
continues to read as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 1102, 1611, 1612, 1613, 1614, and 1631 of 
<!-- PJG 0012 frnewline -->
the Social Security Act; 42 U.S.C. 1302, 1382, 1382a, 1382b, 
<!-- PJG 0012 frnewline -->
1382c, and 1383; sec. 211 of Pub. L. 93&hyph;66, 87 Stat. 154. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. Section 416.732 is revised to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.732 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
No penalty deduction if you have good cause for failure 
<!-- PJG 0012 frnewline -->
to report timely. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) We will find that you have good cause for failure to 
<!-- PJG 0012 frnewline -->
report timely and we will not impose a penalty deduction, if_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) You are ``without fault'' as defined in &sect;416.552; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00039 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) Your failure or delay in reporting is not willful. ``Not 
<!-- PJG 0012 frnewline -->
willful'' means that_ 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) You did not have full knowledge of the existence of your 
<!-- PJG 0012 frnewline -->
obligation to make a required report; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) You did not intentionally, knowingly, and purposely fail 
<!-- PJG 0012 frnewline -->
to make a required report. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
However, in either case we may require that you refund an 
<!-- PJG 0012 frnewline -->
overpayment caused by your failure to report. See subpart E of 
<!-- PJG 0012 frnewline -->
this part for waiver of recovery of overpayments. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) In determining whether you have good cause for failure to 
<!-- PJG 0012 frnewline -->
report timely, we will take into account any physical, mental, 
<!-- PJG 0012 frnewline -->
educational, or linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) you may have.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. The authority citation for subpart I of part 416 is 
<!-- PJG 0012 frnewline -->
revised to read as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Secs. 1102, 1614(a), 1619, 1631 (a), (c) and 
<!-- PJG 0012 frnewline -->
(d)(1), and 1633 of the Social Security Act; 42 U.S.C. 1302, 
<!-- PJG 0012 frnewline -->
1382c(a), 1382h, 1383 (a), (c) and (d)(1), and 1383b; secs. 2, 5, 
<!-- PJG 0012 frnewline -->
6, and 15 of Pub. L. 98&hyph;460, 98 Stat. 1794, 1801, 1802, and 1808. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
9. Section 416.918 is amended by adding a new sentence at 
<!-- PJG 0012 frnewline -->
the end of paragraph (a) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.918 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
If you do not appear at a consultative examination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) *&blank;*&blank;* We will consider your physical, mental, 
<!-- PJG 0012 frnewline -->
educational, and linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) when determining if you have 
<!-- PJG 0012 frnewline -->
a good reason for failing to attend a consultative examination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
10. Section 416.930 is amended by revising the introductory 
<!-- PJG 0012 frnewline -->
text of paragraph (c) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.930 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Need to follow prescribed treatment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Acceptable reasons for failure to follow prescribed 
<!-- PJG 0012 frnewline -->
treatment. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We will consider your physical, mental, educational, and 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) when determining if you have an acceptable 
<!-- PJG 0012 frnewline -->
reason for failure to follow prescribed treatment. The following 
<!-- PJG 0012 frnewline -->
are examples of a good reason for not following treatment: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00040 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
11. Section 416.986 is amended by revising paragraph (c) to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.986
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Why and when we will find that you are no longer 
<!-- PJG 0012 frnewline -->
entitled to benefits based on statutory blindness. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
If you do not cooperate with us. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
If you are asked to give us medical or other evidence or to go 
<!-- PJG 0012 frnewline -->
for a physical or mental examination by a certain date, we will 
<!-- PJG 0012 frnewline -->
find that your blindness ended if you fail, without good cause, 
<!-- PJG 0012 frnewline -->
to do what we ask. Section 416.1411 explains the factors we 
<!-- PJG 0012 frnewline -->
consider and how we will determine generally whether you have 
<!-- PJG 0012 frnewline -->
good cause for failure to cooperate. In addition, &sect;416.918 
<!-- PJG 0012 frnewline -->
discusses how we determine whether you have good cause for 
<!-- PJG 0012 frnewline -->
failing to attend a consultative examination. The month in which 
<!-- PJG 0012 frnewline -->
your blindness ends will be the month in which you fail to do 
<!-- PJG 0012 frnewline -->
what we asked. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
12. Section 416.994 is amended by revising the section 
<!-- PJG 0012 frnewline -->
heading and by revising paragraphs (b)(4)(i) and (b)(4)(ii) to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.994 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
How we will determine whether your disability continues 
<!-- PJG 0012 frnewline -->
or ends. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(4) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A prior determination or decision was fraudulently obtained. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
If we find that any prior favorable determination or decision was 
<!-- PJG 0012 frnewline -->
obtained by fraud, we may find that you are not disabled. In 
<!-- PJG 0012 frnewline -->
addition, we may reopen your claim under the rules in &sect;416.1488. 
<!-- PJG 0012 frnewline -->
In determining whether a prior favorable determination or 
<!-- PJG 0012 frnewline -->
decision was fraudulently obtained, we will take into account any 
<!-- PJG 0012 frnewline -->
physical, mental, educational, or linguistic limitations 
<!-- PJG 0012 frnewline -->
(including any lack of facility with the English language) which 
<!-- PJG 0012 frnewline -->
you may have had at the time. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
You do not cooperate with us. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If there is a question 
<!-- PJG 0012 frnewline -->
about whether you continue to be disabled and we ask you to give 
<!-- PJG 0012 frnewline -->
us medical or other evidence or to go for a physical or mental 
<!-- PJG 0012 frnewline -->
examination by a certain date, we will find that your disability 
<!-- PJG 0012 frnewline -->
has ended if you fail, without good cause, to do what we ask. 
<!-- PJG 0012 frnewline -->
Section 416.1411 explains the factors we consider and how we will 
<!-- PJG 0012 frnewline -->
determine generally whether you have good cause for failure to 
<!-- PJG 0012 frnewline -->
cooperate. In addition, &sect;416.918 discusses how we determine 
<!-- PJG 0012 frnewline -->
whether you have good cause for failing to attend a consultative 
<!-- PJG 0012 frnewline -->
examination. The month in which your disability ends will be the 
<!-- PJG 0012 frnewline -->
first month in which you failed to do what we asked. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
13. Section 416.994a is amended by revising the section 
<!-- PJG 0012 frnewline -->
heading and by revising paragraphs (g)(1) and (g)(2) to read as 
<!-- PJG 0012 frnewline -->
follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.994a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
How we will determine whether your disability 
<!-- PJG 0012 frnewline -->
continues or ends, disabled children. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(g) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A prior determination or decision was fraudulently 
<!-- PJG 0012 frnewline -->
obtained. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If we find that any prior favorable determination or 
<!-- PJG 0012 frnewline -->
decision was obtained by fraud, we may find that you are not 
<!-- PJG 0012 frnewline -->
disabled. In addition, we may reopen your claim under the rules 
<!-- PJG 0012 frnewline -->
in &sect;416.1488. In determining whether a prior favorable 
<!-- PJG 0012 frnewline -->
determination or decision was fraudulently obtained, we will take 
<!-- PJG 0012 frnewline -->
into account any physical, mental, educational, or linguistic 
<!-- PJG 0012 frnewline -->
limitations (including any lack of facility with the English 
<!-- PJG 0012 frnewline -->
language) which you may have had at the time. 
<!-- PJG 0012 frnewline -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
You do not cooperate with us. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If there is a question 
<!-- PJG 0012 frnewline -->
about whether you continue to be disabled and we ask you to give 
<!-- PJG 0012 frnewline -->
us medical or other evidence or to go for a physical or mental 
<!-- PJG 0012 frnewline -->
examination by a certain date, we will find that your disability 
<!-- PJG 0012 frnewline -->
has ended if you fail, without good cause, to do what we ask. 
<!-- PJG 0012 frnewline -->
Section 416.1411 explains the factors we consider and how we will 
<!-- PJG 0012 frnewline -->
determine generally whether you have good cause for failure to 
<!-- PJG 0012 frnewline -->
cooperate. In addition, &sect;416.918 discusses how we determine 
<!-- PJG 0012 frnewline -->
whether you have good cause for failing to attend a consultative 
<!-- PJG 0012 frnewline -->
examination. The month in which your disability ends will be the 
<!-- PJG 0012 frnewline -->
first month in which you failed to do what we asked. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
14. Section 416.996 is amended by adding a new sentence at 
<!-- PJG 0012 frnewline -->
the end of paragraph (g)(2) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.996 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Continued disability or blindness benefits pending 
<!-- PJG 0012 frnewline -->
appeal of a medical cessation determination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00041 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(g) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(2) *&blank;*&blank;* In determining whether you have good cause for 
<!-- PJG 0012 frnewline -->
failure to cooperate and, thus, whether an appeal was made in 
<!-- PJG 0012 frnewline -->
good faith, we will take into account any physical, mental, 
<!-- PJG 0012 frnewline -->
educational, or linguistic limitations (including any lack of 
<!-- PJG 0012 frnewline -->
facility with the English language) you may have which may have 
<!-- PJG 0012 frnewline -->
caused your failure to cooperate. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
15. The authority citation for subpart N of part 416 
<!-- PJG 0012 frnewline -->
continues to read as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Secs. 1102, 1631, and 1633 of the Social Security 
<!-- PJG 0012 frnewline -->
Act; 42 U.S.C. 1302, 1383, and 1383b; section 6 of Pub. L. 
<!-- PJG 0012 frnewline -->
98&hyph;460, 98 Stat. 1802.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
16. Section 416.1411 is amended by removing the word ``and'' 
<!-- PJG 0012 frnewline -->
which follows the semicolon at the end of paragraph (a)(2), by 
<!-- PJG 0012 frnewline -->
removing the period after paragraph (a)(3) and replacing it with 
<!-- PJG 0012 frnewline -->
``; and'', by adding a new paragraph (a)(4), and by revising 
<!-- PJG 0012 frnewline -->
paragraph (b)(9) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.1411 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Good cause for missing the deadline to request review. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(4) Whether you had any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) which prevented you from filing a timely 
<!-- PJG 0012 frnewline -->
request or from understanding or knowing about the need to file a 
<!-- PJG 0012 frnewline -->
timely request for review. 
<!-- PJG 0012 frnewline -->
(b) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(9) Unusual or unavoidable circumstances exist, including the 
<!-- PJG 0012 frnewline -->
circumstances described in paragraph (a)(4) of this section, 
<!-- PJG 0012 frnewline -->
which show that you could not have known of the need to file 
<!-- PJG 0012 frnewline -->
timely, or which prevented you from filing timely.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
17. Section 416.1436 is amended by revising paragraph (d)(7) 
<!-- PJG 0012 frnewline -->
to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.1436 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Time and place for a hearing before an administrative 
<!-- PJG 0012 frnewline -->
law judge. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(7) You are unrepresented, and you are unable to respond to 
<!-- PJG 0012 frnewline -->
the notice of hearing because of a physical, mental, educational, 
<!-- PJG 0012 frnewline -->
or linguistic limitation (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) which you may have.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
18. Section 416.1457 is amended by redesignating paragraphs 
<!-- PJG 0012 frnewline -->
(b)(1) and (b)(2) as paragraphs (b)(1)(i) and (b)(1)(ii) and by 
<!-- PJG 0012 frnewline -->
adding a new paragraph (b)(2) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.1457 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Dismissal of a request for a hearing before an 
<!-- PJG 0012 frnewline -->
administrative law judge. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(2) In determining good cause or good reason under this 
<!-- PJG 0012 frnewline -->
paragraph, we will consider any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) which you may have. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
19. Section 416.1488 is amended by revising paragraph (c) to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00042 </DOCNO>
<PARENT> FR940112-0-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.1488 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Conditions for reopening. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) At any time if it was obtained by fraud or similar fault. In 
<!-- PJG 0012 frnewline -->
determining whether a determination or decision was obtained by 
<!-- PJG 0012 frnewline -->
fraud or similar fault, we will take into account any physical, 
<!-- PJG 0012 frnewline -->
mental, educational, or linguistic limitations (including any 
<!-- PJG 0012 frnewline -->
lack of facility with the English language) which you may have 
<!-- PJG 0012 frnewline -->
had at the time. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
20. The authority citation for subpart Q continues to read 
<!-- PJG 0012 frnewline -->
as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Secs. 1102, 1611(e)(3)(A), 1615, and 1631 of the 
<!-- PJG 0012 frnewline -->
Social Security Act; 42 U.S.C. 1302, 1382(e)(3)(A), 1382d, and 
<!-- PJG 0012 frnewline -->
1383. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
21. Section 416.1715 is amended by revising paragraph (a) to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.1715 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Effect of your rejecting vocational rehabilitation 
<!-- PJG 0012 frnewline -->
services. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ineligible for benefits if you do not have good cause. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If we refer you to the State agency providing vocational 
<!-- PJG 0012 frnewline -->
rehabilitation services, you are not eligible for SSI benefits 
<!-- PJG 0012 frnewline -->
for any month that you refuse, without good cause, to accept 
<!-- PJG 0012 frnewline -->
services available to you (see &sect;416.1328(a) on suspension 
<!-- PJG 0012 frnewline -->
because of a refusal). In determining whether you have good 
<!-- PJG 0012 frnewline -->
cause for refusing vocational rehabilitation services, we will 
<!-- PJG 0012 frnewline -->
take into account any physical, mental, educational, or 
<!-- PJG 0012 frnewline -->
linguistic limitations (including any lack of facility with the 
<!-- PJG 0012 frnewline -->
English language) which may have caused you to refuse such 
<!-- PJG 0012 frnewline -->
services. If you believe good cause exists to refuse these 
<!-- PJG 0012 frnewline -->
services, you will be asked to submit proof showing this. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
22. The authority citation for subpart V continues to read as 
<!-- PJG 0012 frnewline -->
follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 1102, 1615, and 1631(d)(1) and (e) of the 
<!-- PJG 0012 frnewline -->
Social Security Act; 42 U.S.C. 1302, 1382d, and 1383(d)(1) and 
<!-- PJG 0012 frnewline -->
(e); sec. 2344 of Pub. L. 97&hyph;35, 95 Stat. 867. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;416.2203
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
23. In &sect;416.2203, the eighth paragraph, definition of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
good 
<!-- PJG 0012 frnewline -->
cause, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
is amended by changing the cross-reference following the 
<!-- PJG 0012 frnewline -->
parenthetical phrase from ``&sect;416.1715(b)'' to ``&sect;416.1715.'' 
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;711 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4190&hyph;29&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00043 </DOCNO>
<PARENT> FR940112-0-00015 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Food and Drug Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>21 CFR Part 109</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 89N&hyph;0014]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 0905&hyph;AC91</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Requirements for Decorative Ceramicware To Be Deemed not for Food Use
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Food and Drug Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Food and Drug Administration (FDA) is amending its regulations to require that decorative ceramicware bear a
conspicuous stick-on label on a surface that is clearly visible to consumers and a permanent statement on the exterior
surface of the base of the ceramicware stating that the piece is not for food use, and that it may poison food. Alternatively,
the regulation provides that a hole may be bored through the possible food-contact surface of the piece. This final
rule is intended to ensure that decorative ceramicware is not mistakenly used to hold food.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Effective July 13, 1994, for all affected products initially introduced or initially delivered for introduction
into interstate commerce on or after this date.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Cora E. Weeks, Center for Food Safety and Applied Nutrition (HFS&hyph;306), Food and Drug Administration, 200 C St.
SW., Washington, DC 20204, 202&hyph;205&hyph;4681.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
I. Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of June 1, 1989 (54 FR 23485), FDA issued a proposed rule: (1) To establish a regulatory limit on the amount of lead that
may leach from glazes and decorations on the food-contact surface of ceramic food service pitchers, excluding creamers;
and (2) to provide that all decorative or ornamental ceramicware that appears to be suitable for food use will be considered
to be for food use, and will be regulated as such, unless it bears a conspicuous, permanent statement molded or fired
onto the exterior surface of the base of the ceramic piece. The agency proposed to require that this statement say,
``Not for Food Use_May Poison Food,'' in letters at least 3.2 millimeters (mm) (0.125 inch (in)) in height, or that
a hole be bored through the potential food-contact surface to make it unsuitable for food use.
<!-- PJG 0012 frnewline -->
The proposal requested comments on various concerns regarding ceramic foodware and on the impact of the proposed
requirements on decorative ceramicware that resembles foodware and that contains leachable lead.
<!-- PJG 0012 frnewline -->
FDA received requests to extend the comment period on the proposed rule from representatives of domestic and foreign
ceramicware manufacturers, 3suppliers of glazes and decorations containing lead for the ceramics industry and
related trade associations, the European Economic Community, and the Italian Embassy. The requests stated that
additional time was needed to address the issues raised and to provide information solicited by FDA in the proposal.
FDA responded in a notice published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of September 1, 1989 (54 FR 36324), that reopened and extended the comment period until November 30, 1989.
<!-- PJG 0012 frnewline -->
In the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of July 6, 1992 (57 FR 29734), the agency announced the availability of revised Compliance Policy Guide (CPG) 7117.07
``Pottery (Ceramics); Imported and Domestic_Lead Contamination.'' This revision lowered the guidelines on lead
release from all ceramic foodware. This revision was based, among other things, on the agency's review of data submitted
pursuant to its proposal of June 1, 1989 (54 FR 23485), and the agency's concerns about the need to reduce human exposure
to lead.
<!-- PJG 0012 frnewline -->
The lead release levels in CPG 7117.07 are guides that the agency uses in evaluating ceramic foodware for possible
adulteration within the meaning of section 402(a)(2)(C) of the Federal Food, Drug, and Cosmetic Act (the act) (21
U.S.C. 342(a)(2)(C)). In this final rule, the agency is not acting on its proposal regarding a legally binding regulatory
limit on the amount of lead that may leach from the food-contact surfaces of ceramic food service pitchers. The agency
is continuing to review whether the CPG provides adequate protection for the public health, which would mean that
the agency could withdraw its proposal to establish a regulatory limit, or whether further rulemaking is necessary.
<!-- PJG 0012 frnewline -->
This final rule pertains only to ornamental and decorative ceramicware. In the June 1, 1989 (54 FR 23485), proposal,
the agency stated that the then existing policy guidance concerning decorative and ornamental ceramicware in CPG
7117.07 was too general and vague, subject to misinterpretation, and not sufficient to ensure that decorative articles
will be distinguishable from food-service articles. Therefore, the agency's purpose in adopting this final rule
is to ensure that such ware, which may leach hazardous amounts of lead into food, bear adequate indications to distinguish
it from ceramic foodware (i.e., ceramicware intended for holding, storing, or serving food). The agency has made
revisions in the language of &sect;109.16(a) and (b) (21 CFR 109.16(a) and (b)) to make clear that this regulation
pertains only to ornamental and decorative ceramicware and not to any ceramicware intended to hold or store food,
e.g., ceramic pitchers. 
<!-- PJG 0012 frnewline -->
FDA also notes that the provisions of this final rule are not applicable to items such as children's ceramic tea sets.
Such items are usually small copies of articles intended for food use. They are designed for use only by children in
play activities that may involve eating or drinking foods placed in or on these products (see 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
HHS News
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, April 20, 1993.) Lead in these products could leach into food. Those that leach excessive amounts of lead will be subject
to regulatory action, and such ware may not obtain status as a nonfood item by virtue of its bearing any statement that
it is not for food use.
<!-- PJG 0012 frnewline -->
On the effective date of this final rule, all ornamental or decorative ceramicware that appears to be suitable for
food use upon initial introduction or initial delivery for introduction into interstate commerce will be considered
to be foodware and will be evaluated for lead release by the agency as foodware. Ware that meets the requirements of
this final rule will not be considered to be for food use.
<!-- PJG 0012 frnewline -->
The agency is also providing notice that it is deleting the exemption for nonfood service plates from CPG 7117.07.
These articles will be subject to the provisions of this final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Summary of and Response to Comments
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Summary of Comments
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Seven letters, containing one or more comments, were received in response to the proposal on the requirements for
decorative ceramicware that resembles foodware. The comments were submitted by consumer and environmental advocacy
organizations, ceramicware manufacturers and their suppliers, and individuals.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Responses to Comments
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Several comments requested that FDA allow more flexibility regarding the exact wording of the permanent statement
of unsuitability for food use and suggested statements for inclusion in the final rule as alternatives to the proposed
statement. These comments expressed concern that the word ``poison'' would alarm potential purchasers and could
lead them to believe that handling the product is hazardous. The following alternative statements were suggested:
(a) ``Decorative_Not for Food Use. Pigments are Potentially Toxi66c if Ingested,'' (b) ``Not for Food Use_Metallic
Pigments Fired into Surface are Potentially Toxic. For Decorative Purposes Only,'' or (c) ``Warning. Glaze Contains
Soluble Lead. Not for Food Use.''
<!-- PJG 0012 frnewline -->
The agency accepts the recommendation to allow for alternative statements of unsuitability for food use. FDA agrees
that some number of alternative statements can convey the same basic concept as the proposed statement while providing
flexibility in the wording of the message. However, to adequately denote that the ceramicware is unsuitable for food
use, the permanent statement must clearly advise the purchaser or potential user that if the article is used to hold
food, a toxic substance may be added to the food as a result. Alternative (c) does not do so. The alternative statements
(a) and (b) suggested by the comments state that the surface of the ceramic piece itself contains a toxic substance,
but they do not make clear that if the ceramicware is used for food purposes, such use may result in the addition of a toxic
substance to the food. Therefore, the agency is not accepting the statements suggested in the comments as acceptable
alternatives.
<!-- PJG 0012 frnewline -->
In &sect;109.16(b)(1)(i), FDA is providing three alternative statements of unsuitability that meet the criterion
of informing the purchaser that if the article is used for food, a toxic substance may be added to the food as a result.
The alternative statements are, ``Not for Food Use. May Poison Food,'' ``Not for Food Use. Glaze contains lead. Food
Use May Result in Lead Poisoning,'' and ``Not for Food Use_Food Consumed from this Vessel May be Harmful.''
<!-- PJG 0012 frnewline -->
The agency concludes that these three alternative statements of unsuitability provide the industry with a choice
without providing so many different statements as to confuse consumers. Limiting the number of variations in the
statement is necessary to ensure that consumers understand that a consistent message is being presented by the statements
that they find on decorative ceramicware.
<!-- PJG 0012 frnewline -->
As an additional matter, the agency believes that statements that the ware is intended to be decorative may provide
useful information to the consumer about the intended use of the ware. Therefore, FDA is providing in &sect;109.16(c)(1)
for the use of additional optional statements such as ``Decorative'' or ``For Decorative Purposes Only'' when such
statements are placed after the required statement.
<!-- PJG 0012 frnewline -->
2. Some comments expressed concern that statements that ornamental or de2corative ceramicware is unfit for food
use will not protect very young, illiterate, or non-English speaking people. One of the comments suggested that FDA
permit the use of a symbol to designate ceramicware that is not suitable for food use. The comments stated that the symbol
should accompany the statement that the ceramicware is unfit for food use. One comment maintained that the symbol
is responsive to concerns regarding understanding by illiterate persons, non-English speaking people, and children.
The comment suggested that the following symbol, which includes a goblet and a fork, symbols used in the United Kingdom
to indicate materials and articles that are intended to come into contact with food, be enclosed within a circle with
a bar running diagonally across the design to indicate that food use is prohibited. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d72 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSER12JA94.000
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency agrees that the symbol may communicate to individuals, to whom a written statement may not be readily meaningful,
that an article is not foodware. However, because the agency does not have any information concerning the extent to
which the symbol is understood or recognized by consumers, it is not requiring use of the symbol but is making its use
optional in &sect;109.16(c)(2), as an additional cautionary statement to those required in &sect;109.16(b).
<!-- PJG 0012 frnewline -->
3. Some comments expressed concern that a statement placed on the exterior surface of the base of a piece, in letters
that are only 3.2 mm (0.125 inch) in height, may not be seen by many people. Some comments requested that the agency require
that the statement be placed on the side of the ceramicware, and that the required size of letters in the statement be
related to the size of the ceramicware on which it is placed.
<!-- PJG 0012 frnewline -->
FDA agrees that a statement on the side of a piece is more conspicuous than one placed on the exterior surface of the base.
However, a permanent statement on the side would likely render the piece useless for ornamental or decorative purposes.
To respond to the concern of the comments, and to better protect the public, FDA is requiring in &sect;109.16(b)(1)(i)
that a stick-on temporary label bearing one of the alternative statements, in letters at least 3.2 mm (0.125 in) in
height, be placed on a surface of the piece that is clearly visible to the consumer. The temporary label will advise
the consumer that the piece is not for food use and of the reason why it is not for food use. The determination as to the
appropriate surface for the temporary label will depend on the shape of the piece. For example, the appropriate place
on a plate for the temporary label would be the potential food-contact surface, while on a pitcher a temporary label
on the exterior of the side would be suitable.
<!-- PJG 0012 frnewline -->
The requirement for a temporary label is in addition to the requirement of a permanent label that the agency proposed
(54 FR 23485). The purpose of the proposal was to ensure that decorative ceramicware would not be used in a manner that
is unsafe. The comments have convinced the agency that the additional requirement for a temporary label placed on
a conspicuous surface is necessary to ensure that the purposes of this final rule are realized. Without this requirement,
as the comments suggested, there is a significant chance that a consumer will miss the warning on the base of the ceramicware.
<!-- PJG 0012 frnewline -->
The agency does not agree that the size of the letters in the permanent statement must be directly related to the dimensions
of the ornamental or decorative ceramicware piece to be seen. If the statement meets the minimum letter height requirements
of &sect;109.16(b)(1)(ii) and is adequately contrasted or otherwise differentiated or set out from the background
of the piece, the statement will fully serve its function. The agency notes that the requirement for conspicuousness
in declarations of net quantity of contents on food labels (&sect;101.105(i)) includes the specification that the
letter height is not less than one-eighth inch (or 3.2 mm (0.125 in)) if the declaration is blown, embossed, or molded
on a surface. Using this precedent, the agency believes that the minimal letter height of the statement of nonfood
use should generally be not less than 3.2 mm (or one-eighth in) because letters that are less than 3.2 mm (0.125 in) in
height may not be conspicuous enough to be readily seen.
<!-- PJG 0012 frnewline -->
However, the agency recognizes that there may be some ceramicware articles that appear to be suitable for food use
that have bases with surface areas that are too small to fit the required statement if it were to be in letters that are
3.2 mm (0.125 inch) in height. For such articles, the agency is providing in &sect;109.16(b)(1)(ii) that the statement
be written in the largest letters possible, provided the letters are at least 1.6 mm (0.062 inch) high.
<!-- PJG 0012 frnewline -->
4. One comment stated that the agency should not impose a minimum letter size for the permanent statement because of
the limited space available on some articles.
<!-- PJG 0012 frnewline -->
The agency believes that ceramicware pieces that could be mistaken as being intended for holding, storing, or serving
food would have a size and configuration similar to food-use ware and would have bases sufficiently large for88 the
required statement. The agency has accommodated size problems in &sect;109.16(b)(1)(ii). Therefore, the agency
rejects this comment.
<!-- PJG 0012 frnewline -->
5. One comment expressed concern that, in the past, it has been difficult, if not impossible, to keep decorative or
ornamental ceramicware from being used to hold food. Therefore, the comment argued that FDA should not rely on statements
to distinguish ceramicware used for food storage from decorative or ornamental ceramicware. The comment suggested
that FDA consider only ceramicware that has holes bored in the food-contact surface to be decorative or ornamental.
<!-- PJG 0012 frnewline -->
The agency disagrees with this suggestion. A hole bored through some decorative or ornamental ceramicware articles
would render them useless for their intended purpose, e.g., pieces in the shape of pitchers intended for use as vases
for fresh flowers, and would damage the decorative value of others, e.g., commemorative plates. The intent of this
regulation is to distinguish decorative ceramicware from food-service articles by using specified statements
and an optional symbol in a manner that ensures that those statements will be readily seen and understood by the consumer.
FDA concludes, based on the available information, that the measures required under this final rule are appropriate
for this purpose. 
<!-- PJG 0012 frnewline -->
6. One comment suggested that FDA also require that decorative ceramicware (when first sold) be accompanied by a booklet
in which the permanent statement is printed in large type. The comment stated that the booklet should include a paragraph
stating that the object is not to be used to hold, serve, or store food and provide a brief explanation of the dangers
of lead to pregnant women, infants, and children. The comment further suggested that FDA set out the exact wording
of the text of the suggested booklet in the final rule.
<!-- PJG 0012 frnewline -->
FDA does not have information and data that demonstrate that such a booklet is necessary to protect consumers from
the use with food of decorative ceramicware. Accordingly, FDA is not requiring manufacturers to provide such a booklet,
although FDA believes that a booklet describing the potential hazards of misusing decorative ceramicware may be
useful in helping to make consumers aware of the adverse effects of lead. Therefore, the agency has no objection to
the manufacturers providing such a booklet on their own initiative.
<!-- PJG 0012 frnewline -->
The requirement for a temporary label will respond to the comment's objective of ensuring that consumers are informed
about the intended use of the ware. In addition, FDA uses consumer education vehicles such as the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
FDA Consumer
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 magazine to inform the public about issues concerning misuse of ornamental ceramicware to avoid lead exposure from
this source. The agency, in ``Lead Threat Lessens, But Mugs Pose Problem'' in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
FDA Consumer
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of April 1993, and in ``Reducing Exposure to Lead from Ceramic Ware,'' an 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
FDA Backgrounder
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of November 1991, advised consumers to follow label directions on any ornamental product with a warning that the article
is not for food use.
<!-- PJG 0012 frnewline -->
7. One comment stated that the requirement that ornamental or decorative pieces either bear a permanent statement
on the base or have a hole bored into the food-contact surface is not appropriate for antique or secondhand articles
of value.
<!-- PJG 0012 frnewline -->
The agency advises that this final rule applies to new ornamental or decorative articles initially introduced, or
initially delivered for introduction, into interstate commerce after the effective date of the rule and would not
apply to antique or secondhand articles of value.
<!-- PJG 0012 frnewline -->
The agency considers the safe use of antique or secondhand ceramicware to be a subject for consumer education. The
agency, in ``Pretty Poison: Lead and Ceramicware'' in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
FDA Consumer
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of July/August 1987, and in ``Reducing Exposure to Lead from Ceramic Ware'' in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
FDA Backgrounder
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of November 1991, recommended limiting food use of ceramicware manufactured before Federal standards were imposed.
Dealers and merchants can help inform consumers about the risk posed by such ware by affixing stick-on labels or decals
to articles of questionable origin or safety. The labels or decals should state that the articles are to be used only
for decorative or ornamental purposes. The agency intends to continue to caution consumers that substantial amounts
of lead may leach from antique and other ceramic collectibles into food.
<!-- PJG 0012 frnewline -->
8. One comment stated that certain types of hand-painted and hand-carved decorative ceramicware, such as ``coromandel
porcelain,'' are not subject to kiln firing as part of or after the decoration and painting processes. Thus, the required
statement cannot be fired onto the base of such articles. The comment requested that FDA permit the statement to be
painted on the base of the decorative ceramicware with a permanent paint. The comment further stated that this is the
only commercially practical and feasible method of applying a conspicuous and permanent statement to this type of
ceramicware.
<!-- PJG 0012 frnewline -->
FDA agrees that there is a need to provide for the application of the permanent statement to decorative or ornamental
ceramicware that are not fired after decoration. Accordingly, the agency is providing in &sect;109.16(b)(1)(ii)
that the statement may be painted onto ceramicware using permanent paint when the ceramicware is not fired after decoration.
<!-- PJG 0012 frnewline -->
9. Ceramic product manufacturers commented that if FDA requires the use of the symbol in the final rule, 6 months is
not sufficient time to have molds or decals available. These manufacturers requested that the effective date of the
final rule be delayed in order to have time to phase in use of the symbol. 
<!-- PJG 0012 frnewline -->
Because FDA is making the use of the symbol optional, manufacturers who decide to use it are not subject to an FDA-imposed
time constraint in phasing in its use. Therefore, the agency is not extending the effective date. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Conclusions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
After review and consideration of comments received in response to the portion of its June 1, 1989, proposal that relates
to ornamental and decorative ceramicware (54 FR 23485), the agency is adopting that portion of the proposal as a final
rule. The purpose of the regulation that FDA is adopting is to distinguish ornamental or decorative ceramicware that
may leach excessive amounts of lead into food from ceramic foodware (i.e., ceramicware intended for holding, storing,
or serving food). Section 109.16 provides that FDA will consider all decorative or ornamental ceramicware that appears
to be suitable for food use to be for food use and will regulate it as such, unless a stick-on label bearing one of three
specified statements in letters that are at least 3.2 mm (0.125 in) in height is placed on a readily visible surface
of the ceramicware, and one of the three specified statements in letters that are at least 3.2 mm (0.125 in) in height
is permanently affixed to the exterior surface of the base of the ceramicware. However, if insufficient space exists
for the permanent statement to be presented in letters of such height, the statement shall be in the largest letters
that will allow it to fit on the base of the piece, provided that the letters are at least 1.6 mm (0.062 in) in height. In
the alternative, the manufacturer may bore a hole through the potential food-contact surface of the decorative ceramicware
to make it unsuitable for food use. The final rule also provides that the required statement can be painted onto the
exterior surface of the base if the piece is not fired after decoration. Further, the final rule provides that a symbol
may be used, in addition to the statement or hole bored through the ware, to advise the consumer that the article is not
for food use.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Economic Impact
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
FDA has examined the economic implications of this final rule to amend 21 CFR part 109 as required by Executive Order
12866 and the Regulatory Flexibility Act (Pub. L. 96&hyph;354). Executive Order 12866 compels agencies to use a cost-benefit
analysis as a component of decisionmaking. The Regulatory Flexibility Act requires regulatory relief for small
businesses where feasible. FDA has received no new information or comments that would alter its tentative finding
in the proposal that there is no substantive economic issue, and that this rule is not a major rule as defined by either
Executive Order 12866 or the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Environmental Impact
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency considered the environmental effects of this action in the context of the proposed rule (54 FR 23485). At
that time, the agency prepared an environmental assessment (EA) and concluded that the proposed action would not
have a significant impact on the human environment and that an environmental impact statement (EIS) was not required.
<!-- PJG 0012 frnewline -->
One comment received by the agency on the proposed rule stated that the continued use of lead in consumer products has
a major environmental impact when these products are disposed of, and that FDA had failed to consider fully the environmental
impact of its proposal. As explained above, the aspect of the proposed rule concerned with the reduction in limits
on the levels of lead leaching from ceramic foodware has been addressed by a compliance policy guide (CPG) that was
announced in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of July 6, 1992 (57 FR 29734). At that time the agency prepared an EA for the issuance of this CPG in which, among other
things, it addressed the above comment. The conclusion of that EA was that the agency's action to reduce the limits
on the levels of lead leaching from ceramic foodware may also reduce the amount of lead that could potentially enter
the environment from landfill leachate. This EA is on public display at the Dockets Management Branch (address above).
<!-- PJG 0012 frnewline -->
The other part of the proposed rule is covered by this final rule, i.e., the establishment of labeling requirements
for decorative ceramicware that appears to be suitable for food use. FDA actions that establish regulations for labeling
requirements normally do not require the preparation of an EA or an EIS under &sect;25.24(a)(11) (21 CFR 25.24(a)(11))
because such actions meet specific criteria that are intended to ensure that they will not cause significant environmental
effects. These criteria are that there will be no increase in the existing levels of use or change in the intended uses
of the product or its substitutes. Because the intent of this final rule is to prevent decorative ceramicware from
being used for food service, we conclude that these criteria are met, and that the categorical exclusion in &sect;25.24(a)(11)
applies to the action in this final rule. Therefore, the comment cited above does not provide a basis to change the agency's
previous determination that there is no significant impact on the human environment from this action, and that an
EIS is not required.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 21 CFR Part 109
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Food labeling, Food packaging, Foods, Polychlorinated biphenyls (PCB's).
<!-- PJG 0012 frnewline -->
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food
and Drugs, 21 CFR part 109 is amended to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 109_UNAVOIDABLE CONTAMINANTS IN FOOD FOR HUMAN CONSUMPTION AND FOOD-PACKAGING MATERIALS
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for 21 CFR part 109 is revised to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Secs. 201, 306, 402, 406, 408, 409, 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 336, 342, 346, 346a,
348, 371).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. New &sect;109.16 is added to subpart A to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;109.16 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Ornamental and decorative ceramicware.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) Lead is a toxic metal that is used as a component of glazes and decorative decals on ceramics, including some ornamental
and decorative ceramicware. The use of ornamental or decorative ceramicware to prepare, serve, or hold food may result
in the leaching of lead from the glaze or decoration into the food. The provisions of paragraph (b) of this section are
necessary to ensure that ornamental or decorative ceramicware bear adequate indications that they are not to be used
for food-handling purposes.
<!-- PJG 0012 frnewline -->
(b) Ornamental or decorative ceramicware initially introduced or initially delivered for introduction into interstate
commerce on or after July 13, 1994 appears to be suitable for food use will be considered to be for food use unless:
<!-- PJG 0012 frnewline -->
(1) It bears:
<!-- PJG 0012 frnewline -->
(i) A conspicuous stick-on label on a surface clearly visible to consumers that states in legible script in letters
at least 3.2 millimeters (0.125 inch) in height one of the following messages: ``Not for Food Use. May Poison Food,''
``Not for Food Use. Glaze contains lead. Food Use May Result in Lead Poisoning,'' and ``Not for Food Use_Food Consumed
from this Vessel May be Harmful,'' and
<!-- PJG 0012 frnewline -->
(ii) A conspicuous and legible permanent statement of the message selected from paragraph (b)(1)(i) of this section
molded or fired onto the exterior surface of the base or, when the ceramicware is not fired after decoration, permanently
painted onto the exterior surface of the base. This permanent statement shall be in letters at least 3.2 millimeters
(0.125 inch) in height, except that if insufficient space exists for the permanent statement in letters of such height,
the statement shall be in the largest letters that will allow it to fit on the base of the piece, provided that the letters
are at least 1.6 millimeters (0.062 inch) in height; or
<!-- PJG 0012 frnewline -->
(2) A hole is bored through the potential food-contact surface.
<!-- PJG 0012 frnewline -->
(c) In addition to steps required under paragraphs (b)(1) and (b)(2) of this section, the following optional information
may be provided on the ware:
<!-- PJG 0012 frnewline -->
(1) A further explanatory statement concerning the decorative nature of the piece, such as ``Decorative'' or ``For
Decorative Purposes Only,'' may be used; however, such additional statement shall be placed after the required statement.
<!-- PJG 0012 frnewline -->
(2) A symbol may be used to advise that a piece of ornamental or decorative ceramicware is not to be used with food, as
illustrated below.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG STAG 4725 -->

<IMPORT>

<!-- PJG importformat s,d72 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
E:GRAPHICSER12JA94.001
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</IMPORT>

<!-- PJG /STAG -->

<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The circle of the above symbol should be at least 2.54 centimeters (1 inch) in diameter. The symbol may be used on the
temporary label or applied to the base of the piece in the same manner as the permanent statement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Michael R. Taylor,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Commissioner for Policy.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;706 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00044 </DOCNO>
<PARENT> FR940112-0-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Assistant Secretary for Fair Housing and Equal Opportunity</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>24 CFR Part 104 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. R&hyph;93&hyph;1699; FR&hyph;3485&hyph;F&hyph;01] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Administrative Proceedings Under Section 812 of the Fair Housing Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of the Assistant Secretary for Fair Housing and Equal Opportunity, HUD. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This final rule revises the regulations involving discovery procedures in HUD administrative proceedings. The
revision more clearly sets a standard whereby a party or a person in the custody or under the legal control of a party
will not be required to submit to a physical or mental examination, except upon order of the presiding administrative
law judge pursuant to a motion by the party requesting the examination and a showing by the moving party that the physical
or mental condition of the person who is the subject of the request is in controversy and that good cause exists for the
requested examination. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 February 11, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Harry L. Carey, Assistant General Counsel for Fair Housing, Office of the General Counsel, Department of Housing
and Urban Development, room 9238, 451 Seventh Street, SW., Washington, DC 20410&hyph;0500, telephone: (202) 708&hyph;0570.
(This is not a toll-free number.) A telecommunications device for hearing impaired persons (TDD) is available at
1&hyph;800&hyph;543&hyph;8294. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Part 104 of Title 24 of the Code of Federal Regulations contains HUD's regulations governing administrative proceedings
under section 812 of the Fair Housing Act. Under 24 CFR 104.500 and 104.540, any party may serve on any other party a request
to submit to a physical or mental examination by a physician, specifying the time, place, manner, conditions, and
scope of the physical or mental examination, and the person or persons who will make the examination. Relevancy is
the only explicit requirement regarding all methods of discovery provided in the Fair Housing Act's implementing
regulations, 24 CFR 104.500(b) (1992). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Department is revising 24 CFR 104.500 and 104.540 to conform more closely to Rule 35 of the Federal Rules of Civil
Procedure, as interpreted in certain Federal court precedents. This regulatory revision is designed to further
the already developed practice of Federal administrative law judges looking to Federal Rules of Civil Procedure
in instances in which they construe HUD's regulations governing administrative filings and hearings. See, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g., HUD 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Jerrard, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Fair Housing-Fair Lending (P&hyph;H) para. 25,081 at 25,086 (HUDALJ Sept. 28, 1990) (Accepting analogy to Rules
41(b) and 8(c), Fed. R. Civ. P.); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
HUD 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Downs,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 HUDALJ 02&hyph;89&hyph;0322, Order at 2 (June 21, 1991) (Reliance on Rules 28(a), 30(b)(7), and 32(d)(3)(B), Fed.
R. Civ. P., to reject respondents' claim that deposition was technically defective); and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Downs,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Memorandum Opinion at 2 (Nov. 22, 1991) (Finding Rule 24(a), Fed. R. Civ. P., to provide guidance for resolution of
motion to intervene). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
1. Rule 35 Standard 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under Federal Rule of Civil Procedure 35, relevancy is not a sufficient basis for a court to order a physical or mental
examination. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Holder,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 379 U.S. 104, 118 (1964). Rather, because such examinations are a more intrusive form of discovery than other available
discovery methods, Rule 35 requires stringent standards for their use in Federal court litigation. Such examinations
are only provided for by leave of court and in limited circumstances. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Rule 35 provides: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
When the mental or physical condition (including the blood group) of a party or of a person in the custody or under the
legal control of a party, is in controversy, the court in which the action is pending may order the party to submit to
a physical or mental examination by a suitably licensed or certified examiner or to produce for examination the person
in the party's custody or legal control. The order may be made only on motion for good cause shown and upon notice to the
person to be examined and to all parties and shall specify the time, place, manner, conditions, and scope of the examination
and the person or persons by whom it is to be made. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As stated in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guilford National Bank 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Southern R. Co.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 297 F.2d 921, 924 (4th Cir. 1962), ``Under Rule 35, the invasion of the individual's privacy by a physical or mental
examination is so serious that a strict standard of good cause, supervised by the district courts, is manifestly appropriate.''
The Supreme Court, in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf, supra,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 emphasized the limited circumstances under which a court may order mental or physical examinations under Rule 35:

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Sweeping examinations of a party who has not affirmatively put into issue his own mental or physical condition are
not to be automatically ordered *&blank;*&blank;* Mental and physical examinations are only to be ordered upon a
discriminating application by the district judge of the limitations prescribed by the Rule. To hold otherwise would
mean that such examinations could be ordered routinely *&blank;*&blank;* The plain language of Rule 35 precludes
such an untoward result.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Schlagenhauf,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 379 U.S. at 121&hyph;22. See also 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
In re Mitchell,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 563 F.2d 143 (5th Cir. 1977) (Rule 35 order requires greater showing than general discovery under Rule 26). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The requirements under Rule 35 differ from those imposed by other discovery provisions in the Federal Rules of Civil
Procedure, such as the taking of oral and written depositions (Rules 26&hyph;32), interrogatories to parties (Rule
33), and the production of documents (Rule 34). None of these other discovery methods require that a matter be ``in
controversy'' and only Rule 34 imposes a requirement that the moving party affirmatively demonstrate ``good cause.''
See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 379 U.S. at 117. In general, other discovery devices under the Federal Rules of Civil Procedure do not require leave
of court. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Rule 35 requires that the party requesting a physical or mental examination make a motion and meet notice requirements.
For such a motion to be granted, the following standard must be met: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. The physical or mental condition of the person to be examined must be in controversy; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. There must be a showing of good cause. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00045 </DOCNO>
<PARENT> FR940112-0-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These requirements are not met by ``mere conclusory allegations of the pleadings_nor by mere relevance to the case_but
require an affirmative showing *&blank;*&blank;* that each condition as to which the examination is sought is really
and genuinely in controversy and that good cause exists for ordering each particular examination.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 379 U.S. at 118. Precedent establishes that it is the moving party which has the burden of demonstrating that this standard
is met. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
a. ``In Controversy'' Requirement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Federal precedents have varied in their interpretation of the ``in controversy'' requirement. In negligence cases,
courts generally have been receptive to defendants' requests for such examinations where physical or mental injury
is claimed. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brandenberg 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
El Al Israel Airlines,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 79 F.R.D. 543 (1978) (ordering psychiatric examination of plaintiff alleging negligent, careless and reckless
treatment caused her ``physical, emotional, mental stress, and mental and psychiatric injuries''); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Martin 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tindell,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 98 So.2d 473, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
cert. denied,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 355 U.S. 959 (negligence case indicating physical exams are granted as a matter of course in such cases). Even in negligence
cases, however, examinations may not be ordered where damages only for past injury are alleged, rather than damages
for present suffering. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Winters 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Travia,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 495 F.2d 839 (2d Cir. 1974); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Coca-Cola Bottling Co. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Torres,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 255 F.2d 149 (1st Cir. 1958). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the civil rights cases, however, courts have demonstrated greater reluctance to order such examinations. In 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Marriot Corporation,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 103 F.R.D. 421, 422&hyph;23 (D. Mass. 1984), the court indicated that the standard for ordering such examinations
in discrimination cases is more stringent than in tort cases involving negligence. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The reported civil rights cases interpreting Rule 35 have generally involved requests by defendants for mental examinations
of plaintiffs. A review of employment discrimination cases interpreting Rule 35 demonstrates that mental examinations
of plaintiffs are not routinely ordered in such cases simply because plaintiffs may claim damages for emotional distress.
Furthermore, a claim of emotional distress is not considered to place automatically a plaintiff's mental condition
in controversy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 referred to, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
supra,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 was one important employment discrimination case involving the application of Rule 35. Citing 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Cody refused to order a mental examination of a plaintiff who claimed emotional distress as a result of employment
discrimination. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 indicated that the outcome might have been different had the plaintiff not merely ``made a claim of emotional distress''
but instead had made ``a claim of a psychiatric disorder requiring psychiatric or psychological counseling.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 103 F.R.D. at 423. This distinction, based on the severity of the injury alleged, has also been applied in other tort
contexts. See, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g., Anson 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fickel,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 110 F.R.D. 184, 186 (N.D. Ind. 1986) (traffic accident case citing 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and making same distinction). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 also noted that the moving party had shown no authority for the proposition that ``emotional distress'' is synonymous
with ``mental condition,'' as that term is used in Rule 35. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 103 F.R.D. at 422 n.2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 indicated that if, in contrast, the plaintiff were to use the services of a psychiatrist or psychologist at a later
date for use at trial, the court would consider allowing the defendants to conduct the Rule 35(a) examination. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 103 F.R.D. at 423. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thus, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 suggested two factors that differentiate the circumstances in which the ``in controversy'' requirement would or
would not be met. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
b. ``Good Cause'' Requirement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition to the ``in controversy'' requirement, an examination may only be ordered if ``good cause'' is also shown.
The good-cause requirement is not a ``mere formality,'' but is a ``plainly expressed limitation on [Rule 35's] use
*&blank;*&blank;*.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 379 U.S. at 118. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00046 </DOCNO>
<PARENT> FR940112-0-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
noted with approval the discussion of the ``good cause'' requirement in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guilford National Bank 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Southern R. Co., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
297 F.2d 921, 924 (4th Cir. 1962). In 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guilford
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, the court stated that ``the Rules indicate that there must be a greater showing of need under Rules 34 and 35 than under
the other discovery rules,'' and that the requirement would be ``meaningless'' if it could be established by ``merely''
showing that the information sought is relevant. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guilford
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 297 F.2d at 924. Although the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guilford
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 court discussed the ``good cause'' requirement in the context of the plaintiff's Rule 34 request for production of
documents (which the court denied), it stated the policy reason for imposing the ``good cause'' requirement of Rule
35: ``the invasion of an individual's privacy by a physical or mental examination is so serious that a strict standard
of good cause, supervised by the district courts, is manifestly appropriate.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The court further stated, ``[R]elevancy is not the equivalent of good cause *&blank;*&blank;*.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guilford
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 297 F.2d at 925. 
<!-- PJG 0012 frnewline -->
Other precedents establish that ``The ability of the movant to obtain the desired information by other means is also
relevant'' to the determination of whether good cause is shown. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 379 U.S. at 118. This principle has been applied in several subsequent reported decisions. In 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anson, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
110 F.R.D. at 186, a traffic accident case, the court considered the fact that the defendants had utilized other discovery
procedures before seeking a mental examination of the plaintiff. In ordering a mental examination of the plaintiff,

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anson 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
considered the defendant's attempts first to obtain information through alternative means such as submitting the
plaintiff's medical records to the defendants' own expert for analysis. Other tort cases have recognized that where
medical reports are provided, good cause may no longer exist for ordering a mental examination. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hughes 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Groves
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 47 F.R.D. 52, 57 (1969); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Petition of Trinidad Corp.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 238 F. Supp. 928, 935 (1965). 
<!-- PJG 0012 frnewline -->
This principle has been applied as well in cases where the plaintiff seeks a mental examination of the defendant. For
example, in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Marroni 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Matey
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 82 F.R.D. 371 (1979), a tort case involving a child injured in a boating accident, the plaintiff requested a psychological
exam of the defendant boat operator to show that he was incapable of properly operating it and understanding safety
rules. The court denied the request holding that the plaintiff first had to utilize less intrusive methods of discovery
to attempt to obtain the desired information. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Marroni
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 82 F.R.D. at 372. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2. Application of Rule 35 Standard to Fair Housing Cases 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Two recent Federal Administrative decisions, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
HUD 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ocean Sands, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, HUDALJ 04&hyph;90&hyph;0231&hyph;1, Order (April 20, 1993); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
HUD 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ocean Parks Jupiter Condominium Association, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, HUDALJ 04&hyph;90&hyph;0589&hyph;1 and 04&hyph;90&hyph;0604&hyph;1, Order Denying Motion for Protective
Order (December 8, 1992), appear to set a standard under which a defendant may obtain a mental examination of an aggrieved
person simply because damages for emotional distress are being sought. 
<!-- PJG 0012 frnewline -->
The Secretary believes such a standard is inappropriate in fair housing cases. Rather, as provided for in this revised
rule, fair housing cases are governed by a more restrictive standard, consistent with the standards that have been
applied in other civil rights contexts. The Department, following the lead of courts, has commonly relied on civil
rights cases in other contexts, especially employment discrimination precedents, for guidance in housing discrimination
cases under the Fair Housing Act. See, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g., Huntington Branch, N.A.A.C.P. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Town of Huntington
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 844 F.2d 926, 935 (2d Cir.), aff'd, 488 U.S. 15 (1988); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
HUD 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Blackwell
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Fair Housing-Fair Lending (P&hyph;H) para. 25,001 at 25,005 (1989). This rule furthers that practice by looking
to Federal court precedents construing Rule 35 to allow such examinations only in limited circumstances. 
<!-- PJG 0012 frnewline -->
Under the revised standard, the fact that the Secretary, on behalf of an aggrieved person, or an intervening aggrieved
person, may request a large amount of monetary relief and/or significant relief for emotional distress, would not
support an order requiring the aggrieved person to submit to a mental examination. Rather, the Department adopts
a standard consistent with Rule 35 which requires that the moving party demonstrate that the aggrieved person's mental
condition is ``in controversy'' and that ``good cause'' exists. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
a. Application of ``In Controversy'' Requirement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department believes that a claim of emotional distress is different from putting mental condition ``in controversy.''
See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 103 F.R.D. at 422 n.2. Rather, the Department adopts the two factors cited in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, to distinguish circumstances in which the ``in controversy'' requirement is met from those in which the requirement
is not met, where the respondent is seeking a mental examination of an aggrieved person. In general, unless one or more
of these factors is met, an aggrieved person should not be ordered to undergo a mental examination. 
<!-- PJG 0012 frnewline -->
The first factor that the Department will apply is whether the plaintiff has made ``a claim of a psychiatric disorder
requiring psychiatric or psychological counseling'' or ``a claim of emotional distress.'' See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 103 F.R.D. at 423. Generally, in the former circumstance, the ``in controversy'' requirement would be met, while
in the latter circumstance it would not be met. 
<!-- PJG 0012 frnewline -->
The second factor that the Department will apply under the revised standard is whether the aggrieved person intends
to introduce at hearing the expert testimony of a psychiatrist or psychologist to support a claim of mental or emotional
injury. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cody
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 103 F.R.D. at 423. In general, if so, the ``in controversy'' requirement will be met but if not, the ``in controversy''
requirement will not be met. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
b. Application of ``Good Cause'' Requirement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In determining whether the second requirement, ``good cause'' is met, the Department will require more than mere
relevancy. Instead, where there is a claim of mental or emotional distress, the Department will consider whether
the respondents have had and exercised the opportunity to obtain and present information about an aggrieved person's
mental or emotional state through other less intrusive means. These alternatives may, in appropriate circumstances,
include deposing the aggrieved person in advance of trial as to his or her injuries, using direct or cross examination
of the aggrieved person at hearing as to such injuries, interrogatories, requests for production of documents, and,
where aggrieved persons have consulted psychiatrists or psychologists, evaluation of those records by respondents'
own experts. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schlagenhauf
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 379 U.S. at 118; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hughes, supra; Petition of Trinidad Corp., supra; Anson
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 103 F.R.D. at 186. Where a mental examination is requested, the burden shall be on the moving party to establish why
these alternative methods have not been used, or where used, why these alternative methods have proven insufficient.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00047 </DOCNO>
<PARENT> FR940112-0-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department believes that the same policy reason for applying strict standards in federal court litigation in
civil rights cases applies equally to the administrative process, where litigants should not be forced to abandon
their right to privacy by choosing the administrative forum rather than electing, pursuant to 42 U.S.C. 3612, to have
the matter tried in Federal district court. The current administrative standard has been interpreted in a manner
that may make it easier for respondents to obtain orders requiring aggrieved persons to submit to physical or mental
examinations than would be the case in Federal court litigation. Such a situation, if allowed to continue, could lead
HUD complainants to elect to have their matter heard in federal court, rather than in the administrative forum, since
the differing standards would make federal courts better protectors of their privacy rights. This regulatory revision
is intended to ensure that aggrieved persons who have been victims of alleged discrimination will not be victimized
again by being made to undergo unjustified probing into their physical or mental condition by respondents while the
Government endeavors to protect their civil rights. The regulation, however, still allows for examinations in those
limited circumstances where such examinations are shown to be necessary. 
<!-- PJG 0012 frnewline -->
A further negative consequence of recent administrative rulings on this issue is less expeditious and more expensive
discovery and hearings contrary to the dictates of 42 U.S.C. 3612(d)(1) and (2); 24 CFR 104.500(b) (1992). See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
HUD 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Downs
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 2 Fair Housing-Fair Lending (P-H) para. 25,234 at 25,235 n.1 (Nov. 22, 1991). The cost of expert psychiatric or psychological
testimony is prohibitive in many administrative hearings. While expert testimony for both sides in Fair Housing
Act cases might be necessary to the trier of fact in limited circumstances, in general the time and expense involved
in their use would clash directly with Congress's mandate that discovery and hearings be conducted ``as expeditiously
and inexpensively as possible''. 42 U.S.C. 3612(d)(1) and (2). See also 24 CFR 104.500(b); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
HUD 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Downs
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 2 Fair Housing-Fair Lending at 25,235 n.1. Recent interpretations of the current regulation, which appear to order
examinations without the need for the moving party to meet strict ``in controversy'' and ``good cause'' requirements,
could lead to more time-consuming and expensive administrative litigation. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3. Examination by Non-Physicians 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This final rule is revised to conform to Rule 35 in another respect as well. Federal Rule of Civil Procedure 35 was revised
effective December 1, 1991, subsequent to the Department's promulgation of 24 CFR 104.540 at 54 FR 3232 (Jan. 23, 1989).
That revision authorized courts to require physical or mental examinations conducted by any person who is suitably
licensed or certified, rather than limiting such examinations to those conducted by a physician, as under the literal
language of HUD's current regulation.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00048 </DOCNO>
<PARENT> FR940112-0-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Advisory Committee Notes to the 1991 Amendment to Rule 35 are particularly useful in understanding how this change
to the revised rule shall operate. The Advisory Committee Note states:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The rule was revised in 1988 by Congressional enactment to authorize mental examinations by licensed clinical psychologists.
This revision extends that amendment to include other certified or licensed professionals, such as dentists or occupational
therapists, who are not physicians or clinical psychologists, but who may be well-qualified to give valuable testimony
about the physical or mental condition that is the subject of dispute. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The requirement that the examiner be suitably licensed or certified is a new requirement. The court is thus expressly
authorized to assess the credentials of the examiner to assure that no person is subjected to a court-ordered examination
by an examiner whose testimony would be of such limited value that it would be unjust to require the person to undergo
the invasion of privacy associated with the examination. This authority is not wholly new, for under the former rule,
the court retained discretion to refuse to order an examination, or to restrict an examination. 8 Wright &amp; Miller,
Federal Practice &amp; Procedure section 2234 (1986 Supp.). The revision is intended to encourage the exercise of
this discretion, especially with respect to examinations by persons having narrow qualifications. 
<!-- PJG 0012 frnewline -->
The court's responsibility to determine the suitability of the examiner's qualifications applies even to a proposed
examination by a physician. If the proposed examination and testimony calls for an expertise that the proposed examiner
does not have, it should not be ordered, even if the proposed examiner is a physician. The rule does not, however, require
that the license or certificate be conferred by the jurisdiction in which the examination is conducted. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department is publishing this rule as a final rule without prior public notice and opportunity to comment because
the rule's content is technical in nature and limited to the practices and procedures associated with administrative
proceedings. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Other Matters 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
An environmental finding under the National Environmental Policy Act (42 U.S.C. 4321&hyph;4347) is unnecessary
because this rule relates to agency administrative procedures governing discovery of evidence. 
<!-- PJG 0012 frnewline -->
This final rule was determined to be non-significant and therefore was not reviewed by the Office of Management and
Budget under Executive Order 12866, Regulatory Planning and Review, which was signed by the President on September
30, 1993. 
<!-- PJG 0012 frnewline -->
The Secretary, in approving the publication of this rule, certifies in accordance with 5 U.S.C. 605(b) (the Regulatory
Flexibility Act), that this rule does not have a significant economic impact on a substantial number of small entities.
The rule is a technical, procedural change which only affects operations within HUD. The rule does not affect substantive
rights. 
<!-- PJG 0012 frnewline -->
The General Counsel, as the Designated Official under Executive Order 12606, The Family, has determined that this
rule would have no significant impact on family formation, maintenance, and general well-being. 
<!-- PJG 0012 frnewline -->
The General Counsel, as the Designated official under section 6(a) of Executive Order 12612, Federalism, has determined
that this rule, if implemented, would have no significant impact on federalism. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00049 </DOCNO>
<PARENT> FR940112-0-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This rule was listed as item 1623 in the Department's Semiannual Agenda of Regulations published on October 25, 1993
(58 FR 56408, 56445) under Executive Order 12866 and the Regulatory Flexibility Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(The catalog of Federal Domestic Assistance program number and title is 14.400, Equal Opportunity in Housing.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 24 CFR Part 104 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Administrative practice and procedure, Aged, Fair Housing, Individuals with disabilities, Mortgages, Penalties.

<!-- PJG 0012 frnewline -->
Accordingly 24 CFR part 104 is amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 104_ADMINISTRATIVE PROCEEDINGS UNDER SECTION 812 OF THE FAIR HOUSING ACT 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 104 is revised to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 42 U.S.C. 3535(d) and 3600&hyph;3620. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 104.500 is amended by revising paragraph (c)(3) and by adding paragraph (c)(5) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;104.500 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Discovery. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c)&blank;*&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(3) Requests for the production of documents or other evidence, for inspection and other purposes. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(5) Upon motion of a party, the presiding administrative law judge may issue an order requiring a physical or mental
examination of a party or of a person in the custody or under the legal control of a party. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. Section 104.540 is amended by revising the section heading, by removing paragraphs (a)(3) and (b)(4), and by adding
paragraph (d) to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;104.540 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Physical and mental examinations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) Upon motion of any party, when the mental or physical condition (including the blood group) of a party or of a person
in the custody or under the legal control of a party, is in controversy, the presiding administrative law judge may
order the party to submit to a physical or mental examination by a suitably licensed or certified examiner or to produce
for examination the person in the party's custody or legal control. The order may be made only on motion for good cause
shown and upon notice to the person to be examined and to all parties and shall specify the time, place, manner, conditions,
and scope of the examination and the person or persons by whom it is to be made. A report of the examiner shall be made in
accordance with Rule 35(b) of the Federal Rules of Civil Procedure. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 17, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Roberta Achtenberg,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Fair Housing and Equal Opportunity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;691 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;28&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00050 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF DEFENSE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>32 CFR Part 40a</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Defense Contracting; Reporting Procedures on Defense-Related Employment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of the Secretary, DoD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This rule is the fiscal year 1993 revision of the section listing DoD contractors receiving contract awards of $10
million or more. This part is published to comply with the provisions of section 1, Public Law 97&hyph;295, October
12, 1982; 10 U.S.C. 2397.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
September 30, 1993.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Mr. R.S. Drake, Acting Director, Directorate for Information Operations and Reports, Washington Headquarters
Services, 1215 Jefferson Davis Highway, suite 1204, Arlington, VA 22202&hyph;4302; Telephone (703) 746&hyph;0334.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 32 CFR Part 40a
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Armed forces, Conflicts of interest, Government employees, Government procurement, Reporting and recordkeeping
requirements.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Accordingly, 32 CFR part 40a is revised to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 40a_DEFENSE CONTRACTING: REPORTING PROCEDURES ON DEFENSE-RELATED EMPLOYMENT
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
10 U.S.C. 2397.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;40a.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Department of Defense contractors receiving awards of $10 million or more.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Fiscal Year 1993
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
A&amp;E Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AAI Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AAR Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ABB Flakt Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Abu Dhabi National Oil Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ACS Construction Co. of Miss.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AEL Defense Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AIL Systems, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AM General Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AT&amp;T Communications, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AU's Plumbing &amp; Metal Work 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AWD Technologies, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Abacus Technology Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Abbott Laboratories
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Access Energy Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Accudyne Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Actus Corp. &amp; Sundt Corp. JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Advance, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Advanced Electronics Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Advanced Marine Enterprises
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aepco, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aerojet
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aerospace Corp., The
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Afram Lines, Ltd., USA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Agip Petroli SPA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Agusta Aerospace Services_AA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Air BP
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Air Treads, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Airfoil Textron, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aksarben Foods, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Al Rashid Abdullah Abu Nayyan
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Al-Abdulkader Trade &amp; Contract
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alberici Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alisud Handling SPA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All Star Maintenance, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alliant Techsystems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alliant Petro, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Allied Signal Aerospace Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Allied Signal, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alpha Marine Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Altama Delta Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Amerada Hess Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Engineer Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Fuel Cell &amp; Coated Fabrics
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Management Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Overseas Maine Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Systems Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Systems Engineering Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Telephone &amp; Telegraph Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
American Trans Air, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Amerind, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00051 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Ametek, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Amherst Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Amoco Oil Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Amtec Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Analysis &amp; Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Analytic Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Anderson De Bartolo Pan, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Andrulis Research Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Angelo H. &amp; Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applied Data Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applied Research Associates, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applied Technology Associates, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aral AG
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Arctic Slope Regional Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Arinc, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Arinc Research Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Artco Contracting, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Association Momentanee Entre
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Assurance Technology Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Astro Space Div., GE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Astronautics Corp. of America
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atherton Construction, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atlantic Coastal, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atlantic Marine Holding Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atlantic Research Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atlantic Richfield Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Atlas Processing Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Autec Range Services
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Automated Sciences Group, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Avco Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Avco Research Labs
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Avondale Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B&amp;S Transport
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
BAMSI, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
BDM International, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
BDM Management Services Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
BEI Electronics, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
BJS International Associates
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
BP Exploration &amp; Oil Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
BP Oil Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Babcock &amp; Wilcox Co., The 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Baker Michael Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Balfour Beatty Const., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Balfour Beatty, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Balimoy Mfg. Co. of Venice
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ball Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Baltimore Gas &amp; Electric Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bangor Support Project
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Barrett Refining Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bath Iron Works Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Battelle Memorial Institute
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bay Ship Management, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bay Tankers, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bean C.F. Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bear Stearns Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bechtel National, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Beech Aerospace Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Beech Aircraft Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bell Atlantic Network Svcs., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bell BCI Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bell Boeing JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bell Helicopter Services Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bell Helicopter Textron, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bellemead Development Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Belleville Shoe Mfg. Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bender, Allen L., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bender Shipbuilding &amp; Repair Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bendix Field Engineering Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Beneco Enterprises, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Benham Companies, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Betac Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bethlehem Steel Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bionetics Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Black &amp; Decker Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Black &amp; Veatch
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Black &amp; Veatch Holding Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Black Construction Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Blake Construction Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Blue Cross &amp; Blue Shield of South Carolina
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Boeing Aerospace Operations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Boeing Co. &amp; Sikorsky Aircraft JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00052 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Boeing Co., The
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Boeing Sikorsky Comanche Team JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Boland, David, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bollinger Machine Shop &amp; Shipyard
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bolt Beranek &amp; Newman, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bombardier, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Booz Allen &amp; Hamilton, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bozell Jacobs Kenyon Eckhardt
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brimhall-Palmer Construction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brown &amp; Root Services Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brown, Dayton T., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Brunswick Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Bundesamt Fuer Wehrtechnik
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Burch R.A. Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Burle Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Burns &amp; Roe Enterprises, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Burnside Ott Aviation Training Center
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C3, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C Construction Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C-Cubed Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CACI International, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CAE Industries, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CAE Link Holdings Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CAS, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CBPO of America, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CFM International, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CH2M Hill Companies, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CIA Espanola De Petroleos SA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CRS Sirrine Metcalf &amp; Eddy JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CRSS, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CTA, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Caddell Construction Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cadillac Gage Textron, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
California Microwave, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Calore Enterprises, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Calspan Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Camel Manufacturing Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Campbell Soup Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Canadian Commercial Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Canadian National Railways
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cargill, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Carnegie Mellon University
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Carnes Construction, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Carolina Power &amp; Light Co.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cartwright Electronics, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Caterpillar, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Celsiustech Electronics AB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Center For Naval Analyses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Central Coast Water Authority
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Central Gulf Lines, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Century Concrete Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Century Technologies, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ceridian Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Certified Slings, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chamberlain Manufacturing Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chem-Nuclear Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chesapeake &amp; Potomac Telephone Co. of Virginia 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chevron USA, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Childers Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chromalloy Gas Turbine Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Chrysler Technologies Airborne Systems 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cincinnati Bell, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cincinnati Electronics Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cinpac, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Coastal Eagle Point Oil Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Coastal Healthcare Group, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Coastal Oil New England, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Coastal Refining &amp; Marketing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Coastal States Trading, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cocke Bartlett Jr. Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Codar Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Codex Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Colejon Mechanical Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Coleman Research Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Colsa, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Coltec Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Columbia Research Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comarco, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comcon, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Commonwealth of Australia
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Communications Satellite Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00053 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Compania De Petroleos De Chile
<!-- PJG 0012 frnewline -->
Compliance Corp.
<!-- PJG 0012 frnewline -->
Comprehensive Technologies International
<!-- PJG 0012 frnewline -->
Comptek Research, Inc.
<!-- PJG 0012 frnewline -->
Computer Associates International
<!-- PJG 0012 frnewline -->
Computer Dynamics, Inc.
<!-- PJG 0012 frnewline -->
Computer Engineering Association
<!-- PJG 0012 frnewline -->
Computer Sciences Corp.
<!-- PJG 0012 frnewline -->
Computer Sciences Raytheon JV
<!-- PJG 0012 frnewline -->
Computer Systems Development
<!-- PJG 0012 frnewline -->
Conagra, Inc.
<!-- PJG 0012 frnewline -->
Conax Corp.
<!-- PJG 0012 frnewline -->
Concord Hill Group, Inc.
<!-- PJG 0012 frnewline -->
Concurrent Computer Corp.
<!-- PJG 0012 frnewline -->
Conner Brothers Construction Co.
<!-- PJG 0012 frnewline -->
Consolidated Services, Inc.
<!-- PJG 0012 frnewline -->
Contel Corp.
<!-- PJG 0012 frnewline -->
Conti Environmental, Inc.
<!-- PJG 0012 frnewline -->
Continental Maritime of San Diego
<!-- PJG 0012 frnewline -->
Contrack International, Inc.
<!-- PJG 0012 frnewline -->
Contraves, Inc.
<!-- PJG 0012 frnewline -->
Coors Porcelain Co.
<!-- PJG 0012 frnewline -->
Cosmo Oil Co., Ltd.
<!-- PJG 0012 frnewline -->
Cray Research, Inc.
<!-- PJG 0012 frnewline -->
Crowley American Transport, Inc.
<!-- PJG 0012 frnewline -->
Crysen Corp.
<!-- PJG 0012 frnewline -->
Cubic Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cummins Engine Co., Inc.
<!-- PJG 0012 frnewline -->
DBA Systems, Inc.
<!-- PJG 0012 frnewline -->
DCS Corp.
<!-- PJG 0012 frnewline -->
DKH Healthcare Corp.
<!-- PJG 0012 frnewline -->
DME Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
DTH Contract Services, Inc.
<!-- PJG 0012 frnewline -->
Dakota Tribal Industries, Inc.
<!-- PJG 0012 frnewline -->
Dames &amp; Moore
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Danis Companies, The
<!-- PJG 0012 frnewline -->
Data General Corp.
<!-- PJG 0012 frnewline -->
Day &amp; Zimmerman, Inc.
<!-- PJG 0012 frnewline -->
Day &amp; Zimmerman/Basil Corp. JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Decisions Systems Technology
<!-- PJG 0012 frnewline -->
Deere &amp; Company
<!-- PJG 0012 frnewline -->
Del Jen, Inc.
<!-- PJG 0012 frnewline -->
Delta Air Lines, Inc.
<!-- PJG 0012 frnewline -->
Delta Dental Plan of California
<!-- PJG 0012 frnewline -->
Den Norske Stats Oljeselskap AG
<!-- PJG 0012 frnewline -->
Deutsche Bundesbahn
<!-- PJG 0012 frnewline -->
Deutsche Texaco AG
<!-- PJG 0012 frnewline -->
Deval Corp.
<!-- PJG 0012 frnewline -->
Development Sciences Corp.
<!-- PJG 0012 frnewline -->
Devtec Corp.
<!-- PJG 0012 frnewline -->
Diagnostic Retrieval Systems
<!-- PJG 0012 frnewline -->
Diamond Shamrock Refining
<!-- PJG 0012 frnewline -->
Dick, P.J. Contracting, Inc.
<!-- PJG 0012 frnewline -->
Digital Equipment Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Digital Systems Research, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Diversified Services
<!-- PJG 0012 frnewline -->
Donohue &amp; Associates, Inc.
<!-- PJG 0012 frnewline -->
Drake, Donald M. Co.
<!-- PJG 0012 frnewline -->
Draper, Charles Stark Laboratories, Inc.
<!-- PJG 0012 frnewline -->
Dreadnought Marine, Inc.
<!-- PJG 0012 frnewline -->
Drexel Industries, Inc.
<!-- PJG 0012 frnewline -->
Du Pont, E.I. de Nemours &amp; Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Dual, Inc.
<!-- PJG 0012 frnewline -->
Duchossois Enterprises, Inc.
<!-- PJG 0012 frnewline -->
Dynamics Research Corp.
<!-- PJG 0012 frnewline -->
Dyncorp
<!-- PJG 0012 frnewline -->
Dynetics, Inc.
<!-- PJG 0012 frnewline -->
E-Systems, Inc.
<!-- PJG 0012 frnewline -->
EA Engineering &amp; Science Technology
<!-- PJG 0012 frnewline -->
EC III JV
<!-- PJG 0012 frnewline -->
ECC International Corp.
<!-- PJG 0012 frnewline -->
EDO Corp.
<!-- PJG 0012 frnewline -->
EDP Enterprises, Inc.
<!-- PJG 0012 frnewline -->
EER Systems Corp.
<!-- PJG 0012 frnewline -->
EG&amp;G, Inc.
<!-- PJG 0012 frnewline -->
EG&amp;G Management Systems
<!-- PJG 0012 frnewline -->
EG&amp;G Riticon
<!-- PJG 0012 frnewline -->
EG&amp;G Washington Analytical Services Center
<!-- PJG 0012 frnewline -->
ESL, Inc.
<!-- PJG 0012 frnewline -->
ETA Technologies Corp.
<!-- PJG 0012 frnewline -->
Eagan McAllister Associates
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00054 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Eagle Technology, Inc.
<!-- PJG 0012 frnewline -->
Earl Industries, Inc.
<!-- PJG 0012 frnewline -->
Earth Technology Corp.
<!-- PJG 0012 frnewline -->
East Penn Manufacturing Co.
<!-- PJG 0012 frnewline -->
Eastman Kodak Co.
<!-- PJG 0012 frnewline -->
Eaton Corp.
<!-- PJG 0012 frnewline -->
Ebasco Constructors, Inc.
<!-- PJG 0012 frnewline -->
Ebasco Services, Inc.
<!-- PJG 0012 frnewline -->
Ecology &amp; Environment, Inc.
<!-- PJG 0012 frnewline -->
Edge Systems, Inc.
<!-- PJG 0012 frnewline -->
Eldyne, Inc.
<!-- PJG 0012 frnewline -->
Electro Methods, Inc.
<!-- PJG 0012 frnewline -->
Electronic Component Sales
<!-- PJG 0012 frnewline -->
Electronic Data Systems Corp.
<!-- PJG 0012 frnewline -->
Electronic Warfare Associates
<!-- PJG 0012 frnewline -->
Electronics &amp; Space Corp.
<!-- PJG 0012 frnewline -->
Electrospace Systems, Inc.
<!-- PJG 0012 frnewline -->
Elf France
<!-- PJG 0012 frnewline -->
Elometa Corp.
<!-- PJG 0012 frnewline -->
Emergency Medical Services Associates
<!-- PJG 0012 frnewline -->
Empresa Nacional De Energia El
<!-- PJG 0012 frnewline -->
Endevco, Inc.
<!-- PJG 0012 frnewline -->
Engineered Support Systems
<!-- PJG 0012 frnewline -->
Engineering Research Assoc.
<!-- PJG 0012 frnewline -->
Engineering Science, Inc.
<!-- PJG 0012 frnewline -->
Enginetics Corp.
<!-- PJG 0012 frnewline -->
Ensafe/Allen &amp; Hoshall
<!-- PJG 0012 frnewline -->
Ensco, Inc.
<!-- PJG 0012 frnewline -->
Entek, Inc.
<!-- PJG 0012 frnewline -->
Entwistle Co., The
<!-- PJG 0012 frnewline -->
Environmental Research Institute of Michigan
<!-- PJG 0012 frnewline -->
Environmental Science &amp; Engineering
<!-- PJG 0012 frnewline -->
Environmental Technologies Group
<!-- PJG 0012 frnewline -->
Exide Electronics Corp.
<!-- PJG 0012 frnewline -->
Exodyne, Inc.
<!-- PJG 0012 frnewline -->
Exxon Co., USA
<!-- PJG 0012 frnewline -->
Exxon International Services
<!-- PJG 0012 frnewline -->
FEL Corp.
<!-- PJG 0012 frnewline -->
FKW, Inc.
<!-- PJG 0012 frnewline -->
FMC Corp.
<!-- PJG 0012 frnewline -->
FMS Corp.
<!-- PJG 0012 frnewline -->
FN Manufacturing, Inc.
<!-- PJG 0012 frnewline -->
Fairchild Aircraft, Inc.
<!-- PJG 0012 frnewline -->
Fairchild Industries, Inc.
<!-- PJG 0012 frnewline -->
Fairchild Space &amp; Defense Corp.
<!-- PJG 0012 frnewline -->
Falcon Microsystems, Inc.
<!-- PJG 0012 frnewline -->
Farrell Lines, Inc.
<!-- PJG 0012 frnewline -->
Federal Data Corp.
<!-- PJG 0012 frnewline -->
Federal Express
<!-- PJG 0012 frnewline -->
Federal Express, Northwest Airlines, PanAm World Airways, Tower Air &amp; United Parcel Service JV
<!-- PJG 0012 frnewline -->
Federal Prison Industries
<!-- PJG 0012 frnewline -->
Federal Republic of Germany
<!-- PJG 0012 frnewline -->
Federal Sector Services 
<!-- PJG 0012 frnewline -->
Federal Hoffman, Inc.
<!-- PJG 0012 frnewline -->
Ferguson Williams, Inc.
<!-- PJG 0012 frnewline -->
Fidelity Technologies Corp.
<!-- PJG 0012 frnewline -->
Firth Construction Co., Inc.
<!-- PJG 0012 frnewline -->
Flightsafety International, Inc.
<!-- PJG 0012 frnewline -->
Flightsafety Service Corp.
<!-- PJG 0012 frnewline -->
Florida Power &amp; Light Co.
<!-- PJG 0012 frnewline -->
Fluor Corp.
<!-- PJG 0012 frnewline -->
Fluor Daniel, Inc.
<!-- PJG 0012 frnewline -->
Ford, H.J. Associates, Inc.
<!-- PJG 0012 frnewline -->
Foundation Health Corp.
<!-- PJG 0012 frnewline -->
Freedon Forge Corp.
<!-- PJG 0012 frnewline -->
Frito Lay, Inc.
<!-- PJG 0012 frnewline -->
Frontier Engineering, Inc.
<!-- PJG 0012 frnewline -->
G&amp;C Enterprises, Inc.
<!-- PJG 0012 frnewline -->
GDE Holdings Co. (DE)
<!-- PJG 0012 frnewline -->
GDE Systems, Inc.
<!-- PJG 0012 frnewline -->
GEC Avionics, Ltd.
<!-- PJG 0012 frnewline -->
GEC Marconi Co., Ltd.
<!-- PJG 0012 frnewline -->
GM Hughes Electronics Corp.
<!-- PJG 0012 frnewline -->
GTE Corp.
<!-- PJG 0012 frnewline -->
GTE Government Systems Corp.
<!-- PJG 0012 frnewline -->
GTE Hawaiian Telephone Co., Inc.
<!-- PJG 0012 frnewline -->
GTE Products Corp.
<!-- PJG 0012 frnewline -->
GTE Service
<!-- PJG 0012 frnewline -->
GTE Sylvania Products
<!-- PJG 0012 frnewline -->
Gaeco International Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00055 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Galaxy Builders, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Garcia, Luis E., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gary-Williams Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Atomics
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Directorate of PTT
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Dynamics Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Electric Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Mills, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Motors Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Research Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
General Ship Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gentex Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Geo Centers, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Geo Marine, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Georgia Power Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Georgia Tech Research Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Geronimo Service Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Geste Holdings USA, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Giant Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gibraltar, P.R., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gold Line Refining, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Golden Manufacturing Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gonzales, Al
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Goodrich, B.F. Co., The
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Goodyear Tire &amp; Rubber Co., The 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Government Micro Resources
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Government of Canada
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Government Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Government Technology Services
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Great Lakes Dredge &amp; Dock Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Greenland Contractors 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Grimberg, John C. Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Groundwater Tech Govt Ser., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Group Financial Partners, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Grumman Aerospace Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Grumman Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Grumman Data Systems Corp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gulf Coast Trailing Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gulfstream Delaware Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gunver Manufacturing Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Guyco Engineering Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HCC Acquisition Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HFSI, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HRI, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
HSQ Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Halifax Engineering, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Halliburton Nus Envmtl Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Halter Marine, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harbert Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Habor Construction Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harcon, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hardaway Co., Inc., The 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hardie-Tynes Manufacturing Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harding Associates, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harnischfeger Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harris Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harris Magnavox Systems Co. JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Harsco Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hartford Steam Boiler Inspection Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hawaiian Electric Industries
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hawaiian Independent Refinery
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Haworth International, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hazeltine Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Henderson, H.F. Industries
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hensel Phelps Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hercules, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hermes Consolidated, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Heroux, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hess Oil Virgin Islands Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hewlett Packard Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hilton Systems, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hoffmann La Roche, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Holly Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Holmes &amp; Narver, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Holston Defense Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Honam Oil Refinery Co., Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Honeywell, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hooks, Mike, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Horizons Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Houston Executive Air Service 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Howden Group America, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00056 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Howmet Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hughes Aircraft Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hughes Danbury Optical Systems
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hughes Data Systems &amp; BTG, Inc. JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hughes Missile Systems Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hughes Training Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hunt Building Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hyman, George Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Hyster-Yale Materials Handling
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I-Net, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ICF Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ICI Americas, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IIT Research Institute
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ILC Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IPAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IRISS Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IT Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ITT Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ITT Federal Services Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Iber C. &amp; Sons, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Iceland Prime Contractors
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Illinois Glove Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Incore, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Indstrial Data Link Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Information Handling Services Group
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Information Spectrum, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Information Systems Networks Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Information Tech Solutions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Infotec Development, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ingalls Shipbuilding, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Institute for Defense Analyses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Intel Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Intelcom Support Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Intercontinental Manufacturing Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Intergraph Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Intermarine, USA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Intermetrics, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
International Business Machines Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
International Marine
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
International Technology Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Interstate Electronics Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Israel Aircraft Industries, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Israeli Military Industries
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Isratex, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
J&amp;J Maintenance, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
JJMA Holdings, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
JWK International Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jacobs Engineering Group, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
James, T.L. &amp; Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jaycor
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jered Brown Brothers, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jersey Central Power &amp; Light Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Johns Hopkins University
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Johnson, Al Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Johnson Controls World Service
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Johnson, Matthey, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jonathan Corp., The
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jones Group, Inc., The
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jones, John T. Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Jowett, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
K&amp;F Industries Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
K&amp;M Maintenance Services
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
KDI Precision Products, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
KPMG Peat Marwick
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kaiser Aerospace &amp; Electronics Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kaman Aerospace Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kaman Instrumentation Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kaman Sciences Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kato Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kay &amp; Associates, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kaysam Worldwide, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kearfoot Guidance &amp; Navigation Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Keco Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Keflavik Contractors
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kellogg Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kestrel Shipholding Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kiewit Construction Group, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kiewit &amp; Johnson, Al JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kilgallon Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Knoll Group, The
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Kohlberg, Kravis Roberts &amp; Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00057 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Kollmorgen Corp.
<!-- PJG 0012 frnewline -->
Korea Electric Power Corp.
<!-- PJG 0012 frnewline -->
Korean Air Lines Co., Ltd.
<!-- PJG 0012 frnewline -->
Kovatch Mobile Equipment Corp.
<!-- PJG 0012 frnewline -->
Kraemer Edward &amp; Sons, Inc.
<!-- PJG 0012 frnewline -->
Kraft General Foods, Inc.
<!-- PJG 0012 frnewline -->
Krug International Corp.
<!-- PJG 0012 frnewline -->
Kuwait National Petroleum Co.
<!-- PJG 0012 frnewline -->
Kyung In Energy Co., Ltd.
<!-- PJG 0012 frnewline -->
LAS Energy Corp.
<!-- PJG 0012 frnewline -->
LATA Curls 
<!-- PJG 0012 frnewline -->
LAU Acquisition Corp.
<!-- PJG 0012 frnewline -->
LG&amp;E Energy Corp.
<!-- PJG 0012 frnewline -->
LTV Corp.
<!-- PJG 0012 frnewline -->
Laidlaw Environmental Services
<!-- PJG 0012 frnewline -->
Laketon Refining, Inc.
<!-- PJG 0012 frnewline -->
Lane Industries, Inc.
<!-- PJG 0012 frnewline -->
Lanthier, Robert J. Co., Inc.
<!-- PJG 0012 frnewline -->
Law Companies, Inc., The
<!-- PJG 0012 frnewline -->
Lawrence Associates, Inc.
<!-- PJG 0012 frnewline -->
Lear Astronics Corp.
<!-- PJG 0012 frnewline -->
Lear Siegler Holdings Corp.
<!-- PJG 0012 frnewline -->
Leland Electrosystems, Inc.
<!-- PJG 0012 frnewline -->
Lewis, Lee Construction, Inc.
<!-- PJG 0012 frnewline -->
Life Cycle Engineering, Inc.
<!-- PJG 0012 frnewline -->
Light Helicopter Turbine Engine Co.
<!-- PJG 0012 frnewline -->
Lilly, David B. Co., Inc.
<!-- PJG 0012 frnewline -->
Litton Industries, Inc.
<!-- PJG 0012 frnewline -->
Litton Systems, Inc.
<!-- PJG 0012 frnewline -->
Lobar, Inc.
<!-- PJG 0012 frnewline -->
Lockheed Aeromod Center, Inc.
<!-- PJG 0012 frnewline -->
Lockheed Aeronautical Systems Co.
<!-- PJG 0012 frnewline -->
Lockheed Air Terminal, Inc.
<!-- PJG 0012 frnewline -->
Lockheed Corp.
<!-- PJG 0012 frnewline -->
Lockheed Engineering &amp; Science 
<!-- PJG 0012 frnewline -->
Lockheed Fort Worth Co.
<!-- PJG 0012 frnewline -->
Lockheed Missiles &amp; Space Co.
<!-- PJG 0012 frnewline -->
Lockheed Sanders, Inc.
<!-- PJG 0012 frnewline -->
Lockheed Western Export Co.
<!-- PJG 0012 frnewline -->
Locus, Inc.
<!-- PJG 0012 frnewline -->
Loggins Meat Co., Inc.
<!-- PJG 0012 frnewline -->
Logicon, Inc.
<!-- PJG 0012 frnewline -->
Logicon R &amp; D Associates 
<!-- PJG 0012 frnewline -->
Logistic Services International
<!-- PJG 0012 frnewline -->
Logistics Management Institute
<!-- PJG 0012 frnewline -->
Loral Aerospace Corp.
<!-- PJG 0012 frnewline -->
Loral Corp.
<!-- PJG 0012 frnewline -->
Loral Corp., Rolm Mil-Spec Computers Division
<!-- PJG 0012 frnewline -->
Loral Vought Systems
<!-- PJG 0012 frnewline -->
Louis Dreyfus Energy Corp.
<!-- PJG 0012 frnewline -->
Lucas Aerospace
<!-- PJG 0012 frnewline -->
Luhr Brothers, Inc.
<!-- PJG 0012 frnewline -->
Lykes Brothers Steamship Co., Inc.
<!-- PJG 0012 frnewline -->
MCC Construction Corp.
<!-- PJG 0012 frnewline -->
MCI Telecommunications Corp.
<!-- PJG 0012 frnewline -->
MDP Construction Inc.
<!-- PJG 0012 frnewline -->
MDT Advisers, Inc.
<!-- PJG 0012 frnewline -->
MEI Technology Corp.
<!-- PJG 0012 frnewline -->
MK Ferguson of Idaho
<!-- PJG 0012 frnewline -->
MacGregor-Navire USA, Inc.
<!-- PJG 0012 frnewline -->
Maden Tech Consulting, Inc.
<!-- PJG 0012 frnewline -->
Maersk Line, Ltd.
<!-- PJG 0012 frnewline -->
Magnavox Government &amp; Industrial Electronics Co.
<!-- PJG 0012 frnewline -->
Management Systems Application
<!-- PJG 0012 frnewline -->
Manson Construction &amp; Engineering Co.
<!-- PJG 0012 frnewline -->
Mansour General Dynamics, Ltd.
<!-- PJG 0012 frnewline -->
Mantech International Corp.
<!-- PJG 0012 frnewline -->
Manufacturing Technology, Inc.
<!-- PJG 0012 frnewline -->
Mapco Alaska Petroleum, Inc.
<!-- PJG 0012 frnewline -->
Mar, Inc.
<!-- PJG 0012 frnewline -->
Marconi Radar &amp; Control System
<!-- PJG 0012 frnewline -->
Marconi Underwater Systems, Ltd.
<!-- PJG 0012 frnewline -->
Marine Hydraulics International 
<!-- PJG 0012 frnewline -->
Marine Transport Service Sea Barge GP
<!-- PJG 0012 frnewline -->
Mars, Inc.
<!-- PJG 0012 frnewline -->
Martech USA, Inc.
<!-- PJG 0012 frnewline -->
Martin Baker Aircraft Co., Ltd.
<!-- PJG 0012 frnewline -->
Martin Electronics, Inc.
<!-- PJG 0012 frnewline -->
Martin Marietta Corp.
<!-- PJG 0012 frnewline -->
Martin Marietta, Diehl Co's., Thorn &amp; Thompson JV
<!-- PJG 0012 frnewline -->
Martin Marietta Missile System
<!-- PJG 0012 frnewline -->
Martin Marietta Corp. &amp; Westinghouse Electric Co. JV
<!-- PJG 0012 frnewline -->
Mason Hanger Silas Mason Co.
<!-- PJG 0012 frnewline -->
Mason Technologies, Inc.
<!-- PJG 0012 frnewline -->
Massachusetts Institute of Technology
<!-- PJG 0012 frnewline -->
Maxwell Laboratories, Inc.
<!-- PJG 0012 frnewline -->
Mayer, Oscar Foods Corp.
<!-- PJG 0012 frnewline -->
McBride &amp; Associates, Inc.
<!-- PJG 0012 frnewline -->
McRae Industries, Inc.
<!-- PJG 0012 frnewline -->
McDonnell Aircraft Co.
<!-- PJG 0012 frnewline -->
McDonnell Douglas Corp.
<!-- PJG 0012 frnewline -->
McDonnell Douglas Helicopter Co.
<!-- PJG 0012 frnewline -->
McDonnell Douglas Missile &amp; Systems Co.
<!-- PJG 0012 frnewline -->
McDonnell Douglas Space Systems Co.
<!-- PJG 0012 frnewline -->
McDonnell Douglas Training Systems, Inc.
<!-- PJG 0012 frnewline -->
McLaughlin Research Corp.
<!-- PJG 0012 frnewline -->
McMaster Construction, Inc.
<!-- PJG 0012 frnewline -->
Merchants National Corp.
<!-- PJG 0012 frnewline -->
Merck Sharp Dhme Federal Credit Union
<!-- PJG 0012 frnewline -->
Metallgesellschaft Corp.
<!-- PJG 0012 frnewline -->
Metcalf &amp; Eddy, Inc.
<!-- PJG 0012 frnewline -->
Metric Construction Co., Inc.
<!-- PJG 0012 frnewline -->
Metro Machine Corp.
<!-- PJG 0012 frnewline -->
Metters Industries, Inc.
<!-- PJG 0012 frnewline -->
Mevatec Corp.
<!-- PJG 0012 frnewline -->
Michelin Tire Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00058 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Mid Continent Systems Corp.
<!-- PJG 0012 frnewline -->
Mid Eastern Builders
<!-- PJG 0012 frnewline -->
Milcom Systems Corp.
<!-- PJG 0012 frnewline -->
Miles, Inc.
<!-- PJG 0012 frnewline -->
Miller Herman, Inc.
<!-- PJG 0012 frnewline -->
Miltope Group, Inc.
<!-- PJG 0012 frnewline -->
Mine Safety Appliances Co.
<!-- PJG 0012 frnewline -->
Ministry of Defense, UK
<!-- PJG 0012 frnewline -->
Mip Instandsetzungsbetriebe
<!-- PJG 0012 frnewline -->
Mission Research Corp.
<!-- PJG 0012 frnewline -->
Mitre Corp.
<!-- PJG 0012 frnewline -->
Mobil Corp.
<!-- PJG 0012 frnewline -->
Modern Technologies Corp.
<!-- PJG 0012 frnewline -->
Monfort Food Distributing Co.
<!-- PJG 0012 frnewline -->
Montana Refining Co. 
<!-- PJG 0012 frnewline -->
Montgomery, J.M., Consulting Engineers
<!-- PJG 0012 frnewline -->
Montgomery Watson Americas
<!-- PJG 0012 frnewline -->
Morgan Stanley Group, Inc.
<!-- PJG 0012 frnewline -->
Morgen &amp; Oswood Construction Co.
<!-- PJG 0012 frnewline -->
Morrell, John &amp; Co., Inc.
<!-- PJG 0012 frnewline -->
Mortenson, M.A. Co.
<!-- PJG 0012 frnewline -->
Motor Oils Hellas Corinth Refinery 
<!-- PJG 0012 frnewline -->
Motorola Communications &amp; Electronics
<!-- PJG 0012 frnewline -->
Motorola, Inc.
<!-- PJG 0012 frnewline -->
Multi-Electric Manufacturing, Inc.
<!-- PJG 0012 frnewline -->
Murdock, Inc.
<!-- PJG 0012 frnewline -->
NASP National Contractor
<!-- PJG 0012 frnewline -->
NC Dept of Human Resources
<!-- PJG 0012 frnewline -->
NCI Information Systems, Inc.
<!-- PJG 0012 frnewline -->
NCR Corp.
<!-- PJG 0012 frnewline -->
NI Industries, Inc.
<!-- PJG 0012 frnewline -->
Natco LP
<!-- PJG 0012 frnewline -->
Nation, Inc.
<!-- PJG 0012 frnewline -->
National Academy of Sciences
<!-- PJG 0012 frnewline -->
National Apparel, Inc.
<!-- PJG 0012 frnewline -->
National Beef Packing Co.
<!-- PJG 0012 frnewline -->
National Emergency Service
<!-- PJG 0012 frnewline -->
National Forge Co.
<!-- PJG 0012 frnewline -->
National Industries for the Blind
<!-- PJG 0012 frnewline -->
National Maintenance, Inc.
<!-- PJG 0012 frnewline -->
National Patent Development Corp.
<!-- PJG 0012 frnewline -->
National Program Office
<!-- PJG 0012 frnewline -->
National Steel &amp; Shipbuilding Co.
<!-- PJG 0012 frnewline -->
National Systems &amp; Research Co.
<!-- PJG 0012 frnewline -->
National Technologies
<!-- PJG 0012 frnewline -->
Navcom Defense Electronics, Inc.
<!-- PJG 0012 frnewline -->
Navcom Systems, Inc.
<!-- PJG 0012 frnewline -->
Netherlands Ministry of Defense
<!-- PJG 0012 frnewline -->
Network Equipment Technologies, Inc.
<!-- PJG 0012 frnewline -->
New Mexico State University
<!-- PJG 0012 frnewline -->
Newport News Shipbuilding &amp; Dry Dock Co.
<!-- PJG 0012 frnewline -->
Nichols Research Corp.
<!-- PJG 0012 frnewline -->
Nicholson &amp; Associates, Inc.
<!-- PJG 0012 frnewline -->
Nielsons, Inc.
<!-- PJG 0012 frnewline -->
Norden Systems, Inc.
<!-- PJG 0012 frnewline -->
Norfolk Dredging Co., Inc.
<!-- PJG 0012 frnewline -->
Norfolk Shipbuilding &amp; Dry Dock Corp.
<!-- PJG 0012 frnewline -->
Norse, Inc.
<!-- PJG 0012 frnewline -->
Nortel Federal Systems, Inc.
<!-- PJG 0012 frnewline -->
North American Mechanical Services
<!-- PJG 0012 frnewline -->
North Atlantic Industries, Inc.
<!-- PJG 0012 frnewline -->
North Florida Shipyards, Inc.
<!-- PJG 0012 frnewline -->
Northern Telecom, Inc., Del.
<!-- PJG 0012 frnewline -->
Northern Telecom, Ltd.
<!-- PJG 0012 frnewline -->
Northrop Corp.
<!-- PJG 0012 frnewline -->
Northrop Worldwide Aircraft Services
<!-- PJG 0012 frnewline -->
Northwest Environmental Service, Inc.
<!-- PJG 0012 frnewline -->
Norton Co.
<!-- PJG 0012 frnewline -->
Nova Group, Inc.
<!-- PJG 0012 frnewline -->
Novelly/Goldstein Partnership
<!-- PJG 0012 frnewline -->
Nuclear Research Corp.
<!-- PJG 0012 frnewline -->
O'Brian &amp; Gere, Ltd.
<!-- PJG 0012 frnewline -->
OEA, Inc.
<!-- PJG 0012 frnewline -->
OHM Remediation Services Corp.
<!-- PJG 0012 frnewline -->
OMNI Construction, Inc.
<!-- PJG 0012 frnewline -->
Occidental Petroleum Corp.
<!-- PJG 0012 frnewline -->
Ocean Shipholdings, Inc.
<!-- PJG 0012 frnewline -->
Ogden Corp.
<!-- PJG 0012 frnewline -->
Ogden Environmental &amp; Energy Service Co.
<!-- PJG 0012 frnewline -->
Ogden Government Services Corp.
<!-- PJG 0012 frnewline -->
Ogden Services Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00059 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Oil Refineries, Ltd.
<!-- PJG 0012 frnewline -->
Okinawa City Water Works
<!-- PJG 0012 frnewline -->
Okinawa Electric Power Co., Inc.
<!-- PJG 0012 frnewline -->
Oldenburg Group, Inc.
<!-- PJG 0012 frnewline -->
Olin Corp.
<!-- PJG 0012 frnewline -->
Olin Ordnance
<!-- PJG 0012 frnewline -->
Olin Winchester
<!-- PJG 0012 frnewline -->
Omega Group, Inc.
<!-- PJG 0012 frnewline -->
Operational Technologies Corp.
<!-- PJG 0012 frnewline -->
Oracle System Corp.
<!-- PJG 0012 frnewline -->
Orange Shipbuilding Co., Inc.
<!-- PJG 0012 frnewline -->
Orbital Sciences Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Orincon Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Orion International Technologies, Inc.
<!-- PJG 0012 frnewline -->
Osborne Construction Co.
<!-- PJG 0012 frnewline -->
Oshkosh Truck Corp.
<!-- PJG 0012 frnewline -->
Outdoor Venture Corp.
<!-- PJG 0012 frnewline -->
Owl International, Inc.
<!-- PJG 0012 frnewline -->
P&amp;Z Construction Co., Inc.
<!-- PJG 0012 frnewline -->
PCL Construction Associates, Inc.
<!-- PJG 0012 frnewline -->
PHH Holdings, Inc.
<!-- PJG 0012 frnewline -->
PHP Healthcare Corp.
<!-- PJG 0012 frnewline -->
PMB Engineering, Inc.
<!-- PJG 0012 frnewline -->
PRC Engineering Systems, Inc.
<!-- PJG 0012 frnewline -->
PRC Environmental Management
<!-- PJG 0012 frnewline -->
PRC, Inc.
<!-- PJG 0012 frnewline -->
PSG International Language
<!-- PJG 0012 frnewline -->
Pacer Systems, Inc.
<!-- PJG 0012 frnewline -->
Pacific Architects &amp; Engineers, Inc.
<!-- PJG 0012 frnewline -->
Pacific Ship Repair &amp; Fabrication
<!-- PJG 0012 frnewline -->
Pacific Telecom, Inc.
<!-- PJG 0012 frnewline -->
Pacifica Services, Inc.
<!-- PJG 0012 frnewline -->
Pacificorp Capital, Inc.
<!-- PJG 0012 frnewline -->
Paramax Systems Corp.
<!-- PJG 0012 frnewline -->
Parker Hannifin Corp.
<!-- PJG 0012 frnewline -->
Parsons Corp.
<!-- PJG 0012 frnewline -->
Patrol Ofisi A S Genel Mud
<!-- PJG 0012 frnewline -->
Pearse, Jack F.
<!-- PJG 0012 frnewline -->
Peerless Petrochemicals, Inc.
<!-- PJG 0012 frnewline -->
Pemco Aeroplex, Inc.
<!-- PJG 0012 frnewline -->
Pence, Howard W., Inc.
<!-- PJG 0012 frnewline -->
Pennsylvania State University
<!-- PJG 0012 frnewline -->
Penske Transportation, Inc.
<!-- PJG 0012 frnewline -->
Pentastar Eletronics, Inc.
<!-- PJG 0012 frnewline -->
Pepper, Harry &amp; Associates
<!-- PJG 0012 frnewline -->
Pepsico, Inc.
<!-- PJG 0012 frnewline -->
Per Udsen Aircraft Co.
<!-- PJG 0012 frnewline -->
Perini Corp.
<!-- PJG 0012 frnewline -->
Peterson Builders, Inc.
<!-- PJG 0012 frnewline -->
Petroleum Traders Corp.
<!-- PJG 0012 frnewline -->
Philip Morris, Inc.
<!-- PJG 0012 frnewline -->
Phillips &amp; Jordan, Inc.
<!-- PJG 0012 frnewline -->
Phoenix Air Group, Inc.
<!-- PJG 0012 frnewline -->
Phototronics Corp.
<!-- PJG 0012 frnewline -->
Physics International Co.
<!-- PJG 0012 frnewline -->
Pine Bluff Sand &amp; Gravel Co.
<!-- PJG 0012 frnewline -->
Pioneer U. A. V., Inc.
<!-- PJG 0012 frnewline -->
Piquniq Management Corp.
<!-- PJG 0012 frnewline -->
Pizzagalli Construction Co.
<!-- PJG 0012 frnewline -->
Placid Oil Co.
<!-- PJG 0012 frnewline -->
Planning Systems, Inc.
<!-- PJG 0012 frnewline -->
Pneumo Abex Corp.
<!-- PJG 0012 frnewline -->
Potomac Electric Power Co.
<!-- PJG 0012 frnewline -->
Potomac Systems Engineering
<!-- PJG 0012 frnewline -->
Praoil Aromatici E. Raffinazion
<!-- PJG 0012 frnewline -->
Pratt &amp; Whitney
<!-- PJG 0012 frnewline -->
Pride Companies LP
<!-- PJG 0012 frnewline -->
Pride Industries, Inc.
<!-- PJG 0012 frnewline -->
Proctor &amp; Gamble Co., The
<!-- PJG 0012 frnewline -->
Pueblo Laguna Tribe
<!-- PJG 0012 frnewline -->
Puerto Rico Sun Oil Co., Inc.
<!-- PJG 0012 frnewline -->
Pulau Electronics Corp.
<!-- PJG 0012 frnewline -->
Purdy Corp.
<!-- PJG 0012 frnewline -->
Quaker Oats Co., The
<!-- PJG 0012 frnewline -->
Questech, Inc.
<!-- PJG 0012 frnewline -->
Quintron Corp.
<!-- PJG 0012 frnewline -->
RJO Enterprises, Inc.
<!-- PJG 0012 frnewline -->
RMS Technologies, Inc.
<!-- PJG 0012 frnewline -->
Racal Communications, Inc.
<!-- PJG 0012 frnewline -->
Radian Corp.
<!-- PJG 0012 frnewline -->
Rafael Armaments Development
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00060 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Rail Co.
<!-- PJG 0012 frnewline -->
Ran-Paige Co., Inc.
<!-- PJG 0012 frnewline -->
Rand Corp., The
<!-- PJG 0012 frnewline -->
Raven Industries, Inc.
<!-- PJG 0012 frnewline -->
Raytheon Co.
<!-- PJG 0012 frnewline -->
Raytheon Middle East Systems Co.
<!-- PJG 0012 frnewline -->
Raytheon Service Co.
<!-- PJG 0012 frnewline -->
Raytheon Support Services Co.
<!-- PJG 0012 frnewline -->
Red Samm Construction, Inc.
<!-- PJG 0012 frnewline -->
Refinery Associates, Inc.
<!-- PJG 0012 frnewline -->
Reflectone Training Systems
<!-- PJG 0012 frnewline -->
Relm Communications, Inc.
<!-- PJG 0012 frnewline -->
Research &amp; Development Labs
<!-- PJG 0012 frnewline -->
Research Analysis &amp; Maintenance
<!-- PJG 0012 frnewline -->
Resource Consultants, Inc.
<!-- PJG 0012 frnewline -->
Robbins Gioia, Inc.
<!-- PJG 0012 frnewline -->
Rockwell International Corp.
<!-- PJG 0012 frnewline -->
Rockwell Power Systems
<!-- PJG 0012 frnewline -->
Rolls-Royce &amp; Associates, Ltd.
<!-- PJG 0012 frnewline -->
Roofing Constructors, Inc.
<!-- PJG 0012 frnewline -->
Rose Companies, Inc.
<!-- PJG 0012 frnewline -->
Rosenblatt, M. &amp; Son, Inc.
<!-- PJG 0012 frnewline -->
Rust International Corp.
<!-- PJG 0012 frnewline -->
Ryan Co., Inc.
<!-- PJG 0012 frnewline -->
Ryan, Inc., Eastern
<!-- PJG 0012 frnewline -->
SAIC Engineering, Inc.
<!-- PJG 0012 frnewline -->
SCI Systems, Inc.
<!-- PJG 0012 frnewline -->
SD-Scicon PLC
<!-- PJG 0012 frnewline -->
SFA, Inc.
<!-- PJG 0012 frnewline -->
SKF USA, Inc.
<!-- PJG 0012 frnewline -->
SRA Technologies, Inc.
<!-- PJG 0012 frnewline -->
SRI International
<!-- PJG 0012 frnewline -->
SRS Technologies
<!-- PJG 0012 frnewline -->
SSI Services, Inc.
<!-- PJG 0012 frnewline -->
Sabreliner Corp.
<!-- PJG 0012 frnewline -->
Saco Defense, Inc.
<!-- PJG 0012 frnewline -->
Sacramento Municipal Utility
<!-- PJG 0012 frnewline -->
Saft America, Inc.
<!-- PJG 0012 frnewline -->
Samson Tug &amp; Barge Co.
<!-- PJG 0012 frnewline -->
Saudi Oger, Ltd.
<!-- PJG 0012 frnewline -->
Saudi Operations &amp; Maintenance Co.
<!-- PJG 0012 frnewline -->
Saudi Services &amp; Operating Co.
<!-- PJG 0012 frnewline -->
Sauer, Inc.
<!-- PJG 0012 frnewline -->
Schafer, W.J. Associates, Inc.
<!-- PJG 0012 frnewline -->
Schlosser, W.M., Co., Inc.
<!-- PJG 0012 frnewline -->
Science &amp; Technology, Inc.
<!-- PJG 0012 frnewline -->
Science Applications International Corp.
<!-- PJG 0012 frnewline -->
Scientific Ecology Group, Inc.
<!-- PJG 0012 frnewline -->
Scientific Atlanta, Inc.
<!-- PJG 0012 frnewline -->
Scientific Research Corp.
<!-- PJG 0012 frnewline -->
Sea Land Service, Inc.
<!-- PJG 0012 frnewline -->
Seacor Services, Inc.
<!-- PJG 0012 frnewline -->
Sears Roebuck &amp; Co.
<!-- PJG 0012 frnewline -->
Semcor, Inc.
<!-- PJG 0012 frnewline -->
Sentel Corp.
<!-- PJG 0012 frnewline -->
Sequa Corp.
<!-- PJG 0012 frnewline -->
Serv Air, Inc.
<!-- PJG 0012 frnewline -->
Service Engineering Co., Inc.
<!-- PJG 0012 frnewline -->
Sevenson Environmental Services
<!-- PJG 0012 frnewline -->
Sharp, George G., Inc.
<!-- PJG 0012 frnewline -->
Shell Oil Co.
<!-- PJG 0012 frnewline -->
Sherikon, Inc.
<!-- PJG 0012 frnewline -->
Shin Cheon Co., Ltd.
<!-- PJG 0012 frnewline -->
Short Brothers PLC
<!-- PJG 0012 frnewline -->
Showa Shell Sekiyu KK
<!-- PJG 0012 frnewline -->
Siemens Corp.
<!-- PJG 0012 frnewline -->
Sierra Nevada Corp.
<!-- PJG 0012 frnewline -->
Sierra Technologies Corp.
<!-- PJG 0012 frnewline -->
Silicon Graphics, Inc.
<!-- PJG 0012 frnewline -->
Simplex Wire &amp; Cable Co.
<!-- PJG 0012 frnewline -->
Simtec, Inc.
<!-- PJG 0012 frnewline -->
Simula, Inc.
<!-- PJG 0012 frnewline -->
Skipton, James K., III, Inc.
<!-- PJG 0012 frnewline -->
Sletten, Inc.
<!-- PJG 0012 frnewline -->
Slingsby Aviation, Ltd.
<!-- PJG 0012 frnewline -->
Smith, Johnny F., Truck Dragline Svc.
<!-- PJG 0012 frnewline -->
Smithkline Beecham Corp.
<!-- PJG 0012 frnewline -->
Smiths Industries, Inc., USA
<!-- PJG 0012 frnewline -->
Softech, Inc.
<!-- PJG 0012 frnewline -->
Sonalysts, Inc.
<!-- PJG 0012 frnewline -->
Sony Corp. of America
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00061 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
South Carolina Wldlf Mrn Res
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southeastern Public Service Authority
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southern Air Transport, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southern Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southfork Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southwest Marine, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southwest Mobile Systems Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southwest Research Institute
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Southwestern Bell Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Space &amp; Sensors Associates
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Space Applications Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Space Data Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Spacesaver Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sparta, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sparton Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Spaw-Glass, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Spectrum Astro, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Speegle Construction, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sprint Communications Co. LP
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ssangyong Oil Refining Co., Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Standard Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Stanford Telecommunications
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Stanford University
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Statistica, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Steelcase, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sterling Medical Associates
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sterling Software, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Stewart &amp; Stevenson Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Storage Technology Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Strand, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sumaria Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sumitomo Electric Fiber Optics
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sumitomo Heavy Industries, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Summa Technology, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sun Eagle Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sun Microsystems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sun Refining &amp; Marketing Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sundstrand Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sundt Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sunkyong, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Support Systems Associates
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Supreme Beef Processors, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sverdrup Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Symetrics Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Synetics Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Synoptic Systems Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Syscon Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
System Planning Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
System Resources Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Systems &amp; Electronics, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Systems Engineering &amp; Management Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Systems Engineering Solutions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Systems Engineering Energy Management Association
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Systems Research Laboratories
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TASC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TCOM, LP
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TDS, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
TRW, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Talley Defense Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tampa Shipyards, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tape Tech, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Target Sportswear, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Taylor Ball, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tec-Masters, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tech-Sym Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Techmatics, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Technical &amp; Management Services Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Technology Applications Service Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Technology Management &amp; Analisys Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tecolote Research, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tecom, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tektronix, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Teledyne, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Teledyne Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Teleflex, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Telephonics Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Telex Communications, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tennessee Valley Authority
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tesco
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tesoro Petroleum Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tetra Tech, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00062 </DOCNO>
<PARENT> FR940112-0-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Texaco Caribbean, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texas-Capital Contractor, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texas Instruments &amp; Martin Marietta JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texas Instruments, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texcom, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texstar, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Textron, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Therm, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thermo Electron Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thermodyn Mechanical Contrs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thinking Machines Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thiokol Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tiburon Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Timken Co., The
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Titan Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tohoku Denryoku KK
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tokyo Denryoku KK
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Totem Resources Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tracor Aerospace, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tracor Applied Sciences, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tracor, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trans World Airlines, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trans-Tec Services
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Transworld Oil USA, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tri Ex Tower Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tri State Design, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Trident Data Systems, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Triton Group, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Triton Marine Construction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Turtle Mountain Manufacturing Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Tutor Saliba Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
UNC, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
URS Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Unidyne Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Unified Industries, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Uniformed Services Benefit Plans
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Unisys Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United Engineers &amp; Constructors
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United International Engineers
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United Parcel Service, Inc., Ohio
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United States Department of Commerce
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United States Department of Energy
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United Technologies Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
United Technologies Optical Systems
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Universal Propulsion Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
University of California
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
University of Dayton
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
University of Pittsburgh
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
University of Southern California
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
University of Texas
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
University of Washington
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
User Technology Associates
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Utah State University
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
VSE Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Van Ommeren Shipping (USA)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vanee Foods Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Varian Associates, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Varo, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vector Research, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vectura Group, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Veda, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Verac, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vickers, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vinnell Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vinnell Corp., Brown &amp; Root JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vion Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Virtexco Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vitro Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vitronics, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vought Aircraft
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Vredenburg, R. M. &amp; Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wallace Oconner International, Ltd.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wang Laboratories, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Warehouses Services, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Washington Agricultural Dev.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Waste Management, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Waterman Steamship Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Watkins Johnson Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Watterson Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Weeks Marine, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wellco Enterprises, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Western Petroleum Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Western Union Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Westinghouse Electric Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Westmont, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Weston, Roy F., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Whitesell Green, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Whittaker Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wichita Ponca Canvas Products
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Willard Marine, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Willbros USA, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Williams International Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wisconsin Physicians Service Insurance
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Woodward, Clyde Consultants
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
World Auxiliary Power Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
World Rosen Key Amer Etal JV
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Worldcorp, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wornick Co., Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wyle Laboratories
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wylie, C.E. Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Xerox Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Xontech, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Yeager, E.L. Construction Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
You One Construction Co., Ltd
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Young &amp; Rubicam, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Zachry, H.B. Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Zenith Electronics Corp.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;674 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00063 </DOCNO>
<PARENT> FR940112-0-00018 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF EDUCATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>34 CFR Parts 319, 429, 674, and 682 </CFRNO>
<!-- PJG 0012 frnewline -->
Miscellaneous Department of Education Regulations; Corrections 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Department of Education.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rules; correcting amendments.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document corrects certain final regulations published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on July 21, 1992 (57 FR 32342) (Part 674_Federal Perkins Loan Program); August 14, 1992 (57 FR 36720) (Part 429_Bilingual
Vocational Materials, Methods, and Techniques Program); December 18, 1992 (57 FR 60280) (Part 682_Federal Family
Education Loan Programs); and December 29, 1992 (57 FR 62094) (Part 319_Training Personnel for the Education of Individuals
with Disabilities_Grants to State Educational Agencies and Institutions of Higher Education).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The correction to 34 CFR part 674 is effective September 18, 1992. The correction to 34 CFR part 429 is effective September
28, 1992. The correction to 34 CFR part 682 is effective February 1, 1993. The correction to 34 CFR part 319 is effective
February 25, 1993.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Kenneth C. Depew, Division of Regulations Management, U.S. Department of Education, 400 Maryland Avenue, SW., room
5125, FOB&hyph;6, Washington, DC 20202&hyph;2241. Telephone: (202) 401&hyph;2884. Individuals who use a telecommunications
device for the deaf (TDD) may call the Federal Information Relay Service (FIRS) at 1&hyph;800&hyph;877&hyph;8339
between 8 a.m. and 8 p.m., Eastern time, Monday through Friday. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
34 CFR Part 319 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Education of individuals with disabilities, Education_training, Grant programs_education, Student aid, Teachers.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
34 CFR Part 429 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Grant programs-education, Vocational education. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
34 CFR Part 674 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Loan programs_education, Student aid. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
34 CFR Part 682 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Loan programs_education, Student aid, Vocational education.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Judith A. Winston, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
General Counsel.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance Numbers: 84.029 Training Personnel for the Education of Individuals with
Disabilities; 84.038 Perkins Loan Program; 84.077 Bilingual Vocational Training Program; 84.032 Stafford Loan
Program and PLUS Program)
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Parts 319, 429, 674, and 682 of title 34 of the Code of Federal Regulations are corrected by making the following amendments:

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 319_TRAINING PERSONNEL FOR THE EDUCATION OF INDIVIDUALS WITH DISABILITIES_GRANTS TO STATE EDUCATIONAL AGENCIES
AND INSTITUTIONS OF HIGHER EDUCATION 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 319 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
20 U.S.C. 1432, unless otherwise noted. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;319.3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Corrected] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;319.3 the third word of the undesignated introductory text is revised to read ``funds''. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 429_BILINGUAL VOCATIONAL MATERIALS, METHODS, AND TECHNIQUES PROGRAM 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. The authority citation for part 429 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Sec. 441(c) of the Carl D. Perkins Vocational Education Act, 20 U.S.C. 2441(c), as enacted by Pub. L. 98&hyph;524,
unless otherwise noted. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;&sect;429.11, 429.30
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Corrected] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. In &sect;429.11(a) the cross-reference to ``&sect;409.10'' is revised to read ``&sect;429.10''; and in &sect;429.30(a),
(b), and (d) the cross-references to ``&sect;409.31'' are revised to read ``&sect;429.31''.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00064 </DOCNO>
<PARENT> FR940112-0-00018 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 674_FEDERAL PERKINS LOAN PROGRAM 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. The authority citation for part 674 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
20 U.S.C. 1087aa_1087hh and 20 U.S.C. 421&hyph;429, unless otherwise noted.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. Section 674.34 is corrected by adding paragraphs (b)(1)(i) and (ii) and (c)(5)(i) through (v) to read as follows:

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;674.34
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Deferment of repayment_Perkins loans. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b)(1) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(i) An institution of higher education; or 
<!-- PJG 0012 frnewline -->
(ii) A comparable institution outside the U.S. approved by the Secretary for this purpose. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(5) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(i) The borrower serves in an organization that is exempt from taxation under the provisions of section 501(c)(3)
of the Internal Revenue Code of 1954. 
<!-- PJG 0012 frnewline -->
(ii) The borrower provides service to low-income persons and their communities to assist them in eliminating poverty
and poverty-related human, social, and environmental conditions.
<!-- PJG 0012 frnewline -->
(iii) The borrower's compensation does not exceed the compensation received by a full-time volunteer in the Peace
Corps or in a program administered by the ACTION agency. Compensation includes an allowance for subsistence, necessary
travel expenses, and stipends. 
<!-- PJG 0012 frnewline -->
(iv) The borrower, as part of his or her duties, does not give religious instruction, conduct worship service, engage
in religious proselytizing, or engage in fundraising to support religious activities. 
<!-- PJG 0012 frnewline -->
(v) The borrower has agreed to serve on a full-time basis for a term of at least one year. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. Section 674.35 is corrected by adding paragraphs (b)(1)(i) and (ii) and (c)(4)(i) through (v) to read as follows:

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;674.35
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Deferment of repayment_Direct loans made on or after October 1, 1980. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b)(1) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(i) An institution of higher education; or 
<!-- PJG 0012 frnewline -->
(ii) A comparable institution outside the U.S. approved by the Secretary for this purpose. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(4) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(i) The borrower serves in an organization that is exempt from taxation under the provisions of section 501(c)(3)
of the Internal Revenue Code of 1954. 
<!-- PJG 0012 frnewline -->
(ii) The borrower provides service to low-income persons and their communities to assist them in eliminating proverty
and poverty-related human, social, and environmental conditions. 
<!-- PJG 0012 frnewline -->
(iii) The borrower's compensation does not exceed the compensation received by a full-time volunteer in the Peace
Corps or in a program administered by the ACTION agency. Compensation includes an allowance for subsistence, necessary
travel expenses, and stipends. 
<!-- PJG 0012 frnewline -->
(iv) The borrower, as part of his or her duties, does not give religious instruction, conduct worship service, engage
in religious proselytizing, or engage in fundraising to support religious activities. 
<!-- PJG 0012 frnewline -->
(v) The borrower has agreed to serve on a full-time basis for a term of at least one year. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. Section 674.36 is corrected by adding paragraphs (b)(1)(i) and (ii) to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;674.36
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Deferment of repayment_Direct loans made before October 1, 1980 and Defense loans. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b)(1) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(i) An institution of higher education; or 
<!-- PJG 0012 frnewline -->
(ii) A comparable institution outside the U.S. approved by the Secretary for this purpose. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
9. Section 674.49 is corrected by adding paragraphs (e)(4)(i)(A) and (B) and (f)(2)(i) and (ii) to read as follows:

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;674.49
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Bankruptcy of borrower. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(e) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(4)(i) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(A) Whether grounds exist under 11 U.S.C. 1307 to convert or dismiss the case; and 
<!-- PJG 0012 frnewline -->
(B) Whether the borrower has demonstrated entitlement to the ``hardship discharge'' by meeting the requirements
of 11 U.S.C. 1328(b). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(f) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(2) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->
(i) The court has found that repayment of the loan would impose an undue hardship on the borrower and the dependents
of the borrower; or 
<!-- PJG 0012 frnewline -->
(ii)(A) The loan entered the repayment period more than seven years, excluding periods of deferment, before the filing
of the petition; and 
<!-- PJG 0012 frnewline -->
(B) The loan is not excepted from discharge under other applicable provisions of the Code; or 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 682_FEDERAL FAMILY EDUCATION LOAN (FFEL) PROGRAM 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
10. The authority citation for Part 682 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
20 U.S.C. 1071 to 1087&hyph;2, unless otherwise noted. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;682.801
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Corrected] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
11. Section 682.801 is amended by removing ``; and'' at the end of paragraph (e) and adding, in its place, a period.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;440 Filed 1&hyph;11&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4000&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00065 </DOCNO>
<PARENT> FR940112-0-00019 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>ENVIRONMENTAL PROTECTION AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>40 CFR Part 180</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;300299A; FRL&hyph;4746&hyph;5]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN No. 2070&hyph;AB78</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Diallate; Revocation of Tolerances 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document revokes the tolerances for residues of the pesticide diallate 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
S
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
-(2,3-dichloroallyl) diisopropylthiocarbamate, also known as AVADEX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=6 f=3 -->
&reg;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, in or on all raw agricultural commodities. EPA is taking this action because all registered uses of diallate on these
commodities have been cancelled. Therefore, there is no need for maintaining the tolerances once all commodities
treated with diallate have cleared the channels of trade.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This regulation becomes effective February 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written objections, identified by document control number [OPP-300299A], may be submitted to: Hearing Clerk (1900),
Environmental Protection Agency, Rm. M3708, 401 M St., SW., Washington, DC 20460. A copy of any objections and hearing
requests filed with the Hearing Clerk should be identified by the document control number and submitted to: Public
Response and Program Resources Branch, Field Operations Division (7506C), Office of Pesticide Programs, Environmental
Protection Agency, 401 M St., SW., Washington, DC 20460. In person, bring copy of objections and hearing request to:
Rm. 1132, CM #2, 1921 Jefferson Davis Hwy., Arlington, VA 22202. Fees accompanying objections shall be labeled ``Tolerance
Petition Fees'' and forwarded to: EPA Headquarters Accounting Operations Branch, OPP (Tolerance Fees), P.O. Box
360277M, Pittsburgh, PA 15251.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: Philip Poli, Special Review and Reregistration Division (7508W), Environmental Protection Agency, 401
M St., SW., Washington, DC 20460. Office location and telephone number: Special Review Branch, Crystal Station #1,
3rd Floor, 2800 Jefferson Davis Hwy., Arlington, VA, (703)-308-8038.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 of September 30, 1993 (58 FR 51031), EPA issued a proposed rule to revoke the diallate tolerances for all agricultural
commodities under 40 CFR 180.277 pursuant to section 408 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 346a)
by amending those tolerances to include an expiration date of August 30, 1996. A 30-day period was provided to allow
for public comment.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On January 22, 1991, the last EPA registration for a pesticide product containing diallate was cancelled under the
Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), for nonpayment of the annual registration maintenance
fee. Because diallate is no longer registered in the United States for use on any food or animal feed crops, and a tolerance
is generally not necessary for a pesticide chemical which is not registered for a particular food use, EPA is announcing
that it is revoking the tolerances of the pesticide diallate by amending the tolerances to include an expiration date
of August 30, 1996. The delayed revocation date will eliminate concern for a residue problem due to environmental
contamination. Consequently, no action levels will replace the tolerances upon their revocation. 
<!-- PJG 0012 frnewline -->
No comments or requests for referral to an advisory committee were received in response to the proposed rule. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Hearing Procedures
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any person adversely affected by this regulation revoking the tolerances for diallate in or on all raw agricultural
commodities may, within 30 days after publication of this document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, file written objections and/or a request for a hearing with the Hearing Clerk, at the address given above (40 CFR 178.20).
A copy of the objections and/or hearing requests filed with the Hearing Clerk should be submitted to the Office of Pesticide
Programs (OPP) docket for this rulemaking. The objections submitted must specify the provisions of the regulation
deemed objectionable and the grounds of the objections (40 CFR 178.25). Each objection must be accompanied by the
fee prescribed by 40 CFR 180.33(i). If a hearing is requested, the objections must include a statement of the factual
issue(s) on which a hearing is requested, the requester's contentions on each such issue and a summary of any evidence
relied upon by the objector (40 CFR 178.27).
<!-- PJG 0012 frnewline -->
A request for a hearing will be granted if the Administrator determines that the material submitted shows the following:
there is a genuine and substantial issue of fact; there is a reasonable possibility that available evidence identified
by the requester would, if established, resolve one or more of such issues in favor of the requester, taking into account
uncontested claims or facts to the contrary; and resolution of the factual issue(s) in the manner sought by the requester
would be adequate to justify the action requested. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Executive Order 12866
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under Executive Order 12866 (58 FR 51735, Oct. 4, 1993), the Agency must determine whether the regulatory action is
``significant'' and therefore subject to all the requirements of the Executive Order, i.e., Regulatory Impact Analysis,
review by the Office of Management and Budget (OMB). Under section 3(f), the order defines ``significant'' as those
actions likely to lead to a rule (1) having an annual effect on the economy of $100 million or more, or adversely and materially
affecting a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or
State, local or tribal governments or communities (also known as ``economically significant''); (2) creating serious
inconsistency or otherwise interfering with an action taken or planned by another agency; (3) materially altering
the budgetary impacts of entitlement, grants, user fees, or loan programs; or (4) raising novel legal or policy issues
arising out of legal mandates, the President's priorities, or the principles set forth in this Executive Order.
<!-- PJG 0012 frnewline -->
Pursuant to the terms of this Executive Order, EPA has determined that the rule is not ``significant'' and is therefore
not subject to OMB review.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Regulatory Flexibility Act
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This final rule has been reviewed under the Regulatory Flexibility Act of 1980 (Pub. L. 96-354; 94 Stat. 1164, 5 U.S.C.
601 et seq.), and EPA has determined that it will not have a significant economic impact on a substantial number of small
businesses, small governments, or small organizations. Accordingly, I certify that this final rule does not require
a separate regulatory flexibility analysis under the Regulatory Flexibility Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Paperwork Reduction Act
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This final regulatory action does not contain information collection requirements subject to review by OMB under
the Paperwork Reduction Act of 1980, 44 U.S.C. 3501 et seq.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 180
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Administrative practice and procedure, Agricultural commodities, Pesticides and pests, Reporting and recordkeeping
requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dated: December 20, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lynn R. Goldman,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Administrator for Prevention, Pesticides and Toxic Substances. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Therefore, part 180 is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 180_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 180 continues to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 21 U.S.C. 346a and 371.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. By revising &sect;180.277, to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;180.277
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
 S-2,3-Dichloroallyl diisopropylthiocarbamate; tolerances for residues.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Tolerances, set to expire on August 30, 1996, are established for negligible residues of the herbicide 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
S
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-2,3-dichloroallyl diisopropylthiocarbamate in or on the raw agricultural commodities alfalfa (fresh and hay),
barley (grain, forage, and straw), clover (fresh and hay), field corn grain, fodder and forage, flaxseed, lentils,
peas, pea forage and hay, potatoes, safflower seed, soybeans, soybean forage and hay, and sugar beet roots and tops
at 0.05 part per million.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;763 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00066 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Health Care Financing Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>42 CFR Parts 412 and 413 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[BPD&hyph;731&hyph;IFC] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 0938&hyph;AG00 </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Medicare Program; Payment for Preadmission Services 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Health Care Financing Administration (HCFA), HHS. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Interim final rule with comment period. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This interim final rule specifies that inpatient hospital operating costs include certain preadmission services
furnished by the hospital (or by an entity that is wholly owned or operated by the hospital) to the patient up to 3 days
before the date of the patient's admission to that hospital. These provisions implement amendments made to section
1886(a)(4) of the Social Security Act by section 4003 of the Omnibus Budget Reconciliation Act of 1990.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Effective Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This interim final rule with comment period is effective on January 12, 1994. We refer the reader to section V.A. of
this preamble for a discussion of specific provisions that apply to specific periods. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment Period:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Comments will be considered if we receive them at the appropriate address, as provided below, no later than 5 p.m. on
March 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mail written comments (an original and 3 copies) to the following address: 
<!-- PJG 0012 frnewline -->
Health Care Financing Administration, 
<!-- PJG 0012 frnewline -->
Department of Health and Human Services, 
<!-- PJG 0012 frnewline -->
Attention: BPD&hyph;731&hyph;IFC, P.O. Box 7517, 
<!-- PJG 0012 frnewline -->
Baltimore, MD 21207.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If you prefer, you may deliver your written comments (an original and 3 copies) to one of the following addresses:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Room 309&hyph;G, Hubert H. Humphrey Building, 
<!-- PJG 0012 frnewline -->
200 Independence Avenue, SW., 
<!-- PJG 0012 frnewline -->
Washington, DC 20201, or 
<!-- PJG 0012 frnewline -->
Room 132, East High Rise Building, 
<!-- PJG 0012 frnewline -->
6325 Security Boulevard, 
<!-- PJG 0012 frnewline -->
Baltimore, MD 21207.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Because of staffing and resource limitations, we cannot accept comments by facsimile (FAX) transmission. In commenting,
please refer to file code BPD&hyph;731&hyph;IFC. Comments received timely will be available for public inspection
as they are received, generally beginning approximately 3 weeks after publication of a document, in room 309&hyph;G
of the Department's offices at 200 Independence Avenue, SW., Washington, DC, on Monday through Friday of each week
from 8:30 a.m. to 5 p.m. (phone: 202&hyph;690&hyph;7890). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Copies:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To order copies of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 containing this document, send your request to: New Orders, Superintendent of Documents, P.O. Box 371954, Pittsburgh,
PA 15250&hyph;7954. Specify the date of the issue requested and enclose a check or money order payable to the Superintendent
of Documents, or enclose your Visa or Master Card number and expiration date. Credit card orders can also be placed
by calling the order desk at (202) 783&hyph;3238 or by faxing to (202) 275&hyph;6802. The cost for each copy is $4.50.
As an alternative, you can view and photocopy the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 document at most libraries designated as Federal Depository Libraries and at many other public and academic libraries
throughout the country that receive the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Thomas Hoyer, (410) 966&hyph;4607. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00067 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
I. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 1886(a) of the Social Security Act (the Act) establishes a ceiling on the allowable rate of the increase for
Medicare hospital inpatient operating costs. Prior to the Omnibus Budget Reconciliation Act of 1990 (Pub. L. 101&hyph;508),
section 1886(a)(4) of the Act defined the ``operating costs of inpatient hospital services'' to include ``all routine
operating costs, ancillary service operating costs, and special care unit operating costs with respect to inpatient
hospital services as such costs are determined on an average per admission or per discharge basis *&blank;*&blank;*.''

<!-- PJG 0012 frnewline -->
Section 3610.3 (formerly section 3608) of the Medicare Intermediary Manual, Part 3 (HCFA Pub. 13&hyph;3) and section
415.6 of the Medicare Hospital Manual (HCFA Pub. 10) provides that, if a beneficiary with Part A coverage is furnished
outpatient hospital services and is thereafter admitted as an inpatient of the same hospital before midnight of the
next day, the outpatient hospital services furnished to the beneficiary are treated as inpatient services and are
included in the hospital's Part A payment. This administrative policy has been in effect since June 1966. It was adopted
in response to a recommendation by the Health Insurance Benefits Advisory Council (HIBAC), which believed it would
shorten inpatient stays by encouraging hospitals to perform some services connected with the stay prior to the actual
inpatient admission. 
<!-- PJG 0012 frnewline -->
On October 1, 1983, the prospective payment system (PPS) was implemented. PPS is a system of payment for acute inpatient
hospital stays under Medicare Part A (Hospital Insurance) based on prospectively-set rates. Under this system,
Medicare payment is made at a predetermined, specific rate for each hospital discharge. All discharges are classified
according to a list of diagnosis-related groups (DRGs). When PPS was introduced, the costs related to the longstanding
policy concerning the payment for preadmission outpatient services as inpatient services were included in the base
year costs used to calculate the PPS standardized payment amount and the DRG weighting factors (see 49 FR 250, January
3, 1984). Those hospitals excluded from payment under PPS continue to be paid for inpatient hospital services they
furnish, as well as for the preadmission services described above, on the basis of reasonable cost up to the ceiling
specified in section 1886(a) of the Act. Therefore, for both PPS and non-PPS hospitals, these preadmission services
may not be billed separately from the covered inpatient admission that follows, since payment for them is included
in the payment made under Part A for the inpatient stay. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00068 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Statutory Provisions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 4003(a) of Public Law 101&hyph;508 amended the definition of ``operating costs of inpatient hospital services''
contained in section 1886(a)(4) of the Act to include the costs of certain services furnished prior to admission.
These preadmission services are to be included in the Part A payment for the subsequent inpatient stay. For purposes
of this interim final rule with comment period, we will refer to the provision as the ``3-Day Payment Window.'' 
<!-- PJG 0012 frnewline -->
As amended, section 1886(a)(4) of the Act defines the operating costs of inpatient hospital services to include certain
preadmission services furnished by the hospital (or by an entity that is wholly owned or operated by the hospital)
to the patient up to 3 days prior to the date of the patient's admission. The inpatient operating costs definition contained
in section 1886(a)(4) of the Act applies to both PPS and non-PPS hospitals. As an amendment to that definition, the
3-Day Payment Window provision applies to both types of hospitals as well. Further, this provision's placement in
section 1886(a)(4) of the Act rather than in sections 1862(a)(14) or 1866(a)(1)(H) of the Act (each of which deals
with rebundling_the practice of covering as hospital services those nonphysician services furnished to hospital
patients by an outside supplier) indicates that the 3-Day Payment Window provision is separate and distinct from
the rebundling requirement and, as such, may not be subject to the civil monetary penalties that apply to violations
of the latter requirement. 
<!-- PJG 0012 frnewline -->
Section 4003(b) of Public Law 101&hyph;508 provides for implementation of the 3-Day Payment Window provision in
the following three phases: 
<!-- PJG 0012 frnewline -->
&bull;The first phase, effective from November 5, 1990 (the enactment date of Pub. L. 101&hyph;508) through September
30, 1991, includes any services furnished during the day before the date of admission regardless of whether the services
are related to the admission. The Conference Report accompanying Public Law 101&hyph;508 indicates that this phase
simply represents a statutory reiteration of the existing administrative policy. For this reason, the conferees
did not expect that there was a need for any further administrative action by HCFA to implement this phase (H.R. Conf.
Rep. No. 964, 101st Cong., 2d Sess. 701 (1990)). 
<!-- PJG 0012 frnewline -->
&bull;The second phase, effective January 1, 1991, involves diagnostic services (including clinical diagnostic
laboratory tests) that are furnished during the 3 days immediately preceding the date of admission. 
<!-- PJG 0012 frnewline -->
&bull;The third phase, effective October 1, 1991, includes other services related to the admission that are furnished
during the 3 days immediately preceding the date of admission. 
<!-- PJG 0012 frnewline -->
With respect to adjustments to the DRG relative weights, the Conference Report states that, ``[n]othing in this provision
requires the Secretary to take special action to adjust the DRG relative weights to reflect the additional services
that would be covered by the DRG payment under this provision. The conferees expect that no adjustment will be made
before [fiscal year] FY 1993 when Part a [A] billing data that would include the additional services would become available
to recalibrate the relative weights.'' (H.R. Conf. Rep. No. 964, 101st Cong., 2d Sess. 701 (1990).) 
<!-- PJG 0012 frnewline -->
Section 4003(c) of Public Law 101&hyph;508 specifically authorizes the Secretary to implement the 3-Day Payment
Window provision through the issuance of interim final regulations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Provisions of the Rule 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In this interim final rule with comment period, we are amending the Medicare regulations by adding new material to
incorporate the provisions of section 4003(a) of Public Law 101&hyph;508 that amend section 1886(a)(4) of the Act
and to apply the effective dates to these provisions as required under section 4003(b) of Public Law 101&hyph;508.

<!-- PJG 0012 frnewline -->
As indicated in section II of this preamble, the 3-Day Payment Window provision will be implemented in three phases.
Phase one is intended simply to serve as a statutory reiteration of our existing policy as indicated by both section
4003(b)(1) of Public Law 101&hyph;508 and the Conference Report (H.R. Conf. Rep. No. 964, 101st Cong., 2d Sess. 701
(1990)). Phase two, effective January 1, 1991, specifies that payment for inpatient hospital operating costs includes
diagnostic services that are furnished during the 3 days immediately preceding the date of admission. Phase three
specifies that payment for inpatient hospital operating costs includes other (that is, non-diagnostic) services
that are related to the admission and are furnished during the 3 days immediately preceding the date of admission.
Under phase three of the new law, we needed to choose between two possible approaches to the treatment of non-diagnostic
services furnished within 3 days before admission. (Phase two deals only with diagnostic services and, thus, is not
relevant to this issue). Phase one of the 3-Day Payment Window provision and our existing policy for services furnished
on the day before admission are both somewhat broader than phase three, in that they bundle all preadmission services
into the inpatient payment, regardless of whether they are related to the admission. Thus, for the phase one period,
we believe it is appropriate to follow the broader administrative policy, which is already in place. However, for
the implementation of phase three (section 4003(b)(3) of Pub. L. 101&hyph;508) beginning October 1, 1991, we considered
whether to apply this broader policy or impose a policy that follows the narrower wording of the new law, that is, include
non-diagnostic preadmission services only to the extent that they are related to the admission. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00069 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We considered that the Conference Report language (which characterizes the first phase of implementation as embodying
the existing policy) could justify continuing the current, all-inclusive policy for the day before admission, or
even expanding it to apply to the second and third day before admission as well. This approach would not require identifying
any services as being related to the admission and would not require separating out from the inpatient payment any
of the services not related to the admission that are furnished on the day before admission (all services_regardless
of whether the services are related to the admission_are currently included in the inpatient payment under the existing
policy). This approach would also enhance the program savings to be realized from the 3-Day Payment Window provision,
since it folds into the inpatient payment a greater range of preadmission services that, as a consequence, would not
receive a separate payment under Part B. Finally, by maximizing the services to be included in the Part A payment for
the subsequent admission, this approach would clearly be advantageous to beneficiaries who are eligible only for
Part A; further, even beneficiaries who are eligible for both Parts A and B would be able to avoid incurring the Part
B deductible and coinsurance charges to the maximum extent possible. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
However, we note that adopting such an all-inclusive approach for the second and third days before admission is contrary
to the clear language of the new law, which is worded specifically in terms of ``other services related to the admission.''
Furthermore, we have determined that continuing this approach indefinitely even for the day before admission only
would appear to be inconsistent with the new law's implementation provisions; unlike phases two and three, phase
one contains both a starting date and an ending date. We believe this indicates that Congress intended for the existing,
all-inclusive policy to remain in effect, but only during the finite period between those two dates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
After considering these various factors, we have determined that services (other than diagnostic services) furnished
on the second and third days before admission must be related to the admission in order to come under the 3-Day Payment
Window provision. Further, we have determined that effective with services furnished on or after October 1, 1991
(upon the expiration of the first phase of implementation), this qualification will become applicable to non-diagnostic
services furnished on the day before admission as well. We believe that this approach most accurately reflects the
intent of the statutory language of the new provision. We realize that, under this approach, the payment made under
Part A, which currently includes the cost of all non-diagnostic services furnished on the day before admission, will
no longer include non-diagnostic services unless they are related to the admission. However, consistent with the
Conference Report language set out above, we have to date made no DRG payment adjustments to reflect the effects of
the 3-Day Payment Window provision. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For purposes of this provision, we are defining ``other services related to the admission'' as those non-diagnostic
services furnished in connection with the diagnosis (that is, the principal diagnosis) that requires the beneficiary
to be admitted as an inpatient. We considered defining this term more broadly to include services furnished in connection
with secondary diagnoses as well; however, secondary diagnoses can sometimes include complicating events that
do not occur until after admission. Since the law specifies that this provision is to apply to services related to the
inpatient ``admission'' (as opposed to the ensuing inpatient stay), we believe that it is more accurate to use only
the principal diagnosis, as identifying those preadmission services that are related to the actual cause of admission.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Further, the statutory language charges the Secretary with defining those non-diagnostic services that are regarded
as ``related to the admission'' and, thus, are subject to the payment window. In effect, this gives the Secretary the
authority to determine the scope of the payment window's applicability to non-diagnostic services. In this context,
we have determined that ambulance services are not subject to the payment window, even when furnished during the preadmission
period by the admitting hospital or by an entity that it wholly owns or operates. The House Budget Committee Report
accompanying the payment window legislation explained that the underlying objective of this provision is ``* * *
to curb further unbundling which has occurred since the introduction of the DRG payment system * * *'' (H.R. Budget
Comm. Rep. No. 881, 101st Cong., 2d Sess. 250 (1990).) As a Part B benefit, ambulance services (unlike patient transportation
services furnished to inpatients) are not bundled with inpatient services and, thus, have not been subject to the
actions taken to maximize payment under PPS, which prompted Congress's concern. Thus, we believe that ambulance
services are distinct from the type of hospital services that Congress designed the payment window provision to address.
Many hospitals that operate ambulance services do so at a loss. The hospitals continue to furnish the ambulance services
primarily as a means of assuring access to hospital care for individuals who otherwise would be unable to reach hospitals.
Subjecting hospitals that operate ambulance services to still greater fiscal constraints under the payment window
provision could have a major adverse impact on their availability, particularly in remote rural areas. Therefore,
in this rule, we are defining the preadmission services that are subject to the payment window provision as not including
ambulance services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00070 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on our interpretation of the law, we will implement phases two and three of the 3-Day Payment Window provision
set forth in section 1886(a)(4) of the Act and section 4003(b) of Public Law 101&hyph;508 by revising regulations
concerning payment to PPS hospitals (&sect;412.2) and non-PPS hospitals (&sect;413.40) for inpatient hospital
services furnished to Medicare beneficiaries. (We are not amending the regulations with respect to phase one since,
as discussed previously, the Conference Report language indicates that this phase simply embodies our existing
policy and requires no further administrative action to implement.) Specifically, we are adding paragraph (c)(5)
to &sect;412.2 and revising &sect;413.40(c). We will specify that payment for inpatient operating costs for both
PPS and non-PPS hospitals will include certain preadmission services furnished by the hospital or by an entity wholly
owned or operated by the hospital to the patient during the 3 days immediately preceding the date of the patient's admission.
We are interpreting the phrase ``wholly'' owned or operated to include any entity for which the hospital itself is
the sole owner; for purposes of consistency, we are also including in this term any entity for which the hospital is
the sole operator. We note that a hospital need not exercise administrative control over a facility in order to operate
it. An operator implements facility policies, but does not necessarily make the policies; operating a facility simply
involves conducting the facility's day-to-day activities, as opposed to ``control,'' which involves the power
to direct the facility's operations toward specific objectives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Thus, &sect;&sect;412.2 and 413.40 will specify that payment for inpatient operating costs for both PPS and non-PPS
hospitals will include the following services (other than ambulance services): 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Diagnostic services (including clinical diagnostic laboratory tests) furnished on or after January 1, 1991.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Other services related to the admission furnished on or after October 1, 1991. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We will define other services related to the admission to include those non-diagnostic services furnished in connection
with the principal diagnosis that requires the beneficiary to be admitted as an inpatient. We invite comments on our
use of this definition to identify admission-related services. We also invite comments on the feasibility of prescribing
more detailed operational procedures in the regulations. For example, one possible approach might be simply to presume
that certain specific types of preadmission services (such as chronic maintenance dialysis) are never related to
the subsequent admission, or to presume that all preadmission services (other than certain specified exceptions)
are admission-related. Another alternative might be to develop an inclusive list of procedures which are medically
related, against which all claims could be electronically screened. Still another approach could be to define as
related to the principal diagnosis any services that fall within the same major diagnostic category (MDC) as used
under PPS. In establishing a degree of medical relatedness, the MDC approach would have the advantage of administrative
simplicity for hospitals, contractors, and the government, as it would use a patient classification system that
is already in place for hospital services under PPS. We invite comments on the feasibility of prescribing these or
other implementation procedures in the regulations, as well as the relative administrative burden that each type
of approach would impose on the program to develop and implement and on the facilities to comply. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In response to the changes made by section 4003 of Public Law 101&hyph;508, instructions were published in the Medicare
Intermediary Manual, Part 3 (HCFA Pub. 13&hyph;3), ``Claims Process'' in March 1992 (Transmittal No. 1565) and in
the Medicare Hospital Manual (HCFA Pub. 10), in March 1992 (Transmittal No. 633). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We note that we are making some conforming technical changes to &sect;&sect;412.2 (c)(3) and (c)(4), 412.73(c)(1),
412.98(b), and 413.40 (a)(3) and (i)(3). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Other Required Information 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Effective Dates 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The effective date of this interim final rule with comment period is January 12, 1994. As discussed previously, the
Conference Report language indicates that the changes made by section 4003(b)(1) of Public Law 101&hyph;508 (which
are effective from November 5, 1990, through September 30, 1991) simply embody our existing policy and require no
further administrative action to implement; thus, we are not amending the regulations with respect to this aspect
of the provision. Changes made by section 4003(b)(2) of Public Law 101&hyph;508 that include as inpatient hospital
services those diagnostic services that are furnished during the 3 days immediately preceding the date of admission
are applicable for services furnished on or after January 1, 1991. Changes made by section 4003(b)(3) of Public Law
101&hyph;508 that include as inpatient hospital services any other services related to the admission furnished
during the 3 days immediately preceding the date of admission are applicable for services furnished on or after October
1, 1991. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Waiver of Notice of Proposed Rulemaking and 30&hyph;Day Delay in the Effective Date 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We ordinarily publish a notice of proposed rulemaking for a regulation to provide a period for public comment. However
we may waive that procedure if we find good cause that prior notice and comment are impracticable, unnecessary, or
contrary to public interest. In addition, section 1871(b)(2)(A) of the Act provides that the notice of proposed rulemaking
is not required if a statute specifically permits a regulation to be issued in interim final form. Section 4003(c)
of Public Law 101&hyph;508 permits the Secretary to publish the regulations, which will implement the 3-Day Payment
Window provision, on an interim final basis. Therefore, we are implementing this interim final rule with comment
period without first issuing a notice of proposed rulemaking. Nonetheless, we are providing a 60-day period for public
comment, as indicated at the beginning of this interim final rule. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00071 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition, we normally provide a delay of 30 days in the effective date for documents such as this. However, we may
waive the delay in the effective date if we find good cause that adherence to this procedure would be impracticable,
unnecessary, or contrary to public interest. We believe that it is unnecessary to provide a 30-day delay in the effective
date since the Conference Report language, as discussed previously, indicates that no further administrative action
is necessary to effect the first phase of implementation, and section 4003(b) of Public Law 101&hyph;508 prescribes
specific effective dates for the remaining two phases. The regulations in this interim final rule with comment period
merely conform to the effective date requirements set forth in section 4003(b) of Public Law 101&hyph;508. Therefore,
we find good cause to waive the usual 30-day delay. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Collection of Information Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This document does not impose information collection and recordkeeping requirements. Consequently, it need not
be reviewed by the Office of Management and Budget under the authority of the Paperwork Reduction Act of 1980 (44 U.S.C.
3501 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Response to Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Because of the large number of items of correspondence we normally receive on FR documents published for comment,
we are not able to acknowledge or respond to them individually. We will consider all comments we receive by the date
and time specified in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
DATES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 section of this preamble, and, if we proceed with a subsequent document, we will respond to the comments in the preamble
to that document. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VI. Regulatory Impact Analysis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Executive Order 12291
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Executive Order 12291 (E.O. 12291) requires us to prepare and publish a regulatory impact analysis for any interim
final rule with comment period that meets one of the E.O. 12291 criteria for a ``major rule''; that is, that will be likely
to result in_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;An annual effect on the economy of $100 million or more;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;A major increase in costs or prices for consumers, individual industries, Federal, State, or local government
agencies, or geographic regions; or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
&bull;Significant adverse effects on competition, employment, investment, productivity, innovation, or on the
ability of United States-based enterprises to compete with foreign-based enterprises in domestic or export markets.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This interim final rule with comment period is considered a major rule under E.O. 12291 criteria based on our cost projections
for the next 5 Federal fiscal years (FYs). The following discussion constitutes a regulatory impact analysis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This interim final rule with comment period implements section 4003 of Public Law 101&hyph;508, which contains a
provision that expands the timeframe for folding preadmission services into the Part A payment for the subsequent
inpatient stay. The first sentence of section 1886(a)(4) of the Act is amended to include certain preadmission services,
furnished by the hospital, or by an entity that is wholly owned or operated by the hospital, up to 3 days before the date
of the patient's admission. This provision becomes effective in three phases.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The first phase, effective November 5, 1990 through September 30, 1991, included services furnished the day before
admission. This phase merely represented a statutory reiteration of the existing policy. The second phase, effective
January 1, 1991, included diagnostic services that are furnished during the 3 days immediately preceding the date
of admission. The third phase, effective October 1, 1991, includes other services related to the admission that are
furnished during the 3 days immediately preceding the date of admission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00072 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This regulation will result in program savings from discontinuing separate payment under Part B for services performed
up to 3 days before the date of admission instead of 1 day, without an immediate, corresponding increase in the DRG payments
under Part A. The estimated savings will be reduced if physicians elect to have preadmission services performed at
a non-hospital site or more than 3 days before admission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
There will be some savings to beneficiaries as a result of shifting payment for services from Part B outpatient to Part
A inpatient rates. Beneficiaries are responsible for 20 percent copayment for non-diagnostic outpatient services.
Beneficiaries will not be responsible for copayment if the same services are performed up to 3 days before the date
of a hospital admission and are folded into the hospital's inpatient payment. However, because we do not have a breakdown
of the cost or type of services that will be included in the inpatient payment, we are not able to estimate the annual
savings that will be realized by beneficiaries.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following table reflects estimated program savings solely as a result of discontinuing separate Part B payment
for services performed up to 3 days before the date of admission instead of 1 day, without a corresponding DRG relative
weight adjustment for the inpatient stay.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 5,L2,i1,4,4,4,4,4 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Estimated Medicare Part B Savings
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=96 g=1 f=4 -->
[In millions]1
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1FY 1993 
<!-- PJG 007 0150 intable -->
1FY 1994 
<!-- PJG 007 0150 intable -->
1FY 1995 
<!-- PJG 007 0150 intable -->
1FY 1996 
<!-- PJG 007 0150 intable -->
1FY 1997
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
$40 
<!-- PJG 007 0104 intable -->
$70 
<!-- PJG 007 0104 intable -->
$80 
<!-- PJG 007 0104 intable -->
$90 
<!-- PJG 007 0104 intable -->
$100
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
1Rounded to the nearest $10 million.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=4 -->
As indicated above, we do not anticipate that this new provision will cause a significant change in the timing of services
that, until now, have been furnished during the preadmission period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We are limiting the inclusion of non-diagnostic services, even when furnished on the day before admission, to those
that are related to the admission. We believe this interpretation more accurately implements the provisions of the
statute. This means that services furnished on the day before admission which are neither diagnostic nor admission-related
will no longer be rebundled into the inpatient payment. Further, since the law permits the Secretary to define the
types of admission-related services to be included in the payment window, we have determined that it should not include
ambulance services, to which special conditions apply. As a Part B benefit, ambulance services (unlike patient transportation
services furnished to inpatients) are not bundled with inpatient services, and thus, have not been subject to the
attempts to maximize PPS payment through unbundling which prompted Congress to enact the payment window legislation.
The unbundling provision may generate a small amount of additional Part B costs; however, as indicated above, we anticipate
that the overall degree of change that this provision will produce in existing patterns of service delivery will be
minimal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
B. Regulatory Flexibility Act
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
We generally prepare a regulatory flexibility analysis that is consistent with the Regulatory Flexibility Act (RFA)
(5 U.S.C. 601 through 612) unless the Secretary certifies that an interim final rule with comment period will not have
a significant economic impact on a substantial number of small entities. For purposes of the RFA, we consider all hospitals
to be small entities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This interim final rule with comment period will affect all hospitals that are paid under the prospective payment
system, dependent upon the number of additional services that will have to be included in the DRG payment rate. Since
the estimated savings represent less than one-half of one percent of total Medicare funding to hospitals, we have
determined, and the Secretary certifies, that this interim final rule with comment period will not have a substantial
impact on a substantial number of small entities, and we have, therefore, not prepared a regulatory flexibility analysis.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
C. Small Rural Hospitals
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Section 1102(b) of the Act requires the Secretary to prepare a regulatory impact analysis if an interim final rule
with comment period may have a significant impact on the operations of a substantial number of small rural hospitals.
This analysis must conform to the provisions of section 604 of the RFA. For purposes of section 1102(b) of the Act, we
define a small rural hospital as a hospital that is located outside of a Metropolitan Statistical Area and has fewer
than 50 beds.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We believe the 3-Day Payment Window provision will affect small rural hospitals to a lesser degree than larger facilities
where complex procedures are performed and specialized medical conditions are treated, requiring additional preadmission
testing. Therefore, we have determined, and the Secretary certifies, that this interim final rule with comment period
will not have a significant economic impact on the operations of a substantial number of small rural hospitals. Consequently,
we are not preparing an analysis for section 1102(b) of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00073 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=4 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
42 CFR Part 412 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Administrative practice and procedure, Health facilities, Medicare, Puerto Rico, Reporting and recordkeeping
requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=4 -->
42 CFR Part 413 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Health facilities, Kidney diseases, Medicare, Puerto Rico, Reporting and recordkeeping requirements.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=4 -->
42 CFR chapter IV is amended as set forth below: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Part 412 is amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=4 -->
PART 412_PROSPECTIVE PAYMENT SYSTEMS FOR INPATIENT HOSPITAL SERVICES 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
1. The authority citation for part 412 continues to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 1102, 1815(e), 1871, and 1886 of the Social Security Act (42 U.S.C. 1302, 1395g(e), 1395hh, and 1395ww). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Subpart A_General Provisions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;412.2, the introductory language in paragraph (c) is republished, paragraphs (c)(3) and (4) are revised,
and paragraph (c)(5) is added to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;412.2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Basis of payment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Inpatient operating costs. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The prospective payment system provides a payment amount for inpatient operating costs, including_ 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) Special care unit operating costs (intensive care type unit services, as described in &sect;413.53(b) of this
chapter); 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Malpractice insurance costs related to services furnished to inpatients; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Certain preadmission services furnished by the hospital or by an entity wholly owned or operated by the hospital
(that is, any entity for which the hospital itself is the sole owner or operator) to the patient during the 3 days immediately
preceding the date of the patient's admission to the hospital. A hospital is considered the sole operator of an entity
if the hospital has exclusive responsibility for conducting or overseeing the entity's routine operations, regardless
of whether the hospital also has policymaking authority over the entity. The specific preadmission services (other
than ambulance services) included in the inpatient hospital operating costs are the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Diagnostic services (including clinical diagnostic laboratory tests) furnished on or after January 1, 1991.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Other services related to the admission furnished on or after October 1, 1991. Other services related to the admission
means services (other than diagnostic services) that are furnished in connection with the principal diagnosis that
requires the beneficiary to be admitted as an inpatient. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00074 </DOCNO>
<PARENT> FR940112-0-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Subpart E_Determination of Transition Period Payment Rates for Inpatient Operating Costs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;412.73 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. In &sect;412.73(c)(1), the phrase ``the rate-of-increase percentage determined under &sect;413.40(c)(2)
of this chapter,'' is revised to read ``the rate-of-increase percentage determined under &sect;413.40(c)(3) of
this chapter,''. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Subpart G_Special Treatment of Certain Facilities Under the Prospective Payment System for Inpatient Operating
Costs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;412.98 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. In &sect;412.98(b), in the first sentence, the phrase ``under &sect;413.40(c)(3) of this chapter'' is revised
to read ``under &sect;413.40(c)(4) of this chapter''. 
<!-- PJG 0012 frnewline -->
B. Part 413 is amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 413_PRINCIPLES OF REASONABLE COST REIMBURSEMENT; PAYMENT FOR END-STAGE RENAL DISEASE SERVICES 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 413 continues to read as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Secs. 1102, 1814(b), 1815, 1833 (a), (i), and (n), 1861(v), 1871, 1881, 1883, and 1886 of the Social Security Act (42
U.S.C. 1302, 1395f(b), 1395g, 1395l(a), (i), and (n), 1395x(v), 1395hh, 1395rr, 1395tt, and 1395ww); sec. 104(c)
of Pub. L. 100&hyph;360 as amended by sec. 608(d)(3) of Pub. L. 100&hyph;485 (42 U.S.C. 1395ww (note)); and sec. 101(c)
of Pub. L. 101&hyph;234 (42 U.S.C. 1395ww (note)). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Subpart C_Limits on Cost Reimbursement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;413.40 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 413.40 is amended as follows: 
<!-- PJG 0012 frnewline -->
a. In paragraph (a)(3), in the definition for ``net inpatient operating costs'', the first sentence is revised. 
<!-- PJG 0012 frnewline -->
b. Paragraphs (c)(2) through (c)(4) are redesignated as paragraphs (c)(3) through (c)(5), and a new paragraph (c)(2)
is added. 
<!-- PJG 0012 frnewline -->
c. In redesignated paragraph (c)(4)(ii), the phrase ``unless the provisions of paragraph (c)(4)(ii) of this section
apply.'' is revised to read ``unless the provisions of paragraph (c)(5)(ii) of this section apply.'' 
<!-- PJG 0012 frnewline -->
d. In paragraph (i)(3), the phrase ``the applicable rate-of-increase percentages (update factors) described in
paragraph (c)(2) of this section.'' is revised to read ``the applicable rate-of-increase percentages (update factors)
described in paragraph (c)(3) of this section.'' 
<!-- PJG 0012 frnewline -->
The revision and addition are to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;413.40 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Ceiling on the rate of increase in hospital inpatient costs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->
(3) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Net inpatient operating costs
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 include the costs of certain preadmission services as specified in &sect;413.40(c)(2), the costs of routine services,
ancillary services, and intensive care services (as defined in &sect;413.53(b)) incurred by a hospital in furnishing
covered inpatient services to Medicare beneficiaries. *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Preadmission services.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Net inpatient operating costs include certain preadmission services furnished by the hospital or by an entity wholly
owned or operated by the hospital (that is, any entity for which the hospital itself is the sole owner or operator) to
the patient during the 3 days immediately preceding the date of the patient's admission to the hospital. A hospital
is considered the sole operator of an entity if the hospital has exclusive responsibility for conducting or overseeing
the entity's routine operations, regardless of whether the hospital also has policymaking authority over the entity.
The specific preadmission services (other than ambulance services) included in the net inpatient hospital operating
costs are the following: 
<!-- PJG 0012 frnewline -->
(i) Diagnostic services (including clinical diagnostic laboratory tests) furnished on or after January 1, 1991.

<!-- PJG 0012 frnewline -->
(ii) Other services related to the admission furnished on or after October 1, 1991. Other services related to the admission
means services (other than diagnostic services) that are furnished in connection with the principal diagnosis that
requires the beneficiary to be admitted as an inpatient. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance Program No. 93.773, Medicare_Hospital Insurance; and Program No. 93.774,
Medicare_Supplementary Medical Insurance Program) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: July 20, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bruce C. Vladeck, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator, Health Care Financing Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: August 30, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna E. Shalala, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;546 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4120&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00075 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>42 CFR Parts 435 and 436 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[MB&hyph;020&hyph;FC] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 0938&hyph;AB07 </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Medicaid Program; Deduction of Incurred Medical Expenses (Spenddown) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Health Care Financing Administration (HCFA), HHS. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule with comment period. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This final rule with comment period permits States flexibility to revise the process by which incurred medical expenses
are considered to reduce an individual's or family's income to become Medicaid eligible. This process is commonly
referred to as ``spenddown.'' Only States which cover the medically needy, and States which use more restrictive
criteria to determine eligibility of the aged, blind, and disabled, than the criteria used to determine eligibility
for Supplemental Security Income (SSI) benefits (section 1902(f) States) have a spenddown. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
These revisions permit States to: Consider as incurred medical expenses projected institutional expenses at the
Medicaid reimbursement rate, and deduct those projected expenses from income in determining eligibility; combine
the retroactive and prospective medically needy budget periods; either include or exclude medical expenses incurred
earlier than the third month before the month of application (States must, however, deduct current payments on old
bills not previously deducted in any budget period); and deduct incurred medical expenses from income in the order
in which the services were provided, in the order each bill is submitted to the agency, or by type of service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All States with medically needy programs using the criteria of the SSI program may implement any of the provisions.
States using more restrictive criteria than the SSI program under section 1902(f) of the Social Security Act may implement
all of these provisions except for the option to exclude medical expenses incurred earlier than the third month before
the month of application. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 These regulations are effective March 14, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To ensure that comments will be considered, we must 
<!-- PJG 0012 frnewline -->
receive them at the appropriate address, as provided below, no later than 5 p.m. on March 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mail written comments (original and 3 copies) to the following address: Health Care Financing Administration, U.S.
Department of Health and Human Services, Attention: MB&hyph;020&hyph;FC, P.O. Box 26676, Baltimore, MD 21207.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If you prefer, you may deliver your written comments (original and 3 copies) to one of the following addresses: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Room 309&hyph;G, Hubert H. Humphrey Building, 200 Independence Ave., SW., Washington, DC, or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Room 132, East High Rise Building, 6325 Security Boulevard, Baltimore, MD. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Due to staffing and resource limitations, we cannot accept comments by facsimile (FAX) transmission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In commenting, please refer to file code MB&hyph;020&hyph;FC. Comments received timely will be available for public
inspection as they are received, beginning approximately three weeks after publication of this document, in room
309&hyph;G of the Department's offices at 200 Independence Ave., SW., Washington, DC, on Monday through Friday of
each week from 8:30 a.m. to 5 p.m. (phone: 202&hyph;690&hyph;7890). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION, CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Richard Coyne, (410) 966&hyph;4458. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00076 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
I. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
States must provide Medicaid to categorical groups of individuals who are eligible to receive cash payments under
one of the existing cash assistance programs established under the Social Security Act (the Act). In addition, States
may provide Medicaid to the medically needy; that is, to those individuals who meet the categorical group requirements,
have sufficient income to meet basic living expenses and, thus, are ineligible for a cash assistance program but who
have insufficient income to pay for medical expenses. Sections 1902(a)(17) and 1903(f)(2) of the Act provide that,
for individuals applying as medically needy, certain incurred medical expenses must be deducted from income if income
exceeds the eligibility standard established by the State. The process is commonly referred to as ``spenddown.''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the medically needy program, the spenddown process currently operates as follows: The State selects one or more
medically needy budget periods between 1 and 6 months and a medically needy income level, against which countable
income is measured. If countable income, after certain deductions are taken, is equal to or less than the income standard
(medically needy income level), the individual (or family) is eligible for Medicaid. If the income is higher than
this standard, the individual nevertheless may be eligible for Medicaid if, by deducting incurred medical expenses
(i.e., spending down the ``excess'' income), the income equals or falls below the standard.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 1902(f) of the Act contains a similar provision for deduction of incurred medical expenses from income. This
spenddown applies to categorically needy and medically needy aged, blind, and disabled individuals in States using
more restrictive eligibility criteria than those of the Supplemental Security Income (SSI) program. These States
are known as section 1902(f) States. In those States, section 1902(f) of the Act requires that, in determining how
much income is to be counted when determining eligibility, the Medicaid agency must deduct from income: (1) any SSI
benefit received; and (2) any additional benefit paid by the State. If, after these deductions are taken, income is
equal to or less than the State established income standard, the individual is eligible for Medicaid. If income is
higher than the standard, the agency must deduct incurred medical expenses from the individual's countable income
to determine whether or not he or she is eligible.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
States using section 1902(f) criteria may elect to have medically needy programs. Individuals who become eligible
for Medicaid by meeting the section 1902(f) spenddown are categorically needy unless the section 1902(f) State has
a medically needy program. In section 1902(f) States with medically needy programs, an individual who spends down
in order to meet the income test will be either medically needy or categorically needy. If he or she is an SSI or State
supplement recipient, or meets the income test for SSI or a State supplement, he or she will be categorically needy.
Otherwise, when the individual spends down, he or she will be medically needy. Once a section 1902(f) State elects
to use more restrictive standards than those which the State is otherwise obligated to use under title XIX for those
who will qualify as medically needy, its spenddown rules are governed by section 1902(f).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The statutory authority behind the general medically needy and section 1902(f) spenddowns is different. Under the
general medically needy spenddown in section 1902(a)(17), States must take into account, except to the extent prescribed
by the Secretary, the costs incurred for medical care or any other type of remedial care recognized under State law.
Under section 1902(f), the spenddown language is broader. That is, the Secretary has not been granted the same authority
to impose a limit: States must deduct from an individual's countable income incurred expenses for medical care as
recognized under State law. However, section 1902(f) allows States to limit the deductible amount of expenses by
recognizing only the limited amount under State law.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All States are currently required by section 1902(a)(34) of the Act to provide Medicaid benefits 3 months prior to
the month in which an application is filed, subject to certain conditions. These conditions are that the individual
(a) received covered services under the State plan at any time during that 3-month period, and (b) would have been eligible
for Medicaid at the time services were received if he or she had applied.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00077 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Provisions of the Proposed Rule
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Summary of Provisions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On September 2, 1983, we published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (48 FR 39959) a proposed rule (NPRM) to solicit comments on five sets of proposed changes to spenddown procedures (Provisions
A through E, as described below). Our proposals are summarized below.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We proposed that all States with medically needy programs, including those using more restrictive eligibility criteria
than SSI under section 1902(f) of the Act, be permitted to choose option A. In the NPRM we specified that a literal interpretation
of section 1902(f) of the Act would prevent these States from implementing the remaining options (Provisions B through
E).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision A_Allow States to Consider Projected Institutional Expenses at the Medicaid Rate as Incurred Medical
Expenses
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We proposed that all States, including those using more restrictive eligibility criteria than SSI, be permitted
to count as incurred medical expenses in calculating whether spenddown requirements are met, projected institutional
expenses (not subject to payment by a third party) at the Medicaid reimbursement rate instead of using only the private
patient rate, as is currently required.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision B_Allow States To Combine Retroactive and Prospective Medically Needy Budget Periods
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For those States that choose to have a medically needy program, we proposed the use of more flexible budget periods.
These are periods over which an individual's income and medical expenses are compared to the State's medically needy
income level to determine whether or not the individual is eligible. Specifically, States would be able to choose
a medically needy budget period of up to 6 months that could include all or part of the 3-month period before an application
for Medicaid (the retroactive period). Under current regulations, the 3-month retroactive period must be treated
separately from whatever prospective budget period is chosen by the State.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision C_Permit States To Exclude from Incurred Medical Expenses Those Bills for Services Furnished More Than
3 Months Before a Medicaid Application
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Except for current payments on older bills not previously applied in the spenddown process, we proposed that States
be permitted to exclude from incurred medical expenses those bills for services furnished more than 3 months before
the month of application or redetermination. Current regulations and policy require that States deduct all incurred
expenses that an individual incurs before application, regardless of the date of the service, if they have not already
been used in another budget period, if the individual is still liable for them, or if the individual has paid for them
in the current budget period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision D_Permit States to Apply Incurred Medical Expenses to the Spenddown Process in Chronological Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We proposed that States with a medically needy program may deduct incurred medical expenses from income in chronological
order, rather than in the order specified in current regulations, which is by type of expenditure. The chronological
order the State chooses can be either the order in which the services are furnished, or the order in which the bills are
presented to the agency.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision E_Allow States To Limit Deductible Medical Expenses to Services Covered Under the State Plan
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We proposed to allow States to exclude services that are not covered in their State plan from incurred medical expenses,
except for Medicare and health insurance premiums, Medicaid deductibles, copayments or similar cost-sharing charges
imposed by health insurance. Current regulations require that States deduct all incurred medical expenses recognized
under State law that are not subject to payment by a third party.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Revision of NPRM Scope
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We have decided to withdraw Provision E from all States. We explain our reasons under the analysis and response to public
comments section of this preamble.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Analysis and Response to Public Comments
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In response to our request for comments on the September 2, 1983, NPRM, we received 107 letters, 32 from client advocacy
groups, 26 from individuals, 18 from providers or provider organizations, 15 from State governmental agencies,
13 from legal advocacy groups, and 3 from religious affiliated groups. The specific comments are grouped according
to the five provisions identified in the NPRM.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00078 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Comments on Specific Provisions of the NPRM 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Provision A_Allow States to Consider Projected Institutional Expenses at the Medicaid Rate as Incurred Medical
Expenses
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It should also be noted that Provision A does not govern implementation of section 1929(b)(3) of the Act, which permits
States to project medical expenses in determining eligibility for medical assistance for home and community care
under section 1929. Regulations governing section 1929 will be published separately. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several commenters objected to Provision A, believing that allowing States to project institutional expenses at
the Medicaid rate contravenes the law. They believe that since the law requires accounting for ``incurred'' expenses
and since expenses are incurred at the private patient payment rate, a projection of expenses, as a part of accounting
for incurred expenses, should only be at the private patient payment rate. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We do not agree with the commenters. In the preamble to the NPRM, we noted that ``[i]t is currently permissible for States
to project anticipated institutional expenses at the private patient rate'' but that we were proposing to revise
regulations to also ``provide that States may count institutional expenses (not subject to payment by a third party)
at the Medicaid reimbursement rate instead of the private payment rate in calculating spenddown.'' (48 FR 39960).
As discussed in more detail below, we have analyzed the issue further and have concluded that it is inappropriate to
project expenses at the private patient payment rate. 
<!-- PJG 0012 frnewline -->
First, the spenddown rules in sections 1902(a)(17) and 1902(f) of the Act provide for reducing income by ``incurred''
expenses (i.e., expenses for which the individual is liable). Under these provisions, the Secretary does not have
to allow States to project any expenses since projection involves treating an expense as incurred before the liability
arises. However, States are permitted to project expenses under the Secretary's general rulemaking authority in
sections 1102 and 1902(a)(4) of the Act because projection may be necessary for the efficient operation of the Medicaid
program. 
<!-- PJG 0012 frnewline -->
The assumption underlying the projection of expenses is that liability for the expenses will subsequently arise
since only the amounts for which the individual is ultimately liable can be used to reduce income. However, when the
private patient payment rate is higher than the Medicaid rate and expenses are projected at the private payment rate,
liability for the projected expenses may not actually arise. That is, once expenses are projected and spenddown liability
is met, the provider may charge expenses only at the Medicaid rate as specified in &sect;447.15. Thus, expenses projected
at the private payment rate will actually be incurred at the Medicaid rate, and the State will need to reconcile the
amounts accordingly. This reconciliation would make the projection at the private payment rate less efficient than
if the projection were done initially at the Medicaid rate. Further, when expenses ultimately incurred at the Medicaid
rate are insufficient to meet the person's spenddown liability, the determination of eligibility would have been
in error. Only using the Medicaid rate to project expenses avoids these problems. Therefore, we are allowing projections
only at the Medicaid reimbursement rate. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A number of commenters argued that the use of the Medicaid reimbursement rate is arbitrary and generally less than
the private rate. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 States are required by section 1902(a)(13)(A) of the Act to pay for long-term care services using rates that are reasonable
and adequate to meet the costs that efficiently and economically operated facilities must incur to provide care that
conforms to applicable State and Federal laws, regulations, and quality and safety standards. We are clarifying
in these final regulations at &sect;&sect;435.831(g)(1), 435.831(i), 436.831(g)(1), and 436.831(i) that States
may project institutional expenses only at the Medicaid rate. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Many commenters were concerned that if a State uses the Medicaid rate rather than the private rate in the spenddown
process, it could take longer to reduce excess income using the usually lower Medicaid rate. Thus, it would delay eligibility.
A number of commenters were concerned that certain individuals may have insufficient income to pay the private institutional
rate, yet have income in excess of the Medicaid reimbursement rate. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00079 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 As we proposed, an individual is eligible whenever incurred medical expenses, including projected institutional
expenses, equal or exceed the individual's excess income over the State's income standard. (The amount of income
exceeding the State's income standard is referred to as an individual's spenddown liability.) In some instances
the amount of projected institutional expenses at the Medicaid rate may not be enough to meet the individual's spenddown
liability. In that case, the individual remains ineligible. However, the individual will become eligible when actually
incurred institutional expenses at the private rate reduce income enough to establish eligibility. 
<!-- PJG 0012 frnewline -->
As indicated in response to an earlier comment, the State Medicaid rate is the appropriate amount to use in projecting
expenses because it reduces the need to reconcile projected and actually incurred expenses and helps to avoid erroneous
determinations of eligibility. If an individual is not eligible because his or her spenddown liability exceeds institutional
expenses projected over the budget period at the Medicaid rate, the State must determine eligibility based on deducting
actually incurred institutional expenses or based on a combination of expenses actually incurred at the private
payment rate and remaining expenses projected at the Medicaid rate. (If eligibility results and eligibility is retroactive
to the first day of the month because the State provides coverage in whole months, expenses incurred at the private
payment rate prior to the determination of eligibility remain valid. Ordinarily, a participating provider may charge
an eligible individual no more than the Medicaid rate. However, these charges need not be adjusted since the charges
were incurred at the private payment rate and since the charges were part of expenses needed to qualify the individual
for Medicaid under the spenddown. Otherwise, the adjustment could result in the individual no longer being eligible
for Medicaid during the month. Furthermore, unless required under State law or the terms of the State's provider agreement,
Medicaid providers need not accept all Medicaid eligible individuals as Medicaid patients. Thus, during the period
prior to the determination of Medicaid eligibility, the provider could be viewed as only accepting the patient as
a private payment patient. Charges incurred after the determination of eligibility may not exceed the Medicaid rate.)

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Example:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The individual is in the institution as of the first day of the month. The monthly spenddown liability is $1,500. The
projected Medicaid rate for the month is $1,200 ($40 per day). The private rate is $1,800 per month ($60 per day). Since
projected monthly expenses at the Medicaid rate ($1,200) are not sufficient to meet the spenddown liability ($1,500),
the individual is not eligible. However, after remaining in the institution for 15 days the individual has actually
incurred expenses of $900 at the private rate ($60 &times; 15 days). The projected institutional expenses at the Medicaid
rate for the remaining days in the month are $600 ($40 &times; 15 days). Thus, as of the 15th day of the month the combination
of actually incurred bills ($900) plus projected expenses at the Medicaid rate ($600) equal the spenddown liability
($1,500) and the individual is eligible. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Several commenters expressed concern that institutional providers that admit individuals at the private rate will
be paid only at the usually lower Medicaid rate. This payment differential may have negative effects, both on providers
and beneficiaries. Providers will receive less compensation under the proposal, and it may cause providers to admit
fewer potential Medicaid patients. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 It is not clear why the commenters believe that institutional providers will be paid less as a direct result of the policy
to require States to project expenses at the Medicaid payment rate. Providers can charge patients at the private payment
rate for expenses incurred prior to the determination of Medicaid eligibility when spenddown liability was unmet.
The individual is responsible for the full amount of those charges. Providers do not have to accept the Medicaid rate
until after the individual becomes eligible. Therefore, by using the lower Medicaid rate, there may be a delay in meeting
spenddown. This delayed eligibility could actually entitle providers to the higher rate for a longer period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00080 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Some commenters objected to the exclusion of expenses incurred in an acute care facility when considering projection
of institutional expenses in spenddown. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 As noted in the NPRM, we excluded projection of expenses in acute care facilities because these expenses are not as
recurring and predictable as are expenses in long-term care facilities. We believe that it is not as easy to anticipate
the cost of a stay in a hospital or to predict when it may occur as it is to anticipate long-term care costs. While acute
care facility expenses may not be projected, they are valid medical expenses and may be deducted from excess income
in spenddown when they actually occur. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 A number of commenters suggested that the regulations be revised to include actually incurred institutional expenses
in addition to projected institutional expenses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 There was no intention on our part to exclude actually incurred institutional or other medical expenses from spenddown.
Actually incurred (past) institutional expenses may be deducted along with projected (future) additional institutional
expenses. In view of the comments indicating confusion on this point, we are revising paragraph (i) in both &sect;&sect;435.831
and 436.831 of the final regulations to clarify this. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Several commenters pointed out that eligibility begins not on the first day of institutionalization as indicated
in the NPRM, but on the day on which an individual incurs medical expenses (including projected institutional expenses)
equal to or exceeding the spenddown liability. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We generally agree with these comments. In States that elect partial month coverage, the first day of eligibility
is the day that deduction of incurred medical expenses reduces income to the income standard. In States with full month
coverage, eligibility begins on the first day of the month in which spenddown liability is met. However, a State may
not begin eligibility later than the beginning of the budget (spenddown) period if the individual is subject to the
post-eligibility process and, under the post-eligibility process, would owe the provider more than the individual
has in contributable income. This issue can occur when the State uses either a monthly budget period or a multi-month
budget period. We are revising paragraph (i) (paragraph (e) in the NPRM) in both &sect;&sect;435.831 and 436.831
of the regulations to reflect these points. (It should be noted that regardless of when eligibility begins in a budget
period, expenses used to meet spenddown liability are not reimbursable under Medicaid. Since these expenses may
be deductible from income in the post-eligibility process under the requirements of section 1902(r)(2) of the Act,
States may need to reduce the otherwise reimbursable amount of provider charges by spenddown expenses to prevent
the transfer of spenddown liabilities to the Medicaid program. The three examples in the response to the fifth comment
below show in detail how the spenddown and post-eligibility policies interact in these cases.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We considered beginning eligibility in all cases on the first day of the budget period in which spenddown liability
is met. However, this option could increase State administrative burdens without advantaging recipients in cases
not covered by the exception in &sect;&sect;435.831(i)(3) and 436.831(i)(3). Many States use eligibility and claims
payment systems that are automated to pay claims beginning with the date of eligibility. These States would have to
weed out bills from the first day of the budget period (up to 6 months before) that were used to meet spenddown liability
to ensure that their automated systems do not pay those bills. Under these rules, no such weeding is required in States
that begin eligibility with the day spenddown is met. (Note that these States would have to begin eligibility on the
first day of the budget period in cases where the individual, in the post-eligibility process, would otherwise owe
the provider more than he or she has in contributable income.) In States that provide coverage in whole months, weeding
is required only from the first day of the month in which spenddown is met to the day spenddown is met. The failure of the
individual to identify all of his or her incurred expenses before the spenddown determination is made can have an adverse
effect on the date of the individual's eligibility. In these cases, States may, but are not required to reopen the spenddown
determination and take the additional expenses into account. (For individuals in partial-month coverage States
who are subject to the post-eligibility process for the partial month, income and income deductions (e.g., the personal
needs allowance) should be prorated in the post-eligibility process to reflect the number of days of eligibility.)

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Some commenters advocated permitting States to project copayments, deductibles, and insurance premiums in addition
to projecting institutional expenses. Other commenters argued that States should be permitted to deduct any projected
medical expense that is predictable. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This provision is intended to cover only projection of long-term care institutional expenses, at the Medicaid reimbursement
rate, as they are constant and predictable. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We believe expenses mentioned in the comment such as deductibles or coinsurance, which are generally associated
with the utilization and varying costs of other medical services, are difficult to predict. Because of the difficulty
in determining what kinds of care, and what amounts, are predictable, we have limited the application of this provision
to long-term care institutional expenses. Regardless of whether States implement this provision, they are still
required to deduct actually incurred copayments, deductibles and insurance premiums in spenddown. We further discuss
State flexibility concerning copayments and deductibles under the comments and responses on Provision E. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00081 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Several commenters asked how a State would apply the projection of institutional expenses option if it also chooses
to combine the retroactive and prospective budget periods under Provision B. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 If the budget period includes part or all of the 3-month retroactive period, institutional and other medical expenses
actually incurred during that portion of the retroactive period would be added to projected institutional expenses
in the prospective period. An individual is eligible if the combined total of actually incurred plus projected medical
expenses equals or exceeds his or her spenddown liability for the budget period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters suggested that we revise the regulations to clarify that States may continue to use a 1-month budget period
for institutional cases. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We agree that a clarification to the proposed regulations is needed on this point. In regard to medically needy eligibility,
the proposed regulations at &sect;&sect;435.831 and 436.831 specify that, ``[t]he agency must use a budget period
of not more than 6 months to compute income.'' It is clear that any budget period between 1 and 6 months may be used. However,
it was not clear in the proposed rule that a State may use more than one budget period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For example, under the proposed rule, a State may use a 6-month budget period for all medically needy individuals.
Or, the State may use one budget period for institutionalized individuals in long-term care facilities (e.g., 1 month),
and another for noninstitutionalized individuals. A third option would be for a State to use different budget periods
for different groups of institutionalized individuals or use different budget periods for different groups of noninstitutionalized
individuals.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We believe States should have the flexibility to prescribe different spenddown periods to simplify the administration
of their Medicaid programs. For example, for effective and efficient administration in cases where the individual
is institutionalized, the State may wish to use the same time period for determining spenddown liability that the
State uses to determine the Medicaid contribution toward the cost of care. Allowing States to prescribe the spenddown
period in these cases permits States to align the budget period used for spenddown purposes with the budget period
used in the post-eligibility process. Thus, a State that uses a 6-month period for determining medically needy spenddown
liability for noninstitutionalized individuals and a 1-month period for determining contributions toward the
costs of care for the institutionalized may wish to begin new 1-month spenddown periods for medically needy recipients
who become institutionalized. Alternatively, the State may wish to determine contributions toward the costs of
care in 6-month periods to coincide with the 6-month medically needy spenddown period used. In either situation,
administrative simplification could be achieved in some cases by using the same income calculation for both the determination
of spenddown liability and the determination of the contribution toward the costs of care. However, if a State imposes
different spenddown budget periods in different situations, the variations should have general application and
not be applied on an individual-by-individual basis, and the variations should be based on reasonable standards.
We are clarifying this point in the regulations by revising 
<!-- PJG 0012 frnewline -->
&sect;&sect;435.831(a) and 436.831(a) to specify that States are not limited to the use of a single budget period,
but must use budget periods of not more than 6 months to compute income.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Several commenters asked for clarification on how projection at the Medicaid reimbursement rate will be used by a
State when an individual enters an institution during the month rather than on the first day of the month. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 As noted in the response to an earlier comment, actually incurred institutional and other medical expenses are added
to projected institutional expenses during a budget period. If the combined total of these expenses exceeds an individual's
spenddown liability, the individual is eligible on the day that liability is met (or on the first day of the month in
full-month coverage States or, if the exception in &sect;&sect;435.831(i)(3) and 436.831(i)(3) applies, on the
first day of the budget period whether the State uses a monthly budget period or a multi-month budget period). Thus,
depending on individual circumstances, an individual could be eligible on the first day of the budget period, on the
first day of institutionalization occurring on or after the first day of the budget period, or at some other time during
the budget period, as illustrated by the following examples. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Example 1.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The individual enters the institution on the 16th of the month. The monthly spenddown liability is $500. The projected
institutional expenses at the Medicaid rate to the end of the month are $800 ($1,600 monthly rate). The individual
has also incurred $600 in other medical expenses before the month of application, which remain the individual's current
liability. Because the individual has $600 of other medical expenses, the spenddown is met on the first day of the monthly
budget period (before the first day of institutionalization). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00082 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Example 2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The facts are the same as in Example 1 except that the individual has no previously incurred medical expenses, only
institutional expenses. In this case based on projection of expenses at the Medicaid rate, the individual may become
eligible on the first day of institutionalization (the 16th of the month). (Although the State may be a full-month
coverage State, retroactivity to the first day of the month would have no effect because the individual has no previously
incurred medical expenses.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Example 3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The individual enters the institution on the 16th of the month. The monthly spenddown liability is $900. The projected
institutional expenses at the Medicaid rate to the end of the month are $800 (one-half of the $1,600 monthly rate).
The individual has no other expenses at this time. Based on projection of institutional expenses at the Medicaid rate,
the individual does not meet spenddown. Thus, the individual will not be eligible on the 16th of the month. The individual
may become eligible at a later time during the month should the amount of actually incurred and any remaining projected
expenses (e.g., the amount after application of any reasonable limits established by the State) equal or exceed the
spenddown liability. In such a case, eligibility would still be retroactive to the first day of the month in full-month
coverage States. (When a combination of incurred and projected expenses is used, ``remaining projected expenses''
does not include any expenses that have already been incurred. Further, any expense used to meet spenddown liability
is not reimbursable under Medicaid.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Commenters asked how income would be applied to the cost of care after an individual is determined eligible when the
Medicaid rate is used instead of the private payment rate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
There is no change in the treatment of income once an individual is eligible for Medicaid. Regulations at 42 CFR 435.725,
435.733, 435.832 and 436.832 specify how an eligible individual's income is to be applied to the cost of institutional
care. For clarification, we provide some examples.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Example 1: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
An individual's monthly income for post-eligibility purposes is $925. The monthly Medicaid rate is $1,000. The monthly
spenddown liability is $600. The individual is in the institution as of the first day of the month. Since the projected
monthly Medicaid rate ($1,000) exceeds the monthly spenddown liability ($600), the individual is considered eligible
on the first of the month. Thus, the post-eligibility treatment of income rules apply. First, to account for the individual's
responsibility for $600 in spenddown liability, the State should consider as a starting point for the amount it will
pay to the institution only $400 of the $1,000 in institutional charges. However, from the individual's $925 in income,
the State would deduct $630 ($30 protected for personal needs and $600 in unreimbursable medical expenses reflecting
the individual's spenddown liability). (Income also would be protected for the maintenance of the individual's
spouse and family under specified circumstances and, at the option of the State, for the maintenance of the individual's
community home.) This leaves $295 in income that can be contributed toward the $400 in institutional charges taken
into account in the post-eligibility process. Thus, of the original $1,000 bill, the Medicaid program would contribute
$105 ($400_$295) and the individual would contribute $895 ($600 in spenddown liability plus $295 determined in the
post-eligibility process). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Example 2: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The State uses a 3-month budget period. Eligibility is being determined for the last quarter of the year. The individual's
monthly income for post-eligibility purposes is $910 ($2,730 for the quarter). The 3-month Medicaid rate is $3,720
($40 per day &times; 31 days per month &times; 3 months). The 3-month spenddown liability is $2,250 ($750 per month).
The individual is in the institution as of the first day of the quarter (October 1). Since the projected Medicaid rate
for the quarter ($3,720) exceeds the spenddown liability for the quarter ($2,250), the individual is eligible on
the first day of the quarter. Thus, the post-eligibility treatment of income rules apply. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
First, the State would begin eligibility with, and apply the post-eligibility rules for, the same 3-month period
used in the spenddown calculations. (The State may begin eligibility with the month or day spenddown liability is
met, if later, and apply the post-eligibility rules for the shorter period only if the later date does not cause the
individual's share of the institutional charges for the spenddown period to exceed the individual's contributable
income for the period.) To account for the individual's responsibility for $2,250 in spenddown liability, the State
would consider as a starting point only $1,470 of the $3,720 in institutional charges. However, from the individual's
$2,730 in income, the State would deduct $2,340 ($90 protected for personal needs for the quarter and $2,250 in unreimbursable
medical expenses reflecting the individual's spenddown liability). (Income also would be protected for any other
allowable deductions.) This leaves $390 in income that can be contributed toward the $1,470 in institutional charges
taken into account in the post-eligibility process. Thus, of the original $3,720 in charges, the Medicaid program
would contribute $1,080 ($1,470^$390) and the individual would contribute $2640 ($2,250 in spenddown liability
plus $390 determined in the post-eligibility process). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00083 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Example 3:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 An individual's monthly income for post-eligibility purposes is $1,820. The monthly Medicaid rate is $1,200 ($40
per day), and the private rate is $1,800 ($60 per day). The monthly spenddown liability is $1,500. The individual is
in the institution as of the first day of the month and the State projects institutional expenses at the Medicaid rate.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Since projected monthly expenses as of the first day of the month at the Medicaid rate ($1,200) are not sufficient to
meet the spenddown liability ($1,500), the individual is not eligible. However, after remaining in the institution
for 15 days the individual has actually incurred expenses of $900 at the private rate ($60 &times; 15 days). The projected
institutional expenses at the Medicaid rate for the remaining days in the month are $600 ($40 &times; 15 days). Thus,
as of the 15th day of the month, the individual is eligible and the rules on post-eligibility treatment of income apply.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The same post-eligibility procedure described in Examples 1 and 2 apply to Example 3. Since the individual has $900
in actually incurred expenses and another $600 in projected expenses, the individual has met the spenddown liability
of $1,500. However, because the individual remains liable for the $1,500 in institutional charges, reimbursable
institutional expenses are reduced to zero. Therefore, no additional steps apply in the post-eligibility process.
The individual would be expected to use $1,500 of his or her $1,820 in income to cover institutional charges, leaving
the individual with $30 earmarked for personal needs and $290 for discretionary use. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It should be noted that if the individual were to incur additional noninstitutional health care expenses during the
period of Medicaid eligibility, the State, at its option, can have the individual contribute more of his or her discretionary
income toward total health care costs included in the State plan. This can be done by substituting the noninstitutional
expenses (for which the State would otherwise pay) for a corresponding amount of projected institutional costs in
the spenddown calculation. The individual becomes liable for the noninstitutional expenses as part of his or her
spenddown liability and has to contribute remaining discretionary income toward the replaced institutional costs
under the post-eligibility calculation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For example, assume that the individual in this example incurs $200 in noninstitutional physical therapy expenses
included in the State plan and the State substitutes those expenses for $200 of the $600 in projected institutional
charges. The individual's spenddown liability of $1,500 is now composed of $900 in actual institutional charges,
$400 in projected institutional charges, and $200 in physical therapy expenses. The otherwise reimbursable institutional
charges of $1,500 are then reduced to $200 to offset the $1,300 in institutional charges that are deductible from income.
Under the post-eligibility procedures, the individual would have $290 that can be contributed toward the cost of
care ($1,820 total income, less $1,500 in unreimbursable health care expenses, less $30 projected for personal needs)
and, thus, would be responsible for the $200 in reimbursable institutional charges. The individual is now responsible
for $1,700 (instead of $1,500) in health care costs ($1,300 in institutional charges used to meet spenddown liability,
$200 in noninstitutional physical therapy expenses used to meet the spenddown liability, and $200 in institutional
charges under the post-eligibility process). This leaves the individual with $90 in discretionary income instead
of $290, with Medicaid paying $200 less.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00084 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters requested clarification on how to apply the projection option when an individual leaves the institution
before the end of the budget period: if eligibility is based on projected institutional expenses that are, in part,
not actually incurred, how would a State handle this? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This would be treated by a State as a change of circumstances. Whenever a change of circumstances occurs during a budget
period, a State is required by regulations at &sect;435.916 to make a redetermination. The State should be alert for
other changes in circumstances (e.g., changes in levels of institutional care) that could affect the projected amount
of expenses and make any necessary redeterminations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters asked that we clarify how projection of institutional expenses would operate when a third party is responsible
for payment of a portion of an individual's institutional care. For example, if the first 60 days of institutionalization
are paid by a third party, could those expenses be counted as a deduction from an individual's income under the spenddown
process? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Except for the legislative change discussed in the note below, we have made no changes to the policy on treatment of
expenses for which there is third party liability. Thus, in these final rules, as proposed 
<!-- PJG 0012 frnewline -->
(&sect;&sect;435.831(d) and 436.831(d)), we continue existing policy that only incurred medical expenses that
are not subject to payment by a third party may be deducted from income. In the above comment's example, expenses for
the first 60 days of institutionalization, for which a third party is liable, are not allowable deductions under this
provision or under existing regulations.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Under 1987 legislation, States are required to deduct health care expenses reimbursed under another State or local
public program. This amendment will be dealt with more fully in separate regulations. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Several commenters thought that the provision for projection of institutional expenses at the Medicaid rate would
be difficult to administer. They added that if there are many changes in the Medicaid rate, States would be required
to reassess eligibility. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 As discussed in response to an earlier comment, we have concluded that the Medicaid rate is the only appropriate rate
to use for projecting institutional expenses. If a State finds projecting at the Medicaid rate undesirable, the State
may discontinue the practice of projecting expenses and instead, use expenses as they are actually incurred. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Several commenters expressed the opinion that the potential economic impact was greater than what we estimated in
the NPRM and the commenters believe that we should develop regulatory impact and/or regulatory flexibility analyses.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We reviewed our estimates in light of the commenters' criticisms and concluded that the impacts of the provision are
not such as to require regulatory impact or regulatory flexibility analyses. We acknowledge that these provisions
will result in some economic effects. However, we do not believe that the impacts will approach the amounts (e.g.,
$195 million for provision ``A'' alone) that some of the commenters estimated. Further discussion about our estimate
is included in section V (Regulatory Impact Statement) of the preamble. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision B_Allow States To Combine Retroactive and Prospective Medically Needy Budget Periods
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Some commenters questioned the statutory basis for this revision. They asked whether the statute gives us the authority
to make this option available to States. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00085 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We base our revisions to the medically needy budget period on section 1102 of the Act, which gives the Secretary general
authority to adopt rules necessary for the efficient operation of the Medicaid program, and section 1902(a)(17)
of the Act, which authorizes us to prescribe standards for determining eligibility for Medicaid consistent with
the objectives of the program and is also the authority for the medically needy spenddown program. We also base our
revisions on section 1902(a)(34) of the Act, which mandates and describes the 3-month retroactive period for an individual
who was (or upon application would have been) eligible for such medical assistance at the time care and service were
furnished in the retroactive period. If a State uses a 6-month budget period, when it looks at the eligibility of an
individual had he or she applied at a particular time, it would look at 6 months' worth of income. The regulation permits
States to view section 1902(a)(34) of the Act in this manner, rather than considering the retroactive period as a special
and discrete period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Some commenters opposed this provision because, in their view, combining the retroactive and prospective eligibility
periods violates comparability requirements between the medically needy and categorically needy in section 1902(a)(17)
of the Act, since the combined eligibility period affects only the medically needy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We disagree with the commenters' views. We believe that comparability requirements are not violated because the
Act contains different requirements for categorically and medically needy groups. This position was upheld by the
Supreme Court in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Atkins 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Rivera 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
decision (477 U.S. 154 (1986)). The Court found that the length of the medically needy budget period (or spenddown
period) was not required by comparability to be the same as the budget period used for the categorically needy.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters argued that combining the retroactive period with the prospective period results in a potentially
longer budget period, which means that individuals must incur medical expenses over a longer period of time. Few providers
are willing to extend credit over, for example, a 6-month period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The proposed combined budget period can be no longer than the prospective period allowed under the existing requirements
specified in &sect;&sect;435.831 and 436.831. Presently, the prospective period may be no more than 6 months in length.
The proposal, depending on State choices, may result in a combined budget period of 2 to 6 months. Thus, the combined
budget period can be no longer than the maximum (6 month) period permitted under existing regulations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Several commenters asked how States would apply this provision when a prospective budget period would not apply.
For instance, if an individual dies after filing an application for Medicaid, and has unpaid medical bills in the 3-month
period before the application was filed, there is no prospective period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 When there is no prospective period because the individual dies before the prospective period could begin, eligibility
would be determined for the three month retroactive period only. This is consistent with our policy for terminating
a wholly prospective budget period when a recipient dies. In cases where an individual dies after the prospective
period has begun and the State has elected to combine the retroactive and prospective period, the combined period
would terminate with the death of the recipient. In still other cases where the individual, though alive, seeks eligibility
only for the retroactive period in a State that has elected to combine the retroactive and prospective period, the
combined period would still be used to determine eligibility. States, under policies of general applicability,
may treat the entire retroactive period as one budget period or divide the retroactive period into monthly budget
periods. Any portion of the retroactive period may be added to the first prospective period for a combined period not
to exceed 6 months.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00086 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters suggested that we revise the regulations by clarifying that the combined budget period would not
automatically include the entire 3-month retroactive period if the individual has no medical expenses in that period.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The commenter is correct that an individual may be determined eligible for Medicaid in the 3-month period before the
month of application only if an individual received covered services under the State plan at any time during that period
and would have been Medicaid eligible at the time services were received if he or she had applied. This is based on section
1902(a)(34) of the Act and regulations at &sect;435.914. This principle is very clearly specified in &sect;435.914.
However, we have revised &sect;&sect;435.831(a) and 436.831(a) to clarify that the retroactive budget period begins
no earlier than the first month in the 3-month retroactive period in which the individual received covered services.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Many commenters opposed the revision to permit States to combine the retroactive period with the prospective period
because States are permitted to consider an individual's income over a longer period, potentially 6 months, rather
than just the 3 months of the retroactive period. Under the existing rule, an individual who was, for example, hospitalized
and out of work for a 3-month period could apply for Medicaid after he or she had returned to work and have eligibility
determined solely on the 3-month period before application when no income was received. If the individual met other
eligibility requirements, that individual could have been eligible. Under the proposal, and these final rules,
States have the option to consider income over an additional 3-month period extending from the date of application.
When a longer budget period is used, greater income is available to the individual and, when measured against the State's
income standard, that same individual might not be eligible for Medicaid.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individuals may apply for Medicaid to cover high medical expenses that are incurred during a very short period of time,
as in the above example, in the 3-month period before an application, or they may wish to cover expenses incurred over
a longer period. We believe that it is appropriate to consider available income over a longer period than just a period
when acute illness may affect a person's employment or other income. Therefore, we believe the option for States to
select the use of a combined budget period is appropriate.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several commenters asked why we are making these revisions when they know of no evidence that individuals abuse the
current system by manipulating the timing of an application for Medicaid to suit their needs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We agree that it is difficult to document the extent to which individuals may be abusing the existing system. The potential
for abuse exists, however, and we believe States should have the flexibility to control it if it occurs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A number of commenters advocated giving individuals the option to choose the start of the budget period, rather than
giving the State that option. The commenters were concerned that a State might begin the budget period in the retroactive
period, counting income received in such period, when the individual may have had no covered expenses in the period.
The commenters believe that the individual should have the option of restricting the budget period to the first month
in the retroactive period in which covered services were received.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As discussed in response to an earlier comment, we have revised &sect;&sect;435.831(a) and 436.831(a) to clarify
that the retroactive period begins no earlier than the first month in the period in which covered services were received.
Therefore, there is no need for the individual to elect such a restriction.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters believed that the current method of separating the retroactive period from the prospective period
is easier to administer than the proposed method of combining the two periods.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Since this provision is optional, States may select whichever method is easier for them to administer.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters suggested that we require the use of a monthly budget period instead of a flexible period from 1 to 6
months.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Existing regulations, &sect;&sect;435.831 and 436.831, permit States to select a prospective budget period extending
from 1 to 6 months. Administrative flexibility for States was a major consideration in proposing revisions to the
budget period. It is our view that requiring the use of a monthly budget period not only restricts State flexibility
from that currently existing, but requires that a State spend more time evaluating eligibility. Of course, States
that prefer the use of a 1-month period may continue to use it. Therefore, we have decided to retain the flexible budget
period as proposed.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00087 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision C_Permit States To Exclude From Incurred Medical Expenses Those Bills for Services Furnished More Than
Three Months Before a Medicaid Application
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several commenters noted that the Act does not place a limit on the age of bills for medical expenses to be deducted from
income in the spenddown process, nor does it authorize us to place limits on the age of bills.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We agree with the commenters with respect to States that elect to use the eligibility criteria prescribed in section
1902(f) of the Act. Under that provision, States are required to deduct incurred expenses without regard to when the
expenses were incurred. However, as noted in the NPRM, section 1902(a)(17) of the Act gives us the authority to prescribe
the extent to which costs of medical care may be deducted from income when determining Medicaid eligibility. We believe
this authority permits us to place limits on the age of medical bills to be applied to the spenddown process in States
that do not elect to use the more restrictive eligibility criteria permitted under section 1902(f) of the Act. We have
decided to use the authority to set limits on the bills which must be taken into account by authorizing States to adopt
certain limits on which bills will be taken into account.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A few commenters opposed this provision because it appears to penalize individuals when providers do not promptly
furnish bills. These commenters suggested that expenses cannot be deducted from income until the provider's bill
is received. One commenter suggested that we revise the regulations to specify that the age of the expense is measured
by the billing date rather than the date the service was furnished.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We believe that it would be reasonable for States to use the date the service was furnished if the individual incurred
(that is, became liable for) the expense at that time. We do not believe that individuals will be penalized for delays
in billing by providers because other documentation could be furnished to verify that expenses were incurred. For
example, a State could verify an expense by telephoning the provider. A State may presume that liability arises when
services are rendered unless evidence is presented to the contrary. In such a case, the State should determine when
the liability arose and use the resulting date.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We are persuaded, however, by numerous comments on this issue that a rigid 3-month limit on deductible medical bills
would restrict rather than enhance State flexibility. Note that the existing regulations and interpretations specify
that States must deduct all medical expenses incurred before application, no matter how far back in time the expenses
are incurred if they have not already been used in another budget period, if the individual is still liable for them,
or if the individual has paid for them in the current budget period. We are modifying &sect;&sect;435.831(d)(5) and
436.831(d)(5) of the proposed regulations, redesignated in these final regulations as &sect;&sect;435.831(g)(2)
and 436.831(g)(2), to specify that in determining deductible incurred medical expenses, States have the option
to include (or exclude) expenses incurred earlier than the third month before the month of application. The period
chosen by the State must be specified in the State plan. We are also clarifying in new &sect;&sect;435.831 (f)(2) and
(f)(4) and 436.831 (f)(2) and (f)(4) that expenses must be deducted in any spenddown calculation for the retroactive
eligibility period if the expenses were incurred in the retroactive period, were a current liability of the individual
in the period for which the spenddown calculation is made, and had not been previously deducted from income in establishing
Medicaid eligibility.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters objected to this provision on the basis that it is not any easier for States to administer than the existing
provisions. Under the proposal, States must continue to assure that bills are applied no more than once in meeting
the spenddown liability, and that a bill remains the current liability of an individual.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As we mentioned before, since this revision is optional, States may choose either to use it or retain the existing method.
There are certain advantages, however, to applying a limit to the age of medical bills. Limiting bills to expenses
incurred no more than 3 months before the month of application (or the age established by the State, as discussed earlier)
reduces the burden on the State of proving that a bill is no longer an individual's current liability. Bills older than
the State set age limit would not generally be applied in spenddown whether or not an individual remains liable for
the bill.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00088 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters pointed out that States often find that it takes more than 3 months to determine the extent of liability
when a third party is responsible for a medical bill. The commenters suggested that these bills be dated from the point
at which liability is determined. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We acknowledge that there may be a delay in determining the extent of the individual's liability when a third party
may be liable for some or all of the expenses. However, we do not agree that the State should change how it determines
the age of a bill as a result. As we explained in response to an earlier comment, the age of a bill is measured from the date
the expense is incurred_that is, the date the liability arises. (We have clarified in new &sect;&sect;435.831(d)
and 436.831(d) that an expense is incurred on the date liability for the expense arises.) The date of the determination
of the extent of the individual's liability is treated as the date the individual's liability begins. That is the date
from which the age of the individual's expenses is measured. We see no reason why the State should use any other date.

<!-- PJG 0012 frnewline -->
When a third party may be liable for part or all of an expense, any portion of the expense that can be attributed to the
individual with reasonable certainty should be treated as the individual's liability and included in the spenddown
calculation pending the final determination of third party liability. When there is a reasonable question of the
extent of the third party's liability, the State may, but is not required to, include the questionable portion in the
spenddown calculation on an interim basis pending the final determination of liability. In either case, the date
the individual incurs the expense in question is the date of the determination that there is no third party liability
for the expense or, if earlier, the date that the State elects to include the questionable amount in the spenddown calculation
pending the determination of third party liability. When there is a determination of third party liability for the
expense, the amount in question is excluded (retroactively, if necessary) in spenddown calculations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters suggested that we use the phrase, ``3 months before the month of application'', rather than ``3 months
before the date of application''. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We agree with the commenters as this is a more flexible approach. Therefore, we are revising proposed &sect;&sect;435.831(d)(5)
and 436.831(d)(5), designated as &sect;&sect;435.831(g)(2) and 436.831(g)(2) in the final rule, to specify that
States may include bills incurred earlier than 3 months before the month of application. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Some commenters thought that the use of a 3-month period is arbitrary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Under section 1902(a)(17) of the Act, we have authority to prescribe the extent to which costs of medical care may be
deducted from income. We believe that permitting States to limit the applicability of medical expenses to the 3-month
period before the month in which a Medicaid application is filed or to include earlier expenses is reasonable in that
it affords States some administrative relief, while recognizing that individuals may be liable for old bills. It
also corresponds to the 3-month period in section 1902(a)(34) of the Act and, therefore, is not arbitrary. We believe
that Congress' decision to restrict the retroactivity of eligibility to 3 months provides a suitable guideline for
determining how far back States should be required to look in accounting for incurred health care expenses since both
cases reflect efforts to provide a measure of coverage for services received before application is made for medical
assistance. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters were concerned that this provision penalizes individuals who, in trying to pay their own medical bills,
may not apply for Medicaid until they are far behind in payments, often more than 3 months after the bills were incurred.
Commenters suggested that we revise the regulations so that an individual may deduct an entire bill older than 3 months
if the individual verifies that he or she is still liable for the bill. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 By permitting an individual who actually makes payment on old bills to deduct the amount paid toward the spenddown,
the regulation addresses an objective of section 1902(a)(17) of the Act for the medically needy. That objective is
that an individual's income for purposes of Medicaid eligibility should be reduced to cover the costs of his or her
uncovered medical care since if the individual spends this income on medical care, he or she will not have that income
available for maintenance needs. However, if the individual does not pay the old bills, the individual's income need
not be reduced by the amount of a liability which the individual may never satisfy. To give an individual a one shot lifetime
opportunity to reduce income for each unpaid bill encourages individuals to forgo making payment on their liability
for medical care. The regulation permits States to minimize this disincentive to paying old bills.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Some commenters (State agencies) proposed that medical expenses which may be used to meet the spenddown be limited
to those expenses that are incurred within the current budget period. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 It would be unnecessarily harsh to limit income deductions to newly incurred expenses, especially when an expense
is incurred shortly before the current budget period. We believe the requirement to deduct income for expenses incurred
in the retroactive eligibility period is a reasonable compromise between deducting income for all old expenses and
deducting income only for newly incurred expenses. Therefore, we did not adopt the commenter's suggestion.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00089 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters questioned our rationale for the revisions, stating that they knew of no evidence that individuals abuse
the present system. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Concern about abuse of the existing spenddown methods was not the motivation behind these proposals. The primary
objectives of these revisions were to give States greater flexibility to reasonably administer their Medicaid programs
and to ensure that eligibility was appropriately based on need. In our communications with States, we were convinced
that certain spenddown requirements, although originally well intended, had unintended results. Deduction of
older medical bills, for example, was difficult for States to administer, as noted in the NPRM, because we required
that States verify whether an individual remained liable for an old bill. In addition, because bills incurred before
the eligibility period were deductible only if they were unpaid, as specified under prior policy, an incentive was
created for individuals not to pay their bills. The revisions, therefore, are intended to alleviate administrative
problems for States and, by only requiring the deduction of payments on older bills, create an incentive for individuals
to pay older bills. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters suggested that any incurred medical expenses not deducted from income during a budget period should be
carried over to the next budget period. They suggested that the expenses be carried forward whether the spenddown
liability was met (that is, an individual became eligible) or not met (that is, expenses were insufficient to meet
the spenddown requirement) during the first budget period. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We agree, in part, with the commenters. When an individual's incurred expenses exceed his or her spenddown liability
(that is, the person becomes eligible without deducting all of the expenses) and when the excess expenses are unpaid,
the excess expenses are deductible from excess income in subsequent budget periods, but only under certain conditions.
HCFA requires the carryover of excess (that is, unused) expenses to account more fully for incurred unreimbursable
expenses in determining whether the Medicaid income standard is met. If States were not required to carry over excess
expenses, the spenddown provision would be practically meaningless when an individual with a small monthly amount
of excess income incurs a large medical expense. In such a case, the individual could only apply the small amount of
excess income in 1 month based on that expense. We have concluded that such a result would not be in keeping with the objective
of the spenddown provision to account for unreimbursable expenses incurred for necessary care recognized under
State law. Therefore, this final rule provides that medical expenses not deducted from income during one budget period
must be carried over and deducted in the succeeding budget periods under the conditions described below. 
<!-- PJG 0012 frnewline -->
Proposed &sect;&sect;435.831(d)(6) and 436.831(d)(6) (designated as &sect;&sect;435.831(f)(3) and 436.831(f)(3)
in the final rule) provide that medical expenses not deducted from income during one budget period must be carried
over and deducted in the next budget period. These proposed rules were applicable, however, only when the individual
was eligible in the first budget period after meeting the spenddown liability. We are revising what are now &sect;&sect;435.831(f)(3)
and 436.831(f)(3) to clarify when excess, unpaid expenses are deductible in subsequent budget periods. In order
for excess expenses to be carried over under this provision, eligibility must be established for the budget period
in which the excess expenses were unused and in each subsequent budget period in which any part of the excess remains
unused; in addition, the spenddown provision must apply in each such subsequent period. (To relieve States of the
burden of carrying over such excess expenses indefinitely, specific excess amounts need not be carried over beyond
the first subsequent period in which there is no eligibility or no excess income.) 
<!-- PJG 0012 frnewline -->
It should be noted that the ``carryover'' concept is used in these regulations to describe the ongoing deduction of
unused and unpaid expenses, as contrasted to the deduction of expenses based on their being incurred in the retroactive
eligibility period or, at State option, earlier. We make a distinction between the two kinds of expenses because of
the option for States to disregard old expenses (i.e., expenses incurred prior to the retroactive eligibility period).
One of the reasons for allowing old expenses to be disregarded is the administrative difficulty States may encounter
in verifying and documenting whether liability for the expense continues. Once an old, or current, expense is initially
verified and documented, it should not be unduly difficult to determine the extent of continuing liability from one
budget period to another as long as the agency is maintaining contact with the individual. For this reason, we require
that the unused, unpaid portion of such expenses be carried over from one budget period to the next, but only for as long
as the individual is eligible in each such period (ensuring continuing contact with the agency). On this basis, we
are providing that deductible expenses incurred before the month of application may become carryover expenses if
they remain unused and unpaid after eligibility is established. The limit a State may place on the deductibility of
expenses incurred before the retroactive eligibility period does not affect how long expenses remain deductible
under the carryover provision. The age limit that can be placed on old expenses relates to how long before the retroactive
eligibility period expenses can be incurred and be deductible rather than to how long they remain deductible thereafter.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Commenters suggested that we revise the regulations so that both paid and unpaid bills may be carried over from one
budget period to the next. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 We do not agree with the views of the commenters on this point. The spenddown process is based on the principle that an
individual's actual income is reduced by incurred medical expenses (that is, expenses for which he or she is liable)
to the point at which his or her income is equal to or below the State's medically needy income standard. Once the individual
is determined eligible for Medicaid, the State Medicaid program pays medical expenses covered under its State plan
that were not used to satisfy the spenddown. The individual remains liable for payment of incurred bills that he or
she deducted in the spenddown process.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00090 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
When an individual pays a bill, his or her income (or resources) is reduced, thus reducing the countable amount of remaining
income (or resources) in determining whether the individual is eligible (or remains eligible) for medical assistance.
Therefore, there is less justification for deducting the payment in a later spenddown calculation. In contrast,
an enforceable unpaid bill remains a current claim on the individual's income or resources that should be taken into
account when the payment is made. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Commenters suggested that individuals should be able to carry over not only noncovered medical expenses from one
budget period to the next, as we proposed in &sect;&sect;435.831(d)(6) and 436.831(d)(6), but also expenses covered
under the State plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: When an individual is determined eligible, with the exception of bills deducted in spenddown, medically necessary
expenses covered under the State plan are normally paid by Medicaid. Hence, there would be no covered expenses to carry
over. In a State that places payment limits on the amount, duration or scope of services included in the State plan,
however, bills for services that exceed the State's limits are not paid by Medicaid, even though the services are included
in the State plan. In this situation, there would be unreimbursed noncovered expenses. Expenses exceeding amount,
duration or scope limits (like unpaid, unused old bills the State elects to deduct) must be carried over and deducted
from income in the next budget period when an individual is eligible in the immediately preceding budget period (or
periods). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Some commenters suggested that we define current payments on old bills to include only those bills being repaid on
a negotiated payment schedule. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: We have defined ``current payments'' in &sect;&sect;435.831(f)(5) and 436.831(f)(5) to mean only those payments
made in the current budget period. Our intent in proposing that current payments on old bills be counted as deductions
from income was to provide an incentive for individuals to pay those old bills, no matter how small the payments might
be. We believe that to count only payments made on a negotiated payment schedule would act as a disincentive for individuals
to repay the old bills not subject to a payment schedule. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Some commenters objected to this provision on the basis that placing limits on the age of bills which can be deducted
in spenddown acts as a disincentive for individuals to pay old bills. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: We do not believe there is a greater disincentive for individuals to pay old bills under the proposal than under the
policy in existence at the time of the proposed rule or under the existing method. In fact, the policy in existence at
the time of the proposed rule specified that bills incurred before the eligibility period could be deducted from income
only if they were unpaid. Current policy allows current payments and unpaid bills to be deducted. This appears to be
a direct incentive for individuals not to pay old bills. Therefore, we believe no revisions are necessary with regard
to this comment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision D_Permit States To Apply Incurred Medical Expenses to the Spenddown Period in Chronological Order 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Commenters argued that the Act does not authorize us to revise regulations to permit States to deduct medical expenses
in chronological order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: As noted earlier, we have authority under section 1902(a)(17) of the Act to prescribe the extent to which medical
costs may be deducted from income for the medically needy. This covers the order in which incurred medical expenses
will be counted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Some commenters proposed that this provision be extended to States using more restrictive eligibility criteria
than SSI, under section 1902(f) of the Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: We believe it is useful to clarify our earlier, and perhaps overly broad, statement in the NPRM that this provision
cannot be applied to the eligibility process as specified in section 1902(f) of the Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00091 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 1902(f) provides for the deduction of ``incurred expenses for medical care as recognized under State law''
in determining eligibility of certain individuals. As a consequence, that deduction process must allow for consideration
of expenses recognized under State law. Section 1902(a)(17), on which these medically needy regulations are largely
based, provides for taking into account ``except to the extent prescribed by the Secretary, the costs * * * incurred
for medical care or for any type of remedial care recognized under State law'' (emphasis supplied). Thus, while eligibility
of the medically needy generally can be determined using the provisions of these regulations, the eligibility of
those medically needy in the States that use the more restrictive eligibility criteria permitted by section 1902(f)
must be determined using expenses for medical care recognized under State law (including any limitations enacted
under State law on the deductible amount of such expenses from income). However, there is nothing in section 1902(f)
that precludes consideration of medical costs in chronological order for purposes of the spenddown specified in
section 1902(f). Therefore, we are extending this option to States that determine eligibility under the criteria
in section 1902(f). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Some commenters objected to this provision because insurance premiums, copayments, and deductibles and other
cost sharing amounts deducted in chronological order may not count toward spenddown if there are a large number of
other medical bills incurred early in the budget period. The commenters believe that these items should be deducted
no matter when they are incurred. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Many States find it administratively difficult to deduct incurred expenses out of the sequence in which the expenses
are submitted to the agency or the sequence in which the services are provided. Because one of the objectives of the
Medicaid program is the use of efficient methods of administration and since the sequential deduction of incurred
expenses is one such method, we consider it appropriate to permit States to deduct expenses from income in chronological
order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: Some commenters suggested that the proposal is inequitable because individuals with identical medical bills during
a budget period, when deducted in chronological order, can have different eligibility determinations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: First, we point out that two individuals in truly identical situations, meaning that the individuals have the same
medical bills incurred in the same order, would be treated identically under the rule. In other cases, the individuals
are not identical. They may have the same amount of medical expenses but the bills are not identical. In these cases,
assuming other eligibility factors are met and the bills are sufficient to meet spenddown liability, both individuals
will be eligible for Medicaid under this provision. The difference is in which bills are paid once eligibility begins.
For example, if one individual incurs mostly covered services early in the spenddown period, any remaining bills
for noncovered services left over after the spenddown liability is met would not be paid by the State because they are
not covered in the State plan. Conversely, if a second individual incurring mostly noncovered medical expenses early
in the spenddown period is determined eligible, any bills for covered services remaining after meeting the spenddown
liability would be paid by the State. We acknowledge that this result may disadvantage the first individual. However,
we believe that in the interest of efficient operation of the programs, States should be allowed to deduct expenses
in chronological order if they wish to do so. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00092 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters were concerned that under this proposal an individual's eligibility or ineligibility depends on
when a doctor mails the bills or on the arbitrary order in which an eligibility worker itemizes medical bills. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Eligibility does not depend on when a doctor mails bills but on the date the service was furnished; an individual can
document this date without a bill. In addition, eligibility workers are not allowed to choose an arbitrary order but
must itemize bills in the manner prescribed by regulations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Commenters suggested that the result of this proposed provision may be that individuals will defer medical care for
services covered under the State plan if they know that the State will pay for those expenses once they are eligible
for Medicaid. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We have no evidence that indicates that individuals will manipulate the proposed system as suggested by the commenters.
On the contrary, we believe that medical needs will continue to determine utilization of medical services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Commenters requested that we clarify the proposed regulations by specifying that there is no change in the existing
policy that medical expenses which will satisfy the spenddown include those expenses incurred by the individual,
the family or financially responsible relatives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This regulation does not change the existing regulations requiring the use of family members' medical expenses in
the spenddown (except by recodifying at &sect;&sect;435.831(e) and 436.831(e) in the final rule, to take into account
other changes made by this regulation). By making these changes, we do not mean to reaffirm the validity of this facet
of the existing regulations in cases where the courts have set it aside. Numerous Courts of Appeals decisions have
not upheld the underlying assumption of the existing regulations in the context of the standard filing unit cases.
These courts' interpretation of section 1902(a)(17)(D) preclude States from counting medical expenses of family
members (other than a spouse for a spouse and parents for their minor children). Nevertheless, the United States District
Court for the Northern District of California has held that States in the Ninth Circuit must continue to deduct the
medical expenses of family members in determining the spenddown, as long as the present regulations remain extant.
States outside of the Ninth Circuit should assess the continuing validity of the existing regulations for spenddown
purposes in light of any applicable court order invalidating the use of the AFDC standard filing unit rule for purposes
of Medicaid eligibility. The existing regulations would continue to apply to the extent that they do not explicitly
conflict with the court order. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We received a suggestion that States establish a limit on deduction of projected medical expenses incurred by ineligible
family members that are not covered under the State plan. If actual bills exceed this limit, the State could credit
the excess amount in the current or the next spenddown period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This suggestion goes beyond the scope of the proposal. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Provision E_Allow States to Limit Deductible Medical Expenses to Services Covered Under the State Plan 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Commenters questioned our legal authority for making this proposal. They believe that the Act does not authorize
us to permit States to exclude bills for services that are not paid for under the State plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A large number of commenters were not in favor of this proposal because, in their view, it might have a negative impact
on individuals, since many individuals require noncovered services. A variety of concerns were expressed. Some
commenters were concerned that this proposal would delay eligibility for some individuals if noncovered medical
expenses could not be deducted. Other commenters predicted that the proposal would cause individuals to pay a greater
share of their medical bills. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Except in States that determine eligibility under section 1902(f) of the Act, we believe adequate legal authority
exists in section 1902(a)(17) of the Act, which delegates to the Secretary of HHS the authority to prescribe the extent
to which incurred expenses will be taken into account in determining eligibility for Medicaid under the medically
needy option. However, we have decided to withdraw the option and continue the current policy (with respect to expenses
incurred in the current budget period and the 3-month retroactive eligibility period) because the option would have
a potentially severe negative impact on applicants and recipients. We now believe that offering States this administrative
option would reduce a person's Medicaid eligibility or the amount of medical assistance provided. Further, Congress
passed legislation in 1988 amending the Social Security Act (section 1902(r)(1)) to override a similar option we
provided States in the post-eligibility process. We believe it would be inconsistent with the direction taken by
Congress in the post-eligibility process to allow a similar limitation in the spenddown process. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00093 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters predicted that this proposed provision would result in increased Medicaid expenditures because
individuals will choose to obtain more costly services known to be covered under the Medicaid plan, rather than less
costly, possibly noncovered services. Further, they predict that individuals will wait to seek medical treatment
if those expenses are not deductible in the spenddown process instead of getting early treatment for a medical condition.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
While we have withdrawn this option, studies of the effects of cost-sharing on utilization and health status have
been inconclusive. Therefore, it is not clear that patterns of utilization of medical care would have been significantly
altered if we had adopted this option and States had implemented it. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Some commenters questioned why the NPRM did not offer this option to States using more restrictive eligibility criteria
than SSI, under section 1902(f) of the Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As discussed earlier, this option has been dropped altogether. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A commenter suggested that, for purposes of the spenddown provision, we define the term ``medical expenses included
in the plan'' as all services provided to categorically needy individuals. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We have withdrawn the option for States to limit deductible medical expenses to those for services included in the
State plan. Therefore, we have not considered the commenter's suggestion in the context of that option. (States are
required to continue deducting nonreimbursable expenses for premiums, deductibles, and coinsurance and for necessary
care that is recognized under State law, whether or not such expenses are included in the State plan.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
However, while States are required to deduct expenses for services not included in the State plan, States may continue
to place reasonable limits on the deductible amount. Therefore, we considered the commenter's suggestion in this
context, and we disagree with the suggestion. (This issue does not arise in States that determine eligibility under
section 1902(f) of the Act because the inclusion or exclusion of services under State plans is not a factor in the spenddown
process in these States.) States may provide a different range of services for the categorically needy than they do
for the medically needy population. The spenddown procedures in Provisions A through D apply to medically needy individuals
and apply both for AFDC-related cases and for the aged, blind, and disabled. Individuals eligible as medically needy
are eligible for only those specific services that a State has chosen to provide to its medically needy population.
If ``included in the State plan'' referred to services for the categorically needy, as the commenter suggested, the
State would be unable to place reasonable limits on the deductible amount of expenses in the spenddown process, which
only applies to the medically needy in States that are not determining eligibility under section 1902(f). We find
no compelling program reason for such a restriction. Therefore, we believe that it is appropriate to allow each State
to define ``included services'' for purposes of applying ``reasonable limits'' to mean services a State provides
to medically needy individuals (rather than only to categorically needy individuals). In this way, the State may
place reasonable limits on the deductible amounts of expenses for the medically needy except those included in the
State plan. (It should be noted that ``reasonable limits'' refers to the amount, rather than the type, of expense that
is deductible. For example, States may limit the amount, but not the type, of health insurance premiums that are deductible.)

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Commenters predicted that this provision will be error prone in practice, as eligibility workers and providers will
need to distinguish correctly between covered and noncovered services to deduct only covered services during spenddown
accurately. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We withdrew the option because of its negative impact on applicants and recipients. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several States disagreed with our proposal that States may not place amount, duration or scope limits on covered services
in the spenddown process, even though the State applies those limits when paying for services furnished to Medicaid-eligible
individuals. These commenters contended that their authority to place amount, duration and scope limits on services
they pay for under Medicaid is an extension of their authority to decide which services they will cover under the State
plan. They believe that this is an unnecessary restriction on the right to control their Medicaid program. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We do not agree with the commenters on this point. Under existing regulations, which have not been revised, States
may place reasonable limits on the deductible amount of expenses not included in the State plan but may not limit the
deduction of expenses included in the State plan. (Expenses ``included'' in the State plan are those for services
which are listed in the State plan, whether or not Medicaid will pay for them. By contrast, ``covered'' expenses are
a subset of ``included'' expenses. Covered expenses are expenses for services for which Medicaid will pay if furnished
to the individual by a Medicaid provider. Expenses incurred for services which are for care which exceed State plan
limits on amount, duration, and scope are not considered to be covered expenses.) The basic requirement in section
1902(a)(17) is that incurred expenses recognized under State law be taken into account in the spenddown process.
We believe that this is in keeping with the thrust of this requirement to require the deduction from income of expenses
recognized under State law when the State has also included the expenses in the State plan, even though the State limits
the amount of such expenses it pays for. We, therefore, allow States to limit the deductions only for incurred expenses
recognized under State law that are not included in the State plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As we explained in response to a comment under Provision A concerning projecting institutional expenses, we find
adequate authority for this policy in existing sections of the Act. The Secretary has authority under section 1902(a)(17)
of the Act to prescribe the extent to which costs of medical care may be deducted from income in medically needy programs.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00094 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
One State pointed out that it is reasonable to require that States deduct insurance premiums, as this encourages individuals
to continue insurance coverage. The commenter argued that it is not logical, however, for us to require that States
deduct coinsurance and deductibles on services that are not covered under the plan. An individual still benefits
from the insurance coverage because he or she must pay only the deductible or coinsurance rather than 100 percent of
the charge. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As we explained in the response to the first comment in this section, Congress passed legislation on the post-eligibility
process requiring the deduction of expenses for deductibles and coinsurance in the post-eligibility process. It
would be inconsistent with the direction taken by Congress to allow States to exclude these expenses in the spenddown
process altogether. Therefore, States are required to deduct a reasonable amount of these expenses from income.
We rely on the authority in section 1902(a)(17) of the Act to allow States to place reasonable limits on the deductible
amounts of these cost-sharing expenses even though no such limits are allowable in the post eligibility process.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Summary of Changes to the Regulations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
In this final rule, we are making the revisions proposed in the NPRM with the following modifications based on our review
and analysis of public comments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. We are revising proposed &sect;&sect;435.831(e)(1) 
<!-- PJG 0012 frnewline -->
(designated as &sect;435.831(g)(1) in this final rule) and &sect;436.831(e)(1) (designated as &sect;436.831(g)(1)
in this final rule) to clarify that incurred medical expenses may include projected institutional expenses at the
Medicaid reimbursement rate. We are not revising &sect;435.732(c)(3) (redesignated as &sect;435.121(f)(1)(iii))
to make the same clarification since that section applies to States with more restrictive criteria than SSI. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. We are also clarifying in &sect;&sect;435.831(i) and 
<!-- PJG 0012 frnewline -->
436.831(i) (proposed &sect;&sect;435.831(e)(1) and 436.831(e)(1)) that an institutionalized individual is
eligible when incurred medical expenses, including projected institutional expenses, reduce an individual's
income to the income standard, rather than on the first day of institutionalization as indicated in the NPRM. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. We are revising &sect;&sect;435.831(a) and 436.831(a) to 
<!-- PJG 0012 frnewline -->
clarify that an agency is not limited to the use of a single budget period to compute income. However, an agency must
use budget periods of not more than 6 months to compute income. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. In addition to other changes noted, we are 
<!-- PJG 0012 frnewline -->
revising paragraph (d) as proposed in &sect;&sect;435.831 and 436.831 by transferring most of its contents to new
paragraphs (e), (f) and (g) and cross-referring to those sections. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. New paragraph (e) in both sections includes the 
<!-- PJG 0012 frnewline -->
contents of paragraph (d)(1)(ii)(A), (B), and (C) as paragraphs (e)(1), (2), and (3) respectively. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. New paragraph (f)(3) in both sections consists of 
<!-- PJG 0012 frnewline -->
the contents of proposed paragraph (d)(6). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. New paragraph (h) in both sections consists of the contents of paragraph (d)(1)(i), (ii), and (iii) as paragraphs
(h)(2), (1), and (3), respectively. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
d. New paragraphs (g)(1), (2) and (3) in both 
<!-- PJG 0012 frnewline -->
sections contain the contents of paragraphs (d)(4), (5), and (3), respectively. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. We are revising &sect;&sect;435.831(d)(5) and 436.831(d)(5) 
<!-- PJG 0012 frnewline -->
(redesignated as &sect;&sect;435.831(g)(2) and 436.831(g)(2)) to specify that an agency is not required to deduct
expenses incurred earlier than 3 months before the month of application for Medicaid, clarifying that the 3-month
period is measured from the month of application, rather than from the date of application as specified in the NPRM.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00095 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
6. We are clarifying in &sect;&sect;435.831(e)(3) and 
<!-- PJG 0012 frnewline -->
436.831(e)(3) (&sect;&sect;435.831(d)(1)(ii)(C) and 436.831(d)(1)(ii)(C) in the proposed rule) that a State
must deduct expenses for necessary medical and remedial services included in the State plan even when those services
exceed agency limitations on amount, duration or scope. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. We are adding a new paragraph (f)(1) to &sect;&sect;435.831 
<!-- PJG 0012 frnewline -->
and 436.831 to show that the State must deduct expenses incurred during the month of application and any of the preceding
3 months to the extent the individual's liability arose in that period and the expenses have not been deducted previously.
We are also adding a new paragraph (f)(2) to show the State must deduct current payments on old bills not previously
deducted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Request for Additional Public Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
We invite comments on the bases for and the consequences of extending additional flexibility to States using the more
restrictive eligibility criteria of section 1902(f) of the Act to implement any of the provisions in this rule. Because
of the large number of comments we receive, we cannot acknowledge or respond to them individually. If appropriate,
we will respond to public comments received on this issue in a future 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 publication. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VI. Regulatory Impact Statement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Executive Order 12291 requires us to prepare and publish a regulatory impact analysis for regulations that are likely
to have an annual effect on the economy of $100 million or more, cause a major increase in costs or prices, or meet other
threshold criteria that are specified in the Executive Order. Consistent with the Regulatory Flexibility Act, 5
U.S.C. 601&hyph;612, we prepare and publish a regulatory flexibility analysis for regulations unless the Secretary
certifies that the regulations will not have a significant economic impact on a substantial number of small entities.
(For purposes of the Regulatory Flexibility Act, small entities include all nonprofit and most for-profit providers.)
Under both the Executive Order and the Regulatory Flexibility Act, such analyses must, when prepared, show that the
agency issuing the regulations has examined alternatives that might minimize an unnecessary burden or otherwise
ensure that the regulations are cost-effective. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the NPRM published on September 2, 1983 (48 FR 39959), we examined the five separate provisions contained in these
regulations for the significance of their annual economic impact. In four of the five proposed provisions (B, C, D
and E), we could not quantify estimates, but we were confident that any impacts would not meet the threshold criteria
of the Executive Order or the Regulatory Flexibility Act. However, for provision A (Consideration of Projected Institutional
Expenses at the Medicaid Rate as Incurred Medical Expenses), we estimated total Federal and State savings of $18 million.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In light of the public comments received regarding Provision A and because of the need to analyze the effects of these
final regulations, we reviewed the analysis noted in the NPRM. After reviewing our data and assumptions, we have concluded
that the current impact of Provision A will increase from the original estimate of $18 million to $65 million. This
increase is a reflection of Medicaid program growth through 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Savings will occur in the few cases in which an institutionalized individual will not become eligible or will be found
eligible later in time because his or her income significantly exceeded the medically needy income level and the State
Medicaid payment rate was used in the eligibility calculation rather than whatever rate the institution chose to
charge. Delay or denial of an individual's eligibility will reduce State expenditures and Federal contributions,
resulting in negligible savings. Some individuals whose eligibility is delayed and who are spending down at the private
payment rate, rather than the lower Medicaid rate during that period, will spend down to the income standard quicker
and become eligible for Medicaid sooner. Further, this provision is optional and it is an option only for States with
medically needy programs that are not section 1902(f) States. At this time, we do not expect that it will be adopted
by all or most States. In addition, some States have already adopted interpretations of the existing regulations
on the spenddown process that are very close to our final rule. For all these reasons, we now believe that this provision
will have a negligible net impact. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For these reasons, we have found that the effect of the provisions of this final rule will not meet the threshold criteria
of Executive Order 12291. Further, we have determined, and the Secretary certifies, that this final rule will not
result in an annual economic impact that will affect significantly a substantial number of small entities. Therefore,
we conclude that neither a regulatory impact nor a regulatory flexibility analysis is required. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VII. Paperwork Reduction Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
These changes do not impose information collection requirements; consequently, they need not be reviewed by the
Executive Office of Management and Budget under the authority of the Paperwork Reduction Act of 1980 (44 U.S.C. 3501
et seq.). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
42 CFR Part 435 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Aid to families with dependent children, Aliens, Categorically needy, Contracts (agreements_state plan), Eligibility,
Grant-in-aid program_health, Health facilities, Medicaid, Medically needy, Reporting requirements, Spend-down,
Supplemental security income (SSI). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
42 CFR Part 436 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Aid to Families with Dependent Children, Aliens, Contracts (Agreements), Eligibility, Grant-in-Aid program_health,
Guam, Health facilities, Medicaid, Puerto Rico, Supplemental security income (SSI), Virgin Islands.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00096 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. 42 CFR part 435 is amended as set forth below: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 435_ELIGIBILITY IN THE STATES, DISTRICT OF COLUMBIA, THE NORTHERN MARIANA ISLANDS, AND AMERICAN SAMOA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 435 continues to 
<!-- PJG 0012 frnewline -->
read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Sec. 1102 of the Social Security Act, (42 
<!-- PJG 0012 frnewline -->
U.S.C. 1302), unless otherwise noted.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 435.831 is revised to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;435.831 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Income eligibility. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency must determine income eligibility of medically needy individuals in accordance with this section.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Budget periods. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) The agency must use budget periods of not more than 6 months to compute income. The agency may use more than one budget
period. 
<!-- PJG 0012 frnewline -->
(2) The agency may include in the budget period in which income is computed all or part of the 3-month retroactive period
specified in &sect;435.914. The budget period can begin no earlier than the first month in the retroactive period
in which the individual received covered services. This provision applies to all medically needy individuals except
in groups for whom criteria more restrictive than that used in the SSI program apply. 
<!-- PJG 0012 frnewline -->
(3) If the agency elects to begin the first budget period for the medically needy in any month of the 3-month period prior
to the date of the application in which the applicant received covered services, this election applies to all medically
needy groups. 
<!-- PJG 0012 frnewline -->
(b) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determining countable income. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency must deduct the following amounts from income to determine the individual's countable income. 
<!-- PJG 0012 frnewline -->
(1) For individuals under age 21 and caretaker relatives, the agency must deduct amounts that would be deducted in
determining eligibility under the State's AFDC plan. 
<!-- PJG 0012 frnewline -->
(2) For aged, blind, or disabled individuals in States covering all SSI recipients, the agency must deduct amounts
that would be deducted in determining eligibility under SSI. However, the agency must also deduct the highest amounts
from income that would be deducted in determining eligibility for optional State supplements if these supplements
are paid to all individuals who are receiving SSI or would be eligible for SSI except for their income. 
<!-- PJG 0012 frnewline -->
(3) For aged, blind, or disabled individuals in States using income requirements more restrictive than SSI, the agency
must deduct amounts that are no more restrictive than those used under the Medicaid plan on January 1, 1972 and no more
liberal than those used in determining eligibility under SSI or an optional State supplement. However, the amounts
must be at least the same as those that would be deducted in determining eligibility, under &sect;435.121, of the categorically
needy. 
<!-- PJG 0012 frnewline -->
(c) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Eligibility based on countable income. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If countable income determined under paragraph (b) of this section is equal to or less than the applicable income standard
under &sect;435.814, the individual or family is eligible for Medicaid. 
<!-- PJG 0012 frnewline -->
(d) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Deduction of incurred medical expenses. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If countable income exceeds the income standard, the agency must deduct from income medical expenses incurred by
the individual or family or financially responsible relatives that are not subject to payment by a third party. An
expense is incurred on the date liability for the expense arises. The agency must determine deductible incurred expenses
in accordance with paragraphs (e), (f), and (g) of this section and deduct those expenses in accordance with paragraph
(h) of this section. 
<!-- PJG 0012 frnewline -->
(e) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determination of deductible incurred expenses: Required deductions based on kinds of services. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subject to the provisions of paragraph (g), in determining incurred medical expenses to be deducted from income,
the agency must include the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00097 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) Expenses for Medicare and other health insurance premiums, and deductibles or coinsurance charges, including
enrollment fees, copayments, or deductibles imposed under &sect;447.51 or &sect;447.53 of this subchapter; 
<!-- PJG 0012 frnewline -->
(2) Expenses incurred by the individual or family or financially responsible relatives for necessary medical and
remedial services that are recognized under State law but not included in the plan; 
<!-- PJG 0012 frnewline -->
(3) Expenses incurred by the individual or family or by financially responsible relatives for necessary medical
and remedial services that are included in the plan, including those that exceed agency limitations on amount, duration,
or scope of services. 
<!-- PJG 0012 frnewline -->
(f) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determination of deductible incurred expenses: Required deductions based on the age of bills. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subject to the provisions of paragraph (g), in determining incurred medical expenses to be deducted from income,
the agency must include the following: 
<!-- PJG 0012 frnewline -->
(1) For the first budget period or periods that include only months before the month of application for medical assistance,
expenses incurred during such period or periods, whether paid or unpaid, to the extent that the expenses have not been
deducted previously in establishing eligibility;
<!-- PJG 0012 frnewline -->
(2) For the first prospective budget period that also includes any of the 3 months before the month of application for
medical assistance, expenses incurred during such budget period, whether paid or unpaid, to the extent that the expenses
have not been deducted previously in establishing eligibility; 
<!-- PJG 0012 frnewline -->
(3) For the first prospective budget period that includes none of the months preceding the month of application, expenses
incurred during such budget period and any of the 3 preceding months, whether paid or unpaid, to the extent that the
expenses have not been deducted previously in establishing eligibility; 
<!-- PJG 0012 frnewline -->
(4) For any of the 3 months preceding the month of application that are not includable under paragraph (f)(2) of this
section, expenses incurred in the 3-month period that were a current liability of the individual in any such month
for which a spenddown calculation is made and that had not been previously deducted from income in establishing eligibility
for medical assistance; 
<!-- PJG 0012 frnewline -->
(5) Current payments (that is, payments made in the current budget period) on other expenses incurred before the current
budget period and not previously deducted from income in any budget period in establishing eligibility for such period;
and
<!-- PJG 0012 frnewline -->
(6) If the individual's eligibility for medical assistance was established in each such preceding period, expenses
incurred before the current budget period but not previously deducted from income in establishing eligibility,
to the extent that such expenses are unpaid and are: 
<!-- PJG 0012 frnewline -->
(i) Described in paragraphs (e)(1) through (e)(3) of this section; and 
<!-- PJG 0012 frnewline -->
(ii) Carried over from the preceding budget period or periods because the individual had a spenddown liability in
each such preceding period that was met without deducting all such incurred, unpaid expenses. 
<!-- PJG 0012 frnewline -->
(g) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determination of deductible incurred medical expenses: Optional deductions. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In determining incurred medical expenses to be deducted from income, the agency_
<!-- PJG 0012 frnewline -->
(1) May include medical institutional expenses (other than expenses in acute care facilities) projected to the end
of the budget period at the Medicaid reimbursement rate; 
<!-- PJG 0012 frnewline -->
(2) May, to the extent determined by the State and specified in its approved plan, include expenses incurred earlier
than the third month before the month of application (except States using more restrictive eligibility criteria
under the option in section 1902(f) of the Act must deduct incurred expenses regardless of when the expenses were incurred);
and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00098 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) May set reasonable limits on the amount to be deducted for expenses specified in paragraphs (e)(1), (e)(2), and
(g)(2) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(h) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Order of deduction. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency must deduct incurred medical expenses that are deductible under paragraphs (e), (f), and (g) of this section
in the order prescribed under one of the following three options: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Type of service. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under this option, the agency deducts expenses in the following order based on type of expense or service: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Cost-sharing expenses as specified in paragraph (e)(1) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Services not included in the State plan as specified in paragraph (e)(2) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) Services included in the State plan as specified in paragraph (e)(3) of this section but that exceed limitations
on amounts, duration, or scope of services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) Services included in the State plan as specified in paragraph (e)(3) of this section but that are within agency
limitations on amount, duration, or scope of services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chronological order by service date. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under this option, the agency deducts expenses in chronological order by the date each service is furnished, or in
the case of insurance premiums, coinsurance or deductible charges, the date such amounts are due. Expenses for services
furnished on the same day may be deducted in any reasonable order established by the State. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chronological order by bill submission date. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under this option, the agency deducts expenses in chronological order by the date each bill is submitted to the agency
by the individual. If more than one bill is submitted at one time, the agency must deduct the bills from income in the
order prescribed in either paragraph (h)(1) or (h)(2) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Eligibility based on incurred medical expenses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Whether a State elects partial or full month coverage, an individual who is expected to contribute a portion of
his or her income toward the costs of institutional care or home and community-based services under &sect;&sect;435.725,
435.726, 435.733, 435.735 or 435.832 is eligible on the first day of the applicable budget (spenddown) period_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) If his or her spenddown liability is met after the first day of the budget period; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) If beginning eligibility after the first day of the budget period makes the individual's share of health care
expenses under &sect;&sect;435.725, 435.726, 435.733, 435.735 or 435.832 greater than the individual's contributable
income determined under these sections. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) At the end of the prospective period specified in paragraphs (f)(2) and (f)(3) of this section, and any subsequent
prospective period or, if earlier, when any significant change occurs, the agency must reconcile the projected amounts
with the actual amounts incurred, or with changes in circumstances, to determine if the adjusted deduction of incurred
expenses reduces income to the income standard. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Except as provided in paragraph (i)(1) of this section, in States that elect partial month coverage, an individual
is eligible for Medicaid on the day that the deduction of incurred health care expenses (and of projected institutional
expenses if the agency elects the option under paragraph (g)(1) of this section) reduces income to the income standard.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Except as provided in paragraph (i)(1) of this section, in States that elect full month coverage, an individual
is eligible on the first day of the month in which spenddown liability is met. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Expenses used to meet spenddown liability are not reimbursable under Medicaid. To the extent necessary to prevent
the transfer of an individual's spenddown liability to the Medicaid program, States must reduce the amount of provider
charges that would otherwise be reimbursable under Medicaid. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00099 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=3 -->
B. 42 CFR part 436 is amended as set forth below: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=3 -->
PART 436_ELIGIBILITY IN GUAM, PUERTO RICO, AND THE VIRGIN ISLANDS 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. The authority citation for part 436 continues to 
<!-- PJG 0012 frnewline -->
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Sec. 1102 of the Social Security Act (42 
<!-- PJG 0012 frnewline -->
U.S.C. 1302), unless otherwise noted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 436.831 is revised to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;436.831 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Income eligibility. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency must determine income eligibility of medically needy individuals in accordance with this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Budget periods. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) The agency must use budget periods of not more than 6 months to compute income. The agency may use more than one budget
period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The agency must include in the budget period in which income is computed all or part of the 3-month retroactive period
specified in &sect;435.914. The budget period can begin no earlier then the first month in the 
<!-- PJG 0012 frnewline -->
retroactive period in which the individual received covered services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) If the agency elects to begin the first budget period for the medically needy in any month of the 3-month period prior
to the date of application in which the applicant received covered services, this election applies to all medically
needy groups. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determining countable income. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency must, to determine countable income, deduct amounts that would be deducted in determining eligibility
under the State's approved plan for OAA, AFDC, AB, APTD, or AABD. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Eligibility based on countable income. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 If countable income determined under paragraph (b) of this section is equal to or less than the applicable income standard
under &sect;436.814, the individual is eligible for Medicaid. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Deduction of incurred medical expenses. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If countable income exceeds the income standard, the agency must deduct from income medical expenses incurred by
the individual or family or financially responsible relatives that are not subject to payment by a third party. An
expense is incurred on the date liability for the expense arises. The agency must determine deductible incurred expenses
in accordance with paragraphs (e), (f) and (g) of this section and deduct those expenses in accordance with paragraph
(h) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determination of deductible incurred expenses: Required deductions based on kinds of services. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subject to the provisions of paragraph (g) of this section, in determining incurred medical expenses to be deducted
from income, the agency must include the following: (1) Expenses for Medicare and other health insurance premiums,
and deductibles or coinsurance charges, including enrollment fees, copayments, or deductibles imposed under &sect;447.51
or &sect;447.53 of this chapter; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Expenses incurred by the individual or family or financially responsible relatives for necessary medical and
remedial services that are recognized under State law but not included in the plan; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Expenses incurred by the individual or family or by financially responsible relatives for necessary medical
and remedial services that are included in the plan, including those that exceed agency limitations on amount, duration
or scope of services; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determination of deductible incurred expenses: Required deductions based on the age of bills. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subject to the provisions of paragraph (g) of this section, in determining incurred medical expenses to be deducted
from income, the agency must include the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) For the first budget period or periods that include only months before the month of application for medical assistance,
expenses incurred during such period or periods, whether paid or unpaid, to the extent that the expenses have not been
deducted previously in establishing eligibility; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) For the first prospective budget period that also includes any of the 3 months before the month of application for
medical assistance, expenses incurred during such budget period, whether paid or unpaid, to the extent that the expenses
have not been deducted previously in establishing eligibility; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) For the first prospective budget period that includes none of the months preceding the month of application, expenses
incurred during such budget period and any of the 3 preceding months, whether paid or unpaid, to the extent that the
expenses have not been deducted previously in establishing eligibility; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) For any of the 3 months preceding the month of application that are not includable under paragraph (f)(2) of this
section, expenses incurred in the 3-month period that were a current liability of the individual in any such month
for which a spenddown calculation is made and that had not been previously deducted from income in establishing eligibility
for medical assistance; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Current payments (that is, payments made in the current budget period) on other expenses incurred before the current
budget period and not previously deducted from income in any budget period in establishing eligibility for such period;
and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(6) If the individual's eligibility for medical assistance was established in each such preceding period, expenses
incurred before the current budget period but not previously deducted from income, to the extent that such expenses
are unpaid and are: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Described in paragraphs (e)(1) through (e)(3) of this section; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Are carried over from the preceding budget period or periods because the individual had a spenddown liability
in each such preceding period that was met without deducting all such incurred, unpaid expenses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(g) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Determination of deductible incurred medical expenses: Optional deductions. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In determining incurred medical expenses to be deducted from income, the agency_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) May include medical institutional expenses (other than expenses in acute care facilities) projected to the end
of the budget period at the Medicaid reimbursement rate; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) May, to the extent determined by the agency and specified in its approved plan, include expenses incurred earlier
than the third month before the month of application; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00100 </DOCNO>
<PARENT> FR940112-0-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) May set reasonable limits on the amount to be deducted for expenses specified in paragraphs (e)(1), (e)(2), and
(g)(2) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(h) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Order of deduction. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The agency must deduct incurred medical expenses that are deductible under paragraphs (e), (f), and (g) of this section,
in the order prescribed under one of the following three options: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Type of service. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under this option, the agency deducts expenses in the following order based on type of service: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Cost-sharing expenses as specified in paragraph (e)(1) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) Services not included in the State plan as specified in paragraph (e)(2) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) Services included in the State plan as specified in paragraph (e)(3) of this section but that exceed agency limitations
on amount, duration, or scope of services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) Services included in the State plan as specified in paragraph (e)(3) of this section but that are within agency
limitations on amount, duration, or scope of services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chronological order by service date. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under this option, the agency deducts expenses in chronological order by the date each service is furnished, or in
the case of insurance premiums, coinsurance, or deductibles charges the date such amounts are due. Expenses for services
furnished on the same day may be deducted in any reasonable order established by the State. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chronological order by bill submission date. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under this option, the agency deducts expenses in chronological order by the date each bill is submitted to the agency
by the individual. If more than one bill is submitted at one time, the agency must deduct the bills from income in the
order prescribed in either paragraph (h)(1) or (h)(2) of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Eligibility based on incurred medical expenses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Whether a State elects partial or full month coverage, an individual who is expected to contribute a portion of
his or her income toward the costs of institutional care or home and community-based services under &sect;436.832
is eligible on the first day of the applicable budget (spenddown) period_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) If his or her spenddown liability is met after the first day of the budget period; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) If beginning eligibility after the first day of the budget period makes the individual's share of health care
expenses under &sect;436.832 greater than the individual's contributable income determined under this section.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) At the end of the prospective period specified in paragraph (f)(2) or (f)(3) of this section and any subsequent
prospective period or, if earlier, when any significant change occurs, the agency must reconcile the projected amounts
with the actual amounts incurred, or with changes in circumstances, to determine if the adjusted deduction of incurred
expenses reduces income to the income standard. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Except as provided in paragraph (i)(1) of this section, if agencies elect partial month coverage, an individual
is eligible for Medicaid on the day that the deduction of incurred health care expenses (and of projected institutional
expenses if the agency elects the option under paragraph (g)(1) of this section) reduces income to the income standard.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) Except as provided in paragraph (i)(1) of this section, if agencies elect full month coverage, an individual is
eligible on the first day of the month in which spenddown liability is met. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Expenses used to meet spenddown liability are not reimbursable under Medicaid. Therefore, to the extent 
<!-- PJG 0012 frnewline -->
necessary to prevent the transfer of an individual's 
<!-- PJG 0012 frnewline -->
spenddown liability to the Medicaid program, States must reduce the amount of provider charges that would otherwise
be reimbursable under Medicaid. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=3 -->
(Catalog of Federal Domestic Assistance Program No. 93.778, Medical Assistance Program) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dated: July 12, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->
Bruce C. Vladeck, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=3 -->
Administrator, Health Care Financing Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dated: October 4, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->
Donna E. Shalala, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=3 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=3 -->
[FR Doc. 94&hyph;547 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=3 -->
BILLING CODE 4120&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00101 </DOCNO>
<PARENT> FR940112-0-00022 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=3 -->
Wednesday 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=3 -->
January 12, 1994 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=3 -->
Part II 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=3 -->
Department of Transportation 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=3 -->
Federal Aviation Administration 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=3 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=3 -->
14 CFR Part 121, et al. 
<!-- PJG 0012 frnewline -->
Removal of Burn Compound From First-Aid Kits; Final Rule 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
/ Vol. 59, No. 8 / Wednesday, January 12, 1994 / Rules and Regulations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>DEPARTMENT OF TRANSPORTATION </USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Aviation Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
14 CFR Parts 121, 125, 135 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 25154; Amendment No. 121&hyph;236; 125&hyph;19; 135&hyph;47] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Removal of Burn Compound From First-Aid Kits 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration, DOT. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Final rule; request for comment. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This amendment revises the regulations concerning first aid kits required on board air carrier, air taxi, and commercial
aircraft to remove the burn compound from the list of items required for the kits. This amendment responds to a petition
from Air Transport Association, supported by the American Red Cross, that the burn compound be removed from the kits
since the use of ice or cold water is the preferred treatment for minor burns. This amendment will relieve affected
operators from the expense of having to periodically replace an item in the first aid kits that is not needed. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Effective date: January 12, 1994. Comments must be received on or before March 14, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send or deliver comments on the rule in duplicate to: 
<!-- PJG 0012 frnewline -->
Federal Aviation Administration, Office of the Chief Counsel, Attn: Rules Docket (AGC&hyph;204), room 916, 800
Independence Avenue, SW., Washington, DC 20591. Comments may be examined in the Rules Docket weekdays, except Federal
holidays, between 8:30 a.m. and 5 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
Gary Davis, Regulatory Branch, Air Transportation Division, Flight Standards Service, Federal Aviation Administration,
800 Independence Avenue, SW., Washington, DC 20591, telephone: (202) 267&hyph;8096. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
On December 5, 1986, the Air Transport Association (ATA) submitted a petition to delete burn compound (burn ointment)
from the first-aid kits required to be carried on each aircraft operated under part 121 of the Federal Aviation Regulations.
In the petition ATA noted that the application of ice or cold water is the preferred treatment for minor burns. As part
of its supporting data, the petition included a request from Western Airlines to delete burn ointment from their first
aid kits. Also included in the petition were copies of instructions from flight manuals for several other airlines
in which flight attendants were advised to use ice compresses for the treatment of burns and not to use the burn ointment
unless it is requested by the passenger. In addition, ATA stated that burn ointment normally has an expiration date,
which requires replacement, inspection, and record-keeping. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On January 21, 1987, ATA submitted a second letter to the docket that transmitted an American Red Cross statement confirming
their position that burn ointment retains heat within the wound, causing the wound to actually worsen in some cases.
In addition, information provided by the Red Cross indicated that burn ointment must be removed before any other treatment
can be applied. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
ATA submitted additional information on April 9, 1987, in which it cited the March 1987 ATA Cabin Safety Panel meeting
where the subject of first-aid for minor burns was discussed. At that meeting, each panel member present stated that
their flight attendants were trained to use cold water or ice rather than burn ointment, unless burn ointment was specifically
requested by the passenger. Representatives of most of the major airlines were included in this group, constituting
over 80 percent of all the seat miles flown by the major airlines. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
By letter dated July 6, 1987, ATA submitted a comment from the School of Nursing at the University of Miami as an additional
medical opinion. That letter, from an associate professor, stated that emergency care for burns should begin with
stopping the burning process by applying cool water to stop the pain and slow the process of heat damage. This medical
opinion also noted that application of ointments, oils, etc., should be avoided. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00102 </DOCNO>
<PARENT> FR940112-0-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The petition of ATA was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
on February 20, 1987 (52 FR 5309). The comment period closed April 20, 1987. The only comments received on the petition
are those cited above.
<!-- PJG 0012 frnewline -->
By letter dated July 6, 1993, ATA petitioned on behalf of its member airlines and similarly situated operators for
an exemption from the requirement to carry burn ointment in first aid kits as required by appendix A to part 121. A summary
of that petition was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
on August 11, 1993, and the comment period closed August 31, 1993 (58FR42752). Two comments were received. The Air
Line Pilots Association supports the removal of the ointment from first aid kits and notes that this removal would
facilitate maintenance by eliminating the need for purchasing, stocking, record keeping, replacing, and disposing
of the ointment. The Association of Flight Attendants (AFA) agrees that the removal of the ointment from first aid
kits is an appropriate action; however, the AFA also suggests that the FAA should require an equivalent amount of an
antibiotic ointment in its place. AFA adds that more recent information from the American Red Cross suggests that
cool water or wet cloths is the first step in treatment, but that ice is not recommended except for minor burns.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The FAA's Analysis of the Petition
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA agrees with industry practice. Serious burns can be properly treated only by professionals in a medical facility.
Neither burn ointment nor cold water is, by itself, an adequate response to a major burn injury. The intent of the burn
ointment requirement has always been to provide relief from minor burns caused by cigarettes or hot beverages.
<!-- PJG 0012 frnewline -->
In the limited situation of treating minor burns aboard an aircraft, cold water is the preferred treatment. This treatment
avoids the heat retentive properties of burn ointment. Moreover, if the wound requires further medical treatment,
the use of ice or cold water eliminates the need to scrape the wound to remove burn ointment.
<!-- PJG 0012 frnewline -->
Therefore, the FAA has determined that burn ointment should be deleted from the list of items required for first aid
kits in parts 121, 125, and 135. Ice or cold water is carried on aircraft operated under part 121 and on aircraft with
20 or more passenger seats operated under parts 125 and 135 to which aircraft the burn ointment requirement applies.
This will spare air carriers the unnecessary expense of having to maintain an unneeded item.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Good Cause Justification
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the fact that burn ointment is not the preferred treatment for minor burns, the requirement to
carry burn ointment aboard aircraft is inappropriate. Most types of burn ointment have expiration dates, thus new
ointment must be purchased, kits must be opened, the ointment replaced, kit resealed and re-installed, and a record
of the action must be made. The cost of this process, with labor being far more expensive than the ointment itself, represents
a significant nuisance burden for air carriers and commercial operators. ATA carriers are required to maintain over
10,000 kits. This is an unnecessary cost to the industry for which the consumer derives no benefit. It is clearly in
the public interest to delete the requirement.
<!-- PJG 0012 frnewline -->
Since this is a minor amendment in which there is not expected to be any public comment or disagreement from the medical
community, the FAA finds that public notice and comment on this amendment is unnecessary. Moreover, because this
amendment relieves a requirement, it should be made effective upon publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons, however, are invited to submit such comments as they may desire regarding this amendment. Correspondence
should identify the docket number and be submitted in duplicate to the address provided above. All communications
received on or before the close of the comment period will be considered by the Administrator, and this amendment may
be changed in light of comments received. All comments will be available for public review, both before and after the
closing date for comments, in the rules docket.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Trade Impact Statement
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA finds that this amendment will have no impact on international trade.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Economic Assessment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Because the amendment imposes no cost to operators, the only impact of this amendment is expected to be that carriers
will experience some cost savings. Accordingly, the FAA has determined that the impact of this amendment is so minimal
that a full regulatory evaluation is not warranted.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Federalism Implications
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The regulation adopted herein would not have substantial direct effects on the states, on the relationship between
the states, or on the distribution of power and responsibilities among the various levels of government. Therefore,
in accordance with Executive Order 12612, it is determined that this regulation would not have sufficient federalism
implications to warrant the preparation of the Federalism Assessment.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Paperwork Reduction
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This final rule is expected to produce a minor reduction in the record keeping requirements under parts 121, 125, and
135. The paperwork estimation for those parts will be revised accordingly.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00103 </DOCNO>
<PARENT> FR940112-0-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To the extent that this amendment will have an economic effect on the airlines and the general public, it will only be
a minor, positive one. Therefore, the FAA has determined that this amendment involves a regulation that is not a significant
regulatory action under Executive Order 12866 or significant under the Department of Transportation Regulatory
Policies and Procedures (44 FR 11034; February 26, 1979). Since no small entities would be affected by the rule, the
FAA has determined, and it is certified that under the criteria of the Regulatory Flexibility Act, the rule will not
have a significant economic impact, positive or negative, on a substantial number of small entities. The economic
impact is so minimal that it does not warrant a full regulatory evaluation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Parts 121, 125, 135
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Air safety, Air transportation, Aviation safety, Safety, Transportation, Cabin safety, First-aid kits.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, parts 121, 125, and 135 of the Federal Aviation Regulations (14 CFR part 121) are amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 121_CERTIFICATION AND OPERATIONS: DOMESTIC, FLAG, AND SUPPLEMENTAL AIR CARRIERS AND COMMERCIAL OPERATORS
OF LARGE AIRCRAFT
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 121 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. App. 1354(a), 1355, 1356, 1357, 1401, 1421&hyph;1430, 1472, 1485, and 1502; 49 U.S.C. 106(g) (revised,
Pub. L. 97&hyph;449, January 12, 1983).
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In Appendix A to part 121, paragraph (5) is amended by removing the item ``Burn compound, 1/8 ounce or an equivalent
of other burn remedy, quantity 6'' and by moving the remaining six items in the list to the end of the list in paragraph
(4).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 125_CERTIFICATION AND OPERATIONS: AIRPLANES HAVING A SEATING CAPACITY OF 20 OR MORE PASSENGERS OR A MAXIMUM
PAYLOAD CAPACITY OF 6,000 POUNDS OR MORE
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. The authority citation for part 125 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. App. 1354(a), 1421 through 1430, and 1502; 49 U.S.C. 106(g) (Revised Pub. L. 97&hyph;449, January 12, 1983.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;125.207
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. Section 125.207(a)(1)(iii) is amended by removing the item: Burn compound, 1/8 oz or an equivalent of other burn
remedy, quantity 6.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 135_AIR TAXI OPERATORS AND COMMERCIAL OPERATORS
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. The authority citation for part 135 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. App. 1354(a), 1355(a), 1421 through 1431, and 49 U.S.C. 106(g) (Revised Pub. L. 97&hyph;449, January 12,
1983).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;135.177
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. Section 135.177(a)(1)(iii) is amended by removing the item: Burn compound, 1/8 oz or an equivalent of other burn
remedy, quantity 6.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David R. Hinson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;626 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00104 </DOCNO>
<PARENT> FR940112-0-00023 </PARENT>
<TEXT>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part III
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of Transportation
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Research and Special Programs Administration
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
49 CFR Part 173, et al.
<!-- PJG 0012 frnewline -->
Construction of Cargo Tank Motor Vehicles; Final Rule
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January, 12, 1994&blank;/&blank;Rules and Regulations

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>DEPARTMENT OF TRANSPORTATION </USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Research And Special Programs Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
49 CFR Parts 173 and 180 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. HM&hyph;183; Amdt No. 173&hyph;212 and 180&hyph;2] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 2137&hyph;AC37 </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Construction of Cargo Tank Motor Vehicles; Extension of Compliance Date 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Research and Special Programs Administration (RSPA), DOT. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule; extension of compliance date and announcement of a public meeting. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 RSPA is granting an extension for the continued construction of cargo tank motor vehicles to the MC 306, MC 307, MC 312,
MC 331, and MC 338 specifications. The date is extended from April 21, 1994 to August 31, 1995. This extension is based
on comments received from the Truck Trailer Manufacturers Association, the Heil Co., and members of the Compressed
Gas Association. This final rule allows cargo tank manufacturers additional time to implement engineering 
<!-- PJG 0012 frnewline -->
procedures required for manufacture of cargo tank motor 
<!-- PJG 0012 frnewline -->
vehicles to the new DOT 406, DOT 407 and DOT 412 specifications and to implement design modifications as a result of
changes to the structural integrity calculations in the MC 331 and MC 338 specifications.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Effective: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This final rule will become effective on March 14, 1994, unless RSPA receives, by February 11, 1994, comments that
illustrate that extension of the compliance date is not in the public interest. Upon receipt of such comments, RSPA
will publish a document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 withdrawing this final rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Public meeting: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A public meeting will be held on February 7 and 8, 1994. It will begin at 9 a.m. on February 7, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
 Written comments: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments may be mailed or hand-delivered to the Dockets Unit (DHM&hyph;30), Research and Special Programs Administration,
U.S. Department of Transportation, 400 Seventh St., SW., Washington, DC 20590&hyph;0001. Comments should identify
the docket and notice number and be submitted in five copies. Persons wishing to receive confirmation of receipt of
their comments should include a self-addressed stamped postcard. The Dockets Unit is located in room 8421 of the Nassif
Building, 400 Seventh Street, SW., Washington, DC 20590&hyph;0001. Telephone: (202) 366&hyph;5046. Public dockets
may be reviewed between the hours of 8:30 a.m. and 5 p.m., Monday through Friday except Federal holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ADDRESS>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00105 </DOCNO>
<PARENT> FR940112-0-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Public meeting: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The public meeting will be held at the U.S. Department of Transportation (Meeting room 2230, Nassif Building), 400
Seventh Street SW., Washington, DC, 20590&hyph;0001. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Ronald Kirkpatrick, telephone (202) 366&hyph;4545, Office of Hazardous Materials Technology, or Jennifer Karim,
(202) 366&hyph;4488, Office of Hazardous Materials Standards, Research and Special Programs Administration,
U.S. Department of Transportation, Washington, DC 20590&hyph;0001. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
A. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
RSPA published final rules under Docket Nos. HM&hyph;183/HM&hyph;183A establishing three new cargo tank specifications
designated as DOT 406, DOT 407 and DOT 412 (June 12, 1989, 54 FR 24982; May 22, 1990, 55 FR 21035; September 7, 1990, 55
FR 37028; June 17, 1991, 56 FR 27872). The rules also made changes to 
<!-- PJG 0012 frnewline -->
the structural integrity calculations for the MC 331 and MC 338 cargo tanks. 
<!-- PJG 0012 frnewline -->
To allow manufacturers sufficient time to implement changes in their manufacturing operations, RSPA provided for
the continued manufacture of cargo tanks to the MC 306, MC 307 and MC 312 specifications until August 31, 1993. However,
as manufacturers began implementing the new requirements, certain technical issues were brought to RSPA's attention.
To allow time for resolving these issues, RSPA extended the date that cargo tanks may no longer be constructed to the
MC 306, MC 307, MC 312, MC 331 and MC 338 specifications from August 31, 1993 to April 21, 1994 (March 8, 1993, 58 FR 12904).

<!-- PJG 0012 frnewline -->
On March 3, 1993, RSPA published a notice of proposed rulemaking (NPRM) proposing to amend certain requirements for
the manufacture, qualification and maintenance of cargo tank motor vehicles (March 3, 1993, 58 FR 12316). The NPRM
was in response to petitions for rulemaking received after publication of the final rules. The NPRM addressed certain
technical requirements for the construction of the DOT&hyph;400 series specifications and the structural integrity
calculations in the MC 331 and MC 338 specifications. The comment period for the NPRM closed on June 15, 1993. 
<!-- PJG 0012 frnewline -->
A public meeting to address issues raised in the NPRM was held in Chicago on March 24 and 25, 1993. At the meeting, several
significantly different views of design engineers and cargo tank manufacturers were identified. Additionally,
preliminary results were presented at the public meeting of an advanced structural evaluation (using finite element
analysis) of the MC 331 cargo tank which raised questions in regard to stress levels in areas of concentrated loadings.

<!-- PJG 0012 frnewline -->
In response to the NPRM and to issues raised at the public meeting, commenters requested that RSPA provide a one-year
continuation for construction of cargo tanks to the MC 306, MC 307, MC 312, MC 331 and MC 338 specifications. The commenters
stated that they need time to finalize their engineering designs, develop written specifications, order raw materials,
and establish new training requirements. Because of the complexity and impact of issues that will be addressed in
the final rule and new concerns raised by the commenters, RSPA is extending the compliance date to August 31, 1995.
However, because industry did not request an extension of the provisions specified in &sect;178.337&hyph;6, pertaining
to inspection opening or manhole requirements for certain smaller cargo tanks, RSPA is not extending the April 21,
1994 compliance date specified in that section. 
<!-- PJG 0012 frnewline -->
RSPA is issuing this extension of the compliance date because we view this as a noncontroversial amendment and do not
anticipate any adverse comments. This final rule will be effective March 14, 1994, unless by February 11, 1994, RSPA
receives comments that illustrate that extension of the compliance date is not in the public interest. Upon receipt
of such comments, RSPA will withdraw this final rule before the effective date by simultaneously publishing two subsequent
documents. One document will withdraw this final rule and another will begin a new rulemaking by announcing a proposal
to extend the compliance date and establishing a comment period. If no such comments are received, RSPA will publish
a document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 confirming that this final rule will be effective on March 14, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00106 </DOCNO>
<PARENT> FR940112-0-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
B. Public Meeting 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The process of developing the DOT&hyph;400 series cargo tank motor vehicle specifications and of updating the MC
331 and MC 338 cargo tank motor vehicle specifications has extended over more than ten years. During this time, the
process has been conducted in accordance with the Administrative Procedure Act, with the attendant advantage of
offering ample time for manufacturers and users to comment on proposed changes and to provide alternative means of
achieving enhanced safety of cargo tank motor vehicles in hazardous materials service. Some major issues, however,
remain unresolved. These issues pertain to structural integrity, accident damage protection, use of dual function
pressure relief devices, and ASME certification of low pressure cargo tank motor vehicle manufacturers. Changes
endorsed several years ago are now being questioned by some industry members. In addition, RSPA received several
petitions for rulemaking raising certain issues not previously addressed. 
<!-- PJG 0012 frnewline -->
RSPA will conduct a public meeting, in an effort to resolve these issues. The following issues will be discussed at
the times noted: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
February 7, 1994 9 a.m. until 12 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
MC 331 and MC 338 Specifications 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Structural integrity. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several commenters have expressed concern over the application and combination of loadings used to determine the
effective stress at any given point on a cargo tank motor vehicle. Based on industry's experience in design, operation,
maintenance and repair of high pressure cargo tank motor vehicles, RSPA solicits information on loading combinations
that may be encountered during the operation of these tanks. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
February 7, 1994, 1 p.m. until 5 p.m. and February 8, 1994, 8 a.m. until 5 p.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
DOT 406, DOT 407 and DOT 412 Specifications 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Structural integrity. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several commenters have expressed concern over the application and combination of loadings used to determine the
effective stress at any given point on a cargo tank motor vehicle. Based on industry's experience in design, operation,
maintenance and repair of cargo tank motor vehicles, RSPA solicits information on loading combinations that may
be encountered during the operation of these tanks. 
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Accident damage protection. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several commenters have stated that it is not possible to meet the prescribed accident damage protection requirements.
RSPA solicits information on alternative means to provide cargo tank motor vehicles with adequate bottom, rollover,
and rear-end protection. 
<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dual function pressure relief devices. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Several commenters have stated that it is not possible to design dual function pressure relief devices. However,
advertisements in trade magazines indicate that such vents are available. RSPA solicits data on the development
and availability of dual function pressure relief devices. 
<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
ASME certification of low pressure cargo tank motor vehicle manufacturers. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Cargo Tank Manufacturers Association (CTMA) submitted for RSPA's consideration a quality control program for
manufacturers of low pressure DOT 406 cargo tank motor vehicles as an alternative to requiring each manufacturing
facility to have ASME Certification. Copies of the CTMA proposal are available in RSPA's Docket Unit. RSPA solicits
specific comments on the adequacy of the CTMA proposal; particularly in the areas of manufacturing quality control
and independent inspection. 
<!-- PJG 0012 frnewline -->
Information received at the public meeting and in response to the NPRM will be used in the development of the final rule
under Docket HM&hyph;183C. However, RSPA may make certain issues subject to a separate rulemaking action. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
C. Rulemaking Analyses and Notices 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Executive Order 12866 and DOT Regulatory Policies and Procedures 
<!-- PJG 0012 frnewline -->
This rulemaking is exempt from review by the Office of Management and Budget under Executive Order 12866. Although
the June 12, 1989 final rule was significant under the regulatory procedures of the Department of Transportation
(44 FR 11034), this document is not significant because it does not impose additional requirements and has the effect
of extending a compliance date. This rule, in fact, provides regulatory and economic relief in some areas. The original
regulatory evaluation of the final rule was not modified because this final rule does not impose additional requirements
and does not make substantive changes to the final rule. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=3 -->
Executive Order 12612 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
This final rule has been analyzed in accordance with the principles and criteria contained in Executive Order 12612

<!-- PJG 0012 frnewline -->
(``Federalism''). The Hazardous Materials Transportation Act 
<!-- PJG 0012 frnewline -->
contains an express preemption provision (49 App. U.S.C. 1804(a)(4)) that preempts State, local, and Indian tribe
requirements on certain covered subjects. Covered subjects are: 
<!-- PJG 0012 frnewline -->
(i) The designation, description, and classification of hazardous materials; 
<!-- PJG 0012 frnewline -->
(ii) The packing, repacking, handling, labeling, marking, and placarding of hazardous materials; 
<!-- PJG 0012 frnewline -->
(iii) The preparation, execution, and use of shipping documents pertaining to hazardous materials and requirements
respecting the number, content, and placement of such documents; 
<!-- PJG 0012 frnewline -->
(iv) The written notification, recording, and reporting of the unintentional release in transportation of hazardous
materials; or 
<!-- PJG 0012 frnewline -->
(v) The design, manufacturing, fabrication, marking, maintenance, reconditioning, repairing, or testing of a
package or container which is represented, marked, certified, or sold as qualified for use in the transportation
of hazardous materials. 
<!-- PJG 0012 frnewline -->
This final rule concerns the manufacturing requirements for packagings represented as qualified for use in the transportation
of hazardous materials. 
<!-- PJG 0012 frnewline -->
This final rule preempts State, local, or Indian tribe requirements in accordance with the standards set forth above.
The HMTA (49 App. U.S.C. 1804(a)(5)) provides that if DOT issues a regulation concerning any of the covered subjects
after November 16, 1990, DOT must determine and publish in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the effective date of Federal preemption. That effective date may not be earlier than the 90th day following the date
of issuance of the final rule and not later than two years after the date of issuance. RSPA has determined that the effective
date of Federal preemption for these requirements will be 90 days after publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->
Thus, RSPA lacks discretion in this area, and preparation of a federalism assessment is not warranted. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Regulatory Flexibility Act 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
I certify that this final rule will not have a significant economic impact on a substantial number of small entities.
This rule applies to manufacturers of DOT specification cargo tank motor vehicles. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00107 </DOCNO>
<PARENT> FR940112-0-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Paperwork Reduction Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This amendment imposes no changes to the information 
<!-- PJG 0012 frnewline -->
collection and recordkeeping requirements contained in the June 12, 1989 final rule, which was approved by the Office
of Management and Budget (OMB) under the provisions of 44 U.S.C. chapter 35 and assigned control number 2137&hyph;0014.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Regulation Identifier Number (RIN) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A regulation identifier number (RIN) is assigned to each regulatory action listed in the Unified Agenda of Federal
Regulations. The Regulatory Information Service Center publishes the Unified Agenda in April and October of each
year. The RIN number contained in the heading of this document can be used to cross-reference this action with the Unified
Agenda. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
49 CFR Part 173 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Hazardous materials transportation, Packaging and containers, Radioactive materials, Reporting and recordkeeping
requirements, Uranium. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
49 CFR Part 180 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Hazardous materials transportation, Motor carriers, Motor vehicle safety, Packaging and containers, Reporting
and recordkeeping requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In consideration of the foregoing, title 49, chapter I of the Code of Federal Regulations, is amended as set forth below.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 173_SHIPPERS&hyph;GENERAL REQUIREMENTS FOR SHIPMENTS 
<!-- PJG 0012 frnewline -->
AND PACKAGINGS 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 173 continues to read as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 App. U.S.C. 1803, 1804, 1805, 1806, 1807, 1808, 1817; 49 CFR part 1, unless otherwise noted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;173.33 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;173.33, the following changes are made: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. In paragraph (c)(4), the date ``April 21, 1994'' is revised to read ``August 31, 1995''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. In paragraph (d)(1), the date ``April 21, 1994'' is revised to read ``August 31, 1995''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 180_CONTINUING QUALIFICATION AND MAINTENANCE OF PACKAGINGS 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. The authority citation for part 180 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 App. U.S.C. 1803; 49 CFR part 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;180.405 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4. In &sect;180.405, the following changes are made: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. In paragraph (b), the date ``April 21, 1994'' is revised to read ``August 31, 1995''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. In paragraph (c)(1) table, under column 2, the date ``April 22, 1994'' is revised to read ``September 1, 1995.''

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;180.413 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. In &sect;180.413, in paragraphs (d)(1)(i), (ii) and (iii), the date ``April 21, 1994'' is revised to read ``August
31, 1995''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;180.417 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. In &sect;180.417, in the heading of paragraph (a)(3), the date ``April 22, 1994'' is revised to read ``September
1, 1995''. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC on January 6, 1994 under authority delegated in 49 CFR Part 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rose A. McMurray,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Administrator, Research and Special Programs 
<!-- PJG 0012 frnewline -->
Administration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;636 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;60&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00108 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part V
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Federal Trade Commission
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
16 CFR Part 500
<!-- PJG 0012 frnewline -->
Regulations Under Section 4 of the Fair Packaging and Labeling Act; Final Rule
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Rules and Regulations

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>FEDERAL TRADE COMMISSION </USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<USDEPT>16 CFR Part 500 </USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Regulations Under Section 4 of the 
<!-- PJG 0012 frnewline -->
Fair Packaging and Labeling Act
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Trade Commission. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Final rule. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Federal Trade Commission (the ``Commission'' or ``FTC'') amends its regulations issued under section 4 of the
Fair Packaging and Labeling Act (FPLA) to require the use of the units of both the customary inch/pound measurement
system and the metric measurement system in the net quantity statement for certain consumer commodities. This action
is being taken to implement 1992 amendments to the FPLA, which require such dual measurement system disclosure. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 February 14, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Robert E. Easton, Special Assistant_Enforcement, Federal Trade Commission, Washington, DC 20580, (202) 326&hyph;3029
or Bret S. Smart, Consumer Protection Specialist, Los Angeles Regional Office, Federal Trade Commission, 11000
Wilshire Blvd., suite 13209, Los Angeles, CA 90024, (310) 575&hyph;7890. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Statement of Basis and Purpose 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In 1967, Congress enacted the Fair Packaging and Labeling Act (15 U.S.C. 1451 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.) (FPLA). Congress declared that packages and their labels should be marked to enable consumers to obtain accurate
information as to the quantity of the contents and to facilitate value comparisons. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To effectuate its policy of providing consumers accurate quantity information on commodity labels, Congress in
the FPLA set out general disclosure requirements and delegated to various agencies, including the FTC, the duty of
promulgating regulations. The FTC in 1968 published regulations that provided detailed guidance to industry on
what to include in statements of identity of products; in the identification of manufacturers, packers, or distributors;
and in declarations of net quantities (33 FR 4718, March 19, 1968; 16 CFR part 500). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The 1967 FPLA specified that the quantity disclosures be made in the customary American inch/pound system of measurement.
The FTC's implementing regulations thus required use of the inch/pound system of measurement. The FTC regulations,
however, also permitted the use of the metric system of measurement as an additional net quantity disclosure (16 CFR
500.21). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00109 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In 1992, Congress amended the FPLA to require that the quantity disclosure on labels of consumer commodities be in
both the SI metric system and the customary inch/pound system of measurement. This amendment is consistent with the
overall policy that the metric system is the preferred system of weights and measures for commerce in the United States
(Omnibus Trade and Competitiveness Act, Public Law 100&hyph;418, 15 U.S.C. 205b). Because of the metric amendments
to the FPLA, the FTC has conducted this rulemaking to amend its regulations to reflect the requirement for dual disclosure.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This rulemaking has been conducted pursuant to the Commission Rules prescribing special procedures for the promulgation
and amendment of FPLA regulations. (16 CFR part 1, subpart C.) Pursuant to these procedures, interested parties were
afforded the opportunity to participate in the proceeding through the submission of written data, views, or arguments.
On August 17, 1993, the Commission published a Notice of Proposed Rulemaking (NPR) in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that sought comment on the proposed dual disclosure amendments to the Commission's FPLA regulations.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The Commission also sought comments on its consideration of certain statutory and regulatory requirements relating
to this rulemaking, such as the National Environmental Policy Act of 1969 (42 U.S.C. 4321). In the NPR, the Commission
tentatively concluded that the proposed amendments were not ``major'' rule amendments within the meaning of that
statute; were not rules requiring the ``collection of information'' within the meaning of the Paperwork Reduction
Act (44 U.S.C. 3501 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.); and were in compliance with the metric usage requirements of the Metric Conversion Act (15 U.S.C. 205b). Further,
as part of its ongoing regulatory review of existing and proposed regulations, the Commission sought comment about
the overall costs and benefits of the regulations promulgated under the FPLA. Lastly, the Commission, based upon
information currently available, stated its belief that it is unlikely that the proposed amendments would have a
significant economic impact on a substantial number of small firms. However, given the uncertainty on the question,
the Commission published an initial regulatory analysis under the Regulatory Flexibility Act (5 U.S.C. 603&hyph;604)
and requested public comment on the potential costs of the amendments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
58 FR 43726. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission received 20 timely written comments, which are summarized in part III of this notice. The amendments
that the Commission is adopting today are also discussed in part III. The text of the amendments appears at the end of
this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00110 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. The Fair Packaging and Labeling Act 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Fair Packaging and Labeling Act is designed to prevent the use of unfair or deceptive methods of packaging and labeling
of consumer commodities. The FPLA states that it shall be unlawful for persons to sell or distribute commodities whose
labels do not conform ``to the provisions of this Act and of regulations promulgated under the authority of this Act.''
(15 U.S.C. 1452.) The main requirements of the FPLA are that the label on a package disclose the identity of the commodity;
the name and place of business of the manufacturer, packer, or distributor of the commodity; and the net quantity of
contents in terms of weight, measure, or numerical count. (15 U.S.C. 1453.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Shared Enforcement and Implementation Authority 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the FPLA, Congress has established a system of divided authority for implementation and enforcement. The authority
to promulgate and enforce regulations with regard to foods, drugs, devices, or cosmetics is vested in the United States
Food and Drug Administration. (15 U.S.C. 1453(a), 15 U.S.C. 1456(a).) With respect to any other consumer commodity,
authority is vested in the FTC (15 U.S.C. 1454(a), 15 U.S.C. 1456(b)). With regard to imports of consumer commodities
into the United States, the Secretary of the Treasury enforces FPLA. (15 U.S.C. 1456(c).) Additionally, several
other agencies have adopted parallel disclosure schemes on their own initiative.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In developing the proposed amendments that were published in the NPR, the Commission's staff consulted with the staffs
of other relevant agencies to harmonize requirements. The amendments the Commission adopts today are consistent
with the proposed metric amendments to food labeling rules contained in a Notice of Proposed Rulemaking issued by
the FDA on May 21, 1993 (58 FR 29719). As of the date of this FTC Statement of Basis and Purpose, the FDA has issued no final
rules for any of the products it regulates under the FPLA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Consumer Commodities 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FPLA defines consumer commodities as being any food, drug, device, or cosmetic and any other article, product
or commodity of any kind or class which is customarily produced or distributed for sale through retail sales agencies
or instrumentalities for consumption by individuals, or use by individuals for purposes of personal care or in the
performance of services ordinarily rendered within the household, and which usually is consumed or expended in the
course of such consumption or use.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 1459(a). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FPLA grants the FTC authority to exempt commodities it regulates under the Act.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Acting under this authority, the FTC has exempted the following products from certain FPLA requirements_camera
film; Christmas tree ornaments; replacement bags for vacuum cleaners; chamois; paper table covers; certain cellulose
sponges; candles; and solder. (16 CFR part 501.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 1454(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In a similar vein, the FTC has interpreted the meaning of ``consumer commodity'' as used in FPLA as not including 52
commodities or classes of commodities. These include such items as antifreeze and automotive accessories, garden
tools and hardware, toys, typewriter ribbons, and woodenware. (16 CFR part 503.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3. Procedures for Promulgating Regulations Under FPLA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FPLA sets out the procedures to be followed by the FTC in promulgating regulations. The FPLA states that regulations
promulgated by the Commission under section 4 or section 5 shall be promulgated, and shall be subject to judicial review,
by proceedings taken in conformity with the provisions of subsections (e), (f), and (g) of section 701 of the Federal
Food, Drug, and Cosmetic Act (21 U.S.C. 371 (e), (f), and (g)) (``FDC Act'').
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 1455(b). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FTC has implemented this statutory requirement to use the rulemaking procedures of section 371 of the FDC Act by
adopting 16 CFR part 1 subpart C, which sets forth the procedures for the promulgation of rules under authority other
than section 18(a)(1)(B) of the FTC Act. 
<!-- PJG 0012 frnewline -->
Subpart C provides that the effective date of any regulations issued under the FPLA shall not be prior to 30 days after
publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Original FTC Regulations Issued Under the FPLA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In 1968, the FTC issued the original regulations implementing the FPLA. (33 FR 4718, March 19, 1968.) There are twenty-seven
regulations, of which twenty-two relate to the net quantity of contents declaration. Several of the regulations
relate to the measurement system to be used in the net quantity declaration. For example, &sect;500.8 prescribes
the units of weight and measures to be used; &sect;&sect;500.9 through 500.14 set out how weight, fluid measure, length,
width, area, and cubic measure should be expressed; and &sect;500.16 states how fractions should be treated. 
<!-- PJG 0012 frnewline -->
Each of the original regulations mandating measurement disclosure requires the use of customary inch/pound units.
This is because Section 4 of the original FPLA (15 U.S.C. 1453) states that required net quantity disclosure be in pounds,
inches, feet, yards, pints, quarts, gallons, etc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00111 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
One of the FTC regulations issued under the FPLA allows the optional use of metric units in addition to the mandated
inch/pound units. Section 500.21 (16 CFR 500.21) states: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
A separate statement of the net quantity of contents in terms of the metric system is not regarded as a supplemental
net quantity statement and an accurate statement of the net quantity of contents in terms of the metric system of weight
or measure may also appear on the principal display panel or on other panels. Standard metric abbreviations may be
used. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Thus, under the original regulations, manufacturers, packers, and distributors of consumer commodities subject
to FTC regulations were required to make net quantity of contents disclosure using inch/pound units but had the option
of making additional disclosure in metric units. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. The 1992 Metric Amendments to the FPLA 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In 1992, the FPLA was amended to require that the International System of Units (``SI metric system'') as well as the
customary inch/pound system of measure be used in the label declaration of net quantity of contents of consumer commodities.
(Pub. L. 102&hyph;329, August 3, 1992.) It is these statutory changes which the FTC is implementing in adopting the
regulations set out in this notice. 
<!-- PJG 0012 frnewline -->
The 1992 substantive amendments to the FPLA relate to metric. The basic change that the amendments make is that all
labels for consumer commodities printed after February 14, 1994, must state the net quantity of contents in both the
customary inch/pound system of measure and the SI metric system. Apart from the changes made to section 4 (15 U.S.C.
1453), section 5 (15 U.S.C. 1454), and section 13 (15 U.S.C. 1461), the FPLA remains the same. Specifically, the statutory
amendments are as follows. 
<!-- PJG 0012 frnewline -->
Section 4 of FPLA requires that a consumer commodity bear a label which specifies the identity of the commodity, the
name and place of business of the manufacturer, packer, or distributor, and the net quantity of contents. The amendments
to Section 4 require that the contents label be in both the customary inch/pound and metric systems of measurement.

<!-- PJG 0012 frnewline -->
Subsection (a)(2) has been amended to mandate the disclosure of contents in terms of mass as well as weight. The original
FPLA only required weight, a unit of the customary system of measure. Mass (measured in kilograms and multiples and
submultiples) is the metric term for the quantity of matter in an object. 
<!-- PJG 0012 frnewline -->
Subsection (a)(2) specifies that the metric disclosure shall use the ``SI metric system.'' The ``SI'' system is the
International System of Units (Le Systeme International d'Unites) as interpreted or modified for use in the United
States by the Secretary of Commerce. (55 FR 52242, Dec. 20, 1990.) There are several government publications giving
guidance on use of the SI.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See, ``The International System of Units (SI),'' NIST Special Publication 330, U.S. Department of Commerce, August,
1991; ``Guide for the Use of the International System of Units,'' NIST Special Publication 811, U.S. Department of
Commerce, September, 1991; and ``Preferred Metric Units for General Use by the Federal Government,'' Federal Standards
376B (Preprint Copy), General Services Administration, January 27, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subsection (a)(3)(A)(ii) states that decimal fractions of the pound and decimal fractions of the SI metric system
units shall be carried out to no more than three places on random packages, which are packages with varying weight or
mass from a lot of the same consumer commodity. The original FPLA required that decimal fractions of the pound be carried
out to no more than two places. 
<!-- PJG 0012 frnewline -->
Subsection (a)(6) states that content labels containing SI metric disclosure are not required for foods that are
packaged at the retail store level. This amendment affects FDA, rather than FTC, regulations. 
<!-- PJG 0012 frnewline -->
Section 13 of the amended FPLA states that the effective date for the changes to sections 4 and 5 is February 14, 1994.
However, it also provides that, ``The amendments *&blank;*&blank;* have no effect on the sale or distribution of
products whose labels have been printed before such effective date.'' Thus, companies with labels on hand that were
printed before the effective date may continue to use the supply until exhausted. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Identification of Comments Received 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Below is an alphabetical list of the comments submitted in response to the NPR. The list includes the document number
assigned to the comment on the public record and a general description of the commenter (for those comments that included
a description or where the commenter is a publicly recognized company).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
All public comments are filed in the Commission's Rulemaking Record P938902. In this notice, comments are cited by
an identification of the commenter, the comment number assigned by the Secretary of the Commission, and the relevant
page number(s), e.g., ``NCWM, 19, 3.'' 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. Amway Corporation (``Am'')_14. Amway sells products subject to the Commission's FPLA regulations. 
<!-- PJG 0012 frnewline -->
2. Mr. Jeffrey S. Berke (``Berk'')_1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00112 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3. Mr. J. D. Buchanan (``Buch'')_11. Mr. Buchanan is a Canadian resident who had responsibility for metric conversion
in Canada. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Borden, Inc. (``Bord'')_9 and 20. Borden sells products subject to the Commission's FPLA regulations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Cramer Products, Inc. (``Cram'')_18. Cramer is a small, employee-owned manufacturer of products for athletics
and physical education. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. First Brands Corporation (``Frst'')_15. First sells products subject to the Commission's FPLA regulations.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. Maryland State Department of Agriculture, Weights and Measures Section (``Md Ag'')_5. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. Mr. Eugene A. Mechtly (``Mech'')_7. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. Michigan State Department of Agriculture (``Mich Ag'')_6. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
10. Micro Motion, Inc. (``Micr'')_4. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
11. Congresswoman Jan Meyers (``Cong. Meyers'')_17. Congresswoman Meyers is the Ranking Minority Member of the
House Committee on Small Business. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
12. The National Conference on Weights and Measures (``NCWM'')_19. NCWM is a voluntary standards-writing body whose
members are State and local weights and measures officials, as well as Federal Government, business, industry, and
consumer representatives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
13. The National Institute of Standards and Technology_Metric Program (``NIST'')_12. NIST, a unit of the Department
of Commerce, has responsibility for guiding the Federal Government's conversion to usage of the metric system of
measurement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
14. Pier 1 Imports (``Pier'')_2. Pier sells products subject to the Commission's regulations issued under FPLA.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
15. The Procter &amp; Gamble Company (``PG'')_10. PG sells products subject to the Commission's regulations issued
under FPLA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
16. Mr. Louis F. Sokol (``Soko'')_8. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
17. Mr. Larry Stempnik (``Stem'')_13. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
18. Standards and Metric Practices Subcommittee of the Metric Operating Committee of the Interagency Council on
Metric Policy (``SMPS'')_16. SMPS was responsible for writing Federal Standard 376B, ``Preferred Metric Units
for General Use by the Federal Government.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
19. Mr. John H. Woelflein (``Woel'')_3. Mr. Woelflein is a member of the U.S. Metric Association, Inc., the National
Conference on Weights and Measures, and the New Hampshire Metric Advisory Council. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. Comment Suggestions Beyond Commission's Authority Under FPLA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Two comments suggested that the Commission amend the regulations issued under the FPLA in ways that are beyond the
Commission's authority and that would conflict with the 1992 metric amendments to the FPLA. Specifically, NCWM suggested
that packages that are ``rational'' metric sizes, e.g., 250 mL, 500 mL, 1,2,3, and 4 liter, not be required to have inch/pound
content declarations;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and Mr. Berke questioned the value of having metric equivalents on consumer packages and objected to the mandatory
use of metric labeling.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
9
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NCWM, 19, 5.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Berk, 1, 1&hyph;2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As discussed above,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the 1992 amendments to section 4(a)(2) of the FPLA provide that the net quantity of contents shall be stated ``using
the most appropriate units of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
both
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the customary inch/pound system *&blank;*&blank;*&blank; and, *&blank;*&blank;*&blank; the SI metric system''
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
emphasis supplied
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). Thus, Congress has required by statute that both customary inch/pound and SI metric units are to be used for content
disclosure. The Commission cannot issue regulations that contravene the statutory requirement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Section II 3 C, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Discussion of Rule Amendments Being Adopted 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Each amendment the Commission is adopting today is identified below. The substantive revisions are described in
detail. Minor, self-explanatory changes are merely noted. Comments about a proposed amendment are discussed with
that amendment. If none of the comments addressed a proposed amendment, the Commission adopts the amendment without
discussion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00113 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Section 500.2&blank;Terms Defined 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission is making both significant and minor technical changes to this section. The Commission amends subsection
(a) to include a reference to the 1992 statute amending FPLA and subsection (c) to reflect that the Administrator of
the Environmental Protection Agency rather than the Secretary of Agriculture enforces the Federal Insecticide,
Fungicide and Rodenticide Act. Subsection (d) deletes references to repealed statutes. In addition, throughout
these proposed amendments, a few non-substantive, technical changes have been made. In subsection (h), as in other
proposed amendments, the metric equivalent for an existing inch/pound reference is added. The use of both systems
in the regulations is called for by the FPLA and is consistent with the requirements of the Omnibus Trade and Competitiveness
Act of 1988 (Public Law 100, 15 U.S.C. 205b). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subsection (j) is new and defines the term ``SI metric,'' a term used throughout the proposed amendments to the regulations.
The definition is derived from official Federal Government publications relating to metric terminology.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
11
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The definition makes reference to the statutory authority granted to the Secretary of Commerce to interpret and modify
the International System of Units (SI) for the United States. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
``Preferred Metric Units for General Use by the Federal Government,'' Federal Standard 376B, General Services Administration,
January 27, 1993; ``Guide for the Use of the International System of Units,'' NIST Special Publication 811, U.S. Department
of Commerce, September, 1991; and ``The International System of Units (SI),'' NIST Special Publication 330, U.S.
Department of Commerce, August 1991. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Two comments addressed the use of the term ``SI metric'' in the regulations. NIST wrote that it is confusing and redundant:
a) to use the term ``SI metric'' system because it implies that there are metric systems other than the International
System of Units (SI), and b) to use ``SI metric'' to modify a metric unit name.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (An example of the latter would be the reference to ``SI metric kilograms'' in &sect;500.8(d) of the new rules). NIST
recommended using either ``SI'' or ``metric.'' NCWM recommended that ``you consider eliminating use of the terms
`SI metric' in association with the metric units *&blank;*&blank;* because the terms stand by themselves as metric
units.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NIST, 12, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NCWM, 19, 4. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission has decided not to accept these suggestions. The substantive 1992 amendments to section 4 of the FPLA
repeatedly make reference to ``the SI metric system,'' and the Commission in its amendments is merely adopting the
statutory language. While the comments offer other acceptable means of expressing metric terms, the Commission
believes its amendments must be consistent with the statutory language. The rules do not require that labels use the
term ``SI metric'' or any other name for the measurement system. The rules only require the disclosure of the contents
using the units of the SI metric system and the customary inch/pound system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subsection (k) is new and defines the term ``customary inch/pound,'' which is used in the 1992 metric amendments to
section 4(a)(2) of FPLA (15 U.S.C. 1453) and throughout the proposed amendments to the regulations. One comment addressed
this matter. NIST wrote: ``the term `customary inch/pound' should not be used as a compound adjective (e.g., customary
inch/pound system or customary inch/pound statement). Both terms are independent descriptors for the collection
of measurement units we currently use in the United States and their use together is confusing.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The Commission has decided not to accept this suggestion. Congress in amending the FPLA in 1992 used the term ``the
customary inch/pound system of measure.'' The Commission intends to be consistent with the statutory terminology.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
14
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NIST, 12, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subsection (l) is new and defines the term ```e' mark.'' This is a certification mark used in the European Community
(EC) to establish that the package is appropriately filled in accordance with EC standards. The term is defined because
the amendments to section 500.6 (Net Quantity of Contents) allow the term to be used in addition to the mandated content
quantity disclosure. Failure to allow the use of the mark could be an impediment to American companies selling in the
EC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00114 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Section 500.6&blank;Net Quantity of Contents Declaration, Location 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This section relates to the technical requirements to be followed in the presentation of the declaration of contents.
There are several amendments to subsection (b). First, the words ``or mass'' are added after the word ``weight.''
This addition is made necessary by the metric amendments to section 4(a)(2) of the FPLA, which state that the quantity
of contents shall be ``in terms of weight or mass, measure or numerical count.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The same addition is made in each of the regulations that refer to weight so that they uniformly read ``weight or mass.''

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
15
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 The emphasized words were added by the 1992 amendments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
An example of an improper metric qualifier, i.e., ``giant liter,'' has been added to the existing examples of improper
inch/pound qualifiers. This example should aid in the preparation of labels. Further, the amendment includes a parenthetical
metric size descriptor in addition to the existing inch/pound size reference. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The amendment to this section allows the use of the ``e'' mark as part of the statement of the net quantity of contents.
Without the change, the ``e'' mark could be considered an improper qualifier and its use violative of the regulations.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission received two comments relating to the use of the ``e'' mark. The Michigan State Department of Agriculture
commented that the use of the ``e'' mark as part of the statement of quantity of contents is appropriate.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 NCWM commented on the placement of the ``e'' mark.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
17
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The amendment proposed by the Commission reads: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
16
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Mich Ag, 6, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
17
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NCWM, 19, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
When used, the ``e'' mark shall be at least 3 millimeters 
<!-- PJG 0012 frnewline -->
(0.118 inches) in height and shall appear immediately 
<!-- PJG 0012 frnewline -->
after the metric portion of the net quantity of 
<!-- PJG 0012 frnewline -->
contents statement.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NCWM suggests the following alternative:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
When used, the ``e'' mark shall be at least 3 millimeters 
<!-- PJG 0012 frnewline -->
in height and shall be placed in the same field of 
<!-- PJG 0012 frnewline -->
vision as the quantity of contents statement. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
NCWM states that the reason for its suggested change is consistency with the law in the European Community and to avoid
having the FTC impose specific placement requirements on the ``e'' mark. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission agrees that the Commission rules should be flexible enough to allow companies to meet both the Commission
requirements and other reasonable variations, and that specific placement requirements prevent flexibility.
However, the Commission is not persuaded that use of the phrase ``in the same field of vision'' is appropriate. While
this terminology may be a term of art in the European Community, it is doubtful that many American companies, especially
small businesses, would understand its meaning. Accordingly, the amendments refrain from using the phrase ``in
the same field of vision'' and avoid requiring a precise placement of the ``e'' mark, although they permit the use of
the ``e'' mark as part of the statement of the net quantity of contents. The Commission has amended the subject sentence
in Subsection (b) to read: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
When used, the ``e'' mark shall be at least 3 millimeters 
<!-- PJG 0012 frnewline -->
(approx. 1/8 inch) in height.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
18
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NIST commented that the use of an inch declaration to three decimal places (the .118 inches used in the proposed amendment)
was ``superfluous.'' NIST, 12, 3. The Commission adopts NIST's suggestion to use ``approx. 1/8 in.'' in the sentence.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Section 500.7&blank;Net Quantity of Contents, Method of Expression 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The only change to this section is the addition of ``or mass'' each time the term ``weight'' is used. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Section 500.8&blank;Units of Weight or Mass and Measure 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This section specifies the measurement units which must be used in making the content disclosure statements. The
amendments to this section implement the 1992 metric amendments to FPLA by specifying the SI metric units which must
be used in dual declaration statements. Neither the amendments to the FPLA nor the Commission's regulations require
that the measurement systems be used in a particular order.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
19
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thus, manufacturers have discretion to put SI metric units first or customary inch/pound units first as they so choose.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
19
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Section 4(a)(2) of the 1992 amendments to the FPLA states that the quantity of contents shall be stated using units
``*&blank;*&blank;* of both the customary inch/pound system *&blank;*&blank;* and *&blank;*&blank;* the SI metric
system.'' While the inch/pound system precedes the term SI metric in this phrase, there is little reason to infer a
Congressional intent that this also be the order in which quantities are disclosed. The amended rules therefore leave
this choice to manufacturers and distributors. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00115 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The examples of disclosures set out in this section and others are intended to assist manufacturers and distributors
in designing labels which comply with the amendments to the regulations. The examples are not mandatory and set out
different options. For instance, in the only reference to fractions of measurement units, the amendments to the FPLA
state that decimal fractions of pounds and metric mass units may be ``carried out to not more than three decimal places.''
(15 U.S.C. 1453) This is a change from the original FPLA, which restricted decimal fractions to two places. The examples
in the Commission's amended regulations use different decimal places to show that the manufacturer or distributor
can choose which to use. As another instance of options presented to manufacturers or distributors, some of the examples
used in the amended regulations state the SI metric measurement first while others put customary inch/pound units
first. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The high degree of precision used in the examples contained in the proposed amendments generated thirteen comments.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 But for one,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
21
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the comments uniformly stated that the examples use too precise measurements for commercial purposes. The comments
suggest that in most instances three digits, including both whole number and decimals, should be used while in certain
situations two digits should be allowed. As a result of the comments, the Commission has changed the examples throughout
the regulations to use three and two digits as suggested and has added an amendment to &sect;500.19 (see part III.O.
below) embodying such usage.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
22
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
20
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Buch, 11, 1; Md Ag, 15, 1; Mech, 7, 2; Mich Ag, 6, 2; Micr, 4, 2; Cong. Myers, 17, 3; NCWM, 19, 2; NIST, 12, 1; Pier, 2, 1; Soko,
8, 1; Stem, 13, 2; SMPS, 16, 1; and Woel, 3, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
21
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Micro Motion, Inc. (Micr, 4, 2) objected to the imposition of a maximum number of digits that could be used. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
22
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Thus, &sect;500.19(b) states ``(Examples: `1 lb (453 g)' not `1 lb (453.592 g)' or `Net Wt. 2 oz (56 g)' or `Net Wt. 2 oz
(56.6 g)' not `Net Wt. 2 oz (56.69 g)'.)'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The only description of measurement precision in the 1992 amendments to the FPLA is in section 4(a)(3)(A), which states
that for certain packages decimal fractions may be carried out to no more than three places. Based upon this statutory
language, the illustrative examples used in the proposed amendments contained up to three decimal places. Sometimes
this resulted in examples using as many as six total digits, including whole numbers and decimal places. The comments
generally stated that such precision implies a greater measuring accuracy than is likely to be possible.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
23
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The comment from Mr. John Buchanan is illustrative: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
23
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See, NIST, 12, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
I suggest that the regulatory requirement for net quantity be limited to three significant digits, which would still
be consistent with the FPLA specification but would lead to less cluttered labels, greater truth in labeling by removing
the spurious accuracy, and a more rapid conception of the metric system by consumers. *&blank;*&blank;* Conversions
such as 1 lb. (453.59 g) look very intimidating to the average citizen. Some of the implied accuracies are bordering
on the ludicrous, for example, in 500.27 you are suggesting that the linear dimensions of facial tissue can be measured
to one-hundredth of a millimetre, which is less than the diameter of a single fiber! Or, in 500.16, where the capacity
of a 6 fl. oz. cup is expressed to an accuracy of one-hundredth of a millilitre_far less than one drop.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=5 f=1 -->
24
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
24
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Buch, 11, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based upon its consideration of the comments, the Commission has changed the examples used in the final amendments.
The changes require the use of three digits for the quantity declaration (e.g., ``453g (1 lb)'' (&sect;500.9(a))
except where the quantity is below 100 grams, milliliters, centimeters, square centimeters or cubic centimeters
where the quantity declaration can be shown in two figures (e.g. ``17 in.&times;4 in.&times;20 in. (43&times;10&times;50
cm)'' (500.16(a)(1)(ii)). These changes bring the amended regulations into conformity with the Uniform Packaging
and Labeling Regulation adopted by the National Conference on Weights and Measures and the packaging and labeling
regulations of the Canadian Legal Metrology Branch.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
25
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
25
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
NCWM, 19, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Aside from the above changes, subsection (a) requires the use of grams, milligrams, and kilograms as well as pounds
and ounces in weight or mass declarations. Examples of dual declarations are included. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subsection (b) requires the use of liters and milliliters as well as gallons, quarts, and pints in fluid measure disclosure.
The term ``Celsius'' replaces ``Centigrade'' because Centigrade is obsolete for temperature measurement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00116 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subsection (c) states that meters, centimeters, and millimeters must be used as well as inches in linear measure.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subsection (d) requires that area measurement use square meters, square decimeters, square centimeters, and square
millimeters as well as square yards, square feet, and square inches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subsection (e) states that dry measure statements shall use liters and milliliters as well as bushels, pecks, dry
quarts, and pints. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subsection (f) requires, in cubic measure disclosures, the use of cubic meters, cubic centimeters, and, cubic centimeters
as well as cubic yards, cubic feet, and cubic inches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. Section 500.9&blank;Units of Weight and Mass, How Expressed 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission amends this section to include the requirement for the use of mass as well as weight and continues to
describe the appropriate customary inch/pound units to be used on packages of various weights. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Subsection (a) includes the ``net mass'' disclosure and has several metric examples added. The amended subsection
allows the term ``net mass'' as an alternative to ``net weight'' in stating the net quantity of contents. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The comments state that the requirement to use the terms ``net weight'' or ``net mass'' is unnecessary and ``*&blank;*&blank;*
creates clutter on a label that is much better left with free space.*&blank;*&blank;*''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
26
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Declaring contents without ``net weight'' or ``net mass'' is ``already the successful practice in Canada'' and has
been adopted by the National Conference on Weights and Measures.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
27
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Further, the proposed Food and Drug Administration regulations for metric labeling of food products under the FPLA
also make the use of ``net weight'' or ``net mass'' optional. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
26
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Mich Ag, 6, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
27
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Mech, 7, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based upon the reasoning contained in the ten comments on this issue,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
28
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the Commission has determined to make optional the use of the terms ``net weight'' and ``net mass.'' Thus, under the
amendment, a manufacturer or distributor need only state the weight or mass of the contents without using the qualifying
terms ``net weight'' or ``net mass'' (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 ``453g (1 lb).'' However, the amendment to subsection (a) makes it clear that even where the terms are not used, the
quantity of contents declaration shall always declare the net quantity of contents.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
29
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
28
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Am, 14, 1; Bord, 9, 1; Md Ag, 5, 1; Mech, 7, 1; Mich Ag, 6, 2; Micr, 4, 1; NCWM, 19, 2; Pier, 2, 1; Soko, 8, 1; and Woel, 3, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
29
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Section 500.6(a) also requires that the label on a consumer commodity bear the declaration of the net quantity of contents.
The Commission felt it appropriate to restate the point at &sect;500.9(a) to avoid any confusion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Subsection (b)(2) reflects the amendment to the FPLA which deletes the former avoirdupois (the system of weight based
upon the pound of 16 ounces) requirement that packages weighing one pound or more but less than four pounds disclose
both the total number of ounces and the number of pounds, with any remainder in ounces or common or decimal fractions
of the pound. Thus, under the old law, if a package weighed 3 and one-half pounds it would properly be labeled ``56 oz.
(3 lbs. 8 oz.).'' The new law requires only the expression of pounds and remainder of ounces, so that in the prior example
``3 lbs. 8 oz.'' would be sufficient. For weights greater than 1 pound but less than 4 pounds manufacturers will have
the option to include an additional statement of weight in ounces ``immediately adjacent'' to the required expression
in pounds, as subsection (b)(2) has been amended to allow this discretionary second expression of weight. Subsection
(b)(1) retains the requirement that disclosure be given exclusively in ounces for packages containing less than
one pound. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00117 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Proposed subsection (b)(3) as it appeared in the NPR retained the current requirement that for weights of 4 pounds
or more disclosure be given exclusively in whole pounds, with any remainder in ounces or fractions of the pound. The
Commission received two comments on this issue, each of which argued that the use of ounces be permitted as an optional
additional disclosure on products weighing 4 pounds or more. Procter &amp; Gamble wrote:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
We believe manufacturers should be allowed to voluntarily include net contents in units of ounces or fluid ounces
for products containing more than four pounds or more than one gallon. This provision would again promote fair value
comparisons between the largest 1 or 2 sizes of a consumer product such as laundry detergent with the smaller sizes
of the same brand or alternate brands. Comparison between two sizes such as 50 oz (3 lb 2 oz) and 85 oz (5.31 lb) is accomplished
much more easily by comparing ounces. Comparison between two sizes such as 48 fl oz (1 quart 1 pint) and 144 fl oz (1 gallon
1 pint) similarly is accomplished much more easily by comparing fluid ounces. We see important consumer benefits
and no risks in extending voluntary use of ounces or fluid ounces to larger sizes.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=5 f=1 -->
30
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
30
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 PG, 10, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The National Conference on Weights and Measures similarly urges the Commission to allow the voluntary use of ounces
and fluid ounces to larger size packages. NCWM states: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The (Laws and Regulations) Committee believes that allowing manufacturers to voluntarily include dual-quantity
declarations would (1) reduce the cost of implementing the metric amendments; (2) facilitate value comparison by
consumers; (3) minimize change for some manufacturers; (4) not increase label clutter.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=5 f=1 -->
31
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
31
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NCWM, 19, 4.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission is persuaded that permitting the voluntary use of ounces on packages of four pounds or more is in the
public interest and has so amended subsection b(3). The Commission believes that allowing the use of ounces on large
size packages will facilitate price comparisons without any negative consequences. 
<!-- PJG 0012 frnewline -->
Subsection (c) states that for random packages, i.e., packages with varying weights from a lot of the same commodity,
the decimal fractions of the pound should not be carried out to more than three places. Further, this subsection is
changed to reflect the amendment to FPLA that random packages, unlike other packages, are not required to, but may,
include a metric statement of mass. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00118 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
F. Section 500.10&blank;Units of Fluid Measure, How Expressed 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This section continues to describe how the inch/pound fluid measure statement must be expressed. Under the amended
FPLA, there is no requirement that the disclosure in fluid ounces be made when the amount is greater than a pint. Accordingly,
subsection (b)(2) deletes the prior requirement that both the total number of fluid ounces and the largest whole unit
(quarts, quarts and pints, or pints) plus remainder be used for items of at least 1 pint but less than 1 gallon. For quantities
of at least 1 pint but less than 1 gallon, manufacturers will have the option to include an additional statement of net
quantity in fluid ounces ``immediately adjacent'' to the required expression of largest whole unit, as proposed
subsection (b)(2) allows this discretionary second expression of fluid measure. Subsection (b)(1) retains the
requirement that disclosure be given exclusively in fluid ounces for quantities less than one pint. 
<!-- PJG 0012 frnewline -->
Proposed subsection (b)(3) as it appeared in the NPR retained the requirement for quantities of one gallon or more
that disclosure be given exclusively in largest whole unit, with any remainder in terms of fluid ounces or fractions
of the pint or quart. The Commission received two comments on this subsection arguing in favor of permitting the optional
use of fluid ounces for products above one gallon.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
32
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 For the reasons discussed in part III.E. above, the Commission has determined that it is in the public interest to permit
the voluntary additional disclosure of fluid ounces for products above one gallon. Subsection (b)(3) has been amended
to reflect the Commission's determination. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
32
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
NCWM, 19, 4; and PG, 10, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
G. Section 500.11&blank;Measurement of Commodity Length, How Expressed
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This section describes how to express linear measure in terms of yards, feet, and inches. The amendments reflect the
determination by Congress not to continue to require the disclosure of the total number of inches for items one foot
or more in length. For those items one foot or more in length, disclosure should be made in the largest whole unit with
the remainder in inches or common or decimal fractions of the foot or yard. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
H. Section 500.12&blank;Measurement of Commodities by Length and Width, How Expressed 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This section describes how to express the net quantity for bidimensional commodities which are measured by length
and width, such as roll type goods like foils and tapes. The amendments add metric parentheticals to the inch/pound
statements and examples. 
<!-- PJG 0012 frnewline -->
The Commission amends subsection (a)(1) by deleting the requirement that length and width be expressed in ``linear
inches and fractions thereof.'' This requirement is inconsistent with amendments to subsection 500.8(c), which
provide that ``statements of linear measure shall be in terms of both yards, feet, and inches and SI metric meters,
centimeters, or millimeters.'' Consequently, the Commission amends subsection (a)(1) to read that length and width
are to be expressed ``in linear measure'' and that the ``customary inch/pound statement is to be expressed in inches
and fractions thereof.'' 
<!-- PJG 0012 frnewline -->
Subsection (a)(2) has been made consistent with amended subsection 500.8(d), which provides that ``statements
of measure of area shall be in terms of both square yards, square feet, and square inches and SI metric square meters,
square centimeters, and square millimeters.'' The Commission amends the subsection (a)(2) requirement that disclosure
``be expressed in terms of square inches, followed in parentheses by the length and width in the largest whole unit
(yard or foot),'' to read that net quantity is to ``be expressed in terms of area, followed by length and width'' and
that the ``customary inch/pound statement of area is to be expressed in square inches with length and width expressed
in the largest whole unit (yard or foot).'' 
<!-- PJG 0012 frnewline -->
For the same reasons described above, the Commission modifies two other existing subsections in &sect;500.12. Subsection
(a)(3) is rewritten to reconcile it with amendments to the disclosure provisions of subsection 500.8(d), and subsection
(b) is amended to reconcile it with the linear measure disclosure provisions of subsection 500.8(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
I. Section 500.13&blank;Measurement of Commodities by Area Measure Only, How Expressed 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This section describes how to express the net quantity in the inch/pound system for commodities that are measured
in area only. The amendments add metric parentheticals to the inch/pound statements. The amendments reflect the
determination by Congress not to continue to require the disclosure of square inches for areas one square foot or greater.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
J. Section 500.14&blank;Statements of Cubic Measure and Dry Measure 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment to this section deletes a superfluous reference to dual declarations of net quantity of contents. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
K. Section 500.15&blank;Units of Count, More Than One Ply 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendment to this section includes metric in the example. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00119 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
L. Section 500.16&blank;Measurement of Container Type Commodities, How Expressed 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Formerly &sect;500.15a, the Commission renumbers this section and adds metric parentheticals to the inch/pound
statements and examples. 
<!-- PJG 0012 frnewline -->
Further, subsections 500.16(b)(1) and (b)(2) are brought into conformity with other sections of the amendments
by specifying the customary inch/pound units of liquid and dry measurement which should be used. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
M. Section 500.17&blank;Fractions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Formerly &sect;500.16, the Commission renumbers this section and adds the requirement that SI metric declarations
contain only decimal fractions. This prohibition against using common fractions with metric units is consistent
with staff interpretations dating from 1984 and with proper metric usage. In accordance with the amendments to FPLA,
the amendment to this section states that decimal fractions shall not be carried out to more than three decimal places,
rather than the previous two decimal places. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
N. Section 500.18&blank;SI Metric Prefixes 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This is a new section and presents the metric prefixes to be used on labels. Unlike scientific metric prefix charts
which have prefixes for huge amounts, e.g. ``exa-'' for units with eighteen trailing digits (1,000,000,000,000,000,000)
and for minuscule amounts, e.g. ``atto-'' for units with eighteen preceding digits (.000 000 000 000 000 000 1), the
chart is restricted to prefixes usable in the size range of consumer commodities. The chart contained in the proposed
regulation referred to ``kilo-'', ``hecto-'', ``deca-'', ``deci-'', ``centi-'', and ``milli-''. However, based
on comments received, the Commission is adding the prefix ``micro-'' and its appropriate symbol, the Greek letter
``mu'' (&mu;) and deleting the ``hecto-.'' As stated by one commenter, the micrometer ``*&blank;*&blank;* is used
for thickness of plastic and other material thicknesses *&blank;*&blank;*.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
33
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Since the Commission's FPLA regulations govern products such as garbage bags, foil and other household wrapping
products the Commission has determined that it is appropriate to add the prefix for the SI metric unit used to describe
their thickness. The comments stated that the prefix ``hecto'' was not used on consumer products.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
34
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
33
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Stem, 13, 3. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
34
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NCWN, 19, 5; and NIST, 12, 4. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
O. Section 500.19&blank;Conversion of SI Metric Quantities to Inch/Pound and Inch/Pound Quantities to SI metric
Quantities 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This is a new section. Subsection (a) sets out the 
<!-- PJG 0012 frnewline -->
conversion factors for converting from metric to inch/pound and from inch/pound to metric quantities. The chart
facilitates compliance with the 1992 amendments to the FPLA requiring dual inch/pound and metric disclosure by giving
manufacturers the technical information they need to convert one measurement system to the other. The factors used
in this chart are consistent with those published in the ``Guide for the Use of the International System of Units,''
NIST Special Publication 811, Department of Commerce, September, 1991, and ``Preferred Metric Units For General
Use by the Federal Government,'' Federal Standard 376B, General Services Administration, January 27, 1993. Because
many of the products governed by the Commission's regulations issued under the FPLA are measured in the customary
inch/pound unit ``mil'' (1/1000 of an inch), the Commission has added a factor for converting mils into the SI metric
unit micrometer. 
<!-- PJG 0012 frnewline -->
Subsection (b), relating to the number of digits to be used in making the required content disclosures, was not in the
proposed regulation but has been added as the result of the comments received. As discussed in section III.D. above,
the issue of the degree of precision needed in making the disclosures generated 12 comments
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
35
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 11 of which argued for avoiding unneeded degrees of accuracy. Based on the logic contained in the comments, the Commission
has determined that for most declarations of content the use of three significant digits will suffice to give consumers
adequate information. In certain situations, i.e., where the quantity involved is below 100 grams, milliliters,
centimeters, square centimeters or cubic centimeters, the manufacturer or distributor has the option of using two
digits. The prescribed use of three and two digits is consistent with the Uniform Packaging and Labeling Act adopted
by the National Conference on Weights and Measures and the packaging and labeling regulations of the Canadian Legal
Metrology Branch.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
36
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
35
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 See footnote 20, supra. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
36
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 NCWM, 19, 2. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
P. Section 500.20&blank;Conspicuousness 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Formerly &sect;500.17, the Commission renumbers this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Q. Section 500.21&blank;Type Size in Relationship to the Area of the Principal Display Panel 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Formerly &sect;500.18, the Commission renumbers this section and amends it to add metric parentheticals. Subsection
(g) is new and relates to the size requirements of the ```e' mark.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
37
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
37
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 See the discussion of the ``e'' mark at part III.A. and part III.B. above. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00120 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Four comments raised the issue of letter and print size requirements when the metric symbols, especially the ``mL''
symbol, are used.
<FOOTCITE>38</FOOTCITE>
 The comments express concern that the requirement for lower case type for metric symbols may increase the height requirements
for net content declarations in instances where other provisions in &sect;500.21 impose minimum type sizes on lower
case letters.
<FOOTCITE>39</FOOTCITE>
 As a result, the commenters believe that the size of the area taken up by the net contents declaration would increase.
To alleviate this result, the commenters propose amendments to &sect;500.21. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
38
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Bord, 9, 3; Frst, 15, 1; NCWM, 19, 3; and Stem, 13, 6. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
39
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section 500.21 imposes various requirements regarding type size in relation to the area of the principal display
panel. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
First Brands Corporation suggests that ``*&blank;*&blank;* the minimum height requirement for the `m' in the abbreviation
`mL' for milliliter be no less than one-half of the minimum height standards prescribed in *&blank;*&blank;*'' other
parts of &sect;500.21.
<FOOTCITE>40</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
40
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Firs, 15, 2. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The NCWM offers the following proposal for consideration: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Add a new paragraph to &sect;500.21_(h) When upper and lower case, or all lowercase letters are used in SI (metric)
symbols, it is the uppercase ``L,'' lowercase ``d,'' or their equivalent in the print or type used that shall meet the
minimum height requirement. Other letters and exponents must be presented in the same type style and in proportion
to the type size used. However, no letter shall be less than 1.6mm (1/16 inch) in height.
<FOOTCITE>41</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
41
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
NCWM, 19, 3. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Stempnik suggests that the following sentence be added: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The height of the SI declaration shall be equal or greater than the inch pound declaration height.
<FOOTCITE>42</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
42
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Stem, 13, 6. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Borden suggests that ``when upper and lower case letters are used, it is the upper case letter `o' or its equivalent
that shall meet the minimum height standards.''
<FOOTCITE>43</FOOTCITE>

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
43
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Bord, 9, 3. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based upon the comments, the Commission believes that it is necessary to address the issue of type size changes resulting
from the metric amendments to the FPLA. The Commission adopts the proposal made by the National Conference on Weights
and Measures because it presents a standard which is precise, yet not complex or burdensome for industry to follow.
Establishing minimum height and size requirements for type and print of letters should assure adequate disclosure
to consumers without burdening industry by necessitating an increase in the minimum height for the content declaration.
Therefore, the Commission amends section 500.21 by adding a subpart (h) setting out these requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
R. Section 500.22&blank;Abbreviations 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Formerly &sect;500.19, the Commission renumbers this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
S. Section 500.23&blank;Expression of Net Quantity of Contents in SI Metric Units 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This is a new section. Subsection (a) sets out the ``rule of 1000'' which states that, with exceptions, metric disclosure
should be in units ranging in value from 1 to 1000. Thus, the declaration would be ``750 mL'' rather than ``0.75L.''
The ``rule of 1000'' has been used by industry and FTC staff since 1984 and has the effect of simplifying and unifying
label disclosure. 
<!-- PJG 0012 frnewline -->
Subsection (b) sets out the symbols to be used for SI metric units. These symbols are consistent with those preferred
for government usage.
<FOOTCITE>44</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
44
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
``Guide for the Use of the International System of Units,'' NIST Special Publication 811, U.S. Department of Commerce,
September, 1991; and ``Preferrred Metric Units for General Use by the Federal Government,'' Federal Standards 376B
(Preprint Copy), General Services Administration, January 27, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00121 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Based on the eight comments received,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
45
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 the Commission has added the lowercase ``l'' as an alternative to the uppercase ``L'' as the symbol for the SI metric
liter and milliliter. The comments point out that while the uppercase ``L'' is the preferred symbol, there is no international
agreement on requiring only the uppercase ``L.'' Indeed, international law may require permitting the use of the
lowercase ``l.'' As Mr. John H. Woelflein commented:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
45
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Md Ag, 5, 1; Mech, 7, 2; Mich Ag, 6, 2; Micr, 4, 1; NCWM, 19, 3; Pier, 2, 1; Soko, 8, 2; and Woel, 3, 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
</FOOTNOTE>

<!-- PJG ITAG l=21 g=1 f=1 -->
Because the BIPM SI brochure as well as ISO 1000 give the symbol for liter as ``l,L'', the US is obligated as a Meter Convention
signatory to permit the use of either symbol. Otherwise, imported products which use the lower case ``l'' could be
excluded by Customs authorities. Of course, the capital ``L'' is preferred for USA use.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=5 f=1 -->
46
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
46
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Woel, 3, 2.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
</FOOTNOTE>

<!-- PJG ITAG l=11 g=1 f=1 -->
Further, companies that export products often prefer to use the lowercase ``l'' ``as being more acceptable in some
countries.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
47
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
47
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Soko, 8, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG ITAG l=25 g=1 f=1 -->
Section 500.24&blank;Supplemental Statements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 500.25&blank;Net Quantity, Average Quantity, Permitted Variations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 500.26&blank;Representations of Servings, Uses, Applications 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 500.27&blank;Multiunit Packages 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 500.28&blank;Variety Packages 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 500.29&blank;Combination Packages.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amendments to these six sections renumber them, add metric examples and parentheticals, and make reference to
``mass'' as well as weight where appropriate. In the amendment to &sect;500.26 the reference to the National Bureau
of Standards has been changed to read ``National Institute of Standards and Technology.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Other Statutory and Regulatory Considerations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In promulgating the amendments to the FPLA regulations, the Commission has considered certain statutory and regulatory
requirements. These requirements arise under the National Environmental Policy Act of 1969 (42 U.S.C. 4321); the
Paperwork Reduction Act (44 U.S.C. 3501); the Metric Conversion Act (15 U.S.C. 205b); the Commission's Regulatory
Review Program; and the Regulatory Flexibility Act (5 U.S.C. 603).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
 A. National Environmental Policy Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the Commission's rules (16 CFR subpart I, section 1.81 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) implementing the National Environmental Policy Act of 1969 (42 U.S.C. 4321), no ``major'' rule amendment ``significantly
affecting the quality of the human environment'' will be proposed unless an environmental assessment or impact statement
has been prepared (16 CFR 1.82). For the following reasons, it is not appropriate to have an environmental assessment
or statement for the amendments to regulations issued implementing the metric amendments to FPLA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
First, the amendments do not ``significantly affect the quality of the human environment'' because they do not independently
create significant new duties. Moreover, any environmental consequences that may come from metric measurement
translation and disclosure are not the result of the amendments to the regulations, but instead are consequences
of the amendments to FPLA by Congress. Second, the environmental effects, if any, of the amendments are so uncertain
that any environmental analysis would be based on speculation. (See, 16 CFR 1.83(a).) Third, under section 13 of the
amended FPLA, labels printed prior to February 14, 1994 may continue to be used until the supply is exhausted. Thus,
companies will not have to discard unused labels into the waste stream and, by so doing, cause damage to the environment.
Therefore, the amendments to the FPLA regulations are unlikely to cause any significant impact on the environment.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00122 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Paperwork Reduction Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the Paperwork Reduction Act (44 U.S.C. 3501 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), the Commission, before promulgating a rule that requires the ``collection of information,'' must obtain approval
from the Office of Management and Budget. The amendments only require that certain information be disclosed to consumers.
In 1990, the Supreme Court ruled that the authority of the Office of Management and Budget to approve ``collection
of information'' by Federal agencies does not include authority to review agency rules requiring companies to disclose
information to third parties. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dole 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Steelworkers,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 494 U.S. 26, 35 (1990). Under this case, the metric labeling requirements would not be considered collection of information.
Thus, the Commission need not seek approval from the Office of Management and Budget. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. The Metric Conversion Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 205b of the Metric Conversion Act, as amended by the Omnibus Trade and Competitiveness Act, expresses Congressional
policy regarding measurement systems. This Act states that the metric measurement system is the preferred system
of weights and measures in the United States. It also requires federal agencies to use the metric system of measurement
in all procurement, grants, and other business-related activities (which include rulemakings), except to the extent
that such use is impractical or is likely to cause significant inefficiencies or loss of markets to United States firms.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The amendments adopted today by the Commission fully comply with the requirements of the Metric Conversion Act. Each
of the amended regulations providing for quantity disclosure requires a statement of net quantity of contents in
metric units as well as in customary inch/pound units. The amendments add metric examples and parenthetical metric
equivalents to the existing regulations. Further, the amendments explicitly present conversion factors from inch/pound
to metric and vice versa and fully describe metric units and prefixes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. The Commission's Regulatory Review Program 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As part of the Commission's ten-year regulatory-review plan for existing rules and guides, the Commission specifically
sought comments in the NPR on the costs and benefits of the existing and amended regulations under the FPLA and their
regulatory and economic impact. There were two comments that related to the economic impact on small business of the
metric amendments.
<FOOTCITE>48</FOOTCITE>
 There were no comments relating to the economic impact of the regulations on larger businesses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
48
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Cram, 18, 1; and Cong. Meyers, 17, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00123 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Cramer Products stated a concern not with the intent or scope of the regulations, but with the proposed timetable for
compliance. Cramer contends that there would be an average cost of $200 to change the labels for each of the 500 products
it sells for a total of $100,000.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
49
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To alleviate these costs, Cramer proposes changing the effective date from February 14, 1994 to February 14, 1996.
This extension of time would ``allow companies like Cramer to more gradually phase-in the changes, spreading the
cost and personnel requirements over the next 2 years.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
49
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Cramer does not explain the basis for its cost estimates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
50
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Cram, 18, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Congresswoman Meyers, while not supplying any compliance cost data, also stated a concern that small businesses
be given adequate time within which to come into compliance. While acknowledging that the amendments to the FPLA allow
any supply of labels printed before February 14, 1994 to be used until exhausted, she states ``the fact remains that
most small businesses don't have the resources to stockpile labels like big enterprises do.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
51
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
51
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Cong. Meyers, 17, 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A decision by the Commission to adopt a later effective date for its rules would not grant significant relief to small
businesses. By terms of the FPLA statute, all businesses must conform to the new dual disclosure requirements therein
by February 14, 1994, whatever the effective date of the Commission's implementing rules. Thus, businesses would
have to incur the cost of label changes in any event once their existing supply runs out. 
<!-- PJG 0012 frnewline -->
The Commission shares the commenters' concern that there be no undue hardship on businesses that are required to make
the transition to the dual disclosures specified in these rules. However, the comments do not provide factual data
quantifying such costs sufficient for the Commission to conclude that there is a significant economic impact on small
businesses as a class.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
52
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
52
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
However, in an effort ``to allow ample time for industry to become aware of the metric labeling requirements, and to
reduce the burden on industry and thus the cost of updating package labels,'' the Commission has determined not to
take law enforcement actions against non-complying companies until November 8, 1994. See Part V., Enforcement Policy.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Furthermore, while section 5(b) of the FPLA permits the Commission to grant exemptions from statutory requirements
where it is demonstrated that compliance with the new requirements of section 4 is impracticable or not necessary
for adequate protection of consumers, such exemptions are intended to be granted only in exceptional circumstances.
(138 Congressional Record H5345 (daily ed. June 29, 1992).) The rulemaking record in this matter does not allow the
Commission to conclude that exceptional circumstances exist for small firms that would make compliance with the
requirements of the amendments adopted today impracticable or unnecessary adequately to protect consumers. 
<!-- PJG 0012 frnewline -->
As discussed in Part II above, the amended regulations issued today as well as the unamended regulations which continue
in effect are mandated by the FPLA. While there are costs associated with compliance, the Commission has designed
the regulations to minimize the economic burden on businesses, both large and small.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
53
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
53
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For instance, the regulations contain numerous examples of disclosures intended to assist manufacturers and distributors
in designing labels. (See Part III.D., above.) Further, the regulations set out the measurement terms which should
be used in making the quantity disclosures and contain a table which demonstrates how to convert from customary inch/pound
units to SI metric units and vice versa. (See, Part III.M. and N.) Additionally, to reduce compliance costs, to reduce
label clutter and to assist consumer understanding, the Commission in the amendments adopted today has reduced the
degree of precision needed in making the SI metric content disclosure to three significant digits in most cases and
two digits in others. (See Part III.N.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. Regulatory Flexibility Act 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This Statement of Basis and Purpose contains a final regulatory flexibility analysis under the Regulatory Flexibility
Act, 5 U.S.C. 603&hyph;604. A final regulatory flexibility analysis must be conducted unless the head of the agency
``certifies that the rule will not, if promulgated, have a significant economic impact on a substantial number of
small entities.'' (5 U.S.C. 605(b).) Based upon information in the public record, the Commission believes that it
is unlikely that the amendments being adopted today will have a significant economic impact on a substantial number
of small firms. However, given the existing uncertainty on this question, the Commission has decided to publish this
final regulatory analysis. 
<!-- PJG 0012 frnewline -->
The Commission complied with the requirements of section 603 of the Regulatory Flexibility Act by including in the
Notice of Proposed Rulemaking (58 FR 43726, August 17, 1993) certain information for the initial regulatory flexibility
analysis. Specifically, the Commission explained that the reasons for the amendments and their objective are to
implement the explicit directives of Congress in the FPLA. Similarly, the Commission stated that the legal basis
is provided by the FPLA. (5 U.S.C. 603(b)(1)-(2).) Further, the Commission explained that there are no recordkeeping
or reporting requirements in the amendments, and that the compliance requirements are essentially measurement
and labeling tasks described. (5 U.S.C. 603(b)(4).) The Commission stated that there also are no relevant Federal
rules which may duplicate, overlap, or conflict with the proposed rules, inasmuch as the Commission, the FDA, and
other agencies with authority to implement the FPLA are given exclusive jurisdiction over various classes of consumer
commodities. (5 U.S.C. 603(b)(5).) The Commission specifically requested comments on whether the amendments may
have a significant impact on small business. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00124 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission received one comment specifically responding to the request for information on the Regulatory Flexibility
Act
<FOOTCITE>54</FOOTCITE>
 and two comments that otherwise included certain economic material relating to small business costs of compliance.
<FOOTCITE>55</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
54
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Stem, 13, 3. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
55
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Cram, 18, 1; and Cong. Meyers. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Stempnik responded to the regulatory flexibility questions by stating: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Exclusions should be only what is required by the revised FPLA and no more. *&blank;*&blank;* I do not support exemptions
because labels are changed frequently for marketing reasons and companies can stockpile unlimited quantities of
old labels before the deadline and continue to use them until they are used up.
<FOOTCITE>56</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
56
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Stem, 13, 3. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Cramer Products commented, without substantiating information, that there would be an average cost per product
of $200 to change its labels to bring them into compliance, and Congresswoman Meyers was concerned that the deadline
for compliance of February 14, 1994 would cause harm to small business.
<FOOTCITE>57</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
57
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
These comments are discussed in connection with Part IV.D. The Commission's Regulatory Review Program, above. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The amended regulations that the Commission adopts today cover every company in the economy that produces consumer
commodities other than those commodities falling within the authority of other agencies or otherwise exempted from
the statute's coverage. Based on the information now available on the public record, it is not feasible for the Commission
to estimate the number of entities within this class of industry that also are small companies within the meaning of
the Regulatory Flexibility Act. (5 U.S.C. 601(3).) Nevertheless, the information in hand suggests that the overall
economic impact of the metric amendments to the regulations issued under FPLA may not be significant. In essence,
all the amendments require is that companies make simple mathematical conversions from the inch/pound measurement
system into the metric measurement system and include the metric equivalents on already mandated label disclosure
of contents of consumer commodities.
<FOOTCITE>58</FOOTCITE>
 The FPLA states that non-complying labels printed prior to February 14, 1994 may continue to be used until the supply
is exhausted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
58
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Further, whatever economic impact on small business, if any, that may come from metric measurement translation and
disclosure is not the result of the proposed amendments to the regulations but is the consequence of the amendments
to FPLA by Congress. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00125 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Similarly, the direct costs imposed on consumers as a result of the amendments appear to be minimal since consumers
will still obtain disclosures in the customary inch/pound system. There are, however, likely to be some indirect
costs associated with the amendments as firms incur costs associated with complying with the amendments. There are
basically three types of costs that firms incur as a result of labeling regulations. These costs are inventory disposal
costs, administrative costs, and printing costs. Inventory disposal costs consist of the value of inventory that
must be disposed of in order to comply with the proposed regulation. These costs will be zero since the amendments do
not apply to labels that were printed before the effective date of the regulation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Administrative costs represent the additional costs incurred at an administrative level in order to comply with
the regulation. Administrative costs include determining which products fall within the scope of the regulation;
establishing a corporate position on the policy; devising a compliance strategy; and overseeing the compliance
strategy. These costs are likely to be relatively low for the proposed change to the FPLA. Most products that are already
covered by the FPLA will be subject to the amendments adopted today and the amendments appear to clearly state what
products would be excluded. In addition, firms would not need to undertake potentially costly analytic or market
testing to comply with the changes. Thus, it appears that administrative costs per firm would be low. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Printing costs consist of the additional printing costs incurred due to the changes in the regulations adopted today.
These costs will vary among firms depending on various factors including, but not necessarily limited to the following:
(1) How frequently the firm typically changes its label; (2) the average inventory of labels; and (3) the printing
process utilized by the firm. For example, if the firm updates its labels on a yearly basis, it may delay its normal label
update to coincide with changes it will have to make in response to the changes in the FPLA. If so, the additional printing
costs caused by the change would be minimal. If, however, the firm normally updates its labels only once every ten years
and if it has recently updated its labels, then its costs will be higher. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Incremental printing costs will also depend, to some extent, on the average inventory. The greater the time period
between reordering labels, the more likely it is that the label change due to the regulation can be planned to coincide
with a planned label change, all else being equal. The type of printing process utilized by the firm also affects the
incremental printing costs. While firms may be able to simply engrave the new information on existing plates if flexography
or lithography printing methods are used and space permits, new cylinders would be required if gravure printing is
utilized. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Given the relative simplicity of the label change required by the proposed amendment, the fact that many firms already
disclose information in metric, and the fact that many firms are likely to have been aware since late 1992 that the amendments
were scheduled to take effect on February 14, 1994, printing costs per firm associated with the amendments are likely
to be low. Thus, the amendments adopted today, may not have a significant impact on a substantial number of small entities.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
59
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
59
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The FDA, based on studies it conducted to determine the economic impact of its nutritional labeling rules, stated
that the metric amendments to its food labeling rules ``*&blank;*&blank;* may have a significant economic impact
on small businesses *&blank;*&blank;*'' in the food industry (58 FR 29719, May 21, 1993). The FTC does not have equivalent
economic information on the myriad industries covered by the FTC regulations issued under the FPLA, although it sought
such economic information in the NPR. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 604 of the Regulatory Flexibility Act sets out three subjects which must be addressed in the final regulatory
flexibility analysis. Section 605 of the Act (Avoidance of duplicative or unnecessary analysis) states that the
analysis required by section 604 may be done in conjunction with other analysis. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A succinct statement of the need for and the objectives of the rule are set out in Part II above. (5 U.S.C. 604(a)(1).)
A summary of the issues raised by the public comment in response to the initial regulatory flexibility analysis and
the Commission's assessment thereof are discussed above in this section and in Part IV.D., regarding the Commission's
Regulatory Review Program. (5 U.S.C. 604(a)(2).) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
There are no significant alternatives to the amended regulations adopted today which will accomplish the stated
objectives of the applicable statutes and which minimize any significant economic impact on small entities. (5 U.S.C.
604(a)(3).) For example, it would be difficult to devise different or simplified labeling requirements for small
entities that would still implement dual disclosure requirements and yet avoid the principal cost to such businesses,

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
i.e.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, redesigning labels. For the same reason, the use of general performance standards rather than explicit requirements
likely would not result in substantial cost savings. Moreover, the FPLA is quite specific in directing the use of particular
modes of disclosure in most instances. Further, as discussed in Part III.D. regarding the Commission's Regulatory
Review Program, the amendments adopted today have been designed to minimize the economic impact on small business.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00126 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In addition, the Commission has taken further action to reduce any costs of transition for firms which may have been
unaware of the pending metric disclosure requirements of the amended FPLA. As discussed in section V. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
infra, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
the Commission, in order to harmonize with state enforcement policy adopted by NCWM, has stated it will avoid taking
law enforcement action under the new metric amendments to the FPLA rules until November 8, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Enforcement Policy Statement 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The effective date of these regulations is February 14, 1994. In crafting the FPLA statute, Congress acknowledged
the need for businesses to have time within which to learn about the existence of the requirements to use metric measurement
and to come into compliance. Section 13 of the FPLA states that the metric amendments ``shall have no effect on the sale
or distribution of products whose labels have been printed before'' February 14, 1994. (15 U.S.C. 1451(13).) 
<!-- PJG 0012 frnewline -->
The Commission expects that the states, as in the past, will adopt uniform state laws that mirror the Commission's
new FPLA metric requirements. The National Conference on Weights and Measures,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
60
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 which represents state enforcers of such laws, already has adopted an enforcement policy designed to avoid undue
hardship to those firms who may have been unaware of the pending metric requirements. In its ``Resolution on Enforcement
of SI Metric Labeling Requirements,'' NCWM has stated that it is advisable ``to allow ample time for industry to become
aware of the metric labeling requirements, and to reduce the burden on industry and thus reduce the cost of updating
of package labels.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
61
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To achieve these goals, the National Conference has resolved to enforce its metric labeling requirements until November
8, 1994 by sending to non-complying businesses letters which state ``not only the area of noncompliance, but also
the correct way to be in compliance.''
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
62
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
60
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The National Conference on Weights and Measures is a voluntary standards-writing body whose members are State and
local weights and measures officials and which has Federal Government, business, industry and consumer representatives.
NCWM, 19, 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
61
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Id. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
at 6. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
62
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Id. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Commission law enforcement actions during this period against non-complying firms could undercut the objectives
stated in the NCWM resolution. While states enforce independent laws, these laws for the most part mirror the Commission's
FPLA rules. Thus, fear of enforcement by the Commission of the federal version of the new state metric requirements
could lead some firms immediately to incur costs of re-labeling, despite assurances of no state law enforcement actions.
In the interest of promoting harmonization with state enforcement, the Commission therefore has determined to avoid
taking law enforcement actions against companies not in compliance with the metric amendments to the final FPLA regulations
until November 8, 1994.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
63
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
63
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Further, the delay of enforcement gives companies time to learn about these amendments without subjecting them to
the burden of litigation. All other aspects of the Commission's regulations issued under the FPLA will not be affected
by the postponement of enforcement of the SI metric amendments. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00127 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 16 CFR Part 500
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Fair Packaging and Labeling Act, Labeling, Packaging and containers, Trade practices. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For the reasons set out in the preamble, Title 16 of the Code of Federal Regulations is amended by revising part 500 to
read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PART 500_REGULATIONS UNDER SECTION 4 OF THE FAIR PACKAGING AND LABELING ACT 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=70 g=1 f=1 -->
Sec. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
500.1&blank;Scope of the regulations of this part. 
<!-- PJG 0012 frnewline -->
500.2&blank;Terms defined. 
<!-- PJG 0012 frnewline -->
500.3&blank;Prohibited acts, coverage, general labeling requirements, exemption procedures. 
<!-- PJG 0012 frnewline -->
500.4&blank;Statement of identity. 
<!-- PJG 0012 frnewline -->
500.5&blank;Name and place of business of manufacturer, packer or distributor. 
<!-- PJG 0012 frnewline -->
500.6&blank;Net quantity of contents declaration, location. 
<!-- PJG 0012 frnewline -->
500.7&blank;Net quantity of contents, method of expression. 
<!-- PJG 0012 frnewline -->
500.8&blank;Units of weight or mass and measure. 
<!-- PJG 0012 frnewline -->
500.9&blank;Units of weight or mass, how expressed. 
<!-- PJG 0012 frnewline -->
500.10&blank;Units of fluid measure, how expressed. 
<!-- PJG 0012 frnewline -->
500.11&blank;Measurement of commodity length, how expressed. 
<!-- PJG 0012 frnewline -->
500.12&blank;Measurement of commodities by length and width, how expressed. 500.13&blank;Measurement of commodities
by area measure only, how expressed. 
<!-- PJG 0012 frnewline -->
500.14&blank;Statements of cubic measure and dry measure. 
<!-- PJG 0012 frnewline -->
500.15&blank;Units of count, more than one ply. 
<!-- PJG 0012 frnewline -->
500.16&blank;Measurement of container type commodities, how expressed. 
<!-- PJG 0012 frnewline -->
500.17&blank;Fractions. 
<!-- PJG 0012 frnewline -->
500.18&blank;SI metric prefixes. 
<!-- PJG 0012 frnewline -->
500.19&blank;Conversion of SI metric quantities to inch/pound quantities and inch/pound quantities to SI metric
quantities. 
<!-- PJG 0012 frnewline -->
500.20&blank;Conspicuousness. 
<!-- PJG 0012 frnewline -->
500.21&blank;Type size in relationship to the area of the principal display panel.
<!-- PJG 0012 frnewline -->
500.22&blank;Abbreviations. 
<!-- PJG 0012 frnewline -->
500.23&blank;Expression of net quantity of contents in SI Metric units. 
<!-- PJG 0012 frnewline -->
500.24&blank;Supplemental statements. 
<!-- PJG 0012 frnewline -->
500.25&blank;Net quantity, average quantity, permitted variations. 
<!-- PJG 0012 frnewline -->
500.26&blank;Representations of servings, uses, applications. 
<!-- PJG 0012 frnewline -->
500.27&blank;Multiunit packages.
<!-- PJG 0012 frnewline -->
500.28&blank;Variety packages.
<!-- PJG 0012 frnewline -->
500.29&blank;Combination packages.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 15 U.S.C. 1453, 1454, 1455.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00128 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Scope of the regulations of this part. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The regulations in this part establish requirements for labeling of consumer commodities as hereinafter defined
with respect to identity of the commodity; the name and place of business of the manufacturer, packer, or distributor;
the net quantity of contents; and net quantity of servings, uses, or applications represented to be present. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.2 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Terms defined. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As used in this part, unless the context otherwise specifically requires: 
<!-- PJG 0012 frnewline -->
(a) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Act 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means the ``Fair Packaging and Labeling Act'' (Pub. L. 89&hyph;755, approved Nov. 3, 1966; 80 Stat. 1296 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
; 15 U.S.C. 1451 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
., as amended by Public Law 102&hyph;329, August 3, 1992). 
<!-- PJG 0012 frnewline -->
(b) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
regulation 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
or 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
regulations 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means regulations promulgated by the Commission pursuant to sections 4, 5, and 6 of the Act (15 U.S.C. 1453, 1454, 1455).

<!-- PJG 0012 frnewline -->
(c) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
consumer commodity 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
or 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
commodity 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means any article, product, or commodity of any kind or class which is customarily produced or distributed for sale
through retail sales agencies or instrumentalities for consumption by individuals, or use by individuals for purposes
of personal care or in the performance of services ordinarily rendered within the household, and which usually is
consumed or expended in the course of such consumption or use. For purposes of the regulations in this part the term

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
consumer commodity 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
does not include any food, drug, device or cosmetic as defined by section 201 of the Federal Food, Drug, and Cosmetic
Act (21 U.S.C. 321); any meat or meat product, poultry or poultry product, or tobacco or tobacco product; any commodity
subject to packaging or labeling requirements imposed by the Administrator of the Environmental Protection Agency
pursuant to the Federal Insecticide, Fungicide, and Rodenticide Act (7 U.S.C. 136 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.); any commodity subject to the provisions of the eighth paragraph under the heading ``Bureau of Animal Industry''
of the Virus-Serum-Toxin Act (21 U.S.C. 151&hyph;157); any beverage subject to or complying with packaging or labeling
requirements imposed under the Federal Alcohol Administration Act (27 U.S.C. 201 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.); any commodity subject to the provisions of the Federal Seed Act (7 U.S.C. 1551&hyph;1610). 
<!-- PJG 0012 frnewline -->
(d) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
package 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means any container or wrapping in which any consumer commodity is enclosed for use in the delivery or display of that
commodity to retail purchasers. For purposes of the regulations in this part the term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
package 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
does not include shipping containers or wrappings used solely for the transportation of any consumer commodity in
bulk or in quantity to manufacturers, packers, or processors, or to wholesale or retail distributors thereof unless
used in retail display; shipping containers or outer wrappings used by retailers to ship or deliver any commodity
to retail customers if such containers and wrappings bear no printed matter pertaining to any particular commodity;
or containers subject to the provisions of the Act of August 3, 1912 (37 Stat. 250, as amended; 15 U.S.C. 231&hyph;233),
the Act of March 4, 1915 (38 Stat. 1186, as amended; 15 U.S.C. 234&hyph;236); or transparent wrappers or containers
which do not bear written, printed, or graphic matter obscuring any part of the label information required by this
part. 
<!-- PJG 0012 frnewline -->
(e) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
label 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means any written, printed, or graphic matter affixed to or appearing upon any consumer commodity or affixed to or
appearing upon a package containing any consumer commodity; except that: 
<!-- PJG 0012 frnewline -->
(1) An inspector's tag or other nonpromotional matter affixed to or appearing upon a consumer commodity shall not
be deemed to be a label requiring the repetition of label information required by this part, and 
<!-- PJG 0012 frnewline -->
(2) For the purposes of the regulations in this part the term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
label 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
does not include written, printed, or graphic matter affixed to or appearing upon commodities, or affixed to or appearing
upon containers or wrappers for commodities sold or distributed to industrial or institutional users. 
<!-- PJG 0012 frnewline -->
(f) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
person 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
includes any firm, corporation or associations. 
<!-- PJG 0012 frnewline -->
(g) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
commerce 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means: 
<!-- PJG 0012 frnewline -->
(1) Commerce between any State, the District of Columbia, the Commonwealth of Puerto Rico, or any territory or 
<!-- PJG 0012 frnewline -->
possession of the United States, and any place outside thereof, and 
<!-- PJG 0012 frnewline -->
(2) Commerce within the District of Columbia or within any territory or possession of the United States, not organized
with a legislature, but shall not include exports to foreign countries. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00129 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(h) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
principal display panel 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means that part of a label that is most likely to be displayed, presented, shown, or examined under normal and customary
conditions of display for retail sale. The principal display panel must be large enough to accommodate all the mandatory
label information required to be placed thereon by this part without obscuring designs, vignettes, or crowding.
This definition does not preclude utilization of alternate principal display panels on a label of a package, but alternate
principal display panels must duplicate the information required to be placed on the principal display panel by this
part. This definition does not preclude utilization of the container closure as the surface bearing the principal
display panel if that label location is the one most likely to be displayed, presented, shown, or examined under normal
and customary conditions of display for retail sale. The principal display panel of a label appearing on a cylindrical
surface is that 40 percent of the circumference which is more likely to be displayed, presented, shown, or examined
under normal and customary conditions of display for retail sale. The principal display panel of a consumer commodity
marketed in a decorative type container, or a container having a capacity of 1/4 ounce (7.4 mL) or less, may be considered
to be a tear-away tag or tape affixed to the container and bearing the mandatory label information as required by this
part, but the type size of the net quantity of contents statement shall be governed by the dimensions of the container
itself. The principal display panel of a consumer commodity marketed on a display card to which the immediate container
of the commodity is affixed may be considered to be the display panel of the card, and the type size of the net quantity
of contents statement is governed by the dimensions of the display card. 
<!-- PJG 0012 frnewline -->
(i) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
random package 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
means a package which is one of a lot, shipment, or delivery of packages of the same consumer commodity with varying
weights, that is, packages with no fixed weight pattern. 
<!-- PJG 0012 frnewline -->
(j) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
SI metric 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
refers to units belonging to the International System of Units (abbreviated ``SI'' from the French, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Le Systeme International d'Unites
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), as interpreted or modified for use in the United States by the Secretary of Commerce. They include the SI units (together
with their multiples and submultiples) as well as other metric units (e.g., the liter) that are accepted for use with
the SI units because of their practical importance. 
<!-- PJG 0012 frnewline -->
(k) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
customary inch/pound 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
refers to units belonging to the system of units used in the United States based on or derived from the ounce, pound,
and ton for weight; the inch, foot, yard, and mile for length; the fluid ounce, pint, quart, and gallon for volume; and
dry pint, dry quart, peck, and bushel for dry measure. 
<!-- PJG 0012 frnewline -->
(l) The term 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
``e'' mark 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
refers to the symbol ``e'' used in connection with the quantity declarations on labels of some consumer commodities
marketed primarily in the European Community (EC). The ``e'' mark constitutes a representation by the packer or importer
that the package to which it is applied has been filled in accordance with the average system of quantity specified
by the EC. The average system is a method of declaring package fill in the EC and other countries of the world, including
the United States. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.3 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Prohibited acts, coverage, general labeling requirements, exemption procedures. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) No person engaged in the packaging or labeling of any consumer commodity for distribution in commerce, and no person
(other than a common carrier for hire, or a freight forwarder for hire) engaged in the distribution in commerce of any
packaged or labeled consumer commodity, shall distribute or cause to be distributed in commerce any such commodity
if such commodity is contained in a package, or if there is affixed to that commodity a label, which does not conform
to the provisions of the Act and of the regulations in this part. 
<!-- PJG 0012 frnewline -->
(b) Persons engaged in business as wholesale or retail distributors of consumer commodities shall be subject to the
Act and the regulations in this part to the extent that such persons are engaged in the packaging or labeling of consumer
commodities, or prescribe or specify by any means the manner in which such consumer commodities are packaged or labeled.

<!-- PJG 0012 frnewline -->
(c) Each packaged or labeled consumer commodity, unless it has been exempted through proceedings under section 5(b)
of the Act (15 U.S.C. 1454(b)), shall, upon being prepared for distribution in commerce or for sale at retail, and before
being distributed in commerce or offered for sale at retail, be labeled in accordance with the requirements of the
Act and the regulations in this part. 
<!-- PJG 0012 frnewline -->
(d) Each packaged or labeled consumer commodity, unless it has been exempted through proceedings under section 5(b)
of the Act, shall bear a label specifying the identity of the commodity; the name and place of business of the manufacturer,
packer, or distributor; the net quantity of contents; and the net quantity per serving, use or application, where
there is a label representation as to the number of servings, uses, or applications obtainable from the commodity.

<!-- PJG 0012 frnewline -->
(e) Regulations will be promulgated by the Commission exempting particular consumer commodities from one or more
of the requirements of section 4 of the Act and the regulations thereunder to the extent and under such conditions as
are consistent with the declared policy of the Act whenever the Commission finds that, because of the nature, form,
or quantity of the particular consumer commodity, or for other good and sufficient reasons, full compliance with
all the requirements otherwise applicable is impracticable or is not necessary for the adequate protection of consumers.
Proceedings for the promulgation of such exempting regulations may be commenced by the Commission upon its own initiative
or pursuant to petition filed with the Secretary by any interested person or group stating reasonable grounds for
the proposed exemption, pursuant to Section 1.15 of this chapter of the Commission's general procedures. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00130 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.4 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Statement of identity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) The principal display panel of a consumer commodity shall bear a specification of the identity of the commodity.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Such specification of identity shall comprise a principal feature of the principal display panel, shall be in
such type size and so positioned as to render it easily read and understood by the consumer, and shall be in lines generally
parallel to the base on which the package or commodity rests as it is designed to be displayed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Such specification of identity shall be in terms of: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The name now or hereafter specified in or required by any applicable Federal law or regulation; or in the absence
thereof, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The common or usual name of the commodity; or in the absence thereof, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The generic name or in other appropriately descriptive terms such as a specification which includes a statement
of function. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) The specification of identity shall not be false, misleading, or deceptive in any respect. Ingredients or components
which are not present in the commodity in a substantial or significantly effective amount may not be mentioned in the
specification of identity; except that a component present in a formulation in substantial and effective amounts,
but not present in the final product due to conversion or transformation into a different entity (which different
entity is present in the final product), may be mentioned in the specification of identity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.5 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Name and place of business of manufacturer, packer or distributor. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) The label of a consumer commodity shall specify conspicuously the name and place of business of the manufacturer,
packer, or distributor. Where the consumer commodity is not manufactured by the person whose name appears on the label,
the name shall be qualified by a phrase that reveals the connection such person has with such commodity; such as ``Manufactured
for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
,'' ``Distributed by 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
,'' or any other wording that expresses the facts. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) The requirement for declaration of the manufacturer, packer, or distributor shall in the case of a corporation
be deemed to be satisfied only by the actual corporate name, which may be preceded or followed by the name of the particular
division of the corporation. In the case of an individual, partnership, or association, the name under which the business
is conducted shall be used. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) The statement of the place of business shall include the street address, city, State, and Zip Code; however, the
street address may be omitted if it is shown in a current city directory or telephone directory.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) If a person manufactures, packs, or distributes a consumer commodity at a place other than his principal place
of business, the label may state the principal place of business in lieu of the actual place where such consumer commodity
was manufactured or packed or is to be distributed, unless such statement would be misleading. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Standard abbreviations may be used in complying with the requirements of this section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.6 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Net quantity of contents declaration, location. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) The label of a consumer commodity shall bear a declaration of the net quantity of contents separately and accurately
stated on the principal display panel. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) The declaration of net quantity shall appear as a distinct item on the principal display panel, shall be separated
(by at least a space equal to the height of the lettering used in the declaration) from other printed label information
appearing above or below the declaration and, shall not include any term qualifying a unit of weight or mass, measure,
or count such as ``jumbo quart,'' ``giant liter,'' ``full gallon,'' ``when packed,'' ``minimum,'' or words of similar
import. The declaration of net quantity shall be separated (by at least a space equal to twice the width of the letter
``N'' of the style of type used in the net quantity statement) from other printed label information appearing to the
left or right of the declaration. However, the ``e'' mark shall not be considered to be a qualifying word or phrase and
may be used as part of the statement of the net quantity of contents where warranted. When used, the ``e'' mark shall
be at least 3 millimeters (approximately 1/8 in) in height. The declaration of net quantity of contents shall be placed
on the principal display panel within the bottom 30 percent of the area of the label panel in lines generally parallel
to the base on which the package or commodity rests as it is designed to be displayed: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) On consumer commodities having a principal display panel of 5 square inches (32.2 cm
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) or less, the requirement for placement within the bottom 30 percent of the area of the label panel shall not apply when
the declaration of net quantity of contents meets the other requirements of this part, and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The requirements as to separation, location, and type size, specified in this part are waived with respect to variety
and combination packages as defined in this part. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.7 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Net quantity of contents, method of expression. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The net quantity of contents shall be expressed in terms of weight or mass, measure, numerical count, or a combination
of numerical count and weight or mass, size, or measure so as to give accurate information regarding the net quantity
of contents thereof, and thereby facilitate value comparisons by consumers. The net quantity of contents statement
shall be in terms of fluid measure if the commodity is liquid, or in terms of weight or mass if the commodity is solid,
semi-solid, or viscous, or a mixture of solid and liquid. If there is a firmly established general consumer usage and
trade custom of declaring the contents of a liquid by weight or mass, or a solid, semi-solid, or viscous product by fluid
measure, numerical count, and/or size, or (as in the case of lawn and plant care products) by cubic measure, it may be
used, when such declaration provides sufficient information to facilitate value comparisons by consumers. The
declaration may appear in more than one line of print or type. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.8 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Units of weight or mass and measure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) Statements of weight or mass shall be in terms of both avoirdupois pound and ounce and SI metric kilograms, grams,
or milligrams. (Examples of avoirdupois/metric declarations: ``Net Wt 15 oz (425 g)'' or ``Net Wt 11/2 lbs (680 g)''
or `` 2.5 oz (70.8 g)''; examples of metric/avoirdupois declarations: ``Net Mass 425 g (15 oz)'' or ``Net Mass 680 g
(11/2 lbs)'' or ``100 g e (3.5 oz).'') 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00131 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) Statements of fluid measure shall be in terms of both the U.S. gallon of 231 cubic inches and quart, pint, and fluid
ounce subdivisions thereof and SI metric liters or milliliters and shall (except in the case of petroleum products,
for which the declaration shall express the volume at 60&blank;
<!-- PJG 0031 degreeslatlong -->
&cir;Fahrenheit (15.6 
<!-- PJG 0040 degreeslatlong -->
&cir;Celsius)) express the volume at 68 
<!-- PJG 0040 degreeslatlong -->
&cir;Fahrenheit (20 
<!-- PJG 0040 degreeslatlong -->
&cir;Celsius). (Examples of gallon/metric declarations: ``Net 12 fl oz (354 mL)'' or ``Net Contents 1 gal (3.78 L)''
or ``8 fl oz (236 mL)''; examples of metric/gallon declarations: ``Net 500 mL (1.05 pt)'' or ``Net Contents 1 L (1.05
qt).'') 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Statements of linear measure shall be in terms of both yards, feet, and inches and SI metric meters, centimeters,
or millimeters. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Statements of measure of area shall be in terms of both square yards, square feet, and square inches and SI metric
square meters, square decimeters, square centimeters, or square millimeters. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Statements of dry measure shall be in terms of both the U.S. bushel of 2,150.42 cubic inches and peck, dry quart,
and dry pint subdivisions thereof and SI metric liters or milliliters. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(f) Statements of cubic measure shall be in terms of both cubic yard, cubic foot, and cubic inch and SI metric cubic meters,
cubic decimeters, or cubic centimeters. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.9 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Units of weight or mass, how expressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) The term ``net weight'' or ``net mass'' may be used in stating the net quantity of contents in terms of weight or mass.
However, where the term ``net weight'' or ``net mass'' is not used, the quantity of contents shall always disclose
the net quantity of contents. For example: ``453 g (1 lb)'' or ``Net Wt 1 lb (453 g)'' or ``Net Mass 453 g (1 lb)''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) With the exception of random packages, the statement of net quantity of contents in terms of avoirdupois weight
shall be expressed as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) If less than 1 pound, in terms of ounces. (Examples: ``Net Weight 12 oz. (340 g)'' or ``Net Mass 340 g (12 oz)''.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) If at least 1 pound but less than 4 pounds, in whole pounds, with any remainder in ounces or common or decimal fractions
of the pound, except that it shall be optional to include an immediately adjacent additional expression of net quantity
in terms of ounces. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Examples:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
 ``Net Wt. 1 lb. 8 oz. (680 g)'' or ``Net Wt. 1.5 lb./24 oz. (680 g)'' or ``24 oz. (11/2 lb.) 680 g''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) If 4 pounds or more, in terms of whole pounds, with any remainder in terms of ounces or common or decimal fractions
of the pound, except that it shall be optional to include an immediately adjacent additional expression of net quantity
in terms of ounces. (Examples: ``Net Weight 5 pounds 4 ounces (2.38 kg)'' or ``Net Mass 2.38 kg (5 lbs 4 oz)'' or ``Net
Wt. 51/4 lbs. (2.38 kg)'' or ``Net Mass 2.38 kg (51/4 lbs.)'' or ``Net Wt. 5.25 lbs. (2.38 kg) or ``Net Mass 2.38 kg (5.25
lbs)''.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) If the net quantity of contents declaration appears on a random package it may, when the net weight exceeds 1 pound,
be expressed in terms of pounds and decimal fractions of the pound carried out to not more than three decimal places.
When the net weight does not exceed 1 pound, the declaration on the random package may be in terms of decimal fractions
of the pound in lieu of ounces. (Examples: ``Net Wt. 0.75 lb.'' and ``Net Weight 1.05 pounds.'') Such decimal declaration
shall be exempt from the type size and placement requirements of section 4(a) of the Act if the accurate statement of
net weight is presented prominently and conspicuously on the principal display panel of the package. The net quantity
of contents declaration on a random package is not required to, but may include a statement in terms of the SI metric
system carried out to not more than 3 decimal places. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00132 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) It is sufficient to distinguish avoirdupois ounce from fluid ounce through association of terms. (Examples:
``Net Wt. 6 oz.'' vs. ``6 fl. oz.'' or ``Net Contents 6 fl. oz.'') 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.10 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Units of fluid measure, how expressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) Use of the terms ``net'' or ``net contents'' is optional. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Declaration of net quantity of contents in terms of fluid measure shall be identified as such in each instance and
the statement of U.S. gallon of 231 cubic inches and quart, pint, and fluid ounce subdivisions thereof shall be expressed
as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) If less than 1 pint, in terms of fluid ounces. (Example: ``Net Contents 8 fl. oz. (236 mL)'' or ``Net Contents 236
mL (8 fl. oz.)''.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) If at least 1 pint but less than 1 gallon, in terms of the largest whole unit (quarts, quarts and pints or pints, as
appropriate), with any remainder in terms of fluid ounces or common or decimal fractions of the pint or quart, except
that it shall be optional to include an immediately adjacent additional expression of net quantity in terms of fluid
ounces. (Examples: ``1 qt. (946 mL)'' or ``Net contents 1 qt. 1 pt. 8 oz./56 fl. oz. (1.65 L)'', but not in terms of quart
and ounce such as ``1 quart 24 ounces (1.65 L)''.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) If 1 gallon or more, in terms of the largest whole unit (gallons followed by common or decimal fractions of a gallon
or by the next smaller whole unit or units viz, quarts and pints) with any remainder in terms of fluid ounces or common
or decimal fractions of the pint or quart, except that it shall be optional to include an immediately adjacent additional
expression of net quantity in terms of fluid ounces. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Examples: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``Net contents 21/2 gal. (9.46 L)'', ``Contents 2.5 gal. (9.46 L)'', or ``Net contents 2 gallons 2 quarts (9.46 L)''
but not as ``2 gallons 4 pints (9.46 L)''.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.11 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Measurement of commodity length, how expressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Declaration of net quantity in terms of yards, feet, and inches shall be expressed as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) If less than 1 foot, in terms of inches and fractions thereof. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) If 1 foot or more, in terms of the largest whole unit (a yard or foot) with any remainder in terms of inches or common
or decimal fractions of the foot or yard, except that it shall be optional to express the length in the preceding manner
followed by a statement of the length in terms of inches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.12 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Measurement of commodities by length and width, how expressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For bidimensional commodities (including roll-type commodities) measured in terms of commodity length and width,
the declaration of net quantity of contents shall be expressed in the following manner: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) The declaration of net quantity for bidimensional commodities having a width of more than 4 inches (10.1 cm) shall:

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) When the commodity has an area of less than 1 square foot (929 cm2) be expressed in terms of length and width in linear
measure. The customary inch/pound statement is to be expressed in inches and fractions thereof. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) When the commodity has an area of 1 square foot (929 cm2) or more, but less than 4 square feet (37.1 dm2), be expressed
in terms of area, followed by the length and width. The customary inch/pound statement of area is to be expressed in
square inches with length and width expressed in the largest whole unit (yard or foot) with any remainder in inches
or common or decimal fractions of the yard or foot except that a dimension of less than 2 feet (60.9 cm) may be stated in
inches. Commodities consisting of usable individual units (e.g., paper napkins) while requiring a declaration
of unit area need not declare the total area of all such individual units. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) When the commodity has an area of 4 square feet (37.1 dm2) or more, be expressed in terms of area, followed by the length
and width. The customary inch/pound statement of area is to be expressed in square feet with the length and width expressed
in the largest whole units (yards or feet) with any remainder in terms of inches or common or decimal fractions of the
foot or yard except that a dimension of less than 2 feet (60.96 cm) may be stated in inches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) For any commodity for which the quantity of contents is required by paragraph (a) (2) or (3) of this section to include
a declaration of the linear dimensions, the quantity of contents, in addition to being declared in the manner prescribed
by the appropriate provisions of this regulation, may also include, after the customary inch/pound statement of
the linear dimensions of the largest unit of measurement, a parenthetical declaration of the linear dimensions of
said commodity in terms of inches. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
``25 sq. ft. (12 in. x 8.33 yd.) (12 in. x 300 in.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
2.32 m2 (30.4 cm x 7.62 m)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) For bidimensional commodities having a width of 4 inches (10.16 cm) or less, the declaration of net quantity shall
be expressed in terms of width and length in linear measure. The customary inch/pound statement of width shall be expressed
in terms of linear inches and fractions thereof, and length shall be expressed in the largest whole unit (yard or foot)
with any remainder in terms of the common or decimal fractions of the yard or foot, except that it shall be optional to
express the length in the largest whole unit followed by a statement of length in inches or to express the length in inches
followed by a statement of length in the largest whole unit. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
``2 inches x 10 yards (5.08 cm x 9.14 m)'', 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
``2 inches x 10 yards (360 inches) 5.08 cm x 9.14 m'', or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
``2 inches x 360 inches (10 yards) 5.08 cm x 9.14 m''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.13 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Measurement of commodities by area measure only, how expressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For commodities measured in terms of area measure only declaration of net quantity in terms of square yards, square
feet, and square inches shall be expressed in the following manner: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00133 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) If less than 1 square foot (929 cm2), in terms of square inches and fractions thereof. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) If at least 1 square foot (929 cm2) but less than 4 square feet (37.1 dm2), in terms of square feet with any remainder
in terms of square inches or common or decimal fractions of the square foot. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) If 4 square feet (37.1 dm2) or more, in terms of the largest appropriate whole unit (square yards, square yards and
square feet, or square feet) with any remainder in terms of square inches or common or decimal fractions of the square
foot or square yard. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.14 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Statements of cubic measure and dry measure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Statements of cubic measure and dry measure shall be expressed in terms most appropriate to the providing of accurate
information as to the net quantity of contents, and to the facilitating of value comparisons by consumers. When the
content declaration on a commodity sold in compressed form is stated in terms of cubic measure there may also be a statement
indicating the amount of material from which the final product was compressed. Such statement shall not exceed the
actual amount of material that can be recovered. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.15 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Units of count, more than one ply. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If the commodity is in distinct usable units made up of one or more components or ply, the statement of net quantity of
contents shall (in addition to complying with the requirements of linear and area measurement declaration for each
unit as specified in &sect;500.12) include the number of ply and the total number of usable units. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``100 2-ply facial tissues, 81/2 inches x 10 inches'' (21.5 x 25.4 cm).) For the purposes of this section, roll type
commodities (e.g. paper towels), irrespective of perforations, shall not be considered to be usable units, and shall
be labeled in terms of total area measurement and the number of ply. Such area measurement, however, shall be supplemented
by a count statement and the dimensions of a single unit. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.16 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Measurement of container type commodities, how expressed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notwithstanding other provisions of this Part 500 of the regulations pertaining to the expression of net quantity
of contents by measurement, commodities designed and sold at retail to be used as containers for other materials or
objects, such as bags, cups, boxes, and pans, shall be labeled in accordance with the following paragraphs: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) The declaration of net quantity for container commodities shall be expressed as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) For bag type commodities, in terms of count followed by linear dimensions of the bag (whether packaged in a perforated
roll or otherwise) Net quantity of contents in terms of feet and inches shall be expressed as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) When the unit bag is characterized by two dimensions because of the absence of a gusset, the width and length will
be expressed in inches, except that a dimension of 2 feet or more will be expressed in feet with any remainder in terms
of inches or common or decimal fractions of the foot.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``25 bags, 17 in. x 20 in. (43.1 x 50.8 cm)'' or ``200 bags, 20 in. x 2 ft. 6 in. (50.8 x 76.2 cm)'', or ``50 bags, 20 in. x 21/2
ft. (50.8 x 76.2 cm)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(ii) When the unit bag is gussetted, the dimensions will be expressed as width, depth and length in terms of inches except
that any dimensions of 2 feet or more will be expressed in feet with any remainder in terms of inches or the common or decimal
fractions of the foot. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Examples: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``25 bags, 17 in. x 4 in. x 20 in. (43 x 10 x 50 cm)'', or ``200 bags, 20 in. x 12 in. x 21/2 ft. (50.8 x 30.4 x 76.2 cm)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) For other square, oblong, rectangular or similarly shaped containers, in terms of count followed by length, width,
and depth except depth need not be listed when less than 2 inches (5.08 cm). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``2 cake pans, 8 in. x 8 in. (20.3 x 20.3 cm)'', or ``roasting pan, 12 in. x 8 in. x 3 in. (30.4 x 20.3 x 7.62 cm)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) For circular or other generally round shaped containers, except cups, and the like, in terms of count followed
by diameter and depth except depth need not be listed when less than 2 inches (5.08 cm). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``4 pie pans, 8 in. diameter (20.3 cm)'' or ``2 cake pans, 8 in. diameter x 4 in. (20.3 x 10.1 cm)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) When the functional use of the container is related by label reference in standard terms of measure to the capability
of holding a specific quantity of substance or class of substances such references shall be a part of the net quantity
statement and shall specify capacity as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Liquid measure for containers which are intended to be used for liquids, semi-solids, viscous materials or mixtures
of solids and liquids. The customary inch/pound statement of capacity shall be stated in terms of the largest whole
U.S. gallon of 231 cubic inches, quart, pint, or ounce with any remainder in terms of the common or decimal fraction
of that unit. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Freezer Boxes: ``4 boxes, 1 qt. capacity, 6 in. x 6 in. x 4 in. (946 mL capacity, 15.2 x 15.2 x 10.1 cm)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(2) Dry measure for containers which are intended to be used for solids. The customary inch/pound statement of capacity
shall be stated in terms of the largest whole U.S. bushel of 2,150.42 cubic inches, peck, dry quart, or dry pint with
any remainder in terms of the common or decimal fraction of that unit. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Leaf Bags: ``8 bags, 6 bushel capacity, 4 feet x 5 feet (211 L capacity_1.21 m x 1.52 m)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(3) Where containers are used as liners for other more permanent containers, in the same terms as are normally used
to express the capacity of the more permanent container. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Garbage Can Liners: ``10 liners, 2 ft. 6 in. x 3 ft. 1 in., fits up to 30 gallon cans (76.2 x 93.9 cm, fits up to 113 L cans''.)

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) Notwithstanding the above requirements, the net quantity statement for containers such as cups will be listed
in terms of count and liquid capacity per unit. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Example: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``24 cups, 6 fl. oz. capacity (177 mL)''.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00134 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) For purposes of this section, the use of the terms ``capacity,'' ``diameter,'' and ``fluid'' is optional. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.17 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Fractions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) SI metric declarations of net quantity of contents of any consumer commodity may contain only decimal fractions.
Other declarations of net quantity of contents may contain common or decimal fractions. A common fraction shall be
in terms of halves, quarters, eighths, sixteenths, or thirty-seconds; except that: 
<!-- PJG 0012 frnewline -->
(1) If there exists a firmly established general consumer usage and trade custom of employing different common fractions
in the net quantity declaration of a particular commodity, they may be employed, and 
<!-- PJG 0012 frnewline -->
(2) If linear measurements are required in terms of yards or feet, common fractions may be in terms of thirds. A common
fraction shall be reduced to its lowest terms; a decimal fraction shall not be carried out to more than three places.

<!-- PJG 0012 frnewline -->
(b) If a statement includes small fractions, smaller variations in the actual size or weight of the commodity will
be permitted as provided in &sect;500.25, than in cases where the larger fractions or whole numbers are used. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.18 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
SI metric prefixes. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following chart indicates SI prefixes that may be used on a broad range of consumer commodity labels: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,tp0,i1,s25,xls30,xs45 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Prefix
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Symbol
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Multiplying factor1 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Kilo- 
<!-- PJG 007 0104 intable -->
k 
<!-- PJG 007 0104 intable -->
x 103 
<!-- PJG 0012 frnewline -->
Deca- 
<!-- PJG 007 0104 intable -->
da 
<!-- PJG 007 0104 intable -->
x 10 
<!-- PJG 0012 frnewline -->
Deci- 
<!-- PJG 007 0104 intable -->
d 
<!-- PJG 007 0104 intable -->
x 10^1 
<!-- PJG 0012 frnewline -->
Centi- 
<!-- PJG 007 0104 intable -->
c 
<!-- PJG 007 0104 intable -->
x 10^2 
<!-- PJG 0012 frnewline -->
Milli- 
<!-- PJG 007 0104 intable -->
m 
<!-- PJG 007 0104 intable -->
x 10^3 
<!-- PJG 0012 frnewline -->
Micro- 
<!-- PJG 007 0104 intable -->
&mu; 
<!-- PJG 007 0104 intable -->
x 10^6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
1102=100; 103=1000; 10^1=0.1; 10^2=0.01. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
Thus, 2 kg=2x1000 g=2000 g, and 3 cm=3x0.01 m=0.03 m.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.19 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Conversion of SI metric quantities to inch/pound quantities and inch/pound quantities to SI metric quantities.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) For calculating the conversion of SI metric quantities to inch/pound quantities and inch/pound quantities to
metric quantities, the factors in the following chart and none others shall be employed: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,s25,r25 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
SI
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
 Metric Inch/Pound Conversion Factors 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Inch/pound
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Metric 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Length
<!-- PJG 007 0163 intable -->
0
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 mil=25.4 micrometers (&mu;m)* 
<!-- PJG 007 0104 intable -->
1 micrometer= 0.039370 mil.
<!-- PJG 0012 frnewline -->
1 inch=2.54 cm* 
<!-- PJG 007 0104 intable -->
1 millimeter=0.039 370 in. 
<!-- PJG 0012 frnewline -->
1 foot=30.48 cm* 
<!-- PJG 007 0104 intable -->
1 centimeter=0.393 701 in.
<!-- PJG 0012 frnewline -->
1 yard=0.9144m* 
<!-- PJG 007 0104 intable -->
1 meter=3.280 84 ft.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG ITAG l=21 g=1 f=4 -->
Area
<!-- PJG 007 0163 intable -->
0
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 square inch=6.4516 cm2* 
<!-- PJG 007 0104 intable -->
1 square centimeter=0.155 000 in2. 
<!-- PJG 0012 frnewline -->
1 square foot=929.0304 cm2* 
<!-- PJG 007 0104 intable -->
1 square decimeter=0.107 639 ft2. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
=9.290 304 dm2 
<!-- PJG 007 0104 intable -->
1 square meter=10.763 9 ft2. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 square yard=0.836 127 m2
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG ITAG l=21 g=1 f=4 -->
Volume or Capacity
<!-- PJG 007 0163 intable -->
0
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 cubic inch=16.3871 cm3 
<!-- PJG 007 0104 intable -->
1 cubic centimeter=0.061 023 7 in3. 
<!-- PJG 0012 frnewline -->
1 cubic foot=0.028 316 8 m3 
<!-- PJG 007 0104 intable -->
1 cubic decimeter=0.035 314 7 ft3. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
=2.83 168 dm3 
<!-- PJG 007 0104 intable -->
1 cubic meter=35.314 7 ft3.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 cubic yard=0.764 555 m3 
<!-- PJG 007 0104 intable -->
&blank;=1.307 95 yd3. 
<!-- PJG 0012 frnewline -->
1 fluid ounce=29.573 5 mL 
<!-- PJG 007 0104 intable -->
1 milliliter=0.033 814 0 fluid oz.
<!-- PJG 0012 frnewline -->
1 liquid pint=473.177 mL 
<!-- PJG 007 0104 intable -->
1 liter=1.05669 liquid quart.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
=0.473 177 L 
<!-- PJG 007 0104 intable -->
1 liter=0.264 172 gallon.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 liquid quart=946.353 mL 
<!-- PJG 007 0104 intable -->
1 dry pint=550.610 5 mL.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
=0.946 353 L 
<!-- PJG 007 0104 intable -->
1 dry quart=1.101 221 L.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 gallon=3.785 41 L 
<!-- PJG 007 0104 intable -->
1 dry peck=8.809 768 L.
<!-- PJG 0012 frnewline -->
1 bushel=35.2391 L 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0163 intable -->
1
<!-- PJG ITAG l=21 g=1 f=4 -->
Weight or Mass
<!-- PJG 007 0163 intable -->
0
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 007 0162 intable -->
s
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
1 ounce=28.349 5 g 
<!-- PJG 007 0104 intable -->
1 milligram=0.000 035 274 0 oz.
<!-- PJG 0012 frnewline -->
1 pound=453.592 g 
<!-- PJG 007 0104 intable -->
&blank;=0.015 432 4 grain. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=4 -->
=0.453 592 kg 
<!-- PJG 007 0104 intable -->
1 gram=0.035 274 0 oz.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=4 -->
&blank; 
<!-- PJG 007 0104 intable -->
1 kilogram=2.204 62 lb.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
*Exactly.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
Note: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
These conversion factors are given to six significant digits to provide such accuracy when necessary.
<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) The SI metric quantity declaration should be shown in three digits except where the quantity is below 100 grams,
milliliters, centimeters, square centimeters or cubic centimeters, where it can be shown in two figures. In either
case, any final zero appearing to the right of a decimal point need not be shown. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=4 -->
Examples: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
``1 lb (453 g)'' not ``1 lb (453.592 g)''; ``Net Wt. 2 oz (56 g)'' or ``Net Wt 2 oz (56.6 g)'' not ``Net Wt. 2 oz (56.69 g)''.)

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00135 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.20 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Conspicuousness. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The statement of net quantity of contents shall appear in conspicuous and easily legible boldface type or print in
distinct contrast (by typography, layout, color, embossing, or molding) to other matter on the package; except that
a statement of net quantity blown, embossed, or molded on a glass or plastic surface is permissible when all label information
is so formed on the surface. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.21 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Type size in relationship to the area of the principal display panel. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) The statement of net quantity of contents shall be in letters and numerals in a type size established in relationship
to the area of the principal display panel of the package or commodity and shall be uniform for all packages or commodities
of substantially the same size. For this purpose, ``area of the principal display panel'' means the area of the side
or surface that bears the principal display panel, exclusive of tops, bottoms, flanges at tops and bottoms of cans,
and shoulders and necks of bottles and jars. This area shall be: 
<!-- PJG 0012 frnewline -->
(1) In the case of a rectangular package or commodity where one entire side properly can be considered to be a principal
display panel side, the product of the height times the width of that side; 
<!-- PJG 0012 frnewline -->
(2) In the case of a cylindrical or nearly cylindrical container or commodity, 40 percent of the product of the height
of the container or commodity times the circumference; and 
<!-- PJG 0012 frnewline -->
(3) In the case of any otherwise shaped container or commodity, 40 percent of the total surface of the container or commodity:

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, however, that where such container or commodity presents an obvious ``principal display panel'' such as the top
of a triangular or oval shaped container, the area shall consist of the entire top surface. 
<!-- PJG 0012 frnewline -->
(b) With area of principal display panel defined as above, the type size in relationship to area of that panel shall
comply with the following specifications: 
<!-- PJG 0012 frnewline -->
(1) Not less than 1/16 inch (1.5 mm) in height on packages the principal display panel of which has an area of 5 square
inches or (32.2 cm2) less. 
<!-- PJG 0012 frnewline -->
(2) Not less than 1/8 inch (3.1 mm) in height on packages the principal display panel of which has an area of more than
5 (32.2 cm2) but not more than 25 square inches (161 cm2). 
<!-- PJG 0012 frnewline -->
(3) Not less than 3/16 inch (4.7 mm) in height on packages the principal display panel of which has an area of more than
25 (161 cm2) but not more than 100 square inches (6.45 dm2). 
<!-- PJG 0012 frnewline -->
(4) Not less than 1/4 inch (6.35 mm) in height on packages the principal display panel of which has an area of more than
100 square inches (6.45 dm2), except not less than 1/2 (12.7 mm) inch in height if the area is more than 400 square inches
(25.8 dm2). 
<!-- PJG 0012 frnewline -->
(c) Where the statement of net quantity of contents is blown, embossed, or molded on a glass or plastic surface rather
than by printing, typing, or coloring, the lettering sizes specified in paragraph (b) of this section shall be increased
by 1/16 of an inch (1.5 mm). 
<!-- PJG 0012 frnewline -->
(d) Letter heights pertain to upper case or capital letters. When upper and lower case or all lower case letters are
used, it is the lower case letter ``o'' or its equivalent that shall meet the minimum standards. 
<!-- PJG 0012 frnewline -->
(e) The ratio of height to width of a letter shall not exceed a differential of 3 units to 1 unit (no more than 3 times as
high as it is wide). 
<!-- PJG 0012 frnewline -->
(f) When fractions are used, each component shall meet one-half the minimum height standards. 
<!-- PJG 0012 frnewline -->
(g) The type size requirements specified in this section do not apply to the ``e'' mark. (See &sect;500.6(b).)
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00136 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(h) When upper and lower case or all lowercase letters are used in SI metric symbols, it is the uppercase ``L,'' lowercase
``d,'' or their equivalent in the print or type used that shall meet the minimum height requirement. Other letters
and exponents must be presented in the same type style and in proportion to the type size used. However, no letter shall
be less than 1.6 mm (1/16 inch) in height. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
&sect;500.22 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Abbreviations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The following abbreviations and none other may be employed in the required net quantity declaration:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Inch_in. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Feet or foot_ft.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Fluid_fl.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Liquid_liq.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ounce_oz.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Gallon_gal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pint_pt.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pound_lb. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Quart_qt. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Square_sq. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Weight_wt. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Yard_yd. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Avoirdupois_avdp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Cubic_cu.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Periods and plural forms shall be optional. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
&sect;500.23 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Expression of net quantity of contents in SI Metric units. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(a) The selected multiple or submultiple prefixes for SI metric units shall result in numerical values between 1 and
1000, except that centimeters or millimeters may be used where a length declaration is less than 100 centimeters.
For example, ``1.96 kg'' instead of ``1960 g'' and ``750 mL'' instead of ``0.75 L''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) The following symbols for SI metric units and none others may be employed in the required net quantity declaration:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=25 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
centimeter_cm 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
cubic centimeter_cm3 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
cubic decimeter_dm3 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
meter_m 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
milligram_mg 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
liter_L or l 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
milliliter_mL or ml 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
square decimeter_dm2 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
cubic meter_m3 
<!-- PJG 0012 frnewline -->
kilogram_kg
<!-- PJG 0012 frnewline -->
micrometer_&mu;m
<!-- PJG 0012 frnewline -->
gram_g 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
millimeter_mm 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
square meter_m2 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
square centimeter_cm2
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Symbols, except for liter, are not capitalized. Periods should not be used after the symbol. Symbols are always written
in the singular form. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
&sect;500.24 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Supplemental statements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Nothing contained in the regulations in this part shall prohibit supplemental statements, at locations other than
the principal display panel, describing in non-deceptive terms the net quantity of contents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that such supplemental statements of net quantity of contents shall not include any term qualifying a unit of weight
or mass, measure, or count that tends to exaggerate the amount of commodity contained in the package. (Examples of
prohibited language are: ``Giant Quart,'' ``Jumbo Liter,'' ``Full Gallon,'' ``When Packed,'' ``Minimum,'' or
words of similar import.) Required combination declarations of net quantity of contents (for example, a combination
of net weight or mass plus numerical count, numerical count plus dimensions of the commodity, etc.) are not regarded
as supplemental net quantity statements and shall be located on the principal display panel. Dilution directions
or other similar directions for use are not regarded as supplemental net quantity statements and may be located on
the principal display panel. Size characterizations in compliance with standards promulgated under section 5(c)(1)
of the Act may appear on the principal display panel. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
&sect;500.25 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Net quantity, average quantity, permitted variations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(a) The statement of net quantity of contents shall accurately reveal the quantity of the commodity in the container
exclusive of wrappers and other material packed therewith: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that in the case of a commodity packed in a container designed to deliver the commodity under pressure, the statement
shall declare the net quantity of the contents that will be expelled when the instructions for use are followed. The
propellant is included in the net quantity statement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Variations from the stated weight or mass or measure shall be permitted when caused by ordinary and customary exposure,
after the commodity is introduced into interstate commerce, to conditions which normally occur in good distribution
practice and which unavoidably result in change of weight or mass or measure. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Variations from the stated weight or mass, measure, or numerical count shall be permitted when caused by unavoidable
deviations in weighing, measuring, or counting the contents of individual packages which occur in good packaging
practice: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that such variations shall not be permitted to such extent that the average of the quantities in the packages comprising
a shipment or other delivery of the commodity is below the quantity stated, and no unreasonable shortage in any package
will be permitted even though overages in other packages in the same shipment or delivery compensate for such shortage.
Variations from stated quantity of contents shall not be unreasonably large. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00137 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
&sect;500.26 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Representations of servings, uses, applications. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(a) The label of any packaged consumer commodity which bears a representation as to the number of servings, uses, or
applications of such commodity contained in such package shall bear in immediate conjunction therewith, and in letters
the same size as those used for such representations, a statement of the net quantity (in terms of weight or mass, measure,
or numerical count) of each such serving, use, or application: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that such statement may be expressed in terms that differ from terms used in the required statement of net contents
(e.g., cupsful, tablespoonful, etc.), when such differing terms describe a constant quantity. Such statement may
not be misleading in any particular. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Representations as to the total amount of object or objects to which the commodity may be applied or upon which or
in which the commodity may be used, will not be considered to be representations as to servings, uses, or applications,
if such amount is expressed in terms of standard units of weight or mass, measure, size, or count. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) If there exists a voluntary product standard promulgated pursuant to the procedures found in 15 CFR Part 10, by
the Department of Commerce, quantitatively defining the meaning of the terms ``serving,'' ``use,'' or ``application''
with respect to a particular consumer commodity, then any label representation as to the number of servings, uses,
or applications in such packaged consumer commodity shall correspond with such quantitative definition. (Copies
of published standards will be available upon request from the National Institute of Standards and Technology, Department
of Commerce, Washington, DC 20899.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
&sect;500.27 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Multiunit packages. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(a) A multiunit package is a package intended for retail sale, containing two or more individual packaged or labeled
units of an identical commodity in the same quantity. The declaration of net quantity of contents of a multiunit package
shall be expressed as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The number of individual packaged or labeled units; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The quantity of each individual packaged or labeled unit; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) The total quantity of the multiunit package.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
Examples:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Soap bars: ``6 Bars, Net Wt. 3.4 ozs. (96.3 g) each, Total Net Wt. 1 lb. 4.4 oz. (578 g)'' Facial Tissues: ``10 Packs, each
25 two-ply tissues, 9.7 in. x 8.2 in. (24.6 x 20.8 cm), Total 250 Tissues.''
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(b) The individual packages or labeled units of a multiunit package, when intended for individual sale separate from
the multiunit package, shall be labeled in compliance with the regulations under this part 500 applicable to that
package. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) A multiunit package containing unlabeled individual packages which are not intended for retail sale separate
from the multiunit package may contain, in lieu of the requirements of Paragraph (a) of this section, a declaration
of quantity of contents expressing the total quantity of the multiunit package without regard for inner packaging.
For such multiunit packages it shall be optional to include a statement of the number of individual packages when such
a statement is not otherwise required by the regulations.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->

<!-- PJG 0012 frnewline -->
Examples: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Deodorant Cakes: ``5 Cakes, Net Wt. 4 ozs. (113 g) each, Total Net Wt. 1.25 lb. (566 g)'' or ``5 Cakes, Total Net Wt. 1 lb.
4 ozs. (566 g)''; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Soap Packets: ``10 Packets, Net Wt. 2 ozs. (56.6 g) each, total Net Wt 1.25 lb. (566 g)'' or ``Net Wt 1 lb. 4 ozs. (566 g)''
or ``10 Packets, Total Net Wt. 1 lb. 4 ozs. (566 g).'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
&sect;500.28 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Variety packages. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(a) A variety package is a package intended for retail sale, containing two or more individual packages or units of
similar but not identical commodities. Commodities which are generically the same but which differ in weight or mass,
measure, volume, appearance or quality are considered similar but not identical. The declaration of net quantity
for a variety package will be expressed as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) The number of units for each identical commodity followed by the weight or mass, volume, or measure of that commodity:
and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The total quantity by weight or mass, volume, measure, and count, as appropriate, of the variety package. The statement
of total quantity shall appear as the last item in the declaration of net quantity and shall not be of greater prominence
than other terms used. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Examples: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(i) ``2 sponges 41/2 ins. &times; 4 ins. &times;3/4 in. 
<!-- PJG 0012 frnewline -->
(11.4 cm &times; 10.1 cm &times; 1.9 cm); 
<!-- PJG 0012 frnewline -->
1 sponge 41/2 ins. &times; 8 ins. &times;3/4 in. 
<!-- PJG 0012 frnewline -->
(11.4 cm &times; 20.3 cm &times; 1.9 cm); 
<!-- PJG 0012 frnewline -->
4 sponges 21/2 ins. &times; 4 ins. &times;1/2 in. 
<!-- PJG 0012 frnewline -->
(6.3 cm &times; 10.1 cm &times; 1.2 cm) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Total: 7 sponges''. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) ``2 soap bars Net Wt. 3.2 ozs. (90 g) each; 
<!-- PJG 0012 frnewline -->
1 soap bar Net Wt. 5.0 ozs. (141 g). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Total: 3 bars Net Wt. 11.4 ozs. (323 g).''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) Liquid Shoe Polish: ``1 Brown 3 fl. ozs. (88 mL); 1 Black 3 fl. ozs. (88 mL); 1 White 5 fl. ozs. (147 mL).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Total: 11 fl. ozs. (325 mL).''
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iv) Picnic Ware: ``34 spoons; 33 forks; 33 knives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Total: 100 pieces.''
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(b) When the individual units in a variety package are either packaged or labeled and are intended for retail sale as
individual units, each unit shall be labeled in compliance with the applicable regulations under this Part 500. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-0-00138 </DOCNO>
<PARENT> FR940112-0-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4700 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;500.29 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Combination packages. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) A combination package is a package intended for retail sale, containing two or more individual packages or units
of dissimilar commodities. The declaration of net quantity for a combination package will contain an expression
of weight or mass, volume, measure or count or a combination, thereof, as appropriate for each individual package
or unit: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Provided,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that the quantity statements for identical packages or units shall be combined. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Examples
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) Lighter fluid and flints: ``2 cans_each 8 fl. ozs. (236 mL); 1 package_8 flints.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Sponges &amp; Cleaner: ``2 sponges each 4 in. x 6 in. x 1 in. (10.1 x 15.2 x 2.5 cm); 1 box cleaner_Net Wt. 6 ozs. (170
g)'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) Picnic Pack: ``20 spoons, 10 knives and 10 forks, 10 2-ply napkins 10 ins. x 10 ins. (25.4 x 25.4 cm) 10 cups_6 fl. ozs.
(177 mL)''.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) When the individual units in a combination package are either packaged or labeled and are intended for retail sale
as individual units, each unit shall be in compliance with the applicable regulations under this part 500. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By direction of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;767 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;W
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00001 </DOCNO>
<PARENT> FR940112-1-00001 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4702 -->

<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Proposed Rules
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 8
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, January 12, 1994
<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00002 </DOCNO>
<PARENT> FR940112-1-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Aviation Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 39 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93&hyph;CE&hyph;58&hyph;AD] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Airworthiness Directives: Piper Aircraft Corporation 
<!-- PJG 0012 frnewline -->
Models PA34&hyph;200, PA34&hyph;200T, PA34&hyph;220T, PA44&hyph;180, and 
<!-- PJG 0012 frnewline -->
PA44&hyph;180T Airplanes 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Aviation Administration, DOT. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed rulemaking (NPRM). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document proposes to adopt a new 
<!-- PJG 0012 frnewline -->
airworthiness directive (AD) that would apply to 
<!-- PJG 0012 frnewline -->
certain Piper Aircraft Corporation (Piper) Models PA34&hyph;200, PA34&hyph;200T, PA34&hyph;220T, PA44&hyph;180,
and 
<!-- PJG 0012 frnewline -->
PA44&hyph;180T airplanes. The proposed action would require 
<!-- PJG 0012 frnewline -->
repetitively inspecting the main landing gear trunnions 
<!-- PJG 0012 frnewline -->
for cracks, replacing any trunnions found cracked, and 
<!-- PJG 0012 frnewline -->
eventually replacing the landing gear trunnions with 
<!-- PJG 0012 frnewline -->
parts of improved design as terminating action for the 
<!-- PJG 0012 frnewline -->
repetitive inspection requirement. Several reports of 
<!-- PJG 0012 frnewline -->
the main landing gear trunnions cracking on the 
<!-- PJG 0012 frnewline -->
affected airplanes prompted the proposed action. The 
<!-- PJG 0012 frnewline -->
actions specified by the proposed AD are intended to 
<!-- PJG 0012 frnewline -->
prevent collapse of the main landing gear caused by 
<!-- PJG 0012 frnewline -->
cracked trunnions, which could result in airplane 
<!-- PJG 0012 frnewline -->
damage. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before March 
<!-- PJG 0012 frnewline -->
14, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Submit comments in triplicate to the 
<!-- PJG 0012 frnewline -->
Federal Aviation Administration (FAA), Central Region, 
<!-- PJG 0012 frnewline -->
Office of the Assistant Chief Counsel, Attention: Rules 
<!-- PJG 0012 frnewline -->
Docket No. 93&hyph;CE&hyph;58&hyph;AD, room 1558, 601 E. 12th Street, 
<!-- PJG 0012 frnewline -->
Kansas City, Missouri 64106. Comments may be inspected 
<!-- PJG 0012 frnewline -->
at this location between 8 a.m. and 4 p.m., Monday 
<!-- PJG 0012 frnewline -->
through Friday, holidays excepted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Service information that applies to the proposed 
<!-- PJG 0012 frnewline -->
AD may be obtained from the Piper Aircraft Corporation, 
<!-- PJG 0012 frnewline -->
Customer Services, 2926 Piper Drive, Vero Beach, 
<!-- PJG 0012 frnewline -->
Florida 32960. This information also may be examined 
<!-- PJG 0012 frnewline -->
at the Rules Docket at the address above. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Christina Marsh, 
<!-- PJG 0012 frnewline -->
Aerospace Engineer, FAA, Atlanta Aircraft Certification 
<!-- PJG 0012 frnewline -->
Office, 1669 Phoenix Parkway, suite 210C, Atlanta, 
<!-- PJG 0012 frnewline -->
Georgia 30349; telephone (404) 991&hyph;2910; facsimile 
<!-- PJG 0012 frnewline -->
(404) 991&hyph;3606. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments Invited 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons are invited to participate in 
<!-- PJG 0012 frnewline -->
the making of the proposed rule by submitting such 
<!-- PJG 0012 frnewline -->
written data, views, or arguments as they may desire. 
<!-- PJG 0012 frnewline -->
Communications should identify the Rules Docket number 
<!-- PJG 0012 frnewline -->
and be submitted in triplicate to the address specified 
<!-- PJG 0012 frnewline -->
above. All communications received on or before the 
<!-- PJG 0012 frnewline -->
closing date for comments, specified above, will be 
<!-- PJG 0012 frnewline -->
considered before taking action on the proposed rule. 
<!-- PJG 0012 frnewline -->
The proposals contained in this notice may be changed 
<!-- PJG 0012 frnewline -->
in light of the comments received. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00003 </DOCNO>
<PARENT> FR940112-1-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments are specifically invited on the overall 
<!-- PJG 0012 frnewline -->
regulatory, economic, environmental, and energy aspects 
<!-- PJG 0012 frnewline -->
of the proposed rule. All comments submitted will be 
<!-- PJG 0012 frnewline -->
available, both before and after the closing date for 
<!-- PJG 0012 frnewline -->
comments, in the Rules Docket for examination by 
<!-- PJG 0012 frnewline -->
interested persons. A report that summarizes each FAA-public contact concerned with the substance of this 
<!-- PJG 0012 frnewline -->
proposal will be filed in the Rules Docket. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Commenters wishing the FAA to acknowledge receipt 
<!-- PJG 0012 frnewline -->
of their comments submitted in response to this notice 
<!-- PJG 0012 frnewline -->
must submit a self-addressed, stamped postcard on which the following 
<!-- PJG 0012 frnewline -->
statement is made: ``Comments to Docket No. 93&hyph;CE&hyph;58&hyph;AD.'' The postcard will be date stamped and
returned to the commenter. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Availability of NPRMs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any person may obtain a copy of this NPRM by 
<!-- PJG 0012 frnewline -->
submitting a request to the FAA, Central Region, Office 
<!-- PJG 0012 frnewline -->
of the Assistant Chief Counsel, Attention: Rules 
<!-- PJG 0012 frnewline -->
Docket No. 93&hyph;CE&hyph;58&hyph;AD, room 1558, 601 E. 12th Street, 
<!-- PJG 0012 frnewline -->
Kansas City, Missouri 64106. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Discussion 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Service history of certain Piper Models PA34&hyph;200, 
<!-- PJG 0012 frnewline -->
PA34&hyph;200T, PA34&hyph;220T, PA44&hyph;180, and PA44&hyph;180T airplanes 
<!-- PJG 0012 frnewline -->
reveals several occurrences of cracked main landing 
<!-- PJG 0012 frnewline -->
gear (MLG) trunnions. Five of these occurrences 
<!-- PJG 0012 frnewline -->
resulted when the left MLG trunnion, part number (P/N) 
<!-- PJG 0012 frnewline -->
67926&hyph;12, separated from Piper Model PA34&hyph;200T 
<!-- PJG 0012 frnewline -->
airplanes during the landing roll. Further 
<!-- PJG 0012 frnewline -->
investigation revealed that the left MLG collapsed 
<!-- PJG 0012 frnewline -->
because of a transverse fracture in the trunnion at the 
<!-- PJG 0012 frnewline -->
rear web lower end fillet. Metallurgical examination 
<!-- PJG 0012 frnewline -->
of four of these MLG trunnions further disclosed that 
<!-- PJG 0012 frnewline -->
the fractures originated from very shallow fatigue 
<!-- PJG 0012 frnewline -->
cracks originating from several areas along the rear surface 
<!-- PJG 0012 frnewline -->
at the lower end of the fillet web. The length of 
<!-- PJG 0012 frnewline -->
these fatigue cracks ranged from .20 to .40 inches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Piper has issued Service Bulletin (SB) 787B, dated 
<!-- PJG 0012 frnewline -->
August 25, 1993, which specifies procedures for 
<!-- PJG 0012 frnewline -->
inspecting the MLG trunnions on certain Piper Models 
<!-- PJG 0012 frnewline -->
PA34&hyph;200, PA34&hyph;200T, PA34&hyph;220T, PA44&hyph;180, and PA44&hyph;180T 
<!-- PJG 0012 frnewline -->
airplanes, and references replacing MLG trunnions with 
<!-- PJG 0012 frnewline -->
parts of improved design. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
After examining the circumstances and reviewing 
<!-- PJG 0012 frnewline -->
all available information related to the incidents 
<!-- PJG 0012 frnewline -->
described above including the referenced service 
<!-- PJG 0012 frnewline -->
information, the FAA has determined that AD action 
<!-- PJG 0012 frnewline -->
should be taken to prevent collapse of the main landing 
<!-- PJG 0012 frnewline -->
gear caused by cracked trunnions, which could result in 
<!-- PJG 0012 frnewline -->
airplane damage. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Since an unsafe condition has been identified that 
<!-- PJG 0012 frnewline -->
is likely to exist or develop in other Piper Models 
<!-- PJG 0012 frnewline -->
PA34&hyph;200, PA34&hyph;200T, PA34&hyph;220T, PA44&hyph;180, and PA44&hyph;180T 
<!-- PJG 0012 frnewline -->
airplanes of the same type design, the proposed AD 
<!-- PJG 0012 frnewline -->
would require repetitively inspecting the main landing 
<!-- PJG 0012 frnewline -->
gear trunnions for cracks, replacing any trunnions 
<!-- PJG 0012 frnewline -->
found cracked, and eventually replacing the landing 
<!-- PJG 0012 frnewline -->
gear trunnions with parts of improved design as 
<!-- PJG 0012 frnewline -->
terminating action for the repetitive inspection 
<!-- PJG 0012 frnewline -->
requirement. The proposed inspections would be 
<!-- PJG 0012 frnewline -->
accomplished in accordance with Piper SB No. 787B, 
<!-- PJG 0012 frnewline -->
dated August 25, 1993. The proposed replacement would 
<!-- PJG 0012 frnewline -->
be accomplished in accordance with the applicable 
<!-- PJG 0012 frnewline -->
maintenance manual. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00004 </DOCNO>
<PARENT> FR940112-1-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA estimates that 2,265 airplanes in the U.S. registry would be affected by the proposed AD, that it would take
approximately 16 workhours per airplane to accomplish the proposed initial inspection and replacement, and that
the average labor rate is approximately $55 an hour. Parts cost approximately $1,100 per airplane. Based on these
figures, the total cost impact of the proposed AD on U.S. operators is estimated to be $4,484,700. This cost figure
is based on the assumption that none of the affected airplane owners/operators have accomplished the proposed actions.
The FAA believes that some airplane owners/operators have already incorporated the inspection terminating MLG
trunnion replacements. With this in mind, the FAA anticipates that the cost of the proposed AD would be much lower than
the figure referenced above. 
<!-- PJG 0012 frnewline -->
The regulations proposed herein would not have substantial direct effects on the States, on the relationship between
the national government and the States, or on the distribution of power and responsibilities among the various levels
of government. Therefore, in accordance with Executive Order 12612, it is determined that this proposal would not
have sufficient federalism implications to warrant the preparation of a Federalism Assessment. 
<!-- PJG 0012 frnewline -->
For the reasons discussed above, I certify that this action (1) is not a ``significant regulatory action'' under Executive
Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies and Procedures (44 FR 11034, February
26, 1979); and (3) if promulgated, will not have a significant economic impact, positive or negative, on a substantial
number of small entities under the criteria of the Regulatory Flexibility Act. A copy of the draft regulatory evaluation
prepared for this action has been placed in the Rules Docket. A copy of it may be obtained by contacting the Rules Docket
at the location provided under the caption 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
ADDRESSES. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 39 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Air transportation, Aircraft, Aviation safety, Safety. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposed Amendment 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Accordingly, pursuant to the authority delegated to me by the Administrator, the Federal Aviation Administration
proposes to amend 14 CFR part 39 of the Federal Aviation Regulations as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 39_AIRWORTHINESS DIRECTIVES 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for part 39 continues to read as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. App. 1354(a), 1421 and 1423; 49 U.S.C. 106(g); and 14 CFR 11.89. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;39.13
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 39.13 is amended by adding the following new AD: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=4 -->
Piper Aircraft Corporation:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
 Docket 93&hyph;CE&hyph;58&hyph;AD. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Applicability:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The following model and serial number airplanes that are not equipped with main landing gear (MLG) trunnions (both
left and right side) that have either part number (P/N) 67926&hyph;30, 67926&hyph;31, 67926&hyph;32, 67926&hyph;33,
39486&hyph;14, or 39486&hyph;15, as applicable, certificated in any category: 
<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp0,i1,xs54,r20 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 007 0150 intable -->
1Models
<!-- PJG 007 0150 intable -->
1Serial Numbers 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
PA34&hyph;200
<!-- PJG 007 0104 intable -->
34&hyph;7250001 through 34&hyph;7450220 
<!-- PJG 0012 frnewline -->
PA34&hyph;200T
<!-- PJG 007 0104 intable -->
34&hyph;7570001 through 34&hyph;8170092 
<!-- PJG 0012 frnewline -->
PA34&hyph;220T
<!-- PJG 007 0104 intable -->
34&hyph;8133001 through 34&hyph;8233088 
<!-- PJG 0012 frnewline -->
PA44&hyph;180
<!-- PJG 007 0104 intable -->
44&hyph;7995001 through 44&hyph;8195026, and 4495001 through 4495013 
<!-- PJG 0012 frnewline -->
PA44&hyph;180T
<!-- PJG 007 0104 intable -->
44&hyph;8107001 through 44&hyph;8207020 
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Compliance:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Required as indicated, unless already accomplished. 
<!-- PJG 0012 frnewline -->
To prevent collapse of the main landing gear caused by cracked trunnions, which could result in airplane damage, accomplish
the following: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 1: The paragraph structure of this AD is as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Level 1: (a), (b), (c), etc. 
<!-- PJG 0012 frnewline -->
Level 2: (1), (2), (3), etc. 
<!-- PJG 0012 frnewline -->
Level 3: (i), (ii), (iii), etc. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Level 2 and Level 3 structures are designations of the Level 1 paragraph they immediately follow. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(a) Upon the accumulation of 500 hours time-in-service (TIS) on a MLG trunnion, dye-penetrant inspect the MLG trunnion
for cracks in accordance with the INSTRUCTIONS section of Piper Service Bulletin (SB) 787B, dated August 25, 1993.

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 2: If hours TIS on the MLG trunnion are unknown, hours TIS accumulated on the airplane may be substituted. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00005 </DOCNO>
<PARENT> FR940112-1-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(1) For MLG trunnions found cracked, prior to 
<!-- PJG 0012 frnewline -->
further flight, replace the cracked MLG trunnion with a 
<!-- PJG 0012 frnewline -->
part of improved design, P/N 67926&hyph;30, 67926&hyph;31, 67926&hyph;32, 67926&hyph;33, 39486&hyph;14, or
39486&hyph;15, as applicable, in 
<!-- PJG 0012 frnewline -->
accordance with the applicable maintenance manual. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) For MLG trunnions not found cracked, reinspect 
<!-- PJG 0012 frnewline -->
at intervals not to exceed 100 hours TIS until the 
<!-- PJG 0012 frnewline -->
replacement specified in paragraph (b) of this AD is 
<!-- PJG 0012 frnewline -->
accomplished. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) If one trunnion is found cracked and is 
<!-- PJG 0012 frnewline -->
replaced as specified in paragraph (a)(1) of this AD, 
<!-- PJG 0012 frnewline -->
the other trunnion must still be reinspected as 
<!-- PJG 0012 frnewline -->
specified in paragraph (a)(2) of this AD until it also 
<!-- PJG 0012 frnewline -->
is replaced. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Upon the accumulation of 2,000 hours TIS on a 
<!-- PJG 0012 frnewline -->
MLG trunnion, unless already accomplished as specified 
<!-- PJG 0012 frnewline -->
in paragraph (a)(1) of this AD, replace this MLG 
<!-- PJG 0012 frnewline -->
trunnion with a part of improved design, P/N 67926&hyph;30, 
<!-- PJG 0012 frnewline -->
67926&hyph;31, 67926&hyph;32, 67926&hyph;33, 39486&hyph;14, or 39486&hyph;15, as 
<!-- PJG 0012 frnewline -->
applicable, in accordance with the applicable 
<!-- PJG 0012 frnewline -->
maintenance manual. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) If parts for any MLG replacement have been 
<!-- PJG 0012 frnewline -->
ordered from the manufacturer but are not available, 
<!-- PJG 0012 frnewline -->
prior to further flight and thereafter at intervals not 
<!-- PJG 0012 frnewline -->
to exceed 100 hour TIS, dye-penetrant inspect the MLG 
<!-- PJG 0012 frnewline -->
trunnion for cracks in accordance with the INSTRUCTIONS 
<!-- PJG 0012 frnewline -->
section of Piper Service Bulletin (SB) 787B, dated 
<!-- PJG 0012 frnewline -->
August 25, 1993. If any one of the following occurs, 
<!-- PJG 0012 frnewline -->
prior to further flight, terminate the above repetitive 
<!-- PJG 0012 frnewline -->
inspections and replace the trunnion as specified in 
<!-- PJG 0012 frnewline -->
paragraph (b) of this AD: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(i) Parts become available; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii) A trunnion is found cracked; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(iii) 2,500 hours TIS are accumulated on the 
<!-- PJG 0012 frnewline -->
trunnion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Replacing both the left and right MLG trunnion 
<!-- PJG 0012 frnewline -->
with P/N 67926&hyph;30, 67926&hyph;31, 67926&hyph;32, 67926&hyph;33, 39486&hyph;14, or 
<!-- PJG 0012 frnewline -->
39486&hyph;15, as applicable, eliminates the inspection 
<!-- PJG 0012 frnewline -->
requirement of this AD. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Special flight permits may be issued in 
<!-- PJG 0012 frnewline -->
accordance with FAR 21.197 and 21.199 to operate the 
<!-- PJG 0012 frnewline -->
airplane to a location where the requirements of this 
<!-- PJG 0012 frnewline -->
AD can be accomplished. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) An alternative method of compliance or 
<!-- PJG 0012 frnewline -->
adjustment of the compliance time that provides an 
<!-- PJG 0012 frnewline -->
equivalent level of safety may be approved by the 
<!-- PJG 0012 frnewline -->
Manager, Atlanta Aircraft Certification Office 
<!-- PJG 0012 frnewline -->
(ACO),1669 Phoenix Parkway, Suite 210C, Atlanta, 
<!-- PJG 0012 frnewline -->
Georgia 30349. The request shall be forwarded through 
<!-- PJG 0012 frnewline -->
an appropriate FAA Maintenance Inspector, who may add 
<!-- PJG 0012 frnewline -->
comments and then send it to the Manager, Atlanta ACO. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 3: Information concerning the existence of 
<!-- PJG 0012 frnewline -->
approved alternative methods of compliance with this 
<!-- PJG 0012 frnewline -->
AD, if any, may be obtained from the Atlanta ACO. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(e) All persons affected by this directive may 
<!-- PJG 0012 frnewline -->
obtain copies of the document referred to herein upon 
<!-- PJG 0012 frnewline -->
request to the Piper Aircraft Corporation, 2926 Piper 
<!-- PJG 0012 frnewline -->
Drive, Vero Beach, Florida 32960; or may examine this 
<!-- PJG 0012 frnewline -->
document at the FAA, Central Region, Office of the 
<!-- PJG 0012 frnewline -->
Assistant Chief Counsel, Room 1558, 601 E. 12th Street, 
<!-- PJG 0012 frnewline -->
Kansas City, Missouri 64106. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Kansas City, Missouri, on January 5, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Barry D. Clements, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Small Airplane Directorate, Aircraft Certification Service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;700 Filed 01&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;U
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00006 </DOCNO>
<PARENT> FR940112-1-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ASO&hyph;14]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Proposed Establishment of Class D Airspace: Eglin AFB, FL; Eglin AF Aux No. 3 Duke Field, FL; Proposed Amendment of
Class D Airspace: Eglin Hurlburt Field, FL; Proposed Amendment of Class E Airspace: Crestview, FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice proposes to establish Class D airspace located at Eglin Air Force Base, FL, and Eglin AF Aux No 3 Duke Field,
FL. The notice also proposes to amend Class D airspace located at Eglin Hurlburt Field, FL, and Class E airspace at Crestview,
FL. As part of the Terminal Airspace Reclassification, the Valparaiso, Florida Terminal Area was to be changed from
Part 93 Airspace to Class D Airspace. The change included the revocation of the Eglin AFB, Florida Class D airspace
and Eglin AF Aux No. 3 Duke Field, Florida Class D airspace; the modification of the Hurlburt Field, Florida Class D
airspace and Crestview, Florida Class E airspace. The Valparaiso, Florida Terminal Area will remain as Part 93 Airspace
and this notice proposes to return the affected Class D and Class E airspace areas as they were prior to Docket No. 26968,
Amendment No. 71&hyph;19 published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on March 2, 1993.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before: March 1, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send comments on the proposal in triplicate to: Federal Aviation Administration, Docket No. 93&hyph;ASO&hyph;14,
Manager, System Management Branch, ASO&hyph;530, P.O. Box 20636, Atlanta, Georgia 30320.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined in the Office of the Assistant Chief Counsel for Southern Region, room 530, 1701
Columbia Avenue, College Park, Georgia 30337; telephone (404) 305&hyph;5200.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Kenneth R. Patterson, Airspace Section, System Management Branch, Air Traffic Division, Federal Aviation Administration,
P.O. Box 20636, Atlanta, Georgia 30320; telephone (404) 305&hyph;5590.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views
or arguments as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy aspects of the proposal.
Communications should identify the airspace docket and be submitted in triplicate to the address listed above. Commenters
wishing the FAA to acknowledge receipt of their comments on this notice must submit with those comments a self-addressed,
stamped postcard on which the following statement is made: ``Comments to Airspace Docket No. 93&hyph;ASO&hyph;14.''
The postcard will be date/time stamped and returned to the commenter. All communications received before the specified
closing date for comments will be considered before taking action on the proposed rule. The proposal contained in
this notice may be changed in the light of comments received. All comments submitted will be available for examination
in the Office of the Assistant Chief Counsel for Southern Region, room 530, 1701 Columbia Avenue, College Park, Georgia
30337, both before and after the closing date for comments. A report summarizing each substantive public contact
with FAA personnel concerned with this rulemaking will be filed in the docket.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Availability of NPRM's 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Federal Aviation
Administration, Manager, System Management Branch (ASO&hyph;530), Air Traffic Division, P.O. Box 20636, Atlanta,
Georgia 30320. Communications must identify the notice number of this NPRM. Persons interested in being placed on
a mailing list for future NPRM's should also request a copy of Advisory Circular No. 11&hyph;2A which describes the
application procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to establish Class
D airspace at Eglin AFB, Florida; establish Class D airspace at Eglin AF Aux No 3 Duke Field; amend Class D airspace at
Eglin Hurlburt Field, Florida, and amend Class E airspace at Crestview, Florida. The intended effect of this proposal
is to reverse the action of Docket No. 26968, Amendment No. 71&hyph;19 (58 FR 12128, March 2, 1993) to provide adequate
airspace to contain Instrument Flight Rule operations at these four locations. The coordinates for this airspace
docket are based on North American Datum 83. Class D and Class E airspace areas are respectively published in Para 5000
and Para 6002 of FAA Order 7400.9A dated June 17, 1993, and effective September 16, 1993, which is incorporated by reference
in 14 CFR 71.1. The Class D and E airspace listed in this document would be published subsequently in the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
for which frequent and routine amendments are necessary to keep them operationally current. It, therefore, (1) is
not a ``significant regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory
evaluation as the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic
procedures and air navigation, it is certified that this rule, when promulgated, will not have a significant economic
impact on a substantial number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00007 </DOCNO>
<PARENT> FR940112-1-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Aviation safety, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend 14 CFR part 71 as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Para. 5000&blank;Class D Airspace
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASO FL D Eglin AFB, FL [New]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Eglin AFB, FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;29
<!-- PJG 0020 minuteslatlong -->
&rsquo;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;34
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Destin-Fort Walton Beach Airport
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;24
<!-- PJG 0020 minuteslatlong -->
&rsquo;01
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;28
<!-- PJG 0020 minuteslatlong -->
&rsquo;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Duke Field
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;23
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 2,600 feet MSL within a 5.5-mile radius of Eglin AFB
and within a 4-mile radius of Destin-Fort Walton Beach Airport; excluding the portion north of a line connecting the
2 points of intersection within a 5.2-mile radius circle centered on Duke Field, and excluding that airspace east
of a line beginning at lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;43
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;21
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W extending north to the 5.2-mile radius and north of a line beginning at lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;43
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;21
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W extending east to the 5.2-mile radius.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASO FL D Eglin AF Aux No 3 Duke Field, FL [New]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Eglin AF, Aux No. 3 Duke Field, FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;23
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Bob Sikes Airport
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;20
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Eglin AFB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;29
<!-- PJG 0020 minuteslatlong -->
&rsquo;13
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;34
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 2,700 feet MSL within a 5.2-mile radius of Eglin AF
Aux No. 3 Duke Field; excluding the portion north of a line connecting the 2 points of intersection with a 4.2-mile radius
circle centered on Bob Sikes Airport; excluding the portion south of a line connecting the 2 points of intersection
within a 5.5-mile radius circle centered on Eglin AFB. This Class D airspace is effective during the specific days
and times established in advance by a Notice to Airmen. The effective days and times will thereafter be continuously
published in the Airport/Facility Directory.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASO FL D Eglin Hurlburt Field, FL [Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Eglin, Hurlburt Field, FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;25
<!-- PJG 0256 minuteslatlong -->
&rsquo;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo;N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0256 minuteslatlong -->
&rsquo;20
<!-- PJG 0256 minuteslatlong -->
&rsquo;
<!-- PJG 0256 minuteslatlong -->
&rsquo;W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Eglin AFB (lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;29
<!-- PJG 0256 minuteslatlong -->
&rsquo;13
<!-- PJG 0256 minuteslatlong -->
&rsquo;
<!-- PJG 0256 minuteslatlong -->
&rsquo;N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0256 minuteslatlong -->
&rsquo;34
<!-- PJG 0256 minuteslatlong -->
&rsquo;
<!-- PJG 0256 minuteslatlong -->
&rsquo;W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 2,500 feet MSL within a 5.3-mile radius of Hurlburt
Field; excluding the portion within the Eglin AFB, FL, Class D airspace area. This Class D airspace is effective during
the specific days and times established in advance by a Notice to Airmen. The effective days and times will thereafter
be continuously published in the Airport/Facility Directory.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Para. 6002&blank;Class E Airspace Areas Designated as a Surface Area for an Airport
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASO FL E2 Crestview, FL [Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Crestview, Bob Sikes Airport, FL
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;20
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Duke Field
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 30
<!-- PJG 0017 degreeslatlong -->
&cir;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;07
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 86
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;23
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Within a 4.2-mile radius of Bob Sikes Airport; excluding the portion south of a line connecting the 2 points of intersection
with a 5.2-mile radius circle centered on Duke Field. This Class D airspace is effective during the specific days and
times established in advance by a Notice to Airmen. The effective days and times will thereafter be continuously published
in the Airport/Facility Directory.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in College Park, Georgia, on December 19, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Michael J. Powderly,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Manager, Air Traffic Division, Southern Region.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;628 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00008 </DOCNO>
<PARENT> FR940112-1-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ASW&hyph;55]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Proposed Modification of Class D Airspace: Hood Army Airfield and Robert Gray Army Airfield, TX 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice proposes to modify the current Class D airspace at Hood Army Airfield (AAF) and Robert Gray AAF, and to establish
Class E airspace at Killeen Municipal Airport, Killeen, TX. The current Class D airspace encompasses Killeen Municipal
Airport and with airspace reclassification, aircraft operators at Killeen Municipal Airport are now required to
establish two-way radio communication with Hood AAF Air Traffic Airport Traffic Control Tower (ATCT) or when Hood
AAF ATCT is closed, Robert Gray AAF ATCT. This notice proposes to remove the airspace surrounding Killeen Municipal
Airport from Hood AAF's Class D airspace and to establish Class E airspace around Killeen Municipal Airport. The intended
effect of this proposal is to maintain adequate Class D airspace and two-way radio communications at Hood AAF and Robert
Gray AAF, to remove Killeen Municipal Airport, TX, from the current Class D airspace, and to establish Class E airspace
around Killeen Municipal Airport, Killeen, TX.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before February 11, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send comments on the proposal in triplicate to Manager, System Management Branch, Air Traffic Division, Southwest
Region, Docket No. 93&hyph;ASW&hyph;55, Department of Transportation, Federal Aviation Administration, Fort
Worth, TX 76193&hyph;0530.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined in the office of the Assistant Chief Counsel, Southwest Region, Federal Aviation
Administration, 2601 Meacham Boulevard, Fort Worth, TX, between 9 a.m. and 3 p.m., Monday through Friday, except
Federal holidays. An informal docket may also be examined during normal business hours at the System Management Branch,
Air Traffic Division Southwest Region, Federal Aviation Administration, 2601 Meacham Boulevard, Fort Worth, TX.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Alvin DeVane, System Management Branch, Department of Transportation, Federal Aviation Administration, Fort
Worth, TX 76193&hyph;0530; telephone: 817&hyph;222&hyph;5595.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views,
or arguments as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy-related aspects of the proposal.
Communications should identify the airspace docket and be submitted in triplicate to the address listed under the
caption 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
ADDRESSES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Commenters wishing the FAA to acknowledge receipt of their comments on this notice must submit, with those comments,
a self-addressed, stamped, postcard containing the following statement: ``Comments to Airspace Docket No. 93&hyph;ASW&hyph;55.''
The postcard will be date and time stamped and returned to the commenter. All communications received before the specified
closing date for comments will be considered before taking action on the proposed rule. The proposal contained in
this notice may be changed in the light of comments received. All comments submitted will be available for examination
in the Office of the Assistant Chief Counsel, at 2601 Meacham Boulevard, Fort Worth, TX, both before and after the closing
date for comments. A report summarizing each substantive public contact with FAA personnel concerned with this rulemaking
will be filed in the docket. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Availability of NPRM's 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Manager, System
Management Branch, Department of Transportation, Federal Aviation Administration, Fort Worth, TX 76193&hyph;0530.
Communications must identify the notice number of this NPRM. Persons interested in being placed on a mailing list
for future NPRM's should also request a copy of Advisory Circular No. 11&hyph;2A that describes the application procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to modify Class D
airspace at Hood AAF and Robert Gray AAF, TX, and to establish Class E airspace at Killeen Municipal Airport, Killeen,
TX. This modification has been requested by both the operators of Hood AAF and the operators of Killeen Municipal Airport.
The proposal would remove that portion of current Class D airspace which surrounds Killeen Municipal Airport and
would establish Class E airspace around Killeen Municipal Airport. The intended effect of this proposal is to maintain
adequate Class D airspace and two-way radio communications to contain instrument flight rule (IFR) operations at
Hood AAF and Robert Gray AAF, TX, to remove Killeen Municipal Airport from the Class D airspace, and to establish Class
E airspace at Killeen Municipal Airport, Killeen, Texas. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The coordinates for this airspace docket are based on North American Datum 83. Class D airspace designations are published
in Paragraph 5000 and Class E airspace areas designated as surface areas for airports are published in Paragraph 6002
of FAA Order 7400.9A dated June 17, 1993, and effective September 16, 1993, which is incorporated by reference in 14
CFR 71.1 (58 FR 36298; July 6, 1993). The Class D and Class E airspace designations listed in this document would be published
subsequently in the Order. 
<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00009 </DOCNO>
<PARENT> FR940112-1-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
that need frequent and routine amendments to keep them operationally current. It, therefore_(1) is not a ``significant
regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT Regulatory Policies
and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory evaluation as
the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic procedures and
air navigation, it is certified that this rule, when promulgated, will not have a significant impact on a substantial
number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 5000&blank;General
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASW TX D Hood Army Airfield (AAF), TX (Modify)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Hood Army Airfield (AAF), TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;08
<!-- PJG 0020 minuteslatlong -->
&rsquo;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;42
<!-- PJG 0020 minuteslatlong -->
&rsquo;51
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Killeen Municipal Airport, TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;05
<!-- PJG 0020 minuteslatlong -->
&rsquo;08
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Robert Gray Airfield (AAF), TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;40
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 3,500 feet within a 3.8-mile radius of the Hood AAF
excluding that airspace within the Robert Gray AAF, TX, Class D surface area and excluding that airspace southeast
of a direct line between latitude 31
<!-- PJG 0017 degreeslatlong -->
&cir;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., longitude 97
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., and the northeast intersection of the 4.0-mile radius of Killeen Municipal Airport and the 3.8-mile radius
of Hood AAF. This Class D airspace area is effective during the specific dates and times established in advance by a
Notice to Airmen. The effective date and time will thereafter be continuously published in the Airport/Facility
Directory.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASW TX D Robert Gray Army Airfield (AAF), TX [Modify]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Robert Gray Army Airfield (AAF), TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;40
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Hood Army Airfield (AAF), TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;08
<!-- PJG 0020 minuteslatlong -->
&rsquo;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;42
<!-- PJG 0020 minuteslatlong -->
&rsquo;51
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Killeen Municipal Airport, TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;05
<!-- PJG 0020 minuteslatlong -->
&rsquo;08
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 3,500 feet within a 4.7-mile radius of Robert Gray
AAF and within a 3.8-mile radius of Hood AAF, excluding that airspace southeast of a direct line between latitude 31
<!-- PJG 0017 degreeslatlong -->
&cir;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., longitude 97
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., and the northeast intersection of the 4.0-mile radius of Killeen Municipal Airport and the 3.8-mile radius
of Hood AAF, and excluding that airspace within the Hood AAF, TX, Class D surface area when it is effective.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 6002&blank;Class E Airspace Areas Designated as a Surface Area for an Airport
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ASW TX E2 Killeen, TX (New)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Killeen Municipal Airport, TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;05
<!-- PJG 0020 minuteslatlong -->
&rsquo;08
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Hood Army Airfield (AAF), TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;08
<!-- PJG 0020 minuteslatlong -->
&rsquo;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;42
<!-- PJG 0020 minuteslatlong -->
&rsquo;51
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Robert Gray Army Airfield (AAF), TX
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 31
<!-- PJG 0017 degreeslatlong -->
&cir;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 97
<!-- PJG 0017 degreeslatlong -->
&cir;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;40
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface within a 4-mile radius of Killeen Municipal Airport excluding that
airspace within the Robert Gray AAF, TX, Class D surface area and excluding that airspace northwest of a direct line
between latitude 31
<!-- PJG 0017 degreeslatlong -->
&cir;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., longitude 97
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., and the northeast intersection of the 4.0-mile radius of Killeen Municipal Airport and the 3.8-mile radius
of Hood AAF.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Larry L. Craig,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Air Traffic Division, Southwest Region.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;629 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00010 </DOCNO>
<PARENT> FR940112-1-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;35]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Proposed Establishment of Class D Airspace; Hailey, ID
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice proposes to establish Class D airspace at Friedman Memorial Airport, Hailey, Idaho. Midwest ATC Service,
Inc., operates a control tower at Friedman Memorial Airport with an associated airport traffic area. Airspace Reclassification,
which became effective September 16, 1993, discontinued the use of the term ``airport traffic area'' and eliminated
those ATA's not already designated to become Class D airspace. As a result, the requirement for two-way radio communication
with the control tower at Friedman Memorial Airport lapsed. The intended effect of this proposal is to provide adequate
Class D airspace to contain instrument flight rules (IFR) operations and continue the two-way radio communication
requirement at Friedman Memorial Airport.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before February 18, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send comments on the proposal in triplicate to: Manager, System Management Branch, ANM&hyph;530, Federal Aviation
Administration, Docket No. 93&hyph;ANM&hyph;35, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056. Telephone:
(206) 227&hyph;2530.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined at the same address.
<!-- PJG 0012 frnewline -->
An informal docket may also be examined during normal business hours at the address listed above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Robert Brown, Airspace and Procedures Specialist, ANM&hyph;535, Federal Aviation Administration, Docket No.
93&hyph;ANM&hyph;35, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056. Telephone: (206) 227&hyph;2536.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views,
or arguments, as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy related aspects of the proposal.
Communications should identify the airspace docket and be submitted in triplicate to the address listed above. Commenters
wishing the FAA to acknowledge receipt of their comments on this notice must submit with those comments a self-addressed,
stamped postcard on which the following statement is made: ``Comments to Airspace Docket No. 93&hyph;ANM&hyph;35.''
The postcard will be date/time stamped and returned to the commenter. All communications received on or before the
specified closing date for comments will be considered before taking action on the proposed rule. The proposal contained
in this notice may be changed in the light of comments received. All comments submitted will be available for examination
at the address listed above both before and after the closing date for comments. A report summarizing each substantive
public contact with FAA personnel concerned with this rulemaking will be filed in the docket. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Availability of NPRM's
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Federal Aviation
Administration, System Management Branch, ANM&hyph;530, 1601 Lind Avenue, SW., Renton, Washington 98055&hyph;4056.
Cummunications must identify the notice number of this NPRM. Persons interested in being placed on mailing list for
future NPRM's should also request a copy of Advisory Circular No. 11&hyph;2A, which describes the application procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to establish Class
D airspace at Friedman Memorial Airport, Hailey, Idaho. Midwest ATC Service, Inc., operates a control tower at Friedman
Memorial Airport with an associated airport traffic area (ATA). Airspace reclassification, which became effective
September 16, 1993, discontinued the use of the term ``airport traffic area'' and, for control zones with operating
control towers, replaced it with the designation ``Class D airspace.'' Only ATA's already designated to become Class
D airspace continued to exist; Friedman Memorial Airport was not so designated. As a result, the requirement for two-way
radio communication with the control tower at Friedman Memorial Airport lapsed. The intended effect of this proposal
is to provide adequate Class D airspace to contain IFR operations and continue the two-way communication requirement
at Friedman Memorial Airport. The coordinates for this airspace docket are based on North American Datum 83. Class
D airspace is published in paragraph 5000 of FAA Order 7400.9A, dated June 17, 1993, and effective September 16, 1993,
which is incorporated by reference in 14 CFR 71.1 as of September 16, 1993 (58 FR 36398; July 6, 1993). The Class D airspace
listed in the document would be published subsequently in the Order.
<!-- PJG 0012 frnewline -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
for which frequent and routine amendments are necessary to keep them operationally current. It, therefore: (1) Is
not a ``significant regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory
evaluation as the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic
procedures and air navigation, it is certified that this rule will not have a significant economic impact on a substantial
number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects In 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Aviation, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00011 </DOCNO>
<PARENT> FR940112-1-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 5000_General
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM ID D Hailey, Idaho [New]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Friedman Memorial Airport, Hailey, ID
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 43
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;17
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 114
<!-- PJG 0017 degreeslatlong -->
&cir;17
<!-- PJG 0020 minuteslatlong -->
&rsquo;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface to and including 7800 feet MSL within a 4.1-mile radius of the Friedman
Memorial Airport. This Class D airspace area is effective during the specified dates and times established in advance
by a Notice to Airman. The effective date and time will thereafter be continuously published in the Airport/Facility
Directory.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Seattle, Washington, on December 27, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Temple H. Johnson, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Air Traffic Division, Northwest Mountain Region.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;776 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00012 </DOCNO>
<PARENT> FR940112-1-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;39]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Proposed Amendment of Class E Airspace; Lakeview, OR
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice proposes to amend the Lakeview, Oregon Class E airspace. This action is necessary to accommodate a new
instrument approach procedure at the Lake County Airport. The airspace would be depicted on aeronautical charts
for pilot reference
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before February 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send comments on the proposal in triplicate to: Manager, System Management Branch, ANM&hyph;530, Federal Aviation
Administration, Docket No. 93&hyph;ANM&hyph;39, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056, Telephone:
(206) 227&hyph;2530.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined at the same address.
<!-- PJG 0012 frnewline -->
An informal docket may also be examined during normal business hours at the address listed above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Robert Brown, ANM&hyph;535, Federal Aviation Administration, Docket No. 92&hyph;ANM&hyph;39, 1601 Lind Avenue
SW., Renton, Washington 98055&hyph;4056, Telephone: (206) 227&hyph;2535.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views,
or arguments, as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy aspects of the proposal.
Communications should identify the airspace docket and be submitted to the address listed above. Commenters wishing
the FAA to acknowledge receipt of their comments on this notice must submit with those comments a self-addressed,
stamped postcard on which the following statement is made: ``Comments to Airspace Docket No. 93&hyph;ANM&hyph;39.''
The postcard will be date/time stamped and returned to the commenter. All communications received before the specified
closing date for comments will be considered before taking action on the proposed rule. The proposal contained in
this notice may be changed in the light of comments received. All comments submitted will be available for examination
at the address listed above both before and after the closing date for comments. A report summarizing each substantive
public contact with FAA personnel concerned with this rulemaking will be filed in the docket.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Availability of NPRM's 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00013 </DOCNO>
<PARENT> FR940112-1-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Federal Aviation
Administration, System Management Branch, ANM&hyph;530, 1601 Lind Avenue, SW., Renton, Washington 98055&hyph;4056.
Communications must identify the notice number of this NPRM. Persons interested in being placed on mailing list for
future NPRM's should also request a copy of Advisory Circular No. 11&hyph;2A, which describes the application procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to amend the class
E airspace at Lakeview, Oregon, to accommodate a new instrument approach procedure at the Lake County, Airport. The
area would be depicted on aeronautical charts for pilot reference. The coordinates for this airspace docket are based
on North American Datum 83. Class E airspace designations for airspace areas extending upward from 700 feet or more
above the surface of the earth are published in Paragraph 6005 of FAA Order 7400.9A dated June 17, 1993, and effective
September 16, 1993, which is incorporated by reference in 14 CFR 71.1 as of September 16, 1993 (58 FR 36298; July 6, 1993).
The class E airspace designations listed in this document would be published subsequently in the Order.
<!-- PJG 0012 frnewline -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
for which frequent and routine amendments are necessary to keep them operationally current. It, therefore: (1) Is
not a ``significant regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory
evaluation as the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic
procedures and air navigation, it is certified that this rule will not have a significant economic impact on a substantial
number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend 14 CFR part 71, in effect
as of September 16, 1993, as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 6005_
<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=3 -->
Class E Airspace Areas Extending Upward From 700 Feet or More Above the Surface of the Earth
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=3 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=3 -->
ANM OR E5 Lakeview, OR [Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Lake County Airport, OR
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=3 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;09
<!-- PJG 0020 minuteslatlong -->
&rsquo;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 120
<!-- PJG 0017 degreeslatlong -->
&cir;23
<!-- PJG 0020 minuteslatlong -->
&rsquo;57
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Goose NDB, OR
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=3 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;09
<!-- PJG 0020 minuteslatlong -->
&rsquo;11
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 120
<!-- PJG 0017 degreeslatlong -->
&cir;24
<!-- PJG 0020 minuteslatlong -->
&rsquo;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
That airspace extending upward from 700 feet above the surface within a 4.3-mile radius of the Lake County Airport,
and within 1.8 miles each side of the 180
<!-- PJG 0017 degreeslatlong -->
&cir; bearing from the Goose NDB extending from the NDB to 7 miles south of the NDB; that airspace extending upward from
1,200 feet above the surface bounded by a line beginning at lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;22
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 120
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.; to lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;22
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 120
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.; to lat. 41
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long, 120
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W.; to lat. 41
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N., long. 120
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W., to the point of beginning.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=3 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Issued in Seattle, Washington, on December 27, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->
Temple H. Johnson, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=3 -->
Manager, Air Traffic Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=3 -->
[FR Doc. 94&hyph;786 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=3 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00014 </DOCNO>
<PARENT> FR940112-1-00006 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=3 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=3 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;14]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=3 -->
Proposed Amendment to Class E Airspace; Medford, OR
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed rulemaking.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This proposed rule would amend the Medford, Oregon, Class E Airspace. This action is necessary to accomodate an amended
instrument approach procedure and missed approach holding pattern at Medford-Jackson County Airport, Medford,
Oregon. The area would be depicted on aeronautical charts to provide reference for pilots.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before February 15, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Send comments on the proposal in triplicate to: Manager, System Management Branch, ANM&hyph;530, Federal Aviation
Administration, Docket No. 93&hyph;ANM&hyph;14, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined at the same address.
<!-- PJG 0012 frnewline -->
An informal docket may also be examined during normal business hours at the address listed above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Bob Brown, ANM&hyph;535, Federal Aviation Administration, Docket No. 93&hyph;ANM&hyph;14, 1601 Lind Avenue SW.,
Renton, Washington 98055&hyph;4056.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views,
or arguments as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy-related aspects of the proposal.
Communications should identify the airspace docket number and be submitted in triplicate to the address listed above.
Commenters wishing the FAA to acknowledge receipt of their comments on this notice must submit with those comments
a self-addressed, stamped postcard on which the following statement is made: ``Comments to Airspace Docket No. 93&hyph;ANM&hyph;14.''
The postcard will be date/time stamped and returned to the commenter. All communications received on or before the
specified closing date for comments will be considered before taking action on the proposed rule. The proposal contained
in this notice may be changed in the light of comments received. All comments submitted will be available for examination
at the address listed above both before and after the closing date for comments. A report summarizing each substantive
public contact with FAA personnel concerned with this rulemaking will be filed in the docket.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Availability of NPRM's
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Federal Aviation
Administration, System Management Branch, ANM&hyph;530, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056.
Communications must identify the notice number of this NPRM. Persons interested in being placed on a mailing list
for future NPRM's should also request a copy of Advisory Circular No. 11&hyph;2A, which describes the application
procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to amend Class E airspace
at Medford, Oregon to accommodate an amended instrument approach procedure and missed approach holding pattern
at Medford-Jackson County Airport. The area would be depicted on aeronautical charts for pilot reference. The coordinates
for this airspace docket are based on North American Datum 83. Class E airspace designations for airspace areas are
published in paragraphs 6004 and 6005 of FAA Order 7400.9A dated June 17, 1993, and effective September 16, 1993, which
is incorporated by reference in 14 CFR 71.1 as of September 16, 1993 (58 FR 36298; July 6, 1993). The Class E designations
listed in this document would be published subsequently in the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00015 </DOCNO>
<PARENT> FR940112-1-00006 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
for which frequent and routine amendments are necessary to keep them operationally current. It, therefore: (1) Is
not a ``significant regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory
evaluation as the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic
procedures and air navigation, it is certified that this rule, when promulgated, will not have a significant economic
impact on a substantial number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend 14 CFR part 71, in effect
as of September 16, 1993, as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 6004_Class E Airspace Areas Designated as an Extension to a Class D Surface Area
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM OR E5 Medford, OR [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Medford-Jackson County Airport, OR
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;22
<!-- PJG 0020 minuteslatlong -->
&rsquo;20
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;52
<!-- PJG 0020 minuteslatlong -->
&rsquo;21
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Rogue Valley VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;28
<!-- PJG 0020 minuteslatlong -->
&rsquo;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;47
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Pumie LOM
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;27
<!-- PJG 0020 minuteslatlong -->
&rsquo;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface within 1.8 miles west and 2.7 miles east of the Medford ILS localizer
north course extending from the 4.1-mile radius to 2.7 north of Pumie LOM and within 2.7 miles each side of the Rogue
Valley VORTAC 352
<!-- PJG 0017 degreeslatlong -->
&cir; radial extending from the Rogue Valley VORTAC to 11 miles north of the VORTAC, and within 4 miles each side of the
Rogue Valley VORTAC 164
<!-- PJG 0017 degreeslatlong -->
&cir; radial extending from the 4.1-mile radius to 19.3 miles south of the Medford-Jackson County Airport.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
Paragraph 6005_Class E Airspace Areas Extending Upward From 700 Feet or More Above the Surface of The Earth
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM OR E4 Medford, OR
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Medford-Jackson County Airport, OR
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;22
<!-- PJG 0020 minuteslatlong -->
&rsquo;20
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;52
<!-- PJG 0020 minuteslatlong -->
&rsquo;21
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Rogue Valley VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;28
<!-- PJG 0020 minuteslatlong -->
&rsquo;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;47
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Pumie LOM
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;27
<!-- PJG 0020 minuteslatlong -->
&rsquo;03
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Klamath Falls VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;09
<!-- PJG 0020 minuteslatlong -->
&rsquo;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 121
<!-- PJG 0017 degreeslatlong -->
&cir;43
<!-- PJG 0020 minuteslatlong -->
&rsquo;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Fort Jones VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(lat. 41
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;59
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;23
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from 700 feet above the surface within a line from lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;45
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 123
<!-- PJG 0017 degreeslatlong -->
&cir;10
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;48
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;57
<!-- PJG 0020 minuteslatlong -->
&rsquo;06
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W; to lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;36
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W; lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;18
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;58
<!-- PJG 0020 minuteslatlong -->
&rsquo;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W; to lat. 42
<!-- PJG 0017 degreeslatlong -->
&cir;28
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 123
<!-- PJG 0017 degreeslatlong -->
&cir;01
<!-- PJG 0020 minuteslatlong -->
&rsquo;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W; to point of beginning; that airspace extending upward from 1,200 feet above the surface bounded on the east
by V&hyph;452, on the southeast by the 34.8-mile radius of the Klamath Falls VORTAC, on the south by V&hyph;122, on
the west by V&hyph;23, and that airspace southeast of Medford bounded on the north by the south edge of V&hyph;122,
on the east by the 34.8-mile radius of the Klamath Falls VORTAC, on the southeast by a line 4.3 miles southeast and parallel
to the Fort Jones VORTAC 041
<!-- PJG 0017 degreeslatlong -->
&cir; radial, on the west by the east edge of V&hyph;23, and that airspace west of the Rogue Valley VORTAC bounded on
the north by the south edge of V&hyph;287, on the west by the east edge of V&hyph;27, and on the south by the north edge
of V&hyph;122.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Seattle, Washington, on December 27, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Temple H. Johnson, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Air Traffic Division, Northwest Mountain Region.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;787 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00016 </DOCNO>
<PARENT> FR940112-1-00007 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;17]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Proposed Amendment to Class E&hyph;2 Airspace; Oak Harbor, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed rulemaking.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This proposed rule would amend the Oak Harbor, Washington, Class E&hyph;2 airspace. This action is necessary to correct
an error in the airspace description inadvertently committed during the airspace reclassification process. This
action would reduce the size of the Oak Harbor, Washington, Class E&hyph;2 airspace. The area would be depicted on
aeronautical charts for pilot reference.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before February 18, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Send comments on the proposal in triplicate to: Manager, System Management Branch, ANM&hyph;530, Federal Aviation
Administration, Docket No. 93&hyph;ANM&hyph;17, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined at the same address. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
An informal docket may also be examined during normal business hours at the address listed above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Bob Brown, ANM&hyph;535, Federal Aviation Administration, Docket No. 93&hyph;ANM&hyph;17, 1601 Lind Avenue SW.,
Renton, Washington 98055&hyph;4056; telephone number: (206) 227&hyph;2537.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views,
or arguments as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy related aspects of the proposal.
Communications should identify the airspace docket number and be submitted in triplicate to the address listed above.
Commenters wishing the FAA to acknowledge receipt of their comments on this notice must submit with those comments
a self-addressed, stamped postcard on which the following statement is made: ``Comments to Airspace Docket No. 93&hyph;ANM&hyph;17.''
The postcard will be date/time stamped and returned to the Commenter. All communications received on or before the
specified closing date for comments will be considered before taking action on the proposed rule. The proposal contained
in this notice may be changed in the light of comments received. All comments submitted will be available for examination
at the address listed above both before and after the closing date for comments. A report summarizing each substantive
public contact with FAA personnel concerned with this rulemaking will be filed in the docket.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Availability of NPRM's
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Federal Aviation
Administration, System Management Branch, ANM&hyph;530, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056.
Communications must identify the notice number of this NPRM. Persons interested in being placed on a mailing list
for future NPRM's should also request a copy of Advisory Circular No. 11&hyph;2A, which describes the application
procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to amend Class E&hyph;2
airspace at Oak Harbor, WA, to correct an error in the Class E&hyph;2 airspace description. During the airspace reclassification
process the Class E&hyph;2 airspace for Oak Harbor Airpark was miscalculated resulting in the designation of more
controlled airspace than necessary. This action would correct that error. The coordinates for this airspace docket
are based on North American Datum 83. Class E&hyph;2 airspace areas are published in Paragraph 6002 of FAA Order 7400.9A
dated June 17, 1993, and effective September 16, 1993, which is incorporated by reference in 14 CFR 71.1 (58 FR 36298;
July 6, 1993). The Class E&hyph;2 airspace designation listed in this document would be published subsequently in
the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
for which frequent and routine amendments are necessary to keep them operationally current. It, therefore, (1) is
not a ``significant regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory
evaluation as the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic
procedures and air navigation, it is certified that this rule, when promulgated, will not have a significant economic
impact on a substantial number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporation by reference, Navigation (Air).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Paragraph 6002&blank;Airspace areas designated as a surface area for an airport.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
 * * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM WA E&hyph;2 Oak Harbor, WA [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Oak Harbor Airpark, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Lat. 48
<!-- PJG 0017 degreeslatlong -->
&cir;15
<!-- PJG 0020 minuteslatlong -->
&rsquo;05
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 122
<!-- PJG 0017 degreeslatlong -->
&cir;40
<!-- PJG 0020 minuteslatlong -->
&rsquo;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Within a 2.6 mile radius of Oak Harbor Airpark, WA, excluding the portion within the Whidbey Island NAS, WA, Class C
airspace area; within 2.2 mile each side of the 091
<!-- PJG 0017 degreeslatlong -->
&cir; bearing from the airport extending from the 2.6 mile radius to 4.4 miles east of the airport. This Class E airspace
area is effective during the specific dates and times established in advance by a Notice to Airmen. The effective date
and time will thereafter be continuously published in the Airport/Facility Directory.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
 * * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Seattle, Washington, on December 22, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Temple H. Johnson, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Air Traffic Division, Northwest Mountain Region.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;788 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00017 </DOCNO>
<PARENT> FR940112-1-00008 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANM&hyph;9]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Proposed Amendment to Class E Airspace; Coeur d'Alene, Idaho and Spokane, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This proposed rule would amend the Coeur d'Alene, Idaho and Spokane, Washington, Class E airspace areas. This action
is necessary to accommodate a new instrument approach procedure and missed approach holding pattern at Coeur d'Alene
Air Terminal, Coeur d'Alene, Idaho. The areas would be depicted on aeronautical charts to provide reference for pilots.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before February 18, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send comments on the proposal in triplicate to: Manager, System Management Branch, ANM&hyph;530, Federal Aviation
Administration, Docket No. 93&hyph;ANM&hyph;9, 1601 Lind Avenue SW. Renton, Washington, 98055&hyph;4056.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined at the same address.
<!-- PJG 0012 frnewline -->
An informal docket may also be examined during normal business hours at the address listed above.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bob Brown, ANM&hyph;535, Federal Aviation Administration, Docket No. 93&hyph;ANM&hyph;9, 1601 Lind Avenue SW.,
Renton, Washington 98055&hyph;4056.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views,
or arguments as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy related aspects of the proposal.
Communications should identify the airspace docket number and be submitted in triplicate to the address listed above.
Commenters wishing the FAA to acknowledge receipt of their comments on this notice must submit with those comments
a self-addressed, stamped postcard on which the following statement is made: ``Comments to Airspace Docket No. 93&hyph;ANM&hyph;9.''
The postcard will be date/time stamped and returned to the commenter. All communications received on or before the
specified closing date for comments will be considered before taking action on the proposed rule. The proposal contained
in this notice may be changed in the light of comments received. All comments submitted will be available for examination
at the address listed above both before and after the closing date for comments. A report summarizing each substantive
public contact with FAA personnel concerned with this rulemaking will be filed in the docket.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Availability of NPRM's
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Federal Aviation
Administration, System Management Branch, ANM&hyph;530, 1601 Lind Avenue SW., Renton, Washington 98055&hyph;4056.
Communications must identify the notice number of this NPRM. Persons interested in being placed on a mailing list
for future NPRM's should also request a copy of Advisory Circular No. 11&hyph;2A, which describes the application
procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to amend Class E airspace
at Coeur d'Alene, Idaho, and Spokane, Washington, to accommodate a new instrument approach procedure and missed
approach holding pattern at Coeur d'Alene Air Terminal. The areas would be depicted on aeronautical charts for pilot
reference. The coordinates for this airspace docket are based on North American Datum 83. Class E airspace designations
for airspace areas are published in Paragraphs 6004 and 6005 of FAA Order 7400.9A dated June 17, 1993, and effective
September 16, 1993, which is incorporated by reference in 14 CFR 71.1 as of September 16, 1993, (58 FR 36298; July 6,
1993). The Class E designations listed in this document would be published subsequently in the Order.
<!-- PJG 0012 frnewline -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
for which frequent and routine amendments are necessary to keep them operationally current. It, therefore, (1) is
not a ``significant regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory
evaluation as the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic
procedures and air navigation, it is certified that this rule, when promulgated, will not have a significant economic
impact on a substantial number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Airspace, Incorporation by reference, Navigation (Air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend 14 CFR part 71, in effect
as of September 16, 1993, as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation of 14 CFR part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Paragraph 6004&blank;Class E airspace areas designated as an extension to a Class D surface area.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM ID E&hyph;4 Coeur d'Alene, ID [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Coeur d'Alene Air Terminal, ID
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;28
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 116
<!-- PJG 0017 degreeslatlong -->
&cir;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;11
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Coeur d'Alene VOR/DME
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 116
<!-- PJG 0017 degreeslatlong -->
&cir;49
<!-- PJG 0020 minuteslatlong -->
&rsquo;14
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00018 </DOCNO>
<PARENT> FR940112-1-00008 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from the surface within 3.5 miles each side of the Coeur d'Alene VOR/DME 251
<!-- PJG 0017 degreeslatlong -->
&cir; radial extending from the 4.4-mile radius zone to 6 miles southwest of the airport; and that airspace extending
upward from the surface within 1.8 miles each side of the Coeur d'Alene VOR/DME 183
<!-- PJG 0017 degreeslatlong -->
&cir; radial extending from the 4.4-mile radius zone to 8 miles south of the airport.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Paragraph 6005&blank;Class E airspace areas extending upward from 700 feet or more above the surface of the earth.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
ANM WA E5 Spokane, WA [Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Spokane International Airport, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;37
<!-- PJG 0020 minuteslatlong -->
&rsquo;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;32
<!-- PJG 0020 minuteslatlong -->
&rsquo;02
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Fairchild AFB, WA
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;36
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;39
<!-- PJG 0020 minuteslatlong -->
&rsquo;29
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Spokane VORTAC
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;33
<!-- PJG 0020 minuteslatlong -->
&rsquo;54
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;37
<!-- PJG 0020 minuteslatlong -->
&rsquo;37
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Mullan Pass VOR/DME
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
(Lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;27
<!-- PJG 0020 minuteslatlong -->
&rsquo;25
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 115
<!-- PJG 0017 degreeslatlong -->
&cir;38
<!-- PJG 0020 minuteslatlong -->
&rsquo;46
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
That airspace extending upward from 700 feet above the surface bounded on the north by a line beginning at lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;50
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 118
<!-- PJG 0017 degreeslatlong -->
&cir;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, extending to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;50
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;30
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;58
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;51
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;08
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;56
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 116
<!-- PJG 0017 degreeslatlong -->
&cir;47
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 116
<!-- PJG 0017 degreeslatlong -->
&cir;41
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;10
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 116
<!-- PJG 0017 degreeslatlong -->
&cir;44
<!-- PJG 0020 minuteslatlong -->
&rsquo;50
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;31
<!-- PJG 0020 minuteslatlong -->
&rsquo;50
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 116
<!-- PJG 0017 degreeslatlong -->
&cir;56
<!-- PJG 0020 minuteslatlong -->
&rsquo;50
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;40
<!-- PJG 0020 minuteslatlong -->
&rsquo;40
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 116
<!-- PJG 0017 degreeslatlong -->
&cir;56
<!-- PJG 0020 minuteslatlong -->
&rsquo;50
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;37
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;12
<!-- PJG 0020 minuteslatlong -->
&rsquo;50
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;28
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;16
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;17
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 117
<!-- PJG 0017 degreeslatlong -->
&cir;47
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, to lat. 47
<!-- PJG 0017 degreeslatlong -->
&cir;26
<!-- PJG 0020 minuteslatlong -->
&rsquo;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; N, long. 118
<!-- PJG 0017 degreeslatlong -->
&cir;00
<!-- PJG 0020 minuteslatlong -->
&rsquo;04
<!-- PJG 0020 minuteslatlong -->
&rsquo;
<!-- PJG 0020 minuteslatlong -->
&rsquo; W, thence to the point of beginning; that airspace extending upward from 1,200 feet above the surface within
45.3 mile radius of Fairchild AFB, excluding that portion southeast of Spokane bounded on the north by the 33.1-mile
radius of the Fairchild AFB, on the northeast by a line 4 miles south of and parallel to the Spokane VORTAC 107
<!-- PJG 0017 degreeslatlong -->
&cir; radial on the southeast by the 45.3-mile radius of the Fairchild AFB, on the southwest by a line parallel to and
8.7 miles northeast of V&hyph;253, that airspace south of Spokane extending from the 45.3-mile radius bounded on
the east by a line parallel to and 8.7 miles east of V&hyph;253 on the south by V&hyph;536, on the west by the east edge
of V&hyph;444; that airspace southeast of Spokane extending upward from 6,000 feet MSL, bounded on the north by the
33.1-mile radius of Fairchild AFB, on the northeast by a line 4 miles south of and parallel to the Spokane VORTAC 107
<!-- PJG 0017 degreeslatlong -->
&cir; radial, on the southeast by the 45.3-mile radius of the Fairchild AFB, on the southwest by a line parallel to and
8.7 miles northeast of V&hyph;253; The airspace southeast of Spokane extending upward from 7,000 feet MSL bounded
on the northwest by the 45.3-mile radius, on the north by a line 4 miles south of and parallel to the Mullan Pass VOR/DME
260
<!-- PJG 0017 degreeslatlong -->
&cir; radial, on the southeast by the north edge of V&hyph;536 and on the southwest by a line parallel to and 8.7 miles
northeast of V&hyph;253; excluding the Pullman WA, Class E airspace area. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Seattle, Washington, on December 22, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Temple H. Johnson, Jr., 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Air Traffic Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc 94&hyph;789 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00019 </DOCNO>
<PARENT> FR940112-1-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;ANE&hyph;34]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Proposed Alteration of VOR Federal Airways; Maine
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of proposed rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This proposed rule would notify Federal Airways V&hyph;93 and V&hyph;451 located in Maine. Modifying V&hyph;93
and V&hyph;451 is necessary because a section of both airways is defined by radials from the Navy Brunswick, ME, Very
High Frequency Omnidirectional Range/Tactical Air Navigation (VORTAC) facility. Navy Brunswick VORTAC is scheduled
to be decommissioned on April 28, 1994, and the effective date of the final rule, if issued would coincide with that
date.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments must be received on or before March 3, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Send comments on the proposal in triplicate to: Manager, Air Traffic Division, ANE&hyph;500, Docket No. 93&hyph;ANE&hyph;34,
Federal Aviation Administration, 12 New England Executive Park, Burlington, MA 01803.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The official docket may be examined in the Rules Docket, Office of the Chief Counsel, room 916, 800 Independence Avenue,
SW., Washington, DC, weekdays, except Federal holidays, between 8:30 a.m. and 5 p.m.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
An informal docket may also be examined during normal business hours at the office of the Regional Air Traffic Division.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Patricia P. Crawford, Airspace and Obstruction Evaluation Branch (ATP&hyph;240), Airspace-Rules and Aeronautical
Information Division, Air Traffic Rules and Procedures Service, Federal Aviation Administration, 800 Independence
Avenue, SW., Washington, DC 20591; telephone: (202) 267&hyph;9255.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments Invited
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Interested parties are invited to participate in this proposed rulemaking by submitting such written data, views,
or arguments as they may desire. Comments that provide the factual basis supporting the views and suggestions presented
are particularly helpful in developing reasoned regulatory decisions on the proposal. Comments are specifically
invited on the overall regulatory, aeronautical, economic, environmental, and energy-related aspects of the proposal.
Communications should identify the airspace docket number and be submitted in triplicate to the address listed above.
Commenters wishing the FAA to acknowledge receipt of their comments on this notice must submit with those comments
a self-addressed, stamped postcard on which the following statement is made: ``Comments to Airspace Docket No. 93&hyph;ANE&hyph;34.''
The postcard will be date/time stamped and returned to the commenter. All communications received on or before the
specified closing date for comments will be considered before taking action on the proposed rule. The proposal contained
in this notice may be changed in light of comments received. All comments submitted will be available for examination
in the Rules Docket both before and after the closing date for comments. A report summarizing each substantive public
contact with FAA personnel concerned with this rulemaking will be filed in the docket.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Availability of NPRM's
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Any person may obtain a copy of this Notice of Proposed Rulemaking (NPRM) by submitting a request to the Federal Aviation
Administration, Office of Public Affairs, Attention: Public Inquiry Center, APA&hyph;220, 800 Independence Avenue,
SW., Washington, DC 20591, or by calling (202) 267&hyph;3485. Communications must identify the notice number of
this NPRM. Persons interested in being placed on a mailing list for future NPRM's should also request a copy of Advisory
Circular No. 11&hyph;2A, which describes the application procedure.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The FAA is considering an amendment to part 71 of the Federal Aviation Regulations (14 CFR part 71) to modify V&hyph;93
and V&hyph;451. A section of both airways is defined by radials from the Navy Brunswick, ME (NHZ) VORTAC which is scheduled
to be decommissioned on April 28, 1994. This action would ensure that the airways are usable after the navigational
aid has been decommissioned. This proposed action would be come effective concurrent with the decommissioning of
the Navy Brunswick VORTAC. Domestic VOR Federal airways are published in paragraph 6010(a) of FAA Order 7400.9A dated
June 17, 1993, and effective September 16, 1993, which is incorporated by reference in 14 CFR 71.1 (58 FR 36298; July
6, 1993). The airways listed in this document would be published subsequently in the Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FAA has determined that this proposed regulation only involves an established body of technical regulations
for which frequent and routine amendments are necessary to keep them operationally current. It, therefore_(1) is
not a ``significant regulatory action'' under Executive Order 12866; (2) is not a ``significant rule'' under DOT
Regulatory Policies and Procedures (44 FR 11034; February 26, 1979); and (3) does not warrant preparation of a regulatory
evaluation as the anticipated impact is so minimal. Since this is a routine matter that will only affect air traffic
procedures and air navigation, it is certified that this rule, when promulgated, will not have a significant economic
impact on a substantial number of small entities under the criteria of the Regulatory Flexibility Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00020 </DOCNO>
<PARENT> FR940112-1-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=84 g=1 f=2 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Airspace, Incorporation by reference, Navigation (air).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
The Proposed Amendment
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In consideration of the foregoing, the Federal Aviation Administration proposes to amend 14 CFR part 71 as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=2 -->
PART 71_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
1. The authority citation for part 71 continues to read as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;71.1
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
[Amended]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. The incorporation by reference in 14 CFR 71.1 of the Federal Aviation Administration Order 7400.9A, Airspace Designations
and Reporting Points, dated June 17, 1993, and effective September 16, 1993, is amended as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Paragraph 6010(a)_Domestic VOR Federal Airways.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
V&hyph;93&blank;[Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
From Patuxent River, MD, INT Patuxent 013
<!-- PJG 0017 degreeslatlong -->
&cir; and Baltimore, MD, 122
<!-- PJG 0017 degreeslatlong -->
&cir; radials; Baltimore; INT Baltimore 004
<!-- PJG 0017 degreeslatlong -->
&cir; and Lancaster, PA, 214
<!-- PJG 0017 degreeslatlong -->
&cir; radials; Lancaster; Wilkes-Barre, PA; Lake Henry, PA; INT Lake Henry 078
<!-- PJG 0017 degreeslatlong -->
&cir; and Kingston, NY, 270
<!-- PJG 0017 degreeslatlong -->
&cir; radials; Kingston; Pawling, NY; Chester, MA, 12 miles 7 miles wide (4 miles E and 3 miles W of centerline); Keene,
NH; Concord, NH; Kennebunk, ME; INT Kennebunk 045
<!-- PJG 0017 degreeslatlong -->
&cir;T(062
<!-- PJG 0017 degreeslatlong -->
&cir;M) and Bangor, ME, 220
<!-- PJG 0017 degreeslatlong -->
&cir;T(239
<!-- PJG 0017 degreeslatlong -->
&cir;M) radials; Bangor; Princeton, ME; INT Princeton 057
<!-- PJG 0017 degreeslatlong -->
&cir; radial and the United States/Canadian border.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=1 -->
V&hyph;451&blank;[Revised]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
From LaGuardia, NY; INT LaGuardia 063
<!-- PJG 0017 degreeslatlong -->
&cir; and Hampton, NY, 289
<!-- PJG 0017 degreeslatlong -->
&cir; radials; INT Hampton 289
<!-- PJG 0017 degreeslatlong -->
&cir; and Calverton, RI, 044
<!-- PJG 0017 degreeslatlong -->
&cir; radials; INT Calverton 044
<!-- PJG 0017 degreeslatlong -->
&cir; and Groton, CT, 243
<!-- PJG 0017 degreeslatlong -->
&cir; radials; Groton; INT Groton 064
<!-- PJG 0017 degreeslatlong -->
&cir; and Sandy Point, RI; 031
<!-- PJG 0017 degreeslatlong -->
&cir; radials; INT Sandy Point 031
<!-- PJG 0017 degreeslatlong -->
&cir; and Kennebunk, ME, 180
<!-- PJG 0017 degreeslatlong -->
&cir; radials; INT Kennebunk 180
<!-- PJG 0017 degreeslatlong -->
&cir;T(197
<!-- PJG 0017 degreeslatlong -->
&cir;M) and Pease, NH, 093
<!-- PJG 0017 degreeslatlong -->
&cir;T(109
<!-- PJG 0017 degreeslatlong -->
&cir;M) radials.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on January 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Harold W. Becker,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Airspace-Rules and Aeronautical Information Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;784 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00021 </DOCNO>
<PARENT> FR940112-1-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>14 CFR Part 71</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Airspace Docket No. 93&hyph;AGL&hyph;2]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Proposed Alteration VOR Federal Airways
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration (FAA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Proposed rule; withdrawal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This action withdraws the Notice of Proposed Rulemaking (NPRM) published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on October 15, 1993. The NPRM proposed to alter the descriptions of VOR Federal Airways V&hyph;7, V&hyph;51, V&hyph;97,
and V&hyph;399, respectively, by reducing the standard width of these airways. The FAA has determined that withdrawal
of the proposal at this time is warranted because a change in air traffic control (ATC) procedures would alleviate
the need to alter these airways. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This withdrawal is effective January 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Patricia P. Crawford, Airspace and Obstruction Evaluation Branch (ATP&hyph;240), Airspace-Rules and Aeronautical
Information Division, Air Traffic Rules and Procedures Service, Federal Aviation Administration, 800 Independence
Avenue, SW., Washington, DC 20591; telephone: (202) 267&hyph;9255. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On October 15, 1993, a Notice of Proposed Rulemaking was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 to amend 14 CFR part 71 of the Federal Aviation Regulations to alter the descriptions of V&hyph;7, V&hyph;51, V&hyph;97,
and V&hyph;399, respectively, by reducing the standard width of these airways located in the states of Indiana and
Illinois (58 FR 53459). This action was proposed to redefine the lateral boundaries of the airways to provide for more
efficient utilization of the airspace. No comments were received on the proposal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FAA has decided to withdraw the proposal at this time to provide an opportunity to reexamine the operations effecting
these airways in the Lafayette Air Traffic Control Tower (ATCT) and Chicago Air Route Traffic Control Center (ARTCC)
areas. This proposal was initiated to simplify air traffic operations and to provide for more efficient utilization
of that airspace. The FAA has determined that changing the ATC procedures and delegating to Chicago ARTCC the control
responsibility previously handled by Lafayette ATCT would alleviate the need to alter these airways. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 14 CFR Part 71
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Airspace, Incorporation by reference, Navigation (air). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Withdrawal 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In consideration of the foregoing, the Notice of Proposed Rulemaking, Airspace Docket No. 93&hyph;AGL&hyph;2,
as published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on October 15, 1993 (58 FR 53459), is hereby withdrawn.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 49 U.S.C. app. 1348(a), 1354(a), 1510; E.O. 10854, 24 FR 9565, 3 CFR, 1959&hyph;1963 Comp., p. 389; 49 U.S.C. 106(g);
14 CFR 11.69.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Harold W. Becker,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Manager, Airspace-Rules and Aeronautical Information Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;782 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00022 </DOCNO>
<PARENT> FR940112-1-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF ENERGY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Energy Regulatory Commission</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>18 CFR Parts 141, 375 and 385 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RM93&hyph;20&hyph;000] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Electronic Filing of FERC Form No. 1 and Delegation to Chief Accountant; Intent To Act and Response to Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
Issued December 30, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Energy Regulatory Commission, DOE.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed rulemaking; notice of intent to act and response to comments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Federal Energy Regulatory Commission has received comments on its proposal to amend its regulations to provide
for the electronic filing of FERC Form No. 1, ``Annual Report of Major electric utilities, licensees and others''.
The Commission intends to issue a final rule pending the development and testing of the necessary software, and anticipates
that this will be completed for reporting year 1994. The Commission, in this document, is also providing comments
on certain suggestions and recommendations made by interested parties concerning features they believe should
be incorporated in the software.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Form 1 is due on or before April 30, 1994, but no electronic filings. The Commission anticipates it will complete its
final rule in 1994 in order to provide for the electronic filing of Form 1 for the reporting year 1994, due on or before
April 30, 1995.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Richard Mattingly (Legal Information), Electric Rates and Corporate Regulation, Office of the General Counsel,
Federal Energy Regulatory Commission, 825 North Capitol Street NE., Washington, DC 20426, (202) 208&hyph;2070

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
James G. Baird (Technical Information), Office of Chief Accountant, Federal Energy Regulatory Commission, 810
First Street NE., Washington, DC 20426, (202) 219&hyph;2613 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In addition to publishing the full text of this document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, the Commission also provides all interested persons an opportunity to inspect or copy the contents of this document
during normal business hours in room 3104, at 941 North Capitol Street NE., Washington, DC 20426. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission Issuance Posting System (CIPS), an electronic bulletin board service, provides access to the text
of formal documents issued by the Commission. CIPS is available at no charge to the user and may be accessed using a personal
computer with a modem by dialing (202) 208&hyph;1397. To access CIPS, set your communications software to use 300,
1200, or 2400 bps, full duplex, no parity, 8 data bits and 1 stop bit. CIPS can also be accessed at 9600 bps by dialing (202)
208&hyph;1781. The full text of the Final Rule will be available on CIPS for 30 days from the date of issuance. The complete
text on diskette in WordPerfect format may also be purchased from the Commission's copy contractor, La Dorn Systems
Corporation, also located in room 3104, 941 North Capitol Street NE., Washington, DC 20426. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00023 </DOCNO>
<PARENT> FR940112-1-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On July 23, 1993, the Federal Energy Regulatory Commission (Commission) issued a notice of proposed rulemaking (NOPR)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in which the Commission proposed to amend 18 CFR Parts 141 and 385 to provide for the electronic filing of FERC Form No.
1, ``Annual Report of Major electric utilities, licensees and others'' (Form 1). Under the proposed rule, in addition
to paper copies, future Form 1 filings would also be made by means of a computer diskette incorporating software programming
developed by the Commission. Electronic reporting of Form 1 was proposed to commence with reporting year 1993, due
on or before April 30, 1994. No change was proposed in Form 1 itself. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
58 FR 40606 (July 29, 1993); IV FERC Stats. &amp; Regs. &para;32,498 (1993). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission also proposed to amend 18 CFR part 375 to delegate to the Chief Accountant or his designee the authority
to act on requests for waiver of the Form 1 and Form 1&hyph;F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 filing requirements.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
FERC Form No. 1&hyph;F, ``Annual Report of Nonmajor public utilities and licensees.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
No party objected to the proposal to delegate authority to rule on requests for waiver of the Form 1 and Form 1&hyph;F
filing requirements. The proposal is being implemented by a separate order issued concurrently with this notice.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested parties were requested to submit written comments. Comments were received from 22 electric utilities,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
4
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 three industry associations
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and the Energy Information Administration of the U.S. Department of Energy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
American Electric Power System, Arizona Public Service Company, Carolina Power &amp; Light Company, Cincinnati
Gas &amp; Electric Company, Commonwealth Edison Company, Commonwealth Energy System, Delmarva Power &amp; Light
Company, Duke Power Company, Florida Power &amp; Light Company, Florida Power Corporation, Idaho Power Company,
Iowa Illinois Gas &amp; Electric Company, Kansas City Power &amp; Light Company, Kentucky Utilities Company, Nantahala
Power and Light Company, New England Power Service Company, Ohio Edison Company, PSI Energy, Inc., Pennsylvania
Power &amp; Light Company, Southern Company Services, Inc., UtiliCorp United, Inc., Wisconsin Public Service Corporation.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
American Public Power Association, Edison Electric Institute, Wisconsin Utilities Association, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00024 </DOCNO>
<PARENT> FR940112-1-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Having considered these comments, the Commission is deferring issuance of a final rule at this time pending development
and testing of the necessary software. Once that process is complete the Commission intends to issue a final rule providing
for the electronic filing of Form 1. The Commission presently anticipates that that process will be complete in time
for the electronic filing of Form 1 for reporting year 1994, due on or before April 30, 1995. However, there will be no
electronic reporting of Form 1 for reporting year 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the meantime, the Commission believes it useful to comment on certain suggestions and recommendations made by
interested parties concerning features they believe should be incorporated in the software. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Summary of Proposal 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission is presently developing a personal computer (PC) based software package for Form 1 reporting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The software will be available on standard computer diskettes with instructions and documentation, and will be sent
to each Form 1 respondent without charge. This package will display the Form 1, schedule by schedule, on a respondent's
PC. The required data may then be manually key-entered on the respondent's PC. The program will also permit the respondent
to ``import'' the required data from its PC or mainframe computer directly into the software package, thus avoiding
the manual data-entry process. When the data entry process is completed, the respondent, using the software, will
produce a data diskette that will be submitted to the Commission, along with the required paper copies.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The data contained on the data diskette will be in a data base format for use by the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
An IBM compatible, DOS-based system. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The software package will also enable respondents to print paper copies of the form. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission has already initiated the process of procuring the necessary software package for automating Form
1 reporting. The Commission intends to test all aspects of the system, including data input, data output, and print
capability. The Commission also intends to conduct a field test of the software package with volunteer Form 1 respondents.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In the NOPR, the Commission stated that it expected the program to be complete and to have diskettes ready for distribution
to each Form 1 respondent in time to allow reporting for reporting year 1993 by the April 30, 1994 filing deadline; that
time frame is being delayed pending development and testing of the necessary software. Thus, there will be no electronic
reporting of Form 1 for reporting year 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Discussion of Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The commenters generally expressed support for the objectives set forth in the NOPR, although virtually all 
<!-- PJG 0012 frnewline -->
suggested a delay in implementation until at least reporting 
<!-- PJG 0012 frnewline -->
year 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The commenters also made numerous suggestions and recommendations concerning development and implementation
of the proposal. It was the Commission's intention in initiating this proposal that the software would be developed
by the Commission's staff and that modifications or revisions would be made as necessary based on the results of staff
and field tests. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nevertheless, a number of commenters have offered specific suggestions as to features which they believe should
be incorporated in the software, and the Commission has reviewed these various suggestions and is prepared to state
its views on most of these suggestions. Additionally, the Commission's staff will continue to evaluate suggestions
as the software is developed and the field test is undertaken. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Effective Date of Electronic Reporting Requirement and Response to Comments on Software 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A majority of the commenters suggested that implementation be delayed from reporting year 1993; they variously suggest
delays until, for example, reporting year 1994, or voluntary filing in 1994 and mandatory filing in 1995, or until
one year after the software package has been fully tested. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on the comments received, the Commission agrees that the electronic reporting requirement should not be implemented
for the 1993 reporting year. Rather, we believe that the electronic reporting requirement should be delayed pending
development and testing of the required software. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00025 </DOCNO>
<PARENT> FR940112-1-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As stated both in the NOPR and above, the Commission intends to conduct a field test of the Form 1 software with volunteer
respondents and, to the extent needed, modifications will be made. This field testing will be in addition to testing
by the Commission's staff. In order to allow sufficient time for development and testing, the Commission concludes
that the most prudent course at the present time is to defer implementation. 
<!-- PJG 0012 frnewline -->
As noted above, the NOPR only addressed the adoption of an electronic filing requirement and the effective date for
that requirement (and a delegation of authority). It did not address the specifics of the electronic filing, its development
and implementation. The Commission believes that the details of such development and implementation are best done
at the staff level in the first instance. 
<!-- PJG 0012 frnewline -->
Although not specifically solicited in the NOPR, many of the commenters nevertheless made recommendations on features
they would like to see included in the software, or that they felt needed to be included in the software. We anticipate
that many of the recommendations will, in fact, be included in the initial version of the software. There are others
which appear to be worthwhile features which are not contemplated for the initial version software, although they
may be considered and included in future updates. We believe that other recommendations are without merit in that
they are at odds with the intent of the Form 1 as a whole (i.e., uniform reporting), or the purpose of electronic filing.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
It is presently anticipated that the following features suggested by commenters will be incorporated in the initial
software program: 
<!-- PJG 0012 frnewline -->
1. Edit checking within pages and across pages. 
<!-- PJG 0012 frnewline -->
2. Supplemental or continuation page feature. 
<!-- PJG 0012 frnewline -->
3. Use of data base structure in ASCII format. 
<!-- PJG 0012 frnewline -->
4. Compatibility with different types of printers, including laser printers. 
<!-- PJG 0012 frnewline -->
5. Footnote references on schedules by line items and written columns, including headings. 
<!-- PJG 0012 frnewline -->
6. View screen option. 
<!-- PJG 0012 frnewline -->
7. Menu driven screens, including a help function. 
<!-- PJG 0012 frnewline -->
8. Support function to provide assistance to users when implementing the new software. 
<!-- PJG 0012 frnewline -->
9. LAN compatibility. 
<!-- PJG 0012 frnewline -->
Certain additional features suggested by commenters are not considered feasible for incorporation in the initial
software, but may merit consideration in future software updates. 
<!-- PJG 0012 frnewline -->
These features include the following: 
<!-- PJG 0012 frnewline -->
1. Submission by modem rather than diskette. 
<!-- PJG 0012 frnewline -->
2. Electronic dissemination capability to others. 
<!-- PJG 0012 frnewline -->
3. Incorporation of filings on a ``bulletin board'' accessible to the public. 
<!-- PJG 0012 frnewline -->
4. Providing a diskette to update Form 1 schedules without reissue of the entire software package each year. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00026 </DOCNO>
<PARENT> FR940112-1-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
5. Providing a capability to carry over data from year to year in instances where there is no change in the data to be reported.

<!-- PJG 0012 frnewline -->
6. Providing a capability to extract portions of the program onto diskettes for distribution to various individual
departments. 
<!-- PJG 0012 frnewline -->
Certain additional proposed features have been determined to be inconsistent with the basic Form 1 objective of uniform
reporting by the electric utility industry, and are therefore rejected. These features include the following: 
<!-- PJG 0012 frnewline -->
1. Providing a capability to insert user defined rows. 
<!-- PJG 0012 frnewline -->
2. Allowing for center, left and right justification of data within columns. 
<!-- PJG 0012 frnewline -->
3. Elimination of General Instruction II (use of whole numbers, dollars or MWH). 
<!-- PJG 0012 frnewline -->
4. Providing compatibility of the software with Lotus 1&hyph;2&hyph;3 spreadsheet or Windows.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
However, the Commission's software will allow a user to export data files to ASCII, which can then be read by spreadsheets
or other software; also, the Commission's software can be run in a DOS session within windows. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
American Electric Power System (AEP) and Utilicorp United, Inc. suggest that the Form 1 software should be made compatible
with the Securities and Exchange Commission's Electric Data Gathering Analysis and Retrieval (EDGAR) system, or
that a system should be adopted based on EDGAR. The Commission declines to adopt this suggestion. In developing requirements
for the electronic filing of Form 1, a number of approaches were considered initially, including the EDGAR system.
The approach chosen was based on the Commission's information needs, as well as the estimated costs of development
and implementation. It was concluded that the software program should be consistent with the current information
and data formats of Form 1. Consequently the EDGAR approach was not, and is not, adopted. 
<!-- PJG 0012 frnewline -->
Delmarva Power &amp; Light Company and Edison Electric Institute (EEI) suggest that the software program be based
on (or similar to) EEI's electronic Uniform Statistical Report (USR). The Commission declines to adopt this recommendation.
Form 1 reporting is more extensive than that for the USR. Because of the unique information requirements of Form 1,
compatibility with the USR program would be difficult to develop and maintain and would not be cost effective. 
<!-- PJG 0012 frnewline -->
CG&amp;E suggests that, for combination gas and electric utilities, Form 1 reporting under the Federal Power Act
should be compatible with Form 2 reporting under the Natural Gas Act. At this time, there are no plans to attempt to make
Form 1 and Form 2 reporting electronically compatible. 
<!-- PJG 0012 frnewline -->
Florida Power &amp; Light Company (FP&amp;L), Florida Power Corporation, and EEI argue that, because of the emergence
of competition in the industry, sensitive competitive data should no longer be required or publicly disclosed, citing
as an example electric generating plant operating statistics. This issue is beyond the scope of this proceeding and
the Commission will therefore not address it. 
<!-- PJG 0012 frnewline -->
FP&amp;L argues that, before continuing with the electronic filing project, the Commission should review the actual
data required to be reported on Form 1, and should eliminate obsolete or unnecessary information. The subject matter
of this proceeding is the electronic filing of Form 1. It was not intended as, and is not, a forum for evaluation of the
need for the data presently required to be reported. Accordingly, as the issue is beyond the scope of this proceeding,
the Commission will not address it. 
<!-- PJG 0012 frnewline -->
Utilicorp United, Inc. argues that the existing systems used by the many Form 1 respondents are incompatible and that
no product or program exists to convert them to a usable computer format. The Commission agrees that no comprehensive
program exists to convert the various systems in use to the Commission's electronic software. The Commission anticipates,
however, that the Form 1 software program will allow the respondents to develop and use such a conversion program.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Conclusion 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, in light of the foregoing, the Commission hereby gives notice of its intent to defer issuance of a final
rule prescribing the electronic filing of Form 1 at this time. 
<!-- PJG 0012 frnewline -->
The Commission expects that it will issue a final rule in 1994 to 
<!-- PJG 0012 frnewline -->
provide for the electronic filing of Form 1 for reporting year 1994, due on or before April 30, 1995. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By direction of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;682 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00027 </DOCNO>
<PARENT> FR940112-1-00012 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>18 CFR Parts 141 and 388 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RM94&hyph;5&hyph;000] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Treatment of Responses to FERC 
<!-- PJG 0012 frnewline -->
Form No. 580 Interrogatories; Notice of Extension of Time for Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Energy Regulatory Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed rulemaking; extension of time for comments. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On November 24, 1993, the Commission issued a notice of proposed rulemaking that proposes to amend its regulations
to codify an existing requirement for each public utility with a steam-electric generating station of 50 megawatts
or more to file responses to FERC Form 580 interrogatories (58 FR 63312, December 1, 1993). The date for filing comments
is being extended at the request of various interested commenters. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The date for filing comments is extended to and including March 4, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of the Secretary, 825 North Capitol Street, NE., Washington, DC 20426.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Lois D. Cashell, Secretary, (202) 208&hyph;0400.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;684 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00028 </DOCNO>
<PARENT> FR940112-1-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF THE TREASURY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Internal Revenue Service</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>26 CFR Part 1 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[INTL&hyph;0068&hyph;92] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 1545&hyph;AR18 </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Computation of Combined Taxable Income Under the Profit Split Method When the Possession Product Is a Component Product
or an End-Product Form 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Internal Revenue Service (IRS), Treasury.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed rulemaking.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document contains proposed Income Tax Regulations relating to the determination of combined taxable income
under the profit split method. These regulations would amend the current regulations and provide revised rules in
order for taxpayers to compute the combined taxable income under profit split when the possession product chosen
for purposes of section 936(h)(5) of the Internal Revenue Code is a component product or an end-product form. These
regulations are necessary to provide guidance to taxpayers electing the profit split method of computing taxable
income under section 936(h)(5).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments and requests for a public hearing must be received by March 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Send submissions to: Internal Revenue Service, P.O. Box 7604, Ben Franklin Station, Attention: CC:CORP:T:R (INTL&hyph;0068&hyph;92),
room 5228, Washington, DC 20044. In the alternative, submissions may be hand delivered to: CC:DOM:CORP:T:R (INTL&hyph;0068&hyph;92),
Internal Revenue Service, room 5228, 1111 Constitution Avenue, NW., Washington, DC 20224.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Jacob Feldman or Mary Gillmarten of the Office of Associate Chief Counsel (International), Internal Revenue Service,
at 202&hyph;622&hyph;3870 (not a toll-free number). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
This document contains proposed amendments to the Income Tax Regulations (26 CFR part 1) under section 936 of the Internal
Revenue Code of 1986. These amendments to the regulations are proposed to provide simplified rules for computing
combined taxable income under the profit split method for a taxpayer that has chosen a component product or an end-product
form as its possession product. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Explanation of Provisions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The proposed regulations would amend &sect;1.936&hyph;6(b)(1), 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 12, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
with conforming changes made to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 10, A. 11, and A. 13. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the proposed revision, where the possession product is a component product or an end-product form, the combined
taxable income attributable to the possession product will be determined by multiplying the combined taxable income
of the possession corporation and affiliated groups derived from covered sales of integrated products (which includes
the possession product) by a production cost ratio. In the case of a component product, the combined taxable income
of the integrated product would be multiplied by a ratio, the numerator of which equals the production costs of the
component product and the denominator of which equals the production costs of the integrated product. The combined
taxable income of an end-product form is determined in a similar manner using the production costs of the end-product
form. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed change is intended to simplify the computation of combined taxable income under 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 12 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
and to eliminate the need to apply section 482 in cases in which a possession product is a component product or an end-product
form. No inference is intended as to the interpretation or scope of current regulations by the revisions proposed
herein. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The example under &sect;1.936&hyph;6(b)(1), 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 12 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
is modified to reflect the revised rule. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Proposed Effective Date 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The changes made in this document are proposed to be effective for taxable years beginning after December 31, 1993.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00029 </DOCNO>
<PARENT> FR940112-1-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Special Analyses 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
It has been determined that this notice of proposed rulemaking is not a significant regulatory action as defined in
Executive Order 12866. It also has been determined that section 553(b) of the Administrative Procedure Act (5 U.S.C.
chapter 5) and the Regulatory Flexibility Act (5 U.S.C. chapter 6) do not apply to these regulations and, therefore,
a Regulatory Flexibility Analysis is not required. Pursuant to section 7805(f) of the Internal Revenue Code, a copy
of this notice of proposed rulemaking will be submitted to the Chief Counsel for Advocacy of the Small Business Administration
for comment on its impact on small business. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Comments and Request for Public Hearing 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Before these proposed regulations are adopted as final regulations, consideration will be given to any written comments
that are submitted timely (preferably a signed original and eight copies) to the IRS. All comments will be available
for public inspection and copying. A public hearing may be scheduled if requested in writing by a person that timely
submits written comments. If a public hearing is scheduled, notice of the date, time, and place for the hearing will
be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Drafting Information 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The principal author of these proposed regulations is Mary Gillmarten of the Office of Associate Chief Counsel (International),
Internal Revenue Service. Other personnel from the Internal Revenue Service and Treasury Department participated
in developing the regulations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 26 CFR Part 1 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Income taxes, Reporting and recordkeeping requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Proposed Amendments to the Regulations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, 26 CFR part 1 is proposed to be amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 1_INCOME TAXES 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Paragraph 1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The authority citation for part 1 continues to read in part as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 26 U.S.C. 7805 *&blank;*&blank;* 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Par. 2.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The heading of &sect;1.936&hyph;6 is amended by removing the colon after the word ``make'' and by adding in its place
a semicolon.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Par. 3.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Section 1.936&hyph;6, paragraph (b)(1) is amended by: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Revising 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Designating the first sentence of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 11
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 as paragraph (i) and revising it. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Designating the flush text and example following newly designated 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 11 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(i) as paragraph (ii). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Revising 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Revising 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. The revisions read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00030 </DOCNO>
<PARENT> FR940112-1-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;1.936&hyph;6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Intangible property income when an election out is made; cost sharing and profit split options; covered intangibles.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) *&blank;*&blank;* (1) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q. 10:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 If the possessions corporation is entitled to use the profit split method in the situation described in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q. 9
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (leasing units of the possession product or use of such units in the taxpayer's own trade or business), how should it
compute combined taxable income with respect to such units? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 10:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 In the case of an integrated product, combined taxable income shall be computed as if the U.S. affiliate had sold the
units to an unrelated person (or to a foreign affiliate) at the time the units were first leased or otherwise placed
in service by the U.S. affiliate. The sales price shall be equal to the sales price from comparable uncontrolled transactions
determined in accordance with &sect;1.482&hyph;2(e)(2). If a sales price from comparable uncontrolled transactions
cannot be determined in accordance with &sect;1.482&hyph;2(e)(2), then the taxpayer shall not be treated as having
possession sales with respect to such leasing transaction. If the possession product is a component product or an
end-product form, and there is a comparable uncontrolled price for the integrated product which includes the possession
product, the combined taxable income with respect to the possession product shall be determined under 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of this paragraph (b)(1). For purposes of determining the basis of a component product or an end-product form, the
deemed sales price of such product must be determined. The deemed sales price of the component product shall be determined
by multiplying the deemed sales price of the integrated product by a ratio, the numerator of which is the production
costs of the component product and the denominator of which is the production costs of the integrated product. The
deemed sales price of an end-product form shall be determined by multiplying the deemed sales price of the integrated
product by a ratio, the numerator of which is the production costs of the end-product form and the denominator of which
is the production costs of the integrated product. The definition of production costs with respect to the component
product or end-product form shall be determined under the rules of 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of this paragraph (b)(1). The full amount of income received under the lease shall be treated as income of (and taxed
to) the U.S. affiliate and not the possessions corporation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 11:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (i) The U.S. affiliate shall be treated, for purposes of computing its basis in such units, as if it had repurchased
such units immediately following the deemed sale and at the deemed sales price as provided in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q &amp; A. 10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of this paragraph (b)(1). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(ii)&blank;*&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00031 </DOCNO>
<PARENT> FR940112-1-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Q. 12:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 If the possession product is a component product or an end-product form, how is the combined taxable income for such
product to be determined? 
<!-- PJG 0012 frnewline -->
A. 12: (i) Combined taxable income for a component product or an end-product form is computed under the production
cost ratio (PCR) method. 
<!-- PJG 0012 frnewline -->
(ii) Under the PCR method, the combined taxable income for a component product will be the same proportion of the combined
taxable income for the integrated product which the production costs attributable to the component product bear
to the total production costs for the integrated product. Production costs will be the sum of the direct and indirect
production costs as defined for inventory accounting purposes under &sect;1.471&hyph;11 (b), (c) or (d), except
that the costs will not include the costs of materials. 
<!-- PJG 0012 frnewline -->
(iii) Under the PCR method the combined taxable income for an end-product form will be the same proportion of the combined
taxable income for the integrated product which the production costs attributable to the end-product form bear to
the total production costs for the integrated product. Production costs will be the sum of the direct and indirect
production costs as defined for inventory accounting purposes under &sect;1.471&hyph;11 (b), (c) or (d), except
that the costs will not include the costs of materials.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(iv) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Example. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The following example illustrates a possessions corporation, S, engaged in the manufacture of microprocessors.
S obtains a component from a U.S. affiliate, O. S sells its production to another U.S. affiliate, P, which incorporates
the microprocessors into central processing units (CPUs). P transfers the CPUs to a U.S. affiliate, Q, which incorporates
the CPUs into computers for sale to unrelated persons. S chooses to define the possession product as the CPUs. The combined
taxable income for the sale of the possession product on the basis of the given production, sales, and cost data is computed
below: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L0,tp0,p0,8/9,g1,t1,i1,s200,7 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Production costs (excluding costs of materials): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
1. O's costs for the component 
<!-- PJG 007 0104 intable -->
 100 
<!-- PJG 0012 frnewline -->
2. S's costs for the microprocessors 
<!-- PJG 007 0104 intable -->
500 
<!-- PJG 0012 frnewline -->
3. P's costs for the CPU's (the possession 
<!-- PJG 0012 frnewline -->
product) 
<!-- PJG 007 0104 intable -->
200 
<!-- PJG 0012 frnewline -->
4. Q's costs for the computers 
<!-- PJG 007 0104 intable -->
400 
<!-- PJG 0012 frnewline -->
5. Total production costs for the computer 
<!-- PJG 0012 frnewline -->
(Add lines 1 through 4) 
<!-- PJG 007 0104 intable -->
1,200 
<!-- PJG 0012 frnewline -->
6. Combined production costs for the CPU 
<!-- PJG 0012 frnewline -->
(the possession product) (Add lines 1 
<!-- PJG 0012 frnewline -->
through 3) 
<!-- PJG 007 0104 intable -->
800 
<!-- PJG 0012 frnewline -->
7. Ratio of production costs for the CPUs 
<!-- PJG 0012 frnewline -->
(the possession product) to the production 
<!-- PJG 0012 frnewline -->
costs for the computer (the integrated 
<!-- PJG 0012 frnewline -->
product) 
<!-- PJG 007 0104 intable -->
0.667 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=3 -->
Determination of combined taxable income for computers_Sales: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
8. Total possession sales of computers to unrelated customers and foreign affiliates 
<!-- PJG 007 0104 intable -->
7,500 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=3 -->
Total costs of O, S, P, and Q incurred in production 
<!-- PJG 0012 frnewline -->
of a computer: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
9. Production costs 
<!-- PJG 0012 frnewline -->
(enter from line 5) 
<!-- PJG 007 0104 intable -->
1,200 
<!-- PJG 0012 frnewline -->
10. Material costs 
<!-- PJG 007 0104 intable -->
100 
<!-- PJG 0012 frnewline -->
11. Total costs (line 9 plus line 10) 
<!-- PJG 007 0104 intable -->
1,300 
<!-- PJG 0012 frnewline -->
12. Combined gross income from sale of computers 
<!-- PJG 0012 frnewline -->
(line 8 minus line 11) 
<!-- PJG 007 0104 intable -->
6,200 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=3 -->
Expenses of the affiliated group (other than 
<!-- PJG 0012 frnewline -->
foreign affiliates) allocable and apportionable 
<!-- PJG 0012 frnewline -->
to the computers or any component thereof under 
<!-- PJG 0012 frnewline -->
the rules of &sect;&sect;1.861&hyph;8 through 1.861&hyph;14T and 1.936&hyph;6(b)(1), Question and Answer 1:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
13. Expenses (other than research expenses) 
<!-- PJG 007 0104 intable -->
980 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=3 -->
Research expenses of the affiliated group allocable 
<!-- PJG 0012 frnewline -->
and apportionable to the computers: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=3 -->
14. Total sales in the 3-digit SIC Code 
<!-- PJG 007 0104 intable -->
12,500 
<!-- PJG 0012 frnewline -->
15. Possession sales (enter from line 8) 
<!-- PJG 007 0104 intable -->
7,500 
<!-- PJG 0012 frnewline -->
16. Cost sharing fraction 
<!-- PJG 0012 frnewline -->
(divide line 15 by line 14) 
<!-- PJG 007 0104 intable -->
0.6 
<!-- PJG 0012 frnewline -->
17. Research expenses incurred by the affiliated 
<!-- PJG 0012 frnewline -->
group in 3-digit SIC Code multiplied by 120 
<!-- PJG 0012 frnewline -->
percent 
<!-- PJG 007 0104 intable -->
700 
<!-- PJG 0012 frnewline -->
18. Cost sharing amount 
<!-- PJG 0012 frnewline -->
(multiply line 16 by line 17) 
<!-- PJG 007 0104 intable -->
420 
<!-- PJG 0012 frnewline -->
19. Research of the affiliated group (other than 
<!-- PJG 0012 frnewline -->
foreign affiliates) allocable and apportionable 
<!-- PJG 0012 frnewline -->
under &sect;&sect;1.861&hyph;8(e)(3) and 1.861&hyph;14T(e)(2) 
<!-- PJG 0012 frnewline -->
to the computers (the integrated product). 
<!-- PJG 007 0104 intable -->
300 
<!-- PJG 0012 frnewline -->
20. Enter the greater of line 18 or line 19 
<!-- PJG 007 0104 intable -->
420 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=3 -->
Computation of combined taxable income of the computer and the CPU:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
21. Combined taxable income attributable to the 
<!-- PJG 0012 frnewline -->
computer (line 12 minus line 13 and line 20) 
<!-- PJG 007 0104 intable -->
 4,800 
<!-- PJG 0012 frnewline -->
22. Combined taxable income attributable to CPUs 
<!-- PJG 0012 frnewline -->
(multiply line 21 by line 7) (production cost ratio) 
<!-- PJG 007 0104 intable -->
3,200 
<!-- PJG 0012 frnewline -->
23. Share of combined taxable income apportioned 
<!-- PJG 0012 frnewline -->
to S (50 percent of line 22) 
<!-- PJG 007 0104 intable -->
1,600 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=3 -->
Share of combined taxable income apportioned to U.S. affiliate(s) of S:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
24. Adjustments for research expenses (line 18 
<!-- PJG 0012 frnewline -->
minus line 19 multiplied by line 7) 
<!-- PJG 007 0104 intable -->
80 
<!-- PJG 0012 frnewline -->
25. Adjusted combined taxable income 
<!-- PJG 0012 frnewline -->
(line 22 plus line 24) 
<!-- PJG 007 0104 intable -->
3,280 
<!-- PJG 0012 frnewline -->
26. Share of combined taxable income apportioned 
<!-- PJG 0012 frnewline -->
to affiliates of S (line 25 minus line 23) 
<!-- PJG 007 0104 intable -->
1,680 
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 13:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (i) The income shall be allocated to U.S. affiliates as follows_
<!-- PJG 0012 frnewline -->
(A) First, to U.S. affiliates (other than tax-exempt affiliates) within the group (as determined under section 482)
which derive income with respect to the product produced in whole or in part in the possession; 
<!-- PJG 0012 frnewline -->
(B) Second, to U.S. affiliates (other than tax-exempt affiliates) which derive income from the active conduct of
a trade or business in the same product area as the possession product; 
<!-- PJG 0012 frnewline -->
(C) Third, to other U.S. affiliates (other than tax-exempt affiliates); 
<!-- PJG 0012 frnewline -->
(D) Fourth, to foreign affiliates which derive income from the active conduct of a U.S. trade or business in the same
product area as the possession product (or, if the foreign members are resident in a country with which the U.S. has
an income tax convention, then to those foreign members that have a permanent establishment in the United States which
derives income in the same product area as the possession product); and 
<!-- PJG 0012 frnewline -->
(E) Fifth, to all other affiliates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00032 </DOCNO>
<PARENT> FR940112-1-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(ii) The allocations made under paragraph (i)(A) of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 shall be made on the basis of the relative gross income derived by each such affiliate with respect to the product produced
in whole or in part in the possession. Where the product is a component product, the relative gross income with respect
to the component product shall be determined by multiplying the relative gross income of the integrated product by
a ratio, the numerator of which is the production costs of the component product and the denominator of which is the
production costs of the integrated product. Where the product is an end-product form, the relative gross income of
an end-product form shall be determined by multiplying the gross income of the integrated product by a ratio, the numerator
of which is the production costs of the end-product form and the denominator of which is the production costs of the
integrated product. 
<!-- PJG 0012 frnewline -->
(iii) The allocations made under paragraphs (i)(B) and (i)(D) of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 shall be made on the basis of the relative gross income derived by each such affiliate from the active conduct of the
trade or business in the same product area. 
<!-- PJG 0012 frnewline -->
(iv) The allocations made under paragraphs (i)(C) and (i)(E) of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A. 13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 shall be made on the basis of the relative total gross income of each such affiliate before allocating income under
this section. 
<!-- PJG 0012 frnewline -->
(v) Income allocated to affiliates shall be treated as U.S. source and section 863(b) does not apply for this purpose.
For purposes of determining an affiliate's estimated tax liability with respect to income thus allocated, the income
shall be deemed to be received on the last day of the taxable year of each such affiliate in which or with which the taxable
year of the possessions corporation ends. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret Milner Richardson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=3 -->
Commissioner of Internal Revenue
<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;668 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4830&hyph;01&hyph;U
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00033 </DOCNO>
<PARENT> FR940112-1-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF LABOR</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Pension and Welfare Benefits Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>29 CFR Part 2530</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Qualified Domestic Relations Orders
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pension and Welfare Benefits Administration, Labor.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Reopening and extension of comment period.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This document reopens and extends the comment period regarding a request for information by the Department of Labor
(the Department) to assist it in assessing the need for a regulation clarifying certain statutory requirements set
forth in title I of the Employee Retirement Income Security Act (ERISA) and the Internal Revenue Code (the Code) with
regard to qualified domestic relations orders (QDROs). The request for information was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 on October 21, 1993 (58 FR 54444).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department has received a number of requests from members of the public for additional time to prepare comments.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The comment period is reopened and extended through February 18, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments (preferably at least six copies) should be addressed to the Office of Regulations and Interpretations,
Pension and Welfare Benefits Administration, room N&hyph;5669, U.S. Department of Labor, Washington, DC 20210.
Attention: QDRO RFI. All comments received will be available for public inspection at the Public Disclosure Room,
Pension and Welfare Benefits Administration, U.S. Department of Labor, room N&hyph;5507, 200 Constitution Ave.,
NW., Washington, DC 20210.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Deborah Hobbs, Office of Regulations and Interpretations, Pension and Welfare Benefits Administration, U.S. Department
of Labor, Washington, DC 20210, telephone (202) 219&hyph;7901; or Susan Rees, Plan Benefits Security Division,
Office of the Solicitor, U.S. Department of Labor, Washington, DC 20210, telephone (202) 219&hyph;9141. These are
not toll-free numbers.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On October 21, 1993, the Department published a request for information in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 (58 FR 54444) to assist it in assessing the need for a regulation clarifying certain statutory requirements set forth
in title I of ERISA and in the Code with regard to qualified domestic relations orders. In that notice, the Department
invited all interested persons to submit written comments concerning the request for information on or before December
20, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department has received a number of requests from members of the public for additional time to prepare comments.
In order to provide the public with an additional opportunity to submit comments, the Department believes that it
is appropriate to reopen and extend the comment period. Accordingly, this notice reopens and extends the period during
which comments on the request for information will be received through Friday, February 18, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice of Reopening and Extension of Comment Period
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given that the period of time for submission of public comments in response to the request for information
concerning qualified domestic relations orders, published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on October 21, 1993, is reopened and extended through February 18, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Signed at Washington, DC, this 30th day of December, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Olena Berg,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Pension and Welfare Benefits, U.S. Department of Labor.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;639 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4510&hyph;29&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00034 </DOCNO>
<PARENT> FR940112-1-00015 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>ENVIRONMENTAL PROTECTION AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>40 CFR Part 52</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[DE15&hyph;1&hyph;6000; A&hyph;1-FRL&hyph;4825&hyph;6]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Approval and Promulgation of Air Quality Implementation Plans; Delaware&hyph;Small Business Stationary Source
Technical and Environmental Compliance Assistance Program
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Proposed rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 EPA is proposing to approve a State Implementation Plan (SIP) revision submitted by the State of Delaware for the purpose
of establishing a Small Business Stationary Source Technical and Environmental Compliance Assistance Program
(SBTCP). This SIP revision was submitted by Delaware to satisfy the Federal mandate of the Clean Air Act (CAA) to ensure
that small businesses have access to the technical assistance and regulatory information necessary to comply with
the CAA. The rational for approving is set forth in this notice; additional information is available at the address
indicated below. This action is being taken in accordance with the provisions of the Clean Air Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before February 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments may be mailed to Thomas J. Maslany, Director, Air, Radiation, and Toxics Division, U.S. Environmental Protection
Agency, Region III, 841 Chestnut Building, Philadelphia, PA 19107. Copies of the documents relevant to this action
are available for public inspection during normal business hours at the Air, Radiation, and Toxics Division, U.S.
Environmental Protection Agency, Region III, 841 Chestnut Building, Philadelphia, PA 19107; Jerry Kurtzweg (ANR&hyph;443),
U.S. Environmental Protection Agency, 401 M Street, SW., Washington, DC 20460; and Delaware Department of Natural
Resources and Environmental Control, P.O. Box 1401, Dover Delaware 19903. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Lisa M. Donahue, (215) 597&hyph;9781.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Background
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Implementation of the provisions the CAA will require regulation of many small businesses so that areas may attain
and maintain the National ambient air quality standards (NAAQS) and reduce the emission of air toxics. Small businesses
frequently lack the technical expertise and financial resources necessary to evaluate such regulations and to determine
the appropriate mechanisms for compliance. In anticipation of the impact of these requirements on small businesses,
the CAA requires that states adopt a Small Business Stationary Source Technical and Environmental Compliance Assistance
Program, and submit this Program as a revision to the federally approved SIP. In addition, the CAA directs EPA to oversee
these small business assistance programs and report to Congress on their implementation. The requirements for establishing
a Program are set out in section 507 of title V of the CAA. In February 1992, EPA issued 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guidelines for the Implementation of Section 507 of the 1990 Clean Air Act Amendments
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, in order to delineate the Federal and state roles in meeting the new statutory provisions and as a tool to provide further
guidance to the states on submitting acceptable SIP revisions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On January 11, 1993, the State of Delaware submitted a formal revision to its SIP. The SIP revision consists of a plan
for establishing an SBTCP. In order to gain full approval, the state submittal must provide for each of the following
program elements: (1) The establishment of a Small Business Assistance Program (SBAP) to provide technical and compliance
assistance to small businesses; (2) the establishment of a State Small Business Ombudsman to represent the interests
of small businesses in the regulatory process; and (3) the creation of a Compliance Advisory Panel (CAP) to determine
and report on the overall effectiveness of the SBAP. The plan must also determine the eligibility of small business
stationary sources for assistance in the program. The plan includes the duties, funding, and schedule of implementation
for the three program components.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Delaware Department of Natural Resources and Environmental Control (DE DNREC) is authorized to create and administer
the SBTCP. Delaware DNREC can create and administer the SBAP, and create the Office of the Ombudsman. Through an executive
order, the Governor of the State of Delaware will establish the Compliance Advisory Panel. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Summary and Analysis of SIP Revision 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 507(a) of the CAA sets forth seven requirements that Delaware must meet to have an approvable SBAP. Three requirements
will be discussed in the first section, and the remaining four requirements, including the establishment of an Ombudsman,
in the second section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
1. Small Business Assistance Program
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The first requirement is to establish adequate mechanisms for developing, collecting and coordinating information
concerning compliance methods and technologies for small business stationary sources, and programs to encourage
lawful cooperation among such sources and other persons to further compliance with the CAA. Delaware has met this
requirement by establishing a SBAP, with the responsibility of serving as a clearinghouse for information related
to compliance methods and control technologies. 
<!-- PJG 0012 frnewline -->
Small businesses will be referred to state technical experts specifically trained to handle questions relevant
to achieving compliance with the CAA. The SBAP will be coordinated through the Air Quality Management Section and
will respond to inquiries from small businesses received through the ombudsman's toll-free hotline. Information
workshops, industry-specific compliance publications, and roundtable groups are examples of planned outreach
activities. A list of potentially affected parties will be developed in conjunction with the State of Delaware Department
of Labor.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The second requirement is to establish adequate mechanisms for assisting small business stationary sources with
pollution prevention and accidental release detection and prevention, including providing information concerning
alternative technologies, process changes, products and methods of operation that help reduce air pollution. Delaware
DNREC established a Pollution Prevention Program in 1990 which provides education, technical assistance, and financial
incentives to improve environmental quality. Small businesses have access to Delaware's Waste Minimization/Pollution
Prevention Information Clearinghouse. In addition to distributing pollution prevention guides, DE DNREC has established
a Pollution Prevention Industry Roundtable to facilitate technology transfer between large and small businesses.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To address accidental release detection and prevention, the Air Quality Management Section has been administering
Delaware's ``
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Regulation for the Management of Extremely Hazardous Substances
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
'' through the Industrial Disaster Prevention Group (IDPG). Facility visits and compliance discussions are a part
of this program, as is the distribution of generic procedures to assist with compliance with the regulation. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
The third requirement is to develop a compliance and technical assistance program for small business stationary
sources which assists small businesses in determining applicable requirements and in receiving permits under the
CAA in a timely and efficient manner. Delaware has met this requirement through the Engineering and Compliance Branch
(ECB) of the Air Quality Management Section. The ECB will identify applicable rules, determine whether a permit is
needed, identify compliance alternatives, and explain the fees, application process, violations, and appeals,
as needed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2. Ombudsman Office 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The fourth requirement of section 507(a)(3) is the designation of a state office to serve as the Ombudsman for small
business stationary sources. Delaware's Secretary of DE DNREC is authorized to create the ombudsman's office within
DNREC. The ombudsman will be appointed by the Secretary of DE DNREC and will report directly to him or her. The Delaware
Office of the Ombudsman (Delaware Ombudsman) will be independent of the Division of Air and Waste Management and the
Air Quality Management Section.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The fifth requirement is to develop adequate mechanisms to assure that small business stationary sources receive
notice of their rights under the Act in such manner and form as to assure reasonably adequate time for such sources to
evaluate compliance methods and any relevant or applicable proposed or final regulation or standards issued under
the CAA. The Delaware Ombudsman will ensure that small businesses receive notice of their rights in sufficient time
to evaluate compliance. Information delineating legal rights will be disseminated with the technical and compliance
information by the SBAP. In addition, field inspectors will be trained to properly inform small businesses of their
rights during site visits.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The sixth requirement of CAA section 507(a) is to develop adequate mechanisms for informing small business stationary
sources of their obligations under the CAA, including mechanisms for referring such sources to qualified auditors
or, at the option of the state, for providing audits of the operations of such sources to determine compliance with
the CAA. The Delaware Ombudsman will develop procedures for referring sources to qualified auditors. A list of qualified
environmental consulting firms who could conduct audits will be provided by the Delaware Ombudsman to small businesses.
The Delaware Ombudsman, ECB, IDPG and Pollution Prevention Program may elect to provide qualified auditors, if available.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The seventh requirement of CAA section 507(a) is to develop procedures for consideration of requests from a small
business stationary source for modification of: (A) Any work practice or technological method of compliance, or
(B) the schedule of milestones for implementing such work practices or compliance methods. Delaware's Office of
the Ombudsman will receive written requests from a small businesses for modification of work practices. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3. Compliance Advisory Panel 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 507(e) of the CAA requires Delaware to establish a Compliance Advisory Panel (CAP) that must include two members
selected by the Governor who are not owners or representatives of owners of small businesses; four members selected
by the state legislature who are owners, or represent owners, of small businesses; and one member selected by the head
of the agency in charge of the Air Pollution Permit Program. Members of the Delaware CAP will be selected in the following
manner for the first term, after which all will serve four year terms: (1) The majority leader of the Senate shall appoint
one member for 4 years; (2) the minority leader of the Senate shall appoint one member for 2 years; (3) the majority leader
of the House of Representatives will appoint one member for three years; (4) the minority leader of the House of Representatives
shall appoint one member for one year; (5) the Governor will select two members for four years; and (6) the Air Quality
Management Program Administrator will select one member for four years. The makeup of Delaware's CAP is prescribed
as is required by section 507(e). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Delaware CAP will meet at least once per quarter. Any member absent from three consecutive meetings will be replaced.
Administrative and logistical support for the Delaware CAP will be funded through the Delaware Ombudsman's office.
The Delaware Ombudsman will also serve a Secretariat for the development and dissemination of CAP reports.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to establishing the minimum membership of the CAP the CAA delineates four responsibilities of the Panel:
(A) to render advisory opinions concerning the effectiveness of the SBAP, difficulties encountered and the degree
and severity of enforcement actions; (B) to review and assure that information for small business stationary sources
is easily understandable; (C) to develop and disseminate the reports and advisory opinions made through the SBAP;
and (D) to periodically report to EPA concerning the SBAP's adherence to the principles of the Paperwork Reduction
Act, the Equal Access to Justice Act, and the Regulatory Flexibility Act. (Section 507(e)(1)(B) requires the CAP
to report on the compliance of the SBAP with these three statutes. However, since state agencies are not required to
comply with them, EPA believes that the state Program must merely require the CAP to report on whether the SBAP is adhering
to the general principles of these Federal statutes.) The duties and responsibilities described in Delaware's submittal
indicate that the Delaware CAP will be responsible for all four of the activities listed above, except that the Delaware
Ombudsman will disseminate reports.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
4. Source Eligibility
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 507(c)(1) of the CAA defines the term ``small business stationary source'' as a stationary source that:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(A) Is owned or operated by a person who employs 100 or fewer individuals; 
<!-- PJG 0012 frnewline -->
(B) Is a small business concern as defined in the Small Business Act; 
<!-- PJG 0012 frnewline -->
(C) Is not a major stationary source; 
<!-- PJG 0012 frnewline -->
(D) Does not emit 50 tons per year (tpy) or more of any regulated pollutant; and 
<!-- PJG 0012 frnewline -->
(E) Emits less than 75 tpy of all regulated pollutants. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Delaware's submittal duplicates the language of CAA section 507(c)(1) in defining eligible stationary sources.
It also provides for the state, after consultation with the Administrator and the Administrator of the Small Business
Administration and notice and opportunity for public comment, to include or exclude a category or subcategory of
sources. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Summary of SIP Revision
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Delaware has submitted a SIP revision requiring implementation of each of the program elements required by CAA section
507. As previously stated, the authority to implement the SBAP has been delegated to the Department of Natural Resources
and Environmental Control, Air Quality Management Section. Program implementation will begin no later than January
1, 1994. The Secretary of DE DNREC will appoint the Ombudsman by July 1, 1993 and hire the staff dedicated to implementing
the program. An Executive Order establishing the Compliance Advisory Panel will be executed by the Governor of the
State of Delaware by March 1, 1993. In this action, EPA is approving the SIP revision submittal by the State of Delaware.
Accordingly, &sect;52.460 is added to 40 CFR part 52, subpart I&hyph;Delaware to reflect EPA's approval action and
the fact that it is considered part of the Delaware's SIP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPA is proposing to approve the Delaware SIP revision for establishing a Small Business Stationary Source Technical
and Environemental Compliance Assistance Program, which was submitted on January 11, 1993. EPA is soliciting public
comments on the issues discussed in this notice or on other relevant matters. These comments will be considered before
taking final action. Interested parties may participate in the Federal rulemaking procedure by submitting written
comments to the EPA Regional office listed in the Addresses section of this document.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Proposed Action
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 EPA is proposing to approve Delaware's plan for the establishment of a Small Business Stationary Source Technical
and Environmental Compliance Assistance Program.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nothing in this action should be construed as permitting or allowing or establishing a precedent for any future request
for revision to any SIP. Each request for revision to the SIP shall be considered separately in light of specific technical,
economic, and environmental factors and in relation to relevant statutory and regulatory requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the Regulatory Flexibility Act, 5 U.S.C. 600 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, EPA must prepare a regulatory flexibility analysis assessing the impact of any proposed or final rule on small entities.
5 U.S.C. 603 and 604. Alternatively, EPA may certify that the rule will not have a significant impact on a substantial
number of small entities. Small entities include small businesses, small not-for-profit enterprises, and government
entities with jurisdiction over populations of less than 50,000. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In this action, EPA is approving a state program created for the purpose of assisting small businesses in complying
with existing statutory and regulatory requirements. The program being approved does not impose any new regulatory
burden on small businesses; it is a program under which small businesses may elect to take advantage of assistance
provided by the state. Therefore, because the EPA's approval of this program does not impose any new regulatory requirements
on small businesses, I certify that it does not have a
<!-- PJG 0012 frnewline -->
significant economic impact on any small entities affected.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This action has been classified as a Table 2 action for signature by the Regional Administrator under the procedures
published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 19, 1989 (54 FR 2214&hyph;2225), as revised by an October 4, 1993 memorandum from Michael H. Shapiro, Acting
Assistance Administrator for Air and Radiation. On January 6, 1989, the Office of Management and Budget (OMB) waived
Table 2 and Table 3 SIP revisions from the requirements of section 3 of Executive Order 12291 for a period of two years.
EPA has submitted a request for a permanent waiver for Table 2 and 3 SIP revisions. OMB has agreed to continue the waiver
until such time as it rules on EPA's request. This request is still applicable under Executive Order 12866, which superseded
Executive Order 12291 on September 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 52
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Air pollution control, Small business assistance program. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 42 U.S.C. 7401&hyph;7671q. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: October 22, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
W.T. Wisniewski,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Administrator, Region III.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;759 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00035 </DOCNO>
<PARENT> FR940112-1-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>40 CFR Part 52</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[MA&hyph;20&hyph;01&hyph;5783; A&hyph;1-FRL&hyph;4825&hyph;5]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Approval and Promulgation of Title V, Section 507, Small Business Stationary Source Technical and Environmental
Compliance Assistance Program for Massachusetts 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Proposed rule.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The EPA proposes to conditionally approve the State Implementation Plan (SIP) revision submitted by the Commonwealth
of Massachusetts for the purpose of establishing a small business stationary source technical and environmental
compliance assistance program. The SIP revision was submitted by the State to satisfy the Federal mandate to ensure
that small businesses have access to the technical assistance and regulatory information necessary to comply with
the Clean Air Act (CAA). The rationale for the conditional approval is set forth in this proposal; additional information
is available at the address indicated below.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before February 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments may be mailed to Linda M. Murphy, Director, Air, Pesticides and Toxics Management Division, U.S. Environmental
Protection Agency, Region I, JFK Federal Bldg., Boston, MA 02203. Copies of the State submittal and EPA's technical
support document are available for public inspection during normal business hours, by appointment at the Air, Pesticides
and Toxics Management Division, U.S. Environmental Protection Agency, Region I, One Congress Street, 10th floor,
Boston, MA and Department of Environmental Protection, One Winter Street, 8th Floor, Boston, MA 02108.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Emanuel Souza, Jr., (617) 565&hyph;3248.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Background
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Implementation of the provisions of the Clean Air Act Amendments of 1990, will require regulation of many small businesses
so that areas may attain and maintain the National ambient air quality standards (NAAQS) and reduce the emission of
air toxics. Small businesses frequently lack the technical expertise and financial resources necessary to evaluate
such regulations and to determine the appropriate mechanisms for compliance. In anticipation of the impact of these
requirements on small businesses, the CAA requires that States adopt a small business stationary source technical
and environmental compliance assistance program (PROGRAM), and submit this PROGRAM as a revision to the federally
approved SIP. In addition, the CAA directs the Environmental Protection Agency (EPA) to oversee these small business
assistance programs and report to Congress on their implementation. The requirements for establishing a PROGRAM
are set out in section 507 of title V of the CAA. In February 1992, EPA issued 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guidelines for the Implementation of Section 507 of the 1990 Clean Air Act Amendments
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, in order to delineate the Federal and State roles in meeting the new statutory provisions and as a tool to provide further
guidance to the States on submitting acceptable SIP revisions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commonwealth of Massachusetts has submitted a SIP revision to EPA in order to satisfy the requirements of section
507. In order to gain full approval, the State submittal must provide for each of the following PROGRAM elements: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) The establishment of a small business assistance program (SBAP) to provide technical and compliance assistance
to small businesses; 
<!-- PJG 0012 frnewline -->
(2) The establishment of a State small business ombudsman to represent the interests of small businesses in the regulatory
process; and
<!-- PJG 0012 frnewline -->
(3) The creation of a Compliance Advisory Panel (CAP) to determine and report on the overall effectiveness of the SBAP.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Analysis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
1. Small Business Assistance Program
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Massachusetts' SIP revision delegates the responsibility for implementation of the SBAP to various functional
units within the Executive Office of Environmental Affairs (EOEA) and the Department of Environmental Protection
(DEP). SBAP staff will be located in the Office of Technical Assistance. Primary responsibility for program oversight,
development, and coordination will lie with the small business ombudsman and the SBAP staff.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Section 507(a) sets forth six requirements
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that the State must meet to have an approvable SBAP. The first requirement is to establish adequate mechanisms for
developing, collecting and coordinating information concerning compliance methods and technologies for small
business stationary sources, and programs to encourage lawful cooperation among such sources and other persons
to further compliance with the Act. The State has met this requirement by offering a proactive and reactive approach
to gathering and disseminating information on compliance issues and control technologies. This approach includes:
an information clearinghouse, workshops, and an audit program.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A seventh requirement of section 507(a), establishment of an Ombudsman office, is discussed in the next section.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The second requirement is to establish adequate mechanisms for assisting small business stationary sources with
pollution prevention and accidental release detection and prevention, including providing information concerning
alternative technologies, process changes, products and methods of operation that help reduce air pollution. The
State has met this requirement by stating that the Massachusetts Office of Technical Assistance (OTA) will provide
help in identifying pollution prevention opportunities. These services are provided at no charge. Additionally,
the SBAP staff will provide small business stationary sources with information and referral to appropriate sources
regarding requirements related to accidental release detection and prevention.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The third requirement is to develop a compliance and technical assistance program for small business stationary
sources which assists small businesses in determining applicable requirements and in receiving permits under the
Act in a timely and efficient manner. The State has met this requirement. As stated earlier, responsibility for the
implementation of the small business assistance program will involve various units within the EOEA and the DEP, with
primary responsibility for program oversight, development, and coordination lying with the small business ombudsman
and SBAP staff in EOEA, Office of Technical Assistance. The air quality staff at each DEP Regional Office will provide
assistance to small business stationary sources in the following: identifying applicable rules, determining their
need for permits, explanation of the permitting procedures, providing the necessary forms and applications, and
assisting them in preparing the required documents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The fourth requirement is to develop adequate mechanisms to assure that small business stationary sources receive
notice of their rights under the Act in such manner and form as to assure reasonably adequate time for such sources to
evaluate compliance methods and any relevant or applicable proposed or final regulations or standards issued under
the Act. The State has met this requirement by providing that the DEP's Division of Air Quality Control (DAQC) will
be responsible for the development of policies and regulations for implementing the provisions of the CAA. The staff
in that office will provide assistance in identifying applicable rules. Additionally, that office will provide
the necessary information regarding rules and procedures for complying with Federal and state laws and regulations.
Furthermore, it will be the DAQC's responsibility to inform businesses of their rights through brochures and workshops.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The fifth requirement is to develop adequate mechanisms for informing small business stationary sources of their
obligations under the Act, including mechanisms for referring such sources to qualified auditors or, at the option
of the State, for providing audits of the operations of such sources to determine compliance with the Act. The SIP revision
provides that the DAQC is responsible for the development of policies and regulations for implementing the provisions
of the CAA. The SBAP staff will also be responsible for providing audits. These include on-site assessments by the
OTA and through audit referrals. On-site assessments will be arranged in conjunction with technical staff from the
OTA. Audit referrals will be arranged by having the staff provide a list of qualified private sector auditors or consultants
to small business stationary sources.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The sixth requirement is to develop procedures for consideration of requests from a small business stationary source
for modification of: (A) Any work practice or technological method of compliance, or (B) the schedule of milestones
for implementing such work practice or method of compliance preceding any applicable compliance date, based on the
technological and financial capability of any such small business stationary source. The SIP revision provides
that specific regulations for modifications of work practices or technological methods of compliance will be submitted
in November 1993. These regulations will include: (1) Procedures for receiving requests from small businesses to
modify the provisions of State-adopted regulations; (2) format for such requests; (3) procedures for how requests
will be reviewed and acted upon; and (4) requirements to ensure that no such modification may be granted unless it is
in compliance with the applicable requirements of the CAA, the SIP and the applicable Federal regulations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
2. Ombudsman
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 507(a)(3) requires the designation of a State office to serve as the ombudsman for small business stationary
sources. The State has met this requirement by designating the small business ombudsman within the EOEA. The EOEA
is a secretariat answering directly to the Governor. The designation of a small business ombudsman within the Commonwealth's
environmental secretariat but outside of the secretariat's regulatory agency will:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) Enhance impartiality in resolving disputes involving compliance and enforcement;
<!-- PJG 0012 frnewline -->
(2) Reduce potential for conflicts of interest; 
<!-- PJG 0012 frnewline -->
(3) Improve utilization by the business community; 
<!-- PJG 0012 frnewline -->
(4) Allow for a high level of independence, authority, and communication; 
<!-- PJG 0012 frnewline -->
(5) Allow the small business ombudsman to build upon established contacts with the business community and other government
offices and agencies; and 
<!-- PJG 0012 frnewline -->
(6) Strengthen the ombudsman's ability to provide program oversight and evaluation.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=83 g=1 f=1 -->
3. Compliance Advisory Panel
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 507(e) requires the State to establish a Compliance Advisory Panel (CAP) that must include two members selected
by the Governor who are not owners or representatives of owners of small businesses; four members selected by the State
legislature who are owners, or represent owners, of small businesses; and one member selected by the head of the agency
in charge of the Air Pollution Permit Program. The State has not fully met this requirement due to the lack of adequate
statutory authority to establish the CAP. However, EPA expects Massachusetts to submit a legislative resolve to
EPA when it is finally approved. The SIP revision provides that legislative approval and selection of CAP members
will be completed by January 30, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition to establishing the minimum membership of the CAP the CAA delineates four responsibilities for it: (1)
To render advisory opinions concerning the effectiveness of the SBAP, difficulties encountered and the degree and
severity of enforcement actions; (2) to periodically report to EPA concerning the SBAP's adherence to the principles
of the Paperwork Reduction Act, the Equal Access to Justice Act, and the Regulatory Flexibility Act
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
; (3) to review and assure that information for small business stationary sources is easily understandable; and (4)
to develop and disseminate the reports and advisory opinions made through the SBAP. The State has met these requirements
in the SIP revision by authorizing the panel to: render advisory opinions on the effectiveness of the small business
assistance program; prepare periodic reports to EPA on the status of the SBAP with regard to the Paper Work Reduction
Act, the Regulatory Flexibility Act, and the Equal Access to Justice Act; and review information for small business
stationary sources to assure such information is understandable by the layperson. Additionally, the SIP revisions
provide the small business ombudsman with the authority to oversee all aspects of the SBAP and allows for the ombudsman
to act as secretariat to the panel.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section 507(e)(1)(B) requires the CAP to report on the compliance of the SBAP with these three Federal statutes. However,
since State agencies are not required to comply with them, EPA believes that the State PROGRAM must merely require
the CAP to report on whether the SBAP is adhering to the general principles of these Federal statutes.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
4. Eligibility
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 507(c)(1) of the CAA defines the term ``small business stationary source'' as a stationary source that:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(A) Is owned or operated by a person who employs 100 or fewer individuals, 
<!-- PJG 0012 frnewline -->
(B) Is a small business concern as defined in the Small Business Act; 
<!-- PJG 0012 frnewline -->
(C) Is not a major stationary source; 
<!-- PJG 0012 frnewline -->
(D) Does not emit 50 tons per year (tpy) or more of any regulated pollutant; and 
<!-- PJG 0012 frnewline -->
(E) Emits less than 75 tpy of all regulated pollutants. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The SIP revision states that it is the general policy of the EOEA and the DEP to assist all businesses in identifying
applicable regulations and in meeting their obligations under the requirements of the CAA. However, recognizing
the special needs of the small business stationary sources, EOEA and DEP shall, wherever resources become a limiting
factor in providing such assistance, give priority to businesses which meet the definition of small business stationary
source under title V, section 507(c)(1) of the Clean Air Act. Additionally, the Commonwealth of Massachusetts allows
businesses that do not meet the provisions of sections 507(c)(1)(C)-(E) to petition the SBAP for assistance in accordance
with the procedures established in section 507(c)(2) of the CAA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The SBAP staff, with the advice of the ombudsman and the CAP, may consider the development of provisions for excluding
any category or subcategory of sources with sufficient financial and technical resources, from receiving assistance
under the SBAP in accordance with the provisions of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Proposed Action 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commonwealth of Massachusetts has submitted a SIP revision implementing each of the required PROGRAM elements
required by section 507 of the CAA. The State expects all the elements of the PROGRAM to be fully operational by November
14, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The State needs full adequate legal authority to implement the PROGRAM before EPA can fully approve this SIP revision.
Therefore, EPA is proposing to conditionally approve the Massachusetts SIP revision for the small business stationary
source technical and environmental compliance assistance program, which was submitted on November 13, 1993 upon
the condition that Massachusetts submits the additional legal authority necessary to fully implement the PROGRAM.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPA is soliciting public comments on the issues discussed in this proposal or on other relevant matters. These comments
will be considered before EPA takes final action. Interested parties may participate in the Federal rulemaking procedure
by submitting written comments to the EPA Regional office listed in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Addresses
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 section of this action.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Proposed Action
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA is proposing to conditionally approve the small business stationary source technical and environmental compliance
assistance program submitted on November 13, 1992 and July 22, 1993. The one outstanding issue with this SIP revision
concerns Massachusetts' lack of adequate legal authority to establish and implement a compliance advisory panel.
The State plans to address this issue in a legislative resolve which it will forward to EPA by November 14, 1994. For
this reason EPA is proposing to conditionally approve this SIP revision on the condition that the State meet its commitment
to submit a legislative resolve allowing a compliance panel to be established and implemented, incorporating all
the elements listed in section 507(e) of the Clean Air Act and have the program fully operational by November 14, 1994.
Under section 110(k)(4) of the Act, EPA may conditionally approve a plan based on a commitment from the State to adopt
specific enforceable measures by a date certain, but not later than 1 year from the date of approval. If EPA takes final
conditional approval on the commitment, the State must meet its commitment to have the program fully operational
by November 14, 1994. If the State fails to do so, this approval will become a disapproval on that date. EPA will notify
the State by letter that this action has occurred. At that time, this commitment will no longer be a part of the approved
Massachusetts SIP. EPA subsequently will publish a notice in the notice section of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notifying the public that the conditional approval automatically converted to a disapproval. If the State meets
its commitment, within the applicable time frame, the conditionally approved submission will remain a part of the
SIP until EPA takes final action approving or disapproving the new legislative authority. If EPA disapproves the
new submittal, the conditionally approved small business program will also be disapproved at that time. If EPA approves
the submittal, the small business program will be fully approved in its entirety and replace the conditionally approved
program in the SIP.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If EPA determines that it cannot issue a final conditional approval or if the conditional approval is converted to
a disapproval, such action will trigger EPA's authority to impose sanctions under section 110(m) of the CAA at the
time EPA issues the final disapproval or on the date the State fails to meet its commitment. In the latter case, EPA will
notify the State by letter that the conditional approval has been converted to a disapproval and that EPA's sanctions
authority has been triggered. In addition, the final disapproval triggers the Federal implementation plan (FIP)
requirement under section 110(c). Pursuant to section 507(b)(3), EPA will provide for implementation of the program
provisions required under section 507(a)(4) in any State that fails to submit such a program under that subsection.
Therefore, EPA would have to provide for a compliance assistance program which assists small business stationary
sources in determining applicable requirements and in receiving permits under the CAA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 This action has been classified as a Table 2 Action by the Regional Administrator under the procedures published in
the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 19, 1989 (54 FR 2214&hyph;2225) as revised by an October 4, 1993, memorandum from Michael H. Shapiro, Acting
Assistant Administer for Air and Radiation. On January 6, 1989 the Office of Management and Budget (OMB) waived Table
2 and 3 SIP revisions (54 FR 2222) from the requirement of section 3 of Executive Order 12291 for a period of two years.
EPA has submitted a request for a permanent waiver for Table 2 and Table 3 SIP revisions. The OMB has agreed to continue
the waiver until such time as it rules on EPA's request. This request continues in effect under Executive Order 12866
which superseded Executive Order 12291 on September 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Under the Regulatory Flexibility Act, 5 U.S.C. 600 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, EPA must prepare a regulatory flexibility analysis assessing the impact of any proposed or final rule on small entities.
5 U.S.C. 603 and 604. Alternatively, EPA may certify that the rule will not have a significant impact on a substantial
number of small entities. Small entities include small businesses, small not-for-profit enterprises, and government
entities with jurisdiction over populations of less than 50,000.
<!-- PJG 0012 frnewline -->
 By today's action, EPA is conditionally approving a State program created for the purpose of assisting small businesses
in complying with existing statutory and regulatory requirements. The program being proposed for conditional approval
today does not impose any new regulatory burden on small businesses; it is a program under which small businesses may
elect to take advantage of assistance provided by the state. Therefore, because the EPA's conditional approval of
this program does not impose any new regulatory requirements on small businesses, I certify that it does not have a
significant economic impact on any small entities affected.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Regional Administrator's decision to approve or disapprove the SIP revision will be based on whether it meets
the requirements of sections 110(a)(2)(A)-(K) and 110(a)(3) of the Clean Air Act, as amended, and EPA regulations
in 40 CFR part 51.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 52
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Air pollution control, Intergovernmental relations, Small business assistance program.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 42 U.S.C. 7401&hyph;7671q.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 21, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Paul G. Keough,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Administrator, Region I.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;760 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00036 </DOCNO>
<PARENT> FR940112-1-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>40 CFR Part 52</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[CA&hyph;46&hyph;3&hyph;6054; FRL&hyph;4825&hyph;7]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Approval and Promulgation of Implementation Plans; California State Implementation Plan Revision; Sacramento
Metropolitan Air Quality Management District; Santa Barbara County Air Pollution Control District
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of proposed rulemaking.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 EPA is proposing to approve revisions to the California State Implementation Plan (SIP) adopted by the Sacramento
Metropolitan Air Quality Management District (SMAQMD) on February 23, 1993, and by the Santa Barbara County Air Pollution
Control District (SBCAPCD) on December 10, 1991. The California Air Resources Board (CARB) submitted these revisions
to EPA on April 6, 1993, and June 19, 1992, respectively. The revisions concern SMAQMD's Rule 454, Degreasing Operations,
and SBCAPCD's Rule 331, Fugitive Emissions Inspection and Maintenance. SMAQMD's Rule 454 controls volatile organic
compound (VOC) emissions from metal parts cleaning procedures, while SBCAPCD's Rule 331 controls VOC emissions
from equipment leaks at sources such as petroleum refineries. The intended effect of proposing approval of these
rules is to regulate emissions of VOCs in accordance with the
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
requirements of the Clean Air Act, as amended in 1990 (CAA or the Act). EPA's final action on this notice of proposed
rulemaking (NPR) will incorporate these rules into the federally approved SIP. EPA has evaluated each of these rules
and is proposing to approve them under provisions of the CAA regarding EPA action on SIP submittals, SIPs for national
primary and secondary ambient air quality standards and plan requirements for nonattainment areas. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
: Comments must be received on or before February 11, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments may be mailed to: Daniel A. Meer, Chief, Rulemaking Section (A&hyph;5&hyph;3), Air and Toxics Division,
U.S. Environmental Protection Agency, Region 9, 75 Hawthorne Street, San Francisco, CA 94105.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Copies of the rule revisions and EPA's evaluation report of each rule are available for public inspection at EPA's
Region 9 office during normal business hours. Copies of the submitted rule revisions are also available for inspection
at the following locations:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
California Air Resources Board, Stationary Source Division, 2020 L. Street, Sacramento, CA 95814.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sacramento Metropolitan Air Quality Management District, 8411 Jackson Road, Sacramento, CA 95826.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Santa Barbara County Air Pollution Control District, 26 Castilian Drive, B&hyph;23, Goleta, CA 93117.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 William Davis, Rulemaking Section (A&hyph;5&hyph;3), Air and Toxics Division, U.S. Environmental Protection
Agency, Region 9, 75 Hawthorne Street, San Francisco, CA 94105, Telephone: (415) 744&hyph;1183.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On March 3, 1978, EPA promulgated a list of ozone nonattainment areas under the provisions of the Clean Air Act, as amended
in 1977 (1977 CAA or pre-amended Act), that included the Sacramento Metro Area and Santa Barbara County. 43 FR 8964,
40 CFR 81.305. Because these areas were unable to meet the statutory attainment date of December 31, 1982, California
requested under section 172(a)(2), and EPA approved, an extension of the attainment date to December 31, 1987. 40
CFR 52.238. On May 26, 1988, EPA notified the Governor of California, pursuant to section 110(a)(2)(H) of the pre-amended
Act, that the above districts' portions of the California SIP were inadequate to attain and maintain the ozone standard
and requested that deficiencies in the existing SIP be corrected (EPA's SIP-Call). On November 15, 1990, the Clean
Air Act Amendments of 1990 were enacted. Public Law 101&hyph;549, 104 Stat. 2399, codified at 42 U.S.C. 7401&hyph;7671q.
In amended section 182(a)(2)(A) of the CAA, Congress statutorily adopted the requirement that nonattainment areas
fix their deficient reasonably available control technology (RACT) rules for ozone and established a deadline of
May 15, 1991 for states to submit corrections of those deficiencies. 
<!-- PJG 0012 frnewline -->
Section 182(a)(2)(A) applies to areas designated as nonattainment prior to enactment of the amendments and classified
as marginal or above as of the date of enactment. It requires such areas to adopt and correct RACT rules pursuant to pre
amended section 172(b) as interpreted in pre-amendment
<!-- PJG 0012 frnewline -->
guidance.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 EPA's SIP-Call used that guidance to indicate the necessary corrections for specific nonattainment areas. The Sacramento
Metro Area is classified as serious and Santa Barbara County is classified as moderate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
; therefore, these areas were subject to the RACT fix-up requirement and the May 15, 1991 deadline. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 Among other things, the pre-amendment guidance consists of those portions of the proposed post-1987 ozone and carbon
monoxide policy that concern RACT, 52 FR 45044 (November 24, 1987); ``Issues Relating to VOC Regulation Cutpoints,
Deficiencies, and Deviations, Clarification to Appendix D of November 24, 1987 Federal Register Notice'' (Blue
Book) (notice of availability was published in the Federal Register on May 25, 1988); and the existing control technique
guidelines (CTGs).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 The Sacramento Metro Area and Santa Barbara County retained their designations of nonattainment and were classified
by operation of law pursuant to sections 107(d) and 181(a) upon the date of enactment of the CAA. See 55 FR 56694 (November
6, 1991).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On June 22, 1991, EPA, Region 9, notified the State of California that EPA had not received by the May 15, 1991 deadline
all required VOC rule corrections under section 182(a)(2)(A) of the CAA. The finding letter identified six districts
in California, including SMAQMD and SBCAPCD, that had failed to submit required rule corrections. The official finding
notice was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on October 22, 1991 (56 FR 54554). SMAQMD's Rule 454 and SBCAPCD's Rule 331 were listed in that finding notice. As a result,
both SMAQMD and SBCAPCD had 18 months to submit the rules to EPA before a sanction under section 179(a) of the Act would
be imposed. 
<!-- PJG 0012 frnewline -->
The State of California submitted many revised RACT rules for incorporation into its SIP on April 6, 1993 and June 19,
1992, including the rules being acted on in this document. This document addresses EPA's proposed action for SMAQMD's
Rule 454, Degreasing Operations, and SBCAPCD's Rule 331, Fugitive Emissions Inspection and Maintenance. SMAQMD's
submitted Rule 454 and SBCAPCD's Rule 331 were found to be complete on April 28, 1993 and August 27, 1992, respectively,
pursuant to EPA's completeness criteria that are set forth in 40 CFR part 51, appendix V
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and both rules are being proposed for approval into the SIP. The State's complete submittal of SMAQMD's Rule 454 and
SBCAPCD's Rule 331 satisfies the deficiency for which the finding of nonsubmittal, dated October 22, 1991, was made
and stopped the sanction clock.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
 EPA adopted the completeness criteria on February 16, 1990 (55 FR 5830) and, pursuant to section 110(k)(1)(A) of the
CAA, revised the criteria on August 26, 1991 (56 FR 42216).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
SMAQMD's Rule 454 controls VOC emissions from equipment used to clean (degrease) metal parts, while SBCAPCD's Rule
331 controls leaks of VOCs from equipment used in petroleum refining and associated operations. VOCs contribute
to the production of ground level ozone and smog. The rules were adopted as part of each district's efforts to achieve
the National Ambient Air Quality Standard (NAAQS) for ozone and in response to EPA's SIP-Call and the section 182(a)(2)(A)
CAA requirement. The following is EPA's evaluation and proposed action for these rules.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
EPA Evaluation and Proposed Action 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In determining the approvability of a VOC rule, EPA must evaluate the rule for consistency with the requirements of
the CAA and EPA regulations, as found in section 110 and part D of the CAA and 40 CFR part 51 (Requirements for Preparation,
Adoption, and Submittal of Implementation Plans). The EPA's interpretation of these requirements, which forms
the basis for today's action, appears in the various EPA policy guidance documents listed in footnote 1. Among those
provisions is the requirement that a VOC rule must, at a minimum, provide for the implementation of RACT for stationary
sources of VOC emissions. This requirement was carried forth from the pre-amended Act.
<!-- PJG 0012 frnewline -->
For the purpose of assisting state and local agencies in developing RACT rules, EPA prepared a series of Control Technique
Guideline (CTG) documents. The CTGs are based on the underlying requirements of the Act and specify the presumptive
norms for what is RACT for specific source categories. Under the CAA, Congress ratified EPA's use of these documents,
as well as other Agency policy, for requiring States to ``fix-up'' their RACT rules. See section 182(a)(2)(A). The
CTG applicable to SMAQMD's Rule 454 is entitled, ``Control of Volatile Organic Emissions from Solvent Metal Cleaning,''
EPA&hyph;450/2&hyph;77&hyph;022. The CTG applicable to SBCAPCD's Rule 331 is entitled, ``Control of Volatile
Organic Compound Leaks from Petroleum Refinery Equipment,'' EPA&hyph;450/2&hyph;78&hyph;036. Further interpretations
of EPA policy are found in the Blue Book, referred to in footnote 1. In general, these guidance documents have been set
forth to ensure that VOC rules are fully enforceable and strengthen or maintain the SIP.
<!-- PJG 0012 frnewline -->
SMAQMD's submitted Rule 454, Degreasing Operations, includes the following significant changes from the current
SIP:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The definition section has been expanded by 13 terms, which helps to clarify the rule and makes it easier to enforce.
<!-- PJG 0012 frnewline -->
2. The applicability of the rule to solvents is now based on the initial boiling point rather than on solvent vapor pressure.
<!-- PJG 0012 frnewline -->
3. Control Officer discretion for the use of unspecified control equipment has been deleted.
<!-- PJG 0012 frnewline -->
4. The overall (capture and control) efficiency of control equipment has been set at not less than 85%.
<!-- PJG 0012 frnewline -->
5. Records for solvent usage amounts and for maintenance are now required, making the rule more enforceable.
<!-- PJG 0012 frnewline -->
6. Test methods for determining compliance, not identified in the existing SIP rule, are now specified.
<!-- PJG 0012 frnewline -->
SBCAPCD's submitted Rule 331, Fugitive Emissions Inspection and Maintenance, includes the following significant
changes from the current SIP:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The definition section has been expanded by 28 terms, which helps to clarify the rule and makes it easier to enforce.
<!-- PJG 0012 frnewline -->
2. The rule now requires replacement of components that require five or more repairs in one year.
<!-- PJG 0012 frnewline -->
3. The rule now specifies that major leaks (as defined in the rule) be fixed within 5 calendar days, minor leaks within
15 days, and liquid leaks within 24 hours. Also, the leaking component must be tightened (minimized) within one hour
of discovery of the leak.
<!-- PJG 0012 frnewline -->
4. Recordkeeping requirements have been expanded to include not only tags on equipment, but diagrams of component
location, inspection logs, and maintenance records. 
<!-- PJG 0012 frnewline -->
5. The rule has been significantly strengthened by the identification of test methods to use to determine compliance.
<!-- PJG 0012 frnewline -->
EPA has evaluated the submitted rules and has determined that they are consistent with the CAA, EPA regulations, and
EPA policy. Therefore, SMAQMD's Rule 454, Degreasing Operations, and SBCAPCD's Rule 331, Fugitive Emissions Inspection
and Maintenance, are being proposed for approval under section 110(k)(3) of the CAA as meeting the requirements of
section 110(a) and part D. 
<!-- PJG 0012 frnewline -->
Nothing in this action should be construed as permitting or allowing or establishing a precedent for any future request
for revision to any state implementation plan. Each request for revision to the state implementation plan shall be
considered separately in light of specific technical, economic, and environmental factors and in relation to relevant
statutory and regulatory requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Regulatory Process
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the Regulatory Flexibility Act, 5 U.S.C. 600 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, EPA must prepare a regulatory flexibility analysis assessing the impact of any proposed or final rule on small entities.
5 U.S.C. 603 and 604. Alternatively, EPA may certify that the rule will not have a significant impact on a substantial
number of small entities. Small entities include small businesses, small not-for-profit enterprises and government
entities with jurisdiction over populations of less than 50,000.
<!-- PJG 0012 frnewline -->
SIP approvals under sections 110 and 301 and subchapter I, part D of the CAA do not create any new requirements, but simply
approve requirements that the State is already imposing. Therefore, because the Federal SIP-approval does not impose
any new requirements, it does not have a significant impact on any small entities affected. Moreover, due to the nature
of the Federal-state relationship under the CAA, preparation of a 
<!-- PJG 0012 frnewline -->
regulatory flexibility analysis would constitute Federal inquiry into the economic reasonableness of state action.
The CAA forbids EPA to base its actions concerning SIPs on such grounds. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Union Electric Co
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
U.S. E.P.A.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, 427 U.S. 246, 256&hyph;66 (S.Ct. 1976); 42 U.S.C. 7410(a)(2).
<!-- PJG 0012 frnewline -->
This action has been classified as a Table 2 action by the Regional Administrator under the procedures published in
the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on January 19, 1989 (54 FR 2214&hyph;2225). On January 6, 1989, the Office of Management and Budget (OMB) waived Table
2 and Table 3 SIP revisions (54 FR 2222) from the requirements of section 3 of Executive Order 12291 for a period of two
years. EPA has submitted a request for a permanent waiver for Table 2 and Table 3 SIP revisions. OMB has agreed to 
<!-- PJG 0012 frnewline -->
continue the waiver until such time as it rules on EPA's request. This request continues in effect under Executive
Order 12866 which superseded Executive Order 12291 on September 30, 1993. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 52
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Air pollution control, Hydrocarbons, Intergovernmental relations, Ozone, Reporting
and recordkeeping requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 42 U.S.C. 7401&hyph;7671q. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Felicia Marcus,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;761 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00037 </DOCNO>
<PARENT> FR940112-1-00018 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>40 CFR Part 180</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;300319; FRL&hyph;4751&hyph;8]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN No. 2070&hyph;AC18</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
&hyph;C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
) Methacrylate-Methacrylic Acid Copolymer; Tolerance Exemption
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Proposed rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document proposes that an exemption from the requirement of a tolerance be established for residues of alkyl
(C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
-C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer when used as an inert ingredient (stabilizer; component of spray drift
retardant) in pesticide formulations applied to growing crops only. This proposed regulation was requested by Allied
Colloids, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments, identified by the document control number [OPP-300319], must be received on or before February
11, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail, submit written comments to: Public Response and Program Resources Branch, Field Operations Division (7506C),
Office of Pesticide Programs, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. In person,
bring comments to: Rm. 1132, CM #2, 1921 Jefferson Davis Hwy., Arlington, VA 22202.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information submitted as a comment concerning this document may be claimed confidential by marking any part or all
of that information as ``Confidential Business Information'' (CBI). Information so marked will not be disclosed
except in accordance with procedures set forth in 40 CFR part 2. A copy of the comment that does not contain CBI must be
submitted for inclusion in the public record. Information not marked confidential may be disclosed publicly by EPA
without prior notice. All written comments will be available for public inspection in Rm. 1132 at the Virginia address
given above, from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: Connie Welch, Registration Division (7505W), Environmental Protection Agency, 401 M St., SW., Washington,
DC 20460. Office location and telephone number: 2800 Crystal Drive, North Tower, 6th Floor, Arlington, VA 22202,
(703)-308-8320. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Allied Colloids, Inc., P.O. Box 820, Suffolk, VA 23434, has submitted pesticide petition (PP) 4E4277 to EPA requesting
that the Administrator, pursuant to section 408(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 346a(e)),
propose to amend 40 CFR 180.1001(d) by establishing an exemption from the requirement of a tolerance for residues
of alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 -C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer when used as a stabilizer or component of spray drift retardant in pesticide
formulations applied to growing crops only.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Inert ingredients are all ingredients that are not active ingredients as defined in 40 CFR 153.125, and include, but
are not limited to, the following types of ingredients (except when they have a pesticidal efficacy of their own):
solvents such as alcohols and hydrocarbons; surfactants such as polyoxyethylene polymers and fatty acids; carriers
such as clay and diatomaceous earth; thickeners such as carrageenan and modified cellulose; wetting, spreading,
and dispersing agents; propellants in aerosol dispensers; microencapsulating agents; and emulsifiers. The term
``inert'' is not intended to imply nontoxicity; the ingredient may or may not be chemically active. 
<!-- PJG 0012 frnewline -->
The data submitted in the petition and other relevant material have been evaluated. As part of the EPA policy statement
on inert ingredients published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of April 22, 1987 (52 FR 13305), the Agency set forth a list of studies which would generally be used to evaluate the risks
posed by the presence of an inert ingredient in a pesticide formulation. Where it can be determined that the inert ingredient
will present minimal or no risk, the Agency does not need some or all of the listed studies to rule on the proposed tolerance
or exemption for an inert ingredient. The Agency has decided that any data, in addition to that described below, normally
required to support the proposed tolerance exemption for alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer will not need to be submitted. The rationale for this decision is described
below:
<!-- PJG 0012 frnewline -->
In the case of certain chemical substances that are defined as ``polymers,'' the Agency has established a set of criteria
which identify categories of polymers that present low risk. These criteria (described in 40 CFR 723.250) identify
polymers that are relatively unreactive and stable compared to other chemical substances as well as polymers that
typically are not readily absorbed. These properties generally limit a polymer's ability to cause adverse effects.
In addition, these criteria exclude polymers about which little is known. The Agency believes that polymers meeting
the criteria noted above will present minimal or no risk. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
-C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer conforms to the definition of polymers given in 40 CFR 723.250(b)(11)
and meets the following criteria that are used to identify low-risk polymers: 
<!-- PJG 0012 frnewline -->
1. The minimum number average molecular weight of alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer is 11,900. Substances with molecular weights greater than 400 generally
are not absorbed through the intact skin, and substances with molecular weights greater than 1,000 generally are
not absorbed through the intact gastrointestinal (GI) tract. Chemicals not absorbed through skin or GI tract generally
are incapable of eliciting a toxic response.
<!-- PJG 0012 frnewline -->
2. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer is not a cationic polymer, nor is it reasonably anticipated to become
a cationic polymer in a natural aquatic environment.
<!-- PJG 0012 frnewline -->
3. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer does not contain less than 32.0 percent by weight of the atomic element
carbon.
<!-- PJG 0012 frnewline -->
4. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer contains as an integral part of its composition the atomic elements carbon,
hydrogen, nitrogen, and oxygen.
<!-- PJG 0012 frnewline -->
5. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer does not contain as an integral part of its composition, except as impurities,
any elements other than those listed in 40 CFR 723.250(d)(3)(ii).
<!-- PJG 0012 frnewline -->
6. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer is not a biopolymer, a synthetic equivalent of a biopolymer, or a derivative
or modification of a biopolymer that is substantially intact.
<!-- PJG 0012 frnewline -->
7. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer is not manufactured from reactants containing, other than as impurities,
halogen atoms or cyano groups.
<!-- PJG 0012 frnewline -->
8. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer does not contain reactive functional groups that are intended or reasonably
anticipated to undergo further reaction.
<!-- PJG 0012 frnewline -->
9. Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer is not designed or reasonably anticipated to substantially degrade,
decompose, or depolymerize.
<!-- PJG 0012 frnewline -->
Based on the information above and review of its use, EPA has found that, when used in accordance with good agricultural
practice, this ingredient is useful and a tolerance is not necessary to protect the public health. Therefore, EPA
proposes that the exemption from the requirement of a tolerance be established as set forth below.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person who has registered or submitted an application for registration of a pesticide under the Federal Insecticide,
Fungicide, and Rodenticide Act, as amended, which contains any of the ingredients listed herein may request within
30 days after publication of this document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, that this rulemaking proposal be referred to an Advisory Committee in accordance with section 408(e) of the Federal
Food, Drug, and Cosmetic Act.
<!-- PJG 0012 frnewline -->
Interested persons are invited to submit written comments on the proposed regulation. Comments must bear a notation
indicating the document control number, [OPP-300319]. All written comments filed in response to this petition will
be available in the Public Response and Program Resources Branch, at the address given above from 8 a.m. to 4 p.m., Monday
through Friday, except legal holidays.
<!-- PJG 0012 frnewline -->
The Office of Management and Budget has exempted this rule from the requirements of section 2 of Executive Order 12866.
<!-- PJG 0012 frnewline -->
Pursuant to the requirements of the Regulatory Flexibility Act (Pub. L. 96-354, 94 Stat 1164, 5 U.S.C. 601-612), the
Administrator has determined that regulations establishing new tolerances or raising tolerance levels or establishing
exemptions from tolerance requirements do not have an economic impact on a substantial number of small entities.
A certification statement to this effect was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of May 4, 1981 (46 FR 24950). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 180
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and
pests, Reporting and recordkeeping requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dated: December 23, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen L. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Registration Division, Office of Prevention, Pesticides and Toxic Substances.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Therefore, it is proposed that 40 CFR part 180 be amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 180_[AMENDED]
<!-- PJG 0011 horztab -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 180 continues to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 21 U.S.C. 346a and 371.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;180.1001, by amending paragraph (d) in the table therein by adding and alphabetically inserting the following
inert ingredient, to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;180.1001
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
 Exemptions from the requirement of a tolerance.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L1,tp0,s110,r65,r110 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Inert ingredients
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Uses
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;
*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;
*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;
*
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Alkyl (C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
 - C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=5 f=2 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
) methacrylate-methacrylic acid copolymer; minimum molecular weight 11,900
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Stabilizer; component of spray drift retardant.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;
*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;
*&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;&blank;
*
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * * 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;765 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00038 </DOCNO>
<PARENT> FR940112-1-00019 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>40 CFR Part 180</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;300318; FRL&hyph;4751&hyph;7]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN No. 2070&hyph;AC18</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Maleic Acid Monoethyl Ester-Vinyl Methyl Ether Copolymer, Maleic Acid Monoisopropyl Ester-Vinyl Methyl Ether
Copolymer, Maleic Acid Monobutyl Ester-Vinyl Methyl Ether Copolymer; Tolerance Exemptions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Proposed rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document proposes exemptions from the requirement of a tolerance be established for residues of maleic acid
monoethyl ester-vinyl methyl ether copolymer, maleic acid monoisopropyl ester-vinyl methyl ether copolymer,
and maleic acid monobutyl ester-vinyl methyl ether copolymer when used as inert ingredients (seed-coating adhesives,
gels, and antitranspirants) in pesticide formulations applied to growing crops, raw agricultural commodities
after harvest, and animals. This proposed regulation was requested by International Specialty Products.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments, identified by the document control number [OPP-300318], must be received on or before February
11, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail, submit written comments to: Public Response and Program Resources Branch, Field Operations Division (7506C),
Office of Pesticide Programs, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. In person,
bring comments to: Rm. 1132, CM #2, 1921 Jefferson Davis Hwy., Arlington, VA 22202.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information submitted as a comment concerning this document may be claimed confidential by marking any part or all
of that information as ``Confidential Business Information'' (CBI). Information so marked will not be disclosed
except in accordance with procedures set forth in 40 CFR part 2. A copy of the comment that does not contain CBI must be
submitted for inclusion in the public record. Information not marked confidential may be disclosed publicly by EPA
without prior notice. All written comments will be available for public inspection in Rm. 1132 at the Virginia address
given above, from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: Connie Welch, Registration Division (7505C), Environmental Protection Agency, 401 M St., SW., Washington,
DC 20460. Office location and telephone number: 2800 Crystal Drive, North Tower, 6th Floor, 1921 Jefferson Davis
Hwy., Arlington, VA 22202, (703)-308-8320. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 International Specialty Products, 1361 Alps Rd., Wayne, NJ 07470, has submitted to EPA the following pesticide petitions
(PPs): (1) 3E4243, maleic acid monoethyl ester-vinyl methyl ether copolymer; (2) 3E4248, maleic acid monisopropyl
ester-vinyl methyl ether copolymer; and (3) 3E4247, maleic acid monobutyl ester-vinyl methyl ether copolymer requesting
that the Administrator pursuant to section 408(e) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 346a(e),
propose to amend 40 CFR 180.1001(c) and (e) by establishing an exemption from the requirement of a tolerance for residues
of these copolymers when used as inert ingredients (seed-coating adhesives, gels, and antitranspirants) in pesticide
formulations applied to growing crops or to raw agricultural commodities after harvest, and to animals. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Inert ingredients are all ingredients that are not active ingredients as defined in 40 CFR 153.125, and include, but
are not limited to, the following types of ingredients (except when they have a pesticidal efficacy of their own):
solvents such as alcohols and hydrocarbons; surfactants such as polyoxyethylene polymers and fatty acids; carriers
such as clay and diatomaceous earth; thickeners such as carrageenan and modified cellulose; wetting, spreading,
and dispersing agents; propellants in aerosol dispensers; microencapsulating agents; and emulsifiers. The term
``inert'' is not intended to imply nontoxicity; the ingredient may or may not be chemically active. 
<!-- PJG 0012 frnewline -->
The data submitted in the petition and other relevant material have been evaluated. As part of the EPA policy 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
statement on inert ingredients published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of April 22, 1987 (52 FR 13305), the Agency set forth a list of studies which would generally be used to evaluate the risks
posed by the presence of an inert ingredient in a pesticide formulation. Where it can be determined that the inert ingredient
will present minimal or no risk, the Agency does not need some or all of the listed studies to rule on the proposed tolerance
or exemption for an inert ingredient. The Agency has decided that any data, in addition to that described below, normally
required to support the proposed tolerance exemption for maleic acid monoethyl ester-vinyl methyl ether copolymer,
maleic acid monisopropyl ester-vinyl methyl ether copolymer, and maleic acid monobutyl ester-vinyl methyl ether
copolymer will not need to be submitted. The rationale for this decision is described below:
<!-- PJG 0012 frnewline -->
In the case of certain chemical substances that are defined as ``polymers,'' the Agency has established a set of criteria
which identify categories of polymers that present low risk. These criteria (described in 40 CFR 723.250) identify
polymers that are relatively unreactive and stable compared to other chemical substances as well as polymers that
typically are not readily absorbed. These properties generally limit a polymer's ability to cause adverse effects.
In addition, these criteria exclude polymers about which little is known. The Agency believes that polymers meeting
the criteria noted above will present minimal or no risk. Maleic acid monoethyl ester-vinyl methyl ether copolymer,
maleic acid monoisopropyl ester-vinyl methyl ether copolymer, and maleic acid monobutyl ester-vinyl methyl ether
copolymer conform to the definition of polymers given in 40 CFR 723.250(b)(11) and meet the following criteria that
are used to identify low-risk polymers: 
<!-- PJG 0012 frnewline -->
1. The minimum number average molecular weight of the copolymers mentioned above is 46,000. Substances with molecular
weights greater than 400 generally are not absorbed through the intact skin, and substances with molecular weights
greater than 1,000 generally are not absorbed through the intact gastrointestinal (GI) tract. Chemicals not absorbed
through skin or GI tract generally are incapable of eliciting a toxic response.
<!-- PJG 0012 frnewline -->
2. Maleic acid monoethyl ester-vinyl methyl ether copolymer, maleic acid monoisopropyl ester-vinyl methyl ether
copolymer, and maleic acid monobutyl ester-vinyl methyl ether copolymer are not cationic polymers, nor are they
reasonably anticipated to become cationic polymers in a natural aquatic environment.
<!-- PJG 0012 frnewline -->
3. The above-mentioned copolymers do not contain less than 32.0 percent by weight of the atomic element carbon.
<!-- PJG 0012 frnewline -->
4. Maleic acid monoethyl ester-vinyl methyl ether copolymer, maleic acid monisopropyl ester-vinyl methyl ether
copolymer, and maleic acid monobutyl ester-vinyl methyl ether copolymer contain as integral parts of their composition
the atomic elements carbon, hydrogen, nitrogen, and oxygen.
<!-- PJG 0012 frnewline -->
5. The above-mentioned copolymers do not contain as integral parts of their composition, except as impurities, any
elements other than those listed in 40 CFR 723.250(d)(3)(ii).
<!-- PJG 0012 frnewline -->
6. Maleic acid monoethyl ester-vinyl methyl ether copolymer, maleic acid monisopropyl ester-vinyl methyl ether
copolymer; and maleic acid monobutyl ester-vinyl methyl ether copolymer are not biopolymers, synthetic equivalents
of biopolymers, or derivatives or modifications of biopolymers that are substantially intact.
<!-- PJG 0012 frnewline -->
7. The above-mentioned copolymers are not manufactured from reactants containing, other than as impurities, halogen
atoms or cyano groups.
<!-- PJG 0012 frnewline -->
8. Maleic acid monoethyl ester-vinyl methyl ether copolymer, maleic acid monisopropyl ester-vinyl methyl ether
copolymer, and maleic acid monobutyl ester-vinyl methyl ether copolymer do not contain reactive functional groups
that are intended or reasonably anticipated to undergo futher reaction.
<!-- PJG 0012 frnewline -->
9. The above-mentioned copolymers are not designed, nor are they reasonable expected, to substantially degrade,
decompose, or depolymerize.
<!-- PJG 0012 frnewline -->
Based on the information above and review of its use, EPA has found that, when used in accordance with good agricultural
practice, these ingredients are useful and a tolerance is not necessary to protect the public health. Therefore,
EPA proposes that the exemptions from the requirement of a tolerance be established as set forth below.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person who has registered or submitted an application for registration of a pesticide under the Federal Insecticide,
Fungicide, and Rodenticide Act, as amended, which contains any of these three chemicals may request, within 30 days
after publication of this document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, that this rulemaking proposal be referred to an Advisory Committee in accordance with section 408(e) of the Federal
Food, Drug, and Cosmetic Act.
<!-- PJG 0012 frnewline -->
Interested persons are invited to submit written comments on the proposed regulation. Comments must bear a notation
indicating the document control number, [OPP-300318]. All written comments filed in response to this petition will
be available in the Public Response and Program Resources Branch, at the address given above from 8 a.m. to 4 p.m., Monday
through Friday, except legal holidays.
<!-- PJG 0012 frnewline -->
The Office of Management and Budget has exempted this rule from the requirements of section 2 of Executive Order 12866.
<!-- PJG 0012 frnewline -->
Pursuant to the requirements of the Regulatory Flexibility Act (Pub. L. 96-354, 94 Stat. 1164, 5 U.S.C. 601-612),
the Administrator has determined that regulations establishing new tolerances or raising tolerance levels or establishing
exemptions from tolerance requirements do not have an economic impact on a substantial number of small entities.
A certification statement to this effect was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of May 4, 1981 (46 FR 24950).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 180
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and
pests, Reporting and recordkeeping requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dated: December 23, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen L. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Registration Division, Office of Prevention, Pesticides and Toxic Substances.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Therefore, it is proposed that 40 CFR part 180 be amended as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 180_[AMENDED]
<!-- PJG 0011 horztab -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 180 continues to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 21 U.S.C. 346a and 371.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;180.1001, by amending paragraphs (c) and (e) in the tables therein by adding and alphabetically inserting
the following inert ingredients, to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;180.1001
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
 Exemptions from the requirement of a tolerance.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L1,tp0,s110,r65,r110 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Inert ingredients
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Uses
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Maleic acid monoethyl ester-vinyl methyl ether copolymer, CAS No. 25087-06-3, minimum average molecular weight
46,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Seed-coating adhesive, gel, and antitranspirant.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Maleic acid monisopropyl ester-vinyl methyl ether copolmer, CAS No. 31307-95-6, minimum average molecular weight
49,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Seed-coating adhesive, gel, and antitranspirant.
<!-- PJG 0012 frnewline -->
Maleic acid monobutyl ester-vinyl methyl ether copolymer, CAS No. 25119-68-0, minimum average molecular weight
52,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Seed-coating adhesive, gel, and antitranspirant.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(e) *&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L1,tp0,s110,r65,r110 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Inert ingredients
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Uses
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Maleic acid monoethyl ester-vinyl methyl ether copolymer, CAS No. 25087-06-3, minimum average molecular weight
46,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Seed-coating adhesive, gel, and antitranspirant.
<!-- PJG 0012 frnewline -->
Maleic acid monisopropyl ester-vinyl methyl ether copolmer, CAS No. 31307-95-6, minimum average molecular weight
49,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Seed coating adhesive, gel, and antitranspirant.
<!-- PJG 0012 frnewline -->
Maleic acid monobutyl ester-vinyl methyl ether copolymer, CAS No. 25119-68-0, minimum average molecular weight
52,000
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Seed-coating adhesive, gel, and antitranspirant.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;762 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00039 </DOCNO>
<PARENT> FR940112-1-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>40 CFR Part 180</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;300317; FRL&hyph;4749&hyph;1]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN No. 2070&hyph;AC18</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Cross-linked Polyurea-Type Encapsulating Polymer Tolerance Exemption 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Proposed rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This document proposes that an exemption from the requirement of a tolerance be established for residues of cross-linked
polyurea-type encapsulating polymer when used as an inert ingredient (encapsulating agent) in pesticide formulations
for application to animals. This proposed regulation was requested by Zeneca Ag Products.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments, identified by the document control number [OPP-300317], must be received on or before February 11, 1994.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail, submit written comments to: Public Response and Program Resources Branch, Field Operations Division (7506C),
Office of Pesticide Programs, Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. In person,
deliver comments to: Rm. 1132, Crystal Mall Bldg. #2, 1921 Jefferson Davis Hwy., Arlington, VA 22202. Information
submitted as a comment concerning this document may be claimed confidential by marking any part or all of that information
as ``Confidential Business Information'' (CBI). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Information so marked will not be disclosed except in accordance with procedures set forth in 40 CFR part 2. A copy of
the comment that does not contain CBI must be submitted for inclusion in the public record. Information not marked
confidential will be included in the public docket by EPA without prior notice. The public docket is available for
public inspection in Rm. 1132 at the address given above, from 8 a.m. to 4 p.m., Monday through Friday, excluding legal
holidays. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: Connie Welch, Registration Support Branch, Registration Division (7505C), Office of Pesticide Programs,
Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. Office location and telephone number: 2800
Crystal Drive, North Tower, 6th Floor, Arlington, VA 22202, (703)-308-8320.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Zeneca Ag Products, P.O. Box 751, Wilmington, DE 19897, has submitted pesticide petition (PP) 3E4269 to EPA requesting
that the Administrator, pursuant to section 408(e) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 346a(e),
propose to amend 40 CFR 180.1001(e) by establishing an exemption from the requirement of a tolerance for residues
of cross-linked polyurea-type encapsulating polymer when used as an inert ingredient (encapsulating agent) in
pesticide formulations for application to animals.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Inert ingredients are all ingredients that are not active ingredients as defined in 40 CFR 153.125, and include, but
are not limited to, the following types of ingredients (except when they have a pesticidal efficacy of their own):
solvents such as alcohols and hydrocarbons; surfactants such as polyoxyethylene polymers and fatty acids; carriers
such as clay and diatomaceous earth; thickeners such as carrageenan and modified cellulose; wetting, spreading,
and dispersing agents; propellants in aerosol dispensers; microencapsulating agents; and emulsifiers. The term
``inert'' is not intended to imply nontoxicity; the ingredient may or may not be chemically active.
<!-- PJG 0012 frnewline -->
The data submitted in support of the current exemption and also the data submitted in this petition have been evaluated.
As part of the EPA policy statement on inert ingredients published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of April 22, 1987 (52 FR 13305), the Agency set forth a list of studies which would generally be used to evaluate the risks
posed by the presence of an inert ingredient in a pesticide formulation. Where it can be determined that the inert ingredient
will present minimal or no risk, the Agency generally does not need some or all of the listed studies to rule on the proposed
tolerance or exemption for an inert ingredient. The Agency has decided that any data, in addition to that described
below, normally required to support cross-linked polyurea-type encapsulating polymer will not need to be submitted.
The rationale for this decision is described below.
<!-- PJG 0012 frnewline -->
In the case of certain chemical substances which are defined as ``polymers,'' the Agency has established a set of criteria
which identify categories of polymers that present low risk. These criteria (described in 40 CFR 723.250) identify
polymers that are relatively unreactive and stable compared to other chemical substances as well as polymers that
typically are not readily absorbed. These properties generally limit a polymer's ability to cause adverse effects.
In addition, these criteria exclude polymers about which little is known. The Agency believes that polymers meeting
the criteria noted above will present minimal or no risk. Cross-linked polyurea-type encapsulating polymer conforms
to the definition of a polymer given in 40 CFR 723.250(b)(11) and meets the following criteria which are used to identify
low risk polymers:
<!-- PJG 0012 frnewline -->
1. The minimum average molecular weight of the above-mentioned polymer is 5 X 10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Substances with molecular weights greater than 400 generally are not readily absorbed through the intact skin,
and substances with molecular weights greater than 1,000 generally are not absorbed through the intact gastrointestinal
(GI) tract. Chemicals not absorbed through the skin or GI tract generally are incapable of eliciting a toxic response.
<!-- PJG 0012 frnewline -->
2. The above-mentioned polymer is not a cationic polymer, nor is it reasonably anticipated to become a cationic polymer
in a natural aquatic environment. 
<!-- PJG 0012 frnewline -->
3. The above-mentioned polymer does not contain less than 32.0 percent by weight of the atomic element carbon. 
<!-- PJG 0012 frnewline -->
4. The above-mentioned polymer contains as an integral part of its composition the atomic elements carbon, hydrogen,
nitrogen, and oxygen. 
<!-- PJG 0012 frnewline -->
5. The above-mentioned polymer does not contain as an integral part of its composition, except as impurities, any
elements other than those listed in 40 CFR 723.250(d)(3)(ii). 
<!-- PJG 0012 frnewline -->
6. The above-mentioned polymer is not a biopolymer, a synthetic equivalent of a biopolymer, or a derivative or modification
of a biopolymer that is substantially intact. 
<!-- PJG 0012 frnewline -->
7. The above-mentioned polymer is not manufactured from reactants containing, other than as impurities, halogen
atoms or cyano groups.
<!-- PJG 0012 frnewline -->
8. The above-mentioned polymer does not contain reactive functional groups that are intended or reasonably anticipated
to undergo further reaction. 
<!-- PJG 0012 frnewline -->
9. The above-mentioned polymer is not designed or reasonably anticipated to substantially degrade, decompose,
or depolymerize.
<!-- PJG 0012 frnewline -->
Based upon the above information and review of its use, EPA has found that, when used in accordance with good agricultural
practice, this ingredient is useful and a tolerance is not necessary to protect the public health. Therefore, EPA
proposes that the exemption from the requirement of a tolerance be established as set forth below.
<!-- PJG 0012 frnewline -->
Any person who has registered or submitted an application for registration of a pesticide, under the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA) as amended, which contains any of the ingredients listed herein, may request
within 30 days after publication of this document in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that this rulemaking proposal be referred to an Advisory Committee in accordance with section 408(e) of the Federal
Food, Drug, and Cosmetic Act. Interested persons are invited to submit written comments on the proposed regulation.
Comments must bear a notation indicating the document control number, [OPP-300137]. All written comments filed
in response to this petition will be available in the Public Response and Program Resources Branch, at the address
given above, from 8 a.m. to 4 p.m., Monday through Friday, except legal holidays.
<!-- PJG 0012 frnewline -->
The Office of Management and Budget has exempted this rule from the requirements of section 3 of Executive Order 12291.
Pursuant to the requirements of the Regulatory Flexibility Act (Pub. L. 96-354, 94 Stat. 1164, 5 U.S.C. 601-612),
the Administrator has determined that regulations establishing new tolerances or raising tolerance levels or establishing
exemptions from tolerance requirements do not have a significant economic effect on a substantial number of small
entities. A certification statement to this effect was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of May 4, 1981 (46 FR 24950).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 180
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and
pests, Recording and recordkeeping requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Dated: December 23, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen L. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Registration Division, Office of Prevention, Pesticides and Toxic Substances.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Therefore, it is proposed that 40 CFR part 180 be amended as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
PART 180_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 180 continues to read as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 21 U.S.C. 346a and 371.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. Section 180.1001(e) is amended by adding and alphabetically inserting the inert ingredient, to read as follows:

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;180.1001
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
 Exemptions from the requirement of a tolerance.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(e) *&blank;*&blank;* 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L1,tp0,s110,r65,r110 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Inert ingredients
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Limits
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Uses 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Cross-linked polyurea-type encapsulating polymer
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Encapsulating agent 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;764 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00040 </DOCNO>
<PARENT> FR940112-1-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL COMMUNICATIONS COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>47 CFR Part 76</CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[MM Docket No. 93&hyph;290; DA 94&hyph;2]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Cable Television Service; List of Major Television Markets 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Communications Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Proposed rule; extension of time.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Commission extends the time for filing reply comments in its proceeding 58 FR 62085, 11/24/93, proposing to amend
the Commission's rules regarding major cable television markets from January 4, 1994 to January 18, 1994. This action
is being taken to allow parties additional time to analyze and address numerous issues concerning adjustments to
particularly large and complex television markets. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Reply comments are now due on or before January 18, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Communications Commission, Washington, DC 20554.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Alan E. Aronowitz, Mass Media Bureau, Policy and Rules Division, (202) 632&hyph;7792.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In the Matter of Amendment of section 76.51 of the Commission's rules to include Newton, New Jersey, and Riverhead,
New York, in the New York, New York-Linden-Paterson-Newark, New Jersey, Television Market.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
ORDER
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Adopted: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
January 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Released: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
January 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Reply Comment Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
January 18, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By the Chief, Mass Media Bureau: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. We now consider a Motion for Extension of Time for the filing of reply comments in the above-captioned proceeding
filed on December 22, 1993, by WLIG&hyph;TV, Inc. (``WLIG''), licensee of Television Station WLIG&hyph;TV, Riverhead,
New York, and proponent of the amendment of section 76.51 of the rules to include Riverhead in the subject market. The
deadline for filing comments in this proceeding was December 20, 1993, and reply comments are due January 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. WLIG states that although comments were all filed on December 20, 1993, copies were not received by counsel until
December 21 and 22. Seven sets of comments were filed. WLIG contends that the comments respond to a number of issues
raised in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Notice of Proposed Rule Making
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<FOOTCITE>1</FOOTCITE>
 which must be studied and addressed. Although WLIG has begun the process, it requests, noting the intervention of
two Federal holidays, the press of other year-end responsibilities, and pre-exiting vacation schedules, an additional
nine business days, until January 18, 1994, to file its reply comments. Inasmuch as this proceeding was initiated,
in part, by WLIG, it urges that the additional time will foster the paramount public interest in the development of
a full public record for the Commission's decision.
<FOOTCITE>2</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8 FCC Rcd 8136 (1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
WLIG states that counsel for Mountain Broadcasting Corporation, the other original petitioner in this proceeding,
has indicated no objection to the requested extension. Further, counsel for those filing comments in this proceeding
have indicated no objection to WLIG's request. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
3. As set forth in section 1.46 of the Commission's rules, 47 CFR 1.46, it is our policy that extensions of time for filing
comments in rule making proceedings shall not be routinely granted. However, we note that the Notice of Proposed Rule
Making raises numerous issues concerning adjustments to particularly large and complex television markets, and
therein we specifically state our desire for additional information to develop a comprehensive record before deciding
these matters. Thus, it appears reasonable to provide the commenting parties additional time to analyze and address
these issues. Therefore, we will extend the deadline for filing reply comments in this proceeding to January 18, 1994.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Accordingly, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
It is Ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
that the Motion for Extension of Time filed by WLIG&hyph;TV, Inc. IS GRANTED, and the time for filing reply comments
in this proceeding Is Extended to January 18, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. This action is taken pursuant to authority found in section 4(i) and 303(r) of the Communications Act of 1934, as
amended, and section 0.204(b), 0.283, and 1.45 of the Commission's rules. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
Federal Communications Commission
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Roy J. Stewart,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Mass Media Bureau.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;659 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6712&hyph;&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00041 </DOCNO>
<PARENT> FR940112-1-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Highway Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<CFRNO>49 CFR Part 393 </CFRNO>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FHWA Docket No. MC&hyph;93&hyph;34] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 2125&hyph;AD25 </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Parts and Accessories Necessary for Safe Operation; Sleeper Berths on Motorcoaches 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Federal Highway Administration (FHWA), DOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Advance notice of proposed rulemaking (ANPRM).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The FHWA requests public comment on the use and design of driver sleeper berths in the motorcoach industry. Existing
sleeper berth regulations were written with commercial trucks and truck-tractors in mind. The agency seeks comments
on the suitability of these regulations for motorcoaches and the possibility of amending them to account for design
differences between trucks and motorcoaches. This action is being taken in response to comments received at the motorcoach
industry Zero-Base Review hearing held in Miami, Florida, on January 20, 1993, and written requests from the motorcoach
industry.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments must be received on or before March 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 All signed, written comments should refer to the docket number that appears at the top of this document and must be submitted
to HCC&hyph;10, room 4232, Office of the Chief Counsel, Federal Highway Administration, 400 Seventh Street, SW.,
Washington DC 20590. All comments received will be available for examination at the above address from 8:30 a.m. to
3:30 p.m., e.t., Monday through Friday, except legal Federal holidays. Those desiring notification of receipt of
comments must include a self-addressed stamped postcard or envelope.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Mr. Bryan L. Price, Office of Motor Carrier Standards, (202) 366&hyph;5720, or Mr. Charles Medalen, Office of the
Chief counsel, (202) 366&hyph;1354, Federal Highway Administration, Department of Transportation, 400 Seventh
Street SW., Washington, DC 20590. Office hours are from 7:45 a.m. to 4:15 p.m., e.t., Monday through Friday, except
legal Federal holidays.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On January 20, 1993, the FHWA held a public hearing in Miami, FL, as part of our Zero-Base Review of the Federal Motor
Carrier Safety Regulations (FMCSRs) to obtain information, views, and opinions from representatives of the motorcoach
industry (see 57 FR 60784). Four out of ten industry representatives who testified at the hearing voiced concerns
about the suitability of existing sleeper berth regulations for motorcoaches. A common theme among those who testified
on this subject was that the current sleeper berth regulations were written specifically for trucks and truck-tractors
without considering the unique design characteristics of motorcoaches. A complete transcript of this hearing is
on file and available for review in the FHWA docket room under FHWA Docket No. MC&hyph;92&hyph;33&hyph;182. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Both the American Bus Association and the United Bus Owners of America have also indicated to the FHWA that the suitability
of existing sleeper berth regulations for motorcoaches is a concern of their members. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FHWA has also received written requests from the motorcoach industry to revise the current sleeper berth regulations
to account for design differences between motorcoaches and trucks. (Copies of these letters are included in FHWA
Docket No. MC&hyph;93&hyph;34.) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In response to these concerns and as part of the FHWA's efforts to eliminate unnecessarily design-restrictive regulations,
a review of the rulemaking history of the current sleeper berth requirements was completed. The review indicated
that sleeper berths on motorcoaches may not have been considered when the existing sleeper berth regulations were
promulgated. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In a final rule published on May 15, 1952 (17 FR 4422), the Interstate Commerce Commission (ICC) revised most of the
existing Federal Motor Carrier Safety Regulations (FMCSRs) and created a number of new regulations. One new regulation
set forth detailed specifications for sleeper berths. The rule required that every sleeper berth installed in or
on a truck or truck-tractor after December 31, 1952, be located within or immediately adjacent to the cab, or within
the cargo space of a truck, and be provided with a direct and ready means of exit into the driver's compartment (17 FR
4443). These requirements are now codified at 49 CFR 393.76(b)(2) and 393.76(c)(1), respectively. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition, the regulations also required that any sleeper berth which could not meet this standard, in essence those
installed on trucks or truck-tractors before December 31, 1952, be provided with means of communication between
the occupant of the berth and the driver. The berth also had to be designed, constructed, and maintained to provide
the occupant, without the assistance of other persons, at least two means of ready exit from the motor vehicle. These
requirements are now codified at 49 CFR 393.76(d) and 393.76(c)(2)(ii), respectively. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Because motorcoach operators rarely used sleeper berths forty years ago, the ICC drafted a rule for trucks and truck-tractors.
Practices in the motorcoach industry have changed, however, and some operators would like to use sleeper berths to
reduce driver fatigue and to help comply with driver's hours of service regulations. The 1952 regulations did not
address sleeper berths on motorcoaches, nor have any subsequent rulemakings done so. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On July 3, 1970, the FHWA published a final rule relating to seat belts and restraint of sleeper berth occupants (35
FR 10859). That rule differentiated between trucks and buses with regard to seats, seat belt assemblies, and seat
belt assembly anchorage requirements, but not with regard to sleeper berth restraint requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00042 </DOCNO>
<PARENT> FR940112-1-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Another rule on sleeper berth specifications was published on April 26, 1974 (39 FR 14710). It amended &sect;393.76
by increasing the minimum interior dimensions required for sleeper berths. The rule omitted specific references
to trucks and truck-tractors but made no substantive changes to adapt the regulation to the different design configurations
of motorcoaches. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Available information indicates that many sleeper berths installed on motorcoaches today are located in the baggage
area. This area is modified to allow the doors to be opened from inside the compartment, and by adding a mattress, air
conditioning, heat, and a means of communication with the driver. In order to meet the current requirement of &sect;393.76(c)(1)
for direct and ready means of exit from the sleeper berth into the driver's seat or compartment, an aperture that meets
the exit dimensional requirements must be cut into the floor of the motorcoach. This reduces the seating capacity
of the motorcoach. The FHWA would like to know about other motorcoach sleeper berth designs which may or may not meet
the current requirements of &sect;393.76. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FHWA is requesting public comment on the question of whether, and if so how, existing sleeper berth regulations
should be amended to address design differences between motorcoaches and commercial trucks.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Questions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FHWA would appreciate comments on the following questions. Commenters are also encouraged to discuss any other
matters related to sleeper berths on motorcoaches which they believe the FHWA should address. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Should existing sleeper berth regulations be amended to account for design differences between motorcoaches
and trucks? If so, what changes should be made and why? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. What is the current extent of sleeper berth usage within the motorcoach industry? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. How many motorcoaches have been manufactured with sleeper berths as part of their original equipment? How and where
are these sleeper berths installed? How many comply with &sect;393.76? How many do not? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. How many motorcoaches have been retrofitted with sleeper berths? How and where are these sleeper berths installed?
How many comply with &sect;393.76? How many do not? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Do after-market changes, such as cutting holes in the floor or modifying the cargo compartment, affect the structural
integrity of the motorcoach? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. The FHWA notes that if a driver sleeper berth is located within the baggage area and occupied while the motorcoach
is in operation, the occupant could be vulnerable to a side impact collision. Are special requirements needed to ensure
the occupants' safety? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
7. If a driver sleeper berth is located in the baggage area of a motorcoach, should its location be restricted (e.g.,
only the forward-most portion of the baggage area)? If the sleeper berth is used while the vehicle is in operation,
would having the sleeper berth near the rear of the motorcoach subject persons occupying the berth to excessive heat,
noise, or exhaust? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
8. The current requirements of &sect;393.76 for a direct and ready means of exit from the sleeper berth into the driver's
seat or compartment may be design-restrictive for motorcoaches. Should the exit requirements allow a ready means
of exit into the passenger compartment of the motorcoach instead of the driver's seat or compartment? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
9. Would separate motorcoach sleeper berth regulations enhance motorcoach safety or benefit the motorcoach industry?
If yes, how? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Rulemaking Analyses and Notices 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All comments received before the close of business on the comment closing date indicated above will be considered
and will be available for examination in the docket at the above address. Comments received after the comment closing
date will be filed in the docket and will be considered to the extent practical. In addition to late comments, the FHWA
will also continue to file relevant information in the docket as it becomes available after the comment closing date,
and interested persons should continue to examine the docket for new material. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Executive Order 12866 (Regulatory Planning and Review) and DOT Regulatory Policies and Procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The FHWA has determined that this document does not contain a ``significant regulatory action'' under Executive
Order 12866 or a ``significant'' regulation under the regulatory policies and procedures of the DOT. Due to the preliminary
nature of this document and lack of necessary information on costs, however, the FHWA is unable to evaluate the economic
impact of potential changes to regulatory requirements concerning the use and design of driver sleeper berths in
the motorcoach industry. Based on the information received in response to this notice, the FHWA intends to carefully
consider the costs and benefits associated with possible amendments to the regulations. Comments, information,
and data are solicited on the economic impact of the potential changes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00043 </DOCNO>
<PARENT> FR940112-1-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4702 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Regulatory Flexibility Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Due to the preliminary nature of this document and lack of necessary information on costs, the FHWA is unable to evaluate
the effects of the potential regulatory changes on small entities. Based on the information received in response
to this notice, the FHWA intends, in compliance with the Regulatory Flexibility Act (5 U.S.C. 601&hyph;612), to carefully
consider the economic impacts of these potential changes on small entities. The FHWA solicits comments, information,
and data on these impacts. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Executive Order 12612 (Federalism Assessment) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This action has been analyzed in accordance with the principles and criteria contained in Executive Order 12612,
and it has been determined that this action does not have sufficient federalism implications to warrant the preparation
of a federalism assessment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Executive Order 12372 (Intergovernmental Review) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Catalog of Federal Domestic Assistance Program Number 20.217, Motor Carrier Safety. The regulations implementing
Executive Order 12372 regarding intergovernmental consultation on Federal programs and activities apply to this
program. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Paperwork Reduction Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This action does not contain a collection of information requirement for purposes of the Paperwork Reduction Act
of 1980 (44 U.S.C. 3501 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
National Environmental Policy Act 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This agency has analyzed this action for the purpose of the National Environmental Policy Act of 1969 (42 U.S.C. 4321

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) and has determined that this action would not have any effect on the quality of the environment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Regulation Identification Number 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A regulatory identification number (RIN) is assigned to each regulatory action listed in the Unified Agenda of Federal
Regulations. The Regulatory Information Service Center publishes the Unified Agenda in April and October of each
year. The RIN contained in the heading of this document can be used to cross reference this action with the Unified Agenda.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 49 CFR Part 393 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Freight transportation, Highway safety, Highways and roads, Motor carriers, Motor vehicle safety.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
49 U.S.C. app. 2505; 49 U.S.C. 3102; 49 CFR 1.48.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued on January 5, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rodney E. Slater, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Federal Highway Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;738 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;22&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-1-00044 </DOCNO>
<PARENT> FR940112-1-00023 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part IV
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
40 CFR Part 372 
<!-- PJG 0012 frnewline -->
Addition of Certain Chemicals; Toxic Chemical Release Reporting; Community Right-to-Know; Proposed Rule 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Proposed Rules
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>ENVIRONMENTAL PROTECTION AGENCY</USDEPT>

<!-- PJG 0012 frnewline -->

<USDEPT>40 CFR Part 372</USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPPTS&hyph;400082; FRL&hyph;4645&hyph;6]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=91 g=1 f=1 -->

<RINDOCK>RIN 2070&hyph;AC47</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Addition of Certain Chemicals; Toxic Chemical Release Reporting; Community Right-to-Know 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Proposed rule.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 EPA is proposing to add 313 chemicals and chemical categories to the list of toxic chemicals required to be reported
on under section 313 of the Emergency Planning and Community Right-to-Know Act of 1986 and section 6607 of the Pollution
Prevention Act of 1990. The proposed addition of these chemicals and chemical categories is based on their acute human
health effects, carcinogenicity or other chronic human health effects, and/or their environmental effects. EPA
believes that these chemicals and chemical categories meet the EPCRA section 313(d)(2) criteria for addition to
the list of toxic chemicals. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comment on this proposed rule must be received on or before April 12, 1994. The public meeting will take place
on March 2, 1994, at 1 p.m. and adjourn by 5 p.m.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Written comments should be submitted in triplicate to: OPPT Docket Clerk, TSCA Document Receipt Office (7407), Office
of Pollution Prevention and Toxics, Environmental Protection Agency, Rm. E&hyph;G99, 401 M St., SW., Washington,
DC 20460. Comments containing information claimed as confidential must be clearly marked as confidential business
information (CBI). If CBI is claimed, three additional sanitized copies must also be submitted. Nonconfidential
versions of comments on this proposed rule will be placed in the rulemaking record and will be available for public
inspection. Comments should include the docket control number for this proposal, OPPTS&hyph;400082. Unit VI. of
this preamble contains additional information on submitting comments containing information claimed as CBI. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The public meeting will be held at the: Environmental Protection Agency, Auditorium, Education Center, 401 M St.,
SW., Washington, DC. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Maria J. Doa, Emergency Planning and Community Right-to-Know Information Hotline, Environmental Protection Agency,
Mail Stop 5101, 401 M St., SW., Washington, DC 20460, Toll free: 800&hyph;535&hyph;0202 or Toll free TDD: 800&hyph;553&hyph;7672,
Attention: Docket Number OPPTS&hyph;400082.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Statutory Authority
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This proposed rule is issued under sections 313(d) and (e)(1) of the Emergency Planning and Community Right-to-Know
Act of 1986 (EPCRA), 42 U.S.C. 11023. EPCRA is also referred to as Title III of the Superfund Amendments and Reauthorization
Act of 1986. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 313 of EPCRA requires certain facilities manufacturing, processing, or otherwise using listed toxic chemicals
to report their environmental releases of such chemicals annually. Beginning with the 1991 reporting year, such
facilities also must report pollution prevention and recycling data for such chemicals, pursuant to section 6607
of the Pollution Prevention Act, 42 U.S.C. 13106. When enacted, section 313 established an initial list of toxic chemicals
that was comprised of more than 300 chemicals and 20 chemical categories. Section 313(d) authorizes EPA to add chemicals
to or delete chemicals from the list, and sets forth criteria for these actions. Under section 313(e), any person may
petition EPA to add chemicals to or delete chemicals from the list. EPA has added to and deleted chemicals from the original
statutory list.
<!-- PJG 0012 frnewline -->
EPA issued a statement of petition policy and guidance in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of February 4, 1987 (52 FR 3479), to provide guidance regarding the recommended content and format for submitting
petitions. EPA must respond to petitions within 180 days either by initiating a rulemaking or by publishing an explanation
of why the petition is denied. On May 23, 1991 (56 FR 23703), EPA issued guidance regarding the recommended content
of petitions to delete individual members of the section 313 metal compound categories. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Explanation for Expansion of the EPCRA Section 313 Chemical List 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. General Rationale 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Toxics Release Inventory (TRI), through the public access provisions of EPCRA, has proven to be one of the most
powerful forces in empowering the Federal government, State governments, industry, environmental groups, and
the general public, to fully participate in an informed dialogue about the environmental impacts of toxic chemicals
in the United States.
<!-- PJG 0012 frnewline -->
A major section of EPCRA, which Congress passed in 1986, resulted in the creation of the Toxics Release Inventory.
TRI is a publicly available data base that provides quantitative information on toxic chemical releases, transfers,
recycling, and disposal. With the collection of this information for the first time in 1987, came the ability for the
public, government, and the regulated community to understand the magnitude of chemical emissions in the United
States; to compare chemical releases and transfers of chemical wastes among States, industries, facilities, and
environmental media; and perhaps most importantly, to assess the need to reduce and where possible, eliminate these
releases and transfers. TRI enables all interested in environmental progress to establish credible baselines,
to set realistic goals, and to measure progress over time, in meeting those goals. The TRI system has become a neutral
yardstick by which progress can be measured by all interested parties.
<!-- PJG 0012 frnewline -->
The original list of chemicals for which reporting was required consisted of 320 chemicals and chemical categories.
The list was a combination of the Maryland Chemical Inventory Report List of Toxic or Hazardous Substances and the
New Jersey Environmental Hazardous Substance List. The combination of these two lists provided a sound and logical
starting point for the national TRI program. Recognizing however that the list would need to be a dynamic one, EPCRA
specifically authorizes additions to and deletions from the list. To date, EPA has added 16 chemicals to the list and
has deleted 12 chemicals from the list.
<!-- PJG 0012 frnewline -->
With 5 years experience behind the program, EPA, other federal agencies, Congress, and the public have recognized
the need to expand the TRI list beyond the original chemicals and chemical categories and beyond the relatively limited
reporting universe. (Currently reporting is only required from facilities that fall within the manufacturing Standard
Industrial Classification (SIC) codes 20 through 39 that meet certain thresholds).
<!-- PJG 0012 frnewline -->
While the data on the chemicals that are covered have allowed the public and private sectors to be informed and involved
in environmental decisionmaking as they never were before, it has become increasingly evident to those same constituents
that they have access to information on a relatively small number of important chemicals. Congress has echoed this
recognition in the Right-to-Know More bills that were put forward in the 102nd Congress. EPA and State regulatory
agencies have integrated TRI information as a critical component in their environmental decisionmaking and in many
cases are constrained by the lack of similar information on chemicals of concern not covered by the TRI. While the TRI
has been successful in focusing attention on the initial list of chemicals and in many cases fostering emissions reductions
and prevention activities, that same focus has highlighted the need to expand beyond that initial list and to include
additional chemicals that exhibit similar toxicity characteristics. This proposal is one of the first in a series
of actions that EPA plans to use to expand the coverage of the TRI. This first phase will focus on adding chemicals, followed
by a second phase that will identify additional facilities for inclusion. EPA is considering a third phase, which
would look at modification of the data elements currently required by TRI. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In conjunction with these expansion activities EPA has been considering whether other adjustments are needed in
the scope of the TRI program. EPA received petitions from the Small Business Administration and the American Feed
Industry Association seeking an exemption for ``small sources'' (i.e, those facilities that file TRI forms with
zero or small release estimates). EPA previously put those petitions out for public comment and, on review, believes
there is substantial merit to the general concerns raised in the petitions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Agency's plan for proceeding on the small source issue would include the following steps. EPA is examining four
options for establishing a small release exemption from the TRI reporting obligation: Cutoffs at zero, 500 pounds,
1,000 pounds, and 5,000 pounds. EPA will provide the public with a report on these four options by the end of January.
This analysis will consider what data might not be available at both the national and community level, and the cost
savings to the government and to industry of the four exemption levels. EPA plans to hold a public meeting in February
for discussion of the report. Based on this feedback, EPA will then design a regulatory strategy that will align the
small source issue with final action on today's proposal. The Agency's objective will be to minimize unnecessary
data collection and reporting by facilities, including for the chemicals identified in today's proposal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Development of the Chemical Addition Candidates
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As a starting point for screening candidates for addition to the toxic chemical list under EPCRA section 313, EPA chose
to examine the lists of chemicals regulated or identified, as of concern, under various environmental statutes including:
(1) Section 112(b) of the Clean Air Act (CAA) as amended in 1990 (Hazardous Air Pollutants); (2) section 602(b) of the
CAA (Class II ozone depleting substances); (3) section 307(a) of the Clean Water Act (CWA) (Priority Pollutant List);
(4) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Active Ingredients, including Special Review,
Canceled/Denied or Suspended, and Restricted Use Pesticides; (5) section 302 of EPCRA (Extremely Hazardous Substances);
(6) section 102 of the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA); (7) section
3001 of the Resource Conservation and Recovery Act (RCRA) and chemicals listed at 40 CFR 261.33(e) and (f) and Appendix
VIII; (8) section 1412 of the Safe Drinking Water Act as amended; (9) certain chemicals subject to the Toxics Substance
Control Act (Existing Chemicals); and (10) the State of California Safe Drinking Water and Toxic Enforcement Act
of 1986 (Proposition 65) (List of Chemicals Known to the State to Cause Reproductive Toxicity). 
<!-- PJG 0012 frnewline -->
In addition, EPA considered chemicals designated as possible, probable, or known carcinogens in the Monographs
of the International Agency for Research on Cancer (IARC) and the 6th Annual Report on Carcinogens of the National
Toxicology Program (NTP), U.S. Department of Health and Human Services (DHHS). From this initial group of substances,
EPA excluded chemicals that are already listed on section 313 or are already reportable under one of the EPCRA section
313 categories. For example, ``cyanide, total'' is listed under section 307(a) of the CWA. This listing is considered
to be a subset of the EPCRA section 313 cyanide compounds category and the hydrogen cyanide listing. EPA decided not
to propose listing these types of chemicals separately because they are already reportable under one of the existing
section 313 categories. To prioritize chemicals for possible addition to EPCRA section 313, EPA applied a human health
and ecotoxicity screen and a production volume screen, which are described below. The results of the toxicity screen
for a subset of these chemicals were presented at a public meeting on May 29, 1992 (Ref. 4). Other chemicals were also
removed from consideration for this rulemaking because they are the subjects of two recently published EPCRA petition
responses. On March 4, 1992, EPA received a petition from Governor Mario M. Cuomo of New York and the Natural Resources
Defense Council (NRDC) to add 80 chemicals and 2 chemical categories to the list of toxic chemicals under section 313
of EPCRA. All of these chemicals and chemical categories appear on the RCRA list of hazardous wastes under 40 CFR 261.33(f)
and as such are a subset of the chemicals screened by EPA. EPA responded to the petition in a proposed rulemaking on September
8, 1992 (57 FR 41020) and in a final rule adding 22 chemicals on November 30, 1993 (58 FR 63500). 
<!-- PJG 0012 frnewline -->
On December 3, 1991, EPA received a petition from the NRDC, Friends of the Earth, and the Environmental Defense Fund
to add hydrochlorofluorocarbons (HCFCs) to the list of toxic chemicals under section 313 of EPCRA. The HCFCs are listed
under section 602(b) of the CAA as Class II ozone depleting substances and as such are a subset of the chemicals screened
by EPA. EPA responded to the petition in a proposed rulemaking on June 24, 1992 (57 FR 28159) and in a final rule adding
11 HCFCs on November 30, 1993 (58 FR 63496). An additional 16 HCFCs not added to the TRI list by the November 30, 1993 final
rule are proposed for addition in this rulemaking (See Unit IV.B.135. of this preamble). 
<!-- PJG 0012 frnewline -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Toxicity screen
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. A toxicity screen is a limited review of readily available toxicity data (e.g., information in data bases and other
secondary sources) that is used for a preliminary categorization of a chemical during the process of selecting candidates
for possible listing under EPCRA section 313. The toxicity screen is used to identify chemicals for further consideration
and does not reflect a final determination for listing a chemical under EPCRA section 313. Such a determination can
only be made after a hazard assessment is conducted (See Unit II.B.3. of this preamble). The chemicals identified
above were screened for four general effect categories: Acute human health effects, cancer, other chronic human
health effects, and ecological effects. 
<!-- PJG 0012 frnewline -->
The screening criteria associated with each of the effect areas used in the toxicity screen are discussed in detail
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Revised Draft Hazard Assessment Guidelines for Listing Chemicals on the Toxic Release Inventory (Draft Hazard Assessment
Guidelines)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, (Ref. 6). The numerical screening values reflected in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Draft Hazard Assessment Guidelines
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 were developed to capture, in the ``sufficient for listing'' screening category, the majority of chemicals already
listed on various CERCLA and EPCRA lists, and thus known or suspected to be toxic and/or hazardous. These 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Draft Hazard Assessment Guidelines
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 contain guidance for both the screening and hazard assessments of chemicals and are available for review in the docket
associated with this rulemaking. This draft document was distributed at a public meeting on May 29, 1992. A final version
of these guidelines has not yet been developed. Requests for further information about these draft guidelines should
be addressed to the person identified under ``FOR FURTHER INFORMATION CONTACT.'' 
<!-- PJG 0012 frnewline -->
Based on the results of this screen, the chemicals were preliminarily placed in one of three screening categories
defined in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Draft Hazard Assessment Guidelines
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
: ``sufficient;'' ``may be sufficient;'' or ``insufficient.'' EPA received comment in response to the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Draft Hazard Assessment Guidelines
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that objected to the Agency's use of the terms ``sufficient,'' ``may be sufficient,'' and ``insufficient'' as titles
for the toxicity screening categories. The commenter claimed that these terms are appropriate only for the results
of a hazard assessment. The commenter stated that these terms should not be used for screening categories because
the toxicity screen only identifies chemicals for further consideration. EPA agrees that the screening categories
only reflect a preliminary determination on each chemical, and therefore, to avoid further confusion, will refer
to the screening categories as ``high priority,'' ``medium priority,'' and ``low priority'' to reflect the difference
between a toxicity screen and a hazard assessment. These terms will be used throughout this document in reference
to the toxicity screening categories. Chemicals that were categorized as ``low priority'' during the screening
process were not considered further as candidates for addition to the EPCRA section 313 list in this rulemaking. 
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Production volume screen
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. EPCRA section 313(f) establishes reporting thresholds related to the amount of a chemical that is manufactured,
processed, or otherwise used. [The EPCRA section 313 manufacture (includes import) and processing thresholds are
25,000 pounds per facility per year. The otherwise use threshold is 10,000 pounds per facility per year]. EPA anticipates
that the addition of chemicals manufactured, imported, processed, or used in quantities less than the EPCRA section
313 volume thresholds would not result in the submission of TRI reports. Thus, EPA elected to initially focus its attention
on chemicals likely to yield reports. Accordingly, EPA also screened potential candidates for the likelihood of
meeting the EPCRA section 313 volume thresholds. Chemicals for which there were no data to indicate that the chemical
is likely to meet or exceed the EPCRA section 313 volume thresholds were not considered further as possible candidates
for addition to the section 313 list at this time. 
<!-- PJG 0012 frnewline -->
Production volume data on each of the chemicals were gathered primarily from two sources: (1) The TSCA Chemical Update
System (1990); and (2) the FIFRA Section 7 Tracking System. On June 12, 1986 (51 FR 21438), EPA promulgated a rule pursuant
to section 8(a) of TSCA which required manufacturers and importers to report every 4 years, subject to certain threshold
production quantities and other exclusions, the quantities of chemicals they produced (40 CFR part 710). Among the
exceptions to the inventory update rule (IUR) reporting were polymers, biological products, inorganic substances,
and chemicals produced at less than 10,000 pounds, all with certain limitations. Data from the IUR is maintained in
EPA's TSCA Chemical Update System (CUS). 
<!-- PJG 0012 frnewline -->
Section 7 of FIFRA provides the Agency with annual production information on registered pesticides. EPA regulations
implementing FIFRA section 7 (40 CFR part 167) require all manufacturers of pesticidal products (which includes
formulated pesticides, active ingredients, and devices) to submit an annual report detailing the amount of each
type of pesticidal product manufactured, sold and distributed during the past year, and estimated to be manufactured,
imported, and processed during the current year (40 CFR 167.85). 
<!-- PJG 0012 frnewline -->
For industrial inorganic compounds not subject to FIFRA or available on CUS, information from the public literature
was used, supplemented with information from companies. 
<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hazard evaluation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. EPA conducted a hazard evaluation for each of the addition candidates that resulted from the above analyses and determined
based on the weight-of-the evidence if there was sufficient evidence to establish that the candidate chemical met
the statutory criteria for addition to EPCRA section 313. To make this determination, EPA senior scientists reviewed
readily available toxicity information on each chemical for each of the following effect areas: acute human health
effects; cancer; other chronic human effects; and environmental effects. In addition, EPA reviewed, where appropriate,
information on the environmental fate of the chemical. 
<!-- PJG 0012 frnewline -->
The hazard assessment was conducted in accordance with relevant EPA guidelines for each adverse human health or environmental
effect (e.g., the appropriate guidelines for hazard evaluation of chemical carcinogens and for the type of evidence
required to substantiate a determination of carcinogenicity are the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Guidelines for Carcinogen Risk Assessment
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Ref. 2)). The guidelines that were used for each effect are Agency guidelines that are identified in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Draft Hazard Assessment Guidelines
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Ref. 6). During this assessment the severity and significance of the effects induced by the chemical, the dose level
causing the effect, and the quality and quantity of the available data, including the nature of the data (e.g., human
epidemiological, laboratory animal, field or workplace studies) and confidence level in the existing data base,
were all considered. Where a careful review of the scientific data for a particular chemical results in a high level
of confidence that the chemical causes an adverse effect at relatively low dose levels, EPA believes that this evidence
is sufficient for listing the chemical under section 313. On the other hand, where a review of the scientific data indicates
that the chemical will cause various adverse effects at moderate dose levels, EPA believes, based on the total weight-of-the-evidence,
that there is sufficient evidence for listing the chemical under EPCRA section 313. EPA also conducted an analysis
of exposure for each chemical or chemical category proposed for listing under EPCRA section 313(d)(2)(A) (i.e.,
based on adverse acute human health effects), and, where appropriate, under section 313(d)(2)(C) (i.e., based on
adverse ecological effects). For chemicals listed under EPCRA section 313(d)(2)(A), this analysis included estimated
concentrations of the chemical at or beyond the facility site boundary through the use of estimated releases and modelling
techniques. EPA requests comment on its approach in considering exposure as a part of its evaluation of these chemicals
under sections 313(d)(2)(A) and (C).
<!-- PJG 0012 frnewline -->
Based on this analysis for each of the chemicals proposed for listing, EPA determined that one or more of the statutory
criteria were met. A discussion of EPA's interpretation of the EPCRA section 313 criteria is given in Unit III. of this
preamble. A discussion of the evidence supporting EPA's proposal to add each of the chemicals to EPCRA section 313
is presented in Unit IV. of this preamble and in the record supporting this proposed rule. 
<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Other considerations
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. EPA excluded certain chemicals and chemical categories from consideration for proposed listing under EPCRA section
313 in this rulemaking for a number of reasons. Some chemicals were identified only as environmental degradation
products rather than chemicals that are manufactured, processed, or otherwise used by a facility. These chemicals
will only be present in the environment as a result of the release into the environment of precursor chemicals. If the
degradation product meets the toxicity criteria of EPCRA section 313, the precursor chemical may be considered for
listing on EPCRA section 313. The degradation product would not be considered for listing on EPCRA section 313 because
a facility subject to EPCRA section 313 is only required to file a TRI report for a chemical that it manufactures, processes,
or otherwise uses, within the facility boundaries. Therefore, EPA does not believe that it is appropriate to consider
listing such chemicals at this time. 
<!-- PJG 0012 frnewline -->
Some of the lists reviewed by EPA included listings that represented waste streams from particular processes. These
waste streams, such as coke oven emissions, are not discrete chemicals or chemical categories, but contain a wide
range of chemicals, many of which are currently listed individually on EPCRA section 313. The focus of this rulemaking
is on the addition of specific chemicals and chemical categories and, as such, EPA believes that these waste streams
are inappropriate for listing under EPCRA section 313 at this time. EPA also excluded chemicals whose only identified
toxicity concern was a result of their status as a volatile organic compound (VOC). VOCs contribute to the formation
of tropospheric ozone which causes a number of health-related and environmental problems. EPA continues to believe
that VOCs meet the listing criteria of EPCRA section 313. However, EPA intends to address the issue of how VOCs should
be listed on EPCRA section 313 separately. Therefore, chemicals whose only identified toxicity concern is due to
their status as VOCs were excluded from consideration at this time. 
<!-- PJG 0012 frnewline -->
EPA also identified chemicals that are routinely manufactured, processed, or otherwise used at levels far below
the reporting thresholds of EPCRA section 313. These chemicals are not expected to ever be manufactured, processed,
or otherwise used in quantities at or above these reporting thresholds. In this proposed rulemaking, EPA is attempting
to add chemicals to EPCRA section 313 that are manufactured, processed, or otherwise used in quantities greater than
the EPCRA section 313 volume thresholds and thus would result in the submission of TRI reports. Consequently, chemicals
that are manufactured, processed, or otherwise used in quantities less than the EPCRA section 313 volume thresholds
were excluded from further consideration at this time, because no reports would be filed under EPCRA section 313 for
such chemicals. 
<!-- PJG 0012 frnewline -->
Some of the chemicals that are manufactured, processed, or otherwise used below the EPCRA section 313 activity thresholds,
particularly those chemicals that are manufactured in trace amounts in waste streams, are highly toxic at very low
dose levels and have physical, chemical, or biological properties that make the chemicals persist for extended periods
in the environment, and bioaccumulate through the food chain. Persistent bioaccumulative toxic chemicals, such
as dioxins, are of particular concern in ecosystems such as the Great Lakes Basin due to the long retention time of the
individual lakes and the cycling of the chemical from one component of the ecosystem to another. EPA may reconsider
in the future the issue of listing such chemicals in a manner which would result in the submission of TRI reports. EPA
requests comment on the following: Is it appropriate to list such chemicals on EPCRA section 313? If EPA were to add
this type of chemical to EPCRA section 313, what modifications to EPCRA section 313, such as lowering the reporting
thresholds and modifying the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de minimis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in mixture exemptions (40 CFR part 372.38), would be required to insure that release and transfer information would
be collected? 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. EPCRA Section 313 Statutory Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPCRA section 313(d)(2) sets out criteria for adding chemicals to the list of chemicals subject to reporting under
section 313(a). For a chemical (or category of chemicals) to be added to the EPCRA section 313(c) list of toxic chemicals,
the Administrator must determine whether, in her judgement, there is sufficient evidence to establish any one of
the following: 
<!-- PJG 0012 frnewline -->
(A) The chemical is known to cause or can reasonably be anticipated to cause significant adverse acute human health
effects at concentration levels that are reasonably likely to exist beyond facility site boundaries as a result of
continuous, or frequently recurring, releases. 
<!-- PJG 0012 frnewline -->
(B) The chemical is known to cause or can reasonably be anticipated to cause in humans--
<!-- PJG 0012 frnewline -->
(i) cancer or teratogenic effects, or 
<!-- PJG 0012 frnewline -->
(ii) serious or irreversible--
<!-- PJG 0012 frnewline -->
(I) reproductive dysfunctions, 
<!-- PJG 0012 frnewline -->
(II) neurological disorders, 
<!-- PJG 0012 frnewline -->
(III) heritable genetic mutations, or 
<!-- PJG 0012 frnewline -->
(IV) other chronic health effects. 
<!-- PJG 0012 frnewline -->
(C) The chemical is known to cause or can reasonably be anticipated to cause, because of--
<!-- PJG 0012 frnewline -->
(i) its toxicity, 
<!-- PJG 0012 frnewline -->
(ii) its toxicity and persistence in the environment, or 
<!-- PJG 0012 frnewline -->
(iii) its toxicity and tendency to bioaccumulate in the environment, a significant adverse effect on the environment
of sufficient seriousness, in the judgement of the Administrator, to warrant reporting under this section. To remove
a chemical from the section 313(c) list, the Administrator must determine that there is not sufficient evidence to
establish any of the criteria described above as required by EPCRA section 313(d)(3). Thus, the criteria for listing
or delisting a chemical are identical. However, whereas EPA can add a chemical if only one of the criteria is met, it
can only delete a chemical if none of the criteria are met. 
<!-- PJG 0012 frnewline -->
To ascertain whether there is sufficient or insufficient evidence to determine that the statutory criteria are met
for listing a chemical, EPA conducts a hazard assessment on the chemical and determines based on the weight-of-the-evidence,
whether the chemical can reasonably be anticipated to cause any of the adverse effects specified in EPCRA section
313(d)(2). The hazard analysis is described above in Unit II.B.3. of this preamble. EPA's interpretation of the specific
statutory criteria follows. 
<!-- PJG 0012 frnewline -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Section 313(d)(2)(A) (acute human health effects)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. To determine whether the section 313(d)(2)(A) ``acute human health effects'' criterion is met, EPA must examine
the adverse effects associated with the chemical, the ``concentration levels'' which would cause acute human health
effects, and the likelihood of such levels existing ``beyond facility site boundaries as a result of continuous,
or frequently recurring, releases.'' Such a determination may include, among other factors, consideration of production
processes, workplace procedures, pollution controls, and the volume and pattern of production, use, and release,
as well as other chemical-specific factors. EPA believes that to make the section 313(d)(2)(A) determination it
must demonstrate that a chemical can reasonably be anticipated to be released in quantities that result in concentration
levels, or within a reasonable margin of exposure of the concentration levels, that would be expected to cause acute
human health effects beyond the facility site boundary. The margin of exposure applied is dependent upon the type
of hazard data (e.g., data in animals versus human) and the confidence in this hazard data base for acute effects (e.g.,
sufficiency of the hazard data). However, EPA is not required to make a facility-specific finding, nor is it necessary
for EPA to demonstrate that these concentration levels or effects occur at or near any particular facility (Ref. 1).
Furthermore, ``EPA may, but is not required to, conduct new studies or risk assessments or perform site-specific
analyses to establish actual ambient concentrations or to document adverse effects at any particular location''
(Ref. 1). Nor is EPA limited to considering concentration levels and potential acute human health effects at the ``fenceline.''
Rather, the phrase ``beyond facility site boundaries'' reflects Congress' recognition that the ``highest concentration
to which persons outside the site boundary may be exposed'' could occur at ``any point outside the boundaries of the
site on which the facility is located,'' including, for example, where an air emissions plume cools and settles to
the ground (Ref. 1). Therefore, EPA believes that to make a finding under EPCRA section 313(d)(2)(A), the Agency may
estimate concentrations at or beyond the facility site boundary through the use of estimated releases and modelling
techniques. The term ``continuous or frequently recurring releases'' is included only to distinguish routine releases
that are a normal consequence of the operation of a facility from the episodic and accidental releases that are subject
to EPCRA section 304 (Ref. 1). As such, EPA believes that episodic and accidental releases are not pertinent in a determination
that a chemical meets the section 313(d)(2)(A) criterion. 
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Section 313(d)(2)(B) (chronic human health effects)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. In contrast to the section 313(d)(2)(A) criterion, section 313(d)(2)(B) does not require consideration of either
the nature and frequency of releases or concentration levels at facility site boundaries. Rather, section 313(d)(2)(B)
is focused solely on whether the chemical is known or can reasonably be anticipated to cause cancer, teratogenicity,
or other serious or irreversible chronic human health effects. Consequently, EPA believes that it is sufficient
to consider only the toxicity of the subject chemical to make the section 313(d)(2)(B) determination. 
<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Section 313(d)(2)(C) (environmental effects)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The section 313(d)(2)(C) criterion requires EPA to consider a chemical's potential to cause significant adverse
effects on the environment. The statute directs EPA to base its determination on a consideration of the toxicity of
the chemical, either alone or in combination with the persistence of the chemical or the potential for the chemical
to bioaccumulate. Congress intended that EPA consider a broad range of environmental effects when making a determination
under section 313(d)(2)(C).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In determining what constitutes a significant adverse effect on the environment...the Administrator should consider
the extent to which the toxic chemical causes or can reasonably be anticipated to cause any of the following adverse
reactions, even if restricted to the immediate vicinity adjacent to the site: (1) Gradual or sudden changes in the
composition of animal life or plant life, including fungal or microbial organisms in an area. (2) Abnormal number
of deaths of organisms (e.g. fish kills). (3) Reduction of the reproductive success or the vigor of a species. (4) Reduction
in agricultural productivity, whether crops or livestock. (5) Alterations in the behavior or distribution of a species.
(6) Long lasting or irreversible contamination of components of the physical environment, especially in the case
of groundwater, and surface water and soil resources that have limited self-cleansing capability (Ref. 1). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA believes that the environmental effects criterion inherently contains a limited exposure component because
of the statutory requirement for EPA to find a ``significant adverse effect on the environment of sufficient seriousness,
in the judgment of the Administrator, to warrant reporting'' under EPCRA section 313. Unlike section 313(d)(2)(B),
where EPA only has to determine whether certain kinds of effects are ``known or reasonably 
<!-- PJG 0012 frnewline -->
anticipated'' to occur, section 313(d)(2)(C) requires EPA to find the effect to be of sufficient seriousness to warrant
reporting, which implies the possibility that under certain circumstances, a chemical that could theoretically
cause a significant adverse effect on the environment is unlikely to cause one of a magnitude to warrant listing. 
<!-- PJG 0012 frnewline -->
The extent to which exposure is factored into EPA's determination depends upon the inherent toxicity of a chemical,
and a variety of other chemical-specific characteristics. EPA believes that when a chemical is inherently extremely
toxic, that is, it is toxic at very low dose levels, an exposure assessment is not necessary because even minimal releases
of such a chemical may reasonably be anticipated to result in significant adverse environmental effects. In such
cases, EPA could rely on toxicity alone under section 313(d)(2)(C)(i) as a basis for listing. 
<!-- PJG 0012 frnewline -->
However, for chemicals that exhibit adverse effects upon the environment solely based on toxicity at moderately
low doses, EPA believes that consideration of potential exposure is warranted because minimal releases may not result
in significant adverse effects upon the environment. These exposure considerations may include, among other factors,
pollution controls, the volume and pattern of production, use, and release, environmental fate, as well as other
chemical-specific factors, and the use of estimated releases and modelling techniques. 
<!-- PJG 0012 frnewline -->
EPCRA sections 313(d)(2)(C)(ii) and (iii) allow EPA to consider the impacts of other characteristics of a chemical.
Where a chemical exhibits significant adverse effects in the environment based on toxicity and persistence or toxicity
and bioaccumulation at very low to moderately low dose levels, EPA believes that exposure considerations are not
required in addition to those considerations implicit in evaluation of the chemical's potential for persistence
and bioaccumulation. This is because even minimal releases of the chemical may result in elevated concentrations
in the environment or in an organism that can reasonably be anticipated to result in significant adverse effects.
This reflects the increased likelihood that there will be exposure to a chemical that persists due to its longer residence
time in the environment. Repeated minimal releases of a persistent chemical may result in elevated concentrations
in the environment. For a chemical that bioaccumulates, even low levels of the chemical in the environment may result
in increased concentrations in an organism. Therefore, evaluation of a chemical's persistence or bioaccumulation
potential may be considered the functional equivalent of an exposure analysis. 
<!-- PJG 0012 frnewline -->
In addition, for chemicals which induce well-established adverse effects, e.g. chlorofluorocarbons, which cause
stratospheric ozone depletion, EPA believes that an exposure assessment is unnecessary. EPA believes that these
chemicals typically do not affect solely one or two species but rather affect changes across a whole ecosystem. EPA
believes that these effects are of sufficient seriousness that additional exposure considerations are not warranted
because of the scope of their impact and the well-documented evidence supporting the adverse effects. EPA requests
comment on its approach for considering exposure as a part of its evaluation for listing of these chemicals under section
313(d)(2)(C).
<!-- PJG 0012 frnewline -->
In Unit IV.B. of this preamble, EPA identifies each of the chemicals proposed for addition to EPCRA section 313 and
the specific statutory criteria upon which the proposed addition is based. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. EPA's Technical Review 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Data on the chemicals and chemical categories were reviewed for evidence indicating adverse acute and chronic toxicity,
carcinogenicity, mutagenicity, developmental and reproductive effects, neurotoxicity, and environmental effects.
Information on the environmental fate was also reviewed. 
<!-- PJG 0012 frnewline -->
For each chemical proposed for addition to EPCRA section 313 in this rulemaking, EPA conducted an extensive hazard
assessment, and, where appropriate, an analysis of exposure, to determine whether the chemical met one or more of
the EPCRA section 313(d)(2) listing criteria. This hazard assessment is discussed in detail in Unit II.B.3 of this
preamble. Only after this careful review was a final determination made as to whether one of the EPCRA section 313(d)(2)
listing criteria was met for each individual chemical or chemical category proposed for listing below. EPA need only
show that one of the listing criteria is met in order to list a chemical or chemical category under EPCRA section 313.
The information summarized below for each chemical or chemical category represents the key data elements that lead
EPA to believe that there is sufficient evidence to establish that one of the section 313(d)(2) listing criteria is
met. A more extensive review of the existing data base for each chemical or chemical category proposed for listing,
which reflects the entire weight-of-the-evidence considered by EPA, is contained in following support documents:

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Support Document for the Addition of Chemicals from Federal Insecticide, Fungicide, Rodenticide Act (FIFRA) Active
Ingredients to EPCRA Section 313
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Ref 3); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Physical Properties and Environmental Fate of Some TRI Expansion Chemicals
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Ref. 5); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Support Document for the Addition of Chemicals from Section 112(b) of the Clean Air Act Amendments and Chlorinated
Paraffins to EPCRA Section 313
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Ref. 7); and 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Support Document for the Health and Ecological Toxicity Review of TRI Expansion Chemicals
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Ref. 8). These support documents contain a complete list of the references (which can be found in the public record
for this proposed rulemaking) that were used in support of these proposed additions. 
<!-- PJG 0012 frnewline -->
A list of the 313 chemicals and chemical categories and their Chemical Abstract Service (CAS) number, where appropriate,
follows. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. Abamectin (Avermectin B1) (CAS No. 071751-41-2) 
<!-- PJG 0012 frnewline -->
2. Acephate (Acetylphosphoramidothioic acid O,S-dimethyl ester) (CAS No. 030560-19-1) 
<!-- PJG 0012 frnewline -->
3. Acifluorfen sodium salt (5-(2-Chloro-4-(triflouromethyl)phenoxy)-2-nitro-benzoic acid, sodium salt) (CAS
No. 062476-59-9) 
<!-- PJG 0012 frnewline -->
4. Alachlor (CAS No. 015972-60-8) 
<!-- PJG 0012 frnewline -->
5. Aldicarb (CAS No. 000116-06-3) 
<!-- PJG 0012 frnewline -->
6. d-trans-Allethrin [d-trans-Chrysanthemic acid of d-allethrone] (CAS No. 028057-48-9) 
<!-- PJG 0012 frnewline -->
7. Allylamine (CAS No. 000107-11-9) 
<!-- PJG 0012 frnewline -->
8. Aluminum phosphide (CAS No. 020859-73-8) 
<!-- PJG 0012 frnewline -->
9. Ametryn (N-Ethyl-N'-(1-methylethyl)-6-(methylthio)-1,3,5,triazine- 2,4 diamine) (CAS No. 000834-12-8)

<!-- PJG 0012 frnewline -->
10. Amitraz (CAS No. 033089-61-1) 
<!-- PJG 0012 frnewline -->
11. Anilazine (4,6-Dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine) (CAS No. 000101-05-3) 
<!-- PJG 0012 frnewline -->
12. Atrazine (6-Chloro-N-ethyl-N'-(1-methylethyl)-1,3,5,triazine-2,4-diamine) (CAS No. 001912-24-9) 
<!-- PJG 0012 frnewline -->
13. Bendiocarb (2,2-Dimethyl-1,3-benzodioxol-4-ol methylcarbamate) (CAS No. 022781-23-3) 
<!-- PJG 0012 frnewline -->
14. Benfluralin (N-Butyl-N-ethyl-2,6-dinitro-4-(trifluoromethyl) benzenamine) (CAS No. 001861-40-1) 
<!-- PJG 0012 frnewline -->
15. Benomyl (CAS No. 017804-35-2) 
<!-- PJG 0012 frnewline -->
16. o-Benzyl-p-chlorophenol (CAS No. 000120-32-1) 
<!-- PJG 0012 frnewline -->
17. Bifenthrin (CAS No. 082657-04-3) 
<!-- PJG 0012 frnewline -->
18. Bis(tributyltin) oxide (CAS No. 000056-35-9) 
<!-- PJG 0012 frnewline -->
19. Boron trichloride (CAS No. 010294-34-5) 
<!-- PJG 0012 frnewline -->
20. Boron trifluoride (CAS No. 007637-07-2) 
<!-- PJG 0012 frnewline -->
21. Bromacil (5-Bromo-6-methyl-3-(1-methylpropyl)-2,4-(1H,3H)- pyrimidinedione) (CAS No. 000314-40-9) 
<!-- PJG 0012 frnewline -->
22. Bromacil lithium salt (2,4-(1H,3H)-Pyrimidinedione, 5-bromo-6-methyl-3-(1-methylpropyl), lithium salt)
(CAS No. 053404-19-6) 
<!-- PJG 0012 frnewline -->
23. Bromine (CAS No. 007726-95-6) 
<!-- PJG 0012 frnewline -->
24. 1-Bromo-1-(bromomethyl)-1,3-propanedicarbonitrile (CAS No. 035691-65-7) 
<!-- PJG 0012 frnewline -->
25. 2-Bromo-2-nitropropane-1,3-diol (Bronopol) (CAS No. 000052-51-7) 26. Bromoxynil (3,5-Dibromo-4-hydroxybenzonitrile)
(CAS No. 001689-84-5) 27. Bromoxynil octanoate (Octanoic acid, 2,6-dibromo-4-cyanophenyl ester) (CAS No. 001689-99-2)

<!-- PJG 0012 frnewline -->
28. Brucine (CAS No. 000357-57-3) 
<!-- PJG 0012 frnewline -->
29. Butylate (Bis-2-methylpropyl)carbamothioic acid S-ethyl ester) (CAS No. 002008-41-5) 
<!-- PJG 0012 frnewline -->
30. Butylated hydroxyanisole (CAS No. 025013-16-5) 
<!-- PJG 0012 frnewline -->
31. C.I. Acid Red 114 (CAS No. 006459-94-5) 
<!-- PJG 0012 frnewline -->
32. C.I. Direct Blue 218 (CAS No. 028407-37-6) 
<!-- PJG 0012 frnewline -->
33. Calcium hypochlorite (CAS No. 007778-54-3) 
<!-- PJG 0012 frnewline -->
34. Caprolactam (CAS No. 000105-60-2) 
<!-- PJG 0012 frnewline -->
35. Carbofuran (CAS No. 001563-66-2) 
<!-- PJG 0012 frnewline -->
36. Carbon monoxide (CAS No. 000630-08-0) 
<!-- PJG 0012 frnewline -->
37. Carboxin (5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide) (CAS No. 005234-68-4) 
<!-- PJG 0012 frnewline -->
38. Chinomethionat (6-Methyl-1,3-dithiolo[4,5-b]quinoxalin-2-one) (CAS No. 002439-01-2) 
<!-- PJG 0012 frnewline -->
39. Chlorendic acid (CAS No. 000115-28-6) 
<!-- PJG 0012 frnewline -->
40. Chlorimuron ethyl (Ethyl-2-[[[(4-chloro-6-methoxyprimidin-2-yl)-carbonyl]-amino]sulfonyl]benzoate)
(CAS No. 090982-32-4) 
<!-- PJG 0012 frnewline -->
41. Chlorinated paraffins 
<!-- PJG 0012 frnewline -->
42. 1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride (CAS No. 004080-31-3) 
<!-- PJG 0012 frnewline -->
43. p-Chloroaniline (CAS No. 000106-47-8) 
<!-- PJG 0012 frnewline -->
44. 5-Chloro-2-(2,4-dichlorophenoxy)phenol (CAS No. 003380-34-5) 
<!-- PJG 0012 frnewline -->
45. 3-Chloro-2-methyl-1-propene (CAS No. 000563-47-3) 
<!-- PJG 0012 frnewline -->
46. p-Chlorophenyl isocyanate (CAS No. 000104-12-1) 
<!-- PJG 0012 frnewline -->
47. Chloropicrin (CAS No. 000076-06-2) 
<!-- PJG 0012 frnewline -->
48. 3-Chloropropionitrile (CAS No. 000542-76-7) 
<!-- PJG 0012 frnewline -->
49. p-Chloro-o-toluidine (CAS No. 000095-69-2) 
<!-- PJG 0012 frnewline -->
50. Chlorotrifluoromethane (CFC-13) (CAS No. 000075-72-9) 
<!-- PJG 0012 frnewline -->
51. Chlorpyrifos methyl (O,O-Dimethyl-O-(3,5,6-trichloro-2- pyridyl)phosphorothioate) (CAS No. 005598-13-0)

<!-- PJG 0012 frnewline -->
52. Chlorsulfuron (2-Chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulfonamide)
(CAS No. 064902-72-3) 
<!-- PJG 0012 frnewline -->
53. Clomazone (2-[(2-Chlorophenyl)methyl]-4,4-dimethyl-3-isoxazolidinone) (CAS No. 081777-89-1) 
<!-- PJG 0012 frnewline -->
54. Crotonaldehyde (CAS No. 004170-30-3) 
<!-- PJG 0012 frnewline -->
55. Cyanazine (CAS No. 021725-46-2) 
<!-- PJG 0012 frnewline -->
56. Cycloate (CAS No. 001134-23-2) 
<!-- PJG 0012 frnewline -->
57. Cyclohexanol (CAS No. 000108-93-0) 
<!-- PJG 0012 frnewline -->
58. Cyfluthrin (3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, cyano(4-fluoro-3-phenoxyphenyl)methyl
ester) (CAS No. 068359-37-5) 
<!-- PJG 0012 frnewline -->
59. Cyhalothrin (3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2- dimethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl
ester) (CAS No. 068085-85-8) 
<!-- PJG 0012 frnewline -->
60. Cyromazine (N-Cyclopropyl-1,3,5-triazine-2,4,6-triamine) (CAS No. 066215-27-8) 
<!-- PJG 0012 frnewline -->
61. Dazomet (Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione) (CAS No. 000533-74-4) 
<!-- PJG 0012 frnewline -->
62. Dazomet, sodium salt (2H-1,3,5-Thiadiazine-2-thione, tetrahydro-3,5-dimethyl-, ion(1-), sodium) (CAS
No. 053404-60-7) 
<!-- PJG 0012 frnewline -->
63. 2,4-DB (CAS No. 000094-82-6) 
<!-- PJG 0012 frnewline -->
64. 2,4-D butoxyethyl ester (CAS No. 001929-73-3) 
<!-- PJG 0012 frnewline -->
65. 2,4-D butyl ester (CAS No. 000094-80-4) 
<!-- PJG 0012 frnewline -->
66. 2,4-D chlorocrotyl ester (CAS No. 002971-38-2) 
<!-- PJG 0012 frnewline -->
67. Desmedipham (CAS No. 013684-56-5) 
<!-- PJG 0012 frnewline -->
68. 2,4-D 2-ethylhexyl ester (CAS No. 001928-43-4) 
<!-- PJG 0012 frnewline -->
69. 2,4-D 2-ethyl-4-methylpentyl ester (CAS No. 053404-37-8) 
<!-- PJG 0012 frnewline -->
70. Diazinon (CAS No. 000333-41-5) 
<!-- PJG 0012 frnewline -->
71. 2,2-Dibromo-3-nitrilopropionamide (CAS No. 010222-01-2) 
<!-- PJG 0012 frnewline -->
72. Dicamba (3,6-Dichloro-2-methyoxybenzoic acid) (CAS No. 001918-00-9) 73. Dichloran (2,6-Dichloro-4-nitroaniline)
(CAS No. 000099-30-9) 
<!-- PJG 0012 frnewline -->
74. 3,3'-Dichlorobenzidine dihydrochloride (CAS No. 000612-83-9) 
<!-- PJG 0012 frnewline -->
75. 3,3'-Dichlorobenzidine sulfate (CAS No. 064969-34-2) 
<!-- PJG 0012 frnewline -->
76. trans-1,4-Dichloro-2-butene (CAS No. 000110-57-6) 
<!-- PJG 0012 frnewline -->
77. Dichloromethylphenylsilane (CAS No. 000149-74-6) 
<!-- PJG 0012 frnewline -->
78. Dichlorophene (2,2'-Methylenebis(4-chlorophenol) (CAS No. 000097-23-4) 
<!-- PJG 0012 frnewline -->
79. trans-1,3-Dichloropropene (CAS No. 010061-02-6) 
<!-- PJG 0012 frnewline -->
80. Diclofop methyl (2-[4-(2,4-Dichlorophenoxy) phenoxy]propanoic acid, methyl ester) (CAS No. 051338-27-3)

<!-- PJG 0012 frnewline -->
81. Dicyclopentadiene (CAS No. 000077-73-6) 
<!-- PJG 0012 frnewline -->
82. Diethatyl ethyl (CAS No. 038727-55-8) 
<!-- PJG 0012 frnewline -->
83. Diflubenzuron (CAS No. 035367-38-5) 
<!-- PJG 0012 frnewline -->
84. Diglycidyl resorcinol ether (CAS No. 000101-90-6) 
<!-- PJG 0012 frnewline -->
85. Dimethipin (2,3,-Dihydro-5,6-dimethyl-1,4-dithiin 1,1,4,4-tetraoxide) (CAS No. 055290-64-7) 
<!-- PJG 0012 frnewline -->
86. Dimethoate (CAS No. 000060-51-5) 
<!-- PJG 0012 frnewline -->
87. 3,3'-Dimethoxybenzidine dihydrochloride (o-Dianisidine dihydrochloride) (CAS No. 020325-40-0) 
<!-- PJG 0012 frnewline -->
88. 3,3'-Dimethoxybenzidine hydrochloride (o-Dianisidine hydrochloride) (CAS No. 111984-09-9) 
<!-- PJG 0012 frnewline -->
89. Dimethylamine (CAS No. 000124-40-3) 
<!-- PJG 0012 frnewline -->
90. Dimethylamine dicamba (CAS No. 002300-66-5) 
<!-- PJG 0012 frnewline -->
91. 3,3'-Dimethylbenzidine dihydrochloride (o-Tolidine dihydrochloride) (CAS No. 000612-82-8) 
<!-- PJG 0012 frnewline -->
92. 3,3'-Dimethylbenzidine dihydrofluoride (o-Tolidine dihydrofluoride) (CAS No. 041766-75-0) 
<!-- PJG 0012 frnewline -->
93. Dimethyl chlorothiophosphate (CAS. No. 002524-03-0) 
<!-- PJG 0012 frnewline -->
94. Dimethyldichlorosilane (CAS No. 000075-78-5) 
<!-- PJG 0012 frnewline -->
95. N,N-Dimethylformamide (CAS No. 000068-12-2) 
<!-- PJG 0012 frnewline -->
96. 2,6-Dimethylphenol (CAS No. 000576-26-1) 
<!-- PJG 0012 frnewline -->
97. Dinocap (CAS No. 039300-45-3) 
<!-- PJG 0012 frnewline -->
98. Dinoseb (CAS No. 000088-85-7) 
<!-- PJG 0012 frnewline -->
99. Diphenamid (CAS No. 000957-51-7) 
<!-- PJG 0012 frnewline -->
100. Diphenylamine (CAS No. 000122-39-4) 
<!-- PJG 0012 frnewline -->
101. Dipotassium endothall (7-Oxabicyclo(2.2.1)heptane-2,3-dicarboxylic acid, dipotassium salt) (CAS No.
002164-07-0) 
<!-- PJG 0012 frnewline -->
102. Dipropyl isocinchomeronate (CAS No. 000136-45-8) 
<!-- PJG 0012 frnewline -->
103. Disodium cyanodithioimidocarbonate (CAS No. 000138-93-2) 
<!-- PJG 0012 frnewline -->
104. 2,4-D isopropyl ester (CAS No. 000094-11-1) 
<!-- PJG 0012 frnewline -->
105. 2,4-Dithiobiuret (CAS No. 000541-53-7) 
<!-- PJG 0012 frnewline -->
106. Dithiopyr (2-(Difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-3,5-pyridinedicarbothioic
acid S,S-dimethyl ester) (CAS No. 097886-45-8) 
<!-- PJG 0012 frnewline -->
107. Diuron (CAS No. 000330-54-1) 
<!-- PJG 0012 frnewline -->
108. 2,4-D 2-octyl ester (CAS No. 001917-97-1) 
<!-- PJG 0012 frnewline -->
109. Dodine (Dodecylguanidine monoacetate) (CAS No. 002439-10-3) 
<!-- PJG 0012 frnewline -->
110. 2,4-DP (Dichlorprop) (CAS No. 000120-36-5) 
<!-- PJG 0012 frnewline -->
111. 2,4-D propylene glycol butyl ether ester (CAS No. 001320-18-9) 112. 2,4-D sodium salt (CAS No. 002702-72-9)

<!-- PJG 0012 frnewline -->
113. Ethoprop (Phosphorodithioic acid O-ethyl S,S-dipropyl ester) (CAS No. 013194-48-4) 
<!-- PJG 0012 frnewline -->
114. Ethyl dipropylthiocarbamate (EPTC) (CAS No. 000759-94-4) 
<!-- PJG 0012 frnewline -->
115. Famphur (CAS No. 000052-85-7) 
<!-- PJG 0012 frnewline -->
116. Fenarimol (.alpha.-(2-Chlorophenyl)-.alpha.-4-chlorophenyl)-5-pyrimidinemethanol) (CAS No. 060168-88-9)

<!-- PJG 0012 frnewline -->
117. Fenbutatin oxide (hexakis(2-methyl-2-phenylpropyl)distannoxane) (CAS No. 013356-08-6) 
<!-- PJG 0012 frnewline -->
118. Fenoxaprop ethyl (2-(4-((6-Chloro-2 benzoxazolylen)oxy)phenoxy)propanoic acid, ethyl ester) (CAS No.
066441-23-4) 119. Fenoxycarb (2-(4-Phenoxyphenoxy)ethyl]carbamic acid ethyl ester) (CAS No. 072490-01-8) 
<!-- PJG 0012 frnewline -->
120. Fenpropathrin (2,2,3,3-Tetramethylcyclopropane carboxylic acid cyano(3-phenoxyphenyl)methyl ester)
(CAS No. 039515-41-8) 
<!-- PJG 0012 frnewline -->
121. Fenthion (O,O-Dimethyl O-[3-methyl-4-(methylthio) phenyl] ester, phosphorothioic acid) (CAS No. 000055-38-9)

<!-- PJG 0012 frnewline -->
122. Fenvalerate (4-Chloro-alpha-(1-methylethyl)benzeneacetic acid cyano(3-phenoxyphenyl)methyl ester)
(CAS No. 051630-58-1) 
<!-- PJG 0012 frnewline -->
123. Ferbam (Tris(dimethylcarbamodithioato-S,S')iron) (CAS No. 014484-64-1) 
<!-- PJG 0012 frnewline -->
124. Fluazifop butyl (2-[4-[[5-(Trifluoromethyl)-2-pyridinyl]oxy]-phenoxy]propanoic acid, butyl ester)
(CAS No. 069806-50-4) 
<!-- PJG 0012 frnewline -->
125. Flumetralin (2-Chloro-N-(2,6-dinitro-4-(trifluoromethyl)phenyl)-N-ethyl-6-fluorobenzenemethanamine)
(CAS No. 062924-70-3) 
<!-- PJG 0012 frnewline -->
126. Fluorine (CAS No. 007782-41-4) 
<!-- PJG 0012 frnewline -->
127. Fluorouracil (5-Fluorouracil) (CAS No. 000051-21-8) 
<!-- PJG 0012 frnewline -->
128. Fluvalinate (N-[2-Chloro-4-(trifluoromethyl)phenyl]-DL-valine(+)- cyano (3-phenoxyphenyl)methyl
ester) (CAS No. 069409-94-5) 
<!-- PJG 0012 frnewline -->
129. Folpet (CAS No. 000133-07-3) 
<!-- PJG 0012 frnewline -->
130. Fomesafen (5-(2-Chloro-4-(trifluoromethyl)phenoxy)-N methylsulfonyl)-2-nitrobenzamide) (CAS No. 072178-02-0)

<!-- PJG 0012 frnewline -->
131. alpha-Hexachlorocyclohexane (CAS NO. 000319-84-6) 
<!-- PJG 0012 frnewline -->
132. Hexamethylene-1,6-diisocyanate (CAS No. 000822-60-0) 
<!-- PJG 0012 frnewline -->
133. n-Hexane (CAS No. 000110-54-3) 
<!-- PJG 0012 frnewline -->
134. Hexazinone (CAS No. 051235-04-2) 
<!-- PJG 0012 frnewline -->
135. Hydramethylnon (Tetrahydro-5,5-dimethyl-2(1H)pyrimidinone[3-[4-(trifluoromethyl)phenyl]-1-[2-[4(trifluoromethyl)
phenyl]ethenyl]-2 propenylidene]hydrazone) (CAS No. 067485-29-4)
<!-- PJG 0012 frnewline -->
136_151. Hydrochlorofluorocarbons, specifically:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
136. Dichloropentafluoropropane (CAS No. 127564-92-5) 
<!-- PJG 0012 frnewline -->
137. 1,3-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225ea) (CAS No. 136013-79-1) 
<!-- PJG 0012 frnewline -->
138. 2,2-Dichloro-1,1,1,3,3-pentafluoropropane (HCFC-225aa) (CAS No. 128903-21-9)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
139. 1,1-Dichloro-1,2,3,3,3-pentafluoropropane (HCFC-225eb) (CAS No. 111512-56-2)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
140. 1,1-Dichloro-1,2,2,3,3-pentafluoropropane (HCFC-225cc) (CAS No. 13474-88-9)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
141. 1,3-Dichloro-1,1,2,2,3-pentafluoropropane (HCFC-225cb) (CAS No. 000507-55-1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
142. 1,2-Dichloro-1,1,3,3,3-pentafluoropropane (HCFC-225da) (CAS No. 000431-86-7)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
143. 3,3-Dichloro-1,1,1,2,2-pentafluoropropane (HCFC-225ca) (CAS No. 000422-56-0)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
144. 2,3-Dichloro-1,1,1,2,3-pentafluoropropane (HCFC-225ba) (CAS No. 000422-48-0) 
<!-- PJG 0012 frnewline -->
145. 1,2-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225bb) (CAS No. 000422-44-6)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
146. Dichlorofluoromethane (HCFC-21) (CAS No. 000075-43-4)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
147. 1,1,1,2-Tetrachloro-2-fluoroethane (HCFC-121a) (CAS No. 000354-11-0)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
148. 1,1,2,2-Tetrachloro-1-fluoroethane (HCFC-121) (CAS No. 000354-14- 3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
149. 1,2-Dichloro-1,1-difluoroethane (HCFC-132b) (CAS No. 001649-08-7)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
150. 2-Chloro-1,1,1-trifluoroethane (HCFC-133a) (CAS No. 000075-88-7)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
151. 3-Chloro-1,1,1-trifluoropropane (HCFC-253fb) (CAS No. 000460-35-5) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
152. Imazalil (1-[2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl]1H-imidazole) (CAS No. 035554-44-0) 
<!-- PJG 0012 frnewline -->
153. 3-Iodo-2-propynyl butylcarbamate (CAS No. 055406-53-6) 
<!-- PJG 0012 frnewline -->
154. Iprodione (3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide) (CAS
No. 036734-19-7) 
<!-- PJG 0012 frnewline -->
155. Iron pentacarbonyl (CAS No. 013463-40-6) 
<!-- PJG 0012 frnewline -->
156. Isodrin (CAS No. 000465-73-6) 
<!-- PJG 0012 frnewline -->
157. Isofenphos (2-[[Ethoxyl[(1-methylethyl) amino]phosphinothioyl]oxy]benzoic acid 1-methylethyl ester)
(CAS No. 025311-71-1) 
<!-- PJG 0012 frnewline -->
158. Isophorone (CAS No. 000078-59-1) 
<!-- PJG 0012 frnewline -->
159. Isophorone diisocyanate (CAS No. 004098-71-9) 
<!-- PJG 0012 frnewline -->
160. Lactofen (5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitro-2-ethoxy-1-methyl-2-oxoethyl ester) (CAS
No. 077501-63-4) 
<!-- PJG 0012 frnewline -->
161. Linuron (CAS No. 000330-55-2) 
<!-- PJG 0012 frnewline -->
162. Lithium carbonate (CAS No. 000554-13-2) 
<!-- PJG 0012 frnewline -->
163. Malathion (CAS No. 000121-75-5) 
<!-- PJG 0012 frnewline -->
164. Man-made mineral fibers 
<!-- PJG 0012 frnewline -->
165. Mecoprop (CAS No. 000093-65-2) 
<!-- PJG 0012 frnewline -->
166. 2-Mercaptobenzothiazole (MBT) (CAS No. 000149-30-4) 
<!-- PJG 0012 frnewline -->
167. Merphos (CAS No. 000150-50-5) 
<!-- PJG 0012 frnewline -->
168. Metham sodium (Sodium methyldithiocarbamate) (CAS No. 000137-42-8) 169. Methazole (2-(3,4-Dichlorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5-dione)
(CAS No. 020354-26-1) 
<!-- PJG 0012 frnewline -->
170. Methiocarb (CAS No. 002032-65-7) 
<!-- PJG 0012 frnewline -->
171. Methoxone ((4-Chloro-2-methylphenoxy) acetic acid) (MCPA) (CAS No. 000094-74-6) 
<!-- PJG 0012 frnewline -->
172. Methoxone sodium salt ((4-Chloro-2-methylphenoxy) acetate sodium salt) (CAS No. 003653-48-3) 
<!-- PJG 0012 frnewline -->
173. 1,1-Methylene bis(4-isocyanatocyclohexane) (CAS No. 005124-30-1) 174. Methylene bis(thiocyanate) (CAS
No. 006317-18-6) 
<!-- PJG 0012 frnewline -->
175. Methyl isothiocyanate (CAS No. 00556-61-6) 
<!-- PJG 0012 frnewline -->
176. 2-Methyllactonitrile (CAS No. 000075-86-5) 
<!-- PJG 0012 frnewline -->
177. N-Methylolacrylamide (CAS No. 000924-42-5) 
<!-- PJG 0012 frnewline -->
178. Methyl parathion (CAS No. 000298-00-0) 
<!-- PJG 0012 frnewline -->
179. N-Methyl-2-pyrrolidone (CAS No. 000872-50-4) 
<!-- PJG 0012 frnewline -->
180. Methyltrichlorosilane (CAS No. 000075-79-6) 
<!-- PJG 0012 frnewline -->
181. Metiram (CAS No. 009006-42-2) 
<!-- PJG 0012 frnewline -->
182. Metribuzin (CAS No. 021087-64-5) 
<!-- PJG 0012 frnewline -->
183. Mevinphos (CAS No. 007786-34-7) 
<!-- PJG 0012 frnewline -->
184. Molinate (1H-Azepine-1-carbothioic acid, hexahydro-S-ethyl ester) (CAS No. 002212-67-1) 
<!-- PJG 0012 frnewline -->
185. Monuron (CAS No. 000150-68-5) 
<!-- PJG 0012 frnewline -->
186. Myclobutanil (.alpha.-Butyl-.alpha.-(4-chlorophenyl)-1H-1,2,4-triazole-1-propanenitrile) (CAS No.
088671-89-0) 
<!-- PJG 0012 frnewline -->
187. Nabam (CAS No. 000142-59-6) 
<!-- PJG 0012 frnewline -->
188. Naled (CAS No. 000300-76-5) 
<!-- PJG 0012 frnewline -->
189. Nicotine and salts 
<!-- PJG 0012 frnewline -->
190. Nitrapyrin (2-Chloro-6-(trichloromethyl) pyridine) (CAS No. 001929-82-4) 
<!-- PJG 0012 frnewline -->
191. Nitrate ion (CAS No. 014797-55-8) 
<!-- PJG 0012 frnewline -->
192. Nitric oxide (CAS No. 010102-43-9) 
<!-- PJG 0012 frnewline -->
193. p-Nitroaniline (CAS No. 000100-01-6) 
<!-- PJG 0012 frnewline -->
194. Nitrogen dioxide (CAS No. 010102-44-0) 
<!-- PJG 0012 frnewline -->
195. Norflurazon (4-Chloro-5-(methylamino)-2-[3(trifluoromethyl)phenyl]-3(2H)-pyridazinone) (CAS No.
027314-13-2) 
<!-- PJG 0012 frnewline -->
196. Oryzalin (4-(Dipropylamino)-3,5-dinitrobenzenesulfonamide) (CAS No. 019044-88-3) 
<!-- PJG 0012 frnewline -->
197. Oxydemeton methyl (S-(2-(Ethylsulfinyl)ethyl) O,O-dimethyl ester phosphorothioic acid) (CAS No. 000301-12-2)

<!-- PJG 0012 frnewline -->
198. Oxydiazon (3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]-5(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one)
(CAS No. 019666-30-9)
<!-- PJG 0012 frnewline -->
199. Oxyfluorfen (CAS No. 042874-03-3) 
<!-- PJG 0012 frnewline -->
200. Ozone (CAS No. 010028-15-6) 
<!-- PJG 0012 frnewline -->
201. Paraquat dichloride (CAS No. 001910-42-5) 
<!-- PJG 0012 frnewline -->
202. Pebulate (Butylethylcarbamothioic acid S-propyl ester) (CAS No. 001114-71-2) 
<!-- PJG 0012 frnewline -->
203. Pendimethalin (N-(1-Ethylpropyl)-3,4-dimethyl-2,6-dinitrobenzenamine) (CAS No. 040487-42-1) 
<!-- PJG 0012 frnewline -->
204. Pentobarbital sodium (CAS No. 000057-33-0) 
<!-- PJG 0012 frnewline -->
205. Perchloromethyl mercaptan (CAS No. 000594-42-3) 
<!-- PJG 0012 frnewline -->
206. Permethrin (3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, (3-phenoxyphenyl)methyl
ester) (CAS No. 052645-53-1) 
<!-- PJG 0012 frnewline -->
207. Phenanthrene (CAS No. 000085-01-8) 
<!-- PJG 0012 frnewline -->
208. Phenothrin (2,2-Dimethyl-3-(2-methyl-1-propenyl) cyclopropanecarboxylic acid (3-phenoxyphenyl)methyl
ester) (CAS No. 026002-80-2) 
<!-- PJG 0012 frnewline -->
209. 1,2-Phenylenediamine (CAS No. 000095-54-5) 
<!-- PJG 0012 frnewline -->
210. 1,3-Phenylenediamine (CAS No. 000108-45-2) 
<!-- PJG 0012 frnewline -->
211. 1,2-Phenylenediamine dihydrochloride (CAS No. 000615-28-1) 
<!-- PJG 0012 frnewline -->
212. 1,4-Phenylenediamine dihydrochloride (CAS No. 000624-18-0)
<!-- PJG 0012 frnewline -->
213. Phenytoin (CAS No. 000057-41-0) 
<!-- PJG 0012 frnewline -->
214. Phosphine (CAS No. 007803-51-2) 
<!-- PJG 0012 frnewline -->
215. Phosphorus oxychloride (CAS No. 010025-87-3) 
<!-- PJG 0012 frnewline -->
216. Phosphorus pentachloride (CAS No. 010026-13-8) 
<!-- PJG 0012 frnewline -->
217. Phosphorus pentasulfide (CAS No. 001314-80-3) 
<!-- PJG 0012 frnewline -->
218. Phosphorus pentoxide (CAS No. 001314-56-3) 
<!-- PJG 0012 frnewline -->
219. Picloram (CAS No. 001918-02-1) 
<!-- PJG 0012 frnewline -->
220. Piperonyl butoxide (CAS No. 000051-03-6) 
<!-- PJG 0012 frnewline -->
221. Pirimiphos methyl (O-(2-(Diethylamino)-6-methyl-4-pyrimidinyl)-O,O-dimethyl phosphorothioate) (CAS
No. 029232-93-7) 
<!-- PJG 0012 frnewline -->
222_ 249. Polycyclic aromatic compounds (PACs) including:
<!-- PJG 0012 frnewline -->
222. Benz(a)anthracene (CAS No. 000056-55-3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
223. Benzo(a)phenanthrene (CAS No. 000218-01-9)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
224. Benzo(a)pyrene (CAS No. 000050-32-8)
<!-- PJG 0012 frnewline -->
225. Benzo(b)fluoranthene (CAS No. 000205-99-2)
<!-- PJG 0012 frnewline -->
226. Benzo(j)fluoranthene (CAS No. 000205-82-3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
227. Benzo(k)fluoranthene (CAS No. 000207-08-9)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
228. Benzo(rst)pentaphene (CAS No. 000189-55-9)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
229. Carbazole (CAS No. 000086-74-8)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
230. Cyclopenta(cd)pyrene (CAS No. 027208-37-3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
231. Dibenz(a,h)acridine (CAS No. 000226-36-8)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
232. Dibenz(a,j)acridine (CAS No. 000224-42-0)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
233. Dibenz(a,c)anthracene (CAS No. 000215-58-7)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
234. Dibenz(a,j)anthracene (CAS No. 000224-41-9)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
235. Dibenzo(a,h)anthracene (CAS No. 000053-70-3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
236. Dibenzo(a,e)fluoranthene (CAS No. 005385-75-1)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
237. Dibenzo(a,e)pyrene (CAS No. 000192-65-4)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
238. Dibenzo(a,h)pyrene (CAS No. 000189-64-0)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
239. Dibenzo(a,l)pyrene (CAS No. 000191-30-0)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
240. 7H-Dibenzo(c,g)carbazole (CAS No. 000194-59-2)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
241. 7,12-Dimethylbenz(a)anthracene (CAS No. 000057-976)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
242. Indeno[1,2,3-cd]pyrene (CAS No. 000193-39-5)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
243. 2-Methylchrysene (CAS No. 003351-32-4)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
244. 3-Methylchrysene (CAS No. 003351-31-3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
245. 4-Methylchrysene (CAS No. 003351-30-2)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
246. 5-Methylchrysene (CAS No. 003697-24-3)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
247. 6-Methylchrysene (CAS No. 001705-85-7)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
248. 2-Methylfluoranthene (CAS No. 033543-31-6)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
249. 1-Nitropyrene (CAS No. 005522-43-0) 
<!-- PJG 0012 frnewline -->
250. Potassium bromate (CAS No. 007758-01-2) 
<!-- PJG 0012 frnewline -->
251. Potassium dimethyldithiocarbamate (CAS No. 000128-03-0) 
<!-- PJG 0012 frnewline -->
252. Potassium N-methyldithiocarbamate (CAS No. 000137-41-7) 
<!-- PJG 0012 frnewline -->
253. Primisulfuron (Methyl 2-[[[[[4,6-bis(difluoromethoxy)-2pyrimidinyl]-amino]carbonyl]amino]sulfonyl]benzoate)
(CAS No. 086209-51-0) 
<!-- PJG 0012 frnewline -->
254. Profenofos (O-(4-Bromo-2-chlorophenyl)-O-ethyl-S-propyl phosphorothioate) (CAS No. 041198-08-7) 
<!-- PJG 0012 frnewline -->
255. Prometryn (N,N'-Bis(1-methylethyl)-6-methylthio-1,3,5-triazine-2,4-diamine) (CAS No. 007287-19-6)

<!-- PJG 0012 frnewline -->
256. Propachlor (2-Chloro-N-(1-methylethyl)-N-phenylacetamide) (CAS No. 001918-16-7) 
<!-- PJG 0012 frnewline -->
257. Propanil (N-(3,4-Dichlorophenyl)propanamide) (CAS No. 000709-98-8) 258. Propargite (CAS No. 002312-35-8)

<!-- PJG 0012 frnewline -->
259. Propargyl alcohol (CAS No. 000107-19-7) 
<!-- PJG 0012 frnewline -->
260. Propetamphos (3-[(Ethylamino)methoxyphosphinothioyl]oxy]-2-butenoic acid, 1-methylethyl ester) (CAS
No. 031218-83-4) 
<!-- PJG 0012 frnewline -->
261. Propiconazole (1-[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]-methyl-1H-1,2,4,-triazole)
(CAS No. 060207-90-1) 
<!-- PJG 0012 frnewline -->
262. Quizalofop-ethyl (2-[4-[(6-Chloro-2-quinoxalinyl) oxy]phenoxy] propanoic acid ethyl ester) (CAS No. 076578-14-8)

<!-- PJG 0012 frnewline -->
263. Resmethrin ([5-(Phenylmethyl)-3-furanyl]methyl 2,2-dimethyl-3-(2-methyl-1-propenyl) cyclopropanecarboxylate])
(CAS No. 010453-86-8) 
<!-- PJG 0012 frnewline -->
264. Sethoxydim (2-[1-(Ethoxyimino)butyl]-5-[2(ethylthio)propyl]-3-hydroxyl-2-cyclohexen-1-one) (CAS
No.074051-80-2) 
<!-- PJG 0012 frnewline -->
265. Simazine (CAS No. 000122-34-9) 
<!-- PJG 0012 frnewline -->
266. Sodium azide (CAS No. 026628-22-8) 
<!-- PJG 0012 frnewline -->
267. Sodium chlorite (CAS No. 007758-19-2) 
<!-- PJG 0012 frnewline -->
268. Sodium dicamba (3,6-Dichloro-2-methoxybenzoic acid, sodium salt) (CAS No. 001982-69-0) 
<!-- PJG 0012 frnewline -->
269. Sodium dimethyldithiocarbamate (CAS No. 000128-04-1) 
<!-- PJG 0012 frnewline -->
270. Sodium fluoroacetate (CAS. No. 000062-74-8) 
<!-- PJG 0012 frnewline -->
271. Sodium hypochlorite (CAS No. 007681-52-9) 
<!-- PJG 0012 frnewline -->
272. Sodium nitrite (CAS No. 007632-00-0) 
<!-- PJG 0012 frnewline -->
273. Sodium pentachlorophenate (CAS No. 000131-52-2) 
<!-- PJG 0012 frnewline -->
274. Sodium o-phenylphenoxide (CAS No. 000132-27-4) 
<!-- PJG 0012 frnewline -->
275. Sodium 2-pyridinethiol-1-oxide (CAS No. 015922-78-8) 
<!-- PJG 0012 frnewline -->
276. Strychnine and salts 
<!-- PJG 0012 frnewline -->
277. Sulfur dioxide (CAS No. 007446-09-5) 
<!-- PJG 0012 frnewline -->
278. Sulfur trioxide (CAS No. 007446-11-9) 
<!-- PJG 0012 frnewline -->
279. Sulfuryl fluoride (Vikane) (CAS No. 002699-79-8) 
<!-- PJG 0012 frnewline -->
280. Sulprofos (O-Ethyl O-[4-(methylthio)phenyl]phosphorodithioic acid S- propyl ester) (CAS No. 035400-43-2)

<!-- PJG 0012 frnewline -->
281. Tebuthiuron (N-[5-(1,1-Dimethylethyl)-1,3,4-thiadiazol-2-yl)- N,N'-dimethylurea) (CAS No. 034014-18-1)

<!-- PJG 0012 frnewline -->
282. Tefluthrin (CAS No. 079538-32-2) 
<!-- PJG 0012 frnewline -->
283. Temephos (CAS No. 003383-96-8) 
<!-- PJG 0012 frnewline -->
284. Terbacil (5-Chloro-3-(1,1-dimethylethyl)-6-methyl- 2,4-(1H,3H)-pyrimidinedione) (CAS No. 005902-51-2)

<!-- PJG 0012 frnewline -->
285. Tetracycline hydrochloride (CAS No. 000064-75-5) 
<!-- PJG 0012 frnewline -->
286. Tetramethrin (2,2-Dimethyl-3-(2-methyl-1-propenyl) cyclopropanecarboxylic acid (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl
ester) (CAS No. 007696-12-0) 
<!-- PJG 0012 frnewline -->
287. Tetrasodium ethylenediaminetetraacetate (CAS No. 000064-02-8) 288. Thiabendazole (2-(4-Thiazolyl)-1H-benzimidazole)
(CAS No. 000148-79-8) 
<!-- PJG 0012 frnewline -->
289. Thiabendazole, hypophosphite salt (2-(4-Thiazolyl) benzimidazole, hypophosphite salt) (CAS No. 028558-32-9)

<!-- PJG 0012 frnewline -->
290. Thiobencarb (Carbamic acid, diethylthio-, S-(p-chlorobenzyl)) (CAS No. 028249-77-6) 
<!-- PJG 0012 frnewline -->
291. Thiodicarb (CAS No. 059669-26-0) 
<!-- PJG 0012 frnewline -->
292. Thiophanate ethyl ([1,2-Phenylenebis (iminocarbonothioyl)] biscarbamic acid diethyl ester) (CAS No. 023564-06-9)

<!-- PJG 0012 frnewline -->
293. Thiophanate-methyl (CAS No. 023564-05-8) 
<!-- PJG 0012 frnewline -->
294. Thiosemicarbazide (CAS No. 000079-19-6) 
<!-- PJG 0012 frnewline -->
295. Triadimefon (1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone) (CAS No. 043121-43-3)

<!-- PJG 0012 frnewline -->
296. Triallate (CAS No. 002303-17-5) 
<!-- PJG 0012 frnewline -->
297. Tribenuron methyl (2-(((((4-Methoxy-6-methyl-1,3,5-triazin-2-yl)-methylamino)carbonyl)amino)sulfonyl)-,
methyl ester) (CAS No. 101200-48-0) 298. Tributyltin fluoride (CAS No. 001983-10-4) 
<!-- PJG 0012 frnewline -->
299. Tributyltin methacrylate (CAS No. 002155-70-6) 
<!-- PJG 0012 frnewline -->
300. S,S,S-Tributyltrithiophosphate (DEF) (CAS No. 000078-48-8)
<!-- PJG 0012 frnewline -->
301. Trichloroacetyl chloride (CAS No. 000076-02-8)
<!-- PJG 0012 frnewline -->
302. Trichloroethylsilane (CAS No. 000115-21-9)
<!-- PJG 0012 frnewline -->
303. Trichlorophenylsilane (CAS No. 000098-13-5) 
<!-- PJG 0012 frnewline -->
304. 1,2,3-Trichloropropane (CAS No. 000096-18-4)
<!-- PJG 0012 frnewline -->
305. Triclopyr triethylammonium salt (CAS No. 057213-69-1)
<!-- PJG 0012 frnewline -->
306. Triethylamine (CAS No. 000121-44-8)
<!-- PJG 0012 frnewline -->
307. Triforine (N,N'-[1,4-Piperazinediylbis(2,2,2-trichloroethylidene)] bisformamide) (CAS No. 026644-46-2)

<!-- PJG 0012 frnewline -->
308. Trimethylchlorosilane (CAS No. 000075-77-4) 
<!-- PJG 0012 frnewline -->
309. 2,3,5-Trimethylphenyl methylcarbamate (CAS No. 002655-15-4)
<!-- PJG 0012 frnewline -->
310. Triphenyltin chloride (CAS No. 000639-58-7)
<!-- PJG 0012 frnewline -->
311. Triphenyltin hydroxide (CAS No. 000076-87-9)
<!-- PJG 0012 frnewline -->
312. Vanadium pentoxide (CAS No. 001314-62-1)
<!-- PJG 0012 frnewline -->
313. Vinclozolin (3-(3,5-Dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione) (CAS No. 050471-44-8)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A limited discussion of the health and environmental effects associated with each of the 313 chemicals and chemical
categories is provided below in Unit IV.B. of this preamble. Each chemical is identified by chemical name, CAS No.,
and the list(s) from which the chemical originated. These lists are designated as follows: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
CAA HAP: Clean Air Act section 112(b) ``Hazardous Air Pollutants.'' 
<!-- PJG 0012 frnewline -->
CAA OD: Clean Air Act section 602(b) Class II ozone depleters. 
<!-- PJG 0012 frnewline -->
CAL: State of California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65) ``List of Chemicals
Known to the State to Cause Reproductive Toxicity.'' 
<!-- PJG 0012 frnewline -->
CERCLA: Comprehensive Environmental Response, Compensation, and Liability Act section 102. 
<!-- PJG 0012 frnewline -->
CWA PPL: Clean Water Act section 307(a) ``Priority Pollutant List.'' 
<!-- PJG 0012 frnewline -->
EPCRA EHS: EPCRA section 302 ``Extremely Hazardous Substances.'' 
<!-- PJG 0012 frnewline -->
FIFRA AI: Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) ``Active Ingredients.'' 
<!-- PJG 0012 frnewline -->
FIFRA SR: FIFRA ``Special Review, Canceled/Denied or Suspended, and Restricted Use Pesticides.'' 
<!-- PJG 0012 frnewline -->
IARC: Monographs of the International Agency for Research on Cancer. 
<!-- PJG 0012 frnewline -->
NTP: The 6th Annual Report on Carcinogens of the National Toxicology Program. 
<!-- PJG 0012 frnewline -->
RCRA APP8: Resource Conservation and Recovery Act (RCRA) Chemicals listed at 40 CFR part 261 Appendix VIII. 
<!-- PJG 0012 frnewline -->
RCRA P: RCRA Chemicals listed at 40 CFR part 261.33(e). 
<!-- PJG 0012 frnewline -->
SDWA: Safe Drinking Water Act section 1412. 
<!-- PJG 0012 frnewline -->
TSCA: Toxic Substances Control Act ``Existing Chemicals.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA requests comment on the sufficiency of the evidence for each of the chemicals proposed for addition. In addition,
EPA requests comment on any issues that may be specific to any of the individual chemicals or chemical categories.
For example, should chemicals be listed on EPCRA section 313 that meet the EPCRA section 313 criteria but whose only
use is as a drug product. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Chemicals Proposed for Addition to EPCRA Section 313 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Abamectin (avermectin B1)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 071751-41-2) (FIFRA AI) (Ref. 3). This compound induces developmental toxicity in several species with
the mouse being the most sensitive species. Increased retinal folds in weanlings, decreased viability and lactation
indices, and decreased body weight were noted in a two-generation rat reproduction study. The lowest-observed-effect
level (LOEL) was 0.4 milligram per kilogram per day (mg/kg/day) and the no-observed-effect level (NOEL) was 0.12
mg/kg/day. Based on the NOEL, EPA derived a reference dose (RfD) of 0.0004 mg/kg/day. EPA believes that there is sufficient
evidence for listing abamectin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
developmental toxicity data. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for abamectin include a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 9.6 parts per billion (ppb), a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 3.6 ppb, and a daphnid 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.34 ppb. EPA believes that there is sufficient evidence for listing abamectin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Acephate (acetylphosphoramidothioic acid O,S-dimethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 030560-19-1) (FIFRA AI) (Ref. 3). In a 28&hyph;month feeding study in rats, inhibition of brain, plasma,
and red blood cell cholinesterase activities was observed at 50 parts per million (ppm) (2.5 mg/kg/day). The NOEL
for this study was 5 ppm (0.25 mg/kg/day). Similar findings were noted in a 2&hyph;year feeding study in dogs. The LOEL
for this study was 100 ppm (2.5 mg/kg/day) and the NOEL was 30 ppm (0.75 mg/kg/day). EPA believes that there is sufficient
evidence for listing acephate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
neurotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Acifluorfen sodium salt (5-(2-chloro-4-(triflouromethyl)phenoxy)-2-nitro-benzoic acid, sodium salt)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 062476-59-9) (FIFRA AI) (Ref. 3). Acifluorfen is classified as a Group B2 compound, i.e., the chemical is
a probable human carcinogen. Acifluorfen produced an increased incidence of combined malignant and benign liver
tumors in two different strains of mice. The compound also displayed positive mutagenic activity in several non-mammalian
test systems, and is structurally similar to four other diphenyl ether herbicide compounds which caused increased
incidences of liver tumors in two different strains of mice. EPA believes that there is sufficient evidence for listing
acifluorfen sodium salt on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity
data. 
<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Alachlor
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 015972-60-8) (FIFRA SR) (Ref. 8). Alachlor is an aniline-type herbicide. Dose-related hemolytic anemia
with reductions in red blood cell counts, hematocrit and hemoglobin, as well as hemosiderosis in the liver, spleen
and kidney occurred in male dogs orally exposed to alachlor for 1&hyph;year. The LOEL based on these effects was 3.0
mg/kg/day, and the NOEL was 1.0 mg/kg/day. Effects in female dogs in the same study were not demonstrated as clearly
as in males but were considered suggestive of anemia. EPA derived an oral RfD of 0.01 mg/kg/day from this study. 
<!-- PJG 0012 frnewline -->
In a three-generation reproduction study in rats, chronic nephritis and increased relative and absolute kidney
weights were reported in F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 adult males and F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 pups. The LOEL was 10 mg/kg/day, and the NOEL was 3 mg/kg/day. Rabbits (Dutch Belted strain) that received alachlor
via oral gavage during gestation days 6 to 27 had an increased rate of preimplantation loss (49 percent) and offspring
with increased incidences of developmental malformations including major vessel variations, presacral vertebrae,
and rudimentary and full 13th ribs. The increased incidence of rudimentary and full 13th ribs was dose-related, and
a lowest-observed-adverse-effect level (LOAEL) of 10 mg/kg/day was determined based on this effect. The no-observed-adverse
effect level (NOAEL) was not determined. 
<!-- PJG 0012 frnewline -->
EPA has classified alachlor as a category Group B2 compound, i.e., the chemical is a probable human carcinogen. In
a 2&hyph;year rat feeding study with Long-Evans rats, there were increased incidences of nasal turbinate tumors,
malignant stomach tumors and thyroid follicular adenomas and carcinomas in both sexes at doses greater than or equal
to 42 mg/kg/day. In an 18&hyph;month study in female CD-1 mice, bronchiolar tumors occurred at an increased incidence
at 200 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing alachlor on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the chronic toxicity and carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aldicarb
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000116-06-3) (CERCLA; EPCRA EHS; FIFRA SR; RCRA APP8; RCRA P) (Ref. 8). Aquatic acute toxicity test data for
aldicarb include a measured 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 50 ppb for bluegill and a measured 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 70 ppb for daphnid. In addition, the measured 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for daphnid is 51 ppb. Measured terrestrial acute toxicity data for wildlife include an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for female mallard ducks of 3.4 milligram per kilogram (mg/kg) and an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for California quail of 2.58 mg/kg in males and 4.67 mg/kg in females. EPA believes that there is sufficient evidence
for listing aldicarb on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
6. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
d-trans-Allethrin [d-trans-Chrysanthemic acid of dallethrone]
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 028057-48-9) (FIFRA AI) (Ref. 3). Centrilobular hydropic degeneration of the liver (LOEL was 1,000 ppm or
25 mg/kg/day; the NOEL was 200 ppm or 5 mg/kg/day) was seen in dogs fed allethrin for 3 months. Increases in serum liver
enzymes in female rats and increased liver weights in male and female rats (the LOEL was 250 mg/kg/day; the NOEL was
1,500 ppm or 75 mg/kg/day) were observed in rats fed allethrin for 3 months. Histopathology data were not presented
in this study. Taken together, the results of these studies indicate hepatotoxic potential for d-trans-allethrin.
EPA believes that there is sufficient evidence for listing d-trans-allethrin on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available hepatic toxicity data. 
<!-- PJG 0012 frnewline -->
7. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Allylamine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000107-11-9) (EPCRA EHS) (Ref. 8). Repeated inhalation exposure to 5 ppm (0.011 mg/L) allylamine for 50 exposures
of 7 hours caused liver and renal damage and myocarditis in rats. Congestion of the liver and kidney was observed in
rats, rabbits, and dogs exposed to 5 or 20 ppm (0.011 or 0.044 milligram per liter (mg/L)) allylamine for 8 hours/day,
5 days/week, for 1&hyph;year. EPA believes that there is sufficient evidence for listing allylamine on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the hepatotoxicity and nephrotoxicity data for this chemical.

<!-- PJG 0012 frnewline -->
8. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Aluminum phosphide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 020859-73-8) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). The median lethal dose of aluminum phosphide
in humans is 20 mg/kg. The acute inhalation toxicity of aluminum phosphide is attributed to phosphine gas resulting
from decomposition of aluminum phosphide on contact with moisture in the air. Symptoms of phosphine poisoning include
restlessness, headache, dizziness, fatigue, chest tightness, nausea, vomiting, lethargy, stupor, coma, convulsions,
lowered blood pressure, pulmonary edema and respiratory failure; disorders of the kidney, liver, heart and brain
can also occur. In female CFT-Wistar rats exposed to phosphine gas generated from aluminum phosphide pellets in distilled
water, 100 percent mortality was observed after a 6&hyph;hour exposure to 40 ppm (0.1 mg/L), and exposure to 20 to 40
ppm (0.05 to 0.1 mg/L) for 6 hours resulted in 33 percent mortality. Symptoms of toxicity reported in these animals
included dyspnea, loss of muscular coordination, polyuria, and paralysis. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that aluminum phosphide concentrations are likely to exist beyond facility site
boundaries, as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated
to cause significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing
aluminum phosphide on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity
and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
9. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ametryn (N-Ethyl-N'-(1-methylethyl)-6-(methylthio)1,3,5,-triazine- 2,4-diamine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000834-12-8) (FIFRA AI) (Ref. 3). Fatty degeneration of the liver was observed in rats administered 100 mg/kg/day
ametryn by gavage, 6 days per week for 13 weeks. The NOEL was 10 mg/kg/day (8.6 mg/kg/day adjusted for duration). In
another study, hepatic effects (severe vascular congestion, centrilobular liver necrosis and fatty degeneration
of individual liver cells) were observed in rats that died following gavage administration of 500 mg/kg/day ametryn
for 6 days per week for 28 days. The NOEL was 250 mg/kg/day. EPA believes that there is sufficient evidence for listing
ametryn on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatotoxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
The 72-hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for green algae is 14 ppb. Ametryn is a herbicide and may be expected to affect nontarget plants such as algae. EPA believes
that there is sufficient evidence for listing ametryn on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C)
based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
10. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Amitraz
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 033089-61-1) (FIFRA SR) (Ref. 8). Amitraz is an aniline-type insecticide. In a 2&hyph;year beagle dog feeding
study, effects noted at the LOAEL dose (1.0 mg/kg/day) at various times during the study included significantly increased
mean blood glucose concentration, slight hypothermia, and slight central nervous system depression (the latter
effect occurred immediately after dosing on days 1 and 2). The NOAEL in this study was 0.25 mg/kg/day and the oral RfD
derived from the NOAEL was 0.0025 mg/kg/day. These findings were supported by similar results obtained in a 90&hyph;day
feeding study in dogs. In studies with rats or mice exposed to amitraz from 90 days to 2 years, LOAELs less than or equal
to 12 mg/kg/day were derived based on effects that included decreased body weight gain and changes in organ (brain
or heart) weight (the NOELs were less than or equal to 3 mg/kg/day). 
<!-- PJG 0012 frnewline -->
A three-generation reproduction study in rats demonstrated decreased litter size and increased mortality during
suckling. The fetotoxic LOAEL in this study was 5 mg/kg/day and the NOAEL was 1.6 mg/kg/day. In a teratology study in
rabbits, a fetotoxicity LOAEL of 5 mg/kg/day and NOAEL of 1 mg/kg/day were based on the incidences of cleft palate and
meningocoele associated with small ears and displaced toes. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing amitraz on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the chronic toxicity and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
11. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Anilazine (4,6-dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000101-05-3) (FIFRA AI) (Ref. 3). When anilazine was administered to rats, maternal reproductive parameters
were not affected. The systemic maternal NOEL was 150 mg/kg and the LOEL was 500 mg/kg, based on decreased body weight
gain. The developmental NOEL was 1,500 mg/kg, which was the highest dose tested. In rabbits, the maternal toxicity
NOEL was 15 mg/kg and the LOEL was 40 mg/kg, based on increased mortalities and decreased body weight gain (also decreased
percentage of pregnant does at 75 mg/kg). The developmental NOEL was 40 mg/kg and the LOEL was 75 mg/kg, based on increased
fetal mortality, decreased fetal weight, and increased postimplantation loss and inhibited ossification (phalanges).
EPA believes that there is sufficient evidence for listing anilazine on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available developmental toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for anilazine include a scud (Gammarus) 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.27 ppb and an oyster 96&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (growth) of 46 ppb. EPA believes that there is sufficient evidence for listing anilazine on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
12. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Atrazine (6-chloro-N-ethyl-N'-(1-methylethyl)-1,3,5,-triazine-2,4-diamine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001912-24-9) (FIFRA AI) (Ref. 3). Based on sufficient evidence of carcinogenicity in animals, the International
Agency for Research on Cancer (IARC) has classified atrazine as a Group 2B compound; i.e., the chemical is possibly
carcinogenic to humans. Administration of atrazine to Sprague Dawley rats was associated with an increased incidence
of mammary gland fibroadenomas and adenocarcinomas in female rats. A hormonal mechanism may be involved in the induction
of mammary tumors by atrazine. Therefore there is sufficient evidence for listing atrazine on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
13. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bendiocarb (2,2-dimethyl-1,3-benzodioxol-4-ol methylcarbamate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 022781-23-3) (FIFRA AI) (Ref. 3). Depressed blood cholinesterase levels were reported in numerous species.
In a developmental toxicity study in rats, cholinergic signs were observed in maternal animals at 4 mg/kg/day (LOEL).
The maternal NOEL was 1 mg/kg/day; no adverse effects were observed in fetuses. A LOEL of 2.5 mg/kg/day for cholinesterase
inhibition was reported in dogs in a 4&hyph;month dietary study. The NOEL was 0.5 mg/kg/day. Decreases in cholinesterase
activity were observed in female rats fed 20, 30, or 40 mg/kg/day for 28 days. No NOEL was established in this study.
However, no details regarding clinical signs or histopathological changes in neural tissue were reported. EPA believes
that there is sufficient evidence for listing bendiocarb on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available neurological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for bendiocarb include a mysid 96&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 6.7 ppb and a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 29.2 ppb. Avian acute toxicity values include a mallard duck LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 3.1 mg/kg. EPA believes that there is sufficient evidence for listing bendiocarb on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 14. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Benfluralin (N-butyl-N-ethyl-2,6-dinitro-4(trifluoromethyl) benzenamine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001861-40-1) (FIFRA AI) (Ref. 3). Increased relative liver weights, decreased red blood cell counts and
decreased hematocrit and hemoglobin levels were observed in dogs orally administered benfluralin at a dose of 125
mg/kg/day for 2 years. The NOAEL was 25 mg/kg/day. Based on the NOAEL, EPA has established an oral RfD of 0.003 mg/kg/day.
EPA believes that there is sufficient evidence for listing benfluralin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hematological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
15. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Benomyl
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 017804-35-2) (CAL; FIFRA SR) (Ref. 8). In a three-generation study in rats, a dietary level of 25 mg/kg/day
of benomyl resulted in decreased weanling weights. The no-effect level was 5 mg/kg/day. Microphthalmia (the LOEL
was 62.5 mg/kg/day; the NOEL was 30 mg/kg/day) was reported in a rat developmental toxicity study. Decreased fetal
weight (the LOEL was 62.5 mg/kg/day; the NOEL was 30 mg/kg/day) was observed in another rat developmental toxicity
study. The developmental effects were observed at doses that were not toxic to the maternal animal. Anomalies consisting
of supra occipital scars, subnormal vertebral centrum, supernumary ribs, and cleft palate were reported in an oral
developmental toxicity study in mice (the LOEL was 100 mg/kg/day; the NOEL was 50 mg/kg/day). An increase in the incidence
of anomalies including encephalocele, hydrocephalus, microphthalmia, and anophthalmia was noted following administration
of benomyl to rats by intubation during the first 20 days of pregnancy at doses of 125, 250, and 500 mg/kg. The developmental
effects were always associated with death and were considered to be the cause of death. EPA believes that there is sufficient
evidence for listing benomyl on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the developmental
toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
16. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
o-Benzyl-p-chlorophenol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000120-32-1) (FIFRA AI) (Ref. 3). In a 16&hyph;day oral rat study, dose-related increases in liver and kidney
weights (absolute and relative) and nephrosis were observed at a dose level of greater than or equal to 62.5 mg/kg/day.
A NOEL was not established. When the compound was administered by gavage for 13 weeks, rats developed multifocal dilation
of renal tubules and increased liver weights (16 percent) at 240 mg/kg/day. The NOEL was 120 mg/kg/day. In a 90&hyph;day
oral study, mice receiving 30 mg/kg/day developed kidney lesions. Increased liver weights were also noted. No NOEL
was established in this study. EPA believes that there is sufficient evidence for listing o-benzyl-p-chlorophenol
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatic and renal toxicity data
for this chemical. 
<!-- PJG 0012 frnewline -->
17. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bifenthrin
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 082657-04-3) (FIFRA AI) (Ref. 3). Tremors or head and forelimb twitching were noted in dogs, rats and rabbits
exposed to various doses. NOEL values based on the appearance of tremors (often transient) ranged from 1 to 2.67 mg/kg/day.
The oral RfD for bifenthrin was based on a 1year beagle dog feeding study, in which the LOEL, based on tremors observed
during weeks 15 to 29, was 3.0 mg/kg/day and the NOEL was 1.5 mg/kg/day. The RfD based on this NOEL was 0.015 mg/kg/day.

<!-- PJG 0012 frnewline -->
In a rat teratology study, an increased incidence of hydroureter (without hydronephrosis) was noted in fetuses at
2 mg/kg/day (LOEL). The NOEL was 1 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing bifenthrin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological and developmental toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for bifenthrin include a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.35 ppb, a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.15 ppb, a sheepshead minnow LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 17.5 ppb, and a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.6 ppb. EPA believes that there is sufficient evidence for listing bifenthrin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
18. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bis(tributyltin) oxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000056-35-9) (FIFRA AI) (Ref. 3). Adverse effects on the immune system were reported in rats exposed to various
doses of bis(tributyltin) oxide for a duration as short as 4 weeks. SPF-derived Wistar rats were fed the compound for
17 months. In this study, a LOEL of 0.25 mg/kg/day and a NOEL of 0.025 mg/kg/day were based on immunotoxicity manifested
as decreased resistance to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Trichinella spiralis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, reduced natural killer (NK) cell activity in the spleen and reduced macrophage function. The RfD derived from this
NOEL was 0.00003 mg/kg/day. Similar immunological effects were reported in 4- and 6-week rat feeding studies with
20 and 80 ppm (1 and 4 mg/kg/day; the LOEL was 1 mg/kg/day). 
<!-- PJG 0012 frnewline -->
In rats that received dietary levels (of a range of doses that included 50 mg/kg/day) for 106 weeks, kidney function
was decreased and serum levels of alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase
were increased. At the end of the 2&hyph;year study, nephrosis and vacuolization and pigmentation of the proximal
tubular epithelium were reported in animals administered 50 mg/kg/day. On the basis of marginal effects at 5 mg/kg/day
(LOEL), a NOEL of 0.5 mg/kg/day was established. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing bis(tributyltin) oxide on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available immunological and renal toxicity data. Aquatic acute toxicity
values for bis(tributyltin) oxide include a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 7.6 ppb, a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 6.9 ppb, a measured fathead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 2.7 ppb, and a daphnid 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.67 ppb. EPA believes that there is sufficient evidence for listing bis(tributyltin) oxide on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
19. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Boron trichloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010294-34-5) (EPCRA EHS) (Ref. 8). Boron trichloride is corrosive to the skin and mucosal tissue due to its
rapid hydrolysis to hydrochloric acid and boric acid, the former acid being the corrosive species. Single, relatively
large doses of boron administered through any route affects the central nervous system causing depressed circulation,
diarrhea, vomiting, shock, and coma. The kidneys are the most severely affected organ. Symptoms of acute irritation
of the upper airways were observed in humans at exposure levels of greater than or equal to 0.004 mg/L. Inhalation of
0.48 mg/L of boron trichloride proved fatal to certain laboratory animals. Inhalation of 0.096 mg/L of boron trichloride
for 7 hours produced adverse effects on the respiratory tract, and weight loss. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that boron trichloride concentrations are likely to exist beyond facility site
boundaries, as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated
to cause significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing
boron trichloride on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity
and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
20. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Boron trifluoride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007637-07-2) (EPCRA EHS) (Ref. 8). Boron trifluoride is a colorless gas that is corrosive to tissues due to
its rapid hydrolysis to hydrofluoric acid and boric acid. The principal acute effect in animals is irritation of the
mucous membranes of the respiratory tract and eyes; post mortem examination also revealed pneumonia and degenerative
changes in renal tubules. The kidneys are most severely affected because boric acid concentrates in this organ. Exposure
of six animal species to 0.28 mg/L of boron trifluoride for 4 to 7 hours a day, 5 days a week killed all animals within 30
days. Rats, rabbits, and guinea pigs were exposed to boron trifluoride via inhalation. Guinea pigs died of respiratory
failure after being exposed to 0.036 mg/L for 19 days; rats experienced fluorosis of the teeth at this concentration.
All three species were minimally affected at 0.004 mg/L. In a 2-week rat inhalation study, all animals died after 6
daily exposures to 0.18 mg/L. Rats exposed to 0.024 mg/L showed signs of respiratory irritation, increased lung weights,
and depressed liver weights. Rats exposed to 0.17 mg/L of boron trifluoride 6 hours/day, 5 days a week for 13 weeks developed
necrosis of the proximal tubular epithelium of the kidneys. Guinea pigs exposed to 0.035 mg/L, 7 hours/day, 5 days
a week for 3 months developed severe pneumonitis and pulmonary changes indicating chemical irritation. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing boron trifluoride on EPCRA section 313 pursuant to section
313(d)(2)(B) based on the available chronic toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
21. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bromacil (5-bromo-6-methyl-3-(1-methylpropyl)-2,4-(1H,3H)-pyrimidinedione)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000314-40-9) (FIFRA AI) (Ref. 3). Increased thyroid activity was seen in male and female rats fed 5,000 ppm
(250 mg/kg/day) bromacil for 90 days. In a 2&hyph;year dietary study, thyroid hyperplasia was seen in female rats
fed 1,250 ppm (62.5 mg/kg/day). Thyroid follicular adenoma was observed in one female. EPA believes that there is
sufficient evidence for listing bromacil on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available thyroid toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
22. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bromacil lithium salt (2,4-(1H,3H)-pyrimidinedione, 5-bromo-6-methyl-3-(1-methylpropyl), lithium salt)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 05340419-6) (FIFRA AI) (Ref. 3). Bromacil lithium salt will dissociate into bromacil, which is soluble in
aqueous systems and lithium ion. Defects of the palate, eye, and external ear were reported in the offspring of rats
administered 50 mg lithium chloride intraperitoneally on gestation days 1, 4, 7, and 9 followed by 20 mg/day until
day 17. Cleft palates were also observed in mouse fetuses when mothers were gavaged with 300 to 465 mg/kg/day lithium
carbonate on gestation day 6 to 15. An increase in Ebstein's anomaly was reported among offspring of women taking lithium;
cardiovascular defects were found in 212 offspring exposed in utero to lithium therapy. Increased thyroid activity
was seen in male and female rats fed 5,000 ppm (250 mg/kg/day) bromacil for 90 days. In a 2&hyph;year dietary study,
thyroid hyperplasia was seen in female rats fed 1,250 ppm (62.5 mg/kg/day). Thyroid follicular adenoma was observed
in one female. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing bromacil lithium salt on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(B) based on the available developmental and thyroid toxicity data. 
<!-- PJG 0012 frnewline -->
23. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bromine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007726-95-6) (EPCRA EHS) (Ref. 8). Rats fed bromine at a dose of 0.01 mg/kg/day for 6 months experienced changes
in their reflexes and blood indexes. Rats, mice, and rabbits inhaling 0.001 mg/kg/day for 4 months developed functional
abnormalities of the respiratory, nervous, and endocrine systems. Data on the acute and chronic effects of bromine
in humans are limited. Bromine is very corrosive to the eyes, skin, and mucous membranes in either the liquid or vapor
form. A concentration of 10 ppm of bromine in air is intolerable in humans, and can cause severe irritation of the upper
respiratory tract. Other clinical symptoms include neurologic, dermatologic, and gastrointestinal effects.
The maximum concentration allowable in humans for a 0.5 to 1-hour exposure to bromine is 4 ppm. Bromine can cause lacrimation
at concentrations less than 1 ppm. Chronic exposure to bromine (estimated concentration at 0.6 ppm) can result in
eye irritation, upper respiratory irritation, coughing, and headache. Neurological symptoms have also been reported
following chronic exposure to bromine. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing bromine on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available chronic toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
24. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1-Bromo-1-(bromomethyl)-1,3-propanedicarbonitrile
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 035691-65-7) (FIFRA AI) (Ref. 3). In a 3&hyph;month dietary study where rats were administered 83.5, 500,
and 3,000 ppm (4, 25, and 150 mg/kg/day) 1-bromo-1-(bromomethyl)-1,3-propanedicarbonitrile, a NOEL of 83.5 ppm
(4 mg/kg/day) and a LOEL of 500 ppm (25 mg/kg/day) were established (based on neonatal splenic hematopoiesis, decreased
parental body weight and food consumption, increased male urinary epithelial cells, amorphous casts, and crystals).
At 3,000 ppm (150 mg/kg/day) there was decreased lactase dehydrogenase, increased total cholesterol, total protein,
and albumin, elevated female organ-to-body weight ratio for thyroid, liver, spleen, ovaries, and pituitary. In
a 13-week dietary study in beagle dogs (administered 167, 1,000, and 4,000 ppm; 4, 25, and 100 mg/kg/day) the LOEL was
greater than 167 ppm (4 mg/kg/day) (increased male thyroid and female ovary organ to body weight ratio). At 1,000 ppm
(25 mg/kg/day), the same signs were seen as at 167 ppm (4 mg/kg/day), plus diarrhea and increased organ to body weight
ratio of thyroid, heart, liver, and adrenals. At 4,000 ppm (100 mg/kg/day), emesis and ataxia in males, decreased
body weight gain/food consumption, decreased hematocrit, hemoglobin, immature red blood cells, and alkaline phosphatase,
extramedullary hematopoiesis in the liver and spleen, thyroid enlargement with follicular cell hyperplasia, increased
organ to body weight ratios for thyroid, adrenals, liver and spleen were seen. In a 13&hyph;week dietary study where
beagle dogs were administered 167 ppm (4 mg/kg/day), thyroid stimulating hormone (TSH)-stimulated T3 and T4 increased
in both sexes. Thyroids were enlarged (both sexes) with absolute weights and organ to body weight ratios increased
in females. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing 1-bromo-1-(bromomethyl)-1,3-propanedicarbonitrile
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
25. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2-Bromo-2-nitropropane-1,3-diol (bronopol)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000052-51-7) (FIFRA AI) (Ref. 3). Severe irritation was reported in the gastrointestinal tracts of rats,
mice or dogs administered single or multiple oral doses of 2-bromo-2-nitropropane-1,3-diol. In an acute oral study
in mice, the LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 374 mg/kg resulted in ulceration of the stomach and duodenum, thickening of the intestinal wall, and adhesions
of the stomach to the liver. Severe gastric irritation was reported in dogs administered a single oral dose of 250 mg/kg.
The NOEL was 100 mg/kg. Superficial ulceration with epithelial hyperplasia and hyperkeratosis, and congested vessels
in the gastrointestinal mucosa, was observed in rats fed 80 mg/kg/day (LOEL) in their diet for 13 weeks. The NOEL was
20 mg/kg/day. Vomiting was noted in dogs fed 20 mg/kg/day in their diet for 13 weeks. The NOEL in this study was 8 mg/kg/day.
In addition, blood was noted in the urine of these dogs. Mortality, irritation of the gastrointestinal tract, ulceration
and stomach lesions were reported in a 2&hyph;year dietary study in rats fed 40 mg/kg/day. The NOEL was 10 mg/kg/day.
EPA believes that there is sufficient evidence for listing 2-bromo-2-nitropropane-1,3-diol on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(B) based on the available toxicity data. 
<!-- PJG 0012 frnewline -->
26. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bromoxynil (3,5-dibromo-4-hydroxybenzonitrile)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001689-84-5) (FIFRA AI) (Ref. 3). Developmental effects (hydrocephalus, microphthalmia, anophthalmia
and severe defects in ossification of the skull) were observed in rabbits administered 60 mg/kg/day bromoxynil by
gavage. The NOEL was 30 mg/kg/day. Developmental toxicity (increases in all forms of supernumerary ribs) was also
observed in rats at 5 mg/kg/day. The NOEL was 1.5 mg/kg/day. The maternal LOEL (based on body weight loss) was 30 mg/kg/day.
Several other developmental studies indicate potential developmental toxicity of bromoxynil. EPA believes that
there is sufficient evidence for listing bromoxynil on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
27. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bromoxynil octanoate (octanoic acid, 2,6-dibromo-4-cyanophenyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001689-99-2) (FIFRA AI) (Ref. 3). Bromoxynil octanoate hydrolyzes to yield bromoxynil and octanol. In a
dermal developmental toxicity study, bromoxynil octanoate was developmentally toxic to rat fetuses (increased
incidences of supernumerary ribs) at 15 mg/kg/day (LOEL). The NOEL was 10 mg/kg/day. The maternal LOEL for decreased
body weight gain was 20 mg/kg/day. The NOEL was 15 mg/kg/day. Developmental effects (hydrocephalus, microphthalmia,
anophthalmia and severe defects in ossification of the skull) were observed in rabbits administered 60 mg/kg/day
bromoxynil by gavage. The NOEL was 30 mg/kg/day. Developmental toxicity (increases in all forms of supernumerary
ribs) was also observed in rats at 5 mg/kg/day. The NOEL was 1.5 mg/kg/day. The maternal LOEL (based on body weight loss)
was 30 mg/kg/day. EPA believes that there is sufficient evidence for listing bromoxynil octanoate on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for bromoxynil and
bromoxynil octanoate. 
<!-- PJG 0012 frnewline -->
28. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Brucine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000357-57-3) (CERCLA; RCRA APP8; RCRA P) (Ref. 8). Brucine is an alkaloid similar in structure to strychnine.
It is capable of causing death or permanent injury due to exposures in normal use. In humans, brucine can cause central
and peripheral paralysis, convulsions, and respiratory failure. A potentially lethal oral dose in small children
is 5 to 10 mg. The lethal oral dose for an adult may be as low as 30 mg. The acute oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in rabbits is 4 mg/kg. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that brucine concentrations are likely to exist beyond facility site boundaries,
as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated to cause
significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing brucine
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data
for this chemical. 
<!-- PJG 0012 frnewline -->
29. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Butylate (Bis-2-methylpropyl)carbamothioic acid S-ethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002008-41-5) (FIFRA AI) (Ref. 3). In a 2&hyph;year feeding study in mice, hepatic (cellular infiltrates,
focal necrosis) and renal effects (amyloidosis, chronic nephritis, lymphocytic foci) were observed at 80 mg/kg/day.
The NOEL was 20 mg/kg/day. In a separate study, liver pericholangitis was observed in rats fed 180 mg/kg/day for 56
weeks. The NOEL was 30 mg/kg/day. An increased relative liver weight was observed in male dogs fed 25 mg/kg/day for
1&hyph;year. The NOEL was 5 mg/kg/day. Based on the NOEL, EPA has established a chronic oral RfD of 0.05 mg/kg/day.
EPA believes that there is sufficient evidence for listing butylate on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic and renal toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
30. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Butylated hydroxyanisole
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 025013-16-5) (CAL; IARC; NTP) (Ref. 8). Butylated hydroxyanisole is classified by IARC as a Group 2B compound;
i.e., the chemical is possibly carcinogenic to humans. Butylated hydroxyanisole has been shown to induce gastrointestinal
tumors in rats and hamsters. EPA believes that there is sufficient evidence for listing butylated hydroxyanisole
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
31. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
C.I. Acid Red 114
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 006459-94-5) (TSCA) (Ref. 8). In a 2&hyph;year bioassay conducted by the National Toxicology Program (NTP)
in which F344 rats were exposed to C.I. Acid Red 114 via drinking water, hepatocellular carcinomas of the liver, tumors
of the skin, and adenomas or carcinomas in the Zymbal's gland of both sexes were observed. In the same study, female
rats also had increased incidences of adenoma or carcinoma in the clitoral gland, and squamous cell papilloma or carcinoma
in the oral cavity. The exposure concentrations in this study ranged from 70 to 300 ppm (9.8 to 42 mg/kg/day) for males
and from 150 to 600 ppm (21 to 84 mg/kg/day) for females. EPA believes that there is sufficient evidence for listing
C.I. Acid Red 114 on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
32. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
C.I. Direct Blue 218
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 028407-37-6) (NTP) (Ref. 8). In an NTP bioassay, there was clear evidence of carcinogenicity of C.I. Direct
Blue 218 in male and female B6C3F1 mice based on significantly increased incidence of hepatocellular adenomas and
carcinomas. In a 2&hyph;year NTP feeding study in rats, there was some evidence of carcinogenicity in male F344 rats
based on a significant increase in the incidence of squamous cell papillomas of the pharynx in the high dose group (500
mg/kg/day). EPA believes that there is sufficient evidence for listing C.I. Direct Blue 218 on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
33. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Calcium hypochlorite
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007778-54-3) (CERCLA) (Ref. 8). Aquatic acute toxicity data for calcium hypochlorite include a 96&hyph;hour
measured LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for rainbow trout of 60 ppb and a 96&hyph;hour measured LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for the Atlantic silverside of 37 ppb. EPA believes that there is sufficient evidence for listing calcium hypochlorite
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the available ecotoxicity data for this chemical.

<!-- PJG 0012 frnewline -->
34. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Caprolactam
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000105-60-2) (CAA HAP) (Ref. 7). Rats were administered caprolactam by oral gavage at doses of 0, 100, 500,
and 1,000 mg/kg/day on gestation days 6 through 20. This resulted in a LOAEL of 1,000 mg/kg/day and a NOAEL of 500 mg/kg/day
for fetal resorption. Rabbits were administered caprolactam by oral gavage at doses of 0, 50, 150, and 250 mg/kg/day
on gestation days 6 through 28. This resulted in a LOAEL of 150 mg/kg/day for maternal and fetal body weight depression.
In addition, a slight increase in the severity of spontaneous nephropathy (10,000 ppm) was observed in male rats of
the first parental generation fed 10,000 ppm of caprolactam in a three-generation reproductive study, resulting
in a NOAEL of 1,000 ppm (50 mg/kg/day). Mean body weights and food consumption were reduced in both parental generations
at 5,000 and 10,000 ppm. Body weights of offspring were also reduced at these dietary concentrations (the LOAEL was
250 mg/kg/day). EPA believes that there is sufficient evidence for listing caprolactam on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
35. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Carbofuran
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001563-66-2) (CERCLA; EPCRA EHS; FIFRA SR) (Ref. 8). Aquatic acute toxicity test data for carbofuran include
a measured 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for bluegill of 80 ppb. In addition, the measured 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for daphnids is 35 ppb. Measured terrestrial acute toxicity data for wildlife include an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for mallard ducks of 0.397 mg/kg for females and 0.480 mg/kg for males and an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for female ring-necked pheasants of 4.15 mg/kg. EPA believes that there is sufficient evidence for listing carbofuran
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
36. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Carbon monoxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000630-08-0) (CAL) (Ref. 8). Cardiovascular (e.g., electrocardiograph changes, atrial fibrillation,
ventricular arrhythmias) and neurological (e.g., headache, dizziness, convulsions, and coma) effects were reported
in humans exposed to carbon monoxide. In humans, histological effects in the brain include extensive demyelination
of white matter, and necrosis. Neuropsychiatric disorders have also been reported. Persistant electrocardiograph
changes, and degeneration of myocardial muscle fibers, hemorrhage and necrosis were observed following inhalation
exposure of dogs to 100 ppm (0.11 mg/L) carbon monoxide, 5.5 hours/day, 6 days/week, for 11 weeks. Some of the dogs showed
disturbances in gait and in postural and position reflexes. The toxicity of carbon monoxide results from its combination
with hemoglobin in the blood to form carboxyhemoglobin which is a poor oxygen carrier. Thus, oxygen delivery by the
blood is severely compromised, which leads to tissue hypoxia and possibly tissue poisoning, resulting in the toxic
effects (including death) known for this substance. Infants born to women who survive acute exposure to high concentrations
of carbon monoxide during pregnancy often display neurological sequelae and gross brain damage. Exposure of pregnant
rats to 150 ppm (0.17 mg/L) carbon monoxide caused reduced pup growth rate, and altered behavior (poor performance
on negative geotaxis and homing tests) in pups. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing carbon monoxide on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available chronic neurological, myocardial, and developmental toxicity data
for this chemical. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Carbon monoxide is regulated under Title I of the CAA (Provisions for Attainment and Maintenance of National Ambient
Air Quality Standards). In addition to this proposal to add carbon monoxide to EPCRA section 313, in Units IV.B.179.
and 235, EPA is proposing to add two other chemicals, nitrogen dioxide and sulfur dioxide, that are regulated under
Title I of the CAA. Sulfur dioxide is also regulated under Title IV of the CAA (Acid Deposition Control). Extensive
data, which are highly technical, are collected on these chemicals as required by the CAA. EPA requests comment on
the following: (1) Is the information collected under the CAA sufficient for public right-to-know purposes; and
(2) suggestions on how the data collected on these chemicals pursuant to CAA Titles I and IV could be used to meet the
purposes of EPCRA section 313.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
37. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Carboxin (5,6-dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 005234-68-4) (FIFRA AI) (Ref. 3). Decreased body weight gain and food consumption, increased mortality,
and reduced kidney, heart and spleen weights were observed in rats fed 600 ppm (30 mg/kg/day) carboxin for 2 years.
The NOEL is 200 ppm (10 mg/kg/day). A similar NOEL was established in a three-generation rat reproduction study. Based
on the NOEL, EPA established an oral RfD of 0.01 mg/kg/day. In a 90&hyph;day feeding study in rats, degeneration of
the kidneys was seen at 600 ppm (30 mg/kg/day). The NOEL was 10 mg/kg/day. EPA believes that there is sufficient evidence
for listing carboxin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available renal toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
38. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chinomethionat (6-methyl-1,3-dithiolo[4,5-b]quinoxalin-2-one)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002439-01-2) (FIFRA AI) (Ref. 3). Increases in liver weight, liver protein, and both total liver and microsomal
RNA levels, as well as inhibition of mixed-function oxidase enzymes (e.g., N-demethylase, cytochrome P-450) were
noted in rats administered 75 mg/kg/day by oral gavage for 4 days or in female rats administered 75 mg/kg/day in their
diet for 21 days. Liver enlargement was reported in rats fed 10 mg/kg/day in their diet for 35 days. The increase in liver
size was attributed to increased cellular protein and an increase in water content. Rats exposed orally to 2,700 mg/kg
for 90 days (30 mg/kg/day) had changes in liver weight and effects on the hepatic microsomal oxidases as well as weight
loss or decreased body weight gain. In a 1-year dog study, the NOEL was established at 0.6 mg/kg/day for the test material
in the diet. The LOEL was 1.9 mg/kg/day as indicated by extra medullary hematopoietic nodules in the liver. 
<!-- PJG 0012 frnewline -->
In a developmental toxicity study in rats, increased resorption and decreased fetal weight were reported at 37.5
mg/kg/day (the highest dose tested). The NOEL was 12.5 mg/kg/day. In another developmental study in rats given 30
mg/kg/day in carboxy methyl cellulose by gavage from gestation day 6 to 20, cleft palate, anasarca and micrognathia
was observed. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing chinomethionat on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available hepatic and developmental toxicity data. 
<!-- PJG 0012 frnewline -->
39. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chlorendic acid
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000115-28-6) (NTP) (Ref. 8). Based on sufficient evidence of carcinogenicity in animals IARC classified
chlorendic acid as a Group 2B compound; i.e., it is possibly carcinogenic in humans. In an NTP bioassay, there was clear
evidence of liver carcinogenicity in both rats and mice. EPA believes that there is sufficient evidence for listing
chlorendic acid on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
40. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chlorimuron ethyl (ethyl-2-[[[(4-chloro-6-methoxyprimidin-2-yl)-carbonyl]-amino]sulfonyl]benzoate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 090982-32-4) (FIFRA AI) (Ref. 3). In a 1&hyph;year dog study, dietary administration of 37.5 mg/kg/day (LOEL)
produced an increase in white blood cells in both sexes, a decrease in red blood cells, hematocrit, and hemoglobin
in females, and an increase in alkaline phosphatase in males. The NOEL was 6.25 mg/kg/day. Based on the NOEL, an oral
RfD of 0.02 mg/kg/day was derived. This study was given a high confidence rating. In a 2&hyph;year rat feeding study,
changes in hematology parameters were observed at the LOEL of 125 mg/kg/day. The NOEL was 12.5 mg/kg/day. In an 18&hyph;month
mouse feeding study, centrilobular hepatocellular hypertrophy was observed at 90 days at 187.5 mg/kg/day (LOEL).
The NOEL was 18.75 mg/kg/day. EPA believes that there is sufficient evidence for listing chlorimuron ethyl on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hematological toxicity data. 
<!-- PJG 0012 frnewline -->
41. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chlorinated paraffins category
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAA HAP) (Ref. 7). Chlorinated paraffins are defined as mixtures of linear saturated chlorinated hydrocarbons
obtained through the partial chlorination of paraffin, olefin, or acetylene feedstocks which have an average chain
length of 10 to 30 carbon atoms and contain average chlorine levels ranging from 40 to 70 percent by weight. Chlorinated
paraffins can be described by the general formula: C
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
x
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
H
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2x-y+2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Cl
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
y
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 where x ranges from 10 to 30 and y ranges from 3 to 26. Both 58 percent-chlorinated, short-chain (10 to 12 carbons) and
43 percent-chlorinated, long-chain (22 to 26 carbons) chlorinated paraffins were tested in rats and mice by gavage
in a 2&hyph;year bioassay. The 58 percent-chlorinated, short-chain (10 to 12 carbons) chlorinated paraffins were
carcinogenic in rats and mice: dosed male and female mice showed increased incidences of liver tumors, dosed male
rats had increased incidences of kidney tubular cell hyperplasia and adenomas or adenocarcinomas (combined), and
dosed female rats and mice showed increased thyroid gland follicular cell neoplasms, indicating an EPA Group B2 classification,
i.e., a probable human carcinogen. The 43 percent-chlorinated, long-chain (22 to 26 carbons) chlorinated paraffins
were carcinogenic in male mice showing an increased incidence of malignant lymphomas, and marginal increase in hepatocellular
neoplasms in female mice and adrenal gland pheochromocytomas in female rats, indicating an EPA Group B2 category
classification, i.e., the chemical is a probable human carcinogen. EPA believes that there is sufficient evidence
for listing chlorinated paraffins on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
carcinogenicity data for these chemicals. 
<!-- PJG 0012 frnewline -->
The following ecotoxicity data (LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
s followed by experiment duration in parenthesis) have been reported for short chain (10 to 13 carbons) and intermediate
chlorination (59 percent chlorine) chlorinated paraffins: daphnid, 46 ppb (48&hyph;hour); mysid shrimp, 14 ppb
(96&hyph;hour); marine algae, 42 ppb (96&hyph;hour); daphnid, 2 ppb and 9 ppb (21&hyph;day chronic study); and midge,
78 ppb (49&hyph;day chronic study). Ranges of chronic toxicity values are as follow: Freshwater invertebrates,
2 to 162 ppb; freshwater fish, 3 to 17.2 ppb; marine invertebrates, 2.4 to 24 ppb; and marine fish, 2.4 ppb to 620.5 ppm.
Chlorinated paraffins are persistent with a half-life of greater than 30 days in the environment. EPA believes that
there is sufficient evidence for listing the category chlorinated paraffins on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the available ecotoxicity data for these chemicals and their persistence in the environment.

<!-- PJG 0012 frnewline -->
EPCRA section 313 requires threshold determinations for chemical categories to be based on the total of all chemicals
in the category manufactured, processed, or otherwise used. For example, a facility that manufactures three members
of a chemical category would count the total amount of all three chemicals manufactured towards the manufacturing
threshold for that category. When filing reports for chemical categories the releases are determined in the same
manner as the thresholds. One report if filed for the category and all releases are reported on this form. 
<!-- PJG 0012 frnewline -->
42. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 004080-31-3) (FIFRA AI) (Ref. 3). Decrease in heart weight, obliterative vasculitis, and perivasculitis
of the hepatic blood vessels were observed in dogs orally administered 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane
for 90 days. The NOEL was 7.5 mg/kg/day; the LOEL was 15 mg/kg/day. EPA believes that there is sufficient evidence for
listing 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available chronic toxicity data for 1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane.

<!-- PJG 0012 frnewline -->
43. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
p-Chloroaniline
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000106-47-8) (CERCLA; RCRA APP8; RCRA P) (Ref. 8). In a 78&hyph;week study in which rats were fed p-chloroaniline,
non-neoplastic proliferative lesions of the splenic capsule (focal fibrosis with subcapsular mesenchymal proliferation)
were observed. The LOAEL was 12.5 mg/kg/day (the lowest dose tested) and the RfD derived from this data is 0.004 mg/kg/day.
EPA believes that there is sufficient evidence for listing p-chloroaniline on EPCRA section 313 pursuant to section
313(d) (2)(B) based on the chronic toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
44. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
5-Chloro-2-(2,4-dichlorophenoxy)phenol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 003380-34-5) (FIFRA AI) (Ref. 3). In a 3&hyph;month dog feeding study, decreased red blood cell and hemoglobin
values, increased serum alkaline phosphatase, jaundice, and increased liver weight were observed at 25 mg/kg/day
(LOEL). No NOEL could be established. In another 3&hyph;month dog feeding study, the LOEL of 25 mg/kg/day produced
morphologic changes in the liver (focal acidophilic granular degeneration of cytoplasm). The NOEL was 12.5 mg/kg/day.
In a 3&hyph;month rat feeding study, 125 mg/kg/day (LOEL) produced increased liver weights in males. The NOEL was
50 mg/kg/day. At 150 mg/kg/day (LOEL), decrease in triglycerides, increase in creatinine, decrease in red blood
cells, increase in spleen and heart weight, and cytomegaly were observed in another 3&hyph;month rat feeding study
(NOEL was 50 mg/kg/day). In a 2&hyph;year study, dietary administration of 15 mg/kg/day produced decreases in red
blood cells, hemoglobin concentration, and hematocrit as well as hepatic necrosis in males. At 50 mg/kg/day, there
were decreases in red blood cells in females. EPA believes that there is sufficient evidence for listing 5-chloro-2-(2,4-dichlorophenoxy)phenol
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hematological toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
45. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3-Chloro-2-methyl-1-propene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000563-47-3) (NTP) (Ref. 8). In an NTP gavage bioassay there was clear evidence of carcinogenicity from 3-chloro-2-methyl-1-propene
in rats and mice. The substance induced adrenal cortex, testicular and gastrointestinal tumors in rats and adrenal
cortex and gastrointestinal tumors in mice. EPA believes that there is sufficient evidence for listing 3-chloro-2-methyl-1-propene
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
46. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
p-Chlorophenyl isocyanate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000104-12-1) (TSCA) (Ref. 8). p-Chlorophenyl isocyanate is very lethal following inhalation. The 4&hyph;hour
mouse inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value is 0.053 mg/L. In addition, isocyanates as a class are generally severe skin, eye, and respiratory irritants
following acute exposure. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that p-chlorophenyl isocyanate concentrations are likely to exist beyond facility
site boundaries, as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated
to cause significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing
p-chlorophenyl isocyanate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute
toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
47. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chloropicrin
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000076-06-2) (FIFRA AI) (Ref. 3). Measured aquatic acute toxicity data for chloropicrin include a rainbow
trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 16.5 ppb, a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 105 ppb, and a 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 80 ppb. EPA believes that there is sufficient evidence for listing chloropicrin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
48. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3-Chloropropionitrile
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000542-76-7) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). 3-Chloropropionitrile is metabolized by hepatic
cytochrome P450 enzymes to release cyanide. The substance is readily absorbed both dermally and orally. The mouse
oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is 51.3 mg/kg. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that 3-chloropropionitrile concentrations are likely to exist beyond facility
site boundaries, as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated
to cause significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing
3-chloropropionitrile on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute
toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
49. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
p-Chloro-o-toluidine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000095-69-2) (IARC; NTP) (Ref. 8). p-Chloro-o-toluidine is classified as a Group B2 carcinogen by EPA; i.e.,
the compound is a probable human carcinogen. It is classified as a Group 2B carcinogen by IARC; i.e., a possible human
carcinogen. Epidemiology studies are inadequate in evaluating the carcinogenic potential of 4-chloro-o-toluidine
hydrochloride in humans. In a long-term feeding study by NCI, p-chloro-o-toluidine hydrochloride induced hemangiomas,
hemangiosarcomas, and vascular tumors in mice. An increase in the incidence of pituitary chromophobe adenomas was
observed in female rats following dietary administration. EPA believes that there is sufficient evidence for listing
p-chloro-o-toluidine on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
50. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chlorotrifluoromethane (CFC-13)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000075-72-9) (CAA OD) (Ref. 8). Chlorofluorocarbons, including chlorotrifluoromethane (CFC-13) are
known to release chlorine radicals into the stratosphere. Chlorine radicals act as catalysts to reduce the net amount
of stratospheric ozone. Stratospheric ozone shields the earth from ultraviolet-B (UV-B) radiation (i.e., 290 to
320 nanometers). Decreases in total column ozone will increase the percentage of UV-B radiation, especially at its
most harmful wavelengths, reaching the earth's surface.
<!-- PJG 0012 frnewline -->
Exposure to UV-B radiation has been implicated by laboratory and epidemiologic studies as a cause of two types of nonmelanoma
skin cancers: squamous cell cancer and basal cell cancer. Studies predict that for every 1 percent increase in UV-B
radiation, nonmelanoma skin cancer cases would increase by about 1 to 3 percent. 
<!-- PJG 0012 frnewline -->
Recent epidemiological studies, including large case control studies, suggest that UV-B radiation plays an important
role in causing malignant melanoma skin cancer. Recent studies predict that for each 1 percent change in UV-B intensity,
the incidence of melanoma could increase from 0.5 to 1 percent. 
<!-- PJG 0012 frnewline -->
Studies have demonstrated that UV-B radiation can suppress the immune response system in animals, and, possibly,
in humans. Increases in exposure to UV-B radiation are likely to increase the incidence of cataracts and could adversely
affect the retina.
<!-- PJG 0012 frnewline -->
Aquatic organisms, particularly phytoplankton, zooplankton, and the larvae of many fishes, appear to be susceptible
to harm from increased exposure to UV-B radiation because they spend at least part of their time at or near the surface
of waters they inhabit. 
<!-- PJG 0012 frnewline -->
Increased UV-B penetration has been shown to result in adverse impacts on plants. Field studies on soybeans suggest
that yield reductions could occur in some cultivars of soybeans, while evidence from laboratory studies suggest
that two out of three cultivars are sensitive to UV-B. 
<!-- PJG 0012 frnewline -->
Because this increased UV-B radiation can be reasonably anticipated to lead to cancer and other chronic human health
effects and significant adverse environmental effects, there is sufficient evidence for listing chlorotrifluoromethane
(CFC-13) on EPCRA section 313 pursuant to EPCRA sections 313(d)(2)(B) and (C). 
<!-- PJG 0012 frnewline -->
51. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chlorpyrifos methyl (O,O-dimethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothioate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 005598-13-0) (FIFRA AI) (Ref. 3). Humans experienced a 10 percent reduction in plasma cholinesterase activity
after 10 dermal exposures to 10 mg/kg/day and a 47 percent reduction after 4 dermal exposures to 25 mg/kg/day (exposures
were for 12 hours per day). Rabbits experienced a 97 to 100 percent reduction in plasma cholinesterase activity after
5 dermal exposures to 10 mg/kg/day for 12 hours a day or 2 dermal exposures to 25 mg/kg/day for 12 hours a day. In a 2&hyph;year
rat feeding study, red blood cell and plasma cholinesterase inhibition were observed at 1 mg/kg/day (LOEL). The NOEL
was 0.1 mg/kg/day. In a 2&hyph;year dog feeding study, plasma cholinesterase inhibition was observed at 1 mg/kg/day
(LOEL). The NOEL was 0.1 mg/kg/day. The oral rat LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is between 1,159 mg/kg and 3,833 mg/kg. Lethargy, ataxia, diarrhea, salivation, and tremors were observed in these
studies. EPA believes that there is sufficient evidence for listing chlorpyrifos methyl on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available neurological toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for chlorpyrifos methyl include a daphnid 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.11 ppb and a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 12.6 ppb. EPA believes that there is sufficient evidence for listing chlorpyrifos methyl on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
52. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Chlorsulfuron (2-chloro-N-[[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulfonamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 064902-72-3) (FIFRA AI) (Ref. 3). In a rabbit developmental study, an increased incidence of fetal resorptions
was observed at the LOEL of 75 mg/kg/day. The NOEL was 25 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a 3-generation rat reproduction study, a decrease in fertility index was observed at 125 mg/kg/day (LOEL). The
NOEL was 25 mg/kg/day. EPA believes that there is sufficient evidence for listing chlorsulfuron on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental and reproductive toxicity data
for this chemical. 
<!-- PJG 0012 frnewline -->
53. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Clomazone (2-[(2-chlorophenyl)methyl]-4,4-dimethyl-3-isoxazolidinone)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 081777-89-1) (FIFRA AI) (Ref. 3). In a 90&hyph;day dog feeding study, increased cholesterol and increased
absolute and relative liver weights were observed at 62.5 mg/kg/day (LOEL). The NOEL was 12.5 mg/kg/day. Dietary
administration of 62.5 mg/kg/day (LOEL) to dogs for 1&hyph;year also produced increased cholesterol and increased
liver weights. The NOEL was 12.5 mg/kg/day. In a 90&hyph;day mouse feeding study, megalocytosis of the liver cells
was seen at 2.6 mg/kg/day (LOEL). No NOEL was established. In a 2&hyph;year rat feeding study, elevated cholesterol
levels and liver-to-body weight ratios were observed at 21.5 mg/kg/day (LOEL). The NOEL was 4.3 mg/kg/day. Dietary
administration of 62.5 mg/kg/day (LOEL) to dogs for 1&hyph;year increased cholesterol and liver weights. The NOEL
was 12.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a two-generation reproduction study, decreased pup viability, reduced survival, decreased body weight, and
nonfunctional limbs were observed in the offspring of rats that were orally administered 50 mg/kg/day (LOEL). The
NOEL was 5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing clomazone on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic and developmental toxicity data. 
<!-- PJG 0012 frnewline -->
54. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Crotonaldehyde
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 004170-30-3) (RCRA APP8) (Ref. 8). Crotonaldehyde has been tested for carcinogenicity in one animal study.
When crotonaldehyde was administered to male F344 rats at 0, 42, or 421 mg/L for 113 weeks, there was a statistically
significant increase in the incidence of hepatocellular neoplasms (benign and malignant combined) in the low dose
group. The lack of tumorigenic effects at the high-dose group is believed to be due to the hepatotoxicity observed
in this group. At high dose, crotonaldehyde is cytotoxic; cells died before neoplasms are manifested. Crotonaldehyde
and other alpha, beta-unsaturated carbonyls are chemically reactive compounds which can readily react with cellular
macromolecules such as DNA and proteins. Mutagenicity studies in a slightly modified preincubation Ames test have
clearly shown that crotonaldehyde is mutagenic. EPA believes that there is sufficient evidence for listing crotonaldehyde
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity and mutagenicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
55. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cyanazine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 021725-46-2) (CAL; FIFRA SR) (Ref. 8). Cyanazine is a triazine-type herbicide. In a three-generation reproduction
study in Long-Evans rats, F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
b female weanlings had increased relative brain weights and decreased relative kidney weights. The LOAEL was 4.05
mg/kg/day and the NOAEL was 1.35 mg/kg/day. In rabbits that received cyanazine in gelatin capsules during gestation
days 6 to 18, there was increased postimplantation loss, decreased litter size, and alterations in ossification.
In addition, there were increased malformations in the offspring, including anophthalmia/microphthalmia, dilated
brain ventricles, dome cranium and thoracoschisis (the LOAEL was 2 mg/kg/day; the NOAEL was 1 mg/kg/day). Similar
developmental effects were reported in Fischer 344 rats administered cyanazine during gestation days 6 to 15 (the
LOAEL was 25 mg/kg/day; the NOAEL 5 was mg/kg/day). EPA believes that there is sufficient evidence for listing cyanazine
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the developmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
56. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cycloate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001134-23-2) (FIFRA AI) (Ref. 3). Cycloate, a carbamate pesticide, is a cholinesterase inhibitor. Symptoms
of poisoning include salivation, lacrimation, convulsions, and death. Depressed plasma cholinesterase was observed
in a 9&hyph;week rat inhalation study at 0.0025 mg/L. The NOEL was less than 0.0025 mg/L. Decreased serum cholinesterase
(in males and females) and Wallerian degeneration of nerve fibers in spinal cord and sciatic nerve (females) were
observed at 0.12 mg/L in a 10-week rat inhalation study (cholinesterase NOEL is 0.012 mg/L). In both inhalation studies,
animals were exposed for 6 hours/day, 5 days/week. Plasma, red blood cell, and brain cholinesterase inhibition was
reported in rats fed 8 mg/kg/day for 2 years. The NOEL was less than 8 mg/kg/day. Dose-related neuropathy and muscle
myopathy were observed. In a 2&hyph;year rat feeding study, distended myelin sheath demyelination and nerve fiber
loss occurred at 3 mg/kg/day (LOEL). The NOEL was 0.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Decreased weight and survival were observed in the offspring of rats orally administered 24 mg/kg/day (LOEL) and
72 mg/kg/day of cycloate, respectively (duration and frequency of dosing not reported). The reproductive NOEL was
8 mg/kg/day. Decreased pup weight was observed at 20 mg/kg/day and decreased pup survival was observed at 50 mg/kg/day
in a 2-generation rat reproduction study. The NOEL values for these endpoints were 2.5 mg/kg/day and 20 mg/kg/day,
respectively. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing cycloate on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological and developmental toxicity data. 
<!-- PJG 0012 frnewline -->
57. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cyclohexanol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000108-93-0) (TSCA) (Ref. 8). Four rabbits exposed to 997 ppm (4 mg/L) for 11 days (6 hours/day, 5 days/week)
and a rabbit receiving dermal applications of approximately 2,500 mg/kg/day for 10 days (1 hour/day) developed tremors,
central nervous system depression, lethargy or hypothermia. 
<!-- PJG 0012 frnewline -->
Microscopic or degenerative changes were observed in the livers and kidneys of rabbits inhaling 145 ppm (0.59 mg/L)
of cyclohexanol for 50 days (6 hours/day, 5 days/week), or repeated doses at 272 ppm (1.1 mg/L). In addition, degenerative
myocardial effects were observed at this exposure level. Repeated inhalation exposure to higher doses (997 to 1,229
ppm; 4 to 5 mg/L) in rabbits resulted in degenerative changes in the brain and heart as well as liver and kidneys. 
<!-- PJG 0012 frnewline -->
Reproductive effects including testicular atrophy, loss of Type A spermatogonia, spermatocytes and spermatozoa,
``shrinkage'' of seminiferous tubules and Leydig cells, reductions in RNA protein, sialic acid, and glycogen in
testes, epididymis and seminal vesicles and increased testicular cholesterol and alkaline phosphatase were observed
in male rats or gerbils exposed to 15 mg/kg of cyclohexanol for 21 to 37 days. These changes were accompanied with decreased
fertility, and occurred at exposure levels which had no effect on the liver or kidney. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing cyclohexanol on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the chronic neurological, hepatic, renal, myocardial, and reproductive toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
58. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cyfluthrin (3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, cyano(4-fluoro-3-phenoxyphenyl)methyl
ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 068359-37-5) (FIFRA AI) (Ref. 3). In a 14&hyph;day rat study, oral administration of 60 mg/kg/day produced
tremors, uncoordinated gait, salivation, slight brain hemorrhages, necrosis of the skeletal muscle fibers, and
death. The NOEL was not defined. In another study, salivation, straddled gait, axonal degeneration of sciatic nerve,
microtubular dilation, and mitochondria degeneration in the sciatic and femoral nerves were observed in rats administered
80 mg/kg/day orally for 5 days and 40 mg/kg/day for the following 9 days. No NOEL was established. 
<!-- PJG 0012 frnewline -->
Liver and adrenal weight increases were observed in rats orally administered 40 to 80 mg/kg/day for 28 days. The highest
dose of 80 mg/kg/day was reduced to 40 mg/kg/day. The NOEL was 20 mg/kg/day. Liver weight changes and urobilinogen
and ketone bodies in the urine were observed in rats fed 15 mg/kg/day for 28 days. No NOEL was established. In a 28&hyph;day
mouse feeding study, increased liver weight was observed at 50 mg/kg/day (LOEL). The NOEL was 15 mg/kg/day. Inflammatory
foci in the kidneys of females were observed at 7.5 mg/kg/day in a 2&hyph;year rat feeding study. The NOEL was 2.5 mg/kg/day.
Based on the NOEL of the study, an oral RfD of 0.025 mg/kg/day was determined. Increased alkaline phosphatase activity
was observed in males at 7.5 mg/kg/day in a 23&hyph;month mouse feeding study. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing cyfluthrin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological, hepatic, and renal toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for cyfluthrin include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.68 ppb, a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.5 ppb, and a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.14 ppb. EPA believes that there is sufficient evidence for listing cyfluthrin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
59. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cyhalothrin (3-(2-chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl
ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 068085-85-8) (FIFRA AI) (Ref. 3). Cyhalothrin administered orally (in capsules) to dogs at 10 mg/kg/day
for 26 weeks produced occasional disturbances of the nervous system (unsteadiness and/or muscular trembling).
The NOEL for these effects was not defined. In a 1&hyph;year dog study, ataxia, muscle tremors, and convulsions were
observed following oral administration at 3.5 mg/kg/day. Abnormal gait and convulsions were observed at 0.5 mg/kg/day.
The LOEL of the study was 0.5 mg/kg/day and the NOEL was 0.1 mg/kg/day. EPA believes that there is sufficient evidence
for listing cyhalothrin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available neurological
toxicity data. 
<!-- PJG 0012 frnewline -->
60. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cyromazine (N-cyclopropyl-1,3,5-triazine-2,4,6-triamine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 066215-27-8) (FIFRA AI) (Ref. 3). In a 6&hyph;month dog feeding study, 7.5 mg/kg/day (LOEL) produced changes
in hematocrit and hemoglobin levels. The NOEL was 0.75 mg/kg/day. Based on the NOEL, an oral RfD of 0.0075 mg/kg/day
was derived. In a 90&hyph;day dog feeding study, the LOEL of 25 mg/kg/day produced an increase in relative liver weights
in males. The NOEL was 7.5 mg/kg/day. In a 90&hyph;day rat feeding study, the LOEL of 15 mg/kg/day produced a decrease
in relative liver weights in males. The NOEL was 1.5 mg/kg/day. EPA believes that there is sufficient evidence for
listing cyromazine on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hematological
toxicity data. 
<!-- PJG 0012 frnewline -->
61. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dazomet (tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000533-74-4) (FIFRA AI) (Ref. 3). Animals fed dazomet at a dietary dose of 40 ppm for 2 years showed focal necrosis
and fatty metamorphosis of the liver. Rats fed 30.3 mg/kg/day experienced decreased weight gain and changes in liver
weight. Renal focal tubular necrosis was seen in rats fed 10 ppm (0.5 mg/kg/day) for 2 years. EPA believes that there
is sufficient evidence for listing dazomet on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available hepatic and renal toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
62. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dazomet sodium salt (tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione, ion(1-), sodium)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 053404-60-7) (FIFRA AI) (Ref. 3). The available toxicity data is on dazomet. Rats fed 80 ppm for 2 years (4 mg/kg/day)
showed focal necrosis and fatty metamorphosis of the liver. Rats fed 30.3 mg/kg/day experienced decreased weight
gain and changes in liver weight. Renal focal tubular necrosis was seen in rats fed 10 ppm (0.5 mg/kg/day) for 2 years.
EPA believes that there is sufficient evidence for listing dazomet sodium on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available renal toxicity data for its free acid, dazomet. 
<!-- PJG 0012 frnewline -->
63. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-DB
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000094-82-6) (FIFRA SR) (Ref. 8). 2,4-DB (4-(2,4-dichlorophenoxy)butanoic acid) is a 2,4-dichlorophenoxy-type
herbicide. In a study involving beagle dogs fed a diet containing 2,4-DB for 90 days, a LOAEL of 25 mg/kg/day was determined,
based on internal hemorrhaging and mortality observed during the first 3 to 9 weeks of treatment. The NOAEL in this
study was 8 mg/kg/day. At this dose level, slight increases in liver weights were observed, but unaccompanied by any
gross or histopathologic lesions. EPA has derived an oral RfD of 0.008 mg/kg/day from the LOAEL. In a subchronic rat
feeding study, the LOAEL and NOAEL values determined were higher (the LOAEL was approximately 80 to 100 mg/kg/day;
the NOAEL was approximately 25 to 30 mg/kg/day), and were based on severe liver and kidney damage. 
<!-- PJG 0012 frnewline -->
In the above-mentioned subchronic (90&hyph;day) dog feeding study, it was observed that the animals exposed to doses
of 2,4-DB at 25 mg/kg/day (the LOAEL) and higher exhibited aspermatogenesis within the first 3 to 9 weeks of treatment.
The offspring of rats orally exposed to 17 mg/kg of 2,4-DB during days 1 to 7 of gestation developed abnormalities.
There was also an increase in stillbirths at this dose level. In a separate study, offspring of rats orally exposed
to 416 mg/kg on days 5 or 9 of gestation exhibited increased preimplantation loss and/or developmental toxicity.

<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing 2,4-DB on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the hepatic, reproductive, and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
64. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D butoxyethyl ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001929-73-3) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D butoxyethyl ester is a 2,4-dichlorophenoxy-type
herbicide. In mammals, the butoxyethyl ester of 2,4-D is hydrolyzed to yield the free acid, 2,4-D. Therefore, the
toxicity of 2,4-D butoxyethyl ester is expected to be similar to that of 2,4-D, in which the kidney, liver, and nervous
system are the primary targets of injury. EPA believes that there is sufficient evidence for listing 2,4-D butoxyethyl
ester on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the known chronic effects of its metabolite
2,4-D. 
<!-- PJG 0012 frnewline -->
65. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D butyl ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000094-80-4) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D butyl ester is a 2,4-dichlorophenoxytype herbicide.
In mammals, the butyl ester of 2,4-D is hydrolyzed to yield the free acid, 2,4-D. Therefore, the toxicity of 2,4-D butyl
ester is expected to be similar to that of 2,4-D, in which the kidney, liver, and nervous system are the primary targets
of injury. EPA believes that there is sufficient evidence for listing 2,4-D butyl ester on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the known toxic effects of its metabolite 2,4-D. 
<!-- PJG 0012 frnewline -->
66. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D chlorocrotyl ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002971-38-2) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D chlorocrotyl ester is a 2,4-dichlorophenoxy-type
herbicide. In mammals, the chlorocrotyl ester of 2,4-D is hydrolyzed to yield the free acid, 2,4-D. Therefore, the
toxicity of 2,4-D chlorocrotyl ester is expected to be similar to that of 2,4-D, in which the kidney, liver and nervous
system are the primary targets of injury. EPA believes that there is sufficient evidence for listing 2,4-D chlorocrotyl
ester on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the known toxic effects of its metabolite
2,4-D. 
<!-- PJG 0012 frnewline -->
67. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Desmedipham
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 013684-56-5) (FIFRA AI) (Ref. 3). In a 90&hyph;day dog study, groups of four beagles/sex were fed diets containing
0 to 5.24 mg/kg/day. This caused increased methemoglobin at 5.24 mg/kg/day (LOEL). EPA believes that there is sufficient
evidence for listing desmedipham on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
hematological toxicity data. 
<!-- PJG 0012 frnewline -->
68. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D 2-ethylhexyl ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001928-43-4) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D 2-ethylhexyl ester is a 2,4-dichlorophenoxy-type
herbicide. The 2-ethylhexyl moiety contains eight carbons and, therefore, is an isooctyl group. Developmental
toxicity following maternal exposure to 2,4-D isooctyl esters has been demonstrated in the rat and mouse. Fetotoxicity
occurred in offspring of rats exposed to 528 mg/kg during gestation days 8 through 11. Rats orally exposed to doses
as low as 302 mg/kg during gestation days 9 through 12 had musculoskeletal abnormalities. Exposure to a lower dose
(188 mg/kg) for a longer period during gestation (days 6 through 15) caused developmental effects on homeostasis
and effects on newborn growth statistics. In mice, 438 mg/kg administered orally during gestation days 8 to 12 also
caused effects on newborn growth statistics. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing 2,4-D 2-ethylhexyl ester on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the developmental toxicity data for 2,4-D isooctyl esters, and on the toxic
effects of its metabolite 2,4-D. 
<!-- PJG 0012 frnewline -->
The aquatic acute toxicity data for 2,4-D isooctyl esters include a measured 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 8.8 ppm for bluegill. In addition, 2,4-D isooctyl esters are expected to bioaccumulate based on the estimated log
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
ow
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 6.6. EPA believes that there is sufficient evidence for listing 2,4-D 2-ethylhexyl ester on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data and the potential for bioaccumulation.

<!-- PJG 0012 frnewline -->
69. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D 2-ethyl-4-methylpentyl ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 053404-37-8) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D 2-ethyl-4-methylpentyl ester is a 2,4-dichlorophenoxy-type
herbicide. The 2-ethyl-4-methylpentyl ester moiety contains eight carbons and, therefore, is an isooctyl group.
Developmental toxicity following maternal exposure to 2,4-D isooctyl esters has been demonstrated in the rat and
mouse. Fetotoxicity occurred in offspring of rats exposed to 528 mg/kg during gestation days 8 through 11. Rats orally
exposed to doses as low as 302 mg/kg during gestation days 9 through 12 had musculoskeletal abnormalities. Exposure
to a lower dose (188 mg/kg) for a longer period during gestation (days 6 through 15) caused developmental effects on
homeostasis and effects on newborn growth statistics. In mice, 438 mg/kg administered orally during gestation days
8 through 12 also caused effects on newborn growth statistics. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing 2,4-D 2-ethyl-4-methylpentyl ester on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the developmental toxicity data for 2,4-D isooctyl esters, the
toxic effects of its metabolite 2,4-D. The aquatic acute toxicity data for 2,4-D isooctyl esters include a measured
48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 8.8 ppm for bluegill. In addition, 2,4-D isooctyl esters are expected to bioaccumulate based on the estimated log
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
ow
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 6.6. EPA believes that there is sufficient evidence for listing 2,4-D 2-ethyl-4-methylpentyl ester on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data and the potential
for bioaccumulation. 
<!-- PJG 0012 frnewline -->
70. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diazinon
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000333-41-5) (CERCLA; FIFRA SR) (Ref. 8). Diazinon, an organophosphate insecticide, causes plasma cholinesterase
inhibition and central nervous system depression. Significant inhibition of plasma cholinesterase was observed
in two men administered five doses of 0.025 mg/kg/day. Diazinon administered to men at doses of 0.05 mg/kg/day for
28 days caused a 35 to 40 percent reduction in plasma cholinesterase. A NOEL for cholinesterase inhibition of 0.02
mg/kg/day was identified from several controlled studies in humans. Clinical symptoms of diazinon poisoning include
headache, nausea, sweating, vomiting, and diarrhea all of which are indicative of neurotoxicity. Plasma cholinesterase
inhibition (93 percent) and red blood cell inhibition (90 percent) occurred in monkeys orally exposed to diazinon
in doses of 5 mg/kg/day for 52 weeks. The NOEL for inhibition of cholinesterase in this study was 0.05 mg/kg/day and
the LOEL was 0.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Urogenital defects in the offspring of female rats orally administered diazinon at doses of 26.4 mg/kg on days 12 to
15 of gestation has been reported. Diazinon also induced musculoskeletal abnormalities in offspring when administered
orally to mothers at doses of 45 mg/kg on days 8 to 12 of gestation. Post-implantation mortality was increased in female
rats administered 63.5 mg/kg on day 10 of gestation. Similar reproductive and developmental effects were observed
in mice. Oral administration of 3.96 mg/kg of diazinon (days 1 to 22 of gestation) caused decreased litter size and
delayed behavioral effects in the newborn. Doses of 0.210 mg/kg and 3.78 mg/kg administered orally on days 1 to 21 of
gestation caused abnormalities in the immune and reticuloendothelial system and biochemical and metabolic abnormalities
of the offspring, respectively. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing diazinon on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the developmental and chronic neurotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity data for diazinon include a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for rainbow trout of 90 ppb and a daphnid 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.90 ppb. In addition, measured terrestrial wildlife acute toxicity data for diazinon include an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for male mallard ducks of 3.54 mg/kg and an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for male pheasants of 4.33 mg/kg. EPA believes that there is sufficient evidence for listing diazinon on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
71. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,2-Dibromo-3-nitrilopropionamide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010222-01-2) (FIFRA AI) (Ref. 3). Oral administration of 50 mg/kg/day (LOEL) to rats for 4 weeks produced
dyspnea and weight loss. The NOEL was 25 mg/kg/day. Oral administration of 30 mg/kg/day to rats for 13 weeks produced
dyspnea. The NOEL was 13 mg/kg/day. These data may be indicative of direct effects of the compound on the respiratory
system. EPA believes that there is sufficient evidence for listing 2,2-dibromo-3-nitrilopropionamide on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available chronic respiratory data. 
<!-- PJG 0012 frnewline -->
72. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dicamba (3,6-Dichloro-2-methyoxybenzoic acid)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001918-00-9) (FIFRA AI) (Ref. 3). Decreased fetal body weights and increased post-implantation loss was
observed in the offspring of rabbits receiving 10 mg/kg/day of dicamba on days 6 through 18 of gestation. The LOEL was
10 mg/kg/day and NOEL was 3 mg/kg/day. Based on the NOEL, EPA derived an oral RfD value of 0.03 mg/kg/day. In a separate
study, disorders of oxidative phosphorylation and focal necrosis in the heart were observed in newborn rats following
transplacental exposure to dicamba. In a developmental toxicity study, an increase in skeletal malformations was
seen in the offspring of rats orally administered 64 mg/kg/day on days 6 through 19 of gestation. EPA believes that
there is sufficient evidence for listing dicamba on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based
on the available developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
73. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dichloran (2,6-Dichloro-4-nitroaniline)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000099-30-9) (FIFRA AI) (Ref. 3). Dichloran, an aniline, is a potential inducer of methemoglobinemia. Either
single or repeated oral doses of dichloran produced enlarged livers and induction of microsomal enzymes in the rat.
Dogs fed 21 mg/kg/day had increases in serum transaminases. In Rhesus monkeys, where dichloran does not induce hepatic
enzymes, 160 mg/kg/day for 3 months caused hepatic centrilobular fatty infiltration and death. Inhalation exposure
to 0.17 mg/L produced elevated cholesterol levels and increased liver weight in a 3&hyph;month rabbit study and increased
liver weight in a 21&hyph;day rat study. In a 2&hyph;year mouse study, dietary administration of 102.7 mg/kg/day
(LOEL) produced centrilobular hepatocyte enlargement, focal necrosis, acute inflammatory cell infiltration,
vacuolization of centrilobular hepatocytes, increased weight of the liver and increased incidence of erythropoiesis
in males. The NOEL was 30 mg/kg/day. EPA believes that there is sufficient evidence for listing dichloran on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatic toxicity data. 
<!-- PJG 0012 frnewline -->
74. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3,3'-Dichlorobenzidine dihydrochloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000612-83-9) (TSCA) (Ref. 8). IARC has classified 3,3'dichlorobenzidine (o-dichlorobenzidine) as a group
2B compound, i.e. this chemical is possibly carcinogenic in humans. IARC uses the generic name 3,3'-dichlorobenzidine
interchangeably with 3,3'-dichlorobenzidine dihydrochloride. The dihydrochloride salt of 3,3'-dichlorobenzidine
is expected to be equally as toxic as the free base (3,3'-dichlorobenzidine). EPA believes that there is sufficient
evidence for listing 3,3'-dichlorobenzidine dihydrochloride on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on its potential to cause cancer in humans. 
<!-- PJG 0012 frnewline -->
75. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3,3'-Dichlorobenzidine sulfate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 064969-34-2) (TSCA) (Ref. 8). IARC has classified 3,3'-dichlorobenzidine (o-dichlorobenzidine) as a
group 2B compound, i.e. this chemical is possibly carcinogenic in humans. The sulfate salt of 3,3'dichlorobenzidine
is expected to be equally as toxic as the free base (3,3'-dichlorobenzidine). EPA believes that there is sufficient
evidence for listing 3,3'-dichlorobenzidine sulfate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on its potential to cause cancer in humans. 
<!-- PJG 0012 frnewline -->
76. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
trans-1,4-Dichloro-2-butene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000110-57-6) (EPCRA EHS) (Ref. 8). Mortality in two of six rats was observed following inhalational exposure
to 62 ppm (0.34 mg/L) for 4 hours. An acute inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in rats was 86 ppm (0.44 mg/L). EPA's exposure analysis indicates that trans-1,4-dichloro-2-butene concentrations
are likely to exist beyond facility site boundaries, as a result of continuous, or frequently recurring releases,
at levels that can reasonably be anticipated to cause significant adverse acute human health effects. EPA believes
that there is sufficient evidence for listing trans-1,4-dichloro-2-butene on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(A) based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
77. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dichloromethylphenylsilane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000149-74-6) (EPCRA EHS) (Ref. 8). As a class, chlorinated silanes are very corrosive to the skin and mucous
membranes and liberate hydrochloric acid in the presence of water. The 2&hyph;hour mouse inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value for dichloromethylphenylsilane is 0.17 mg/L. EPA's exposure analysis indicates that dichloromethylphenylsilane
concentrations are likely to exist beyond facility site boundaries, as a result of continuous, or frequently recurring
releases, at levels that can reasonably be anticipated to cause significant adverse acute human health effects.
EPA believes that there is sufficient evidence for listing dichloromethylphenylsilane on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
78. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dichlorophene (2,2'-methylenebis(4-chlorophenol)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000097-23-4) (FIFRA AI) (Ref. 3). Increased incidence of microphthalmia was observed in the offspring of
rats administered 25 mg/kg/day (teratogenic LOEL). The NOEL was 5.0 mg/kg/day. A dose of 75 mg/kg/day (fetotoxic
LOEL) produced delayed ossification of vertebral centra and sternaebrae, reduced body weight and length, and increased
resorptions in rat fetuses. The fetotoxic NOEL was 5.0 mg/kg/day. No other developmental studies were available.
EPA believes that there is sufficient evidence for listing dichlorophene on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available developmental toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for dichlorophene include a measured 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 50 ppb for Spicodioptomus (calanoid copipod). EPA believes that there is sufficient evidence for listing dichlorophene
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data.

<!-- PJG 0012 frnewline -->
79. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
trans-1,3-Dichloropropene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010061-02-6) (CERCLA; CWA PPL) (Ref. 8). Clinical reports have documented the occurrence of histiocytic
lymphoma in two firemen and acute myelomonocytic leukemia in a farmer exposed accidently to 1,3-dichloropropene.
Information on the isomer or isomer mixture (i.e., trans/cis isomers) was not specified. The lymphoma and leukemia
were refractory to treatment, and all three men died. There is evidence that 1,3-dichloropropene may cause cancer
in rats and mice after oral exposure. In a 2&hyph;year gavage study, rats treated with 25 or 50 mg/kg/day 1,3-dichloropropene
(53 percent cis isomer, 45 percent trans isomer, 1 percent epichlorhydrin) developed squamous cell papillomas and
carcinomas of the forestomach. Male rats also developed neoplastic nodules of the liver. Female mice that received
50 or 100 mg/kg/day developed squamous cell papillomas and carcinomas of the forestomach, transitional cell carcinomas
of the urinary bladder, and an increased incidence of alveolar/bronchiolar adenomas. A statistically significant
increase in bronchioalveolar adenomas was noted in male mice exposed to 60 ppm (272 mg/L) 1,3-dichloropropene vapors
(50 percent cis isomer, 43 percent trans isomer). This benign lung tumor was not seen in female mice or in male or female
rats. IARC assigned 1,3-dichloropropene to Group 2B, i.e., possibly carcinogenic in humans. EPA believes that there
is sufficient evidence for listing trans-1,3-dichloropropene on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available carcinogenicity data for 1,3-dichloropropene (unspecified isomer). 
<!-- PJG 0012 frnewline -->
80. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diclofop methyl (2-[4-(2,4-dichlorophenoxy) phenoxy]propanoic acid, methyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 051338-27-3) (FIFRA AI) (Ref. 3). In a rat teratology study, increased resorptions, reduced body weights,
and dilation of the renal pelvis or distension of the ureter in offspring were reported in rats fed 1.6 mg/kg/day (LOEL).
The NOEL was 0.5 mg/kg/day. Increased pup mortality was observed at 5 mg/kg/day (LOEL) in a 3-generation rat reproduction
study. The NOEL was 1.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a 30&hyph;day rat feeding study, increased relative heart, liver, and kidney weights were observed at the LOEL
of 4 mg/kg/day. No NOEL was established. Jaundice, increased bilirubin, increased serum glutamic-pyruvic transaminase
and serum glutamic-oxaloacetic transaminase, and increased liver and kidney weights were observed in a 30&hyph;day
dog feeding study at 50 mg/kg/day. The NOEL was 12.5 mg/kg/day. In a 90&hyph;day rat feeding study, elevated liver
weights and centrilobular enlargement of hepatic cells were observed at 4 mg/kg/day. The NOEL was 1.6 mg/kg/day.
Dogs fed 6.25 mg/kg/day for 90 days had increased lipid content and focal changes in the renal cortex. The NOEL was 2
mg/kg/day. EPA believes that there is sufficient evidence for listing diclofop methyl on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available developmental, hepatic, and renal toxicity data. 
<!-- PJG 0012 frnewline -->
81. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dicyclopentadiene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000077-73-6) (TSCA) (Ref. 8). Convulsions were reported in rats or mice following inhalation of dicyclopentadiene
at dosage levels of 332 or 145 ppm (1.8 or 0.78 mg/L), respectively, for 1 or 2 days. The reported acute oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in rats is 353 mg/kg. Animals at this dose level had convulsions and muscle weakness. In a 90&hyph;day inhalation study
in dogs, neurotoxic symptoms observed included diarrhea, excessive salivation and lack of control of hind quarters.
The NOAEL in this study was 8.9 ppm (0.048 mg/L); no LOEL was reported. EPA believes that there is sufficient evidence
for listing dicyclopentadiene on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the chronic neurotoxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
82. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diethatyl ethyl
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 038727-55-8) (FIFRA AI) (Ref. 3). In a 2&hyph;year study, groups of six beagles/sex were given doses orally
from 0 to 31.25 mg/kg/day. The lowest dose (0.25 mg/kg/day) produced a positive Coombs test. EPA believes that there
is sufficient evidence for listing diethatyl ethyl on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based
on the available hematological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
83. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diflubenzuron
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 035367-38-5) (FIFRA SR) (Ref. 8). In a 2&hyph;year study in which beagle dogs received diflubenzuron daily
in gelatin capsules, the LOAEL for increases in sulfhemoglobin and methemoglobin was 10 mg/kg/day and the NOAEL was
2 mg/kg/day. EPA has derived an oral RfD of 0.02 mg/kg/day for this chemical from this study. Similar effects were noted
in two separate 2&hyph;year rat feeding studies (the LOAEL was 7.8 to 8 mg/kg/day; the NOAEL was 2 mg/kg/day), and in
a lifetime oral study in mice (the LOAEL was 12 mg/kg/day; the NOAEL was 2.4 mg/kg/day). EPA believes that there is sufficient
evidence for listing diflubenzuron on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
hematological toxicity data. Measured aquatic acute toxicity data for diflubenzuron include a 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.55 ppb for daphnids. EPA believes that there is sufficient evidence for listing diflubenzuron on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
84. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diglycidyl resorcinol ether
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000101-90-6) (IARC; NTP) (Ref. 8). Diglycidyl resorcinol ether is classified by IARC as a Group 2B compound,
i.e., it is possibly carcinogenic in humans. In an NTP bioassay, rats orally administered 12 mg/kg of diglycidyl resorcinol
ether 5 days a week for 103 weeks developed squamous cell papillomas and squamous cell carcinomas of the stomach. Mice
orally administered 50 mg/kg 5 days a week for 103 weeks developed squamous cell carcinomas and squamous cell papillomas
of the stomach. Mice orally administered 70.5 mg/kg/day of diglycidyl resorcinol ether for 2 years developed blood
lymphomas and Hodgkin's disease. Mice receiving dermal applications of diglycidyl resorcinol ether for 1&hyph;year
developed skin tumors. EPA believes that there is sufficient evidence for listing diglycidyl resorcinol ether on
EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
85. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dimethipin (2,3,-Dihydro-5,6-dimethyl-1,4-dithiin 1,1,4,4-tetraoxide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 055290-64-7) (FIFRA AI) (Ref. 3). In a 1&hyph;year dog feeding study, decreased erythrocyte, hemoglobin,
and hematocrit levels as well as increased platelet levels were observed at 75 mg/kg/day. The LOEL for systemic toxicity
based on decreased body weight was 7.5 mg/kg/day. No NOEL could be established. In a 2&hyph;year rat feeding study,
increased absolute and relative liver weights were observed at 10 mg/kg/day (LOEL). The NOEL was 2 mg/kg/day. Based
on the NOEL in the study, EPA established an oral RfD of 0.02 mg/kg/day. EPA believes that there is sufficient evidence
for listing dimethipin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hematological
and hepatic toxicity data. 
<!-- PJG 0012 frnewline -->
86. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dimethoate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000060-51-5) (CERCLA; EPCRA EHS; FIFRA SR; RCRA APP8; RCRA P) (Ref. 8). Dimethoate is an organophosphate
insecticide. In humans, dimethoate causes typical symptoms of cholinesterase inhibition (sweating, diarrhea,
salivation, headache, difficulty in breathing, etc.). In a controlled human study, subjects were administered
dimethoate for 57 days. Whole blood and erythrocyte cholinesterase inhibition was observed from day 20 on. The NOEL
was 0.202 mg/kg/day, and the LOEL was 0.434 mg/kg/day. In another study in which humans were administered dimethoate
for 57 days, the NOEL for cholinesterase inhibition was 15 mg/day (0.2 mg/kg based on a 70 kg person). The LOEL was not
specified. Cholinergic symptoms reflective of cholinesterase inhibition following dimethoate administration
have also been observed in laboratory animals. A 2&hyph;year feeding study in rats determined the NOEL and LOEL for
plasma and brain cholinesterase inhibition to be 0.05 and 0.5 mg/kg/day, respectively. 
<!-- PJG 0012 frnewline -->
Dimethoate was tested for developmental effects in Wistar rats. Cygon 4E (47.3 percent dimethoate, 52.7 percent
unspecified constituents) was administered to pregnant females on days 6 to 15 of gestation. The NOEL for developmental
effects was 6 mg/kg/day. At a LOEL of 12 mg/kg/day, an increase in the incidence of wavy ribs was observed in the fetuses.
An increase in offspring mortality occurred in a five-generation chronic feeding study (actual doses were 9.5 to
10.5 mg/kg/day) in male and female CD-1 mice. At 12 mg/kg/day (120 mg/kg, gestation days 6 to 15), musculoskeletal
abnormalities were observed in the rat offspring. EPA believes that there is sufficient evidence for listing dimethoate
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental and neurotoxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
87. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3,3'-Dimethoxybenzidine dihydrochloride (o-Dianisidine dihydrochloride)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 020325-40-0) (TSCA) (Ref. 8). IARC has classified 3,3'-dimethoxybenzidine (o-dianisidine) as a Group
2B compound, i.e., this chemical is possibly carcinogenic. In an NTP carcinogenicity bioassay, increases in neoplasms
of the skin, oral cavity, large intestine, liver, uterus, and cervix were noted in rats administered this chemical
in drinking water at dose levels of 6, 12, or 21 mg/kg/day in males and 7, 14, or 23 mg/kg/day in females. The dihydrochloride
salt of o-dianisidine is expected to be equally as toxic as the free base (o-dianisidine). EPA believes that there
is sufficient evidence for listing 3,3'-dimethoxybenzidine dihydrochloride on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on its potential to cause cancer in humans. 
<!-- PJG 0012 frnewline -->
88. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3,3'-Dimethoxybenzidine hydrochloride (o-Dianisidine hydrochloride)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 111984-09-9) (TSCA) (Ref. 8). IARC has classified 3,3'-dimethoxybenzidine (o-dianisidine) as a Group
2B compound, i.e., this chemical is possibly carcinogenic. In an NTP carcinogenicity bioassay, increases in neoplasms
of the skin, oral cavity, large intestine, liver, uterus and cervix were noted in rats administered this chemical
in drinking water at dose levels of 6, 12, or 21 mg/kg/day in males and 7, 14, or 23 mg/kg/day in females. The hydrochloride
salt of o-dianisidine is expected to be equally as toxic as the free base (o-dianisidine). EPA believes that there
is sufficient evidence for listing 3,3'dimethoxybenzidine hydrochloride on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on its potential to cause cancer in humans. 
<!-- PJG 0012 frnewline -->
89. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dimethylamine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000124-40-3) (TSCA) (Ref. 8). Dimethylamine is corrosive to the mucous membranes, respiratory tract and
eyes of treated animals. B6C3F1 mice and F344 rats exposed to 10 to 175 ppm (0.018 to 0.32 mg/L) dimethylamine via inhalation
for 6 to 12 months developed dose-related lesions in the respiratory and olfactory epithelium. Significant decreases
in body weight occurred in high-dose (175 ppm; 0.32 mg/L) animals of both species, and some of the high-dose mice died
following exposure. Centrilobular fatty degeneration and necrosis of parenchymal cells were reported in mice,
rats, rabbits or guinea pigs administered 97 or 183 ppm (0.18 or 0.34 mg/L) dimethylamine via inhalation for 18 to 20
weeks. Increased liver weight without any histopathological changes were reported following 8&hyph;month oral
exposure of rats to 0.35 mg/kg/day and guinea pigs exposed to 3.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Rats administered oral doses of dimethylamine as low as 0.035 mg/kg for 8 months exhibited changes in conditional
reflexes including marked attenuation of the excitation process and speedier extinction of the positive reflex.
EPA believes that there is sufficient evidence for listing dimethylamine on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the chronic respiratory, hepatic, and neurological toxicity of this chemical. 
<!-- PJG 0012 frnewline -->
90. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dimethylamine dicamba
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002300-66-5) (FIFRA AI) (Ref. 3). In a pilot rabbit developmental toxicity study, an increase in early and
late fetal resorptions was observed in animals receiving the LOEL of 1.0 mg/kg/day. The NOEL was 0.5 mg/kg/day (oral
doses, days 6 to 18 of gestation). In another study, increased post-implantation loss was observed in rabbits receiving
the LOEL of 10 mg/kg/day (oral doses, days 6 to 18 of gestation). Developmental toxicity was also observed at doses
of 10 mg/kg/day in studies with dicamba. EPA believes that there is sufficient evidence for listing dimethylamine
dicamba on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
91. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3,3'-Dimethylbenzidine dihydrochloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (o-Tolidine dihydrochloride) (CAS No. 000612-82-8) (TSCA) (Ref. 8). In a bioassay conducted by NTP, 3,3'-dimethylbenzidine
dihydrochloride was found to be carcinogenic in both mice and rats. Male and female mice exposed to concentrations
of 5 to 140 ppm (0.95 to 26.6 mg/kg/day) in drinking water for 112 weeks developed lung alveolar cell adenoma and adenocarcinoma.
Male and female F344 rats exposed to concentrations of 30 to 150 ppm (4.2 to 21 mg/kg/day) in drinking water for 60 to
61 weeks developed tumors in the gastrointestinal tract, liver, lung and oral cavity. Tumors in the skin, Zymbal's
gland, preputial gland in males, clitoral gland and mammary gland in females, and leukemia in females were also noted
in this study. EPA believes that there is sufficient evidence for listing 3,3'-dimethylbenzidine dihydrochloride
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on its potential to cause cancer in humans. 
<!-- PJG 0012 frnewline -->
92. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3,3'-Dimethylbenzidine dihydrofluoride (o-Tolidine dihydrofluoride)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 041766-75-0) (TSCA) (Ref. 8). Neither IARC or EPA has classified 3,3'-dimethylbenzidine dihydrofluoride
with respect to carcinogenicity. In a bioassay conducted by NTP, however, 3,3'-dimethylbenzidine dihydrochloride
was found to be carcinogenic in both mice and rats. Male and female mice exposed to concentrations of 5 to 140 ppm (0.952
to 6.6 mg/kg/day) in drinking water for 112 weeks developed lung alveolar cell adenoma and adenocarcinoma. Male and
female F344 rats exposed to concentrations of 30 to 150 ppm (4.2 to 21 mg/kg/day) in drinking water for 60 to 61 weeks
developed tumors in the gastrointestinal tract, liver, lung, and oral cavity. Tumors in the skin, Zymbal's gland,
preputial gland in males, clitoral gland and mammary gland in females, and leukemia in females were also noted in this
study. EPA believes that there is sufficient evidence for listing 3,3'-dimethylbenzidine dihydrofluoride on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on its potential to cause cancer in humans and on the carcinogenicity
data for 3,3'-dimethylbenzidine dihydrochloride. 93. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dimethyl chlorothiophosphate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS. No. 002524-03-0) (EPCRA EHS) (Ref. 8). In a dominant lethal study, male rats were administered dimethyl chlorothiophosphate
by gavage for 5 consecutive days and mated to untreated females. The LOEL of 7.5 mg/kg/day was determined based on an
increase in preimplantation losses and dead implants. No NOEL for dimethyl chlorothiophosphate was determined
from this study. EPA believes that there is sufficient evidence for listing dimethyl chlorothiophosphate on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
94. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dimethyldichlorosilane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000075-78-5) (CERCLA; EPCRA EHS) (Ref. 8). As a class, however, chlorinated silanes are very corrosive to
the skin and mucous membranes and liberate hydrochloric acid in the presence of water. Dimethyldichlorosilane causes
severe burns and the vapor is harmful to humans. The 2&hyph;hour mouse inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value is 0.30 mg/L. EPA's exposure analysis indicates that dimethyldichlorosilane concentrations are likely to
exist beyond facility site boundaries, as a result of continuous, or frequently recurring releases, at levels that
can reasonably be anticipated to cause significant adverse acute human health effects. EPA believes that there is
sufficient evidence for listing dimethyldichlorosilane on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A)
based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
95. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
N,N-Dimethylformamide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000068-12-2) (CAA HAP) (Ref. 7). In humans, N,N-dimethylformamide (DMF) produced an increase in subjective
symptoms suggestive of mild liver dysfunction in workers and changes in objective measurements of liver damage (serum
enzymes and liver enlargement) via inhalation exposure, resulting in a LOAEL of 22 mg/m3 (adjusted LOAEL of 7.9 mg/m3)).
Although there are several additional studies which are generally inadequate when considered individually, taken
together, these studies demonstrate that DMF exposure is associated with hepatic toxicity in humans. Several animal
inhalation studies further support the hepatotoxic effects of DMF. EPA believes that there is sufficient evidence
for listing N,N-dimethylformamide on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based upon the available
hepatotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
96. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,6-Dimethylphenol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (000576-26-1) (TSCA) (Ref. 8). Oral administration of 2,6-dimethylphenol to rats for 8 months produced histologic
lesions (the LOEL was 6.0 mg/kg/day; the NOEL was 0.6 mg/kg/day) in the liver, kidneys, and spleen. Another supporting
oral study in rats that also reported histological lesions in the liver and kidneys (the LOEL was 6.0 mg/kg/day; the
NOEL was 0.06 mg/kg/day) of rats following subchronic oral administration of 2,6-dimethylphenol. EPA believes
that there is sufficient evidence for listing 2,6-dimethylphenol on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the hepatotoxicity and nephrotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
97. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dinocap
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 039300-45-3) (CAL; FIFRA SR) (Ref. 8). Dinocap is a dinitrophenyl-type fungicide. In mice, oral administration
of 25 mg/kg/day of dinocap on days 7 to 16 of gestation has been shown to increase post-implantation mortality and reduce
newborn viability. Oral administration of 5.0 mg/kg/day to pregnant mice produced developmental toxicity in the
offspring (administration of 10 mg/kg/day resulted in abnormalities of the musculoskeletal and hepatobiliary
system in the offspring). In the same study, oral administration of 20 mg/kg/day on days 7 to 16 of gestation produced
craniofacial abnormalities in offspring. In the same study, behavioral abnormalities and delayed growth were observed
in offspring of mice receiving 12 mg/kg/day on days 7 to 16 of gestation. EPA believes that there is sufficient evidence
for listing dinocap on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the developmental toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity data for dinocap indicate that the LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for rainbow trout is 15 ppb and the LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for bluegill is 20 ppb. EPA believes that there is sufficient evidence for listing dinocap on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
98. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dinoseb
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000088-85-7) (CAL; EPCRA EHS; FIFRA SR; RCRA APP8; RCRA P; SDWA) (Ref. 8). Dinoseb is a dinitrophenyl-type
herbicide and insecticide. In a three generation reproduction study dinoseb produced decreased pup weights (the
LOEL was 1 mg/kg/day; the NOEL was not determined) in the F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
1b
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2a
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3a
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 pups. The F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
1b
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 pup weights diminished (combined sexes) by day 21 at dose levels greater than 1 mg/kg/day. Other studies have shown
biologically and statistically significant increases in developmental malformations and/or anomalies (the LOEL
was 10 mg/kg/day; the NOEL was 3 mg/kg/day), and an increased incidence of an absence of ossification for a number of
skeletal sites and supernumerary ribs (the LOEL was not specified; the NOEL was 3 mg/kg/day). Dinoseb administered
by gavage to rabbits from days 6 to 18 of gestation produced neural tube defects (the LOEL was 10 mg/kg/day; the NOEL
was 3 mg/kg/day). 
<!-- PJG 0012 frnewline -->
The fertility index in male rats was reduced in a reproductive study in animals fed dinoseb at dose levels of 15.6 mg/kg/day
or 22.2 mg/kg/day over an 11&hyph;week period. Decreased seminal vesicle weight, decreased sperm count and increased
incidence of abnormal sperm were noted at dose levels of 9.1 mg/kg/day and higher. The NOEL was 3.8 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing dinoseb on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the developmental and reproductive toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity data for dinoseb include a measured fat-head minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 88 ppb. EPA believes that there is sufficient evidence for listing dinoseb on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
99. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diphenamid
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000957-51-7) (FIFRA SR) (Ref. 8). Diphenamid is a diphenylacetamide-type herbicide. In a 2&hyph;year study
in dogs fed diphenamid, an increase in liver weight and an increase in portal macrophages and fibroblasts were seen
at the LOEL of 10 mg/kg/day. The NOEL was 3 mg/kg/day. Based on the NOEL, an RfD of 0.03 mg/kg/day was derived. In a 2&hyph;year
study in rats fed diphenamid, an increase in liver weight was seen at the LOEL of 30 mg/kg/day; the NOEL was 10 mg/kg/day.
Although, no histopathological changes were reported in these studies, biochemical changes accompanied by histo-pathological
changes were observed in a 2&hyph;generation study in rat pups. EPA believes that there is sufficient evidence for
listing diphenamid on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatotoxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
100. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diphenylamine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000122-39-4) (RCRA APP8) (Ref. 8). Increased liver and kidney weights were noted in dogs that received 25
mg/kg/day (the LOAEL) of diphenylamine in their feed for 2 years. The NOAEL in this study was 2.5 mg/kg/day and the oral
RfD was 0.025 mg/kg/day. Pronounced anemia and decreased body weight gain were also noted in these animals. The hepatotoxicity
induced by diphenylamine is manifested by peripherolobular fat changes and increased lipids. Vacuolar degeneration
and hepatocyte necrosis were reported in rats or guinea pigs that received 2 or 4 percent (i.e., 1,000 or 2,000 mg/kg/day
for rats and 800 to 1,600 mg/kg/day for guinea pigs) of diphenylamine in the diet for 6 months. In another 2&hyph;year
rat study, changes reported in the kidney in diphenylamine-fed animals included epithelial necrosis in the proximal
tubule, cystic dilatation of tubules, and interstitial inflammation. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing diphenylamine on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the chronic hepatic and renal toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
101. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dipotassium endothall (7-oxabicyclo(2.2.1)heptane-2,3-dicarboxylic acid, dipotassium salt)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002164-07-0) (FIFRA AI) (Ref. 3). In a 2&hyph;year dog feeding study, increased absolute and relative weight
of the stomach and small intestine was observed at 6 mg/kg/day (LOEL). The NOEL was 2 mg/kg/day. An oral RfD of 0.02 mg/kg/day
was derived based on the NOEL. EPA believes that there is sufficient evidence for listing dipossium endothall on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available chronic toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
102. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dipropyl isocinchomeronate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000136-45-8) (FIFRA AI) (Ref. 3). Dipropyl isocinchomeronate has been classified by EPA as a Group B2 compound,
i.e., a probable human carcinogen. This classification is based on the findings of multiple malignant and benign
tumors in the rat (liver adenomas and carcinomas in both sexes, kidney carcinomas in both sexes, benign testes tumors
in males and uterine tumors in females), and multiple malignant tumors in the mouse (liver adenomas and carcinomas
in both sexes and lung/bronchiolar adenomas and carcinomas in males). EPA believes that there is sufficient evidence
for listing dipropyl isocinchomeronate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available carcinogenicity toxicity data. 
<!-- PJG 0012 frnewline -->
103. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Disodium cyanodithioimidocarbonate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000138-93-2) (FIFRA AI) (Ref. 3). Rats administered disodium cyanodithioimidocarbonate by gavage on gestation
days 6 to 15 demonstrated increased skeletal variations in offspring. The NOEL is 6 mg/kg, and the LOEL is 18 mg/kg.
In a rabbit teratology study, increased resorptions were observed in rabbits administered the compound by gavage
on gestation days 6 to 18. The NOEL is 3 mg/kg, and the LOEL is 10 mg/kg. EPA believes that there is sufficient evidence
for listing disodium cyanodithioimidocarbonate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based
on the available developmental toxicity data. 
<!-- PJG 0012 frnewline -->
104. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D isopropyl ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000094-11-1) (CERCLA; FIFRA AI: IARC) (Ref. 8). 2,4-D isopropyl ester is a 2,4-dichlorophenoxy-type herbicide.
In mammals, the isopropyl ester of 2,4-D is hydrolyzed to yield the free acid, 2,4-D. Therefore, the toxicity of 2,4-D
isopropyl ester is expected to be similar to that of 2,4-D, in which the kidney, liver, and nervous system are the primary
targets of injury. 2,4-D is presently included in the EPCRA section 313 list of toxic chemicals. EPA believes that
there is sufficient evidence for listing 2,4-D isopropyl ester on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the known toxic effects of its metabolite 2,4-D. 
<!-- PJG 0012 frnewline -->
105. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-Dithiobiuret
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000541-53-7) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). In experimental animals, 2,4-dithiobiuret
is a highly toxic substance that causes death through respiratory depression and respiratory failure. Rats receiving
1 mg/kg/day for 6 days suffered from delayed onset of neuromuscular depression. Rats given 2,4-dithiobiuret for
52 days showed signs of muscle weakness after a latency period of 3 to 4 days. The NOEL was determined to be 0.125 mg/kg/day.
The LOEL was 0.25 mg/kg/day. The cause of the muscle weakness was depressed neuromuscular transmission. EPA believes
that there is sufficient evidence for listing 2,4-dithiobiuret on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the chronic neurotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
106. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dithiopyr (2-(difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-3,5-pyridinedicarbothioic acid
S,S-dimethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 097886-45-8) (FIFRA AI) (Ref. 3). In a 2-generation rat reproduction study, decreased body weight, diffuse
hepatocellular swelling, and ``white spots'' on the livers were observed in the offspring of rats administered greater
than or equal to 16.4 mg/kg/day. The NOEL values were 1.7 mg/kg/day. In a 13&hyph;week rat feeding study, the LOEL of
6.62 mg/kg/day produced diffuse hepatocellular swelling. The NOEL was 0.662 mg/kg/day. In a 13-week dog feeding
study, increased alkaline phosphatase, discolored livers, and cholestasis was observed at 10 mg/kg/day (LOEL).
The NOEL was 1 mg/kg/day. In addition, at 30 mg/kg/day, increased serum glutamic-pyruvic transaminase and serum
glutamic oxaloacetic transaminase, increased liver and kidney weights, and decreased cholesterol and albumin
were observed. EPA believes that there is sufficient evidence for listing dithiopyr on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available hepatic and renal toxicity data. 
<!-- PJG 0012 frnewline -->
107. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Diuron
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000330-54-1) (CERCLA) (Ref. 8). In a 2&hyph;year study in dogs administered diuron, sulfhemoglobin (an
abnormal blood pigment) was detected following doses as low as 3.125 mg/kg/day (LOAEL). The NOAEL was 0.625 mg/kg/day.
Higher doses (6.25 and 31.25 mg/kg/day) caused decreased red blood cell, hemoglobin, and hematocrit values. The
highest dose tested (31.25 mg/kg/day) also caused an increase in erythrogenic activity in the bone marrow, hemosiderosis
in the spleen, increased liver weight, and body weight loss. EPA has derived an oral RfD of 0.002 mg/kg/day for this
chemical from this study. Similar effects (anemia, increased erythrogenic activity in the bone marrow, and abnormal
pigments in the blood) were also observed in rats exposed orally to doses as low as 6.25 mg/kg/day for 2 years, or to 250
mg/kg/day for 90 days. In a 7&hyph;week study, rats receiving diuron doses of greater than or equal to 10 mg/kg/day
had decreased red blood cells and significantly increased methemoglobinemia. 
<!-- PJG 0012 frnewline -->
Offspring of Wistar rats fed diuron during days 6 to 15 of gestation showed developmental toxicity, that included
malformed ribs, extra ribs, and delayed ossification. The developmental LOAEL in this study was 100 mg/kg/day. No
NOAEL was determined. Maternal and fetal body weights decreased at 400 mg/kg/day. In a three-generation reproduction
study in rats fed diuron at 6.25 mg/kg/day, decreased body weights were reported in the F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2b
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3a
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 litters. EPA believes that there is sufficient evidence for listing diuron on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available hematological and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
The measured aquatic toxicity data for diuron includes a 1.5&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.010 ppm (10 ppb) for marine green algae. EPA believes that there is sufficient evidence for listing diuron on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
108. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D 2-octyl ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001917-97-1) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D 2-octyl ester is a 2,4-dichlorophenoxy-type herbicide.
The 2-octyl moiety contains eight carbons and, therefore, is an isooctyl group. Developmental toxicity following
maternal exposure to 2,4-D isooctyl esters has been demonstrated in the rat and mouse. Fetotoxicity occurred in offspring
of rats exposed to 528 mg/kg during gestation days 8 to 11. Rats orally exposed to doses as low as 302 mg/kg during gestation
days 9 through 12 had musculoskeletal abnormalities. Exposure to a lower dose (188 mg/kg) for a longer period during
gestation (days 6 through 15) caused developmental effects on homeostasis and effects on newborn growth statistics.
In mice, 438 mg/kg administered orally during gestation days 8 through 12 also caused effects on newborn growth statistics.

<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing 2,4-D 2-octyl ester on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the developmental toxicity data for 2,4-D isooctyl esters, and the toxic effects of
its metabolite 2,4-D. 
<!-- PJG 0012 frnewline -->
The aquatic acute toxicity data for 2,4-D isooctyl esters include a measured 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 8.8 ppm for bluegill. In addition, 2,4-D isooctyl esters are expected to bioaccumulate based on the estimated log
K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
ow
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 6.6. EPA believes that there is sufficient evidence for listing 2,4-D isooctyl esters on EPCRA section 313 pursuant
to section EPCRA 313(d)(2)(C) based on the available environmental toxicity data and the potential for bioaccumulation.

<!-- PJG 0012 frnewline -->
109. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dodine (dodecylguanidine monoacetate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002439-10-3) (FIFRA AI) (Ref. 3). Aquatic acute toxicity values for dodine include a daphnid 48&hyph;hour
EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 17.8 ppb. EPA believes that there is sufficient evidence for listing dodine on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
110. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-DP (dichlorprop)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000120-36-5) (FIFRA SR; IARC) (Ref. 8). 2,4-DP (2-(2,4-dichlorophenoxy)propionic acid) is a 2,4-dichlorophenoxy-type
herbicide. Developmental toxicity has been reported in rats and mice administered oral doses of 2,4-DP as low as 20
mg/kg during gestation days 4 through 18. Behavioral changes and physical effects were observed in newborn rats,
while increased post-implantation loss was observed in the mothers. Exposure of mice to much higher doses (3,000
and 4,000 mg/kg) for shorter durations (i.e., gestation days 6 through 15) caused musculoskeletal abnormalities
and fetotoxicity. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing 2,4-DP on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
111. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D propylene glycol butyl ether ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001320-18-9) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D propylene glycol butyl ether ester is a 2,4-dichlorophenoxy-type
herbicide. In mammals, the propylene glycol butyl ether ester is expected to hydrolyze to yield the free acid, 2,4-D.
Therefore, the toxicity of 2,4-D propylene glycol butyl ether ester is expected to be similar to that of 2,4-D, in which
the kidney, liver, and nervous system are the primary targets of injury. EPA believes that there is sufficient evidence
for listing 2,4-D propylene glycol butyl ether ester on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the chronic toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
112. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,4-D sodium salt
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002702-72-9) (CERCLA; FIFRA AI; IARC) (Ref. 8). 2,4-D sodium salt is a 2,4-dichlorophenoxy-type herbicide.
In mammals, the sodium salt is expected to hydrolyze to yield the free acid, 2,4-D. Therefore, the toxicity of 2,4-D
sodium salt is expected to be similar to that of 2,4-D, in which the kidney, liver, and nervous system are the primary
targets of injury. 2,4-D is presently included in the EPCRA section 313 list of toxic chemicals. EPA believes that
there is sufficient evidence for listing 2,4-D sodium salt ester on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the systemic toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
113. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ethoprop (phosphorodithioic acid O-ethyl S,S-dipropyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 013194-48-4) (FIFRA AI) (Ref. 3). Ethoprop is acutely toxic to animals. The acute oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in rats is 5.62 mg/kg/day. Clinical signs of toxicity observed in animals at this dose level included depression,
salivation, inactivity, convulsions and prostration. Similar signs were reported at the 4&hyph;hour inhalation
LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.12 mg/L in rats. In a 2&hyph;year rat chronic feeding study, plasma, red blood cell, and brain cholinesterase
inhibition were observed in both sexes at 0.5 mg/kg/day. The NOEL was 0.05 mg/kg/day. Similar results were reported
in a chronic dietary study in mice at 0.1 mg/kg/day. The NOEL was 0.01 mg/kg/day. The two chronic studies together with
the results of acute studies indicate the potential neurotoxicity of ethoprop. EPA believes that there is sufficient
evidence for listing ethoprop on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
neurological toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for ethoprop include a mysid 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 7.5 ppb, a shrimp 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 13 ppb, and a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 93 ppb. Avian acute and dietary toxicity data include a ring-necked pheasant 14&hyph;day LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.2 mg/kg and a mallard duck 14&hyph;day LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 12.6 mg/kg. EPA believes that there is sufficient evidence for listing ethoprop on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
114. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ethyl dipropylthiocarbamate (EPTC)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000759-94-4) (FIFRA AI) (Ref. 3). EPTC is a cholinesterase inhibitor. Workers exposed to EPTC complained
of headache, malaise, nausea, and impaired working ability. Poisoned animals exhibited salivation, lacrimation,
blepharospasm, and depression. Neuropathy was observed in rats orally administered 25 mg/kg/day for 2 years. The
LOEL was 25 mg/kg/day and the NOEL was 5 mg/kg/day. Decreased brain cholinesterase activity was observed in female
rats orally administered 15 mg/kg/day (LOEL). The NOEL was 3 mg/kg/day. The 4-hour inhalation rat and cat lowest-lethal-concentration
values are 0.2 mg/L and 0.4 mg/L, respectively. Somnolence and salivation were observed in exposed animals. The dermal
rabbit LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is 10,000 mg/kg. Depressed righting reflexes, prostration, and clonic convulsions were observed. 
<!-- PJG 0012 frnewline -->
In a 2&hyph;year dietary rat study, degenerative cardiomyopathy was observed in males receiving 9 mg/kg/day of EPTC.
No NOEL was established. This effect was observed in females at 36 mg/kg/day. The NOEL was 18 mg/kg/day. In a 2-generation
rat reproduction study, parental toxicity included cardiomyopathy observed in rats orally administered 10 mg/kg/day.
Based on the NOEL of 2.5 mg/kg/day, EPA derived an oral RfD of 0.025 mg/kg/day. In a 2&hyph;year dietary rat study, chronic
myocarditis was observed at the LOEL of 125 mg/kg/day. The NOEL was 25 mg/kg/day. 
<!-- PJG 0012 frnewline -->
An increased incidence of fetal resorptions, increased incidence of fetal retardations, and decreased fetal body
weights were observed in rats receiving 300 mg/kg/day of EPTC on days 6 to 15 of gestation. The LOEL was 300 mg/kg/day
and the NOEL was 100 mg/kg/day. The NOEL was 10 mg/kg/day. In a 2-generation rat reproduction study, decreased pup
weight was observed in both generations at 40 mg/kg/day. The NOEL was 10 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing EPTC on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available neurological, cardiovascular, and reproductive toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
115. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Famphur
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000052-85-7) (CERCLA; FIFRA AI; RCRA APP8; RCRA P) (Ref. 8). Famphur is a thiophosphate-type cholinesterase
inhibitor. In a 90&hyph;day feeding study, rats given diets supplemented with famphur showed decreased plasma and
brain cholinesterase activity at 1.25 mg/kg/day, and decreased whole blood cholinesterase activity at 0.15 mg/kg/day.
A bull was treated with famphur for 43 days before signs of neurotoxicity appeared. The symptoms, including paresis
of all four limbs, were attributed to focal cervical or diffuse spinal cord lesions. Calves receiving 60.75 mg/kg
showed marked inhibition of whole blood cholinesterase. EPA believes that there is sufficient evidence for listing
famphur on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the chronic neurotoxicity known for
this chemical. 
<!-- PJG 0012 frnewline -->
Measured terrestrial wildlife acute toxicity data for famphur indicate that the oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values for the redwinged blackbird and the starling are 1.78 mg/kg and 4.22 mg/kg, respectively. In addition, the
measured oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for mallard ducks is 3.45 mg/kg (based on 35 percent active ingredient). EPA believes that there is sufficient evidence
for listing famphur on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
116. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fenarimol (.alpha.-(2-chlorophenyl)-.alpha.-4-chlorophenyl)-5-pyrimidinemethanol)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 060168-88-9) (FIFRA AI) (Ref. 3). In a 3&hyph;month mouse feeding study, liver weights were increased in
males at levels greater than or equal to 620 ppm (80.6 mg/kg/day) and in females at levels greater than 1,100 ppm (143
mg/kg/day). At higher doses (143 to 260 mg/kg/day), decreased total bilirubin, hepatomegaly, and/or periportal
fatty liver changes were observed. Mice exposed to dietary levels of 78 mg/kg/day for 1&hyph;year had increased liver
weight and slight fatty changes. One year feeding studies in Wistar rats also resulted in increased liver weights
(the LOEL was 17.5 mg/kg/day; the NOEL was 6.5 mg/kg/day). In a 2&hyph;year feeding study with Wistar rats, fatty changes
in the liver were observed at 17.5 mg/kg/day (LOEL). The NOEL was 6.5 mg/kg/day. A 2&hyph;year feeding study in mice
resulted in fatty liver changes. The LOEL was 78 mg/kg/day and the NOEL was 22.1 mg/kg/day. EPA believes that there
is sufficient evidence for listing fenarimol on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on
the available hepatic toxicity data. 
<!-- PJG 0012 frnewline -->
117. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fenbutatin oxide (hexakis(2-methyl-2-phenylpropyl)distannoxane)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 013356-08-6) (FIFRA AI) (Ref. 3). In a rat teratology study, the LOEL for developmental toxicity (toxic to
zygote) was 60 mg/kg/day and the NOEL was 30 mg/kg/day. In a rabbit teratology study, oral administration of 5 mg/kg/day
produced intrauterine lethality and was also toxic to maternal animals. The NOEL was 1 mg/kg/day. In a 3-generation
rat reproduction study, administration of 15 mg/kg/day (LOEL) produced decreased viability index. The NOEL was
5 mg/kg/day. EPA believes that there is sufficient evidence for listing fenbutatin oxide on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for fenbutatin oxide include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.7 ppb, a fathead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.9 ppb, a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 3.1 ppb, a bluegill sunfish 96&hyph;hour of LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.8 ppb, and a sheepshead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 20.8 ppb. Avian acute toxicity values include a quail oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.007 mg/kg. EPA believes that there is sufficient evidence for listing fenbutatin oxide on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
118. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fenoxaprop ethyl (2-(4-((6-chloro-2-benzoxazolylen)oxy)phenoxy)propanoic acid,ethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 066441-23-4) (FIFRA AI) (Ref. 3). In a 30&hyph;day mouse feeding study, liver weight increases were observed
(LOEL 20 ppm or 2.6 mg/kg/day and NOEL 10 ppm or 1.3 mg/kg/day). In a 32&hyph;day rat feeding study, changes in the liver
and kidney as well as altered lipid metabolism and decreased cholesterol were observed. The LOEL in the rat study was
80 ppm (4 mg/kg/day). The NOEL was 20 ppm (1 mg/kg/day). Inflammatory changes in the kidney (chronic interstitial
nephritis) were reported in dogs that received a 3&hyph;month feeding of 80 ppm (2 mg/kg/day, the LOEL). The NOEL was
16 ppm or 0.4 mg/kg/day. Decreased serum lipids and cholesterol were reported in rats exposed for 2 years to dietary
levels greater than or equal to 180 ppm (9 mg/kg/day, the LOEL). The NOEL in this study was 30 ppm (1.5 mg/kg/day). 
<!-- PJG 0012 frnewline -->
In a developmental toxicity study, fetotoxic effects (slightly impaired growth and delayed ossification) were
reported at 100 mg/kg/day. The NOEL was 32 mg/kg/day. These effects were observed at doses that were also toxic to maternal
animals. In a 2&hyph;generation reproductive toxicity feeding study in rats, decreased survival, decreased body
weight at study termination, and significant changes in kidney and liver weights were reported in the F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2a
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2b
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 litters. The fetotoxic LOEL in this study was 5 ppm (0.25 mg/kg/day, the lowest dose tested). The LOEL and NOEL for maternal
toxicity (increased kidney and liver weights) were 80 ppm (4 mg/kg/day) and 30 ppm (1.5 mg/kg/day), respectively.
Thus, the fetotoxic effects were observed at doses lower than those that produced maternal toxicity. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing fenoxaprop ethyl on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available renal and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for fenoxaprop ethyl include a mysid 96&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 98 ppb. EPA believes that there is sufficient evidence for listing fenoxaprop ethyl on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
119. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fenoxycarb (2-(4-phenoxyphenoxy)ethyl]carbamic acid ethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 072490-01-8) (FIFRA AI) (Ref. 3). Liver changes (including fatty changes, glycogen depletion, hepatocyte
hypertrophy and multinucleated hepatocytes) were reported in mice (the LOEL was 80 mg/kg/day; the NOEL was not determined)
and rats (the LOEL was 300 mg/kg/day; the NOEL was 100 mg/kg/day) following 3&hyph;month dietary exposures. Dose-related
changes in the liver of male rats, including increased relative liver weight, focal necrosis, centrilobular hypertrophy
and pigmented histiocytes, were reported after the first year of a 2&hyph;year oncogenicity study. The LOEL for these
effects was 600 ppm (30 mg/kg/day) and the NOEL was 200 ppm (10 mg/kg/day). Male and female rats exposed to a higher dose
(1,800 ppm or 90 mg/kg/day) in this study had increased alkaline phosphatase and reduced platelets and white blood
cells, and fibrosis was present in the hepatic lesions in the males. 
<!-- PJG 0012 frnewline -->
In a reproduction study in rats, delays in pinna unfolding and eye opening were reported at 10 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing fenoxycarb on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
120. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fenpropathrin (2,2,3,3-tetramethylcyclopropane carboxylic acid cyano(3-phenoxyphenyl)methyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 039515-41-8) (FIFRA AI) (Ref. 3). In a 1&hyph;year feeding study, tremors were noted in dogs exposed to 6.25
mg/kg/day. The NOEL was 2.5 mg/kg/day. In a developmental toxicity study in rats, signs of neurotoxicity reported
in the pregnant dams included ataxia, tremors, convulsions, lacrimation, prostration of death. The LOEL for maternal
toxicity was 10 mg/kg/day and the NOEL was 6 mg/kg/day. In 2&hyph;year dietary studies in rats and mice, body tremors
and increased mortality were observed in male rats (the LOEL was 30 mg/kg/day; the NOEL was 22.5 mg/kg/day), whereas
only marginally increased hyperactivity was noted in female mice (the LOEL was 65.2 mg/kg/day; the NOEL was 16.2 mg/kg/day).
EPA believes that there is sufficient evidence for listing fenpropathrin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for fenpropathrin include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 2.3 ppb, a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 2.2 ppb, a sheepshead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 3.1 ppb, and a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.53 ppb. EPA believes that there is sufficient evidence for listing fenpropathrin on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
121. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fenthion (O,O-dimethyl O-[3-methyl-4-(methylthio) phenyl] ester, phosphorothioic acid)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000055-38-9) (FIFRA AI) (Ref. 3). In cases of human poisonings from fenthion exposure, reported cholinergic
manifestations included the following: A man who ingested 257 mg/kg had an increased pulse rate (no effect on blood
pressure) and gastrointestinal symptoms including diarrhea and nausea or vomiting; a woman that ingested 525 mg/kg
experienced muscle contraction or spasticity, respiratory depression, and miosis; a woman that ingested an unspecified
amount of fenthion did not exhibit the initial cholinergic crisis until 5 days postexposure, and symptoms (primarily
psychosis) recurred 24 days later. Similar signs of toxicity, characteristic of organophosphate poisoning, were
observed in rats that were fed 300 ppm (15 mg/kg/day). Symptoms reported in these rats included spasms, nervousness,
salivation and diarrhea as well as ophthalmological symptoms such as eyeball protrusion and corneal turbidity.
LOEL and NOEL values for cholinesterase inhibition from animal studies of various durations include the following:
In a 28&hyph;day feeding study in rats, the LOEL was 10 ppm (0.5 mg/kg/day) and the NOEL was 5 ppm (0.65 mg/kg/day) for
brain cholinesterase inhibition; in another 28&hyph;day rat feeding study, plasma and erythrocyte cholinesterase
recovered 2 weeks postexposure. The LOEL for cholinesterase inhibition in a 30&hyph;day inhalation study in rats
was 0.163 mg/L. In a 63&hyph;day rat feeding study, significant cholinesterase inhibition occurred by day 3 at 25
mg/kg/day. In a 16&hyph;week feeding study in rats, the LOEL for cholinesterase inhibition was 5 ppm in females (0.65
mg/kg/day) and the NOEL was 3 ppm (0.15 mg/kg/day). EPA believes that there is sufficient evidence for listing fenthion
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available neurological toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for fenthion include a daphnid 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.62 ppb for immobilization. Acute toxicity values for other non-standard aquatic invertebrates range from a
48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.024 ppb for brown shrimp to a 96&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 110 ppb for scud. Avian acute toxicity values include a male mallard duck oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 5.94 mg/kg, a male bobwhite quail LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4 mg/kg, and a mourning dove oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.63 mg/kg. EPA believes that there is sufficient evidence for listing fenthion on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
122. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fenvalerate (4-chloro-alpha-(1-methylethyl)benzeneacetic acid cyano(3-phenoxyphenyl)methyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 051630-58-1) (FIFRA AI) (Ref. 3). Excitement and ataxia were observed in rats administered fenvalerate
at the oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 dose of 70.2 mg/kg. The oral mouse LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for fenvalerate is 185 mg/kg. Tremor, convulsions, and ataxia were observed in this study. Neurological dysfunctions
consisting of jerky leg movements, exaggerated flexion of the hind limb, and unsteady gait were observed in rats fed
7.5 mg/kg/day (LOEL) of fenvalerate for 13 weeks. The NOEL was 2.5 mg/kg/day. Based on the NOEL of the study, EPA derived
an oral RfD of 0.0025 mg/kg/day. Peripheral nerve and spinal cord lesions were observed in rats orally administered
360 mg/kg. 
<!-- PJG 0012 frnewline -->
In a 6&hyph;month dog feeding study, normocytic anemia, increased serum cholesterol levels, and hepatic microgranulomatosis
were observed in animals administered fenvalerate at 6.25 mg/kg/day (LOEL). No NOEL was defined. In a 2&hyph;year
mouse feeding study, multifocal granulomata in the liver was observed in males and females fed fenvalerate at 7.5
and 37.5 mg/kg/day, respectively. The male NOEL was 1.5 mg/kg/day and the female NOEL was 7.5 mg/kg/day. In a 20&hyph;month
mouse feeding study, decreased erythrocyte count, increased mean cell volume of the blood, and granulomatous changes
in the liver were observed at 15 mg/kg/day (LOEL). The NOEL was 4.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing fenvalerate on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological, hepatic, and hematological toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity data for fenvalerate include a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.26 ppb, a fathead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.33 ppb, a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.2 ppb, an Atlantic salmon 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.2 ppb, and a sheepshead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.4 ppb. In addition, the 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for daphnids is 0.05 ppb. EPA believes that there is sufficient evidence for listing fenvalerate on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
123. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ferbam (tris(dimethylcarbamodithioato-S,S')iron)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 014484-64-1) (FIFRA AI) (Ref. 3). In an 80&hyph;week feeding study in rats, females fed 96 mg/kg/day had ataxia
that progressed to hind limb paralysis. The NOEL was not determined. Symptoms of neurotoxicity reported in mice following
acute oral exposure included somnolence, excitement and ataxia, although the doses at which these signs occurred
were much higher (the LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in this study was 3,400 mg/kg). EPA believes that there is sufficient evidence for listing ferbam on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available neurological toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for ferbam include a daphnid 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 90 ppb, a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 52 ppb for the eastern oyster, and a guppy 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 90 ppb. EPA believes that there is sufficient evidence for listing ferbam on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
124. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fluazifop butyl (2-[4-[[5-(trifluoromethyl)-2-pyridinyl]oxy]-phenoxy]propanoic acid, butyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 069806-50-4) (FIFRA AI) (Ref. 3). A 3&hyph;month rat feeding study demonstrated hepatocyte hypertrophy
in males (the LOEL was 5 mg/kg/day; the NOEL was 0.5 mg/kg/day). In a 1&hyph;year feeding study, dogs had changes in
serum alkaline phosphatase and alanine aminotransferase and/or alanine sulfatransferase (the LOEL was 25 mg/kg/day;
the NOEL was 5 mg/kg/day). Similar changes were also reported in dogs following 3 months exposure in their diet (the
LOEL was 125 mg/kg/day). In a carcinogenicity study, male mice fed 20 ppm (2.6 mg/kg/day, the LOEL) had an increased
incidence of hepatocyte hypertrophy. The NOEL was 5 ppm or 0.65 mg/kg/day. Male and female mice exposed to a higher
dose of 80 ppm (10.4 mg/kg/day) had increased liver weight (relative and absolute) and hypertrophy of periacinal
hepatocytes. Males in this dose group also had increased pigmentation in hepatocytes and Kupffer cells. 
<!-- PJG 0012 frnewline -->
In a teratogenicity study in Sprague-Dawley rats exposed via oral gavage, delayed ossification and an increased
incidence of hydroureter were observed in fetuses (the fetotoxic LOEL was 5 mg/kg/day; the NOEL 1 mg/kg/day) and a
teratogenic LOEL of 200 mg/kg/day (the NOEL was 10 mg/kg/day) was determined based on the incidence of diaphragmatic
hernia. Maternal toxicity was observed in this study at doses higher than those causing fetotoxicity and included
reduced body weight gain and decreased gravid uterus (the maternal LOEL was 200 mg/kg/day; the NOEL was 10 mg/kg/day).
In a 2-generation reproductive toxicity dietary study in Wistar rats, the reproductive LOEL of 250 ppm (12.5 mg/kg/day;
the NOEL was 80 ppm or 4 mg/kg/day) was based on reduced litter sizes, reduced viability, reduced testis and epididymis
weights and tubular atrophy in offspring. Fetotoxicity (delayed ossification and eye opacities) was also demonstrated
in New Zealand White rabbits (the LOEL was 30 mg/kg/day; the NOEL was 10 mg/kg/day). EPA believes that there is sufficient
evidence for listing fluazifop butyl on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
hepatic and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
125. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Flumetralin (2-chloro-N-(2,6-dinitro-4-(trifluoromethyl)- phenyl)-N-ethyl-6-fluorobenzenemethanamine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 062924-70-3) (FIFRA AI) (Ref. 3). Aquatic acute toxicity values for flumetralin include a daphnid 48&hyph;hour
EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of greater than 2.8 ppb, a bluegill sunfish 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of greater than 3.2 ppb, and a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of greater than 3.2 ppb. EPA believes that there is sufficient evidence for listing flumetralin on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
126. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fluorine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007782-41-4) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). Inhalation of fluorine causes initial coughing,
choking and chills, which is followed 1 or 2 days later with pulmonary edema. Fluorine has a strong caustic action on
mucous membranes, eyes and skin. In human volunteers exposed to 100 ppm (0.16 mg/L) for 30 seconds, much irritation
to the nose and eyes was reported. In acute inhalation studies in animals, lethality occurs at a fairly uniform level
and is the result of pulmonary edema. Following 1 hour exposures in mice, rats or guinea pigs, the inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values ranged from 150 to 185 ppm (0.23 to 0.29 mg/L). The LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for rabbits following a 30-minute exposure was 270 ppm (0.42 mg/L). EPA's exposure analysis indicates that fluorine
concentrations are likely to exist beyond facility site boundaries, as a result of continuous, or frequently recurring
releases, at levels that can reasonably be anticipated to cause significant adverse acute human health effects.
EPA believes that there is sufficient evidence for listing fluorine on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(A) based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
127. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fluorouracil (5-Fluorouracil)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000051-21-8) (CAL; EPCRA EHS) (Ref. 8). A major use of fluorouracil is in the palliative treatment of carcinoma
of the colon, rectum, breast, stomach, and pancreas that is not amenable to surgery or irradiation. The major toxic
effects of fluorouracil are on the normal, rapidly proliferating tissues particularly of the bone marrow and lining
of the gastrointestinal tract. Leukopenia, predominantly of the granulocytopenic type, thrombocytopenia, and
anemia occur commonly with intravenous fluorouracil therapy at doses ranging from 6 to 12 mg/kg. Pancytopenia and
agranulocytosis also have occurred.
<!-- PJG 0012 frnewline -->
Developmental abnormalities or other effects on newborns were reported in offspring of women receiving 150 or 240
mg/kg fluorouracil intravenously during weeks 11 to 14 or 20 to 31 of pregnancy. In addition, maternal toxicity to
the reproductive organs, toxicity to the fetus, and developmental abnormalities have been reported in mice, rats,
and hamsters receiving oral, intraperitoneal, or intramuscular doses of fluorouracil ranging from 10 to 700 mg/kg.

<!-- PJG 0012 frnewline -->
Chronic neurotoxic effects were noted in dogs fed fluorouracil at a dietary dose of 2 mg/kg/day for 6 months. In this
study, animals were examined at the end of 3 months and 6 months. At the end of the experiment, or at death, the brain was
removed and examined (only one dog survived the entire 6&hyph;month period). Histological sections of the brain
showed the presence large multiple monolocular vacuoles in the wall of the fornix of the third ventricle. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing fluorouracil on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the toxicity of this substance to bone marrow, and on the developmental and chronic neurotoxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
128. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fluvalinate (N-[2-chloro-4-(trifluoromethyl)phenyl]DL-valine(+)- cyano (3-phenoxyphenyl)methyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 069409-94-5) (FIFRA AI) (Ref. 3). Delayed ossification and decreased weight and length of fetuses were observed
in offspring of rats orally administered 50 mg/kg/day (LOEL) on days 6 to 15 of gestation. The NOEL was 10 mg/kg/day.
These effects were observed at doses that produced maternal toxicity. Curved tibia and fibula were observed in the
offspring of rabbits orally administered 125 mg/kg/day (LOEL). The NOEL was 25 mg/kg/day. In a 2&hyph;generation
reproduction study, a decrease in pup weight and growth were observed in offspring of rats orally administered 5 mg/kg/day
(LOEL). The NOEL was 1 mg/kg/day. Significantly decreased weight and survival were observed in offspring of rats
orally administered 25 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a range finding study, dietary administration of 50 mg/kg/day for 30 days produced skin lesions in rats. The NOEL
was not determined. A 2&hyph;year rat feeding study was terminated at 64 weeks due to dermal lesions produced in animals
at 15 mg/kg/day. The NOEL was 2 mg/kg/day. Dietary administration of 10 mg/kg/day (LOEL for effect) to mice for 2 years
produced scabbing and dermal abrasion. No NOEL for these effects was established. An increase in plantar ulcers was
observed in rats fed 2.5 mg/kg/day (LOEL) for 2 years. The NOEL was 1 mg/kg/day. Decreases in body weight gain were also
observed in this study. Based on the NOEL of the study, an oral RfD of 0.01 mg/kg/day was derived. In a 2&hyph;generation
rat reproduction study, dietary administration of 5 mg/kg/day produced decreased body weight gain and skin lesions
in parents and offspring. 
<!-- PJG 0012 frnewline -->
Dietary administration of 2.5 mg/kg/day to rats for 13 weeks produced anemia in blood parameters (decreased hematocrit,
hemaglobin, and red blood cells). The NOEL was 1.0 mg/kg/day. Dietary administration of 30 mg/kg/day (LOEL) to rats
for 3 months produced decreased hemoglobin, hematocrit, and red blood cell count in rats. The NOEL was 3 mg/kg/day.

<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing fluvinate on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available developmental, dermal, and hematological toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for fluvalinate include a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.40 ppb, a bluegill sunfish 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.9 ppb, a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 2.9 ppb, and a sheepshead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 10.8 ppb. EPA believes that there is sufficient evidence for listing fluvinate on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
129. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Folpet
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000133-07-3) (CAL) (Ref. 8). Folpet is classified as a Group B2 compound by EPA; i.e., the substance is a probable
human carcinogen. Folpet has been shown to induce carcinoma and adenoma of the duodenum in both sexes of CD-1 and B6C3F1
mice. EPA believes that there is sufficient evidence for listing folpet on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity test data for folpet include a measured 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 39 ppb for rainbow trout, and a measured 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 72 ppb (0.072 ppm) for bluegill. EPA believes that there is sufficient evidence for listing folpet on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
130. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Fomesafen (5-(2-chloro-4-(trifluoromethyl)phenoxy)-N methylsulfonyl)-2-nitrobenzamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 072178-02-0) (FIFRA AI) (Ref. 3). Decreased plasma cholesterol and triglycerides and increased liver weights
(reversible at 7 days post-treatment) were observed at 50 mg/kg/day (only dose tested) when administered in the diet
of rats for 4 weeks. In a 90&hyph;day rat study, dietary administration of 5 mg/kg/day (LOEL) produced alterations
in lipid metabolism and increases in liver weight. The NOEL was 0.25 mg/kg/day. In a 26-week dog study, dietary administration
of 25 mg/kg/day (LOEL) produced alterations in lipid metabolism and liver changes (changes not defined). The NOEL
was 1 mg/kg/day. Liver toxicity (increased liver masses, discolored hepatocytes, and pigmented Kupffer cells)
was observed in a 2&hyph;year rat feeding study at 50 mg/kg/day (LOEL). The NOEL was 5 mg/kg/day. Metabolism studies
have shown that fomesafen accumulates in the liver. EPA believes that there is sufficient evidence for listing fomesafen
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatic toxicity data for this
chemical. 
<!-- PJG 0012 frnewline -->
131. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
alpha-Hexachlorocyclohexane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000319-84-6) (CERCLA; CWA PPL; FIFRA SR) (Ref. 8). alpha-Hexachlorocyclohexane is classified by EPA as
a Group B2 compound; i.e., the substance is a probable human carcinogen. Although human data are limited, there is
a case report of acute leukemia in a Japanese sanitation employee following occupational exposure to alpha-hexachlorocyclohexane
and DDT. alpha-Hexachlorocyclohexane has been shown in dietary studies to cause an increase in the incidence of liver
tumors in five mouse strains and in Wistar rats. EPA believes that there is sufficient evidence for listing alpha-hexachlorocyclohexane
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity test data for alpha-hexachlorocyclohexane include a 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 800 ppb for daphnids. This chemical is expected to bioaccumulate in aquatic systems because the measured bioconcentration
factor (BCF) for rainbow trout is 1950. EPA believes that there is sufficient evidence for listing alpha-hexachlorocyclohexane
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical
and its potential for bioaccumulation. 
<!-- PJG 0012 frnewline -->
132. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hexamethylene-1,6-diisocyanate or Diisocyanates category
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000822-60-0) (CAA HAP) (Ref. 7). Hexamethylene-1,6-diisocyanate (HDI) is extremely toxic via the inhalation
route. The rat LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for HDI ranges from 56 (385 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) to 45 ppm (310 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). The mouse LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for HDI is 4 ppm (30 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). HDI also induces irritation of the upper respiratory tract in mice after acute exposure. The mouse LOAEL was 0.062
ppm (0.43 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) for a 3&hyph;hour exposure. A NOAEL was not established. Acute exposures to HDI vapors may induce pulmonary irritation
in the rat at 60 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, but data were insufficient to generate a LOAEL or NOAEL for this effect. 
<!-- PJG 0012 frnewline -->
Although the data are insufficient to evaluate the potential for HDI to produce pulmonary hypersensitivity, indirect
evidence suggests that inhalation of monomeric HDI may cause pulmonary sensitivity. In addition, data are insufficient
to evaluate the potential for HDI to elicit an allergic reaction in previously sensitized animals or people; however,
indirect evidence suggests that inhalation of monomeric HDI may elicit allergic responses (i.e., asthma, alveolitis)
in isocyanate-sensitized individuals. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that HDI concentrations are likely to exist beyond facility site boundaries,
as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated to cause
significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing hexamethylene-1,6-diisocyanate
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data
for this chemical. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPA is proposing to list HDI as an individual chemical on EPCRA section 313. In addition, in Units IV.B.144. and 158.
of this preamble, EPA is proposing to individually list isophorone diisocyanate and 1,1-methylene bis(4-isocyanatocyclohexane)
on EPCRA section 313. As an alternative proposal to the individual listing of HDI, isophorone diisocyanate, and 1,1-methylene
bis(4-isocyanatocyclohexane), EPA is proposing to create a diisocyanates category that includes HDI, isophorone
diisocyanate, 1,1-methylene bis(4-isocyanatocyclohexane), and 16 other diisocyanates. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPCRA section 313 requires threshold determinations for chemical categories to be based on the total of all chemicals
in the category manufactured, processed, or otherwise used. For example, a facility that manufactures three members
of a chemical category would count the total amount of all three chemicals manufactured towards the manufacturing
threshold for that category. When filing reports for chemical categories, the releases are determined in the same
manner as the thresholds. One report is filed for the category and all releases are reported on this form. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The chemicals selected for this proposed category are members of the diisocyanates category under review by EPA's
Office of Pollution Prevention and Toxics. This category has been defined as monomeric diisocyanates of molecular
weight less than or equal to 300, plus polymeric diphenylmethane diisocyanate (which is only 40 to 60 percent polymerized).
Chemicals were included in this category based on similar chronic and acute adverse respiratory effects. The following
chemicals are the proposed members of the EPCRA section 313 diisocyanates category: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1,3-Bis(methylisocyanate)cyclohexane (CAS No. 038661-72-2) 
<!-- PJG 0012 frnewline -->
1,4-Bis(methylisocyanate)cyclohexane (CAS No. 010347-54-3) 
<!-- PJG 0012 frnewline -->
1,4-Cyclohexane diisocyanate (CAS No. 002556-36-7) Diethyldiisocyanatobenzene (CAS No. 134190-37-7) 
<!-- PJG 0012 frnewline -->
4,4'-Diisocyanatodiphenyl ether (CAS No. 004128-73-8) 
<!-- PJG 0012 frnewline -->
2,4'-Diisocyanatodiphenyl sulfide (CAS No. 075790-87-3) 
<!-- PJG 0012 frnewline -->
3,3'-Dimethoxybenzidine-4,4'-diisocyanate (CAS No. 000091-93-0) 
<!-- PJG 0012 frnewline -->
3,3'-Dimethyl-4,4'-diphenylene diisocyanate (CAS No. 000091-97-4) 
<!-- PJG 0012 frnewline -->
3,3'-Dimethyldiphenylmethane-4,4'-diisocyanate (CAS No. 000139-25-3) Hexamethylene-1,6-diisocyanate (CAS
No. 000822-06-0) 
<!-- PJG 0012 frnewline -->
Isophorone diisocyanate (CAS No. 004098-71-0) 
<!-- PJG 0012 frnewline -->
4-Methyldiphenylmethane-3,4-diisocyanate (CAS No. 075790-84-0) 
<!-- PJG 0012 frnewline -->
1,1-Methylene bis(4-isocyanatocyclohexane) (CAS No. 005124-30-1) 
<!-- PJG 0012 frnewline -->
1,5-Naphthalene diisocyanate (CAS No. 003173-72-6) 
<!-- PJG 0012 frnewline -->
1,3-Phenylene diisocyanate (CAS No. 000123-61-5) 
<!-- PJG 0012 frnewline -->
1,4-Phenylene diisocyanate (CAS No. 000104-49-4) 
<!-- PJG 0012 frnewline -->
Polymeric diphenylmethane diisocyanate (CAS No. 009016-87-9) 
<!-- PJG 0012 frnewline -->
2,2,4-Trimethylhexamethylene diisocyanate (CAS No. 016938-22-0) 
<!-- PJG 0012 frnewline -->
2,4,4-Trimethylhexamethylene diisocyanate (CAS No. 015646-96-5) 
<!-- PJG 0012 frnewline -->
These diisocyanates represent a category of chemicals that may effect many organ systems. However, the primary toxicity
target for diisocyanates is the upper and lower respiratory tract resulting in chronic pulmonary irritation. Diisocyanates
are also known respiratory and dermal sensitizing agents. Both acute and chronic effects may result from acute or
chronic exposures. These effects may be immune- or non-immune mediated. EPA believes that diisocyanates should
be listed as a category because it is the isocyanate functionality that is responsible for the observed chronic pulmonary
irritation associated with exposures to members of this category. The other part of the molecule does not mitigate
to any large degree the observed toxic effects. EPA believes that there is sufficient evidence for listing diisocyanates
as a category on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available toxicity data for
members of the category. 
<!-- PJG 0012 frnewline -->
Currently there are four other diisocyanates listed on EPCRA section 313, these are: 
<!-- PJG 0012 frnewline -->
Toluene-2,4-diisocyanate (CAS No. 000584-84-9) 
<!-- PJG 0012 frnewline -->
Toluene-2,6-diisocyanate (CAS No. 000091-08-7) 
<!-- PJG 0012 frnewline -->
Toluenediisocyanate (mixed isomers) (CAS No. 026471-62-5) Methylenebis(phenylisocyanate) (CAS No. 000101-68-8)

<!-- PJG 0012 frnewline -->
EPA intends to maintain the individual listings for the three toluene diisocyanate compounds. In addition to the
effects discussed above, these compounds have been classified as probable carcinogens. EPA intends to continue
to individually list diisocyanates that are possible of probable carcinogens. Methylenebis(phenylisocyanate)
has not been shown to be a carcinogen and EPA is proposing to remove it as an individually listed chemical, and add it
to the diisocyanates category if the alternative proposal for creation of the category is finalized. 
<!-- PJG 0012 frnewline -->
EPA requests comment on the alternative proposal to create a diisocyanates category and what other diisocyanates
should be included in such a category. 133. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
n-Hexane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000110-54-3) (CAA HAP) (Ref. 7). In an epidemiology study, no neurological abnormalities were noted in workers.
However, neurophysiological tests showed that the mean motor nerve conduction velocities of the exposed group was
significantly decreased over the values for the control group. Also, the residual latency of motor nerve conduction
of the posterior tibial nerve in the exposed group was significantly slowed when compared with the nonexposed group.
A LOAEL of 204 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (58 ppm, LOAEL(ADJ) of 73 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) was established for these electrophysiological alterations in humans. The alterations observed are consistent
with n-hexane-induced peripheral neuropathy observed in other studies in humans and in animals. EPA believes that
there is sufficient evidence for listing n-hexane on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based
upon the available neurotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
134. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hexazinone
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 051235-04-2) (FIFRA AI) (Ref. 3). In a 2&hyph;year mouse feeding study, liver hypertrophy, hyperplastic
nodules and focal necrosis were observed at 375 mg/kg/day (LOEL). The NOEL was 30 mg/kg/day. In a 90&hyph;day feeding
study in dogs, decreased body weight, increased alkaline phosphatase activity, decreased albumin/globulin ratio
and increased absolute and relative liver weights were noted in both sexes at 5,000 ppm (125 mg/kg/day; LOEL). The
NOEL was 1,000 ppm (25 mg/kg/day). EPA believes that there is sufficient evidence for listing hexazinone on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity test data for hexazinone include an EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 7 ppb for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
S. capricornutum
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. EPA believes that there is sufficient evidence for listing hexazinone on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
135. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hydramethylnon (tetrahydro-5,5-dimethyl-2(1H)-pyrimidinone[3-[4- (trifluoromethyl)phenyl]-1-[2-[4(trifluoromethyl)
phenyl]ethenyl]-2-propenylidene]hydrazone)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 067485-29-4) (FIFRA AI) (Ref. 3). In a 90&hyph;day dog feeding study, testicular atrophy was observed at
6 mg/kg/day (LOEL). The NOEL was 3 mg/kg/day. In a 90&hyph;day rat study, dietary administration of 5 mg/kg/day (LOEL)
produced testicular atrophy. The NOEL was 2.5 mg/kg/day. Dietary administration of 6.5 mg/kg/day for 18 months produced
testicular lesions in mice. The NOEL was 2.75 mg/kg/day. In a 2&hyph;year rat study, dietary administration of 5 mg/kg/day
produced decreased testicular weight and testicular atrophy. The NOEL was 2.5 mg/kg/day. In a 3-generation rat reproduction
study, oral administration of 5 mg/kg/day produced male infertility. The NOEL was 2.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Decreased fetal weight was observed in the offspring of rats administered 30 mg/kg/day (LOEL). The NOEL was 10 mg/kg/day.
Increased post implantation loss and decreased fetal viability were observed in the offspring of rabbits administered
15 mg/kg/day (LOEL). The NOEL was 5 mg/kg/day. Vertebral anomalies were seen in the offspring of rabbits administered
10 mg/kg/day (LOEL). The NOEL was 5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Dietary administration of 1 mg/kg/day (LOEL) for 6 months to dogs produced increased absolute and relative liver
weights. The NOEL was 0.33 mg/kg/day. Based on the NOEL of the study, an oral RfD of 0.0003 mg/kg/day was derived. EPA
believes that there is sufficient evidence for listing hydramethylnon on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available reproductive, developmental, and hepatic toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
The 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in the Chanel Catfish was 90 ppb. Bioaccumulation factors in bluegill sunfish are 1300 for the whole fish, 780 for the
fillet, and 1900 for viscera. EPA believes that there is sufficient evidence for listing hydramethylon on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data and the potential
for bioaccumulation. 
<!-- PJG 0012 frnewline -->
136. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Hydrochlorofluorocarbons
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAA OD) (Ref. 8). Hydrochlorofluorocarbons are known to release chlorine radicals into the stratosphere. Chlorine
radicals act as catalysts to reduce the net amount of stratospheric ozone. 
<!-- PJG 0012 frnewline -->
Stratospheric ozone shields the earth from ultraviolet-B (UV-B) radiation (i.e., 290 to 320 nanometers). Decreases
in total column ozone will increase the percentage of UV-B radiation, especially at its most harmful wavelengths,
reaching the earth's surface.
<!-- PJG 0012 frnewline -->
Exposure to UV-B radiation has been implicated by laboratory and epidemiologic studies as a cause of two types of nonmelanoma
skin cancers: squamous cell cancer and basal cell cancer. Studies predict that for every 1 percent increase in UV-B
radiation, nonmelanoma skin cancer cases would increase by about 1 to 3 percent. 
<!-- PJG 0012 frnewline -->
Recent epidemiological studies, including large case control studies, suggest that UV-B radiation plays an important
role in causing malignant melanoma skin cancer. Recent studies predict that for each 1 percent change in UV-B intensity,
the incidence of melanoma could increase from 0.5 to 1 percent. 
<!-- PJG 0012 frnewline -->
Studies have demonstrated that UV-B radiation can suppress the immune response system in animals, and, possibly,
in humans. Increases in exposure to UV-B radiation are likely to increase the incidence of cataracts and could adversely
affect the retina.
<!-- PJG 0012 frnewline -->
Aquatic organisms, particularly phytoplankton, zooplankton, and the larvae of many fishes, appear to be susceptible
to harm from increased exposure to UV-B radiation because they spend at least part of their time at or near the surface
of waters they inhabit. 
<!-- PJG 0012 frnewline -->
Increased UV-B penetration has been shown to result in adverse impacts on plants. Field studies on soybeans suggest
that yield reductions could occur in some cultivars of soybeans, while evidence from laboratory studies suggest
that two out of three cultivars are sensitive to UV-B. 
<!-- PJG 0012 frnewline -->
Because this increased UV-B radiation can be reasonably anticipated to lead to cancer and other chronic human health
effects and significant adverse environmental effects, EPA believes there is sufficient evidence for listing the
following HCFCs that are commercially viable on EPCRA section 313 pursuant to EPCRA sections 313(d)(2)(B) and (C).
EPA is proposing that the following HCFCs be added individually to EPCRA section 313: 
<!-- PJG 0012 frnewline -->
Dichloropentafluoropropane (CAS No. 127564-92-5) 
<!-- PJG 0012 frnewline -->
1,3-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225ea) (CAS No. 136013-79-1) 
<!-- PJG 0012 frnewline -->
2,2-Dichloro-1,1,1,3,3-pentafluoropropane (HCFC-225aa) (CAS No. 128903-21-9) 
<!-- PJG 0012 frnewline -->
1,1-Dichloro-1,2,3,3,3-pentafluoropropane (HCFC-225eb) (CAS No. 111512-56-2) 
<!-- PJG 0012 frnewline -->
1,1-Dichloro-1,2,2,3,3-pentafluoropropane (HCFC-225cc) (CAS No. 13474-88-9) 
<!-- PJG 0012 frnewline -->
1,3-Dichloro-1,1,2,2,3-pentafluoropropane (HCFC-225cb) (CAS No. 000507-55-1) 
<!-- PJG 0012 frnewline -->
1,2-Dichloro-1,1,3,3,3-pentafluoropropane (HCFC-225da) (CAS No. 000431-86-7) 
<!-- PJG 0012 frnewline -->
3,3-Dichloro-1,1,1,2,2-pentafluoropropane (HCFC-225ca) (CAS No. 000422-56-0) 
<!-- PJG 0012 frnewline -->
2,3-Dichloro-1,1,1,2,3-pentafluoropropane (HCFC-225ba) (CAS No. 000422-48-0) 
<!-- PJG 0012 frnewline -->
1,2-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225bb) (CAS No. 000422-44-6) 
<!-- PJG 0012 frnewline -->
Dichlorofluoromethane (HCFC-21) (CAS No. 000075-43-4) 
<!-- PJG 0012 frnewline -->
1,1,1,2-Tetrachloro-2-fluoroethane (HCFC-121a) (CAS No. 000354-11-0) 1,1,2,2-Tetrachloro-1-fluoroethane
(HCFC-121) (CAS No. 000354-14-3) 
<!-- PJG 0012 frnewline -->
1,2-Dichloro-1,1-difluoroethane (HCFC-132b) (CAS No. 001649-08-7) 
<!-- PJG 0012 frnewline -->
2-Chloro-1,1,1-trifluoroethane (HCFC-133a) (CAS No. 000075-88-7) 
<!-- PJG 0012 frnewline -->
3-Chloro-1,1,1-trifluoropropane (HCFC-253fb) (CAS No. 000460-35-5). 
<!-- PJG 0012 frnewline -->
137. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Imazalil (1-[2-(2,4-dichlorophenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 035554-44-0) (FIFRA AI) (Ref. 3). In a rat teratology study, increased maternal mortality, decreased litter
size, and increased number of dead fetuses were observed in animals administered 40 mg/kg/day (LOEL). The NOEL was
10 mg/kg/day. Stillbirths and altered live birth index were observed in rats orally administered 80 mg/kg/day days
16 through 22 of gestation and 21 days post gestation. Altered lactation index was observed in rats orally administered
20 mg/kg/day on days 16 through 22 of gestation and 21 days post gestation. Post-implantation loss was observed in
rabbits orally administered 0.63 mg/kg/day on days 6 through 18 of gestation. Altered viability index was observed
in rabbits orally administered 2.5 mg/kg/day on days 6 through 18 of gestation. EPA believes that there is sufficient
evidence for listing imazalil on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
138. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3-Iodo-2-propynyl butylcarbamate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 055406-53-6) (FIFRA AI) (Ref. 3). In a 90&hyph;day rat study, oral administration of 50 mg/kg/day (LOEL)
produced increased liver-to-body-weight ratios. The NOEL was 20 mg/kg/day. In a 2&hyph;year rat study, dietary
administration of 40 and 80 mg/kg/day produced significant non-neoplastic pathological changes in the stomach.
No NOEL was established; the LOEL was 20 mg/kg/day. Based on this study, EPA derived an oral RfD of 0.07 mg/kg/day. EPA
believes that there is sufficient evidence for listing 3-iodo-2-propynyl butylcarbamate on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available chronic toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
139. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Iprodione (3-(3,5-dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 036734-19-7) (FIFRA AI) (Ref. 3). Increased red blood cell Heinz bodies and decreased prostate weight (the
LOEL was 15 mg/kg/day; the NOEL was 4.2 mg/kg/day) were observed in dogs fed iprodione for 1&hyph;year. Increased
Heinz bodies were also seen in females at 15 mg/kg/day. At 90 mg/kg/day, increased liver weight was noted in male and
female dogs. Based on the NOEL, an oral RfD of 0.04 mg/kg/day was derived. In another 1&hyph;year feeding study in dogs,
decreased red blood cell counts and hemoglobin and hematocrit levels (the LOEL was 600 ppm or 15 mg/kg/day; the NOEL
was 100 ppm or 2.5 mg/kg/day) were observed. At 3,600 ppm (90 mg/kg/day), increased absolute and relative liver weights
and increase liver alkaline phosphatase, serum glutamic-pyruvic transaminase, serum glutamic-oxaloacetic transaminase,
and lactate dehydrogenase activities were noted. Decreased red blood cell count and decreased hemoglobin and hematocrit
levels (the LOEL was 24.6 mg/kg/day in males, 26.4 mg/kg/day in females; the NOEL was 17.5 mg/kg/day in males, 18.4
mg/kg/day in females). EPA believes that there is sufficient evidence for listing iprodione on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(B) based on the available hematological and hepatic toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Acute aquatic toxicity data include a green algae 120&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 21 ppb. EPA believes that there is sufficient evidence for listing iprodione on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
140. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Iron pentacarbonyl
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 013463-40-6) (EPCRA EHS) (Ref. 8). Humans exposed to high concentrations of iron pentacarbonyl immediately
experience headache and dizziness. These effects are followed 12 to 36 hours after exposure by symptoms such as fever,
cyanosis, cough, and shortness of breath. In humans, iron pentacarbonyl has also been known to cause adverse effects
on the respiratory and central nervous system, liver, and kidney. The rat oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is 25 mg/kg and the rat inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value is 0.044 mg/L. The 4&hyph;hour inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
100
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in mice is 0.007 mg/L. The rabbit oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is 12 mg/kg. EPA's exposure analysis indicates that iron pentacarbonyl concentrations are likely to exist beyond
facility site boundaries, as a result of continuous, or frequently recurring releases, at levels that can reasonably
be anticipated to cause significant adverse acute human health effects. EPA believes that there is sufficient evidence
for listing iron pentacarbonyl on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available
acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
141. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Isodrin
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000465-73-6) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). Measured aquatic acute toxicity data for isodrin
include a 24&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 12 ppb for bluegills and a 24&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 6 ppb for minnows. EPA believes that there is sufficient evidence for listing isodrin on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
142. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Isofenphos (2-[[ethoxyl[(1-methylethyl) amino] phosphinothioyl] oxy] benzoic acid 1-methylethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 025311-71-1) (FIFRA AI) (Ref. 3). In a 108&hyph;week feeding study in mice, inhibition of brain cholinesterase
(the LOEL was 100 ppm or 13 mg/kg/day; the NOEL was 10 ppm or 1.3 mg/kg/day) and plasma cholinesterase (the LOEL was 10
ppm or 1.3 mg/kg/day; the NOEL was 0.13 mg/kg/day) was observed. Inhibition of red blood cell cholinesterase (the
LOEL was 10 ppm or 0.5 mg/kg/day; the NOEL was 1 ppm or 0.05 mg/kg/day) was seen in a 2&hyph;year feeding study in rats.
Other studies (14&hyph; and 90&hyph;day feeding studies in dogs, 30&hyph; and 90&hyph;day studies in rats, and a
3&hyph;week inhalation study in rats) also demonstrate cholinesterase (plasma, red blood cell or brain) inhibition
in rats and dogs. EPA believes that there is sufficient evidence for listing isophenphos on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available neurological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for isofenphos include a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.6 ppb and a mysid 96&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.7 ppb. EPA believes that there is sufficient evidence for listing isofenphos on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 143. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Isophorone
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000078-59-1) (CAA HAP) (Ref. 7). Isophorone has been shown to cause neurotoxic effects in humans exposed
to atmospheric concentrations of 5 to 8 ppm. After being exposed for 1 month, workers complained of fatigue and malaise.
Neurotoxicity was also observed in humans following acute exposure. At 40 to 85 ppm, effects included nausea, headache,
dizziness, faintness, inebriation, and a feeling of suffocation. Increasing exposure concentrations resulted
in increasing severity of symptoms. Irritation and central nervous system (CNS) depression were observed at concentrations
of 200 to 400 ppm. EPA believes that there is sufficient evidence for listing isophorone on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available neurotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
144. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Isophorone diisocyanate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 004098-71-9) (TSCA) (Ref. 8). The 4&hyph;hour inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value of isophorone diisocyanate in rats is 0.123 mg/L. The rat and mouse 3&hyph;hour inhalation RD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (50 percent reduction in respiratory rate) values are 0.0046 mg/L and 0.0019 mg/L, respectively. A 50&hyph;year
old man developed severe asthma after exposure to an unspecified amount of paint containing isophorone diisocyanate.
A 1&hyph;hour exposure to an unspecified amount of the compound caused eczema in three out of four workers. In addition,
isocyanates as a class are generally severe skin, eye and respiratory irritants. EPA's exposure analysis indicates
that isophorone diisocyanate concentrations are likely to exist beyond facility site boundaries, as a result of
continuous, or frequently recurring releases, at levels that can reasonably be anticipated to cause significant
adverse acute human health effects. EPA believes that there is sufficient evidence for listing isophorone diisocyanate
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data
for this chemical. 
<!-- PJG 0012 frnewline -->
As detailed in Unit IV.B.132. of this preamble, as an alternative proposal to the individual listing of HDI, isophorone
diisocyanate, and 1,1-methylene bis(4-isocyanatocyclohexane), EPA is proposing to create a diisocyanates category
that includes HDI, isophorone diisocyanate, 1,1-methylene bis(4-isocyanatocyclohexane), and 16 other diisocyanates.

<!-- PJG 0012 frnewline -->
145. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Lactofen (5-(2-chloro-4-(trifluoromethyl)phenoxy)-2-nitro-2-ethoxy-1-methyl-2-oxoethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 077501-63-4) (FIFRA AI) (Ref. 3). Lactofen meets the criteria of an EPA Group B2 compound, i.e., a probable
human carcinogen. This conclusion was based on an increased incidence of hepatocellular carcinomas in males and
combined incidence of hepatocellular adenomas and carcinomas in both sexes of CD-1 mice following dietary administration
of lactofen. In CD rats, there was increased incidence of liver neoplastic nodules in both sexes. Four structurally
similar chemicals, acifluorfen, nitrofen, oxyfluorfen, and fomesafen, all produced hepatocellular tumors in
rodents. 
<!-- PJG 0012 frnewline -->
Results of several subchronic and chronic studies indicated the liver and kidney as target organs for lactofen. Increased
absolute and relative liver weight and hepatocytomegaly (the LOEL was 1.5 mg/kg/day; the NOEL was not determined)
were observed in male mice fed lactofen for 78 weeks. At 37.5 mg/kg/day, there was also an increased incidence of cataracts
and renal pigmentation. Based on the LOEL, an oral RfD of 0.002 mg/kg/day was derived. Renal dysfunction and decreased
hemoglobin and hematocrit levels and red blood cell counts (the LOEL was 25/75 mg/kg/day; the NOEL was 5 mg/kg/day)
were observed in a 1&hyph;year feeding study in dogs. Increased renal and hepatic pigmentation (the LOEL was 50 mg/kg/day;
the NOEL was 25 mg/kg/day) were noted in a 2&hyph;year feeding study in rats. In a 90&hyph;day mouse study, increased
alkaline phosphatase, serum glutamate oxaloacetate transaminase (SGOT), and serum gleutanic pyruvic transaminase
(SGPT) activities, increased liver weight, hepatic necrosis, biliary hyperplasia, decreased hematocrit and hemoglobin
levels and red blood cell counts, extramedullary hematopoiesis, and kidney nephrosis and fibrosis (the LOEL was
26 mg/kg/day; the NOEL was not determined) were seen. Decreased hemoglobin and hematocrit levels, decreased red
blood cell counts, and brown pigment in the kidney and liver (the LOEL was 50 mg/kg/day) were noted in a 90&hyph;day
feeding study in rats. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing lactofen on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available carcinogenicity data and hepatic, renal, and hematological toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
146. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Linuron
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000330-55-2) (FIFRA SR) (Ref. 8). The appearance of sulfhemoglobin in the blood of dogs, rats, or mice exposed
to linuron has been reported. In fact, available animal data from feeding studies of various durations (30 days to
2 years) with linuron as well as from studies with structurally similar urea-based herbicides indicate that the presence
of sulfhemoglobin (abnormal blood pigment) and morphological changes in red blood cells provide the most sensitive
indicator of exposure to linuron. In a 2&hyph;year feeding study with beagle dogs, the LOAEL, based on the presence
of the sulfhemoglobin, was 0.625 mg/kg/day. This was the lowest dose tested. Red blood cell counts were decreased
in dogs exposed to higher doses of linuron. EPA has derived an oral RfD of 0.002 mg/kg/day for linuron from this study.
Similar findings were reported in two separate 2&hyph;year rat feeding studies. In one of these studies, the LOAEL
was 31.25 mg/kg/day and the NOAEL was 6.25 mg/kg/day. These values were based on spleen and bone marrow changes indicative
of hemolysis, and an increase in mortality and growth retardation. In the other 2&hyph;year rat study, a LOAEL of 2.5
mg/kg/day (the lowest dose tested) was based on decreased red blood cell counts and reticulocytosis. Elevated sulfhemoglobin
levels were reported in rats exposed for as little as 30 days to 150 mg/kg/day. This exposure level also caused severe
growth retardation and increased mortality. The LOAEL for decreased body weight gain was 15 mg/kg/day and the NOAEL
was 3 mg/kg/day. Chronic administration of linuron at 4 mg/kg/day to rats caused hypochromic anemia, decreased cholinesterase
and peroxidase activities in the blood.
<!-- PJG 0012 frnewline -->
A LOAEL of 31.25 mg/kg/day was established in a 3&hyph;generation reproductive toxicity study in which linuron (in
the diet) caused reduced weanling weights, reduced liver and kidney weights, liver atrophy, and reduced pup survival.
In a separate developmental toxicity study in rats administered linuron orally, a LOAEL of 31.25 mg/kg/day was based
on an increased incidence of fetal resorptions. The LOAEL for maternal toxicity in this study was 6.25 mg/kg/day (NOAEL
2.50 mg/kg/day), and was based on decreased food consumption and decreased body weight gain. An oral teratology study
in rabbits indicated a LOAEL of 5 mg/kg/day (lowest dose tested) based on decreased fetal body weight, decreased litter
size and an increase in skull malformations. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing linuron on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the hematological and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
147. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Lithium carbonate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000554-13-2) (CAL) (Ref. 8). A major use of lithium carbonate is in the treatment of manic episodes of manic-depressive
illness. Decreases in the number of implantations, number of live fetuses and fetal body weight, and increases in
resorptions and various limb/skeletal anomalies were reported in the offspring of Wistar rats that received 100
mg/kg (the fetotoxic LOEL; the fetotoxic NOEL was 50 mg/kg) during gestation days 6 through 15. Offspring of mice that
received 465 mg/kg/day during gestation days 6 through 15 had increased craniofacial abnormalities. Fetal death
and reductions in litter size were also noted. EPA believes that there is sufficient evidence for listing lithium
carbonate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
148. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Malathion
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000121-75-5) (CERCLA) (Ref. 8). Malathion is a phosphorothioate insecticide. Its insecticidal properties
are due to cholinesterase inhibition. A 42&hyph;year old woman ingested a minimum of 120 ml of a 50 percent solution
(approximately 850 mg/kg). She quickly became comatose, cyanotic, flaccid, devoid of tendon reflexes, and miotic.
Her serum cholinesterase activity was 22 percent of normal for 9 days and her red blood cell cholinesterase activity
was 10 to 25 percent of normal for 45 days. Thirty-five cases of poisoning by ingestion were reported in India. The symptoms
observed were cyanosis, excess salivation, pinpoint pupils, pulmonary edema, and electrocardiographic abnormalities;
all of which are indicative of cholinesterase inhibition. Autopsy of the fatalities indicated damage to the myocardium.
In a 56&hyph;day study in which men were orally administered malathion, the NOEL for neurotoxic effects was 0.23 mg/kg/day
and the LOEL was 0.34 mg/kg/day. Plasma and red blood cell cholinesterase inhibition was observed at 0.34 mg/kg/day;
however, no clinical signs of overt toxicity were noted at this dose. Based on the NOEL, EPA has derived an oral RfD of
0.02 mg/kg/day for this chemical. Cholinesterase inhibition symptoms have also been observed in experimental animals
exposed to malathion. EPA believes that there is sufficient evidence for listing malathion on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the chronic neurotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity data for malathion include a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 68 ppb for rainbow trout, a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 51 ppb for sheepshead minnow, and a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 76 ppb for lake trout. In addition, the measured 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for daphnids is 0.9 ppb. EPA believes that there is sufficient evidence for listing malathion on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
149. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Man-made mineral fibers category
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAA HAP) (Ref. 7). Man-made mineral fibers are synthetic, amorphous (noncrystalline) fibers which consist of three
major groups: Glass fibers; mineral wool fibers (which includes mainly rock wool and slag wool); and refractory ceramic
fibers. Health concerns for these fibers are based on the morphological and toxicologic similarities with asbestos,
a known human carcinogen, causing lung cancer and mesotheliomas in humans and non-malignant respiratory diseases
(e.g. lung fibrosis). Injection studies, in which glass wool and glass microfibers were directly placed into the
respiratory airways, the pleural or abdominal cavities of laboratory animals, have shown consistent evidence of
carcinogenesis. Experimental studies have shown evidence of carcinogenesis by injection of rock wool and slag wool.
IARC has classified glass wool, rock wool, and slag wool fibers as Group 2B compounds, i.e., possible human carcinogens.
EPA has classified refractory ceramic fibers as Group B2 compounds, i.e., probable human carcinogen. EPA believes
that there is sufficient evidence for listing man-made mineral fibers as a category on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for these fibers. 
<!-- PJG 0012 frnewline -->
EPCRA section 313 requires threshold determinations for chemical categories to be based on the total of all chemicals
in the category manufactured, processed, or otherwise used. For example, a facility that manufactures three members
of a chemical category would count the total amount of all three chemicals manufactured towards the manufacturing
threshold for that category. When filing reports for chemical categories, the releases are determined in the same
manner as the thresholds. One report is filed for the category and all releases are reported on this form. 
<!-- PJG 0012 frnewline -->
EPA considered a number of options for listing man-made mineral fibers on EPCRA section 313. In 1977, the National
Institute for Occupational Safety and Health (NIOSH) recommended that exposures to fibers be limited to 3 fibers
per cubic centimeters (f/cc) for fibers that are less than 3.5 micrometers in diameter and longer than 10 micrometers
in length. NIOSH has since commented that in order to protect workers from lung cancer it will be necessary to lower
the exposure to 0.2 f/cc for fibrous glass. In 1992, the Occupational Safety and Health Administration (OSHA) proposed
a 1 f/cc 8&hyph;hour time-weighted average (TWA) limit for respirable fibers of fibrous glass, including refractory
ceramic fibers. Respirable fibers are generally defined as fibers with a diameter of less than 3.5 micrometers whose
length is at least 3 times the diameter (i.e., an aspect ratio (fiber length divided by fiber diameter) of 3 or greater).
In order to ease the burden of reporting, EPA considered listing fibers based on an aspect ratio that simply discriminates
between particles and fibers. This, however, seemed to be overly inclusive in that it would cover nonrespirable as
well as respirable fibers. EPA also considered using a diameter criteria without an aspect ratio but this option also
appears to be too inclusive since it may include particles as well as fibers. EPA is proposing to list man-made mineral
fibers as a category that includes glass microfibers, glass wool fibers, rock wool fibers, slag wool fibers, and refractory
ceramic fibers that have a diameter less than 3.5 micrometers and an aspect ratio greater than 3. This definition is
consistent with both the NIOSH and OSHA recommendations and is limited to fibers that are respirable. EPA requests
comment on this definition of man-made mineral fibers and any other options for defining a fibers category. 
<!-- PJG 0012 frnewline -->
150. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Mecoprop
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000093-65-2) (IARC) (Ref. 8). Mecoprop is a mono-chloro, mono-methylphenoxy isopropanoic acid type herbicide.
IARC has assigned mecoprop to Group 2B, i.e., it is possibly carcinogenic to humans. 
<!-- PJG 0012 frnewline -->
In several animal studies, changes in liver or kidney weights were the most sensitive indicators of mecoprop toxicity.
In a 90&hyph;day rat feeding study, the LOAEL was 9 mg/kg/day and the NOAEL was 3 mg/kg/day. At 26 mg/kg/day, the changes
in organ weights were accompanied by decreased glucose levels in males and increased creatinine levels in females.
EPA has derived an oral RfD of 0.001 mg/kg/day from this study. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing mecoprop on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the hepatic and renal toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
151. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2-Mercaptobenzothiazole (MBT)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000149-30-4) (TSCA) (Ref. 8). The 21&hyph;day maximum acceptable toxicant concentration (MATC) for daphnids
range from 240 to 470 ppb. The 60-day MATC for rainbow trout range from 41 to 78 ppb. EPA's exposure analysis indicates
that releases of 2-mercaptobenzothiazole will result in concentration levels that can reasonably be anticipated
to cause significant adverse environmental effects. EPA believes that there is sufficient evidence for listing
2-mercaptobenzothiazole on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental
toxicity data and exposure data for this chemical. 152. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Merphos
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000150-50-5) (FIFRA SR) (Ref. 8). Merphos is a thiophosphate-type cholinesterase inhibitor. Delayed neurotoxic
effects have been reported in a 28-year old man following accidental exposure to the chemical over a period of 3 days.
Fourteen days later, he developed complete facial diplegia and decreased conduction velocity in his nerve fibers.
He recovered completely. Both immediate and delayed neurotoxic effects following exposure to merphos have been
reported in experimental animals. In a 3&hyph;month hen feeding study the NOEL for neurotoxic effects was 0.1 mg/kg/day
and the LOEL was 0.5 mg/kg/day. At 0.5 mg/kg, hens showed delayed neurotoxicity, ataxia, and equivocal changes in
the spinal cord and peripheral nerves. Based on the NOEL, EPA derived an oral RfD of 0.00003 mg/kg/day for this chemical.
In a 112-day rat feeding study, females showed red blood cell cholinesterase inhibition at the LOEL of 0.25 mg/kg/day.
The NOEL was 0.1 mg/kg/day. In a 90&hyph;day rat feeding study, animals showed reduced brain cholinesterase activity
at the LOEL of 3.8 mg/kg/day. The NOEL was 1.8 mg/kg/day. In a 90&hyph;day dog feeding study, plasma cholinesterase
inhibition was observed at the LOEL of 2.5 mg/kg/day. The NOEL was 0.75 mg/kg/day. Fourteen cattle and 20 sheep administered
single doses of merphos (25 to 200 mg/kg) or 10 daily doses of merphos (2.5 mg/kg/day) showed emaciation, diarrhea,
and depression of blood cholinesterase. Ingested merphos is rapidly metabolized to n-butyl mercaptan within the
gastrointestinal tract. n-Butyl mercaptan has been shown to be responsible for the acute neurotoxic effects of merphos.
Thus, oral exposure to merphos is expected to cause acute neurotoxic symptoms while dermal exposure to merphos is
expected to cause delayed neurotoxic symptoms. EPA believes that there is sufficient evidence for listing merphos
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the chronic neurotoxicity data for this chemical.

<!-- PJG 0012 frnewline -->
153. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Metham sodium (sodium methyldithiocarbamate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000137-42-8) (FIFRA AI) (Ref. 3). Postimplanatation loss was observed in rabbits administered metham sodium
at 30 mg/kg/day (LOEL) on days 6 to 18 of gestation. The NOEL was 10 mg/kg/day (4.2 mg/kg/day based on active ingredient).
In rats fed metham sodium, increased variations, retardations, and anomalies were reported at doses of 10 mg/kg/day
(LOEL) administered on days 6 to 15. The NOEL was less than or equal to 10 mg/kg/day (less than or equal to 4.2 mg/kg/day
based on active ingredient). Although neither study was considered to be fully adequate due to study design and reporting
deficiencies, the weight of evidence indicates that metham sodium induces developmental toxicity. In addition,
metham sodium is metabolized to carbon disulfide, a potent developmental toxicant. EPA believes that there is sufficient
evidence for listing metham sodium on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
developmental toxicity data for this chemical and its metabolite, carbon disulfide. 
<!-- PJG 0012 frnewline -->
154. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methazole (2-(3,4-dichlorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5-dione)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 020354-26-1) (FIFRA AI) (Ref. 3). Rabbits receiving 30 or 60 mg/kg/day by gavage on days 6 to 18 of gestation
exhibited increased embryolethality. The NOEL was 10 mg/kg/day. EPA believes that there is sufficient evidence
for listing methazole on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental
toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
155. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methiocarb
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002032-65-7) (CERCLA; EPCRA EHS) (Ref. 8). Measured terrestrial acute toxicity data for wildlife include
an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.6 mg/kg for red-winged blackbirds. EPA believes that there is sufficient evidence for listing methiocarb on
EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
156. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methoxone ((4-Chloro-2-methylphenoxy) acetic acid) (MCPA)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000094-74-6) (FIFRA SR; IARC) (Ref. 8). Methoxone is a chlorophenoxy-type herbicide. Animal studies indicate
that the kidney and liver are the primary target organs of methoxone toxicity. Beagle dogs fed diets containing methoxone
for 1&hyph;year developed liver toxicity, which was demonstrated by increased liver weights associated with alterations
in serum glutamate-pyruvate transaminase, serum glutamate-oxaloacetate transaminase, bilirubin, triglyceride
and cholesterol levels. These effects occurred at doses of 0.75 mg/kg/day (LOAEL) and higher. The NOAEL was 0.15 mg/kg/day.
Kidney changes in the treated animals included deposition of kidney pigment in the proximal tubular epithelium (the
LOAEL was 0.75 mg/kg/day; the NOAEL was 0.15 mg/kg/day), and was accompanied by alterations in creatinine, urea,
and potassium levels. EPA derived an oral RfD of 0.0005 mg/kg/day from this study. Similar changes suggesting liver
and kidney toxicity were reported in another 90&hyph;day dog feeding study (the LOAEL was 3 mg/kg/day; the NOAEL was
1 mg/kg/day) and in rats in a 90&hyph;day feeding study (the LOAEL was 7.5 mg/kg/day; the NOAEL was 2.5 mg/kg/day).

<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing methoxone on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic and renal toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
157. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methoxone sodium salt ((4-chloro-2-methylphenoxy) acetate sodium salt)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 003653-48-3) (FIFRA SR; IARC) (Ref. 8). Methoxone sodium salt is a chlorophenoxy-type herbicide. Animal
studies indicate that the kidney and liver are the primary target organs of methoxone toxicity. Beagle dogs fed diets
containing methoxone for 1&hyph;year developed liver toxicity, which was demonstrated by increased liver weights
associated with alterations in serum glutamate-pyruvate transaminase, serum glutamate-oxaloacetate transaminase,
bilirubin, triglyceride and cholesterol levels. These effects occurred at doses of 0.75 mg/kg/day (LOAEL) and higher.
The NOAEL was 0.15 mg/kg/day. Kidney changes in the treated animals included deposition of kidney pigment in the proximal
tubular epithelium (the LOAEL was 0.75 mg/kg/day; the NOAEL was 0.15 mg/kg/day), and was accompanied by alterations
in creatinine, urea, and potassium levels. EPA derived an oral RfD of 0.0005 mg/kg/day from this study. Similar changes
suggesting liver and kidney toxicity were reported in another 90&hyph;day dog feeding study (the LOAEL was 3 mg/kg/day;
the NOAEL was 1 mg/kg/day) and in rats in a 90&hyph;day feeding study (the LOAEL was 7.5 mg/kg/day; the NOAEL was 2.5
mg/kg/day). 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing methoxone sodium salt on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(B) based on its potential to cause cancer and on the available hepatic and renal toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
158. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1,1-Methylene bis(4-isocyanatocyclohexane)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 005124-30-1) (TSCA) (Ref. 8). The 5&hyph;hour rat inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value for 1,1-methylenebis(4-isocyanatocyclohexane) is 0.21 mg/L. The 3&hyph;hour mouse inhalation RD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (50 percent reduction in respiratory rate) value is 0.027 mg/L. In addition, isocyanates as a class are generally
severe skin, eye, and respiratory irritants. EPA's exposure analysis indicates that 1,1-methylenebis(4-isocyanatocyclohexane)
concentrations are likely to exist beyond facility site boundaries, as a result of continuous, or frequently recurring
releases, at levels that can reasonably be anticipated to cause significant adverse acute human health effects.
EPA believes that there is sufficient evidence for listing 1,1-methylenebis(4-isocyanatocyclohexane) on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data for this
chemical. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As detailed in Unit IV.B.132. of this preamble, as an alternative proposal to the individual listing of HDI, isophorone
diisocyanate, and 1,1-methylene bis(4-isocyanatocyclohexane), EPA is proposing to create a diisocyanates category
that includes HDI, isophorone diisocyanate, 1,1-methylene bis(4-isocyanatocyclohexane), and 16 other diisocyanates.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
159. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methylene bis(thiocyanate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 006317-18-6) (FIFRA AI) (Ref. 3). The minimal human lethal dose for methylene bis(thiocyanate) is 15 to 30
g (214 to 429 mg/kg), although fatalities have been reported at 300 mg (4.3 mg/kg). Clinical effects may include decreased
blood pressure, apnea, cerebral excitation, convulsions, coma, vomiting, diarrhea, abdominal cramping, albuminuria,
skin rashes, exfoliative dermatitis, muscle weakness, goiter, and toxic psychosis. The intravenous mouse LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is 3.6 mg/kg. The subcutaneous rabbit DLo is 20 mg/kg; convulsions and lowered blood pressure were observed in this
study. EPA believes that there is sufficient evidence for listing methylene bis(thiocyanate) on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(B) based on the available neurological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
160. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methyl isothiocyanate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 00556-61-6) (FIFRA AI) (Ref. 3). Aquatic acute toxicity values for methyl isothiocyanate include a fish
96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 94 ppb, a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 130 ppb for bluegills, and a daphnid 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 55 ppb. EPA believes that there is sufficient evidence for listing methyl isothiocyanate on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
161. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2-Methyllactonitrile
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000075-86-5) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). 2-Methyllactonitrile belongs to a class of
substances known as the cyanohydrins. Cyanohydrins are generally quite toxic because they can release hydrogen
cyanide. An oral dose of 5 mg/rat (approximately 14 mg/kg) of 2-methyllactonitrile administered twice weekly for
3 to 8 months produced liver and kidney lesions. Inhalation of 10.2 mg/L 
<!-- PJG 0012 frnewline -->
twice weekly for 3 to 8 months (duration of each individual exposure not reported) produced kidney lesions, desquamation
of the bronchial epithelium, and bronchial ulcerations. EPA believes that there is sufficient evidence for listing
2-methyllactonitrile on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the chronic toxic effects
to the liver, kidney, and bronchi caused by this chemical. 
<!-- PJG 0012 frnewline -->
162. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
N-Methylolacrylamide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000924-42-5) (CAL) (Ref. 8). There was clear evidence of carcinogenicity from N-methylolacrylamide in
a 2&hyph;year study using B6C3F1 mice administered the substance by oral gavage. In both sexes, there were increased
incidences of Harderian gland adenomas or carcinomas, hepatocellular adenomas or carcinomas, and alveolar or bronchiolar
adenomas and carcinomas. There was also an increase in ovarian granulosa cell tumors. EPA believes that there is sufficient
evidence for listing N-methylolacrylamide on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on
the carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
163. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methyl parathion
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000298-00-0) (CERCLA; FIFRA SR; RCRA APP8; RCRA P) (Ref. 8). Methyl parathion is a thiophosphate-type cholinesterase
inhibitor. Methyl parathion is highly toxic when administered to experimental animals at low doses. The rat and mouse
oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values are reported to be 6.01 mg/kg and 18 mg/kg, respectively. The rat and mouse 4-hour inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values are reported to be 0.034 mg/L and 0.12 mg/L, respectively, at which symptoms of cholinesterase inhibition
were observed. 
<!-- PJG 0012 frnewline -->
Human volunteers showed a 37 percent decrease in red blood cell cholinesterase activity following oral administration
of 0.43 mg/kg/day of methyl parathion for 10 days. The LOEL was 0.43 mg/kg/day and the NOEL was 0.31 mg/kg/day. In a 90&hyph;day
dog feeding study, brain, red blood cell, and plasma cholinesterase inhibition was observed at the LOEL of 1.0 mg/kg/day.
The NOEL was 0.3 mg/kg/day. In a chronic rat feeding study, plasma and erythrocyte cholinesterase were inhibited
throughout the study and brain cholinesterase was depressed at the termination of the study at 2.5 mg/kg/day. The
NOEL for systemic toxicity was 0.025 mg/kg/day. An adequate NOEL for neurologic changes was not defined. Overt signs
of cholinergic toxicity (tremors, abnormal gait, alopecia) were observed in the animals at a dose of 2.5 mg/kg/day.
Histologic examination revealed evidence of peripheral neuropathy in animals administered this dose. EPA has derived
an oral RfD of 0.00025 mg/kg/day based on the systemic NOEL for this chemical. Hepatocellular swelling, degeneration,
and fatty change have been observed in humans acutely intoxicated with methyl parathion. Hepatocellular changes
were observed in patients that survived for 28 hours to 9 days after intoxication. Methyl parathion was orally administered
to rats in increasing doses for 36 days (starting with 0.37 mg/kg/day and increasing by a factor of 1.5 on every 4th day).
Weight loss, hyperglycemia, and macrocytic anemia, all secondary to hepatotoxicity, were observed. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing methyl parathion on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the chronic neurotoxicity and hepatic toxicity data for this chemical. Measured aquatic
acute toxicity data for methyl parathion include a 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.14 ppb for daphnids and a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 15 ppb for crayfish. EPA believes that there is sufficient evidence for listing methyl parathion on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
164. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
N-Methyl-2-pyrrolidone
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000872-50-4) (TSCA) (Ref. 8). In a 2&hyph;generation reproductive study, there was evidence of reproductive
toxicity in the F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 generation after exposure to 50 mg/kg/day (LOAEL; no NOAEL was established). Exposure to 50 mg/kg/day or more resulted
in significant reductions in the male fertility index and in the female fecundity index. In addition, exposure to
500 mg/kg/day resulted in an increased incidence of dams with decreased corpora lutea. There was also evidence of
developmental toxicity in both generations after exposure to 500 mg/kg/day as demonstrated by reduced litter size,
reduced postnatal survival, and reduced pup weight. 
<!-- PJG 0012 frnewline -->
Maternal toxicity (significant reduction in mean body weight gain) was observed in rabbits receiving 175 mg/kg by
gavage on days 6 through 18 of gestation (The NOAEL was 55 mg/kg/day). Exposure to 540 mg/kg/day (LOAEL) resulted in
developmental toxicity as demonstrated by a significant increase in resorptions, and malformations (misshapen
skull bone and cardiovascular malformations). The NOAEL for developmental toxicity was 175 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing N-methylpyrrolidone on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(B) based on the available developmental and reproductive toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
165. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Methyltrichlorosilane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000075-79-6) (EPCRA EHS) (Ref. 8). As a class, chlorinated silanes are very corrosive to the skin and mucous
membranes and liberate hydrochloric acid in the presence of water. Methyltrichlorosilane causes severe burns and
the vapor is harmful to humans. The 2&hyph;hour mouse inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value is 0.180 mg/L. EPA's exposure analysis indicates that methyltrichlorosilane concentrations are likely to
exist beyond facility site boundaries, as a result of continuous, or frequently recurring releases, at levels that
can reasonably be anticipated to cause significant adverse acute human health effects. EPA believes that there is
sufficient evidence for listing methyltrichlorosilane on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A)
based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
166. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Metiram
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 009006-42-2) (FIFRA SR) (Ref. 8). Metiram is an ethylene bisdithiocarbamate (EBDC) fungicide. Evidence
suggests that ethylene bisthiocarbamate fungicides and ethylenethiourea (a common contaminant, metabolite,
and degradation product of these fungicides) cause cancer and adverse developmental effects in experimental animals.
In a 2&hyph;year diet study, ethylenethiourea caused liver adenomas and carcinomas in mice, and thyroid follicular
cell adenomas and carcinomas in mice and rats. A NOAEL of less than or equal to 5 mg/kg has been reported for ethylenethiourea,
based on a rat developmental toxicity study. Ethylenethiourea caused delayed ossification or hardening of the parietal
bone in pups. EPA believes that there is sufficient evidence for listing metiram on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the carcinogenicity and developmental toxicity data for ethylenethiourea, a metabolite
and degradation product of metiram. 
<!-- PJG 0012 frnewline -->
In Unit IV.B.172. of this preamble, EPA is proposing to add another ethylene bisdithiocarbamate (EBDC), nabam. An
additional two EBDCs, zineb and maneb, are currently individually listed on the EPCRA section 313 list of toxic chemicals.
The category of EBDCs has recently been added to EPCRA section 313 (December 1, 1993, 58 FR 63500). EPA requests comment
on the following: (1) Should the individual EBDCs, metiram and nabam, be added individually to EPCRA section 313 even
though they are members of the EBDC category, which is listed on EPCRA section 313; and (2) should the individual listings
for two EBDCs, zineb and maneb, be deleted and added as members of the newly created EBDC category. 
<!-- PJG 0012 frnewline -->
167. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Metribuzin
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 021087-64-5) (FIFRA AI) (Ref. 3). In a rabbit teratology study, the NOEL for maternal and fetotoxicity was
15 mg/kg/day, and the LOEL was 45 mg/kg/day. Developmental effects including irregular spinus process and decreased
pup body weight were observed in rats treated with metribuzin (Sencor) during gestation day 7 to 19 at 85 mg/kg/day
(LOEL). The NOEL for developmental toxicity was 30 mg/kg/day. The LOEL and NOEL for maternal toxicity were 30 and 10
mg/kg/day, respectively. 
<!-- PJG 0012 frnewline -->
In a 2&hyph;year dog feeding study, adverse effects observed at 1,500 ppm (37.5 mg/kg/day; LOEL) included weight
reduction, increased mortality, hematologic changes, and liver/kidney damage. The systemic NOEL was 100 ppm (2.5
mg/kg/day). In a 2&hyph;year rat feeding study, decreased weight gain, mortality, and pathological changes in the
liver and kidney were observed at 300 ppm (15 mg/kg/day). The NOEL was 100 ppm (5 mg/kg/day). 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing metribuzin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic, renal, and developmental toxicity data for this chemical. 168. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Mevinphos
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007786-34-7) (CERCLA; EPCRA EHS) (Ref. 8). Measured aquatic acute toxicity values for mevinphos include
a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 70 ppb for bluegills, and a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.16 ppb for daphnids. Measured acute avian toxicity data include a pheasant oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.37 mg/kg, a mallard duck oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.63 mg/kg, and a sharp-tailed grouse oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.34 mg/kg. EPA believes that there is sufficient evidence for listing mevinphos on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
169. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Molinate (1H-azepine-1-carbothioic acid, hexahydro-S-ethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002212-67-1) (FIFRA AI) (Ref 3). In a rat developmental toxicity study, adverse effects observed following
administration of molinate at 35 mg/kg/day (LOEL) included increased post-implantation loss, lower fetal body
weight, increased incidence of runts, and external/soft tissue/skeletal variants; the NOEL was 2.2 mg/kg. In a rabbit
developmental study, adverse effects such as an increase in the number of abortions, and a decrease in the number of
females with live fetuses were noted at 200 mg/kg/day. The NOEL was 20 mg/kg/day. The developmental effects were observed
at levels which were toxic to maternal animals. 
<!-- PJG 0012 frnewline -->
In a rat fertility test, reductions in fertility, dose-related altered sperm morphology, and a reduction in the number
of viable fetuses were observed following administration of molinate. The NOEL was 0.2 mg/kg/day and the LOEL was
4 mg/kg/day. Based on the NOEL of the study, an oral RfD of 0.002 mg/kg/day was derived. In a 90&hyph;day study in male
rats, the lowest toxic oral dose of 324 mg/kg produced adverse effects on spermatogenesis, male fertility, and viability
index. The 20&hyph;day inhalation male rat lowest-toxic contentration (TCLo) is 0.0006 mg/L. At this exposure level
adverse effects on spermatogenesis and male fertility index were reported. In a 2-generation rat reproduction study,
the reproductive NOEL was 0.3 mg/kg/day, and the LOEL was 2.5 mg/kg/day based on reduced fecundity and increased incidence
of ovarian vacuolation/hypertrophy. In a 3&hyph;month rat inhalation study, testicular degeneration and abnormal
spermatozoa were observed at 0.002 mg/L (LOEL). No NOEL was determined. 
<!-- PJG 0012 frnewline -->
In a 2&hyph;year study in rats fed molinate, adverse effects seen at 0.35 mg/kg/day included degeneration and demyelination
of the sciatic nerve and skeletal muscle atrophy/reserve cell hyperplasia; no NOEL was determined. In a 1&hyph;year
study in dogs administered molinate orally, adverse effects observed at 50 mg/kg/day included anemia, loss of ability
to bark, ataxia, splayed hind limbs, vacuolation of the medulla, demyelination of the pons and spinal cord, tremors,
and eosinophilic bodies in the nervous system. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing molinate on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available developmental, reproductive, and neurological toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
170. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Monuron
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000150-68-5) (FIFRA SR) (Ref. 8). The measured aquatic toxicity data for monuron include a 1.5-hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 90 ppb and a 10-day EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 100 ppb for marine algae. EPA believes that there is sufficient evidence for listing monuron on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
171. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Myclobutanil (alpha-butyl-alpha-(4-chlorophenyl)-1H-1,2,4-triazole-1-propanenitrile)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 088671-89-0) (FIFRA AI) (Ref. 3). Hepatocellular hypertrophy (the LOEL was 5.9 mg/kg/day; the NOEL was 0.3
mg/kg/day) was seen in a 90&hyph;day feeding study in dogs. In another 90&hyph;day feeding study, hepatocellular
necrosis and hypertrophy (the LOEL was 147.2 mg/kg/day; the NOEL was 49.1 mg/kg/day) were observed in rats. Hepatocellular
hypertrophy (the LOEL was 14.3 mg/kg/day in males and 15.7 mg/kg/day in females; the NOEL was 3.1 mg/kg/day in males
and 3.83 mg/kg/day in females) was noted in a 1&hyph;year feeding study in dogs. Hepatic effects (centrilobular hepatocytic
hypertrophy, kupffer cell pigmentation, periportal vacuolation and altered foci) were observed in mice fed 75 mg/kg/day
myclobutanil for 2 years. At 15 mg/kg/day, increased liver mixed function oxidase (the NOEL was 3 mg/kg/day) was also
seen. 
<!-- PJG 0012 frnewline -->
Testicular atrophy (the LOEL was 9.84 mg/kg/day; the NOEL was 2.49 mg/kg/day) was observed in a 2&hyph;year chronic
feeding study in rats. The seminiferous tubules were frequently devoid of spermatid formation and germinal epithelial
cells. Based on the NOEL, an oral RfD of 0.025 mg/kg/day was derived. Testicular atrophy (the LOEL was 46.4 mg/kg/day;
the NOEL was 9.28 mg/kg/day) was also noted in a 2-generation reproduction study.
<!-- PJG 0012 frnewline -->
In a developmental toxicity study in rats, increased resorption and decreased viability were observed at 93.8 mg/kg/day
(LOEL). The NOEL was 31.3 mg/kg/day. In a developmental toxicity study in rabbits, an increased number of resorptions
per litter, reduced viability index, and reduced litter size were observed at 200 mg/kg/day (LOEL). The NOEL was 60
mg/kg/day.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing myclobutanil on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic, reproductive, and developmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
172. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nabam
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000142-59-6) (FIFRA SR) (Ref. 8). Nabam is an ethylene bisthiocarbamate fungicide. Evidence suggests that
ethylene bisthiocarbamate fungicides and ethylenethiourea (a common contaminant, metabolite, and degradation
product of these fungicides) cause cancer and adverse developmental effects in experimental animals. In a 2&hyph;year
diet study ethylenethiourea caused liver adenomas and carcinomas in mice, and thyroid follicular cell adenomas
and carcinomas in mice and rats. A NOAEL of less than or equal to 5 mg/kg has been reported for ethylenethiourea, based
on a rat developmental toxicity study. Ethylenethiourea caused delayed ossification or hardening of the parietal
bone in pups. EPA believes that there is sufficient evidence for listing nabam on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the carcinogenicity and developmental toxicity data for ethylenethiourea, a metabolite
and degradation product of nabam.
<!-- PJG 0012 frnewline -->
173. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Naled
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000300-76-5) (CERCLA; FIFRA SR) (Ref. 8). Naled is an organophosphate-type cholinesterase inhibitor.
In a human acute poisoning case, toxic symptoms included abdominal cramps, hypersecretion, emesis, perspiration,
anxiety, vertigo and horizontal nystagmus, and persisted for 4 months. In a 2&hyph;year rat feeding study the NOEL
for neurotoxic effects was 0.2 mg/kg/day and the LOEL was 2.0 mg/kg/day. It was observed in this study that, at 2.0 mg/kg/day,
brain cholinesterase activity was inhibited by approximately 24 percent. At 10.0 mg/kg/day, brain cholinesterase
activity was inhibited by approximately 60 percent, and both plasma and red blood cell cholinesterase were also inhibited.
Based on the NOEL, EPA has an oral RfD of 0.002 mg/kg/day for this chemical. In a 1-year feeding study using dogs as the
test species, plasma and red blood cell cholinesterase activity were inhibited at 2.0 mg/kg/day. The NOEL was 0.2
mg/kg/day and the LOEL was 2.0 mg/kg/day.
<!-- PJG 0012 frnewline -->
In a 2-generation reproduction study of naled in rats, the NOEL was 6 mg/kg/day. At 18 mg/kg/day, decreased litter
size, survival, and pup body weight were observed.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing naled on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the chronic neurotoxicity and reproductive toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity values for naled include a 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.35 ppb for daphnids and a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 87 ppb for lake trout. EPA believes that there is sufficient evidence for listing naled on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
174. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nicotine and salts
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAL; CERCLA; EPCRA EHS; FIFRA AI; RCRA APP8; RCRA P) (Ref. 8). Nicotine salts will dissociate in aqueous solutions
to yield soluble nicotine. Nicotine is highly toxic in humans. The estimated lethal oral dose in adults is approximately
40 to 60 mg. The onset of toxicity is rapid. Symptoms include nausea, salivation, abdominal pain, vomiting, diarrhea,
headache, weakness, sweating, and confusion. Nicotine markedly stimulates the central nervous system, causing
tremors and convulsions. The stimulation is followed by depression, and death resulting from paralysis of respiratory
muscles. Nicotine can also activate parasympathetic ganglia and cholinergic nerve endings resulting in gastrointestinal
hyperactivity.
<!-- PJG 0012 frnewline -->
Skeletal defects and occasional cleft palates were observed in mice injected with 25 mg/kg nicotine on gestation
days 9 to 11. Reduced size in the newborn of rats and limb deformities in the offspring of swine were reported in swine
and rats following oral exposure to 1,058 ppm nicotine (approximately 53 mg/kg/day). Deformities were found in some
rabbit fetuses when dams were administered nicotine at a dose of 20 mg/kg 5 times during pregnancy. Pregnant swine
fed aqueous leaf extracts of tobacco at the rate of 16 and 32 mg/kg nicotine produced arthrogrypotic newborn pigs.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing nicotine and its salts as a category on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(B) based on the developmental toxicity data for these substances. EPCRA section
313 requires threshold determinations for chemical categories to be based on the total of all chemicals in the category
manufactured, processed, or otherwise used. For example, a facility that manufactures three members of a chemical
category would count the total amount of all three chemicals manufactured towards the manufacturing threshold for
that category. When filing reports for chemical categories, the releases are determined in the same manner as the
thresholds. One report if filed for the category and all releases are reported on this form. 
<!-- PJG 0012 frnewline -->
175. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nitrapyrin (2-chloro-6-(trichloromethyl) pyridine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001929-82-4) (FIFRA AI) (Ref. 3). In a 1&hyph;year study in dogs fed nitrapyrin adverse effects noted included
increased cholesterol and alkaline phosphatase, increased absolute and relative liver weight and panlobular/centrilobular
hepatocellular hypertrophy. The NOEL was 3 mg/kg/day and the LOEL was 15 mg/kg/day. In a 10&hyph;week reproductive
rat study, adverse effects observed included increased incidence of fetal liver hypertrophy and vacuolization
at 75 mg/kg/day (LOEL). The NOEL was 20 mg/kg/day. In a 90&hyph;day rat feeding study, hepatocellular fatty change
and necrosis, renal tubule epithelial cell swelling and increasingly severe interstitial nephritis were observed
at 50 mg/kg/day. The NOEL was 15 mg/kg/day. In a 2&hyph;year rat feeding study, an increase in glomerulonephropathy
was observed in males dosed with 60 mg/kg/day and an increase in hepatic hypertrophy and vacuolization was observed
in males and females dosed with 60 mg/kg/day. The NOEL was 20 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Increased incidence of crooked hyoid bone and craniofacial abnormalities were observed in the offspring of rabbits
orally administered nitrapyrin at 30 mg/kg/day (LOEL) on days 6 through 18 of gestation. The NOEL was 10 mg/kg/day.
Decreased weight and hypertrophy and vacuolization of the liver were observed in offspring of rats dosed with 75 mg/kg/day
(LOEL) for 10 weeks prior to mating. The NOEL was 20 mg/kg/day. EPA believes that there is sufficient evidence for listing
nitrapyrin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available renal, hepatic, and
developmental toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
176. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nitrate ion
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 014797-55-8) (SDWA) (Ref. 8). Nitrate refers to the nitrate ion (NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). Infantile methemoglobinemia occurs in human infants exposed to aqueous solutions of nitrate ion and can progress
to cyanosis and death. Based on numerous epidemiological and clinical studies, EPA has determined a LOAEL of 1.8 to
3.2 mg/kg/day and a NOAEL and RfD of 1.6 mg/kg/day, corresponding to 10 mg/L nitrate-nitrogen or 44 mg/L nitrate ion
in drinking water. Infants weighing an average of 4 kg (0 to 3 months of age) are the most sensitive population to nitrate-induced
methemoglobinemia. This is primarily due to their higher stomach pH which favors the growth of nitrate-reducing
bacteria, the immaturity of their metabolic enzyme systems, and reduced capacity of their erythrocytes to reduce
methemoglobin to hemoglobin. EPA believes that there is sufficient evidence for listing nitrate ion on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available hematological toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
In nitrogen-limited waters, nitrates have the potential to cause increased algal growth leading to eutrophication
in the aquatic environment. (Nitrate-nitrogen is the form of nitrogen most available to plants.) Studies of estuarine
water at several locations along the eastern coast of the United States have indicated that low concentrations of
dissolved nitrogen (e.g., nitrate) limit primary production of plants. 
<!-- PJG 0012 frnewline -->
Additions of nitrate to such estuarine systems stimulate primary production of plants and can produce changes in
the dominant species of plants, leading to cultural eutrophication and ultimately to deterioration of water quality,
including algal blooms.
<!-- PJG 0012 frnewline -->
It has been determined that lakes with a spring maximum concentration of more than 300 ug/L of inorganic nitrogen (e.g.,
nitrates) could be expected to have algal nuisances in the summer. 
<!-- PJG 0012 frnewline -->
Toxic effects result from oxygen depletion as the algae die and decay. Toxic effects have also been related to the release
of decay products or direct excretion of toxic substances from sources such as blue-green algae. EPA believes that
there is sufficient evidence for listing nitrate ion on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C)
based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
177. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nitric oxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010102-43-9) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). The acute toxicity of nitric oxide has been rated
high. Nitric oxide causes death or permanent injury after very short exposure to small quantities. Exposure to nitric
oxide can result in acute and chronic changes of the pulmonary system including pulmonary edema, pneumonitis, bronchitis,
bronchiolitis, emphysema, and methemoglobinemia. Neurologic effects (fatigue, restlessness, anxiety, mental
confusion, lethargy, loss of consciousness) have also been reported. The effects of nitric oxide may be related to
the formation of methemoglobin. EPA believes that there is sufficient evidence for listing nitric oxide on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available neurological and hematological toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
178. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
p-Nitroaniline
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000100-01-6) (CERCLA; RCRA APP8; RCRA P) (Ref. 8). In a 14&hyph;day study in mice fed p-nitroaniline in doses
as low as 10 mg/kg, 5 days per week, methemoglobin concentrations were found to be significantly higher than those
in control animals. In the same study, hematocrit values in mice that received 300 mg/kg, and total erythrocyte counts
in mice that received 100 or 300 mg/kg, were significantly lower than those of control animals. Similar effects were
observed in 13&hyph;week and 2&hyph;year mouse studies. In the 2&hyph;year study, lesions related to the administration
of p-nitroaniline occurred in the spleen, liver, and bone marrow (primarily in mice receiving 30 or 100 mg/kg) and
were observed at 9 and 15 months. In addition, increases in the incidence or severity of splenic congestion, hematopoiesis,
pigment (hemosiderin) accumulation, Kupffer cell pigmentation in the liver, and bone marrow hypercellularity
(hyperplasia). EPA believes that there is sufficient evidence for listing p-nitroaniline on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the chronic toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
179. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Nitrogen dioxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010102-44-0) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). Acid precipitation occurs in large regions
of the Eastern United States and Canada, Europe, and Japan. This widespread occurrence of acid precipitation and
dry deposition results in large part from man-made emissions of oxides of sulfur and nitrogen (e.g., nitrogen dioxide).
These substances are transformed in the atmosphere into sulfuric acid and nitric acid, transported over great distances
and deposited on vegetation, soils, surface waters, and materials. These substances are transferred from the atmosphere
into ecosystems by the absorption of gases, the impaction and gravitational settling of fine aerosols and coarse
particles, and precipitation. 
<!-- PJG 0012 frnewline -->
Acids contained in polluted snow are released as contaminated meltwater. The resulting release of pollutants can
cause major or rapid changes in the acidity of streams and lake waters. Interference with normal reproduction in fish
populations is induced by acidity of lake and stream waters. Reproduction of frogs and salamanders is also inhibited
by atmospheric acidification of surface waters. 
<!-- PJG 0012 frnewline -->
Atmospheric deposition of sulfuric acid and nitric acid can cause serious damage to crops and forests. Biological
effects include induction of necrotic lesions, loss of nutrients due to leaching from foliar organs, accelerated
erosion of waxes and leaf surfaces, and interference with normal reproductive processes. Acidification also decreases
the rate of many soil processes such as nitrogen fixation and the breakdown of organic matter. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing nitrogen dioxide on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Nitrogen dioxide is regulated under Title I of the CAA (Provisions for Attainment and Maintenance of National Ambient
Air Quality Standards). In addition to this proposal to add nitrogen dioxide to EPCRA section 313, in Units IV.B.36.
and 235, EPA is proposing to add two other chemicals, carbon monoxide and sulfur dioxide, that are regulated by Title
I of the CAA. Sulfur dioxide is also regulated by Title IV of the CAA (Acid Deposition Control). Extensive data, which
are highly technical, are collected on these chemicals as required by the CAA. EPA requests comment on the following:
(1) Is the information collected under the CAA sufficient for public right-to-know purposes; and (2) suggestions
on how the data collected on these chemicals pursuant to CAA Titles I and IV could be used to meet the purposes of EPCRA
section 313. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
180. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Norflurazon (4-Chloro-5-(methylamino)-2-[3(trifluoromethyl)phenyl]-3(2H)-pyridazinone)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 027314-13-2) (FIFRA AI) (Ref. 3). Congestion of the liver, hepatocyte swelling and increased liver weights,
and increase in colloid vacuole in the thyroid were observed in dogs fed 450 ppm (10.25 mg/kg/day) norflurazon for
6 months. The NOEL was 150 ppm (3.75 mg/kg/day). An oral RfD of 0.04 mg/kg/day has been determined. Increased relative
liver weight and hypertrophy of the thyroid with depletion of colloid were seen in rats fed 2,500 ppm (125 mg/kg/day)
norflurazon for 90 days. The NOEL was 500 ppm (25 mg/kg/day). Hepatic hyperplasia and hypertrophy and increased relative
liver weight were noted in a 28&hyph;day feeding study in rats. The LOEL was 1,000 ppm (50 mg/kg/day) and the NOEL was
500 ppm (25 mg/kg/day). Increased relative liver weight and diffuse and smooth granular livers were seen in a 28&hyph;day
feeding study in mice. The LOEL was 2,520 ppm (328 mg/kg/day) and the NOEL was 420 ppm (55 mg/kg/day). EPA believes that
there is sufficient evidence for listing norflurazon on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available hepatic and thyroid toxicity data.
<!-- PJG 0012 frnewline -->
181. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Oryzalin (4-(Dipropylamino)-3,5-dinitrobenzene sulfonamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 019044-88-3) (FIFRA AI) (Ref. 3). Reduced hemoglobin and hematocrit levels, decreased red blood cell count,
increased blood urea nitrogen (BUN) and alkaline phosphatase and SGPT, anemia, hepatic changes, splenic hematopoiesis
and hyperplastic bone marrow were observed in dogs fed 56.25 mg/kg/day (the NOEL was 18.75 mg/kg/day) for 3 months.
Increases in serum cholesterol levels, alkaline phosphatase activity, and relative liver and kidney weights and
decreases in alanine transaminase (the LOEL was 50 mg/kg/day; the NOEL was 5 mg/kg/day) were observed in dogs fed oryzalin
for 1&hyph;year. Decreased red blood cell count and hematocrit and hemoglobin levels (LOEL was 45 mg/kg/day; NOEL
was 15 mg/kg/day) were noted in a 1-year feeding study in rats. In a 2&hyph;year feeding study in rats, decreased red
blood cell count and hematocrit and hemoglobin levels, and increased BUN and liver and kidney weights (the LOEL was
45 mg/kg/day; the NOEL was 15 mg/kg/day) were observed. EPA believes that there is sufficient evidence for listing
oryzalin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatic and hematological
toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
182. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Oxydemeton methyl (S-(2-(Ethylsulfinyl)ethyl) O,O-dimethyl ester phosphorothioic acid)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000301-12-2) (FIFRA AI) (Ref. 3). Two multigeneration reproduction studies indicate a variety of reproductive
effects at 2.1 to 2.5 mg/kg/day. These effects include decreased litter size and viability, decreased weight of the
testes and ovaries, and increased epididymal vacuolation. The NOELs were 0.38 and 0.5 mg/kg/day. A NOEL of 0.9 mg/kg/day
was determined in a 5&hyph;day study in the rat. The LOEL for decreased fertility and epididymal sperm motility was
5 mg/kg/day.
<!-- PJG 0012 frnewline -->
Oxydemeton methyl can cause inhibition of brain, plasma, and red blood cell cholinesterase. In a 2-generation reproduction
study, statistically significant inhibition of red blood cell and brain cholinesterase activity (the NOEL was less
than 0.043 mg/kg/day) was observed in adult males and females of the F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
0
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and F
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 generations. In a 5&hyph;day feeding (dominant lethal plus) study, inhibition of plasma cholinesterase activity
(the LOEL was 1.5 mg/kg/day; the NOEL was 0.45 mg/kg/day) was observed. EPA believes that there is sufficient evidence
for listing oxydemeton methyl on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
reproductive and neurological toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
183. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Oxydiazon (3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]5- (1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 019666-30-9) (FIFRA AI) (Ref. 3). Rats given 40 mg/kg/day by gavage on days 6 to 15 of gestation exhibited increased
fetal resorptions. The NOEL was 12 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Increased liver and kidney weight (associated with no pathology) and increased alkaline phosphatase activity were
observed in rats fed 100 mg/kg/day (the NOEL was 25 mg/kg/day) for 90 days. Increased levels of SGPT and alkaline phosphatase
activities and increased liver weight (the LOEL was 5 mg/kg/day; the NOEL was 0.5 mg/kg/day) were observed in a 2&hyph;year
feeding study in rats. Effects noted at 150 mg/kg/day included liver pathology, hemolytic anemia, increased kidney
weight, and pigment nephrosis. Based on the NOEL, an oral RfD of 0.005 mg/kg/day was derived. EPA believes that there
is sufficient evidence for listing oxydiazon on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on
the available developmental, hepatic, and renal toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
184. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Oxyfluorfen
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 042874-03-3) (FIFRA SR) (Ref. 8). Oxyfluorfen is a phenoxyphenyl-type herbicide. Several chronic oral
toxicity studies suggest that oxyfluorfen may be hepatotoxic. Hepatic effects (e.g. increased absolute liver weight,
necrosis, regeneration, and hyperplastic nodules) were observed in mice fed diets containing greater than 3 mg/kg/day
oxyfluorfen for 20 months (the NOEL was 0.3 mg/kg/day). Based on these findings, an oral RfD value of 0.003 mg/kg/day
was derived. This study was supported by other chronic feeding studies that demonstrated increases in liver weight,
alkaline phosphatase activity, and bile pigmented hepatocytes (the LOEL was 15 mg/kg/day; the NOEL was 2.5 mg/kg/day)
in dogs, and minimal hypertrophy of centrilobular hepatocytes (the LOEL was 40 mg/kg/day; the NOEL was 2 mg/kg/day)
in rats. EPA believes that there is sufficient evidence for listing oxyfluorfen on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the hepatotoxic effects of this chemical.
<!-- PJG 0012 frnewline -->
The estimated chronic MATC values for fish and daphnids are 9 ppb and 20 ppb oxyfluorfen, respectively. The estimated
log K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
ow
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is 6.1. EPA believes that there is sufficient evidence for listing oxyfluorfen on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the environmental toxicity data and potential for bioaccumulation for this chemical.

<!-- PJG 0012 frnewline -->
185. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Ozone
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010028-15-6) (EPCRA EHS) (Ref. 8). Information from a large number of studies of both humans and animals indicate
that ozone can affect structure, function, metabolism, pulmonary defense against bacterial infection, and extrapulmonary
effects. Among these extrapulmonary effects are: (1) Cardiovascular effects; (2) reproductive and teratological
effects; (3) central nervous system effects; (4) alterations in red blood cell morphology; (5) enzymatic activity;
and (6) cytogenetic effects on circulating lymphocytes. EPA believes that there is sufficient evidence for listing
ozone on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Effects of ozone on green plants include injury to foliage, reductions in growth, losses in yield, alterations in
reproductive capacity, and alterations in susceptibility to pests and pathogens. Based on the known interrelationships
of different components of ecosystems, such effects, if of sufficient magnitude, may potentially lead to irreversible
changes of sweeping nature to ecosystems. 
<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity values for ozone include a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 80 ppb for striped bass, a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 30 ppb for channel catfish, and a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 9.3 ppb for rainbow trout. EPA believes that there is sufficient evidence for listing ozone on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(C) based on the available ecotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
186. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Paraquat dichloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001910-42-5) (EPCRA EHS; FIFRA SR) (Ref. 8). Paraquat can cause death in humans as a consequence of severe
injury to the lungs, or as a result of kidney, liver, or heart failure. Following exposure, death may occur in 24 hours
or less. The acute oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values for paraquat are reported as 57, 120, 25, 50 and 35 mg/kg in the rat, mouse, dog, monkey, and cat, respectively.
Chronic pneumonitis (the LOEL was 0.93 mg/kg/day; the NOEL was 0.45 mg/kg/day) was reported in dogs fed diets containing
paraquat dichloride for 52 weeks. These results are supported by the results of a 2&hyph;year feeding study in rats
(the LOEL was 3.75 mg/kg/day based on nonneoplastic lung lesions; the NOEL was 1.25 mg/kg/day) and a 90&hyph;day feeding
study in dogs (the LOEL was 1.5 mg/kg/day based on increased lung weight, alveolitis, and alveolar collapse; the NOEL
was 0.5 mg/kg/day).
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing paraquat dichloride on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the chronic toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
187. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pebulate (Butylethylcarbamothioic acid S-propyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001114-71-2) (FIFRA AI) (Ref. 3). In a 1-year dog feeding study, a NOEL of greater than 5 mg/kg/day was established
due to abnormal behavior, ataxia, convulsions, and neurological effects in the brain and spinal cord at 100 mg/kg/day.
EPA believes that there is sufficient evidence for listing pebulate on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological toxicity data.
<!-- PJG 0012 frnewline -->
188. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pendimethalin (N-(1-Ethylpropyl)-3,4-dimethyl-2,6-dinitrobenzenamine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 040487-42-1) (FIFRA AI) (Ref. 3). Increased liver weights and alkaline phosphatase activity and hepatic
lesions (the LOEL was 50 mg/kg/day; the NOEL was 12.5 mg/kg/day) were observed in dogs fed pendimethalin for 2 years.
EPA derived an oral RfD of 0.04 mg/kg/day. Hypertrophy of the liver and increased liver weights were observed in rats
fed 5,000 ppm (250 mg/kg/day) for 3 months. The NOEL was 25 mg/kg/day. EPA believes that there is sufficient evidence
for listing pendimethalin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatic
toxicity data.
<!-- PJG 0012 frnewline -->
189. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pentobarbital sodium
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000057-33-0) (CAL) (Ref. 8). Pentobarbital sodium is commonly used as a sedative hypnotic. The average adult
sedative dose is 20 to 40 mg orally. The average adult hypnotic dose is 100 to 200 mg orally. Pentobarbital is also used
parenterally or rectally to provide basal hypnosis for general, spinal, or regional anesthesia. Like other barbiturates,
a common adverse effect to using pentobabital sodium is central nervous system depression. Chronic exposure to pentobarbital
sodium may lead to psychological and physical dependence.
<!-- PJG 0012 frnewline -->
Intraperitoneal injection of 20 mg/kg on day 1 of pregnancy produced adverse effects on fertility in rats. Intraperitoneal
injections of 80 mg/kg to rats on day 1 of pregnancy caused preimplantation loss. Intraperitoneal injection of 94.5
mg/kg on day 2 of pregnancy decreased fertility and caused fetal death in rats. Intraperitoneal injection of 22 mg/kg
on day 10 of pregnancy caused adverse effects in rat fetuses (details of study not reported). Subcutaneous injection
of 520 mg/kg of pentobarbital sodium on days 9 to 21, or administration of 30 mg/kg on day 19 of pregnancy produced abnormal
behavioral effects in rat offspring. Exposure to pentobarbital sodium during pregnancy can cause fetal addiction
to the substance.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing pentobarbital sodium on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(B) based on the developmental, reproductive, and chronic neurological toxicity data for
this chemical.
<!-- PJG 0012 frnewline -->
190. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Perchloromethyl mercaptan
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000594-42-3) (CERCLA; EPCRA EHS) (Ref. 8). The rat oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 and 4&hyph;hour rat inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values for perchloromethyl mercaptan are 8.26 mg/kg and 0.26 mg/L, respectively. The 2&hyph;hour mouse inhalation
LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value is reported to be 0.296 mg/L. In an eye irritation test, 50 micrograms (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g) (0.13 mg/kg/day) placed in a rabbit's eye for 24 hours produced a severe reaction. EPA's exposure analysis indicates
that perchloromethyl mercaptan concentrations are likely to exist beyond facility site boundaries, as a result
of continuous, or frequently recurring releases, at levels that can reasonably be anticipated to cause significant
adverse acute human health effects. EPA believes that there is sufficient evidence for listing perchloromethyl
mercaptan on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure
data for this chemical.
<!-- PJG 0012 frnewline -->
191. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Permethrin (3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, (3-phenoxyphenyl)methyl
ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 052645-53-1) (FIFRA AI) (Ref. 3). Increased liver weights (the LOEL was 500 ppm or 25 mg/kg/day; the NOEL was
100 ppm or 5 mg/kg/day) were observed in rats fed permethrin for 2 years. Based on the NOEL, EPA derived an oral RfD of
0.05 mg/kg/day. Decreased alkaline phosphatase activity, hepatocellular swelling, and increased liver weight
(the LOEL was 100 mg/kg/day; the NOEL was 5 mg/kg/day) were observed in dogs orally administered (in capsules) permethrin
for 1&hyph;year. Tremors, excessive salivation, convulsions, and incoordination were noted at 1,000 mg/kg/day.
EPA believes that there is sufficient evidence for listing permethrin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic toxicity data. Aquatic acute toxicity values for permethrin include
a fathead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 3.5 ppb, a rainbow trout 96&hyph;hour measured LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.62 ppb, a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 2.52 ppb, an Atlantic silverside 96&hyph;hour measured LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 2.2 ppb, and a daphnid 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.32 ppb. EPA believes that there is sufficient evidence for listing permethrin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
192. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phenanthrene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000085-01-8) (CERCLA; CWA PP) (Ref. 8). Measured aquatic acute toxicity data for phenanthrene include a
48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 700 ppb for daphnids. The measured 28&hyph;day LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for rainbow trout is 40 ppb, and teratogenetic effects were noted. The measured bioconcentration factor (BCF) values
include a fathead minnow 28&hyph;day BCF of 5,100 and a daphnid 24&hyph;hour BCF of 1,165. EPA believes that there
is sufficient evidence for listing phenanthrene on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based
on the available environmental toxicity data for this chemical and its potential to bioaccumulate. 
<!-- PJG 0012 frnewline -->
193. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phenothrin (2,2-dimethyl-3-(2-methyl-1-propenyl) cyclopropanecarboxylic acid (3-phenoxyphenyl)methyl
ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 026002-80-2) (FIFRA AI) (Ref. 3). Hepatocellular enlargement and increased absolute and relative liver
weights were observed in a chronic feeding study in dogs. The LOEL was 27.7 mg/kg/day in males and 26.8 mg/kg/day in
females. The NOEL was 8.2 mg/kg/day in males and 7.1 mg/kg/day in females. Hepatocellular hypertrophy and increased
relative liver weight (the LOEL was 150 mg/kg/day; the NOEL was 50 mg/kg/day) were observed in a chronic oncogenicity
study in rats. Increased liver weight (the LOEL was 150 mg/kg/day, the NOEL was 45 mg/kg/day) was noted in another chronic
oncogenicity feeding study in mice. EPA believes that there is sufficient evidence for listing phenothrin on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatic toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for phenothrin include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 16.7 ppb and a goldfish 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 100 ppb. EPA believes that there is sufficient evidence for listing phenothrin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
194. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1,2-Phenylenediamine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000095-54-5) (RCRA APP8) (Ref. 8). EPA has classified 1,2-phenylenediamine as a Group B2 compound, i.e.,
a probable human carcinogen. 1,2&hyph;Phenylenediamine dihydrochloride appeared to be carcinogenic in both rats
and mice, as evidenced by an increased incidence of hepatocellular carcinomas in both species. A significantly increased
incidence of hepatocellular carcinomas was observed in high dose group male rats and mice, and female mice of both
treated groups. EPA believes that there is sufficient evidence for listing 1,2-phenylenediamine on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for 1,2&hyph;phenylenediamine dihydrochloride.

<!-- PJG 0012 frnewline -->
195. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1,3-Phenylenediamine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000108-45-2) (RCRA APP8) (Ref. 8). Increased absolute and relative liver weights and degenerative liver
lesions (the LOEL was 18 mg/kg/day; the NOEL was 6.0 mg/kg/day) were noted in a 90&hyph;day oral study in rats exposed
to 1,3-phenylenediamine. EPA believes that there is sufficient evidence for listing 1,3-phenylenediamine on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the hepatotoxicity data for this chemical.
<!-- PJG 0012 frnewline -->
196. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1,2-Phenylenediamine dihydrochloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000615-28-1) (RCRA APP8) (Ref. 8). EPA has classified 1,2&hyph;phenylenediamine as a Group B2 compound,
i.e., a probable human carcinogen. 1,2-Phenylenediamine dihydrochloride appeared to be carcinogenic in both rats
and mice, as evidenced by an increased incidence of hepatocellular carcinomas in both species. A significantly increased
incidence of hepatocellular carcinomas was observed in high dose group male rats and mice, and female mice of both
treated groups. EPA believes that there is sufficient evidence for listing 1,2-phenylenediamine dihydrochloride
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity data for this chemical.
<!-- PJG 0012 frnewline -->
197. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1,4-Phenylenediamine dihydrochloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000624-18-0) (RCRA APP8) (Ref. 8). Measured aquatic acute toxicity for 1,4-phenylenediamine include a
fish 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 60 ppb. EPA believes that there is sufficient evidence for listing 1,4-phenylenediamine dihydrochloride on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for 1,4-phenylenediamine.
<!-- PJG 0012 frnewline -->
198. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phenytoin
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000057-41-0) (CAL; IARC; NTP) (Ref. 8). Phenytoin is a hydantoin-type anticonvulsant, and is used mainly
in the prophylactic management of tonic-clonic (grand mal) seizures and partial seizures with complex symptomatology.
In doses used to treat seizure disorders (i.e., 300 mg/day in adults, 5 mg/kg/day in children) phenytoin can cause
adverse effects such as constipation, dysphagia, nausea, vomiting, anorexia and weight loss. Ingestion of 4.5 g
(64 mg/kg/day) by adults and 0.6 g (60 mg/kg/day) by children has produced transient coma with motor restlessness.
Ingestion of 11 mg/kg/day produced changes in motor activity in a child (duration of study not reported). Oral administration
of 7.8 mg/kg/day for 4 days produced encephalitis, hallucinations, and irritability in a man. Ingestion of 7.6 mg/kg/day
for 2 weeks caused encephalitis, hallucinations, and ataxia in a woman.
<!-- PJG 0012 frnewline -->
Phenytoin is classified as a Group 2B compound by IARC; i.e., possible human carcinogen. Ingestion of 16.5 mg/kg/day
for 1&hyph;year produced lymphoma including Hodgkin's disease and skin tumors in a child. Oral exposure to phenytoin
produced lymphoma in mice (doses and duration of study not reported).
<!-- PJG 0012 frnewline -->
Oral administration of 5.9 mg/kg/day to a woman for the first 39 weeks of pregnancy induced kidney tumors in the offspring.
In another study, oral administration of 5.9 mg/kg/day to a woman for the first 39 weeks of pregnancy induced brain
tumors in the offspring. Oral administration of 2 mg/kg/day to a woman for 1&hyph;year produced lymphoma including
Hodgkin's disease. Congenital malformation was reported in 6.12 percent of births to 98 epileptic mothers receiving
phenytoin regularly during the first 4 months of pregnancy. Hypothrombinemia and hemorrhage has occurred in newborns
of mothers who received phenytoin during pregnancy. Oral doses of 4.0 to 5.9 mg/kg/day administered to women for the
first 39 weeks of pregnancy produced craniofacial abnormalities, nervous system disorders, and delayed physical
effects in their children. Doses of 2.0 mg/kg/day given to a woman for the first 39 weeks of pregnancy produced abnormalities
of skin, appendages, and musculoskeletal system in her child as well as other developmental abnormalities. Oral
doses of 5.0 mg/kg/day produced biochemical and metabolic abnormalities in the offspring. Higher doses of phenytoin
(130 mg/kg/day) orally administered to rats produced behavioral, growth, musculoskeletal, and nervous system
abnormalities in the offspring. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing phenytoin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the chronic neurological and developmental toxicity data and on the carcinogenicity data
for this chemical. 
<!-- PJG 0012 frnewline -->
199. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phosphine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007803-51-2) (CAA HAP) (Ref. 7). Available data on phosphine indicate that its inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for rats is between 4 and 40 ppm (the exposure time was 4 hours). Phosphine is a highly-toxic gas with a probable oral
lethal dose of 5 mg/kg. An air concentration of 3 ppm is safe for long-term exposure, 500 ppm is lethal in 30 minutes,
and a concentration of 1,000 ppm is lethal after a few breaths. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that phosphine concentrations are likely to exist beyond facility site boundaries,
as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated to cause
significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing phosphine
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data
for this chemical.
<!-- PJG 0012 frnewline -->
200. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phosphorus oxychloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010025-87-3) (CERCLA; EPCRA EHS) (Refs. 5 and 8). Phosphorus oxychloride reacts with water to yield phosphoric
acid and hydrochloric acid.
<!-- PJG 0012 frnewline -->
Phosphoric acid, as well as other phosphates, have the potential to cause increased algal growth leading to eutrophication
in the aquatic environment.
<!-- PJG 0012 frnewline -->
Eutrophication may result when nutrients, especially phosphates, enter into an aquatic ecosystem in the presence
of sunlight and nitrogen. The phosphate ion is a plant nutrient, which can be a major limiting factor for plant growth
in freshwater environments. In excess, phosphates can cause algal blooms. Toxic effects result from oxygen depletion
as the algae die and decay. Toxic effects have also been related to the release of decay products or direct excretion
of toxic substances from sources such as blue-green algae.
<!-- PJG 0012 frnewline -->
Laboratory studies indicate that eutrophication may occur at phosphate concentrations as low as 50 ppb in lakes.
The resulting oxygen depletion and toxic decay products (e.g., hydrogen sulfide) kill many invertebrates and fish.
<!-- PJG 0012 frnewline -->
Although green algae are more sensitive to growth stimulation by phosphates in fresh water, blue-green algal blooms
may cause greater damage. At least three species of blue-green algae are known to excrete toxins. Secretion by cyanobacteria
of dyalyzable metabolites have inhibited the growth of other species of algae and may result in algal monoculture.
When algal blooms of these toxic species occur in a reservoir, lake, slough, or pond, the cells and toxins can become
sufficiently concentrated to cause illness or death in invertebrates and vertebrates. Major losses have been reported
for cattle, sheep, hogs, birds (domestic or wild) and fishes, minor losses for dogs, horses, small wild animals, amphibians,
and invertebrates.
<!-- PJG 0012 frnewline -->
Eutrophication may occur in slow moving rivers, but is less likely in swift rivers where rapid mixing occurs. Light
is the most important limiting factor because rivers are murkier than lakes thus, the chances of eutrophication in
swift rivers are slight. However, lakes and reservoirs collect phosphates from influent streams and store a fraction
of them within consolidated sediments, thus serving as a phosphate sink. 
<!-- PJG 0012 frnewline -->
The available information derived from animal and controlled human studies clearly indicates that exposure to acid
aerosols can produce health effects of concern, particularly in sensitive subgroups of the population and after
chronic exposure. The bulk of these studies, however, have examined sulfuric acid exposures. Data for other acid
species and mixtures are extremely limited. However, as the effects appear to be due to the acidity of the species,
this data should pertain to acid aerosols consisting of other mineral acids, such as hydrochloric acid. The effects
seen range from mild and transient changes, such as small, reversible functional effects in exercising asthmatics,
to more substantial effects that may have acute or chronic health consequences, such as persistently altered clearance
and structural changes that may be suggestive of chronic lung disease. In addition, there are some notable consistencies
in the health effects information across various studies and disciplines.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing phosphorous oxychloride on EPCRA section 313 pursuant
to EPCRA sections 313(d)(2)(B) and (C) based on the available chronic human and environmental toxicity data for its
degradation products phoshoric acid and hydrochloric acid. 
<!-- PJG 0012 frnewline -->
201. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phosphorus pentachloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010026-13-8) (EPCRA EHS) (Refs. 5 and 8). Phosphorus pentachloride reacts with water to yield phosphoric
acid and hydrochloric acid. As described in Unit IV.B.200. of this preamble, phosphates, including phosphoric acid,
have the potential to cause increased algal growth leading to eutrophication and fish kills in the aquatic environment.
<!-- PJG 0012 frnewline -->
The available information derived from animal and controlled human studies clearly indicates that exposure to acid
aerosols can produce health effects of concern, particularly in sensitive subgroups of the population and after
chronic exposure. The bulk of these studies, however, have examined sulfuric acid exposures. Data for other acid
species and mixtures are extremely limited. However, as the effects appear to be due to the acidity of the species,
this data should pertain to acid aerosols consisting of other mineral acids, such as hydrochloric acid. The effects
seen range from mild and transient changes, such as small, reversible functional effects in exercising asthmatics,
to more substantial effects that may have acute or chronic health consequences, such as persistently altered clearance
and structural changes that may be suggestive of chronic lung disease. In addition, there are some notable consistencies
in the health effects information across various studies and disciplines.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing phosphorus pentachloride on EPCRA section 313 pursuant
to EPCRA sections 313(d)(2)(B) and (C) based on the available chronic human and environmental toxicity data for its
degradation products phoshoric acid and hydrochloric acid.
<!-- PJG 0012 frnewline -->
202. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phosphorus pentasulfide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001314-80-3) (CERCLA) (Refs. 5 and 8). Phosphorus pentasulfide reacts in water to yield phosphoric acid
and hydrogen sulfide.
<!-- PJG 0012 frnewline -->
As described in Unit IV.B.200. of this preamble, phosphates, including phosphoric acid, have the potential to cause
increased algal growth leading to eutrophication and fish kills in the aquatic environment.
<!-- PJG 0012 frnewline -->
Acute exposures to large amounts of hydrogen sulfide (approximately 250 ppm or more) have produced pulmonary edema,
unconsciousness, respiratory paralysis, asphyxiation, and/or death in some individuals. Similar effects are
also noted in animals. In a subchronic study, inflammation of the nasal mucosa occurred in mice following 90&hyph;day
inhalation of hydrogen sulfide, resulting in a NOAEL of 42.5 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (30.5 ppm; Human Equivalent Concentration (HEC) is 0.93 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
) and a LOAEL of 110 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (80 ppm; HEC is 2.4 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
). Other respiratory effects, such as alveolar edema, infiltrates in the bronchioles, cellular necrosis, hyperplasia,
and exfoliation in various respiratory tissues, have been reported in rats.
<!-- PJG 0012 frnewline -->
Aquatic toxicity test data for hydrogen sulfide show that measured fish 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values range from 7 to 776 ppb.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing phosphorus pentasulfide on EPCRA section 313 pursuant
to EPCRA sections 313(d)(2)(B) and (C) based on the available chronic human and environmental toxicity data for its
degradation products, phosphoric acid and hydrogen sulfide.
<!-- PJG 0012 frnewline -->
203. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Phosphorus pentoxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001314-56-3) (EPCRA EHS) (Refs. 5 and 8). Phosphorus pentoxide rapidly hydrolyzes in the presence of water
to yield phosphoric acid.
<!-- PJG 0012 frnewline -->
As described in Unit IV.B.200. of this preamble, phosphates, including phosphoric acid, have the potential to cause
increased algal growth leading to eutrophication and fish kills in the aquatic environment. EPA believes that there
is sufficient evidence for listing phosphorous pentoxide on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C)
based on the available environmental toxicity data for its degradation product phosphoric acid.
<!-- PJG 0012 frnewline -->
204. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Picloram
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001918-02-1) (FIFRA AI; SDWA) (Ref. 8). Animal studies in dogs, rats, or mice for various durations (2 weeks
to 2 years) have indicated the liver as the primary target of picloram toxicity. In a 6&hyph;month feeding study in
beagle dogs, a LOAEL of 35 mg/kg/day and a NOAEL of 7 mg/kg/day were determined for increased liver weights (relative
and absolute). At a higher dose (175 mg/kg/day), there were increases in serum alkaline phosphatase concomitant
with the increases in liver weight. Other toxic effects in the higher dosed animals included reduced food consumption
and body weight. EPA has derived an oral RfD of 0.07 mg/kg/day for this chemical based on the findings of this study.
Hepatotoxicity has also been reported in a 2&hyph;year rat feeding study. The LOAEL was 60 mg/kg/day based on changes
in liver histopathology. The NOAEL was 20 mg/kg/day. Hepatotoxicity was also observed in a 90&hyph;day rat feeding
study. The LOAEL was 150 mg/kg/day based on changes in liver histopathology, necrosis, and bile duct proliferation.
The NOAEL was 50 mg/kg/day. Increased liver weights were also reported in mice following dietary exposure to picloram
for 13 weeks. The LOAEL was 1,000 mg/kg/day. Liver swelling was reported in rats administered picloram in feed for
13 weeks. The LOAEL was 150 mg/kg/day. EPA believes that there is sufficient evidence for listing picloram on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatotoxicity data for this chemical.
<!-- PJG 0012 frnewline -->
205. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Piperonyl butoxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000051-03-6) (FIFRA SR) (Ref. 8). Measured aquatic acute toxicity data for piperonyl butoxide include a
96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 3.4 ppb for rainbow trout and a 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 4.2 ppb for bluegill. EPA believes that there is sufficient evidence for listing piperonyl butoxide on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
206. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pirimiphos methyl (O-(2-(diethylamino)-6-methyl-4-pyrimidinyl)-O,O-dimethyl phosphorothioate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 029232-93-7) (FIFRA AI) (Ref. 3). Pirimiphos methyl is a cholinesterase inhibitor in humans and other mammalian
species. A mild and transient decrease in plasma cholinesterase activity was observed in 2 of 4 female humans given
pirimiphos methyl daily in a capsule at dose levels of 0.25 mg/kg/day for 56 days. This effect was not seen in 3 of 3 males.
The dose level of 0.25 mg/kg/day was considered a NOEL for plasma cholinesterase inhibition. Based on the NOEL, an
oral RfD of 0.01 mg/kg/day was derived. The findings of the 56&hyph;day study were corroborated by the 28&hyph;day
feeding study (capsule) with 5 male human volunteers where 1 individual showed borderline cholinesterase depression.
Inhibition of brain cholinesterase (LOEL was 0.5 mg/kg/day, the NOEL for cholinesterase inhibition was not determined)
was observed in a 2&hyph;year feeding study in dogs. Inhibition of plasma cholinesterase activity (the LOEL was 2.5
mg/kg/day; the NOEL was 0.5 mg/kg/day) was seen in a 2&hyph;year feeding study in rats. No clinical signs were reported
for the above studies. EPA believes that there is sufficient evidence for listing pirimiphos methyl on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available neurological toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
207. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Polycyclic aromatic compounds (PACs)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. NA) (CAA HAP) (Ref. 7). Polycyclic aromatic compounds are a class of chemicals that include polycyclic aromatic
hydrocarbons, azapolycyclic aromatic hydrocarbons, thio-polycyclic aromatic hydrocarbons, nitroarenes, and
others. PACs can be formed in any combustion process that involves the burning of fuels or, more generally, materials
containing carbon and hydrogen. Some industrial sources include coke ovens, catalytic cracking of crude oil, carbon
black production, and iron and steel processes. 
<!-- PJG 0012 frnewline -->
Materials containing mixtures of PACs have been shown to be carcinogenic. Several epidemiology studies have shown
increased mortality due to lung cancer in humans exposed to coke-oven emissions, roofing-tar emissions, and cigarette
smoke. Each of these mixtures contains benzo(a)pyrene, benzo(a)anthracene, benzo(b)fluoranthene, benzo(a)phenanthrene,
and dibenzo(a,h)anthracene as well as other potentially carcinogenic PACs and other carcinogenic and potentially
carcinogenic chemicals, tumor promotors, initiators, and co-carcinogens such as nitrosoamines, coal tar pitch,
and creosote. Although it is impossible to evaluate the contribution of any individual PAC to the total carcinogenicity
of these mixtures to humans, reports of this nature provide qualitative evidence of the potential for mixtures containing
PACs to cause cancer in humans. In addition, several PACs caused cancer in animals when orally (e.g., benz(a)anthracene,
benzo(a)pyrene, dibenz(a,h)anthracene), dermally (e.g., benz(a)anthracene, benzo(a)phenanthrene, benzo(b)fluoranthene,
benzo(a)pyrene, dibenz(a,h)anthracene, and indeno (1,2,3-cd)pyrene) or inhalationally (e.g., benzo(a)pyrene)
exposed. EPA believes that there is sufficient evidence for listing these PACs on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available carcinogenicity data for these chemicals. EPA is proposing to create
a delimited category for PACs that includes the chemicals discussed below. 
<!-- PJG 0012 frnewline -->
a. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Benzo(b)fluoranthene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000205-99-2). Benzo(b)fluoranthene is classified as a Group B2 compound by EPA, i.e., the compound is a probable
human carcinogen. It is classified as a Group 2B compound by IARC, i.e., the compound is a possible human carcinogen.
Benzo(b)fluoranthene produced tumors in mice after lung implantation, intraperitoneal or subcutaneous injection
and skin painting. EPA believes that there is sufficient evidence for listing benzo(b)fluoranthene on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
b. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Benzo(j)fluoranthene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000205-82-3). Benzo(j)fluoranthene is classified as a Group 2B compound by IARC, i.e., the compound is a
possible human carcinogen. In multiple skin painting assays and in a mouse-skin initiation-promotion assay, benzo(j)fluoranthene
produced tumors in female mice. EPA believes that there is sufficient evidence for listing benzo(j)fluoranthene
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this
chemical. 
<!-- PJG 0012 frnewline -->
c. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Benzo(k)fluoranthene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000207-08-9). Benzo(k)fluoranthene is classified as a Group B2 compound by EPA, i.e., the compound is a probable
human carcinogen. It is also classified as a Group 2B compound by IARC, i.e., the compound is a possible human carcinogen.
Benzo(k)fluoranthene produced tumors after lung implantation in mice and when administered with a promoting agent
in skin painting studies. Equivocal results have been found in a lung adenoma assay in mice. Benzo(k)fluoranthene
is mutagenic in bacteria. EPA believes that there is sufficient evidence for listing benzo(k)fluoranthene on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
d. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Carbazole
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000086-74-8). Mice fed a basal diet containing carbazole showed a dose-related increase in liver nodules
and hepatocellular carcinomas after oral administration. EPA believes that there is sufficient evidence for listing
carbazole on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data
for this chemical. 
<!-- PJG 0012 frnewline -->
e. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Cyclopenta(cd)pyrene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 027208-37-3). In a skin painting assay and in several mouse-skin initiation-promotion assays, cyclopenta(cd)pyrene
produced tumors in female mice. Cyclopenta(cd)pyrene is also mutagenic to Salmonella and mammalian cells in vitro
and induces morphologic transformation in C3H10T1/2 cells in vitro. EPA believes that there is sufficient evidence
for listing cyclopenta(cd)pyrene on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
f. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenz(a,c)anthracene (CAS No. 000215-58-7)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. In a skin painting assay and in several mouse-skin initiation-promotion assays, dibenz(a,c)anthracene produced
tumors in female mice. EPA believes that there is sufficient evidence for listing dibenz(a,c)-anthracene on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
g. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenz(a,h)acridine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000226-36-8). Dibenz(a,h)acridine is classified as a Group 2A compound by IARC, i.e., the compound is a probable
human carcinogen. Dibenz(a,h)acridine has been shown to be carcinogenic in animals. EPA believes that there is sufficient
evidence for listing dibenz(a,h)acridine on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
h. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenz(a,j)acridine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000224-42-0). Dibenz(a,j)acridine is classified as a Group 2B compound by IARC, i.e., the compound is a possible
human carcinogen. Dibenz(a,j)acridine has been shown to be carcinogenic in animals. EPA believes that there is sufficient
evidence for listing dibenz(a,j)acridine on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
i. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenz(a,j)anthracene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000224-41-9). Dibenz(a,j)anthracene produced tumors after subcutaneous injection and after skin painting
in female mice. EPA believes that there is sufficient evidence for listing dibenz(a,j)anthracene on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
j. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenzo(a,e)fluoranthene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 005385-75-1). Dibenzo(a,e)fluoranthene produced tumors in female mice after mouse-skin initiation-promotion
assay and skin painting. Dibenzo(a,e)fluoranthene also produced tumors in both male and female mice after subcutaneous
injection. EPA believes that there is sufficient evidence for listing dibenzo(a,e)fluoranthene on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
k. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenzo(a,e)pyrene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000192-65-4). Dibenzo(a,e)pyrene is classified as a Group 2B compound by IARC, i.e., the compound is a possible
human carcinogen. Dibenzo(a,e)pyrene has been shown to be carcinogenic in animals. EPA believes that there is sufficient
evidence for listing dibenzo(a,e)pyrene on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
l. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenzo(a,h)pyrene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000189-64-0). Dibenzo(a,h)pyrene is classified as a Group 2B compound by IARC, i.e., the compound is a possible
human carcinogen. Dibenzo(a,h)pyrene has been shown to be carcinogenic in animals. EPA believes that there is sufficient
evidence for listing dibenzo(a,h)pyrene on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dibenzo(a,l)pyrene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000191-30-0). Dibenzo(a,l)pyrene is classified as a Group 2B compound by IARC, i.e., the compound is a possible
human carcinogen. Dibenzo(a,l)pyrene produced tumors in both male and female mice after subcutaneous (s.c.) injection
and tumors in female mice after skin painting. EPA believes that there is sufficient evidence for listing dibenzo-(a,l)pyrene
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this
chemical. 
<!-- PJG 0012 frnewline -->
n. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
7H-Dibenzo(c,g)carbazole
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000194-59-2). 7H-Dibenzo(c,g)carbazole is classified as a Group 2B compound by IARC, i.e., the compound
is a possible human carcinogen. 7H-Dibenzo(c,g)carbazole has been shown to be carcinogenic in animals. EPA believes
that there is sufficient evidence for listing 7H-dibenzo(c,g)carbazole on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
o. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2-Methylchrysene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 003351-32-4). In a skin painting assay and in a mouse-skin initiation-promotion assay, 2-methylchrysene
produced tumors in female mice. EPA believes that there is sufficient evidence for listing 2-methylchrysene on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
p. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3-Methylchrysene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 003351-31-3). In a skin painting assay and in a mouse-skin initiation-promotion assay, 3-methylchrysene
produced tumors in female mice. EPA believes that there is sufficient evidence for listing 3-methylchrysene on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
q. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
4-Methylchrysene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 003351-30-2). In a skin painting assay and in a mouse-skin initiation-promotion assay, 4-methylchrysene
produced tumors in female mice. EPA believes that there is sufficient evidence for listing 4-methylchrysene on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
r. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
5-Methylchrysene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 003697-24-3). 5-Methylchrysene is classified as a Group 2B compound by IARC, i.e., the compound is a possible
human carcinogen. In a skin-painting assay and in a mouse-skin initiation-promotion assay, 5-methylchrysene produced
tumors in female mice. EPA believes that there is sufficient evidence for listing 5-methylchrysene on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
s. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
6-Methylchrysene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001705-85-7). In a skin painting assay and in a mouse-skin initiation-promotion assay, 6-methylchrysene
produced tumors in female mice. EPA believes that there is sufficient evidence for listing 6-methylchrysene on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical.

<!-- PJG 0012 frnewline -->
t. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2-Methylfluoranthene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 033543-31-6). In a skin painting assay, 2-methylfluoranthene produced benign and malignant skin tumors
in female mice. In a female mouse-skin initiation-promotion assay, 2-methylfluoranthene produced skin papillomas.
EPA believes that there is sufficient evidence for listing 2-methylfluoranthene on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this chemical. 
<!-- PJG 0012 frnewline -->
u. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1-Nitropyrene
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 005522-43-0). 1-Nitropyrene is classified as a Group 2B compound by IARC, i.e., the compound is a possible
human carcinogen. 1-Nitropyrene produced mammary adenocarcinomas and squamous-cell carcinomas in a dose-dependent
manner by oral administration in rats, papillomas (not statistically significant) by skin application in mice,
and lung adenomas by intratracheal instillation in hamsters. In a s.c. injection study, 1-nitropyrene produced
tumors (i.e., one extraskeletal osteosarcoma and seven malignant fibrous histiocytomas) at the injection site
in male Fisher rats. In another s.c. injection study, 1-nitropyrene produced tumors at the injection site in both
male and female CD rats and mammary tumors in females. EPA believes that there is sufficient evidence for listing 1-nitropyrene
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity data for this
chemical. 
<!-- PJG 0012 frnewline -->
In addition to the above compounds, EPA proposes that the PAC category also include the following seven PACs: 
<!-- PJG 0012 frnewline -->
Benz(a)anthracene (CAS No. 000056-55-3) 
<!-- PJG 0012 frnewline -->
Benzo(a)phenanthrene (CAS No. 000218-01-9) 
<!-- PJG 0012 frnewline -->
Benzo(a)pyrene (CAS No. 000050-32-8) 
<!-- PJG 0012 frnewline -->
Benzo(rst)pentaphene (CAS No. 000189-55-9) 
<!-- PJG 0012 frnewline -->
Dibenzo(a,h)anthracene (CAS No. 000053-70-3) 
<!-- PJG 0012 frnewline -->
7,12-Dimethylbenz(a)anthracene (CAS No. 000057-97-6)
<!-- PJG 0012 frnewline -->
Indeno[1,2,3-cd]pyrene (CAS No. 000193-39-5)
<!-- PJG 0012 frnewline -->
These PACs were proposed for listing individually in EPA's response to a petition to add certain chemicals that appear
on the RCRA list of toxic wastes under 40 CFR 261.33(f) to EPCRA section 313 (57 FR 41020, September 8, 1992). These chemicals
were proposed for addition based on the available carcinogenicity data. Due to the similarities of these seven PACs
to the chemicals listed in Unit IV.B.207.a. through IV.B.207.u. of this preamble, EPA believes that these chemicals
should be added to EPCRA section 313 as part of the delineated PAC category rather than listed individually. 
<!-- PJG 0012 frnewline -->
EPCRA section 313 requires threshold determinations for chemical categories to be based on the total of all chemicals
in the category manufactured, processed, or otherwise used. For example, a facility that manufactures three members
of a chemical category would count the total amount of all three chemicals manufactured towards the manufacturing
threshold for that category. When filing reports for chemical categories the releases are determined in the same
manner as the thresholds. One report is filed for the category and all releases are reported on this form. In the case
of the delimited PAC category, only the 28 chemicals listed above would be included for purposes of making the threshold
determinations and in filing reports on releases. 
<!-- PJG 0012 frnewline -->
The Clean Air Act Amendments section 112(b) Hazardous Air Pollutants list includes a listing for polycyclic organic
matter (POM) that includes PACs. The definition given for the POM category is broad and chemically non-specific and
may be delineated by test method. For the purpose of listing under EPCRA section 313, EPA considered the following
more chemically-specific definition for a PAC category: ``includes all chemical species from the polycyclic aromatic
hydrocarbon, aza-polycyclic, thio-polycyclic, or nitroarene families where polycyclic means three or more fused
rings. More specifically, it means any combination of three or more fused six or five membered hydrocarbon rings with
at least two or more rings being aromatic. The structure may contain fused non-aromatic five-membered rings, a ring
nitrogen, a ring sulfur, one or more attached nitro groups, or one or more attached alkyl groups.'' As an alternative
to the delimited category, EPA is proposing to add a PAC category based on this broad definition. Although this definition
may include chemicals of low or no concern, it may be less of a burden for facilities to report their total PACs rather
than trying to determine which and how much of the specific PACs covered by the delimited category they are producing
and releasing. EPA requests comment on the addition of the delimited PACs category versus the alternative PAC category
based on the broader definition. 208. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Potassium bromate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007758-01-2) (IARC) (Ref. 8). IARC has assigned potassium bromate to Group 2B, i.e., it is possibly carcinogenic
to humans. Male and female rats orally exposed to 250 or 500 ppm (35 to 70 mg/kg/day) potassium bromate in drinking water
for 110 weeks had an increased incidence of renal cell adenomas and adenocarcinomas and, in males, there was also an
increased incidence of mesothelioma in the peritoneal cavity. EPA believes that there is sufficient evidence for
listing potassium bromate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
209. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Potassium dimethyldithiocarbamate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000128-03-0) (FIFRA AI) (Ref. 3). New Zealand White rabbits given 38 mg/kg/day by gavage on days 6 to 18 of gestation
exhibited malalignment of sternebrae, total postimplantation loss, and fetal weight decrement. Also at this dose
level, various malformations including adactyly, gastroschisis, short tail, anal atresia, spina bifida, atelectasis,
costal cartilage anomaly, vertebral anomaly with/without rib, caudal vertebrea anomaly, and severe sternebrae
malalignment were observed in 6 of 52 fetuses from 5 of 11 litters. At the 77 mg/kg/day dose level, there was severe fetal/embryo
lethality. The NOEL was 12.8 mg/kg/day. EPA believes that there is sufficient evidence for listing potassium dimethyldithiocarbamate
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
210. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Potassium N-methyldithiocarbamate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000137-41-7) (FIFRA AI) (Ref. 3). By analogy to the analogue, potassium dimethyldithiocarbamate, potassium
N-methyldithiocarbamate can reasonably be anticipated to cause fetotoxicity, postimplantation loss and malformations.
Data on potassium dimethyldithiocarbamate follows. New Zealand White rabbits given 38 mg/kg/day by gavage on days
6 to 18 of gestation exhibited malalignment of sternebrae, total postimplantation loss, and fetal weight decrement.
Also at this dose level various possible malformations including adactyly, gastroschisis, short tail, anal atresia,
spina bifida, atelectasis, costal cartilage anomaly, vertebral anomaly with/without rib, caudal vertebrea anomaly,
and severe sternebrae malalignment in 6 of 52 fetuses from 5 of 11 litters. At the 77 mg/kg/day dose level, there was
severe fetal/embryo lethality. The NOEL was 12.8 mg/kg/day. EPA believes that there is sufficient evidence for listing
potassium N-methyldithiocarbamate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
developmental toxicity data for potassium dimethyldithiocarbamate. 
<!-- PJG 0012 frnewline -->
211. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Primisulfuron (methyl 2-[[[[[4,6-bis(difluoromethoxy)2-pyrimidinyl]-amino] carbonyl] amino]sulfonyl]
benzoate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 086209-51-0) (FIFRA AI) (Ref. 3). In a 90&hyph;day dog feeding study, reduced thyroid weights accompanied
by colloid depletion and parafollicular hyperplasia and anemia were observed at the LOEL of 25 mg/kg/day. The NOEL
was 0.625 mg/kg/day. In a 1-year dog study, dietary administration of 250/125 mg/kg/day (LOEL: the dose was changed
after week 10 in the study) produced thyroid hyperplasia, anemia, increased platelet levels, vacuolar changes,
and increased absolute and relative liver weights. The NOEL was 25 mg/kg/day. In an 18&hyph;month study in mice, dietary
administration of 1.7 mg/kg/day produced increased absolute and relative liver weights in females. No NOEL was established.
Based on this study, an oral RfD of 0.006 mg/kg/day was derived. In a 2&hyph;year mouse study, increases in absolute
and relative liver weights were observed at 408 mg/kg/day in males and 1.7 mg/kg/day in females. The systemic LOEL
and NOEL in males was 408 mg/kg/day and 40.2 mg/kg/day, respectively. The systemic LOEL in females was 1.7 mg/kg/day
and a NOEL could not be established. EPA believes that there is sufficient evidence for listing primisulfuron on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available thyroid and liver toxicity data for this
chemical. 
<!-- PJG 0012 frnewline -->
Plant toxicity values include a duckweed 14&hyph;day EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.27 ppb and an algae 7&hyph;day EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 24 ppb. EPA believes that there is sufficient evidence for listing primisulfuron on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
212. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Profenofos (O-(4-bromo-2-chlorophenyl)-O-ethyl-Spropyl phosphorothioate)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 041198-08-7) (FIFRA AI) (Ref. 3). In a 6&hyph;month feeding study in dogs, inhibition of plasma and red blood
cell cholinesterase activities were observed at 2 ppm (0.05 mg/kg/day). The NOEL was 0.2 ppm (0.005 mg/kg/day). Based
on the NOEL, EPA derived an oral RfD of 0.00005 mg/kg/day. Other studies (21, 28, and 90&hyph;day studies in rat, rabbit
and dog) also demonstrate cholinesterase (plasma, red blood cell or brain) inhibition in rats and mice. EPA believes
that there is sufficient evidence for listing profenofos on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available neurological toxicity data. 
<!-- PJG 0012 frnewline -->
213. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Prometryn (N,N'-bis(1-methylethyl)-6-methylthio-1,3,5-triazine-2,4-diamine)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007287-19-6) (FIFRA AI) (Ref. 3). Degenerative changes in the liver and kidney, and bone marrow atrophy (the
LOEL was 37.5 mg/kg/day; the NOEL was 3.75 mg/kg/day) were observed in dogs fed prometryn for 2 years. Based on the NOEL,
EPA derived an oral RfD of 0.004 mg/kg/day. Fatty liver degeneration (the LOEL was 500 mg/kg; the NOEL was 250 mg/kg)
was observed in rats fed prometryn for 28 days. 
<!-- PJG 0012 frnewline -->
In a teratology study in rabbits, test material was administered by gavage from gestation day 7 to 19. Increased abortions
and late resorptions occurred at 72 mg/kg/day. The NOEL was 12 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing prometryn on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic, renal, bone marrow, and developmental toxicity data. 
<!-- PJG 0012 frnewline -->
214. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Propachlor (2-chloro-N-(1-methylethyl)-N-phenylacetamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001918-16-7) (FIFRA AI) (Ref. 3). No evidence of maternal toxicity was seen in rabbits administered propachlor
by gavage at 0, 5, 15, or 50 mg/kg/day on days 7 to 19 of gestation. Statistically significant increases in mean resorptions/postimplantation
loss with corresponding decreases in the mean number of viable fetuses were reported at 15 and 50 mg/kg/day when compared
to controls. EPA believes that there is sufficient evidence for listing propachlor on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data. 
<!-- PJG 0012 frnewline -->
215. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Propanil (N-(3,4-dichlorophenyl)propanamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000709-98-8) (FIFRA AI) (Ref. 3). Results of several subchronic and chronic toxicity studies indicated
the liver and spleen as the target organs for propanil. Increased relative spleen weight (the LOEL was 20 mg/kg/day;
the NOEL was 5 mg/kg/day) was noted in female rats fed propanil for 2 years. Based on the NOEL, EPA derived an oral RfD
of 0.005 mg/kg/day. Histopathological changes (the LOEL was 30 mg/kg/day; the NOEL was 25 mg/kg/day) in the liver
and spleen were observed in mice orally administered propanil for 90 days. At higher dose levels (i.e., 240 and 1,920
mg/kg/day) cyanosis, methemoglobinemia, and increased liver and spleen weight were noted. In a 90&hyph;day rat
study, increased spleen weight (the LOEL was 50 mg/kg/day; the NOEL was 16.5 mg/kg/day) was seen in females. Decreased
hemoglobin levels was seen in males. Increased SGOT and SAP activities (the LOEL was 100 mg/kg/day; the NOEL was 15
mg/kg/day) were observed in dogs orally administered propanil for 2 years. EPA believes that there is sufficient
evidence for listing propanil on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
hepatic toxicity data. 
<!-- PJG 0012 frnewline -->
216. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Propargite
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002312-35-8) (CERCLA) (Ref. 8). In a developmental toxicity study in which rabbits were exposed via oral
gavage to doses greater than or equal to 6 mg/kg/day (fetotoxic LOAEL) of propargite during gestation days 6 to 18,
delayed ossification, increased fetal resorption, decreased fetal viability and reductions in fetal body weight
were noted. The maternal LOAEL in this study was also 6 mg/kg/day and was based on body weight reductions. The NOEL for
maternal and fetal toxicity was 2 mg/kg/day. Developmental effects (increased incidence of missing sternebrae)
were also reported in offspring of rats exposed orally during gestation days 6 to 15. The fetotoxicity LOAEL was 25
mg/kg/day and the NOAEL was 6 mg/kg/day. EPA believes that there is sufficient evidence for listing propargite on
EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the developmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity data for propargite include a bluegill sunfish LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 31 ppb. EPA believes that there is sufficient evidence for listing propargite on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
217. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Propargyl alcohol
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000107-19-7) (CERCLA; RCRA APP8; RCRA P) (Ref. 8). Histopathological changes in the liver and kidney were
reported in a subchronic rat feeding study following exposure to propargyl alcohol in the diet for as little as 4 weeks.
The liver changes included increased organ weight, hepatocytic megalocytosis with proliferation of bile ducts
and cytoplasmic vacuolization of hepatocytes, as well as hematological and serum enzyme changes indicative of liver
damage. The kidney weights were increased in females only, and both sexes had karyomegaly of the renal tubular epithelial
cells. The LOAEL for these changes was 15 mg/kg/day and the NOAEL was 5 mg/kg/day. EPA derived an oral RfD of 0.002 mg/kg/day
from this study. EPA believes that there is sufficient evidence for listing propargyl alcohol on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(B) based on the hepatotoxicity and nephrotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
218. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Propetamphos (3-[[(Ethylamino)methoxyphosphinothioyl] oxy]-2-butenoic acid, 1-methylethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 031218-83-4) (FIFRA AI) (Ref. 3). Purebred beagle dogs were given propetamphos for 52 weeks in feed. A dose
of 2.5 mg/kg/day caused increased relative liver weight and increased liver enzymes. Dogs given 12.5 mg/kg/day developed
hepatocellular necrosis. The NOEL was 0.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
Red blood cell and plasma cholinesterase inhibition were seen in a 2-week rat inhalation study at 1 mg/kg/day (LOEL).
No NOEL could be established. Cholinesterase inhibition was observed at 0.4 mg/kg/day in a 13&hyph;week rat dietary
study. The NOEL was 0.2 mg/kg/day. Cholinesterase inhibition was also observed at 0.1 mg/kg/day (LOEL) in a 6&hyph;month
dog dietary study. The NOEL was 0.05 mg/kg/day. In a 92&hyph;week mouse feeding study, red blood cell, brain, and plasma
cholinesterase were inhibited at 1.0 mg/kg/day (LOEL). The NOEL was 0.5 mg/kg/day. Based on this study, an oral RfD
of 0.005 mg/kg/day was derived. In a 2&hyph;year dietary rat study, plasma cholinesterase depression was observed
at 0.6 mg/kg/day (LOEL). The cholinesterase NOEL was 0.3 mg/kg/day. Alopecia and hyperflexia were observed at 6 mg/kg/day
(systemic LOEL). The systemic NOEL was 0.6 mg/kg/day. In a lifetime mouse study, dietary administration of 1 mg/kg/day
produced plasma, red blood cell, liver, and brain cholinesterase depression. The NOEL was 0.05 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing propetamphos on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic and neurological toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
219. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Propiconazole (1-[2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]- methyl-1H-1,2,4,-triazole)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 060207-90-1) (FIFRA AI) (Ref. 3). In a 2-generation rat reproduction study, dietary administration of 25
mg/kg/day produced an increased incidence of hepatic clear cell change in parental animals and administration of
125 mg/kg/day produced an increased incidence of hepatic lesions in offspring. The parental NOEL was 5 mg/kg/day
and the developmental NOEL was 25 mg/kg/day. In a 2&hyph;year mouse study, dietary administration of 65 mg/kg/day
(LOEL) produced increased liver lesions and liver weight in males, whereas, administration of 325 mg/kg/day produced
increased liver tumors, increased SGPT and SGOT levels, increased liver weight, hepatocyte enlargement, and vacuolation
and fat deposition in the liver of both sexes. The NOEL was 13 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a 3&hyph;month dog dietary study, lymphoid follicles were observed in the mucous membranes of the pyloric part
of the stomach at 6.25 mg/kg/day. The NOEL was 1.25 mg/kg/day. In a 1&hyph;year dog study, dietary administration
of 6.25 mg/kg/day produced mild gastric mucosal irritation. The NOEL was 1.25 mg/kg/day. Based on the NOEL of the study,
an oral RfD of 0.013 mg/kg/day was derived. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing propiconazole on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic and gastrointestinal toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
220. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Quizalofop-ethyl (2-[4-[(6-chloro-2-quinoxalinyl) oxy]phenoxy] propanoic acid ethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 076578-14-8) (FIFRA AI) (Ref. 3). In a 3&hyph;month rat study, dietary administration of 6.4 mg/kg/day produced
changes in liver weight and liver lesions. The NOEL was 2 mg/kg/day. In a 6&hyph;month dietary dog study, 10 mg/kg/day
produced testicular atrophy in males. The NOEL was 2.5 mg/kg/day. Liver cell enlargement was observed at 3.7 mg/kg/day
in males and 4.6 mg/kg/day in females (LOELs) in a 2&hyph;year rat dietary study. The NOELs for males and females were
0.9 mg/kg/day and 1.1 mg/kg/day, respectively. Based on the study, an oral RfD of 0.009 mg/kg/day was derived. Increased
liver weights were observed in pregnant rats in a teratology study. The maternal LOEL was 100 mg/kg/day and the NOEL
was 30 mg/kg/day. No teratogenic NOEL could be established. In a 2-generation rat reproduction study, increased
liver weights and increased incidence of eosinophilic changes in the liver were observed in the offspring at 5 mg/kg/day
(LOEL). The NOEL was 1.25 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing quizalofop-ethyl on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available reproductive and hepatic toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
221. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Resmethrin ([5-(phenylmethyl)-3-furanyl]methyl 2,2-dimethyl-3-(2-methyl-1-propenyl) cyclopropanecarboxylate])
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 010453-86-8) (FIFRA AI) (Ref. 3). Oral administration of 30 mg/kg/day (LOEL) in capsules for 6 months produced
increases in liver weights in female dogs. The NOEL was 10 mg/kg/day. In a 2&hyph;year rat study, dietary administration
of 125 mg/kg/day produced increases in liver weight and pathological lesions. The NOEL was 25 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a one-generation reproduction rat study, administration of 25 mg/kg/day (LOEL) in the diet produced an increase
in dead pups and lower pup weight among survivors. No NOEL could be established. In a 3-generation reproduction rat
study, dietary administration of 25 mg/kg/day (LOEL) produced an increase in pups cast dead and lower pup weight among
survivors. No NOEL could be established. Based on the NOEL of the study, an oral RfD of 0.03 mg/kg/day was derived.
<!-- PJG 0012 frnewline -->
Signs of neurotoxicity, including piloerection, ataxia, sensory changes in peripheral nerves, changes in locomotor
activity, salivation, tremors, and convulsions were observed in rats, dogs, mice, and rabbits given acute oral,
intravenous or intraperitoneal injections greater than or equal to 160 mg/kg. In a 3&hyph;month rat inhalation study,
0.1 mg/L (LOEL) produced behavioral effects and 1 mg/L produced decreased locomotor activity, tremors, and other
behavioral changes. No NOEL could be established. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing resmethrin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic, reproductive, and neurological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for resmethrin include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.275 ppb (89 percent a.i.), a bluegill sunfish 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.750 ppb (89 percent a.i.), a lake trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.7 ppb (84.5 percent a.i.), and a fathead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 3.0 ppb. EPA believes that there is sufficient evidence for listing resmethrin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
222. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sethoxydim (2-[1-(ethoxyimino)butyl]-5-[2(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 074051-80-2) (FIFRA AI) (Ref. 3). Mild anemia (the LOEL was 17.5 mg/kg/day; the NOEL was 8.9 mg/kg/day) was
observed in male dogs fed sethoxydim for 1&hyph;year. Based on the NOEL, EPA derived an oral RfD of 0.09 mg/kg/day.
Swollen liver cells (the LOEL was 117 mg/kg/day; the NOEL was 45 mg/kg/day) were seen in mice fed sethoxydim for 14 weeks.
Pathological effects in the liver (the LOEL was 45 mg/kg/day; the NOEL was 15 mg/kg/day) were noted in rats fed sethoxydim
for 14 weeks. Nonneoplastic liver lesions (the LOEL was 54 mg/kg/day; the NOEL was 18 mg/kg/day) were observed in mice
fed sethoxydim for 2 years. Decreased phenosulfophthalein (PSP) clearance (the NOEL was greater than 3 mg/kg/day;
the LOEL not determined) was noted in dogs given sethoxydim in the diet for 26 weeks. Decreased PSP clearance (the LOEL
was 20 mg/kg/day; the NOEL was 2 mg/kg/day) was also noted in a 6&hyph;month feeding study in dogs. EPA believes that
there is sufficient evidence for listing sethoxydim on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available hematological, hepatic, and renal toxicity data. 
<!-- PJG 0012 frnewline -->
223. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Simazine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000122-34-9) (FIFRA SR; SDWA) (Ref. 8). Simazine is a triazine-type herbicide. Chronic exposure of sheep
to low doses (approximately 1.4 to 6 mg/kg/day) of simazine caused fatty and granular degeneration in the liver, and
increased SGOT and alkaline phosphatase. Neuronophagia, diffuse kidney degeneration, diffuse glial proliferation
and degeneration of ganglion cells in the cerebrum and medulla were also reported in these animals. Dogs that received
1,500 ppm (37.5 mg/kg/day) simazine in a 2&hyph;year feeding study also had slight increases in serum alkaline phosphatase
and SGOT, indicative of liver damage. 
<!-- PJG 0012 frnewline -->
Sheep that received 1.4 mg/kg/day simazine for 37 to 111 days had necrotic changes in the germinal epithelium of the
testis and disturbances in spermatogenesis. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing simazine on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the hepatic, renal, neurological, and reproductive toxicity of this chemical. 
<!-- PJG 0012 frnewline -->
224. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium azide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 026628-22-8) (CERCLA; EPCRA EHS; RCRA P) (Ref. 8). Although not used clinically, sodium azide is a direct
acting vasodilator. A reduction in blood pressure was noted in hypertensive patients orally exposed to sodium azide
during an investigation of the substance in treating cancer. Reductions in blood pressure were also reported in animals
following acute exposure. The minimal hypotensive dose in humans has been estimated to be approximately 0.2 to 0.4

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=6 f=1 -->
m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
g/kg (0.0002 to 0.0004 mg/kg). EPA believes that there is sufficient evidence for listing sodium azide on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the ability of this substance to lower blood pressure. 
<!-- PJG 0012 frnewline -->
225. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium chlorite
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007758-19-2) (FIFRA AI) (Ref. 3). A decrease in erythrocyte half-life (the LOEL was 100 ppm or 7.3 mg/kg/day;
the NOEL was 50 ppm or 3.65 mg/kg/day) was observed in cats administered sodium chlorite in the drinking water for 90
days. Increase in glucose-6-phosphatase dehydrogenase activity, mean corpuscular volume (MCV), osmotic fragility,
and acanthocytes were observed in mice administered 100 ppm (19 mg/kg/day) in the drinking water for 30 days. In another
30&hyph;day drinking water study, increased glucose-6-phosphatase dehydrogenase activity, MCV, and osmotic
fragility were noted in mice administered 100 ppm (19 mg/kg/day). The NOEL was 1.9 mg/kg/day. The results of in vitro
studies show that sodium chlorite can result in oxidative damage to erythrocytes. EPA believes that there is sufficient
evidence for listing sodium chlorite on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
hematological toxicity data. 
<!-- PJG 0012 frnewline -->
226. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium dicamba (3,6-Dichloro-2-methoxybenzoic acid, sodium salt)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001982-69-0) (FIFRA AI) (Ref. 3). No toxicity data are available for sodium dicamba. However, data are available
on dicamba as discussed below. In solution, sodium dicamba will dissociate into sodium ion and the dicamba anion.
Decreased fetal body weights and increased postimplantation loss were observed in the offspring of rabbits receiving
10 mg/kg/day on days 6 through 18 of gestation. The LOEL was 10 mg/kg/day and NOEL was 3 mg/kg/day. Based on the NOEL,
EPA derived an oral RfD value of 0.03 mg/kg/day. In a separate study, disorders of oxidative phosphorylation and focal
necrosis in the heart were observed in newborn rats following transplacental exposure to dicamba. In a developmental
toxicity study, an increase in skeletal malformations was seen in the offspring of rats orally administered 64 mg/kg/day
on days 6 through 19 of gestation. EPA believes that there is sufficient evidence for listing sodium dicamba on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for dicamba.

<!-- PJG 0012 frnewline -->
227. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium dimethyldithiocarbamate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000128-04-1) (FIFRA AI) (Ref. 3). By analogy to potassium dimethyldithiocarbamate, sodium dimethyldithiocarbamate
can reasonably be anticipated to cause fetotoxicity, postimplantation loss and malformations. Data on potassium
dimethyldithiocarbamate follows. New Zealand white rabbits given 38 mg/kg/day by gavage on days 6 to 18 of gestation
exhibited malalignment of sternebrae, total postimplantation loss, and fetal weight decrement. Also at this dose
level, various possible malformations including adactyly, gastroschisis, short tail, anal atresia, spina bifida,
atelectasis, costal cartilage anomaly, vertebral anomaly with/without rib, caudal vertebrea anomaly, and severe
sternebrae malalignment in 6 of 52 fetuses from 5 of 11 litters. At the 77 mg/kg/day dose level, there was severe fetal/embryo
lethality. The NOEL was 12.8 mg/kg/day. EPA believes that there is sufficient evidence for listing sodium dimethyldithiocarbamate
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for
the analogue potassium dimethyldithiocarbamate. 
<!-- PJG 0012 frnewline -->
228. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium fluoroacetate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS. No. 000062-74-8) (CERCLA; EPCRA EHS; FIFRA SR; RCRA APP8; RCRA P) (Ref. 8). In a 13&hyph;week oral study in rats,
gavage administration of sodium fluoroacetate (0.02 mg/kg/day) resulted in decreased testis weight and altered
spermatogenesis in males (the NOAEL was 0.05 mg/kg/day). In addition, increased heart weight was noted in females
and males administered 0.20 mg/kg/day of sodium fluoroacetate. The increase in heart weight, however, was only accompanied
by subacute, minimal inflammation (not dose-related). Also, fluorocitrate levels were significantly increased
after 4 weeks in males administered 0.50 mg/kg/day and after 13 weeks in both male and female rats administered 0.20
or 0.50 mg/kg/day. The testicular and cardiac effects were reported to be consistent with those noted in the literature.

<!-- PJG 0012 frnewline -->
A case study reported a deliberate ingestion of an unspecified dose of sodium fluroacetate by a healthy female. The
woman experienced nausea, vomiting, and abdominal pain 30 minutes after ingestion, with subsequent seizures occurring
60 minutes after the initial onset of symptoms. Neurological examination after 2 weeks revealed severe cerebellar
dysfunction. By 18 months, memory disturbances and depressive behavior persisted. Inhalation exposure to unspecified
levels of sodium fluoroacetate caused salivation, loss of speech, violent convulsions, and coma in a male worker.
The patient ultimately recovered. Neurological effects have also been reported in rats in a 13&hyph;week oral study.
Four of 20 female rats treated with 0.50 mg/kg/day (the highest dose tested) exhibited convulsions at day 79, with
no recurrences for the remainder of the study. An estimated lethal dose of sodium fluoroacetate in humans ranges from
5 to 10 mg/kg. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing sodium fluoroacetate on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(B) based on the neurologic, reproductive, and myocardial toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
Measured oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values of fluoroacetate in the house sparrow, redwinged blackbird, starling and golden eagle are 3.0, 4.22, 2.37,
and 1.25 to 5 mg/kg, respectively. In addition, measured acute toxicity data for mammalian wildlife include an oral
LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.22 to 0.44 mg/kg for mule deer, an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.41 mg/kg for male ferrets, and an oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.5 to 1.0 mg/kg for bears. EPA believes that there is sufficient evidence for listing sodium fluoroacetate on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
229. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium hypochlorite
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007681-52-9) (CERCLA) (Ref. 8). Aquatic acute toxicity data for sodium hypochlorite include a 96&hyph;hour
measured LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 100 ppb for bluegill and a 96&hyph;hour measured LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 80 ppb for fathead minnow. In addition, the 96&hyph;hour measured LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values for non-standard test species range from 32 ppb for coho salmon to 82 ppb for Pacific sand lance. EPA believes
that there is sufficient evidence for listing sodium hypochlorite on EPCRA section 313(d)(2)(C) based on the available
ecotoxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
230. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium nitrite
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007632-00-0) (CERCLA) (Ref. 8). Sodium nitrite causes conversion (oxidation) of hemoglobin to methemoglobin.
Methemoglobin cannot combine reversibly with oxygen and its formation can cause anemic hypoxia which may lead to
intense cyanosis. Infants are particularly susceptible to this effect because of their higher stomach pH, immature
enzyme systems, the reduced capacity of newborn erythrocytes to reduce methemoglobin to hemoglobin, and the increased
rate of nitrite-induced oxidation of fetal hemoglobin to methemoglobin (approximately twice the rate of adult hemoglobin
oxidation). Coma and methemoglobinemia/ carboxyhemoglobinemia were reported in a human that received sodium nitrite
(71 mg/kg) orally. In animal studies, methemoglobinemia was reported in dogs that received an intravenous dose of
30 mg/kg sodium nitrite and in rats administered a 10 mg/kg dose of sodium nitrite subcutaneously. 
<!-- PJG 0012 frnewline -->
Fetotoxicity (fetal death) was reported following oral exposure of pregnant rats to sodium nitrite (30 mg/kg/day)
during gestation days 1 through 22. In mice exposed orally to 80 mg/kg/day during gestation days 6 to 15 there was increased
preimplantation loss and fetal death, and in mice exposed to a lower dose (20 mg/kg/day) during gestation days 1 to
14, abnormalities of the blood or lymphatic system were reported in offspring. In offspring of rats orally exposed
to 26 to 256 mg/kg/day during pregnancy (gestation days 1 through 22) and/or during lactation (20 to 21 days after birth),
effects on growth including biochemical and/or metabolic changes were noted. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing sodium nitrite on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available chronic hematological and developmental toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
231. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium pentachlorophenate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000131-52-2) (FIFRA AI) (Ref. 3). Pentachlorophenol has been classified by EPA as a Group B2 compound, i.e.,
a probable human carcinogen. This was based on occurrence of increased combined incidence of hemangiosarcomas,
liver tumors, and pheochromocytomas in female mice. EPA believes that there is sufficient evidence for listing sodium
pentachlorophenate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available carcinogenicity
data for its parent compound, pentachlorophenol.
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for sodium pentachlorophenate include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 55 ppb, a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 44 ppb, a fathead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 20 ppb, and a shrimp 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 84 ppb. EPA believes that there is sufficient evidence for listing sodium pentachlorophenate on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
232. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium o-phenylphenoxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000132-27-4) (CERCLA; IARC) (Ref. 8). Sodium o-phenylphenoxide has been classified by IARC as a Group 2B
compound; i.e., the substance is possibly carcinogenic in humans. EPA believes that there is sufficient evidence
for listing sodium o-phenylphenoxide on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the carcinogenicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
233. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sodium 2-pyridinethiol-1-oxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 015922-78-8) (FIFRA AI) (Ref. 3). New Zealand white rabbits were tested with test material dermally on days
6 to 18 of gestation. At 0.5 mg/kg/day, pups exhibited missing or defective vertebrae, ribs and sternebrae. No NOEL
was established. EPA believes that there is sufficient evidence for listing sodium 2-pyridinethiol-1-oxide on
EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
234. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Strychnine and salts
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CERCLA; EPCRA EHS; FIFRA SR; RCRA APP8; RCRA P) (Ref. 8). Strychnine salts will dissociate in aqueous solutions to
yield soluble strychnine. Strychnine, an alkaloid, can cause violent convulsions in humans. Other effects include
agitation, hypertonicity of muscles, and painful muscle spasms. Renal failure and respiratory paralysis generally
ensues, from severe or prolonged convulsions. A potentially lethal oral dose in a small child is 5 to 10 mg. The lethal
oral dose for an adult may be as low as 30 mg. Similar effects have also been reported in animals exposed at lethal doses
ranging from 0.25 to 2.35 mg/kg via oral and parenteral routes of exposure. EPA's exposure analysis indicates that
strychnine and strychnine salts concentrations are likely to exist beyond facility site boundaries, as a result
of continuous, or frequently recurring releases, at levels that can reasonably be anticipated to cause significant
adverse acute human health effects. EPA believes that there is sufficient evidence for listing strychnine and salts
as a category on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and
exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
EPCRA section 313 requires threshold determinations for chemical categories to be based on the total of all chemicals
in the category manufactured, processed, or otherwise used. For example, a facility that manufactures three members
of a chemical category would count the total amount of all three chemicals manufactured towards the manufacturing
threshold for that category. When filing reports for chemical categories, the releases are determined in the same
manner as the thresholds. One report if filed for the category and all releases are reported on this form. 
<!-- PJG 0012 frnewline -->
235. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sulfur dioxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007446-09-5) (CERCLA; EPCRA EHS) (Ref. 8). Acid precipitation occurs in large regions of the Eastern United
States and Canada, Europe, and Japan. This widespread occurrence of acid precipitation and dry deposition results
in large part from man-made emissions of oxides of sulfur (e.g., sulfur dioxide) and oxides of nitrogen. These substances
are transformed in the atmosphere into sulfuric acid and nitric acid, transported over great distances and deposited
on vegetation, soils, surface waters, and materials. These substances are transferred from the atmosphere into
ecosystems by the absorption of gases, the impaction and gravitational settling of fine aerosols and coarse particles
and, precipitation. 
<!-- PJG 0012 frnewline -->
Acids contained in polluted snow are released as contaminated meltwater. The resulting release of pollutants can
cause major or rapid changes in the acidity of streams and lake waters. Interference with normal reproduction in fish
populations is induced by acidity of lake and stream waters. Reproduction of frogs and salamanders is also inhibited
by atmospheric acidification of surface waters. 
<!-- PJG 0012 frnewline -->
Atmospheric deposition of sulfuric acid and nitric acid can cause serious damage to crops and forests. Biological
effects include induction of necrotic lesions, loss of nutrients due to leaching from foliar organs, accelerated
erosion of waxes and leaf surfaces, and interference with normal reproductive processes. Acidification decreases
the rate of many soil processes such as nitrogen fixation and the breakdown of organic matter. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing sulfur dioxide on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Limited data on long-term human exposure to sulfuric acid with respect to occupational settings are available. Recent
studies suggest that sulfuric acid aerosols at levels as low as 0.02 to 0.04 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may cause significant effects on lung function in humans. Effects noted include increased risk of chronic bronchitis
in smokers and reduced tracheobronchial clearance rate. Other studies suggest that sulfuric acid at concentrations
as low as 0.04 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may act synergistically with copollutants such as ozone, NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and metal particulates in causing decreased pulmonary diffusing capacity and bronchial hypersensitivity. These
effects are presumably attributable to the acidic and oxidative properties of sulfuric acid, and are therefore pH
and concentration dependent. EPA believes that there is sufficient evidence for listing sulfur dioxide on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available chronic toxicity data for sulfuric acid,
the hydrolysis product of sulfur dioxide.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sulfur dioxide is regulated under Title I of the CAA (Provisions for Attainment and Maintenance of National Ambient
Air Quality Standards) and Title IV of the CAA (Acid Deposition Control). In addition to this proposal to add sulfur
dioxide to EPCRA section 313, in Units IV.B.36. and 179, EPA is proposing to add two other chemicals, carbon monoxide
and nitrogen dioxide, that are regulated under Title I of the CAA. Extensive data, which are highly technical, are
collected on these chemicals as required by the CAA. EPA requests comment on the following: (1) Is the information
collected under the CAA sufficient for public right-to-know purposes; and (2) suggestions on how the data collected
on these chemicals pursuant to CAA Titles I and IV could be used to meet the purposes of EPCRA section 313.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
236. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sulfur trioxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007446-11-9) (EPCRA EHS) (Ref. 8). IARC has classified sulfur trioxide in Group 1, i.e., the chemical is carcinogenic
to humans based on sufficient evidence of carcinogenicity in humans. EPA believes that there is sufficient evidence
for listing sulfur trioxide on EPCRA section 313 pursuant to section 313(d)(2)(B) based on the carcinogenicity data
for this chemical.
<!-- PJG 0012 frnewline -->
Acid precipitation occurs in large regions of the Eastern United States and Canada, Europe, and Japan. This widespread
occurrence of acid precipitation and dry deposition results in large part from man-made emissions of oxides of sulfur
(e.g., sulfur trioxide) and oxides of nitrogen. These substances are transformed in the atmosphere into sulfuric
acid and nitric acid, transported over great distances and deposited on vegetation, soils, surface water, and materials.
These substances are transferred from the atmosphere into ecosystems by the absorption of gases, the impaction and
gravitational settling of fine aerosols and coarse particles and, precipitation. 
<!-- PJG 0012 frnewline -->
Acids contained in polluted snow are released as contaminated meltwater. The resulting release of pollutants can
cause major or rapid changes in the acidity of streams and lake waters. Interference with normal reproduction in fish
populations is induced by acidity of lake and stream waters. Reproduction of frogs and salamanders is also inhibited
by atmospheric acidification of surface waters.
<!-- PJG 0012 frnewline -->
Atmospheric deposition of sulfuric acid and nitric acid can cause serious damage to crops and forests. Biological
effects include induction of necrotic lesions, loss of nutrients due to leaching from foliar organs, accelerated
erosion of waxes and leaf surfaces, and interference with normal reproductive processes. Acidification decreases
the rate of many soil processes such as nitrogen fixation and the breakdown of organic matter.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing sulfur trioxide on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the available environmental toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
Limited data on long-term human exposure to sulfuric acid with respect to occupational settings are available. Recent
studies suggest that sulfuric acid aerosols at levels as low as 0.02 to 0.04 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may cause significant effects on lung function in humans. Effects noted include increased risk of chronic bronchitis
in smokers and reduced tracheobronchial clearance rate. Other studies suggest that sulfuric acid at concentrations
as low as 0.04 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 may act synergistically with copollutants such as ozone, NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, and metal particulates in causing decreased pulmonary diffusing capacity and bronchial hypersensitivity. These
effects are presumably attributable to the acidic and oxidative properties of sulfuric acid, and are therefore pH
and concentration dependent. EPA believes that there is sufficient evidence for listing sulfur trioxide on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available chronic toxicity data for sulfuric acid,
the hydrolysis product of sulfur trioxide.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
237. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sulfuryl fluoride (Vikane)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002699-79-8) (FIFRA AI) (Ref. 3). The primary effects of sulfuryl fluoride in humans are respiratory irritation
and central nervous system depression, followed by excitation and possibly convulsions. Rabbits exposed via inhalation
(6 hours/day, 5 days/week, for 2 weeks) to sulfuryl fluoride showed hyperactivity, convulsions and vacuolation
of the cerebrum at 600 ppm (2.5 mg/L). Renal lesions were present in all rats exposed by inhalation (6 hours/day, 5 days/week,
for 2 weeks) to 600 ppm (2.5 mg/L) sulfuryl fluoride. Minimal renal changes were noted in rats exposed to 300 ppm (1252
mg/L), whereas no effects occurred at 100 ppm (4.2 mg/L). Convulsions at near lethal concentrations were reported
in rabbits, mice, and rats. In a 30-day inhalation study, loss of control, tremors of the hind quarters, and histopathological
changes in the lung, liver, and kidney were reported in rabbits exposed to 400 ppm (1.6 mg/L) for 7 hours/day, 5 days/week
for 5 weeks. The NOEL was 200 ppm (0.83 mg/L). Cerebral vacuolation and/or malacia and inflammation of nasal tissues
were observed in rabbits exposed by inhalation to 100 or 300 ppm (0.4 or 1.25 mg/L) for 13 weeks. The NOEL was 30 ppm (0.125
mg/L). Rats exposed by inhalation to 100 to 600 ppm (0.4 to 0.25 mg/L) sulfuryl fluoride for 13 weeks developed mottled
teeth (indicative of fluoride toxicity), renal and respiratory effects, and cerebral vacuolation. EPA believes
that there is sufficient evidence for listing sulfuryl fluoride on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B)
based on the available neurological, renal, and respiratory toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
238. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sulprofos (O-Ethyl O-[4-(methylthio)phenyl] phosphorodithioic acid S-propyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 035400-43-2) (FIFRA AI) (Ref. 3). The acute dermal rabbit LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is between 745 mg/kg and 994 mg/kg. Ataxia, tremors, and diarrhea were observed. In a 28&hyph;day dietary study, administration
of 1 mg/kg/day produced decreased red blood cell and brain cholinesterase activity. The NOEL was 0.1 mg/kg. Dietary
administration of 15 mg/kg/day for 3 months produced hyperactivity in female rats. The NOEL was 5 mg/kg/day. In the
same study, 5 mg/kg/day produced red blood cell and brain cholinesterase inhibition in both sexes. The cholinesterase
NOEL was 1.5 mg/kg/day. Red blood cell and brain cholinesterase inhibition, diarrhea, vomiting, and some hind limb
paralysis were seen in dogs orally administered 5 mg/kg/day (LOEL) for 3 months. The NOEL was 0.5 mg/kg/day. In a 22&hyph;month
dietary mouse study, plasma and red blood cell cholinesterase were inhibited at 3.25 mg/kg/day. The NOEL was 0.325
mg/kg/day. Plasma, red blood cell, and brain cholinesterase inhibition were seen at a dietary administration of
2.5 mg/kg/day (LOEL) in a 2&hyph;year dog study. The NOEL was 0.25 mg/kg/day. Based on this study, an oral RfD of 0.003
mg/kg/day was derived. Dietary administration of 3 mg/kg/day (LOEL) produced plasma and red blood cell cholinesterase
depression in a 2&hyph;year rat study. The NOEL was 0.3 mg/kg/day. Increased unossified sternebrae were observed
in the offspring of rats given 10 mg/kg/day (LOEL) by gavage during days 6 to 15 of gestation. No NOEL was established.

<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing sulprofos on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological and developmental toxicity data for this chemical.
<!-- PJG 0012 frnewline -->
The aquatic acute values for sulprofos include bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value of 1.03 ppm and 11 ppm (technical product). The channel catfish bioconcentration factor for whole fish is 704
to 1006. EPA believes that there is sufficient evidence for listing sulprofos on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(C) based on the available environmental toxicity data and the potential for bioconcentration.

<!-- PJG 0012 frnewline -->
239. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tebuthiuron (N-[5-(1,1-Dimethylethyl)-1,3,4-thiadiazol-2-yl)- N,N'-dimethylurea)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 034014-18-1) (FIFRA AI) (Ref. 3). Administration of 25 mg/kg/day (LOEL) on days 6 through 18 of gestation
produced reduced body weights in offspring of rabbits. The NOEL was 10 mg/kg/day. In a 3&hyph;month rat study, dietary
administration of 125 mg/kg/day (LOEL) produced growth suppression and pancreatic lesions. The NOEL was 50 mg/kg/day.
In a 2-generation rat reproduction study, depressed body weight gain was observed in the female parental generation
at 14 mg/kg/day. The NOEL was 7 mg/kg/day. Based on the NOEL of the study, an oral RfD of 0.07 mg/kg/day was derived. In
a 3-generation rat reproduction study, decreased body weight was observed in the offspring of animals administered
20 mg/kg/day (LOEL). No NOEL was established. Dietary administration of 40 mg/kg/day to rats for 2 years produced
growth suppression. The NOEL was 20 mg/kg/day. EPA believes that there is sufficient evidence for listing tebuthiuron
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for
this chemical.
<!-- PJG 0012 frnewline -->
240. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tefluthrin
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 079538-32-2) (FIFRA AI) (Ref. 3). Delayed ossification was seen in the offspring of rats administered 5 mg/kg/day
(LOEL) orally on days 7 through 16 of gestation. The NOEL was 3 mg/kg/day.
<!-- PJG 0012 frnewline -->
In a 3&hyph;month rat study, dietary administration of 10 mg/kg/day produced plasma, red blood cell, and brain cholinesterase
inhibition. The NOEL was 5 mg/kg/day. In a 6&hyph;month dog study, dietary administration of 10 mg/kg/day (LOEL)
produced plasma cholinesterase inhibition. The NOEL was 1 mg/kg/day. In a 21-day rat dietary study, administration
of 20 mg/kg/day (LOEL for females) produced decreased platelet counts, increased white blood cell, lymphocyte,
and neutrophil counts in males and females. The NOEL for females was 5 mg/kg/day. Increased absolute and relative
liver weights were observed at 5 mg/kg/day in males, thus no NOEL could be established for males. Dietary administration
of 10 mg/kg/day (LOEL) for 3 months to rats produced increased absolute liver weights, decreased bilirubin levels,
and hepatocellular hypertrophy. The NOEL was 5 mg/kg/day. In a 6&hyph;month dog study, dietary administration of
10 mg/kg/day (LOEL) produced hepatotoxicity (effects not reported). The NOEL was 1 mg/kg/day. In a 2&hyph;year mouse
study, dietary administration of 13.5 mg/kg/day produced liver necrosis. The NOEL was 3.4 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing tefluthrin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available developmental, neurological, hepatic, and hematological toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for tefluthrin include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.06 ppb, a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.13 ppb, a sheepshead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.13 ppb, a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.07 ppb, and a mysid 96&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.053 ppb. EPA believes that there is sufficient evidence for listing teflurin on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
241. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Temephos
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 003383-96-8) (FIFRA AI) (Ref. 3). Temephos is a cholinesterase inhibitor in many mammalian species. The
LOELs at which the cholinesterase inhibition was observed ranged from 0.3 to 10 mg/kg/day. However, human subjects
that ingested 256 mg/day for 5 days or 64 mg/day for 4 weeks showed no clinical signs or effects on plasma or red blood
cell cholinesterase activities. Dietary exposure of rats to 350 mg/kg/day for 90 days resulted in cholinesterase
inhibition only; no clinical signs were reported. Rabbits and guinea pigs tolerated 10 mg/kg/day for extended periods
without clinical effects, and dogs tolerated 3 to 4 mg/kg/day, the highest dose tested. EPA believes that there is
sufficient evidence for listing temephos on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the
available neurological toxicity data. 
<!-- PJG 0012 frnewline -->
242. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Terbacil (5-chloro-3-(1,1-dimethylethyl)-6-methyl- 2,4-(1H,3H)-pyrimidinedione)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 005902-51-2) (FIFRA AI) (Ref. 3). Decreases in the number of implantations and live fetuses, were observed
in rats administered 62.5 mg/kg/day (LOEL) orally for days 6 to 15. The NOEL was 12.5 mg/kg/day. Significantly reduced
body weights were observed in the offspring of rabbits orally administered 600 mg/kg/day (LOEL) orally on days 6 to
18 of gestation. The NOEL was 200 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a 2&hyph;week rat dietary study, administration of 1,000 mg/kg/day produced increased absolute and relative
liver weights. In a 3&hyph;month rat dietary study, administration of 25 mg/kg/day (LOEL) produced increased liver
weights and vacuolization and hypertophy of hepatocytes. The NOEL was 5 mg/kg/day. In a 1-year dog study, dietary
administration of 48 mg/kg/day to males and 12 (LOEL) and 48 mg/kg/day to females produced increased alkaline phosphatase
and alanine transaminase levels. The NOEL was 3 mg/kg/day. In a 2&hyph;year dog study, dietary administration of
6.25 mg/kg/day (LOEL) produced slight increases in liver weights, elevated alkaline phosphatase levels, and increased
thyroid-to-body-weight ratios. The NOEL was 1.25 mg/kg/day. Based on the NOEL, an oral RfD of 0.013 mg/kg/day was
established. Hypertrophy of centrilobular hepatocytes was observed in male mice administered 162.5 mg/kg/day
(LOEL) in the diet. The NOEL was 6.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing terbacil on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic and developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
243. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tetracycline hydrochloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000064-75-5) (CAL) (Ref. 8). Tetracycline hydrochloride is widely used as an antibiotic for the treatment
of many common infections. The average oral adult dose for most infections is 1 to 2 grams per day in equally divided
doses. The most frequent adverse reactions to orally administered tetracycline hydrochloride are gastrointestinal
effects including nausea, vomiting, diarrhea, bulky loose stools, and abdominal discomfort. Photosensitivity,
manifested as an exaggerated sunburn reaction on sun-exposed areas of the body has occurred following oral therapy
with tetracycline hydrochloride. Photosensitivity reactions of this type generally develop within a few minutes
to several hours after sun exposure and usually persist 1 to 2 days after discontinuance of tetracycline hydrochloride.

<!-- PJG 0012 frnewline -->
Manufacturers of tetracycline hydrochloride state that this substance should not be used in women during the last
half of pregnancy or in children younger than 8 years of age unless other appropriate drugs are ineffective or contraindicated.
The American Academy of Pediatrics recommends that tetracycline hydrochloride be used only in children who are 9
years of age or older, except under unusual circumstances. Use of tetracycline hydrochloride in pregnant women or
infants has resulted in retardation of skeletal development and bone growth in the fetus or child. Because tetracycline
hydrochloride localizes in the dentin and enamel of developing teeth, use of this substance during tooth development
may cause enamel hypoplasia and permanent yellow-gray to brown discoloration of the teeth. Use of tetracycline hydrochloride
may result in discoloration of the deciduous teeth of children if the substance is used during pregnancy or in children
up to 4 to 6 months of age. These effects are most common following long-term use of tetracycline hydrochloride but
have occured following repeated short-term use. Premature infants treated with tetracycline have demonstrated
a 40 percent depression of bone growth. This effect is readily reversible if exposure to the substance is short. 
<!-- PJG 0012 frnewline -->
Intraperitoneal injection of 85 mg/kg/day on days 14 to 18 of gestation has resulted in abortion and extra embryonic
structures in rat offspring. Subcutaneous injection of 48 mg/kg/day on days 16 through 20 of gestation and intramuscular
injection of 40 mg/kg/day to rats on days 10 through 15 of gestation resulted in embryo/fetotoxicity. Exposure to
50 mg/kg/day on days 7 to 15 of pregnancy resulted in postimplantation loss and fetotoxicity in rats. Exposure to 85
mg/kg/day on days 7 to 15 of pregnancy resulted in abortion in rats. Fetotoxicity was observed in mice receiving 86
mg/kg/day of tetracycline hydrochloride on days 8 to 13 of gestation. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing tetracycline hydrochloride on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data and other chronic toxicity data
for this chemical. 
<!-- PJG 0012 frnewline -->
244. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tetramethrin (2,2-Dimethyl-3-(2-methyl-1-propenyl) cyclopropanecarboxylic acid (1,3,4,5,6,7-hexahydro-1,3-dioxo-2-H-isoindol-2-yl)methyl
ester
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 007696-12-0) (FIFRA AI) (Ref. 3). Depression, salivation, ataxia, lethargy, and convulsions were observed
in acute rat studies in which the oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values were greater than or equal to 4,400 mg/kg. Tremors, excitement, and increased urine volume were observed in
an acute dermal rat study in which the LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 was greater than 2,500 mg/kg. Tremors, ataxia, dyspnea, gastointestinal hypermotility, and diarrhea were observed
in rats and mice administered tetramethrin subcutaneously or intraperitonealy. The LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 was greater than 500 mg/kg. In a 6&hyph;month dog dietary study, administration of 62.5 mg/kg/day produced nervouseness
and tremors. The NOEL was 31.25 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing tetramethrin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available neurological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for tetramethrin include a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 21 ppb (mixed isomers, technical product) and 69 ppb. EPA believes that there is sufficient evidence for listing
tetramethrin on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity
data for this chemical. 
<!-- PJG 0012 frnewline -->
245. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tetrasodium ethylenediaminetetraacetate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000064-02-8) (FIFRA AI) (Ref. 3). Increased occurrence of 13th rudimentary ribs was observed in the offspring
of rats orally administered 5 mg/kg/day (LOEL). No NOEL was established and the dosing duration was not reported.
EPA believes that there is sufficient evidence for listing tetrasodium ethylenediaminetetraacetate on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
246. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Thiabendazole (2-(4-Thiazolyl)-1H-benzimidazole)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000148-79-8) (FIFRA AI) (Ref. 3). Oral administration of 600 mg/kg/day (LOEL) to rats on days 6 through 15
of gestation produced cleft palate and open eyes. Musculoskeletal abnormalities were observed in the offspring
of mice orally administered 240 mg/kg on day 9 of gestation. Musculoskeletal abnormalities were also observed in
the offspring of rats orally administered 296 mg/kg/day on days 8 through 15 of gestation. Decreased litter size,
and skin abnormalities were observed in the offspring of rats orally administered 667 mg/kg/day on days 8 through
15 of gestation. Oral administration of 1,300 mg/kg/day produced musculoskeletal abnormalities and fetal death
in the offspring of mice. Oral administration of 2,400 mg/kg/day on day 11 of gestation produced craniofacial abnormalities
in the offspring of mice. EPA believes there is sufficient evidence for listing thiabendazole on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(B) based on the available developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for thiabendazole include a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 560 ppb, a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.31 ppb, and a mysid 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 340 ppb. EPA believes that there is sufficient evidence for listing thiabendazole on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data.
<!-- PJG 0012 frnewline -->
247. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Thiabendazole, hypophosphite salt (2-(4-thiazolyl) benzimidazole, hypophosphite salt)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 028558-32-9) (FIFRA AI) (Ref. 3). Few toxicity data are available on thiabendazole, hypophosphite salt.
However, data are available on the parent compound, thiabendazole, as discussed below. Oral administration of 600
mg/kg/day (LOEL) to rats on days 6 through 15 of gestation produced cleft palate and open eyes. Musculoskeletal abnormalities
were observed in the offspring of mice orally administered 240 mg/kg on day 9 of gestation. Musculoskeletal abnormalities
were also observed in the offspring of rats orally administered 296 mg/kg/day on days 8 through 15 of gestation. Decreased
litter size and skin abnormalities were observed in the offspring of rats orally administered 667 mg/kg/day on days
8 through 15 of gestation. Oral administration of 1,300 mg/kg/day produced musculoskeletal abnormalities and fetal
death in the offspring of mice. Oral administration of 2,400 mg/kg/day on day 11 of gestation produced craniofacial
abnormalities in the offspring of mice. EPA believes that there is sufficient evidence for listing thiabendazole
hypophosphite salt on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available developmental
toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
No laboratory data are available for thiabendazole hypophosphite salt. Ecotoxicity data are available for the parent
compound thiabendazole. Aquatic acute toxicity values for thiabendazole include a rainbow trout 96&hyph;hour
LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 560 ppb, a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.31 ppb, and a mysid 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 340 ppb. EPA believes that there is sufficient evidence for listing thiabendazole hypophosphite salt on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
248. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Thiobencarb (carbamic acid, diethylthio-, s-(p-chlorobenzyl))
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 028249-77-6) (FIFRA AI) (Ref. 3). Measured aquatic acute toxicity values for thiobencarb include a chinook
salmon 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 760 ppb, a striped bass 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 760 ppb, a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 790 ppb, and a green algae 72&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 30 ppb (population reduction). EPA believes that there is sufficient evidence for listing thiobencarb on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
249. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Thiodicarb
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 059669-26-0) (FIFRA AI) (Ref. 3). Thiodicarb is a cholinesterase inhibitor in mammalian species. In addition,
hematological effects have been observed in various species. Tremors and pinpoint pupils (the NOEL was less than
0.043 mg/L) were noted in rats exposed by inhalation to thiodicarb for 9 days. Macrocytic anemia (the LOEL was 2 g/kg;
the NOEL was 1 g/kg) was observed in a 21&hyph;day dermal study in rabbits. In another 21&hyph;day dermal study, decreased
red blood cell counts and decreased hemoglobin levels (the LOEL was 4 g/kg/day; the NOEL was 1 g/kg/day) were reported.
Decreased plasma and red blood cell cholinesterase activities (the LOEL was 30 mg/kg/day; the NOEL was 10 mg/kg/day)
were observed in rats fed thiodicarb for 28 days. Decreased red blood cell cholinesterase activity and decreased
hemoglobin levels (the LOEL was 10 mg/kg/day; the NOEL was 3 mg/kg/day) were seen in a 13&hyph;week feeding study in
rats. Inhibition of plasma and red blood cell cholinesterase activities (the LOEL was 45 mg/kg/day; the NOEL was 15
mg/kg/day) was noted in dogs fed thiodicarb for 6 months. Significant hematological and clinical chemistry values
were also seen at 45 mg/kg/day (the NOEL was 15 mg/kg/day). Reductions in red blood cell cholinesterase activity (the
LOEL was 12.8 mg/kg/day; the NOEL was 4.5 mg/kg/day) were also seen in a 1-year feeding study in dogs. In addition, decreased
red blood cell and decreased hemoglobin and hematocrit levels, and increased relative spleen and liver weights (the
LOEL was 38.3 mg/kg/day; the NOEL was 12.8 mg/kg/day) were reported. EPA believes that there is sufficient evidence
for listing thiodicarb on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available neurological
and hematological toxicity data. 
<!-- PJG 0012 frnewline -->
Aquatic acute toxicity values for thiodicarb include a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.47 ppm , a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 2.65 ppm, a sheepshead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 530 ppb, a daphnid 48&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 27 ppb, a mysid 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 29.3 ppb, an eastern oyster 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 1.0 ppb, and an algae 96&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 450 ppb. EPA believes that there is sufficient evidence for listing thiodicarb on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
250. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Thiophanate ethyl ([1,2-phenylenebis (iminocarbonothioyl)] biscarbamic acid diethyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 023564-06-9) (FIFRA AI) (Ref. 3). In a 6&hyph;month dog study, dietary administration of 500 mg/kg/day (LOEL)
produced thyroid changes. The NOEL was 50 mg/kg/day. Thyroid follicular hypertrophy was observed at 50 mg/kg/day
(LOEL) in a rat 2&hyph;year dietary study. The NOEL was 10 mg/kg/day. EPA believes that there is sufficient evidence
for listing thiophanate ethyl on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available
thyroid toxicity data for this chemical. 251. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Thiophanate-methyl
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 023564-05-8) (FIFRA SR) (Ref. 8). Decreased spermatogenesis was observed in male rats fed 32 mg/kg/day thiophanate-methyl.
The NOEL was 8 mg/kg/day. Other effects noted at the 32 mg/kg/day dose level included decreased body weight and histological
evidence of hyperthyroidism. 
<!-- PJG 0012 frnewline -->
In a 3-generation reproductive study in rats, reduced litter weights were seen at a daily dietary dose of 32 mg/kg thiophanate-methyl.
The NOEL was 8 mg/kg/day. A decrease in the number of implantations was observed in mice administered a limit dose of
1,000 mg/kg/day.
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing thiophanate-methyl on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the reproductive toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
252. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Thiosemicarbazide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000079-19-6) (CERCLA; EPCRA EHS; RCRA APP8; RCRA P) (Ref. 8). The oral LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
s for thiosemicarbazide in rats and dogs are 9.16 and 10 mg/kg, respectively. The LDLo in the mouse is 94 mg/kg. Cats
orally administered thiosemicarbazide experienced convulsions, salivation, and vomiting; the LD
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 was 20 mg/kg. Intraperitoneal injection of 2.5 mg/kg of thiosemicarbazide produced restlessness, running fits,
and convulsions in rabbits. EPA's exposure analysis indicates that thiosemicarbazide concentrations are likely
to exist beyond facility site boundaries, as a result of continuous, or frequently recurring releases, at levels
that can reasonably be anticipated to cause significant adverse acute human health effects. EPA believes that there
is sufficient evidence for listing thiosemicarbazide on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A)
based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
253. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Triadimefon (1-(4-chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 043121-43-3) (FIFRA AI) (Ref. 3). Decreased hematocrit, red blood cell count, and hemoglobin volume were
observed in dogs orally administered 60 mg/kg/day (LOEL) for 13 weeks. No NOEL was established. In a 2&hyph;year dietary
rat study, decreased hemoglobin and erythrocyte counts were observed at 25 mg/kg/day (LOEL). The NOEL was 2.5 mg/kg/day.
Based on the NOEL of the study, an oral RfD of 0.03 mg/kg/day was derived. Dietary administration of 25 mg/kg/day (LOEL)
for 2 years to dogs produced increased serum alkaline phosphatase and N-demethylase activity and increased liver
weight. The NOEL was 2.5 mg/kg/day. Increased erythrocyte count, thrombocyte count, hemoglobin, and hematocrit
levels in females and increased serum alkaline phosphatase, serum glutamic-pyruvic transaminase, serum glutamic-oxaloacetic
transaminase, liver weights, and hyperplastic nodules in both sexes were observed at 234 mg/kg/day in a 2&hyph;year
mouse dietary study. The NOEL was 6.5 mg/kg/day and the LOEL was 39 mg/kg/day. In another 2&hyph;year mouse dietary
study, administration of 234 mg/kg/day produced hepatocellular adenomas. Doses of 39 mg/kg/day in males (LOEL)
and 6.5 mg/kg/day in females (LOEL) produced nonneoplastic and preneoplastic changes in the liver, increased liver
weights with correlating effects on serum enzymes, and hepatocellular hypertrophy. The NOEL in males was 6.5 mg/kg/day
and no NOEL in females could be established. 
<!-- PJG 0012 frnewline -->
Cleft palates were observed in the offspring of rats orally administered 75 mg/kg/day (LOEL). The NOEL was 30 mg/kg/day.
Increased incidence of abnormal ribs, extra ribs, and distended urinary bladders were observed in the offspring
of rats orally administered 90 mg/kg/day (LOEL). The NOEL was 30 mg/kg/day. Increases in fetal resorptions were observed
in rabbits given 100 mg/kg/day by gavage (LOEL). The NOEL was 30 mg/kg/day. Increased incidences of incomplete ossification
of pelvic pubes and phalanges, and irregular spinous processes were observed in the offspring of rabbits orally administered
50 mg/kg/day (LOEL) on days 6 through 18 of gestation. The NOEL was 20 mg/kg/day. 
<!-- PJG 0012 frnewline -->
In a 3-generation rat reproduction study, decreased fertility and decreased litter size were observed at 90 mg/kg/day
(LOEL). The NOEL was 15 mg/kg/day. In a 2-generation reproduction study in rats, decreased pup weights, decreased
litter size, and decreased pup viability were observed at 90 mg/kg/day (LOEL). The NOEL was 2.5 mg/kg/day. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing triadimefon on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hepatic, hematological, developmental, and reproductive toxicity data for
this chemical. 
<!-- PJG 0012 frnewline -->
254. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Triallate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002303-17-5) (FIFRA SR) (Ref. 8). Triallate, a dithiocarbamate insecticide, is a cholinesterase inhibitor.
When triallate was administered to rats at a dose of 147.1 mg/kg/day orally and to cats at a dose of 0.028 mg/L/day (via
aerosol) for 2 months, the animals developed fatal morphological changes in neurons of the cerebral cortex, subcortical
area, cerebellum, and spinal cord. Doses of 30 mg/kg/day caused head bobbing and circling in pregnant rats. The NOEL
was 7.5 mg/kg/day. The LOEL and NOEL for liver effects in a 2&hyph;year study in dogs fed diets containing triallate
were 4.25 mg/kg/day and 1.28 mg/kg/day, respectively. At 4.25 mg/kg/day an increase in hemosiderin deposition and
serum alkaline phosphatase was observed in both sexes, and an increase in liver weight was observed in females. Based
on the NOEL, an oral RfD of 0.013 mg/kg/day was derived. In a hamster chronic feeding study, decreased triglycerides
were seen in males at the LOEL of 30 mg/kg/day. The NOEL was 5 mg/kg/day. Ninety-day feeding studies in rats (10 mg/kg/day)
and dogs (5 mg/kg/day) showed no treatment related adverse effects except for increased liver-to-body-weight ratios
in the dogs. EPA believes that there is sufficient evidence for listing triallate on EPCRA section 313 pursuant to
EPCRA section 313(d)(2)(B) based on the chronic neurological and hepatic toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
255. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tribenuron methyl (2-(((((4-methoxy-6-methyl-1,3,5-triazin-2-yl)-methylamino)carbonyl)amino)sulfonyl)-,
methyl ester)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 101200-48-0) (FIFRA AI) (Ref. 3). In a 1-year feeding study in dogs, elevated serum bilirubin and aspartate
aminotransferase (AST) levels and increased urinary volume were reported in males receiving 8.16 mg/kg/day (LOEL).
The NOEL for males was 0.79 mg/kg/day. The LOEL for females was 52.02 mg/kg/day (the highest dose tested) and was based
on increased serum creatinine and transient increases in AST, globulin, and serum bilirubin. These females had an
18.2 percent decrease in body weight gain. The NOEL for females was 8.18 mg/kg/day. The highest dose in males (51.46
mg/kg/day) caused increases in serum creatinine and a 20 percent decrease in body weight gain. The oral RfD, derived
from the NOEL for males, was 0.008 mg/kg/day. In a 90&hyph;day feeding study, decreased absolute and relative liver
and kidney weights, serum glucose, globulin and cholesterol levels were observed in rats at 87.5 mg/kg/day (LOEL).
The NOEL was 5 mg/kg/day. EPA believes that there is sufficient evidence for listing tribenuron methyl on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(B) based on the available hepatic and renal toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
256. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tributyltin fluoride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001983-10-4) (FIFRA AI) (Ref. 3). Aquatic acute toxicity values for tributyltin fluoride include a bleak
fish 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 2.3 ppb, an algae 72&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 9.3 ppb, and a Harpacticoid copepod 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 0.8 ppb. EPA believes that there is sufficient evidence for listing tributyltin fluoride on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(C) based on the available environmental toxicity data. 
<!-- PJG 0012 frnewline -->
257. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tributyltin methacrylate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002155-70-6) (FIFRA AI) (Ref. 3). Pregnant rats were given tributyltin methacrylate by gavage on days 6 to
19 of gestation. Mean fetal weight and maternal body weight gain were decreased at 18 mg/kg/day. Fetal resorptions
were also significantly increased. The fetotoxic NOEL for this study was 9 mg/kg/day. EPA believes that there is sufficient
evidence for listing tributyltin methacrylate on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based
on the available developmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
258. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
S,S,S-Tributyltrithiophosphate (DEF)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000078-48-8) (FIFRA AI) (Ref. 8). S,S,S-Tributyltrithiophosphate (DEF) is a cholinesterase inhibitor.
Both immediate and delayed neurotoxic effects have been reported in humans following exposure to DEF. The exposure
levels at which these effects occurred, however, were not reported. In a 3&hyph;month hen feeding study, the NOEL
for neurotoxic effects was 0.1 mg/kg/day and the LOEL was 0.5 mg/kg/day. At 0.5 mg/kg day, hens showed delayed neurotoxicity,
ataxia, and equivocal changes in the spinal cord and peripheral nerves. Based on the NOEL, EPA has derived an oral RfD
of 0.00003 mg/kg/day for this chemical. In a 12&hyph;week dog feeding study, animals showed over sensitivity to stimuli
at 0.62 mg/kg/day; the NOEL was 0.12 mg/kg/day. In the same study, the LOEL for cholinesterase inhibition was 0.12
mg/kg/day and a NOEL was not established. Brain cholinesterase inhibition was observed in a chronic rat feeding study
at 1.25 mg/kg/day. The NOEL was 0.25 mg/kg/day. EPA believes that there is sufficient evidence for listing S,S,S-tributyltrithiophosphate
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the chronic neurotoxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Measured acute aquatic toxicity data for S,S,S&hyph;tributyltrithiophosphate include a rainbow trout 96&hyph;hour
LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 660 ppb (0.660 ppm) and a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 620 ppb (0.620 ppm). The measured log K
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
ow
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 is 5.7. EPA believes that there is sufficient evidence for listing S,S,S-tributyltrithiophosphate on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical and its potential
for bioaccumulation. 
<!-- PJG 0012 frnewline -->
259. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Trichloroacetyl chloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000076-02-8) (EPCRA EHS) (Ref. 8). Trichloroacetyl chloride is highly toxic in humans by the oral and inhalation
routes of exposure. Numerous cases of strong irritation of the eyes, skin, and respiratory tract and fever, nausea,
and vomiting following exposure to trichloroacetyl chloride have been reported. The acute inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 values for mice and rats are 0.445 mg/L and 0.475 mg/L, respectively, indicating that trichloroacetyl chloride is
highly toxic by inhalation in these species. EPA's exposure analysis indicates that trichloroacetyl chloride concentrations
are likely to exist beyond facility site boundaries, as a result of continuous, or frequently recurring releases,
at levels that can reasonably be anticipated to cause significant adverse acute human health effects. EPA believes
that there is sufficient evidence for listing trichloroacetyl chloride on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(A) based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
260. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Trichloroethylsilane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000115-21-9) (EPCRA EHS) (Ref. 8). Chlorinated silanes are very corrosive to the skin and mucous membranes
and liberate hydrochloric acid in the presence of water. Trichloroethylsilane causes severe burns and the vapor
is harmful to humans. The mouse 2&hyph;hour inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value is 0.30 mg/L. EPA's exposure analysis indicates that trichloroethylsilane concentrations are likely to exist
beyond facility site boundaries, as a result of continuous, or frequently recurring releases, at levels that can
reasonably be anticipated to cause significant adverse acute human health effects. EPA believes that there is sufficient
evidence for listing trichloroethylsilane on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on
the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
261. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Trichlorophenylsilane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000098-13-5) (EPCRA EHS) (Ref. 8). Chlorinated silanes are very corrosive to the skin and mucous membranes
and liberate hydrochloric acid in the presence of water. Trichlorophenylsilane causes severe burns and the vapor
is harmful to humans (concentration not specified). The 2&hyph;hour mouse inhalation LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 value is 0.33 mg/L. EPA's exposure analysis indicates that trichlorophenylsilane concentrations are likely to
exist beyond facility site boundaries, as a result of continuous, or frequently recurring releases, at levels that
can reasonably be anticipated to cause significant adverse acute human health effects. EPA believes that there is
sufficient evidence for listing trichlorophenylsilane on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A)
based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
262. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1,2,3-Trichloropropane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000096-18-4) (RCRA APP8) (Ref. 8). Results of a subchronic oral toxicity study in rats and mice reveal that
the primary target organs for 1,2,3-trichloropropane are the liver and kidney. Renal and hepatic necrosis were observed
in rats administered 1,2,3-trichloropropane by gavage for 17 weeks. The LOAEL was 16 mg/kg/day and the NOAEL was 8
mg/kg/day for hepatic effects. The LOAEL was 32 mg/kg/day and the NOAEL was 16 mg/kg/day for renal effects. Hepatic
necrosis in mice occurred at 125 mg/kg/day. The NOAEL was 63 mg/kg/day. Less severe renal necrotic changes were seen
at 250 mg/kg/day. The NOAEL was 125 mg/kg/day. The renal and hepatic lesions were accompanied by increases in organ
weights and alterations in serum enzymes that were indicative of hepatic and renal toxicity. At lower dose levels
(the LOAEL was 16 mg/kg/day), nonregenerative anemia (decreased hematocrit, hemoglobin, and erythrocyte count)
was observed in rats. The NOAEL was 8 mg/kg/day. Nonregenerative anemia is considered to be one of the most sensitive
effects of 1,2,3-trichloropropane. 
<!-- PJG 0012 frnewline -->
The respiratory tract is a principal target of inhaled 1,2,3-trichloropropane in humans and animals. Irritation
of the eyes and throat has been reported in humans acutely exposed (15 minutes) to 100 ppm (0.602 mg/L) of 1,2,3-trichloropropane
via inhalation. Irritative effects on the olfactory epithelium have been observed in rats exposed by inhalation
to 3 ppm (the LOAEL was 0.018 mg/L; the NOAEL was 0.006 mg/L) of 1,2,3-trichloropropane for 11 days. Histological effects
have also been seen in the nasal cavity (the LOEL was 125 mg/kg/day; the NOAEL was 63 mg/kg/day) in rats and in the bronchiolar
epithelium (the LOEL was 63 mg/kg/day; the NOAEL was 32 mg/kg/day) in mice that were exposed to 1,2,3-trichloropropane
by oral intubation for 17 weeks. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing 1,2,3-trichloropropane on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the hematological, respiratory, hepatic, and renal toxicity data for this
chemical. 
<!-- PJG 0012 frnewline -->
263. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Triclopyr triethylammonium salt
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 057213-69-1) (FIFRA AI) (Ref. 3). Degeneration of proximal tubules (the LOEL was 20 mg/kg/day; the NOEL was
5 mg/kg/day) was noted in male and female rats fed triclopyr for 3 months. A LOEL of 2.5 mg/kg/day, based on phenosulfophthalein
(PSP) excretion, was reported in dogs fed triclopyr for 6 months. A similar effect was also noted at the LOEL of 5 mg/kg/day,
determined in dogs fed triclopyr for 8 months. The NOEL was greater than 5 mg/kg/day. Significant increases in absolute
and relative kidney weights were observed in rats fed 36 mg/kg/day for 2 years. The NOEL was 12 mg/kg/day. In a pharmacokinetic
study, reduced PSP excretion was seen in dogs administered 5 mg/kg/day, whereas no effect on PSP excretion was seen
in monkeys administered 20 mg/kg/day. No details on the route and length of exposure were provided. EPA believes that
there is sufficient evidence for listing triclopyr triethylammonium salt on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available renal toxicity data. 
<!-- PJG 0012 frnewline -->
264. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Triethylamine
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000121-44-8) (CAA HAP) (Ref. 7). Triethylamine is an acute irritant which causes eye and nasal irritation
and pulmonary toxicity in mice and rats and is an acute eye toxicant in man. 
<!-- PJG 0012 frnewline -->
In a survey of workers exposed to triethylamine, none of the workers reported effects at 5 ppm. Slight to mild effects
were noted at concentrations between 5 and 10 ppm and above 10 ppm workers reported visual disturbances which included
halo vision and irritation of the eyes, nose, and throat. In a separate report, eye irritation and visual disturbances
consisting of foggy vision, blue haze or halo vision (halo around lights) was reported in 19 workers exposed to triethylamine.
Exact exposure levels were not determined. The TWA in the work place of those individuals who complained of ``blue
haze'' was 11 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 with a range of 4 to 24 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The American Council of Government and Industrial Hygienists (ACGIH) has set a threshold limit value-time weighted
average (TLV-TWA) of 10 ppm and a threshold limit value-short-term exposure limit (TLV-STEL) of 15 ppm based upon
inhalation toxicity in guinea pigs and rats and skin irritation and eye injury in rabbits. 
<!-- PJG 0012 frnewline -->
EPA's exposure analysis indicates that triethylamine concentrations are likely to exist beyond facility site boundaries,
as a result of continuous, or frequently recurring releases, at levels that can reasonably be anticipated to cause
significant adverse acute human health effects. EPA believes that there is sufficient evidence for listing triethylamine
on EPCRA section 313 pursuant to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data
for this chemical. 
<!-- PJG 0012 frnewline -->
265. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Triforine (N,N'-[1,4-piperazinediylbis(2,2,2-trichloroethylidene)] bisformamide)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 026644-46-2) (FIFRA AI) (Ref. 3). In a 2&hyph;year feeding study in rats, anemia was reported. The LOEL, based
on this effect, was 3,125 ppm (156 mg/kg/day) and the NOEL was 625 ppm (31.25 mg/kg/day). Siderosis of Kupffer cells
and bone marrow cells was reported in dogs exposed to triforine in their diet for 2 years. The LOEL in this study was 1,000
ppm (25 mg/kg/day) and the NOEL was 100 ppm (2.5 mg/kg/day). Effects on red blood cells, hematocrit or hemoglobin were
also noted in dogs or rats in several 13&hyph;week feeding studies. For example, dogs exposed to a 20.6 percent a.i.
formulation of the compound for 13 weeks at dose levels that included 600 ppm (the LOEL, equivalent to 15 mg/kg/day
or 3.1 mg a.i./kg/day) and 100 ppm (the NOEL, equivalent to 2.5 mg/kg/day or 0.5 mg a.i./kg/day) had siderosis in the
liver, spleen, and bone marrow. 
<!-- PJG 0012 frnewline -->
A decrease in mean relative weight of offspring was observed in rabbits exposed to 25 mg/kg triforine (the fetotoxicity
LOEL). The fetotoxicity NOEL was 5 mg/kg. The LOEL and NOEL for maternal toxicity in this developmental toxicity study
were also 25 mg/kg and 5 mg/kg, respectively, and were based on reduced food intake and body weight loss. Fetotoxicity
(decreased number of fetuses and increased resorptions) was also reported in the offspring of rats fed 1,600 mg/kg
(the fetotoxicity LOEL) for an unspecified duration. The fetotoxicity NOEL was 800 mg/kg. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing triforine on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available hematological and developmental toxicity data for this chemical. 266. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Trimethylchlorosilane
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000075-77-4) (EPCRA EHS) (Ref. 8). Chlorinated silanes are very corrosive to the skin and mucous membranes
and liberate hydrochloric acid in the presence of water. Trimethylchlorosilane causes severe burns and the vapor
is harmful to humans. The mouse inhalation LCLo value is 0.10 mg/L. EPA's exposure analysis indicates that trimethylchlorosilane
concentrations are likely to exist beyond facility site boundaries, as a result of continuous, or frequently recurring
releases, at levels that can reasonably be anticipated to cause significant adverse acute human health effects.
EPA believes that there is sufficient evidence for listing trimethylchlorosilane on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(A) based on the available acute toxicity and exposure data for this chemical. 
<!-- PJG 0012 frnewline -->
267. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2,3,5-Trimethylphenyl methylcarbamate
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 002655-15-4) (FIFRA AI) (Ref. 3). Cholinesterase inhibition was reported in a series of studies for this
carbamate pesticide. In dogs that received 2,000 ppm (50 mg/kg/day) 2,3,5-trimethylphenyl methylcarbamate in
their diet for 14 days, there was inhibition of plasma and red blood cell cholinesterases and also weight loss. Brain
cholinesterase was slightly decreased in rats in a 2&hyph;year feeding study at 200 ppm (10 mg/kg/day). At 800 ppm
(40 mg/kg/day), there were fatty changes in the liver which disappeared after 7.5 months. EPA believes that there
is sufficient evidence for listing 2,3,5-trimethylphenyl methylcarbamate on EPCRA section 313 pursuant to EPCRA
section 313(d)(2)(B) based on the available neurological toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
268. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Triphenyltin chloride
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000639-58-7) (EPCRA EHS) (Ref. 8). Oral exposure of male rats to 380 mg/kg triphenyltin chloride over 19 days
caused adverse effects on the testes, epididymis, sperm duct, prostate gland, seminal vesicle, Cowper's gland,
and accessory glands. EPA believes that there is sufficient evidence for listing triphenyltin chloride on EPCRA
section 313 pursuant to EPCRA section 313(d)(2)(B) based on the reproductive toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity data for triphenyltin chloride include a 48&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for carp of 55 ppb and a 72&hyph;hour EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (growth) for marine green algae of 0.92 ppb. In addition, the measured aquatic toxicity information indicates a freshwater
green algae 8&hyph;day EC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (growth) of 2 ppb. EPA believes that there is sufficient evidence for listing triphenyltin chloride on EPCRA section
313 pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
269. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Triphenyltin hydroxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 000076-87-9) (FIFRA SR) (Ref. 8). Triphenyltin hydroxide has been classified by EPA as a Group B2 compound,
i.e., a probable carcinogen. This was based on the significant increases in fetal pituitary gland adenomas in female
Wistar rats and Leydig cell tumors in male Wistar rats fed 1 or 4 mg/kg/day triphenyltin hydroxide for 2 years. There
were significant increases of hepatocellular adenomas and combined hepatocellular (adenoma and/or carcinoma)
tumars in male and female NMRI mice fed 0.65, 2.6, or 10.4 mg/kg/day for 80 weeks. 
<!-- PJG 0012 frnewline -->
In a developmental toxicity study in rats, oral doses of 15 mg/kg of triphenyltin hydroxide during gestation days
1 to 7 prevented implantation. When administered from day 8 and onwards, the compound was fetolethal. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing triphenyltin hydroxide on EPCRA section 313 pursuant
to EPCRA section 313(d)(2)(B) based on the carcinogenicity data and the developmental toxicity data for this chemical.

<!-- PJG 0012 frnewline -->
Measured aquatic acute toxicity data for triphenyltin hydroxide include a fathead minnow 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 5.4 ppb, a bluegill 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 23 ppb, a rainbow trout 96&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 15 ppb, and a marine green algae 72&hyph;hour LC
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=2 -->
50
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of 13.9 ppb. EPA believes that there is sufficient evidence for listing triphenyltin hydroxide on EPCRA section 313
pursuant to EPCRA section 313(d)(2)(C) based on the environmental toxicity data for this chemical. 
<!-- PJG 0012 frnewline -->
270. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Vanadium pentoxide
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 001314-62-1) (CERCLA; EPCRA EHS; RCRA APP8) (Ref. 8). Eighteen workers exposed to vanadium pentoxide dusts
at concentration in excess of 0.5 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (0.0005 mg/L) for a period of up to 2 weeks developed respiratory symptoms that persisted for nearly 2 weeks after removal
from exposure. Inhalation of unspecified levels of vanadium pentoxide for 1 to 5 years produced asthma in 3 of 20 workers.
Mice and rats exposed to 1 to 3 mg/m
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
3
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (0.001 to 0.003 mg/L) vanadium pentoxide 6 hours/day for 3 months developed histopathologic changes in their lungs
and had a decrease in growth rate. EPA believes that there is sufficient evidence for listing vanadium pentoxide on
EPCRA section 313 pursuant to EPCRA section 313(d)(2)(B) based on the available chronic respiratory toxicity data
for this chemical. 
<!-- PJG 0012 frnewline -->
271. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Vinclozolin (3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (CAS No. 050471-44-8) (FIFRA AI) (Ref. 3). The results of a 3&hyph;month feeding study in Wistar rats administered
4,500 ppm (225 mg/kg/day; the only dose tested) indicate that vinclozolin interacts with numerous steroid hormones
in male and female animals. A broad spectrum of steroid hormones were affected in these animals, including increases
in adrenocorticotropic hormone, lutenizing hormone, follicle stimulating hormone, testosterone, corticosterone,
aldosterone, and dehydroepiandrosterone and slight decreases in estradiol levels in males. Female rats had elevated
adrenocorticotropic hormone and luteinizing levels and depressed corticosterone and aldosterone levels, while
follicle stimulating hormone, testosterone, dehydroepiandrosterone and estradiol levels were comparable to
controls. After a 2&hyph;month recovery period postdosing, all male hormone levels were normal except for a slight
elevation in FSH, and all female hormone levels were normal except for a slight elevation in estradiol. The endocrine
changes also were reported in developmental, subchronic, and chronic toxicity studies. 
<!-- PJG 0012 frnewline -->
A broad spectrum of organ changes occurred in dogs exposed to vinclozolin in a 1-year feeding study. Males administered
4.8 mg/kg/day (the LOEL for males) had increases in testes weights, increased bilirubin, and prostate atrophy. The
NOEL in males was 2.4 mg/kg/day. Females in this study had increased adrenal weights, lipid accumulation in the adrenal
glands, and marginally increased hemosiderin in the liver at 5.1 mg/kg/day (the LOEL for females). The NOEL for females
was 2.5 mg/kg/day. At higher doses (47 mg/kg/day in males and 53 mg/kg/day in females), there were increases in weights
of the liver, spleen, testes, adrenal, and thyroid. Other effects included increased diffuse hyperplasia of the
Leydig cells, lipid accumulation in the adrenal cortex, and increased platelets in males, and in females, slight
increases in mean corpuscular volume and mean corpuscular hemoglobin concentration. The oral RfD for this compound,
0.025 mg/kg/day, was based on the findings of a 6&hyph;month feeding study with beagle dogs, in which adrenal weights
(absolute and relative) were significantly increased at 7.5 mg/kg/day (the LOEL). The NOEL was 2.5 mg/kg/day. Both
males and females exposed to higher doses (600 and 2,000 ppm, or 15 and 50 mg/kg/day) had histological changes in the
adrenal glands, including vacuolation of the zona fasciculata. In addition to effects on the adrenal gland, males
exposed to the LOEL dose and higher had decreased absolute kidney weights, and at 600 ppm, fat droplets in the distal
tubule were observed. 
<!-- PJG 0012 frnewline -->
Pseudohermaphroditism (a decrease in anal-genital distance) occurred in male offspring of rats administered doses
of 50 mg/kg (the LOEL) and higher by gavage. The developmental NOEL was 15 mg/kg. The same effect was noted in the offspring
of rats that received dermal applications of 180 mg/kg/day (LOEL; the developmental NOEL was 60 mg/kg/day) during
gestation, and also in a 2-generation reproduction study in rats (the LOEL was 86 mg/kg/day, the NOEL was 25 mg/kg/day).
Other developmental effects observed in the latter study included developmental delays, reduced male and female
pup weight, increased stillbirths and increased pup mortality throughout lactation. 
<!-- PJG 0012 frnewline -->
EPA believes that there is sufficient evidence for listing vinclozolin on EPCRA section 313 pursuant to EPCRA section
313(d)(2)(B) based on the available endocrine, adrenal, renal, hepatic, and developmental toxicity data. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Rationale for Listing 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA is proposing to add the chemical substances identified in Unit IV.B. of this preamble because EPA believes that
these chemicals meet the statutory criteria for listing under section 313(d)(2) of EPCRA. The bases for these determinations
and the specific toxic effects are summarized in Unit IV.B. of this preamble and set forth in more detail in the rulemaking
record. 
<!-- PJG 0012 frnewline -->
EPA intends to evaluate public comment on this proposed rule and issue a final rule by November 30, 1994. Reporting
for the chemicals identified in the final rule would be required for activities during the 1995 calendar year. Such
reports would have to be submitted to EPA and States by July 1, 1996. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VI. Rulemaking Record
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The record supporting this proposed rule is contained in docket number OPPTS&hyph;400082. Nonconfidential documents,
including an index of the docket, are available to the public in the TSCA Nonconfidential Information Center (NCIC),
also known as the TSCA Public Docket Office from 12 noon to 4 p.m., Monday through Friday, excluding legal holidays.
The TSCA Public Docket Office is located at EPA Headquarters, Rm. E&hyph;G102, 401 M St., SW., Washington, DC 20460.

<!-- PJG 0012 frnewline -->
Any person who submits comments claimed as CBI must mark the comments as ``confidential,'' ``CBI,'' or other appropriate
designation. Comments not claimed as confidential at the time of submission will be placed in the public file. Any
comments marked as confidential will be treated in accordance with the procedures in 40 CFR part 2. Any person submitting
comments claimed to be confidential must prepare and submit a nonconfidential public version of the comments in triplicate
that EPA can place in the public file. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VII. Request for Public Comment 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA requests comment on any aspect of this proposal. EPA requests specific comment as detailed in the following paragraphs.

<!-- PJG 0012 frnewline -->
EPA requests comment on the sufficiency of the evidence for each of the chemicals proposed for addition in Unit IV.B.
of this preamble. In addition, EPA requests comment on any issues that may be specific to any of the individual chemicals
or chemical categories. 
<!-- PJG 0012 frnewline -->
EPA requests comment on whether it would be appropriate to list persistent bioaccumulative toxic chemicals that
are manufactured, processed, or otherwise used below the current reporting thresholds on EPCRA section 313. If EPA
were to add this type of chemical to EPCRA section 313, what modifications to EPCRA section 313, such as lowering the
reporting thresholds and modifying the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de minimis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in mixture exemptions, would be required to insure that release and transfer information would be collected? 
<!-- PJG 0012 frnewline -->
In Units IV.B.132., IV.B.144., and IV.B.158., of this preamble, EPA is proposing to add individually three diisocyanates:
hexamethylene-1,6-diisocyante; isophorone diisocyanate; and 1,1-methylene bis(4-isocyanatocyclohexane).
EPA requests comment on its alternative proposal in Unit IV.B.132. of this preamble to create a diisocyanates category
rather than adding diisocyanates individually to EPCRA section 313. EPA also requests comment on what diisocyanates,
other than those listed in IV.B.132. of this preamble, should be included in such a category. 
<!-- PJG 0012 frnewline -->
EPA requests comment on its proposed definition of man-made mineral fibers, given in Unit IV.B.149. of this preamble,
and any other options for defining a fibers category. 
<!-- PJG 0012 frnewline -->
In Unit IV.B.166. and 172. of this preamble, EPA is proposing to add two ethylene bisdithiocarbamates (EBDCs): metiram;
and nabam. An additional two EBDCs, zineb and maneb, are currently listed on the EPCRA section 313 list of toxic chemicals.
The category of EBDCs has recently been added to EPCRA section 313 (December 1, 1993; 58 FR 63500). EPA requests comment
on the following: (1) Should the individual EBDCs, metiram and nabam, be added individually to EPCRA section 313 even
though they are members of the EBDC category, which is listed on EPCRA section 313; and (2) should the individual listings
for two EBDCs, zineb and maneb, be deleted and added as members of the newly created EBDC category? 
<!-- PJG 0012 frnewline -->
EPA requests comment on whether polycyclic aromatic compounds (PACs) should be added as a delineated category consisting
of the PACs listed in Unit IV.B.207. of this preamble or as a category with the definition given in Unit IV.B.207. of
this preamble. 
<!-- PJG 0012 frnewline -->
EPA requests comment on its approach in considering exposure as a part of its evaluation of certain chemicals under
sections 313(d)(2)(A) and (C).
<!-- PJG 0012 frnewline -->
In Units IV.B.36, 179., and 235. of this preamble, EPA is proposing to add three chemicals (sulfur dioxide, nitrogen
dioxide, and carbon monoxide) that are regulated by Title I of the CAA (Provisions for Attainment and Maintenance
of National Ambient Air Quality Standards). In addition, sulfur dioxide is regulated under Title IV of the CAA (Acid
Deposition Control). Extensive data, which are highly technical, are collected on these chemicals as required by
the CAA. EPA requests comment on the following: (1) Is the information collected under the CAA sufficient for public
right-to-know purposes; and (2) suggestions on how the data collected on these chemicals pursuant to CAA Titles I
and IV could be used to meet the purposes of EPCRA section 313.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Comments should be submitted to the address listed under the 
<!-- PJG 0012 frnewline -->
ADDRESSES unit. All comments must be received on or before April 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
VIII. Public Meeting 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
EPA will hold a 1&hyph;day public meeting to discuss the issues presented above. The tentative agenda for this public
meeting will include a discussion of the issues presented in Unit VII. of this preamable. 
<!-- PJG 0012 frnewline -->
Scheduling of oral statements will be on a first come first served basis by calling the telephone number listed under
FOR FURTHER INFORMATION CONTACT. All statements will be made part of the public record and will be considered in the
development of the final rule. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IX. References 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(1) U.S. Congress, House of Representatives. ``Conference Report No. 962,'' 99th Cong., 2nd Session. 294 (1986).

<!-- PJG 0012 frnewline -->
(2) USEPA/OHEA. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Risk Assessment Guidelines for Carcinogen Risk
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. U.S. Environmental Protection Agency, Cincinnati, OH. (1987). 
<!-- PJG 0012 frnewline -->
(3) USEPA/OPP. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Support Document for the Addition of Chemicals from Federal Insecticide, Fungicide, Rodenticide Act (FIFRA) Active
Ingredients to EPCRA Section 313
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. U. S. Environmental Protection Agency, Washington, DC (1993). 
<!-- PJG 0012 frnewline -->
(4) USEPA/OPPT. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Issue Paper Prepared for the Public Meeting on Expansion of the Toxic Release Inventory
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. U. S. Environmental Protection Agency, Washington, DC (1993). 
<!-- PJG 0012 frnewline -->
(5) USEPA/OPPT. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Physical Properties and Environmental Fate of Some TRI Expansion Chemicals
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. U. S. Environmental Protection Agency, Washington, DC (1993). 
<!-- PJG 0012 frnewline -->
(6) USEPA/OPPT. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Revised Draft Hazard Assessment Guidelines for Listing Chemicals on the Toxic Release Inventory
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. U. S. Environmental Protection Agency, Washington, DC (1992). 
<!-- PJG 0012 frnewline -->
(7) USEPA/OPPT. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Support Document for the Addition of Chemicals from Section 112(b) of the Clean Air Act Amendments and Chlorinated
Paraffins to EPCRA Section 313
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. U. S. Environmental Protection Agency, Washington, D.C. (1993). 
<!-- PJG 0012 frnewline -->
(8) USEPA/OPPT. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Support Document for the Health and Ecological Toxicity Review of TRI Expansion Chemicals
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. U. S. Environmental Protection Agency, Washington, DC (1993). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
X. Regulatory Assessment Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Executive Order 12866
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under Executive Order 12866 (58 FR 51735, October 4, 1993), the Agency must determine whether the regulatory action
is ``significant'' and therefore subject to the Office of Management and Budget (OMB) and the requirements of the
Executive Order. Under section 3(f), the order defines a ``significant regulatory action'' as an action likely to
result in a rule (1) Having an annual effect on the economy of $100 million or more, or adversely and materially affecting
a sector of the economy, productivity, competition, jobs, the environment, public health or safety, or State, local,
or tribal governments or communities (also referred to as ``economically significant''); (2) creating serious
inconsistency or otherwise interfering with an action taken or planned by another agency; (3) materially altering
the budgetary impacts of entitlements, grants, user fees, or loan programs; or (4) raising novel legal or policy issues
arising out of legal mandates, the President's priorities, or the principles set forth in this Executive Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pursuant to the terms of this Executive Order, it has been determined that this proposed rule is a ``significant regulatory
action.'' As such, this action was submitted to OMB for review, and any comments or changes made in response to OMB suggestions
or recommendations have been documented in the public record.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Regulatory Flexibility Act
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Regulatory Flexibility Act of 1980 requires each Federal agency to perform a Regulatory Flexibility Analysis
for all rules that are likely to have a ``significant impact on a substantial number of small entities.'' The analysis
supporting this proposed rule estimated the maximum cost that a small business might incur, and calculated the cost
impact percentage (reporting costs divided by average value of shipments) for each employee size, class, and SIC
code. 
<!-- PJG 0012 frnewline -->
Reporting costs are estimated at less than one percent of the average value of shipments per report in the first year,
and less than one-half of one percent of the value of shipments per report in subsequent years. The precise impacts
depend on how many reports an individual small business submits. However, experience with current reporters indicates
that small businesses generally submit fewer reports per facility than larger ones. Most of the reports are anticipated
to be submitted from industries with the lowest impacts. Because of this, no segment of the manufacturing sector is
likely to suffer significant adverse effects due to this rule, Therefore, EPA certifies that this proposed rule will
not have a significant impact on a substantial number of small entities. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Paperwork Reduction Act
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The collection of information and other requirements under section 313 of EPCRA and section 6607 of the PPA are covered
under OMB approval number 2070&hyph;0093, which was issued on May 14, 1992. While this approval normally would have
expired on November 30, 1992, it remains in effect pursuant to the 1993 Department of Veteran Affairs and Housing and
Urban Development and Independent Agencies Appropriations Act, Pub. L. 102&hyph;389, signed October 6, 1992, which
states that:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Notwithstanding the Paperwork Reduction Act of 1980 or any requirements thereunder the Environmental Protection
Agency Toxic Chemical Release Inventory Form R and Instructions, revised 1991 version issued May 19, 1992, and related
requirements (OMB No. 2070&hyph;0093), shall be effective for reporting under section 6607 of the Pollution Prevention
Act of 1990 (Public Law 101508) and section 313 of the Superfund Amendments and Reauthorization Act of 1986 (Public
Law 99-499) until such time as revisions are promulgated pursuant to law. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This proposed rule adds chemicals to the list of toxic chemicals subject to reporting under section 313 of EPCRA and
section 6607 of the PPA and does not change the elements of the TRI reporting form, its instructions, or related requirements.
Accordingly, the Form R and Instructions and related requirements remain in effect, as provided by Pub. L. 102-389.
<!-- PJG 0012 frnewline -->
The industry reporting burden for collecting this information is estimated to average 53 hours per respondent annually,
including time for reviewing instructions, searching existing data sources, gathering and maintaining the data
needed, and completing and reviewing the collection of information. The actual burden to a specific facility may
deviate from this estimate depending on the complexity of the facility's operations and the profile of the release.
<!-- PJG 0012 frnewline -->
Send comments regarding this collection of information, including suggestions for reducing this burden, to Chief,
Information Policy Branch, 2131, U.S. Environmental Protection Agency, 401 M St., SW., Washington, DC 20460; and
to the Office of Information and Regulatory Affairs, Office of Management and Budget, 726 Jackson Place NW., Washington,
DC 20503, marked ``Attention: Desk Officer for EPA.'' The final rule will respond to any OMB or public comments on this
collection of information. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects in 40 CFR Part 372 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Community right-to-know, Reporting and recordkeeping requirements, Toxic chemicals

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Carol M. Browner,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Therefore it is proposed that 40 CFR part 372 be amended to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Part 372_[AMENDED]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The authority citation for part 372 would continue to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: 42 U.S.C. 11013 and 11028.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. In &sect;372.65 by adding chemicals to paragraph (a) alphabetically, to paragraph (b) by CAS no. sequence, and
to paragraph (c) by alphabetically adding four categories to read as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=80 g=1 f=1 -->
&sect;372.65
<!-- PJG /ITAG -->

<!-- PJG ITAG l=89 g=1 f=1 -->
Chemicals and chemical categories to which the part applies.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
&blank;*&blank;*&blank;*&blank;*&blank;*
<!-- PJG 0012 frnewline -->
(a)&blank;*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,tp8,p8,8/8,s160,r30,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Chemical Name
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1CAS No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Effective Date
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAbamectin [Avermectin B1]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l71751-41-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lAcephate (Acetylphosphoramidothioic acid O,S-dimethyl ester)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l30560-19-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAcifluorfen, sodium salt [5-(2-Chloro-4-(triflouromethyl)phenoxy)-2-nitro-benzoic acid, sodium salt]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62476-59-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAlachlor
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l15972-60-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lAldicarb
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l116-06-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
ld-trans-Allethrin [d-trans-Chrysanthemic acid of d-allethrone]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l28057-48-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lAllylamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l107-11-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAluminum phosphide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l20859-73-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lAmetryn (N-Ethyl-N'-(1-methylethyl)-6-(methylthio)-1,3,5,-triazine-2,4-diamine) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l834-12-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAmitraz
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l33089-61-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAnilazine [4,6-dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l101-05-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lAtrazine (6-Chloro-N-ethyl-N'-(1-methylethyl)-1,3,5,-triazine-2,4-diamine) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1912-24-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lBendiocarb [2,2-Dimethyl-1,3-benzodioxol-4-ol methylcarbamate] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l22781-23-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBenfluralin (N-Butyl-N-ethyl-2,6-dinitro-4-(trifluoromethyl)benzenamine) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1861-40-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBenomyl
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l17804-35-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lo-Benzyl-p-chlorophenol 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l120-32-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lBifenthrin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l82657-04-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lBis(tributylin) oxide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l56-35-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBoron trichloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10294-34-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBoron trifluoride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7637-07-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBromacil (5-Bromo-6-methyl-3-(1-methylpropyl)-2,4-(1H,3H)-pyrimidinedione) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l314-40-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBromacil, lithium salt [2,4-(1H,3H)-Pyrimidinedione, 5-bromo-6-methyl-3-(1-methylpropyl), lithium salt]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l53404-19-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBromine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7726-95-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1-Bromo-1-(bromomethyl)-1,3-propanedicarbonitrile 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l35691-65-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2-Bromo-2-nitropropane-1,3-diol (Bronopol) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l52-51-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lBromoxynil (3,5-Dibromo-4-hydroxybenzonitrile) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1689-84-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBromoxynil octanoate (Octanoic acid, 2,6-dibromo-4-cyanophenyl ester) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1689-99-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lBrucine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l357-57-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lButylate (Bis-2-methylpropyl)carbamothioic acid S-ethyl ester)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2008-41-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lButylated hydroxyanisole
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l25013-16-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lC.I. Acid Red 114
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l6459-94-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lC.I. Direct Blue 218
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l28407-37-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCalcium hypochlorite
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7778-54-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lCaprolactam
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l105-60-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCarbofuran
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1563-66-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCarbon monoxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l630-08-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCarboxin (5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l5234-68-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChinomethionat [6-Methyl-1,3-dithiolo[4,5-b]quinoxalin-2-one] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2439-01-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorendic acid
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l115-28-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChlorimuron ethyl [Ethyl-2-[[[(4-chloro-6-methoxyprimidin-2-yl)-carbonyl]-amino]sulfonyl]benzoate]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l90982-32-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4080-31-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lp-Chloroaniline
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l106-47-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l5-Chloro-2-(2,4-dichlorophenoxy)phenol
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3380-34-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l3-Chloro-2-methyl-1-propene
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l563-47-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lp-Chlorophenyl isocyanate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l104-12-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChloropicrin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l76-06-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l3-Chloropropionitrile
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l542-76-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lp-Chloro-o-toluidine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l95-69-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2-Chloro-1,1,1-trifluoro-ethane (HCFC-133a)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l75-88-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChlorotrifluoromethane (CFC-13) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l75-72-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3-Chloro-1,1,1-trifluoro-propane (HCFC-253fb)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l460-35-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChlorpyrifos methyl [O,O-dimethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothioate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l5598-13-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lChlorsulfuron [2-chloro-N-[[4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino]carbonyl]benzenesulfonamide]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l64902-72-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lClomazone [2-[(2-Chlorophenyl)methyl]-4,4-dimethyl-3-isoxazolidinone]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l81777-89-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lCrotonaldehyde
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4170-30-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lCyanazine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l21725-46-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCycloate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1134-23-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCyclohexanol
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l108-93-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lCyfluthrin [3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, cyano(4-fluoro-3-phenoxyphenyl)methyl
ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l68359-37-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lCyhalothrin [3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2-dimethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl
ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l68085-85-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lCyromazine [N-Cyclopropyl-1,3,5-triazine-2,4,6-triamine] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l66215-27-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDazomet(Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l533-74-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDazomet, sodium salt [Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione, ion(1-), sodium] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l53404-60-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4,-DB
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l94-82-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D butoxyethyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1929-73-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D butyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l94-80-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D chlorocrotyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2971-38-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDesmedipham 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l13684-56-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D 2-ethylhexyl ester 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1928-43-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D 2-ethyl-4-methylpentyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l53404-37-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDiazinon
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l333-41-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2,2-Dibromo-3-nitrilopropionamide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10222-01-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDicamba (3,6-Dichloro-2-methyoxybenzoic acid) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1918-00-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDichloran [2,6-Dichloro-4-nitroaniline] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l99-30-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l3,3'-Dichlorobenzidine dihydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l612-83-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3,3'-Dichlorobenzidine sulfate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l64969-34-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
ltrans-1,4-Dichloro-2-butene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l110-57-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,2-Dichloro-1,1-difluoroethane (HCFC-132b)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1649-08-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDichlorofluoromethane (HCFC-21)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l75-43-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDichloromethylphenylsilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l149-74-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDichloropentafluoropropane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l127564-92-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,1-dichloro-1,2,2,3,3-pentafluoropropane (HCFC-225cc) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l13474-88-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,1-dichloro-1,2,3,3,3-pentafluoropropane (HCFC-225eb) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l111512-56-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,2-dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225bb) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l422-44-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,2-dichloro-1,1,3,3,3-pentafluoropropane (HCFC-225da) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l431-86-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,3-dichloro-1,1,2,2,3-pentafluoropropane (HCFC-225cb) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l507-55-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,3-dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225ea) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l136013-79-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,2-dichloro-1,1,1,3,3-pentafluoropropane (HCFC-225aa) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l128903-21-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,3-dichloro-1,1,1,2,3-pentafluoropropane (HCFC-225ba) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l422-48-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3,3-dichloro-1,1,1,2,2-pentafluoropropane (HCFC-225ca) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l422-56-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDichlorophene [ 2,2'-Methylene-bis(4-chlorophenol)]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l97-23-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
ltrans-1,3-Dichloropropene
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10061-02-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDiclofop methyl [2-[4-(2,4-Dichlorophenoxy)phenoxy]propanoic acid, methyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l51338-27-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDicyclopentadiene
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l77-73-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDiethatyl ethyl 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l38727-55-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDiflubenzuron
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l35367-38-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDiglycidyl resorcinol ether
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l101-90-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDimethipin [2,3,-Dihydro-5,6-dimethyl-1,4-dithiin-1,1,4,4-tetraoxide]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l55290-64-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDimethoate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l60-51-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethoxybenzidine dihydrochloride (o-Dianisidine dihydrochloride)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l20325-40-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethoxybenzidine hydrochloride (o-Dianisidine hydrochloride)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l111984-09-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDimethylamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l124-40-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDimethylamine dicamba 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2300-66-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethylbenzidine dihydrochloride (o-Tolidine dihydrochloride)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l612-82-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethylbenzidine dihydrofluoride (o-Tolidine dihydrofluoride)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l41766-75-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDimethyl chlorothiophosphate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2524-03-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDimethyldichlorosilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l75-78-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lN,N-Dimethylformamide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l68-12-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2,6-Dimethylphenol
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l576-26-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDinocap
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l39300-45-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDinoseb
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l88-85-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDiphenamid
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l957-51-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDiphenylamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l122-39-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lDipotassium endothall [7-Oxabicyclo(2.2.1)heptane-2,3-dicarboxylic acid, dipotassium salt] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2164-07-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDipropyl isocinchomeronate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l136-45-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDisodium cyanodithioimidocarbonate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l138-93-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D isopropyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l94-11-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-Dithiobiuret
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l541-53-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDithiopyr [2-(Difluoromethyl)-4-(2-methylpropyl)-6-(trifluoromethyl)-3,5-pyridinedicarbothioic acid
S,S-dimethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l97886-45-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDiuron
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l330-54-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D 2-octyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1917-97-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lDodine [Dodecylguanidine monoacetate] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2439-10-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4,-DP
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l120-36-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D propylene glycol butyl ether ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1320-18-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,4-D sodium salt
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2702-72-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lEthoprop [Phosphorodithioic acid O-ethyl S,S-dipropyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l13194-48-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lEthyl dipropylthiocarbamate [EPTC] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l759-94-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lFamphur
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l52-85-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFenarimol [.alpha.-(2-Chlorophenyl)-.alpha.-4-chlorophenyl)-5-pyrimidinemethanol]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l60168-88-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFenbutatin oxide (Hexakis(2-methyl-2-phenyl-propyl)distannoxane)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l13356-08-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFenoxaprop ethyl [2-(4-((6-Chloro-2-benzoxazolylen)oxy)phenoxy)propanoic acid,ethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l66441-23-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFenoxycarb [2-(4-Phenoxyphenoxy)ethyl]carbamic acid ethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l72490-01-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFenpropathrin [2,2,3,3-Tetramethylcyclopropane carboxylic acid cyano(3-phenoxy-phenyl)methyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l39515-41-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFenthion [O,O-Dimethyl O-[3-methyl-4-(methylthio)phenyl]ester, phosphorothioic acid] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l55-38-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFenvalerate [4-Chloro-alpha-(1-methylethyl)benzeneacetic acid cyano(3-phenoxyphenyl)methyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l51630-58-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFerbam [Tris(dimethylcarbamo-dithioato-S,S')iron] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l14484-64-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFluazifop-butyl [2-[4-[[5-(Trifluoromethyl)-2-pyridinyl]oxy]-phenoxy]propanoic acid, butyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l69806-50-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFlumetralin [2-Chloro-N-(2,6-dinitro-4-(trifluoromethyl)phenyl)-N-ethyl-6-fluorobenzenemethanamine]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62924-70-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lFluorine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7782-41-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFluorouracil (5-Fluorouracil)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l51-21-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFluvalinate [N-[2-Chloro-4-(trifluoromethyl)phenyl]-DL-valine(+)-cyano (3-phenoxyphenyl)methyl ester]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l69409-94-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFolpet
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l133-07-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lFomesafen [5-(2-Chloro-4-(trifluoromethyl)phenoxy)-N-methylsulfonyl)-2-
<!-- PJG 0012 frnewline -->
nitrobenzamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l72178-02-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lalpha-Hexachlorocyclohexane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l319-84-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lHexamethylene-1,6-diisocyanate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l822-60-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
ln-Hexane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l110-54-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lHexazinone 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l51235-04-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lHydramethylnon [Tetrahydro-5,5-dimethyl-2(1H)-pyrimidinone[3-[4- (trifluoromethyl)phenyl]-1-[2-[4-(trifluoromethyl)phenyl]ethenyl]-2-
<!-- PJG 0012 frnewline -->
propenylidene]hydrazone] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l67485-29-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lImazalil [1-[2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l35554-44-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3-Iodo-2-propynyl butylcarbamate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l55406-53-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lIprodione [3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l36734-19-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lIron pentacarbonyl
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l13463-40-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lIsodrin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l465-73-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lIsofenphos [2-[[Ethoxyl[(1-methylethyl)amino]phosphinothioyl]oxy]benzoic 
<!-- PJG 0012 frnewline -->
acid 1-methylethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l25311-71-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lIsophorone
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l78-59-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lIsophorone diisocyanate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l4098-71-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lLactofen [5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitro-2-ethoxy-1- methyl-2-oxoethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l77501-63-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lLinuron
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l330-55-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lLithium carbonate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l554-13-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMalathion
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l121-75-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMecoprop
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l93-65-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2-Mercaptobenzothiazole (MBT)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l149-30-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMerphos
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l150-50-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMetham sodium (Sodium methyldithiocarbamate)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l137-42-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMethazole [2-(3,4-Dichlorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5-dione] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l20354-26-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMethiocarb
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2032-65-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMethoxone (4-Chloro-2-methylphenoxy) acetic acid (MCPA))
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l94-74-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMethoxone-sodium salt ((4-chloro-2-methylphenoxy) acetate sodium salt)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3653-48-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1,1'-Methylene bis(4-isocyanatocyclohexane)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l5124-30-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMethylene bis(thiocyanate) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l6317-18-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMethyl isothiocyanate [Isothiocyanatomethane] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l556-61-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2-Methyllactonitrile
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l75-86-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lN-Methylolacrylamide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l924-42-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMethyl parathion
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l298-00-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lN-Methyl-2-pyrrolidone
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l872-50-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMethyltrichlorosilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l75-79-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMetiram
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l9006-42-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMetribuzin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l21087-64-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lMevinphos
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7786-34-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMolinate (1H-Azepine-1-carbothioic acid, hexahydro-S-ethyl ester) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2212-67-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMonuron
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l150-68-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMyclobutanil [.alpha.-Butyl-.alpha.-(4-chlorophenyl)-1H-1,2,4-triazole-1-propanenitrile] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l88671-89-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lNabam
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l142-59-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lNaled
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l300-76-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lNitrapyrin (2-Chloro-6-(trichloromethyl) pyridine) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1929-82-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lNitrate ion
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l14797-55-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lNitric oxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10102-43-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lp-Nitroaniline
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l100-01-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lNitrogen dioxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10102-44-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lNorflurazon [4-Chloro-5-(methylamino)-2-[3-(trifluoromethyl)phenyl]-3(2H)-pyridazinone] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l27314-13-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lOryzalin [4-(Dipropylamino)-3,5-dinitrobenzenesulfonamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l19044-88-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lOxydemeton methyl [S-(2-(ethylsulfinyl)ethyl) o,o-dimethyl ester phosphorothioic acid] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l301-12-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lOxydiazon [3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l19666-30-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lOxyfluorfen
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l42874-03-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lOzone
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10028-15-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lParaquat dichloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1910-42-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPebulate [Butylethylcarbamothioic acid S-propyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1114-71-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPendimethalin [N-(1-Ethylpropyl)-3,4-dimethyl-2,6-dinitrobenzenamine]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l40487-42-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPentobarbital sodium
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l57-33-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPerchloromethyl mercaptan
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l594-42-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPermethrin [3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, (3-phenoxyphenyl)methyl
ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l52645-53-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPhenanthrene
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l85-01-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPhenothrin [2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid (3-phenoxyphenyl)methyl
ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l26002-80-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,2-Phenylenediamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l95-54-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,3-Phenylenediamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l108-45-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,2-Phenylenediamine dihydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l615-28-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,4-Phenylenediamine dihydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l624-18-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPhenytoin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l57-41-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPhosphine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7803-51-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPhosphorous oxychloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10025-87-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPhosphorous pentachloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10026-13-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPhosphorous pentasulfide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1314-80-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPhosphorous pentoxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1314-56-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPicloram
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1918-02-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPiperonyl butoxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l51-03-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPirimiphos methyl [O-(2-(Diethylamino)-6-methyl-4-pyrimidinyl)-O,O-dimethylphosphorothioate] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l29232-93-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPotassium bromate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7758-01-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPotassium dimethyldithiocarbamate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l128-03-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPotassium N-methyldithiocarbamate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l137-41-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPrimisulfuron [Methyl 2-[[[[[4,6-bis(difluoromethoxy)-2-pyrimidinyl]- amino]carbonyl]amino]sulfonyl]benzoate]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l86209-51-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lProfenofos [O-(4-Bromo-2-chlorophenyl)-O-ethyl-S-propyl phosphorothioate]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l41198-08-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPrometryn [N,N'-Bis(1-methylethyl)-6-methylthio-1,3,5-triazine-2,4- diamine] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7287-19-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPropachlor [2-Chloro-N-(1-methylethyl)-N-phenylacetamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1918-16-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPropanil [N-(3,4-Dichlorophenyl)propanamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l709-98-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPropargite
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2312-35-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPropargyl alcohol
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l107-19-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPropetamphos [3-[[(Ethylamino)methoxyphosphinothioyl]oxy]-2-butenoic acid, 1-methylethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l31218-83-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lPropiconazole [1-[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]- methyl-1H-1,2,4,-triazole] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l60207-90-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lQuizalofop-ethyl [2-[4-[(6-Chloro-2-quinoxalinyl)oxy]phenoxy]propanoic acid ethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l76578-14-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lResmethrin [[5-(Phenylmethyl)-3-furanyl]methyl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate]]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l10453-86-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSethoxydim [2-[1-(Ethoxyimino)butyl]-5-[2-(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l74051-80-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSimazine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l122-34-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium azide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l26628-22-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium chlorite 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7758-19-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium dicamba [3,6-Dichloro-2-methoxybenzoic acid, sodium salt] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1982-69-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium dimethyldithiocarbamate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l128-04-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium fluoroacetate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l62-74-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium hypochlorite
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7681-52-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium nitrite
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7632-00-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium pentachlorophenate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l131-52-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium o-phenylphenoxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l132-27-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSodium 2-pyridinethiol-1-oxide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l15922-78-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSulfur dioxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7446-09-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lSulfur trioxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7446-11-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSulfuryl fluoride [Vikane] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2699-79-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lSulprofos [O-Ethyl O-[4-(methylthio)phenyl]phosphorodithioic acid S-propyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l35400-43-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTebuthiuron [N-[5-(1,1-Dimethylethyl)-1,3,4-thiadiazol-2-yl)-N,N'-dimethylurea] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l34014-18-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTefluthrin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l79538-32-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTemephos 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3383-96-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTerbacil [5-Chloro-3-(1,1-dimethylethyl)-6-methyl-2,4(1H,3H)-pyrimidinedione] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l5902-51-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1,1,1,2-Tetrachloro-2-fluoroethane (HCFC-121a)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l354-11-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,1,2,2-Tetrachloro-1-fluoroethane (HCFC-121)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l354-14-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTetracycline hydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l64-75-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTetramethrin [2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl
ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l7696-12-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTetrasodium ethylenediaminetetraacetate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l64-02-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lThiabendazole [2-(4-Thiazolyl)-1H-benzimidazole] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l148-79-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lThiabendazole, hypophosphite salt [2-(4-Thiazolyl)benzimidazole, hypophosphite salt] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l28558-32-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lThiobencarb [Carbamic acid, diethylthio-, s-(p-chlorobenzyl)] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l28249-77-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lThiodicarb 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l59669-26-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lThiophanate ethyl [[1,2-Phenylenebis(iminocarbonothioyl)]biscarbamic acid diethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l23564-06-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lThiophanate-methyl
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l23564-05-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lThiosemicarbazide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l79-19-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTriadimefon [1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l43121-43-3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTriallate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2303-17-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTribenuron methyl [2-(((((4-Methoxy-6-methyl-1,3,5-triazin-2-yl)- methylamino)carbonyl)amino)sulfonyl)-,
methyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l101200-48-0
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTributyltin fluoride 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1983-10-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTributyltin methacrylate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2155-70-6
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lS,S,S-Tributyltrithiophosphate (DEF)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l78-48-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTrichloroacetyl chloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l76-02-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTrichloroethylsilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l115-21-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTrichlorophenylsilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l98-13-5
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1,2,3-Trichloropropane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l96-18-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTriclopyr, triethylammonium salt 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l57213-69-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTriethylamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l121-44-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTriforine [N,N'-[1,4-Piperazinediyl-bis(2,2,2-trichloroethylidene)] bisformamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l26644-46-2
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lTrimethylchlorosilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l75-77-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2,3,5-Trimethylphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2655-15-4
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTriphenyltin chloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l639-58-7
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lTriphenyltin hydroxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l76-87-9
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lVanadium pentoxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1314-62-1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
lVinclozolin [3-(3,5-Dichlorophenyl)-5-ethenyl-5-methyl-2,4- oxazolidinedione] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l50471-44-8
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b)&blank;*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 3,L2,tp8,p8,8/8,s30,r160,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1CAS No.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Chemical Name
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Effective Date
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l51-03-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPiperonyl butoxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l51-21-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFluorouracil (5-Fluorouracil) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l52-51-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Bromo-2-nitropropane-1,3-diol (Bronopol) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l52-85-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFamphur 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l55-38-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFenthion [O,O-Dimethyl O-[3-methyl-4-(methylthio)phenyl] ester, phosphorothioic acid] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l56-35-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBis(tributyltin) oxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l57-33-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPentobarbital sodium
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l57-41-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhenytoin 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l60-51-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethoate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l62-74-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium fluoroacetate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l64-02-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTetrasodium ethylenediaminetetraacetate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l64-75-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTetracycline hydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l68-12-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lN,N-Dimethylformamide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l75-43-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDichlorofluoromethane (HCFC-21) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l75-72-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorotrifluoromethane (CFC-13) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l75-77-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTrimethylchlorosilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l75-78-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethyldichlorosilane 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l75-79-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethyltrichlorosilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l75-86-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Methyllactonitrile 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l75-88-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Chloro-1,1,1-trifluoroethane (HCFC-133a)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l76-02-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTrichloroacetyl chloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l76-06-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChloropicrin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l76-87-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTriphenyltin hydroxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l77-73-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDicyclopentadiene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l78-48-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lS,S,S-Tributyltrithiophosphate (DEF)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l78-59-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIsophorone
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l79-19-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThiosemicarbazide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l85-01-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhenanthrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l88-85-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDinoseb 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l93-65-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMecoprop
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l94-11-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D isopropyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l94-74-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethoxone (4-Chloro-2-methylphenoxy) acetic acid (MCPA)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l94-80-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D butyl ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l94-82-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-DB 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l95-54-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,2-Phenylenediamine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l95-69-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lp-Chloro-o-toluidine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l96-18-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,2,3-Trichloropropane 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l97-23-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDichlorophene [ 2,2'-Methylene-bis(4-chlorophenol)]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l98-13-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTrichlorophenylsilane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l99-30-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDichloran [2,6-Dichloro-4-nitroaniline]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l100-01-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lp-Nitroaniline 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l101-05-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAnilazine [4,6-dichloro-N-(2-chlorophenyl)-1,3,5-triazin-2-amine]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l101-90-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiglycidyl resorcinol ether 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l104-12-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lp-Chlorophenyl isocyanate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l105-60-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCaprolactam 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l106-47-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lp-Chloroaniline 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l107-11-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAllylamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l107-19-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPropargyl alcohol 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l108-45-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,3-Phenylenediamine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l108-93-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyclohexanol 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l110-54-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
ln-Hexane 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l110-57-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
ltrans-1,4-Dichloro-2-butene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l115-21-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTrichloroethylsilane 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l115-28-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorendic acid 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l116-06-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAldicarb 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l120-32-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lo-Benzyl-p-chlorophenol
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l120-36-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-DP 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l121-44-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTriethylamine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l121-75-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMalathion
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l122-34-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSimazine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l122-39-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiphenylamine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l124-40-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethylamine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l128-03-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPotassium dimethyldithiocarbamate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l128-04-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium dimethyldithiocarbamate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l131-52-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium pentachlorophenate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l132-27-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium o-phenylphenoxide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l133-07-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFolpet 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l136-45-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDipropyl isocinchomeronate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l137-41-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPotassium n-methyldithiocarbamate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l137-42-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMetham Sodium
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l138-93-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDisodium cyanodithioimidocarbonate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l142-59-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNabam
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l148-79-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThiabendazole [2-(4-Thiazolyl)-1H-benzimidazole]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l149-30-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2-Mercaptobenzothiazole
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l149-74-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDichloromethylphenylsilane 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l150-50-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMerphos
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l150-68-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMonuron
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l298-00-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethyl parathion
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l300-76-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNaled
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l301-12-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxydemeton methyl [s-(2-(Ethylsulfinyl)ethyl)o,o-dimethyl ester phosphorothioic acid]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l314-40-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBromacil (5-Bromo-6-methyl-3-(1-methylpropyl)-2,4-(1H,3H)-pyrimidinedione)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l319-84-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lalpha-Hexachlorocyclohexane 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l330-54-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiuron 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l330-55-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLinuron
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l333-41-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiazinon 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l354-11-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,1,1,2-Tetrachloro-2-fluoroethane (HCFC-121a)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l354-14-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,1,2,2-Tetrachloro-1-fluoroethane (HCFC-121)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l357-57-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBrucine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l422-44-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,2-dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225bb) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l422-48-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,3-dichloro-1,1,1,2,3-pentafluoropropane (HCFC-225ba) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l422-56-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3,3-dichloro-1,1,1,2,2-pentafluoropropane (HCFC-225ca) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l431-86-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,2-dichloro-1,1,3,3,3-pentafluoropropane (HCFC-225da) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l460-35-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-chloro-1,1,1-trifluoropropane (HCFC-253fb)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l465-73-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIsodrin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l507-55-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,3-dichloro-1,1,2,2,3-pentafluoropropane (HCFC-225cb) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l533-74-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDazomet (Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l541-53-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-Dithiobiuret 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l542-76-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-Chloropropionitrile 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l554-13-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLithium carbonate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l556-61-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethyl isothiocyanate [Isothiocyanatomethane] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l563-47-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-Chloro-2-methyl-1-propene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l576-26-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,6-Dimethylphenol 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l594-42-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPerchloromethyl mercaptan 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l612-82-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethylbenzidine dihydrochloride (o-Tolidine dihydrochloride)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l612-83-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3,3'-Dichlorobenzidine dihydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l615-28-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,2-Phenylenediamine dihydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l624-18-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,4-Phenylenediamine dihydrochloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l630-08-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCarbon monoxide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l639-58-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTriphenyltin chloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l709-98-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPropanil [N-(3,4-Dichlorophenyl)propanamide]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l759-94-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lEthyl dipropylthiocarbamate (EPTC) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l822-60-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHexamethylene-1,6-diisocyanate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l834-12-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAmetryn (N-Ethyl-N'-(1-methylethyl)-6-(methylthio)-1,3,5,-triazine-2,4-diamine)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l872-50-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lN-Methyl-2-pyrrolidone
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l924-42-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lN-Methylolacrylamide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0170 intable -->
l957-51-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiphenamid 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1114-71-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPebulate [Butylethylcarbamo-thioic acid S-propyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1134-23-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCycloate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1314-56-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphorous pentoxide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1314-62-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lVanadium pentoxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1314-80-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphorous pentasulfide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1320-18-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D propylene glycol butyl ether ester
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1563-66-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCarbofuran 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1649-08-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,2-dichloro-1,1-difluoroethane (HCFC-132b)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1689-84-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBromoxynil (3,5-Dibromo-4-hydroxybenzonitrile)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1689-99-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBromoxynil octanoate (Octanoic acid, 2,6-dibromo-4-cyanophenyl ester) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1861-40-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBenfluralin(N-Butyl-N-ethyl-2,6-dinitro-4-(trifluoromethyl)benzenamine)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1910-42-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lParaquat dichloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1912-24-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAtrazine (6-Chloro-N-ethyl-N'-(1-methylethyl)-1,3,5,-triazine-2,4-diamine)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1917-97-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D 2-octyl ester 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1918-00-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDicamba (3,6-Dichloro-2-methyoxybenzoic acid)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1918-02-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPicloram 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1918-16-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPropachlor [2-Chloro-N-(1-methylethyl)-N-phenylacetamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1928-43-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D 2-ethylhexyl ester 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1929-73-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D butoxyethyl ester 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1929-82-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNitrapyrin (2-Chloro-6-(trichloromethyl)pyridine)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l1982-69-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium dicamba [3,6-Dichloro-2-methoxybenzoic acid, sodium salt]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l1983-10-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTributyltin fluoride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2008-41-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lButylate (Bis-2-methylpropyl) carbamothioic acid S-ethyl ester)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2032-65-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethiocarb
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2155-70-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTributyltin methacrylate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2164-07-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDipotassium endothall [7-Oxabicyclo(2.2.1)heptane-2,3-dicarboxylic acid, dipotassium salt]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2212-67-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMolinate (1H-Azepine-1-carbothioic acid, hexahydro-S-ethyl ester)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2300-66-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethylamine dicamba 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2303-17-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTriallate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2312-35-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPropargite 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2439-01-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChinomethionat [6-Methyl-1,3-dithiolo[4,5-b]quinoxalin-2-one] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2439-10-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDodine [Dodecylguanidine monoacetate] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2524-03-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethyl chlorothiophosphate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2655-15-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,3,5-Trimethylphenyl methylcarbamate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2699-79-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSulfuryl Fluoride [Vikane]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l2702-72-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D sodium salt
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l2971-38-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D chlorocrotyl ester 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l3380-34-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l5-Chloro-2-(2,4-dichlorophenoxy)phenol 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3383-96-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTemephos
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l3653-48-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethoxone - sodium salt (4-Chloro-2-methylphenoxy acetate sodium salt)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l4080-31-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l4098-71-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIsophorone diisocyanate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l4170-30-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCrotonaldehyde
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l5124-30-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,1'-Methylene bis(4-isocyanatocyclohexane) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l5234-68-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCarboxin (5,6-Dihydro-2-methyl-N-phenyl-1,4-oxathiin-3-carboxamide)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l5598-13-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorpyrifos methyl [O,O-dimethyl-O-(3,5,6-trichloro-2-pyridyl)phosphorothioate]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l5902-51-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTerbacil [5-Chloro-3-(1,1-dimethylethyl)-6-methyl-2,4-(1H,3H)-pyrimidinedione]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l6317-18-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethylene bis(thiocyanate)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l6459-94-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lC.I. Acid Red 114 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l7287-19-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrometryn [N,N'-Bis(1-methylethyl)-6-methylthio-1,3,5-triazine-2,4-diamine]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l7446-09-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSulfur dioxide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7446-11-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSulfur trioxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l7632-00-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium nitrite
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7637-07-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBoron trifluoride 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l7681-52-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium hypochlorite
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7696-12-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTetramethrin [2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropane-carboxylic acid (1,3,4,5,6,7-hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl
ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l7726-95-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBromine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7758-01-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPotassium bromate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7758-19-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium chlorite
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7778-54-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCalcium hypochlorite 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7782-41-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFluorine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l7786-34-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMevinphos
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l7803-51-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphine
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l9006-42-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMetiram 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10025-87-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphorous oxychloride 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10026-13-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhosphorous pentachloride 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10028-15-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOzone
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l10061-02-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
ltrans-1,3-Dichloropropene
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10222-01-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dibromo-3-nitrilopropionamide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10102-43-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNitric oxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10102-44-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNitrogen dioxide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10294-34-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBoron trichloride 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l10453-86-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lResmethrin [[5-(Phenylmethyl)-3-furanyl]methyl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate]]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l13194-48-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lEthoprop [Phosphorodithioic acid O-ethyl S,S-dipropyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l13356-08-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFenbutatin oxide (hexakis(2-methyl-2-phenylpropyl)distannoxane) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l13463-40-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIron pentacarbonyl
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l13474-88-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,1-Dichloro-1,2,2,3,3-pentafluoropropane (HCFC-225cc) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l13684-56-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDesmedipham
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l14484-64-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFerbam [Tris(dimethylcarbamo-dithioato-S,S')iron]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l14797-55-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNitrate ion
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l15922-78-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium 2-pyridinethiol-1-oxide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l15972-60-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAlachlor 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l17804-35-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBenomyl 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 007 0170 intable -->
l19044-88-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOryzalin [4-(Dipropylamino)-3,5-dinitrobenzene-sulfonamide] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l19666-30-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxydiazon [3-[2,4-Dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l20325-40-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethoxybenzidine dihydrochloride (Dianisidine dihydrochloride) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l20354-26-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMethazole [2-(3,4-Dichlorophenyl)-4-methyl-1,2,4-oxadiazolidine-3,5-dione] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l20859-73-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAluminum phosphide 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l21087-64-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMetribuzin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l21725-46-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyanazine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l22781-23-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBendiocarb [2,2-Dimethyl-1,3-benzodioxol-4-ol methylcarbamate] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l23564-05-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThiophanate methyl
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l23564-06-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThiophanate ethyl [[1,2-Phenylenebis(iminocarbonothioyl)]biscarbamic acid diethyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l25013-16-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lButylated hydroxyanisole 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l25311-71-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIsofenphos [2-[[Ethoxyl[(1-methylethyl)amino]phosphinothioyl]oxy]benzoic acid 1-methylethyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l26002-80-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPhenothrin [2,2-Dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylic acid 
<!-- PJG 0012 frnewline -->
(3-phenoxyphenyl)methyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l26628-22-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSodium azide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l26644-46-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTriforine [N,N'-[1,4-Piperazinediylbis(2,2,2-trichloroethylidene)] bisformamide]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l27314-13-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lNorflurazon [4-Chloro-5-(methylamino)-2-[3-(trifluoromethyl)phenyl]- 3(2H)-pyridazinone]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l28057-48-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
ld-trans-Allethrin [d-trans-Chrysanthemic acid of d-allethrone]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l28249-77-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThiobencarb [Carbamic acid, diethylthio-, s-(p-chlorobenzyl)] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l28407-37-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lC.I. Direct Blue 218 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l28558-32-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThiabendazole, hypophosphite salt [2-(4-Thiazolyl)benzimidazole, hypophosphite salt]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l29232-93-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPirimiphos methyl [O-(2-(Diethylamino)-6-methyl-4-pyrimidinyl)-O,O-dimethyl phosphorothioate]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l30560-19-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcephate (Acetylphosphoramidothioic acid O,S-dimethyl ester)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l31218-83-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPropetamphos [3-[[(Ethylamino)methoxyphosphino-thioyl]oxy]-2-butenoic acid, 1-methylethyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l33089-61-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAmitraz 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l34014-18-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTerbuthiuron [N-[5-(1,1-Dimethylethyl)-1,3,4-thiadiazol-2-yl)-N,N'- dimethylurea]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l35367-38-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiflubenzuron 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l35400-43-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSulprofos [O-Ethyl O-[4-(methylthio)phenyl]phosphorodithioic acid S-propyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l35554-44-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lImazalil [1-[2-(2,4-Dichlorophenyl)-2-(2-propenyloxy)ethyl]-1H-imidazole]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l35691-65-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1-Bromo-1-(bromomethyl)-1,3-propanedicarbonitrile
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l36734-19-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lIprodione [3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidine-carboxamide]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l38727-55-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiethatyl ethyl
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l39300-45-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDinocap 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l39515-41-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFenpropathrin [2,2,3,3-Tetramethylcyclopropane carboxylic acid cyano(3-phenoxyphenyl)methyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l40487-42-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPendimethalin [N-(1-Ethylpropyl)-3,4-dimethyl-2,6-dinitrobenzen-amine]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l41198-08-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lProfenofos [O-(4-Bromo-2-chlorophenyl)-O-ethyl-S-propyl phosphorothioate]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l41766-75-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethylbenzidine dihydrofluoride (ortho-Tolidine dihydrofluoride)
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l42874-03-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOxyfluorfen
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l43121-43-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTriadimefon [1-(4-Chlorophenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l50471-44-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lVinclozolin [3-(3,5-Dichlorophenyl)-5-ethenyl-5-methyl-2,4- oxazolidinedione] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l51235-04-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHexazinone
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l51338-27-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDiclofop methyl [2-[4-(2,4-Dichlorophenoxy)phenoxy]propanoic acid, methyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l51630-58-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFenvalerate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l52645-53-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPermethrin [3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic acid, (3-phenoxyphenyl)methyl
ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l53404-19-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBromacil, lithium salt [2,4-(1H,3H)-Pyrimidinedione, 5-bromo-6-methyl-3- (1-methylpropyl), lithium salt]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l53404-37-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,4-D 2-ethyl-4-methylpentyl ester 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l53404-60-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDazomet, sodium salt [Tetrahydro-3,5-dimethyl-2H-1,3,5-thiadiazine-2-thione, ion(1-), sodium] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l55290-64-7 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDimethipin [2,3,-Dihydro-5,6-dimethyl-1,4-dithiin 1,1,4,4-tetraoxide]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l55406-53-6 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3-Iodo-2-propynyl butylcarbamate
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l57213-69-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTriclopyr, triethylammonium salt 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l59669-26-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThiodicarb 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l60168-88-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFenarimol [.alpha.-(2-Chlorophenyl)-.alpha.-4-chlorophenyl)-5-pyrimidine- methanol]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l60207-90-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPropiconazole [1-[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]-methyl-1H-1,2,4,-triazole]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l62476-59-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAcifluorfen, sodium salt [5-(2-Chloro-4-(triflouromethyl)phenoxy)-2-nitro-benzoic acid, sodium salt]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l62924-70-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFlumetralin [2-Chloro-N-(2,6-dinitro-4-(trifluoromethyl)-phenyl)-N-ethyl-6-fluorobenzenemethanamine]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l64902-72-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorsulfuron [2-chloro-N-[[4-methoxy-6-methyl-1,3,5-triazin-2-yl)amino] carbonyl]benzenesulfonamide]

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l64969-34-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3,3'-Dichlorobenzidine.sulfate 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l66215-27-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyromazine [N-Cyclopropyl-1,3,5-triazine-2,4,6-triamine] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l66441-23-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFenoxaprop ethyl [2-(4-((6-Chloro-2-benzoxazolylen)oxy)phenoxy) propanoic acid, ethyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l67485-29-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHydramethylnon [Tetrahydro-5,5-dimethyl-2(1H)-pyrimidinone[3-[4- (trifluoromethyl)phenyl]-1-[2-[4-(trifluoromethyl)phenyl]ethenyl]-2-
propenylidene]hydrazone]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l68085-85-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyhalothrin [3-(2-Chloro-3,3,3-trifluoro-1-propenyl)-2,2- dimethylcyclopropanecarboxylic acid cyano(3-phenoxyphenyl)methyl
ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l68359-37-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCyfluthrin [3-(2,2-Dichloro-ethenyl)-2,2-dimethylcyclo-propanecarboxylic acid, cyano(4-fluoro-3-phenoxyphenyl)methyl
ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l69409-94-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFluvalinate [N-[2-Chloro-4-(trifluoromethyl)phenyl]-DL-valine(+)-cyano(3-phenoxyphenyl)methylester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l69806-50-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFluazifop-butyl [2-[4-[[5-(Trifluoromethyl)-2-pyridinyl]oxy]-phenoxy]propanoic acid, butyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l71751-41-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAbamectin [Avermectin B1]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l72178-02-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFomesafen [5-(2-Chloro-4-(trifluoromethyl)phenoxy)-N-methylsulfonyl)-2- nitrobenzamide]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l72490-01-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lFenoxycarb [2-(4-Phenoxyphenoxy)ethyl]carbamic acid ethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l74051-80-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSethoxydim [2-[1-(Ethoxyimino)butyl]-5-[2-(ethylthio)propyl]-3-hydroxy-2-cyclohexen-1-one]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l76578-14-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lQuizalofop-ethyl [2-[4-[(6-Chloro-2-quinoxalinyl)oxy]phenoxy] propanoic acid ethyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l77501-63-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lLactofen [5-(2-Chloro-4-(trifluoromethyl)phenoxy)-2-nitro-2-ethoxy-1-methyl-2-oxoethyl ester] 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l79538-32-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTefluthrin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l81777-89-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lClomazone [2-[(2-Chlorophenyl)methyl]-4,4-dimethyl-3-isoxazolidinone]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l82657-04-3 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lBifenthrin
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l86209-51-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lPrimisulfuron [Methyl 2-[[[[[4,6-bis(difluoromethoxy)-2-pyrimidinyl]- amino]carbonyl]amino]sulfonyl]benzoate]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l88671-89-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMyclobutanil [.alpha.-Butyl-.alpha.-(4-chlorophenyl)-1H-1,2,4-triazole- 1-propanenitrile]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l90982-32-4 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lChlorimuron ethyl [Ethyl-2-[[[(4-chloro-6-methoxyprimidin-2-yl)-carbonyl]-amino]sulfonyl]benzoate]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l97886-45-8 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDithiopyr [2-(Difluoromethyl)-4-(2-methylpropyl)-6-(trifluoro-methyl)-3,5-pyridinedicarbothioic acid
S,S-dimethyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l101200-48-0 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTribenuron methyl [2-(((((4-Methoxy-6-methyl-1,3,5-triazin-2-yl)- methylamino)carbonyl)amino)sulfonyl)-,
methyl ester]
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l111512-56-2 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,1-dichloro-1,2,3,3,3-pentafluoropropane (HCFC-225eb) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l111984-09-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l3,3'-Dimethoxybenzidine hydrochloride (Dianisidine dihydrochloride) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l127564-92-5 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lDichloropentafluoropropane
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l128903-21-9 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l2,2-Dichloro-1,1,1,3,3-pentafluoropropane (HCFC-225aa) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l136013-79-1 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1,3-Dichloro-1,1,2,3,3-pentafluoropropane (HCFC-225ea) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(c)&blank;*&blank;*&blank;*
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp8,p8,8/8,s150,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Category Name
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Effective Date
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lChlorinated paraffins: Includes those chemicals defined by the following formula: 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lCxH2x-y+2Cly 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lwhere x = 10 to 30 and y = 3 to 26 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lMan-made mineral fibers: Includes glass microfibers, glass wool fibers, rock wool fibers, slag wool fibers, and
refractory ceramic fibers that have a diameter less than 3.5 micrometers and an aspect ratio greater than 3.
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lNicotine and salts
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lPolycyclic Aromatic Compounds (PACs): (This category includes only those chemicals listed below) 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
l00056-55-3 Benz(a)anthracene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00218-01-9 Benzo(a)phenanthrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00050-32-8 Benzo(a)pyrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00205-99-2 Benzo(b)fluoranthene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00205-82-3 Benzo(j)fluoranthene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00207-08-9 Benzo(k)fluoranthene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00189-55-9 Benzo(rst)pentaphene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00086-74-8 Carbazole 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l27208-37-3 Cyclopenta(cd)pyrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00226-36-8 Dibenz(a,h)acridine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00224-42-0 Dibenz(a,j)acridine 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00215-58-7 Dibenz(a,c)anthracene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00224-41-9 Dibenz(a,j)anthracene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00053-70-3 Dibenzo(a,h)anthracene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l05385-75-1 Dibenzo(a,e)fluoranthene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00192-65-4 Dibenzo(a,e)pyrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00189-64-0 Dibenzo(a,h)pyrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00191-30-0 Dibenzo(a,l)pyrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00194-59-2 7H-Dibenzo(c,g)carbazole 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00057-97-6 7,12-Dimethylbenz(a)anthracene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l00193-39-5 Indeno[1,2,3-cd]pyrene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l03351-32-4 2-Methylchrysene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l03351-31-3 3-Methylchrysene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l03351-30-2 4-Methylchrysene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l03697-24-3 5-Methylchrysene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l01705-85-7 6-Methylchrysene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l33543-31-6 2-Methylfluoranthene 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0170 intable -->
l05522-43-0 1-Nitropyrene 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 007 0170 intable -->
lStrychnine and salts 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1/1/95
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=22 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;*&blank;&blank;&blank;&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;753 Filed 1&hyph;11&hyph;94; 3:34 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00001 </DOCNO>
<PARENT> FR940112-2-00001 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4703 -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 8
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00002 </DOCNO>
<PARENT> FR940112-2-00001 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF AGRICULTURE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Animal and Plant Health Inspection Service</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93&hyph;162&hyph;1] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Availability of Environmental Assessments and Findings of No Significant Impact </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Animal and Plant Health Inspection Service, USDA. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 We are advising the public that two environmental assessments and findings of no significant impact have been prepared
by the Animal and Plant Health Inspection Service relative to the issuance of permits to allow the field testing of
genetically engineered organisms. The environmental assessments provide a basis for our conclusion that the field
testing of these genetically engineered organisms will not present a risk of introducing or disseminating a plant
pest and will not have a significant impact on the quality of the human environment. Based on its findings of no significant
impact, the Animal and Plant Health Inspection Service has determined that environmental impact statements need
not be prepared. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Copies of the environmental assessments and findings of no significant impact are available for public inspection
at USDA, room 1141, South Building, 14th Street and Independence Avenue SW., Washington, DC, between 8 a.m. and 4:30
p.m., Monday through Friday, except holidays. Persons wishing to inspect those documents are encouraged to call
ahead on 
<!-- PJG 0012 frnewline -->
(202) 690&hyph;2817 to facilitate entry into the reading room. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Dr. Arnold Foudin, Deputy Director, Biotechnology Permits, Biotechnology, Biologics, and Environmental Protection,
APHIS, USDA, room 850, Federal Building, 6505 Belcrest Road, Hyattsville, MD 20782, (301) 436&hyph;7612. For copies
of the environmental assessments and findings of no significant impact, write to Mr. Clayton Givens at the same address.
Please refer to the permit numbers listed below when ordering documents. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The regulations in 7 CFR part 340 (referred to below as the regulations) regulate the introduction (importation,
interstate movement, and release into the environment) of genetically engineered organisms and products that are
plant pests or that there is reason to believe are plant pests (regulated articles). A permit must be obtained before
a regulated article may be introduced into the United States. The regulations set forth the procedures for obtaining
a limited permit for the importation or interstate movement of a regulated article and for obtaining a permit for the
release into the environment of a regulated article. The Animal and Plant Health Inspection Service (APHIS) has stated
that it would prepare an environmental assessment and, when necessary, an environmental impact statement before
issuing a permit for the release into the environment of a regulated article (see 52 FR 22906). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the course of reviewing each permit application, APHIS assessed the impact on the environment that releasing the
organisms under the conditions described in the permit application would have. APHIS has issued permits for the field
testing of the organisms listed below after concluding that the organisms will not present a risk of plant pest introduction
or dissemination and will not have a significant impact on the quality of the human environment. The environmental
assessments and findings of no significant impact, which are based on data submitted by the applicants and on a review
of other relevant literature, provide the public with documentation of APHIS' review and analysis of the environmental
impacts associated with conducting the field tests. 
<!-- PJG 0012 frnewline -->
Environmental assessments and findings of no significant impact have been prepared by APHIS relative to the issuance
of permits to allow the field testing of the following genetically engineered organisms: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 5,L2,tp0,i1,s75,r75,9,r100,r50 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Permit No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Permittee 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Date issued 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Organisms 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Field test location 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
93&hyph;252&hyph;01 
<!-- PJG 007 0104 intable -->
Monsanto Agricultural Company 
<!-- PJG 007 0104 intable -->
11&hyph;17&hyph;93 
<!-- PJG 007 0104 intable -->
Potato plants genetically engineered to express resistance to potato leaf roll virus 
<!-- PJG 007 0104 intable -->
Florida. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
93&hyph;281&hyph;01, renewal of permit 92&hyph;174&hyph;02, issued on 11&hyph;03&hyph;92 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Pioneer Hi-Bred International, Incorporated 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
11&hyph;17&hyph;93 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Corn plants genetically engineered to express resistance to maize dwarf mosaic virus strain A, maize chlorotic mottle
virus, or maize chlorotic dwarf virus 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
Hawaii, Puerto Rico. 
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The environmental assessments and findings of no significant impact have been prepared in accordance with: (1) The
National Environmental Policy Act of 1969 (NEPA) (42 U.S.C. 4321 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
), (2) Regulations of the Council on Environmental Quality for Implementing the Procedural Provisions of NEPA 
<!-- PJG 0012 frnewline -->
(40 CFR parts 1500&hyph;1508), (3) USDA Regulations Implementing NEPA (7 CFR part 1b), and (4) APHIS Guidelines Implementing
NEPA (44 FR 50381&hyph;50384, August 28, 1979, and 44 FR 51272&hyph;51274, August 31, 1979). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Done in Washington, DC, this 6th day of January 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lonnie J. King, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Administrator, Animal and Plant Health Inspection Service. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;672 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;34&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00003 </DOCNO>
<PARENT> FR940112-2-00002 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93&hyph;161&hyph;1] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Receipt of Permit Applications for Release Into the Environment of Genetically Engineered Organisms </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Animal and Plant Health Inspection Service, USDA. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 We are advising the public that four applications for permits to release genetically engineered organisms into the
environment are being reviewed by the Animal and Plant Health Inspection Service. The applications have been submitted
in accordance with 7 CFR part 340, which regulates the introduction of certain genetically engineered organisms
and products. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Copies of the applications referenced in this notice, with any confidential business information deleted, are available
for public inspection in room 1141, South Building, U.S. Department of Agriculture, 14th Street and Independence
Avenue SW., Washington, DC, between 8 a.m. and 4:30 p.m., Monday through Friday, except holidays. Persons wishing
to inspect an application are encouraged to call ahead on (202) 690&hyph;2817 to facilitate entry into the reading
room. You may obtain copies of the documents by writing to the person listed under 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Dr. Arnold Foudin, Deputy Director, Biotechnology Permits, Biotechnology, Biologics, and Environmental Protection,
APHIS, USDA, room 850, Federal Building, 6505 Belcrest Road, Hyattsville, MD 20782, (301) 436&hyph;7612. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The regulations in 7 CFR part 340, ``Introduction of Organisms and Products Altered or Produced Through Genetic Engineering
Which Are Plant Pests or Which There Is Reason to Believe Are Plant Pests,'' require a person to obtain a permit before
introducing (importing, moving interstate, or releasing into the environment) into the United States certain genetically
engineered organisms and products that are considered ``regulated articles.'' The regulations set forth procedures
for obtaining a permit for the release into the environment of a regulated article, and for obtaining a limited permit
for the importation or interstate movement of a regulated article. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to these regulations, the Animal and Plant Health Inspection Service has received and is reviewing the following
applications for permits to release genetically engineered organisms into the environment: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 5,L2,tp0,i1,s75,r75,9,r100,r50 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Application No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Applicant 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Date received 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Organisms 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Field test location 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
93&hyph;320&hyph;01 
<!-- PJG 007 0104 intable -->
U.S. Department of Agriculture, Agricultural Research Service 
<!-- PJG 007 0104 intable -->
11&hyph;16&hyph;93 
<!-- PJG 007 0104 intable -->
Barley plants genetically engineered to express resistance to barley yellow dwarf virus 
<!-- PJG 007 0104 intable -->
California, Idaho, Illinois. 
<!-- PJG 0012 frnewline -->
93&hyph;340&hyph;01, renewal of permit 93&hyph;214&hyph;01, issued on 09&hyph;10&hyph;93 
<!-- PJG 007 0104 intable -->
PanAmerican Seed 
<!-- PJG 007 0104 intable -->
12&hyph;06&hyph;93 
<!-- PJG 007 0104 intable -->
Carrot plants genetically engineered to express modified nutritional value 
<!-- PJG 007 0104 intable -->
Illinois. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
93&hyph;340&hyph;02 
<!-- PJG 007 0104 intable -->
PetoSeed Company Incorporated 
<!-- PJG 007 0104 intable -->
12&hyph;06&hyph;93 
<!-- PJG 007 0104 intable -->
Carrot plants genetically engineered to express modified nutritional value 
<!-- PJG 007 0104 intable -->
Idaho.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
93&hyph;341&hyph;01 
<!-- PJG 007 0104 intable -->
University of California, Berkeley 
<!-- PJG 007 0104 intable -->
12&hyph;07&hyph;93 
<!-- PJG 007 0104 intable -->
A strain of the bacterium 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
Erwinia herbicola 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
genetically engineered to inhibit production of 3-indole acetic acid 
<!-- PJG 007 0104 intable -->
California.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Done in Washington, DC, this 6th day of January 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lonnie J. King,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Actng Administrator, Animal and Plant Health Inspection Service. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;673 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;34&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00004 </DOCNO>
<PARENT> FR940112-2-00003 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF COMMERCE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Oceanic and Atmospheric Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Marine Mammals
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Marine Fisheries Service (NMFS), NOAA, Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Issuance of permit modifications.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice is hereby given that pursuant to the provisions of &sect;&sect;216.33 (d) and (e) of the Regulations Governing
the Taking and Importing of Marine Mammals (50 CFR part 216), nine public display permits are modified to extend the
authority to take Atlantic bottlenose dolphins (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Tursiops truncatus
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
) for public display purposes until December 31, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
These modifications are effective January 1, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The permits, as modified, are available for review by appointment in the Permits Division, Office of Protected Resources,
NMFS, 1315 East-West Highway, room 13130, Silver Spring, Maryland 20910, (301) 713&hyph;2289.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The following public display permits have been extended: Public Display Permit No. 558, issued to Loro Parque, S.A.,
38400 Puerto de la Cruz, Tenerife, Spain; Public Display Permit No. 588, issued to Mystic Marinelife Aquarium, 55
Coogan Boulevard, Mystic, Connecticut 06355&hyph;1997; Public Display Permit No. 608, issued to Aquarium of Niagara
Falls, 701 Whirlpool Street, Niagara Falls, New York 14301&hyph;1094; Public Display Permit No. 627, issued to Horizons
West, Ltd., dba Marine Life Aquarium, 6001 South Highway 16, Rapid, City, South Dakota 57701; Public Display Permit
No. 628, issued to the Indianapolis Zoological Society, Inc., 1200 West Washington Street, Indianapolis, Indiana
46222; Public Display Permit No. 632, issued to Marine World Foundation, Marine World Parkway, Vallejo, California
94589; Public Display Permit No. 647, issued to Gulf World, Inc., 15412 Front Beach Road, Panama City Beach, Florida
32407; Public Display Permit No. 649 issued to Marine Animal Productions, Inc., Gulfport, Mississippi 39502&hyph;4078;
Public Display Permit No. 656 issued to the National Aquarium in Baltimore, Pier 3, 501 East Pratt Street, Baltimore,
Maryland 21202. All conditions of the original permits and subsequent modifications shall remain in effect.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A voluntary moratorium has been in effect on the removal of dolphins from the Gulf of Mexico since February 1990. During
that time, NMFS has extended the public display permits of permit holders, who had previously been authorized to capture
Atlantic bottlenose dolphins, but deferred collecting the animals as a result of the moratorium. The permit holders
listed above have requested that their permits authorizing the collection of dolphins be extended through 1994.
NMFS has granted their requests. However, in light of questions about the status and health of wild populations of
Atlantic bottlenose dolphins and the availability of dolphins from sources other than the wild, NMFS is continuing
to ask collectors to participate in a voluntary moratorium on dolphin collection. NMFS will consider requests to
collect only if there is reasonable indication that dolphins from the wild are necessary to maintain a public display
collection.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William W. Fox, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Protected Resources, National Marine Fisheries Service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;697 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;22&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00005 </DOCNO>
<PARENT> FR940112-2-00004 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF DEFENSE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Public Information Collection Requirement Submitted to OMB for Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Department of Defense has submitted to OMB for clearance, the following proposal for collection of information
under the provisions of the Paperwork Reduction Act (44 U.S.C., chapter 35).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
DoD FAR Supplement (DFARS), Part 225, International Acquisition, and Subpart 252.2, Texts of Provisions and Clauses.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Type of request: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Emergency Processing_Approval date requested: December 31, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Number of respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3,465.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Responses per respondent: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4.7.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Annual responses: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
16,333.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Average burden per response: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.25 Hours.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Annual burden hours: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4,083.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Needs and uses: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The provisions at DFARS 252.225&hyph;7006, Buy American Act_Trade Agreements Act_Balance of Payment Program Certificate,
and 252.227&hyph;7035, Buy American Act_North American Free Trade Agreement Implementation Act_Balance of Payments
Program Certificate, require offerors to identify end products that are not domestic. This information is necessary
to evaluate offerors under policy providing a preference for certain products. Under trade agreements, including
the North American Free Trade Agreement Implementation Act, unless specifically exempted by statute or regulation,
agencies are required to evaluate offers (over certain dollar limitations), without regard to restrictions of the
Buy American Act or the Balance of Payments program. Offerors identify excluded end products in these two provisions.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Affected public: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Businesses of other for-profit; non-profit institutions; and small businesses or organizations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On occasion.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondent's obligation: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Required to obtain or retain a benefit.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
OMB desk officer: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. Peter N. Weiss. Written comments and recommendations on the proposed information collection should be sent to
Mr. Weiss at the Office of Management and Budget, Desk Officer for DoD, room 3235, New Executive Office Building, Washington,
DC 20503.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
DOD clearance officer: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mr. William P. Pearce. Written requests for copies of the information collection proposal should be sent to Mr. Pearce,
WHS/DIOR, 1215 Jefferson Davis Highway, suite 1204, Arlington, VA 22202&hyph;4302. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;675 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00006 </DOCNO>
<PARENT> FR940112-2-00005 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Secretary</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Industry Executive Subcommittee of the National Security Telecommunications Advisory Committee; Meeting </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Communications System, DoD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A meeting of the Industry Executive Subcommittee of the National Security Telecommunications Advisory Committee
will be held on Monday, January 31, 1994 from 9 a.m. to 3 p.m. at the Mitre-Hayes Building, 7525 Colshire Drive, McLean,
VA 27006. The agenda is as follows: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
_Call to Order 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_NSTAC XVI Planning and Status of NSTAC XV Recommendations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_IES&hyph;OMNCS&hyph;COP Issues Ad Hoc Group
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Common Channel Signaling Task Force 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Wireless Services Task Force 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_National Information Infrastructure Task Force 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Network Security Steering Committee 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Global Games 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_New Business 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
_Adjournment. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Due to the requirement to discuss classified information, in conjunction with the issues listed above, the meeting
will be closed to the public in the interest of National Defense. Any person desiring information about the meeting
may telephone (703) 692&hyph;9274 or write the Manager, National Communications System, 701 S. Court House Road,
Arlington, VA 22204&hyph;2198.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;676 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00007 </DOCNO>
<PARENT> FR940112-2-00006 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Defense Science Board Task Force on Defense Acquisition Reform (Phase II); Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of advisory committee meetings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Defense Science Board Task Force on Defense Acquisition Reform (Phase II) will meet in closed session on February
9, 1994 at the Pentagon, Arlington, Virginia.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The mission of the Defense Science Board is to advise the Secretary of Defense through the Under Secretary of Defense
for Acquisition and Technology on scientific and technical matters as they affect the perceived needs of the Department
of Defense. At this meeting the Task Force will further define the elements of pilot industry initiatives for jet engines
and a segment of electronics, further define the elements of pilot initiatives for two unified commands, and assess
the DoD review comments on our Phase I report and recommend changes in approach if appropriate.
<!-- PJG 0012 frnewline -->
In accordance with section 10(d) of the Federal Advisory Committee Act, Public Law 92&hyph;463, as amended (5 U.S.C.
App. II, (1988)), it has been determined that this DSB Task Force meeting, concerns matters listed in 5 U.S.C. 552b(c)(1)
(1988), and that accordingly this meeting will be closed to the public.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;678 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00008 </DOCNO>
<PARENT> FR940112-2-00007 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Defense Science Board Task Force on Chemical Weapons; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of advisory committee meetings.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Defense Science Board Task Force on Chemical Weapons will meet in closed session on March 24&hyph;25, 1994 at the
Pentagon, Arlington, Virginia.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The mission of the Defense Science Board is to advise the Secretary of Defense through the Under Secretary of Defense
for Acquisition on scientific and technical matters as they affect the perceived needs of the Department of Defense.
At this meeting the Task Force will review all available intelligence and reports of detection of chemical agents
and toxins during Desert Shield, Desert Storm, and the post war period. Also, review scientific and medical evidence
relating exposure to nerve agents at low levels and long term health effects.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In accordance with section 10(d) of the Federal Advisory Committee Act, Public Law 92&hyph;463, as amended (5 U.S.C.
App. II (1988)), it has been determined that this DSB Task Force meeting concerns matters listed in 5 U.S.C. 552b(c)(1)
(1988), and that accordingly this meeting will be closed to the public.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;679 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00009 </DOCNO>
<PARENT> FR940112-2-00008 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Strategic Environmental Research and Development Program, Scientific Advisory Board; Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;463), announcement is
made of the following Committee meeting:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of Meeting:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Wednesday, January 26, 1994 thru Friday, January 28, 1994. 0800 to approximately 1700.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Place:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Los Alamos National Laboratory, J. Robert Oppenheimer Study Center, Los Alamos, New Mexico.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Matters To Be Considered:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Research and Development proposals requesting SERDP funds in excess of $1M will be reviewed.
<!-- PJG 0012 frnewline -->
This meeting is open to the public. Any interested person may attend, appear before, or file statements with the Scientific
Advisory Board at the time and in the manner permitted by the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
For Further Information Contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Ms. Ann Maxwell or Mr. John Rupnik, 2200 Clarendon, suite 900, Arlington, VA 22201, 703&hyph;525&hyph;9400.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
L.M. Bynum,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Alternate OSD Federal Register Liaison Officer, Department of Defense.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;677 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 5000&hyph;04&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00010 </DOCNO>
<PARENT> FR940112-2-00009 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Department of the Army</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Army Science Board; Open Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;463), announcement is
made of the following Committee Meeting:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Name of Committee: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Army Science Board (ASB).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of Meeting: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
3 &amp; 4 February 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Time of Meeting: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
0830&hyph;1700.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Washington, DC, Pentagon.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agenda: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Army Science Board's C3I Issue Group study team will meet on 3 February 1994 in conference room 3E384 and 4 February
1994 in conference room 2E465 to finalize their study on ``Moving Army Tactical Command and Control System (ATCCS)
from a Character-Oriented Message System to a Data-Oriented Message System.'' This meeting will be open to the public.
Any interested person may attend, appear before, or file statements with the committee at the time and in the manner
permitted by the committee. The ASB Administrative Officer, Sally Warner, may be contacted for further information
at (703) 695&hyph;0781.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sally A. Warner,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrative Officer, Army Science Board.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;791 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3710&hyph;08&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00011 </DOCNO>
<PARENT> FR940112-2-00010 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Military Personal Property and Claims Symposium_Open Meeting </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agency:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Military Traffic Management Command, DOD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
action:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of open meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;463), announcement is
made of the following Committee Meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Name of Committee:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Military Personal Property and Claims Symposium.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Date of the Meeting:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Thursday, 27 January 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Place:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Best Western Old Colony Inn, Alexandria, VA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Time:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 0830&hyph;1600.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agenda:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The purpose of the symposium is to provide an open discussion and the free exchange of ideas with the public on procedural
changes to the Personal Property Traffic Management Regulation, DOD 4 500.34R. and the handling of other matters
of mutual interest concerning the Department of Defense Personal Property Shipment and Storage Program.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All interested persons desiring to submit topics to be discussed should contact the Commander, Military Traffic
Management Command, ATTN: MTOP&hyph;QSS, (703) 756&hyph;0754, Between 0800&hyph;1630 hours. Topics to be discussed
should be received on or before 7 January 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Kenneth L. Denton, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Army Federal Register Liaison Officer. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;792 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3710&hyph;08&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00012 </DOCNO>
<PARENT> FR940112-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF ENERGY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Energy Regulatory Commission</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. ER93&hyph;712&hyph;000, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
PSI Energy, Inc., et al.; Electric Rate and Corporate Regulation Filings 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 5, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
1. PSI Energy, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER93&hyph;712&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that PSI Energy, Inc. (PSI) and the City of Logansport, Indiana on December 17, 1993, tendered for filing
additional supporting information to the FERC Filing in Docket No. ER93&hyph;712&hyph;000 to comply with a FERC
staff request. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing were served on the City of Logansport Indiana and the Indiana Utility Regulatory Commission.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
2. Madison Gas Electric Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;66&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 17, 1994, Madison Gas and Electric Company (MGE) tendered for filing with the Federal
Energy Regulatory Commission revised pages from the Interchange Agreements it and Heartland Energy Services, Inc.
(HES). The revision caps the price of the daily rate for Negotiated Capacity and General Purpose Energy at the rate
for weekly service. MGE and HES respectfully request an effective date of December 31, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MGE states that a copy of the filing has been provided to HES and the Public Service Commission of Wisconsin. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
3. Florida Power Corp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;275&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 16, 1993, Florida Power Corporation (Florida Power) requested the Commission to disclaim
jurisdiction over agreements under which Florida Power rents distribution facilities to the City of Mount Dora,
Florida, and Reedy Creek Utilities Company, respectively, or, if the Commission asserts jurisdiction, to accept
the agreements for filing to become effective September 1, 1988 and June 5, 1978, respectively. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
4. Arizona Public Service Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;276&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 16, 1993, Arizona Public Service Company (APS) tendered for filing the Interconnection
Agreement (Agreement) between The United States of America on Behalf of The Colorado River Indian Irrigation Project
(CRIP) and APS and Service Schedules A and B to the Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Agreement provides a means by which the Parties will develop and operate their respective electric systems in
a coordinated manner. The Service Schedules allow for various reciprocal transmission related services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing have been served upon CRIP and the Arizona Corporation Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
5. PacifiCorp 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;283&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that PacifiCorp, on December 17, 1993, tendered for filing in accordance with the Commission's Order
pertaining to agreements involving final amnesty for jurisdictional service and waiver of notice, issued July 30,
1993 under Docket No. PL93&hyph;2&hyph;002, (Final Order) the Western Systems Coordinating Council (WSCC) Agreement,
as amended, dated August 4, 1967 and the Western Systems Coordinating Council Agreement, dated November 18, 1993.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were supplied to all parties to the WSCC Agreement, the Public Utility Commission of Oregon and
the Utah Public Service Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PacifiCorp requests that the Commission disclaim jurisdiction of the WSCC Agreements or if the Commission does assert
jurisdiction PacifiCorp requests in accordance with the Final Order and 18 CFR 35.11 of the Commission's Rules and
Regulations and that a waiver of prior notice requirements be granted. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
6. Wisconsin Public Service Corp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;284&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 17, 1993, Wisconsin Public Service Corporation (WPSC) tendered for filing an executed
Transmission Service Agreement between WPS and Heartland Energy Services Inc. The Agreement provides for transmission
service under the T&hyph;1 Transmission Tariff, FERC Original Volume No. 4. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
WPS asks that the agreement become effective January 1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00013 </DOCNO>
<PARENT> FR940112-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
7. New England Power Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;286&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, New England Power Company (NEP) submitted for filing executed Amendments to
its Service Agreements with Granite State Electric Company, New Hampshire Electric Cooperative, and the Town of
Littleton, New Hampshire (hereinafter Customers) under NEP's FERC Electric Tariff, Original Volume No. 1. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
NEP states that the proposed Amendments provide a monthly credit to its New Hampshire Customers based on a portion
of the savings received by NEP through the issuance of tax-exempt financing authorized by the State of New Hampshire.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
NEP requests waiver of the Commission's notice requirements so that the Amendments may become effective on January
1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
8. Green Mountain Power Corp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;287&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Green Mountain Power Corporation (GMP) tendered for filing a Service Agreement
and Certificate of Concurrence for Montaup Electric Company under FERC Electric Tariff No. 2, known as GMP's Opportunity
Transaction Tariff (Tariff). The Service Agreement is intended to supersede the unexecuted Service Agreement for
Eastern Utilities Associates. The Service Agreement and Certificate of Concurrence will allow Montaup to enter
into transactions, including exchange unit transactions, in accordance with the Tariff. No terms or conditions
of the Tariff are affected by the form of Service Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
9. Midwest Power Systems Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;288&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Midwest Power Systems Inc. (MPSI) tendered for filing a ``Construction and
Financing Agreement'' (Financing Agreement) dated March 5, 1990, and a ``First Amendment to Financing Agreement''
(Amendment) dated December 10, 1992, between Associated Electric Cooperative, Inc. (AEC) and Iowa Power Inc., n/k/a
MPSI. The Financing Agreement and the Amendment provide for the financing of MPSI's portion of certain MINT Line project
facilities by AEC. MPSI received no financial gain from the Financing Agreement and the Amendment. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On July 30, 1993, the Commission issued its ``Final Order'' in Docket No. PL93&hyph;2&hyph;002, ``Prior Notice and
Filing Requirement'', clarifying that agreements for joint ownership of transmission facilities must be filed.
The Final Order also established an amnesty period during which such filings can be brought up to date. This filing
falls within the provisions of the amnesty period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MPSI requests a waiver of the Commission's rules so that the Financing Agreement may be approved retroactive to March
5, 1990, and the Amendment may be approved retroactive to October 1, 1992. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MPSI states that copies of this filing were served on Associated Electric and the Iowa Utilities Board. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
10. Midwest Power Systems Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;289&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Midwest Power Systems, Inc. (MPSI) tendered for filing a Peaking Capacity Sales
Agreement (Agreement) dated June 6, 1991, between Corn Belt Power Cooperative (Corn Belt) and Iowa Public Service
Company, n/k/a MPSI. This Agreement's principle purpose is to establish terms for MPSI to purchase capacity and energy
from Corn Belt from June 1, 1994, through September 30, 2000. Paragraph 12 of the Agreement allows for MPSI to sell capacity
and energy to Corn Belt, at Corn Belt's sole option, in the months of October and November of each respective year. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On July 30, 1993, the Commission issued its ``Final Order'' in Docket No. PL93&hyph;2&hyph;002, ``Prior Notice and
Filing Requirements'', clarifying that agreements for ``the sale of electric power and energy to any person'' must
be filed. The Final Order also established an amnesty period during which such filings can be brought up to date. This
filing falls within the provisions of the amnesty period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MPSI requests that the Peaking Capacity Sales Agreement be approved effective June 1, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MPSI states that copies of this filing were served on Corn Belt and the Iowa Utilities Board. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00014 </DOCNO>
<PARENT> FR940112-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
11. Midwest Power Systems Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;290&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Midwest Power Systems Inc. (MPSI) tendered for filing a Transmission Line Terminal
Facilities Agreement (Facilities Agreement) dated March 5, 1990, between Nebraska Public Power District (NPPD);
Omaha Public Power District (OPPD), City of Lincoln, Nebraska (Lincoln); and Iowa Power Inc., n/k/a MPSI. The primary
purpose of the Facilities Agreement is to provide for the construction, finance, maintenance, and ownership responsibilities
of the Cooper Terminal Facilities. MPSI, OPPD, and Lincoln shall make payments to NPPD for the right to use the Cooper
Substation, including the Cooper Terminal Facilities, for the purpose of scheduling power and energy transactions
pursuant to the MINT Line Coordinating Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On July 30, 1993, the Commission issued its ``Final Order'' in Docket No. PL93&hyph;2&hyph;002, ``Prior Notice and
Filing Requirements'', clarifying that agreements for the joint ownership of transmission facilities must be filed.
The Final Order also established an amnesty period during which such filings can be brought up to date. This filing
falls within the provisions of the amnesty period. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MPSI respectfully requests a waiver of the Commission's rules so that the Transmission Line Facilities Agreement
may be approved retroactive to March 5, 1990. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MPSI states that copies of this filing were served on NPPD, OPPD, and Lincoln and the Iowa Utilities Board. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
12. Northeast Utilities Service Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;291&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Northeast Utilities Service Company (NUSCO) tendered for filing a Service
Agreement to provide non-firm transmission service to Massachusetts Municipal Wholesale Electric Company (MMWEC)
under the NU System Companies' Transmission Service Tariff No. 2. 
<!-- PJG 0012 frnewline -->
NUSCO states that a copy of this information has been mailed to MMWEC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
13. PacifiCorp 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;292&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that PacifiCorp, on December 20, 1993, tendered for filing in accordance with Commission's Order pertaining
to agreements involving final amnesty for jurisdictional service and waiver of notice, issued July 30, 1993 under
Docket No. PL93&hyph;2&hyph;002, agreements which contain provisions involving a return of energy losses associated
with the purchase of Formula Power Transmission service from the Bonneville Power Administration (Bonneville).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were supplied to Bonneville, the Public Utility Commission of Oregon and the Utah Public Service
Commission. 
<!-- PJG 0012 frnewline -->
PacifiCorp requests in accordance with 18 CFR 35.11 of the Commission's Rules and Regulations and that a waiver of
prior notice requirements be granted and that the filed agreements be accepted for filing effective as indicated
for each of the agreements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
14. PacifiCorp 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;293&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that PacifiCorp, on December 20, 1993, tendered for filing a Draft Harrison Interconnection and Transmission
Facilities Conveyance Agreements between PacifiCorp and Portland General Electric Company (Portland General),
dated September 9, 1993 which provide for an interconnection between PacifiCorp's and Portland's systems at PacifiCorp's
Harrison Substation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PacifiCorp requests that a waiver of prior notice be granted pursuant to the Commission's Final Order in Docket No.
PL93&hyph;2&hyph;002 and that an effective date of October 31, 1990 be assigned to the filed agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were supplied to Portland and the Public Utility Commission of Oregon. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
15. PacifiCorp 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;294&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, PacifiCorp tendered for filing, Amendment No. 2 to Contract No. 14&hyph;06&hyph;100&hyph;1152,
Contract Between The United States of America and PacifiCorp For Use of Facilities For The Transmission of Electrical
Power and Energy whereby PacifiCorp provides transfers to the Bureau of Reclamation (BuRec) Burbank Pumping Plants
No. 2 and No. 3. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PacifiCorp requests a waiver of the Commission's prior notice requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing have been supplied to BuRec, the South Columbia Basin Irrigation District, the Washington Utilities
and Transportation Commission, the Public Utility Commission of Oregon and the Utah Public Service Commission.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
16. PacifiCorp 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;295&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that PacifiCorp on December 20, 1993, tendered for filing a Letter Agreement between PacifiCorp and the
City of Idaho Falls, Idaho (Idaho Falls), dated January 16, 1989 for reciprocal emergency backup electrical service.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PacifiCorp requests a waiver of prior notice be granted and that an effective date of February 28, 1989 be assigned
to the Letter Agreement. This date is the date Idaho Falls executed the Letter Agreement. 
<!-- PJG 0012 frnewline -->
Copies of this filing were supplied to Idaho Falls and the Bonneville Power Administration. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00015 </DOCNO>
<PARENT> FR940112-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
17. Wisconsin Power and Light Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;296&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 17, 1993, Wisconsin Power and Light Company tendered for filing with the Federal Energy
Regulatory Commission four Letter Agreements between Wisconsin Power and Light Company (WP&amp;L) and Manitowoc
Public Utilities (MPU). Under the Negotiated Capacity Agreement, WP&amp;L will make capacity and associated energy
available to MPU and negotiated degrees of firmness, variable capacity charges, and variable time duration. Under
the General Purpose Energy Agreement, WP&amp;L will make non-firm energy available to MPU, with terms and quantities
to be arranged by mutual agreement. Under the Emergency Energy Agreement, WP&amp;L will make non-firm emergency
energy available to MPU in quantities that, in WP&amp;L's sole judgement, it can supply. Under the Negotiated Capacity
Sub-Agreement, WP&amp;L will supply MPU with 10 MW of firm power and energy from June 1, 1994 through 
<!-- PJG 0012 frnewline -->
May 31, 1995. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Wisconsin Power and Light respectfully requests an effective date sixty (60) days from the date of filing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A copy of the filing has been served on the Public Service Commission of Wisconsin. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
18. Commonwealth Edison Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;297&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Commonwealth Edison Company (Edison) submitted a Service Agreement, dated
November 16, 1993, establishing PSI Energy, Inc. (PSI) as a customer under the terms of Edison's Power Sales Tariff
PS&hyph;1 (PS&hyph;1 Tariff). The Commission has previously designated the PS&hyph;1 Tariff as FERC Electric Tariff,
Original Volume No. 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Edison requests an effective date of December 1, 1993, and accordingly seeks waiver of the Commission's notice requirements.
Copies of this filing were served upon PSI and the Illinois Commerce Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
19. Jersey Central Power &amp; Light Co., et al. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;298&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Jersey Central Power &amp; Light Company, Metropolitan Edison Company, Pennsylvania
Electric Company and GPU Nuclear Corporation, (the GPU Companies) tendered for filing rate schedules relating to
the provision of operating and maintenance services for five generating stations located in New Jersey and Pennsylvania,
namely, the Yards Creek and Kinzua (Seneca) pumped storage hydroelectric stations, the Homer City coal-fired generating
station, and the Three Mile Island Oyster Creek nuclear generating stations. The subject rate schedules were filed
in response to the Orders of the Federal Energy Regulatory Commission issued July 30, 1993 and October 19, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing have been furnished to the Pennsylvania Public Utility Commission of New Jersey Board of Regulatory
Commissioners. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
20. Jersey Central Power &amp; Light Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;299&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, in response to the Orders of the Commission, dated July 30, 1993 and October 19,
1993, relating to the Prior Notice and Filing Requirements of the Federal Power Act in FERC Docket No. PL93&hyph;2,
Jersey Central Power &amp; Light Company (JCP&amp;L) tendered for filing a proposed rate schedule supplement showing
JCP&amp;L's charges to Atlantic City Electric Company (ACE) to defray JCP&amp;L's cost of operation and maintenance
of certain interconnection facilities during the years 1982&hyph;1993 and proposed for 1994 relating to JCP&amp;L's
Interconnection Agreement with Atlantic City Electric Company (ACE) dated as of March 1, 1978. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing have been furnished to the New Jersey Board of Regulatory Commissioners. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
21. Central Vermont Public Service Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;300&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that Central Vermont Public Service Corporation (CVPS) on December 20, 1993, tendered for filing Borderline
Agreement between New York State Electric &amp; Gas Corporation and CVPS. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CVPS requests the Commission to waive its notice of filing requirements to permit the original contracts to become
effective according to their respective terms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
22. Central Hudson Gas &amp; Electric Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;302&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Central Hudson Gas and Electric Corporation (CHG&amp;E) tendered for filing
an amendment to FERC Docket No. ER85&hyph;648&hyph;000 dated May 4, 1990 between CHG&amp;E and New York Power Authority
(NYPA). The amended agreement expands the firm transmission service provided by CHG&amp;E for NYPA to include service
on behalf of Economic Development Customers located in Orange &amp; Rockland Utilities, Inc. service territory.
In addition, the point of delivery of NYPA power and energy to CHG&amp;E will be changed to CHG&amp;E's Rock Tavern
substation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All other provisions of Docket ER85&hyph;648&hyph;000 shall remain in effect. CHG&amp;E states that copies of the
subject filing were served upon NYPA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00016 </DOCNO>
<PARENT> FR940112-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
23. Central Hudson Gas &amp; Electric Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;303&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Central Hudson Gas &amp; Electric Corporation (CHG&amp;E) tendered for filing
an amendment to FERC Contract No. 73 dated March 11, 1991 between CHG&amp;E and Orange &amp; Rockland Utilities, Inc.
(O&amp;R). The amended contract expands the transmission wheeling service provided by CHG&amp;E to O&amp;R to include
the purchase of capacity and energy from the various sources of the New York Power Authority. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All other provisions including the rate that will be charged, of the existing contract remain in effect. CHG&amp;E
states that copies of the subject filing were served upon O&amp;R. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
24. Central Hudson Gas &amp; Electric Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;304&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Central Hudson Gas &amp; Electric Corporation (CHG&amp;E) tendered for filing
an amendment to FERC Contract No. 26 dated August 26, 1993 between CHG&amp;E and New York State Electric and Gas Corporation
(NYSEG). The amended contract provides for an increase in the facilities charge associated with investment at the
Smithfield Substation due to the replacement of a motor-operated manually controlled air break switch with a supervisory
controlled circuit breaker. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The facilities charge increases from $57.00 per month to $2,415.00 per month and is retroactive to August 16, 1991
the date on which the circuit breaker was placed in service. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All other provisions of FERC Contract No. 26 shall remain in effect. CHG&amp;E states that copies of the subject filing
were served upon NYSEG. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
25. Nevada Power Co.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;305&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Nevada Power Company (NPC), tendered for filing the Participation Agreement
Reid Gardner Unit 4 (Agreement) between NPC and the California Department of Water Resources (CDWR) and subsequent
changes to the transmission rate included in this Agreement. This Agreement provides for the Terms and Conditions
for participation in the operation of the Reid Gardner Unit 4, a coal-fired steam generation unit of approximately
250 MW located at NPC's Reid Gardner generating station site in Clark County, Nevada. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pursuant to 18 CFR 35.11, NPC requests waiver of the Commission's notice requirements, 18 CFR 35.3, to allow for an
effective date of May 10, 1983. Additionally, pursuant to the Commission's findings in FERC docket No. PL93&hyph;2&hyph;002,
NPC requests that all amnesty provisions be allowed. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were served on CDWR and the Nevada Public Service Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
26. Keystone Energy Service Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;306&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Keystone Energy Service Company, L.P. (Keystone) tendered for filing, pursuant
to Section 205 of the Federal Power Act and Rule 207 of the Rules of Practice and Procedure of the Federal Energy Regulatory
Commission (the ``Commission'') a ``Petition for Acceptance of Initial Rate Schedule and Waiver of Certain Commission
Regulations'' and an Initial Rate Schedule requesting the Commission approve, on a market basis, an Agreement for
the Purchase of Electric Power between Keystone and Atlantic City Electric Company (ACE), as amended for the sale
of capacity and associated from Keystone's cogeneration facility located in Logan Township, New Jersey. Keystone
has requested a waiver of the notice requirements to permit filing of the Initial Rate Schedule more than 120 days prior
to the proposed effective date. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Keystone has served a copy of the Petition on ACE. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
27. Central Vermont Public Service Corp.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;307&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Central Vermont Public Service Corporation Inc. (CVPS), tendered for filing
six Interconnections Agreements with the following Vermont facilities: Comtu Falls Corporation, Hydro Energies
Corporation, Emerson Falls Hydro, Inc., Killington Hydroelectric Inc., Martinsville Hydro Corporation, and Springfield
Hydroelectric Company as provided for pursuant to PL93&hyph;2&hyph;002. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
CVPS requests the Commission to waive its notice of filing requirements to permit the original contracts to become
effective according to their respective terms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
28. Illinois Power Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;311&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, Illinois Power Company (IP) tendered for filing changes to Appendix A to the
Interconnection Agreement between Central Illinois Power Service Company (CIPS), Illinois Power Company (IP),
and Union Electric Company (UE). The changes provide for an additional point of interconnection between CIPS and
IP, CIPS-IP Connection 39 - Sidney - West Kansas. IP proposes an effective date of October 1, 1983, and therefore, requests
waiver of the Commission's notice requirements. The other changes to Appendix A include minor revisions to existing
connection point working and the deletion of four connection points. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
IP also tenders for filing a Reserve and Emergency Interchange Agreement and appendices ``G'', ``H'', ``I'', and
``J'' dated December 15, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Finally, IP tenders for filing a revised Appendix ``Q'' to the Facility Use Agreement between IP and CIPS dated January
17, 1956. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the filing have been served on CIPS, UE, and the Illinois Commerce Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00017 </DOCNO>
<PARENT> FR940112-2-00011 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
29. PacifiCorp 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;312&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 20, 1993, PacifiCorp, tendered for filing in accordance with the Commission's Order
pertaining to agreements involving final amnesty for jurisdictional service and waiver of notice, issued July 30,
1993 under Docket No. PL93&hyph;2&hyph;003 (Final Order). Agreement Limiting Liability Among Western Interconnection
Systems and related materials entitled Western Interconnected Electric Systems Blackout/Brownout Insurance
Program (Related Materials). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were supplied to all parties to WIES, the Public Utility Commission of Oregon and the Utah Public
Service Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PacifiCorp requests that the Commission disclaim jurisdiction of the Agreement Limiting Liability Among Western
Interconnected Systems and/or Related Materials or, in the alternative, grant a waiver of prior notice pursuant
to 18 CFR 35.11 of the Commission's Rules and Regulations to allow the Agreement to become effective as of the date that
each jurisdictional party executed the Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
30. San Diego Gas &amp; Electric Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;317&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 21, 1993, San Diego Gas &amp; Electric Company (SDG&amp;E) tendered for filing and acceptance,
pursuant to 18 CFR 35.12, an Interchange Agreement (Agreement) between SDG&amp;E and the City of Riverside (Riverside).

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
SDG&amp;E requests that the Commission allow the Agreement to become effective on the 1st of March, 1994 or at the earliest
possible date. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing were served upon the Public Utilities Commission of the State of California and Riverside. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
31. Tucson Electric Power Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;322&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 21, 1993, Tucson Electric Power Company (Tucson) tendered for filing an Amendment No.
1 to an Economy Energy Agreement between Tucson and Arizona Power Authority (APA). The Amendment was executed in response
to a Staff request for more specific definition of certain terms contained in the Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The parties request an effective date of November 22, 1993, and therefore request waiver of the Commission's regulations
with respect to notice of filing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of this filing have been served upon all parties affected by this proceeding. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
32. Montaup Electric Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;324&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 21, 1993, Montaup Electric Company filed an Exhibit A designated Series No. 11, Newport
No. 5, specifying electric power to be transmitted under the Service Agreement No. 6 with Newport Electric Corporation
dated September 30, 1989 on file with the Commission under Docket No. ER85&hyph;391&hyph;000. Under the Amnesty
Order issued July 30, 1993 in Docket No. PL93&hyph;2&hyph;002, Montaup requests waiver of the 60-day notice requirement
to permit the service to become effective on March 1, 1985. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
33. New England Power Co. and Granite State Electric Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;326&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 21, 1993, New England Power Company (NEP) and Granite State Electric Company, tendered
for filing a Property Sharing Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pursuant to the Commission's Final Order in Docket No. PL93&hyph;2&hyph;000, dated July 31, 1993, the two companies
request waiver of the Commission's notice requirements so that the Agreement may be made effective November 2, 1993.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
34. Niagara Mohawk Power Corp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;328&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 21, 1993, Niagara Mohawk Power Corporation (Niagara Mohawk), tendered for filing an
agreement between Niagara Mohawk and the New York Power Authority (NYPA) dated December 13, 1993 providing for the
terms and conditions of loss compensation for control area transactions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The effective date of January 1, 1988 is requested by Niagara Mohawk.
<!-- PJG 0012 frnewline -->
Copies of this filing were served upon NYPA and the New York State Public Service Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
35. Niagara Mohawk Power Corp. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. ER94&hyph;329&hyph;000] 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 21, 1993, Niagara Mohawk Power Corporation (Niagara Mohawk), tendered for filing an
agreement between Niagara Mohawk and Lockport Energy Associates, L.P. (Lockport) dated April 24, 1992 providing
for the terms and conditions of an interconnect between Lockport's cogeneration facility and Niagara Mohawk's transmission
system. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The effective date of April 24, 1992 is requested by Niagara Mohawk. 
<!-- PJG 0012 frnewline -->
Copies of this filing were served upon Lockport and the New York State Public Service Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 20, 1994, in accordance with Standard Paragraph E at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Paragraphs 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
E. Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Rules 211
and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 18 CFR 385.214). All such motions or
protests should be filed on or before the comment date. Protests will be considered by the Commission in determining
the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing
to become a party must file a motion to intervene. Copies of this filing are on file with the Commission and are available
for public inspection. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;685 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00018 </DOCNO>
<PARENT> FR940112-2-00012 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 2354&hyph;018]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE></DOCTITLE>
<!-- PJG 0012 frnewline -->
Georgia Power Co.; Notice of Intent To Prepare an Environmental Assessment 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Energy Regulatory Commission (FERC) has received an application for relicensing of the existing North
Georgia Hydroelectric Project (project). The project is located on the Tallulah, Tugalo, and Chattooga Rivers in
Northeast Georgia and Northwest South Carolina. The project consists of six hydroelectric developments and is within
the Savannah River Basin. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The FERC staff intends to prepare an Environmental Assessment (EA) on the hydroelectric project in accordance with
the National Environmental Policy Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The EA will objectively consider both site-specific and cumulative environmental impacts of the project and reasonable
alternatives, and will include economic and engineering analyses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A draft EA will be issued and circulated for review by all interested parties. All comments filed on the draft EA will
be analyzed by the staff and considered in the final EA. The staff's conclusions and recommendations will then be presented
for the consideration of the Commission in reaching its final licensing decision. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The purpose of this notice and the scoping document, which is being sent to interested individuals, organizations,
and agencies with environmental expertise and concerns, is to solicit from those entities comments that will assist
the staff in identifying the scope of environmental issues that should be analyzed in the EA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The scoping document will: (1) Identify preliminary environmental issues related to the proposed project, (2) identify
preliminary resource issues that are not important and do not require detailed analysis, (3) identify reasonable
alternatives to be addressed in the EA, and (4) solicit all available information, especially quantified data, on
the resource issues, including points of view in opposition to, or in support of, the staff's preliminary views. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Written comments must be filed no later than March 3, 1994 with: 
<!-- PJG 0012 frnewline -->
Secretary, Federal Energy Regulatory Commission, 825 North Capitol Street, NE., 
<!-- PJG 0012 frnewline -->
Washington, DC 20426.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
All written correspondence should clearly show the following caption on the first page: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
North Georgia Hydroelectric Project, (FERC Project No. 2354&hyph;018) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Intervenors, those on the Commission's service list for this proceeding (parties), are reminded of the Commission's
Rules of Practice and Procedure, requiring parties filing documents with the Commission, to serve a copy of the document
on each person whose name appears on the official service list. Further, if a party or interceder files comments or
documents with the Commission relating to the merits of an issue that may affect the responsibilities of a particular
resource agency, they must also serve a copy of the document on that resource agency. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A two-day site visit to the project is planned for January 31 and February 1, 1994. Those who wish to attend should contact
Ms. JoLee Gardner, Georgia Power Company, at (404) 526&hyph;3576, by January 20, 1994, for details. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any questions regarding this notice may be directed to 
<!-- PJG 0012 frnewline -->
Joe Davis, Environmental Coordinator, at (202) 219&hyph;2865. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;717 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00019 </DOCNO>
<PARENT> FR940112-2-00013 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. JD94&hyph;01916T Oklahoma&hyph;63]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE></DOCTITLE>
<!-- PJG 0012 frnewline -->
State of Oklahoma; NGPA Notice of Determination by Jurisdictional Agency Designating Tight Formation 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Take notice that on December 29, 1993, the Corporation Commission of the State of Oklahoma (Oklahoma) submitted the
above-referenced notice of determination pursuant to &sect;271.703(c)(3) of the Commission's regulations, that
the Red Oak common source of supply underlying portions of Pittsburgh and Latimer Counties, Oklahoma, qualifies
as a tight formation under section 107(c)(5) of the Natural Gas Policy Act of 1978. The recommended area is described
as:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Pittsburgh County 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sections 35 and 36, T7N, R18E 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Latimer County 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Sections 31 through 33, T7N, R19E 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sections 1, 2, 10, 11, and 12, T6N, R18E 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sections 4 through 9, T6N, R19E
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The notice of determination also contains Oklahoma's findings that the referenced formation meets the requirements
of the Commission's regulations set forth in 18 CFR part 271. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The application for determination is available for inspection, except for material which is confidential under
18 CFR 275.206, at the Federal Energy Regulatory Commission, 825 North Capitol Street, NE., Washington DC 20426.
Persons objecting to the determination may file a protest, in accordance with 18 CFR 275.203 and 275.204, within 20
days after the date this notice is issued by the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;718 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00020 </DOCNO>
<PARENT> FR940112-2-00014 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. JD94&hyph;01918T Oklahoma&hyph;65]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>State of Oklahoma; NGPA Notice of Determination by Jurisdictional Agency Designating Tight Formation </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 29, 1993, the Corporation Commission of the State of Oklahoma (Oklahoma) submitted the
above-referenced notice of determination pursuant to &sect;271.703(c)(3) of the Commission's regulations, that
the Douglas (Tonkawa) Formation, underlying portions of Roger Mills and Ellis Counties, Oklahoma, qualifies as
a tight formation under section 107(b) of the Natural Gas Policy Act of 1978. The recommended area is described as all
of Sections 9, 10, 15&hyph;22, and 28&hyph;30, in Township 17 North, Range 24 West, and Sections 24 and 25, in Township
17 North, Range 25 West. 
<!-- PJG 0012 frnewline -->
The notice of determination also contains Oklahoma's findings that the referenced formation meets the requirements
of the Commission's regulations set forth in 18 CFR Part 271. 
<!-- PJG 0012 frnewline -->
The application for determination is available for inspection, except for material which is confidential under
18 CFR 275.206, at the Federal Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426.
Persons objecting to the determination may file a protest, in accordance with 18 CFR 275.203 and 275.204, within 20
days after the date this notice is issued by the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;719 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00021 </DOCNO>
<PARENT> FR940112-2-00015 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. CP94&hyph;166&hyph;000, et al.] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Viosca Knoll Gathering System, et al.; Natural Gas Certificate Filings </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that the following filings have been made with the Commission: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
1. Viosca Knoll Gathering System 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. CP94&hyph;166&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 29, 1993, Viosca Knoll Gathering System (Viosca Knoll), 600 Travis, 7200 Texas Commerce
Tower, Houston, Texas 77002, filed a petition for declaratory order in Docket No. CP94&hyph;116&hyph;000, requesting
that the Commission declare that certain facilities Viosca Knoll proposes to construct along the edge of the Outer
Continental Shelf (OCS) would have the primary function of gathering natural gas and would thereby be exempt from
the Commission's jurisdiction pursuant to Section 1(b) of the Natural Gas Act (NGA), all as more fully set forth in
the petition which is on file with the Commission and open to public inspection. 
<!-- PJG 0012 frnewline -->
Viosca Knoll states that it proposes to construct approximately 95 miles of 20-inch O.D. pipeline extending from
a platform owned and operated by Shell Offshore, Inc. in Main Pass Block 252 in a generally southwesterly direction
to a terminating interconnection with the facilities of Tennessee Gas Pipeline Company (Tennessee) in South Pass
Block 55 Offshore Louisiana. It is stated that Viosca Knoll's facilities would also include, in their initial configuration,
a junction platform and six miles of 16-inch O.D. lateral interconnect with facilities owned by Southern Natural
Gas Company (Southern) in Main Pass Block 289. It is also stated that Viosca Knoll's facilities would interconnect
with production platforms and flow lines from production platforms at numerous locations along its entire length.
Viosca Knoll indicates that its facilities would not include compression, would be operated at pressures ranging
from 900 to 1,350 psig, and would be configured to gather natural gas from both the shallow and deepwater OCS and redeliver
it to the nearest pipeline interconnections having adequate take-away capacity consistent with Viosca Knoll's
objective of providing gas gathering infrastructure along the edge of the OCS. Viosca Knoll states that it is a partnership
composed of Leviathan Gas Pipeline Partners, L.P. (Leviathan), and Tenneco Gas Gathering Co. (Tenneco Gathering)
with each partner holding equal ownership shares. Viosca Knoll further states that Leviathan would be the administrative
operator and that the system would not interconnect with any interstate pipeline affiliated with Leviathan. It is
stated that Tenneco Gathering would physically operate and maintain the facilities. 
<!-- PJG 0012 frnewline -->
Viosca Knoll seeks a declaratory order holding that its proposed facilities would have the primary function of gathering
natural gas and would thereby be exempt from the Commission's jurisdiction pursuant to Section 1(b) of the Natural
Gas Act. Viosca Knoll requests that an expedited decision be issued permitting the facilities to be placed into service
by November 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 25, 1994, in accordance with the first paragraph of Standard Paragraph F at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
2. Florida Gas Transmission Co. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
[Docket No. CP94&hyph;155&hyph;000]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 22, 1993, Florida Gas Transmission Company (FGT), 1400 Smith Street, Houston, Texas
77002, filed in Docket No. CP94&hyph;155&hyph;000 an application pursuant to Section 7(b) of the Natural Gas Act
for permission and approval to abandon and transfer by sale to Onyx Pipeline Company, L.C. (Onyx), three compressor
units, 15.7 miles of the Encinal Channel Lateral, the Phillips East White Point Lateral, the Shell East White Point
Lateral, the Nueces Bay Lateral and related metering and appurtenant facilities, including permission to transfer
by sale to Onxy the Phillips Spradley Lateral, all as more fully set forth in the application on file with the Commission
and open to public inspection. 
<!-- PJG 0012 frnewline -->
FGT states that the facilities it has agreed to sell to Onyx are located primarily in San Patricio County, Texas. FGT
further states that the abandonment and sale proposed herein would not impair any current services nor would it disadvantage
any FGT customer. FGT says that the proposed abandonment and sale of the subject facilities would save FGT approximately
$10,500 per year in operating and maintenance costs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Comment date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
January 25, 1994, in accordance with Standard Paragraph F at the end of this notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Standard Paragraphs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
F. Any person desiring to be heard or to make any protest with reference to said application should on or before the comment
date, file with the Federal Energy Regulatory Commission, Washington, DC 20426, a motion to intervene or a protest
in accordance with the requirements of the Commission's Rules of Practice and Procedure (18 CFR 385.214 or 385.211)
and the Regulations under the Natural Gas Act (18 CFR 157.10). All protests filed with the Commission will be considered
by it in determining the appropriate action to be taken but will not serve to make the protestants parties to the proceeding.
Any person wishing to become a party to a proceeding or to participate as a party in any hearing therein must file a motion
to intervene in accordance with the Commission's Rules. 
<!-- PJG 0012 frnewline -->
Take further notice that, pursuant to the authority contained in and subject to the jurisdiction conferred upon the
Federal Energy Regulatory Commission by Sections 7 and 15 of the Natural Gas Act and the Commission's Rules of Practice
and Procedure, a hearing will be held without further notice before the Commission or its designee on this application
if no motion to intervene is filed within the time required herein, if the Commission on its own review of the matter
finds that a grant of the certificate and/or permission and approval for the proposed abandonment are required by
the public convenience and necessity. If a motion for leave to intervene is timely filed, or if the Commission on its
own motion believes that a formal hearing is required, further notice of such hearing will be duly given. 
<!-- PJG 0012 frnewline -->
Under the procedure herein provided for, unless otherwise advised, it will be unnecessary for applicant to appear
or be represented at the hearing. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;686 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00022 </DOCNO>
<PARENT> FR940112-2-00016 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 11356&hyph;001 Utah]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Long Park Hydro Associates, </DOCTITLE>
<!-- PJG 0012 frnewline -->
dba Current Power Technologies; Surrender of Preliminary Permit 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that Long Park Hydro Associates, Permittee for the Long Park Project No. 11356, has requested that its
preliminary permit be terminated. The preliminary permit for Project No. 11356 was issued April 20, 1993, and would
have expired March 31, 1996. The project would have been located on Sheep Creek in Daggett County, Utah. 
<!-- PJG 0012 frnewline -->
The Permittee filed the request on December 17, 1993, and the preliminary permit for Project No. 11356 shall remain
in effect through the thirtieth day after issuance of this notice unless that day is a Saturday, Sunday or holiday as
described in 18 CFR 385.2007, in which case the permit shall remain in effect through the first business day following
that day. New applications involving this project site, to the extent provided for under 18 CFR Part 4, may be filed
on the next business day. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;720 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00023 </DOCNO>
<PARENT> FR940112-2-00017 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Project No. 11357&hyph;001 Utah]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Moon Lake Hydro Associates, dba Current Power Technologies; Surrender of Preliminary Permit </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that Moon Lake Hydro Associates, Permittee for the Moon Lake Project No. 11357, has requested that its
preliminary permit be terminated. The preliminary permit for Project No. 11357 was issued April 23, 1993, and would
have expired March 31, 1996. The project would have been located on the West Fork of the Lake Fork River in Duchesne County,
Utah. 
<!-- PJG 0012 frnewline -->
The Permittee filed the request on December 17, 1993, and the preliminary permit for Project No. 11357 shall remain
in effect through the thirtieth day after issuance of this notice unless that day is a Saturday, Sunday or holiday as
described in 18 CFR 385.2007, in which case the permit shall remain in effect through the first business day following
that day. New applications involving this project site, to the extent provided for under 18 CFR part 4, may be filed
on the next business day. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;721 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00024 </DOCNO>
<PARENT> FR940112-2-00018 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket Nos. RP94&hyph;37&hyph;001 and RP94&hyph;90&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Alabama-Tennessee Natural Gas Co.; Proposed Change in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Take notice that Alabama-Tennessee Natural Gas Company (Alabama-Tennessee), on December 23, 1993, tendered for
filing the following revisions to its FERC Gas Tariff, Second revised Volume No. 1, to be made effective November 1,
1993:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Second Revised Sheet No. 4B
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 140
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
According to Alabama-Tennessee, this filing is being made to comply with the order issued by the Commission on November
26, 1993 in Alabama-Tennessee Natural Gas Co., 65 FERC &para;61, 262 (1993). Alabama-Tennessee states that the first
of these revised tariff sheets reflects certain minor changes to its proposed treatment of the Account No. 191 credit
balance amounts contained in its original filing in this docket which it submitted on October 29, 1993. Second Revised
Sheet No. 140 provides additional clarifying language that Alabama-Tennessee will flowthrough any purchased gas
adjustment refunds regardless of when it receives such refunds. In addition, in connection with its filing, Alabama-Tennessee
has submitted various working papers in connection with its proposed treatment of the Account No. 191 credit balance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alabama-Tennessee has requested such waiver of the Commission's regulations as may be necessary to accept and approve
its filing as proposed.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Alabama-Tennessee states that copies of its filing were served upon the Company's customers and affected state commissions
as well as all the parties shown on the Commission's official service list established in this proceeding.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules and Regulations. All such motions or protests should be filed on or before January
13, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken but will
not serve to make protestants parties to the proceeding. Any person wishing to become a party to the proceeding must
file a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;722 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00025 </DOCNO>
<PARENT> FR940112-2-00019 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket Nos. RP93&hyph;161&hyph;004, RP94&hyph;1&hyph;004 and RP94&hyph;108&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Columbia Gas Transmission Corp.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 3, 1994, Columbia Gas Transmission Corporation (Columbia), entered for filing as part
of its FERC Gas Tariff, Second Revised Sheet No. 31 and Original Sheet No. 31A, to be made effective January 1, 1994.

<!-- PJG 0012 frnewline -->
Columbia states that this filing is being made in order to allow those customers that do not contest the settlement
submitted on January 3, 1994, by Columbia and Supporting Intervenors in these proceedings to receive the immediate
benefits of a reduction in Columbia's Weighted Cost of Gas (WACOG) surcharge filing in Docket No. RP94&hyph;1 from
7.22
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=8 f=1 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 per Dth to 3.8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=8 f=1 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 per Dth, effective January 1, 1994, as provided for under the settlement. This surcharge applies to all City Gate deliveries
under firm Rate Schedules FTS, SST and FTS for Columbia's current and former wholesale customers, including replacement
shippers for capacity released by such customers. Parties will be eligible for such reduced WACOG surcharge if they
do not advise Columbia or the Commission prior to January 24, 1994 that they contest the settlement or seek modifications
or conditions to the settlement which are unacceptable to Columbia and the Supporting Intervenors. Contesting parties
will continue to pay the currently effective 7.22
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=8 f=1 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 per Dth WACOG surcharge, subject to refund. 
<!-- PJG 0012 frnewline -->
Columbia states that the parties are on notice that Columbia has the right to reimplement the 7.22
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=8 f=1 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 per Dth surcharge, effective January 1, 1994, in the event that the Commission rejects the settlement or provides
modifications or conditions to the settlement which are unacceptable to Columbia or the Supporting Intervenors.

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed on or
before January 13, 1994. Protests will be considered by the Commission in determining the appropriate action to be
taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file
a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection
in the public reference room. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;723 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00026 </DOCNO>
<PARENT> FR940112-2-00020 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket Nos. RP94&hyph;92&hyph;000, TQ94&hyph;3&hyph;23&hyph;000 and TM94&hyph;5&hyph;23&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Eastern Shore Natural Gas Co., Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that Eastern Shore Natural Gas Company (Eastern Shore) tendered for filing on December 30, 1993 certain
revised tariff sheets included in Appendix A to the filing (to be in effect for November and December, 1993 and January,
1994) and also submitted for filing are tariff sheets in Appendix B (regular scheduled quarterly PGA filing) proposed
to be effective February 1, 1994.
<!-- PJG 0012 frnewline -->
Eastern Shore states that the purpose of the instant filing is threefold: (1) To further modify the tracking provisions
contained in Section 24 of the General Terms and Conditions of Eastern Shore's FERC Gas Tariff with respect to its CWS
and CFSS rate schedules; (2) to track changes in Eastern Shore's pipeline suppliers' storage service rates; and (3)
to reflect changes in Eastern Shore's commodity and demand sales rates.
<!-- PJG 0012 frnewline -->
Eastern Shore states that it seeks to reduce its CD commodity and increase its demand sales rates by $0.1559 and $0.1129
per dt, respectively, as compared to those sales rates filed in Eastern Shore's Out-Of-Cycle filing in Docket Nos.
TQ94&hyph;2&hyph;23&hyph;000 and TM94&hyph;4&hyph;23&hyph;000. Such reduction in the CD commodity sales rate
and increase in the demand sales rate are due to (1) lower prices being paid to Eastern Shore's suppliers under its market
responsive gas supply contracts and (2) an increase in demand-related costs from upstream suppliers due to a revision
in their Gas Research Institute (GRI) Charge effective January 1, 1994.
<!-- PJG 0012 frnewline -->
Eastern Shore states that copies of the filing have been served upon its jurisdictional customers and interested
State Commissions. Any person desiring to be heard or to protest said filing should file a motion to intervene or protest
with the Federal Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance
with Rule 211 and Rule 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 385.214). All such
motions or protests shall be filed on or before January 13, 1994. Protests will be considered by the Commission in determining
the appropriate action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing
to become a party must file a motion to intervene. Copies of this filing are on file with the Commission and are available
for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;724 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00027 </DOCNO>
<PARENT> FR940112-2-00021 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;91&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Granite State Gas Transmission, Inc.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 28, 1993, Granite State Gas Transmission, Inc. (Granite State) tendered for filing the
tariff sheets listed below in its FERC Gas Tariff, Third Revised Volume No. 1, containing changes in rates for effectiveness
on December 28, 1993:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Original Sheet No. 32
<!-- PJG 0012 frnewline -->
Original Sheet No. 33
<!-- PJG 0012 frnewline -->
Original Sheet No. 34
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
According to Granite State, three additional tariff sheets, having no rate effect, are also submitted for editorial
purposes in the tariff:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
First Revised Sheet No. 20_Revised Index
<!-- PJG 0012 frnewline -->
Original Sheet Nos. 27&hyph;30 and 35&hyph;99_Reservations for Future Use
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Granite State further states that the rate changes on Original Sheet Nos. 32 through 34 are submitted as a limited Section
4 filing to pass through to its customers, Bay State Gas Company and Northern Utilities, Inc., transitional costs
pursuant to Order Nos. 636, et al., that have been directly billed to Granite State by upstream pipeline suppliers
following the effectiveness of their restructuring proceedings. According to Granite State, it has been directly
billed transitional costs by Algonquin Gas Transmission Company, Tennessee Gas Pipeline Company and National Fuel
Gas Supply Corporation and its filing allocates such directly billed costs to its customers.
<!-- PJG 0012 frnewline -->
Granite State further states that it commenced its restructured operations on November 1, 1993, pursuant to a compliance
plan approved by the Commission in Docket No. RS93&hyph;1&hyph;000. It is further said that Granite State previously
filed tariff sheets with the Commission to recover certain of the upstream supplier transitional costs and the filing
was rejected in a Letter Order issued July 28, 1993 advising that Granite State could file to recover such costs in a
limited Section 4 filing when it had completed its restructuring process. (Docket Nos. TM93&hyph;14&hyph;4&hyph;000,
et al.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Granite State states that copies of its filing have been served on its customers, Bay State Gas Company and Northern
Utilities, Inc., and the regulatory commissions of the States of Maine, Massachusetts and New Hampshire.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Sections
211 and 214 of the Commission's Rules of Practice and Procedures (18 CFR 385.211 and 385.214). All such motions or protests
should be filed on or before January 13, 1994. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;725 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00028 </DOCNO>
<PARENT> FR940112-2-00022 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. TM94&hyph;1&hyph;117&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>K N Wattenberg Transmission Limited Liability Co.; Tariff Filing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On December 22, 1993, K N Wattenberg Transmission Limited Liability Company (``K N Wattenberg'') tendered for filing
the following revised tariff sheet:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Original Volume No. 1 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
First Revised Sheet No. 6
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
K N Wattenberg states that this tariff sheet reflects the Commission's revised Annual Charge Adjustment (ACA) unit
charge and requests that the tariff sheet be made effective on October 1, 1993.
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or a protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed on or
before January 13, 1994. Protests will be considered by the Commission in determining the appropriate action to be
taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file
a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection
in the public reference room.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;726 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00029 </DOCNO>
<PARENT> FR940112-2-00023 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. TM94&hyph;2&hyph;117&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>K N Wattenberg Transmission Limited Liability Co.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Take notice that K N Wattenberg Transmission Limited Liability Company, (K N Wattenberg) on December 22, 1993, tendered
for filing proposed changes in its FERC Gas Tariff. Such adjustment is to track the revised GRI funding mechanism,
effective January 1, 1994 per Commission Opinion No. 384 dated October 5, 1993, in Docket No. RP93&hyph;140&hyph;000.
Copies of this filing were served upon the company's jurisdictional customers, and interested public bodies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or a protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC, 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules and Regulations. All such motions or protests should be filed on or before January
13, 1994. Protests will be considered by the Commission in determining the appropriate action to be taken, but will
not serve to make protestants parties to the proceeding. Any person wishing to become a party must file a motion to intervene.
Copies of this filing are on file with the Commission and are available for public inspection in the public reference
room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;727 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00030 </DOCNO>
<PARENT> FR940112-2-00024 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;107&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Northwest Pipeline Corp.; Compliance Filing</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 30, 1993, Northwest Pipeline Corporation (Northwest) tendered for filing and acceptance
reconciling PGA workpapers.
<!-- PJG 0012 frnewline -->
Northwest states that the purpose of this filing is to comply with part 154 of the regulations of the Federal Energy
Regulatory Commission (Commission) and with Order No. 636 and other orders issued by the Commission that required
Northwest to file an estimate of its Account No. 191 balance as of October 31, 1993, and to file an estimated reconciliation
of its Account No. 191 activity from its last filed annual PGA until October 31, 1993.
<!-- PJG 0012 frnewline -->
Northwest states that a copy of this filing has been served upon each of Northwest's affected sales customers, all
intervenors in Docket No. RS92&hyph;69, consolidated with the official service list in all dockets to which the order
pertained, and upon affected state regulatory commissions.
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or protest said filing should file a motion to intervene of protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed on or
before January 13, 1994. Protests will be considered by the Commission in determining the appropriate action to be
taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file
a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection
in the public reference room.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;728 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00031 </DOCNO>
<PARENT> FR940112-2-00025 </PARENT>
<TEXT>
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;104&hyph;000] </RINDOCK>
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Overthrust Pipeline Co.; Proposed Changes in FERC Gas Tariff </DOCTITLE>
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 3, 1994, Overthrust Pipeline Company (Overthrust), tendered for filing and acceptance
tariff sheets to Original Volume No. 1 and First Revised Volume No. 1&hyph;A of its FERC Gas Tariff to implement revised
base rates, to become effective February 1, 1994. This filing is a general rate case submitted principally to comply
with the terms of Overthrust's last settlement at Docket No. RP85&hyph;60. Overthrust tendered for filing and acceptance
the following tariff sheets to is FERC Gas Tariff: 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Original Volume No. 1 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Sixteenth Revised Sheet No. 6 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 8 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 40 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 41 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
First Revised Volume No. 1&hyph;A 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
First Revised Sheet No. 4 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
First Revised Sheet No. 5 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
First Revised Sheet No. 12 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
First Revised Sheet No. 21 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
First Revised Sheet No. 70 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
First Revised Sheet No. 76 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
First Revised Sheet No. 77 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Overthrust requests an effective date of February 1, 1994, for the tendered tariff sheets. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Overthrust states that the rates that it has proposed are based on the overall cost of service for the test period consisting
of the twelve months ended October 31, 1993, adjusted to include the annual effect of: (a) Those costs which began to
be incurred during the twelve month period but were not in effect for the full period; (b) those costs which have been
incurred, increased or decreased since October 31, 1993; and (c) those added costs which are known and measurable
with reasonable accuracy and which will become effective within nine months after October 31, 1993. Further, Overthrust
states that the proposed rates would increase annual transportation revenues by approximately $3.1 million based
on the 12-month period ended October 31, 1993. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Overthrust further states that it has included the Commission's Annual Adjustment Charge (ACA) as a direct cost in
the rate case and proposes to eliminate the ACA provision from its FERC Gas Tariffs. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Overthrust states that copies of this filing were served upon Overthrust's jurisdictional customers, the Public
Service Commission of The State of New York and the Public Service Commission of Wyoming. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with Rules 211
and 214 of the Commission's Rules of Practice and Procedure (18 CFR 385.211 and 385.214). All such motions or protests
should be filed on or before January 13, 1994. Protests will be considered by the Commission in determining the appropriate
action to be taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a
party must file a motion to intervene. Copies of this filing are on file with the Commission and are available for public
inspection. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;729 Filed 1&hyph;11&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00032 </DOCNO>
<PARENT> FR940112-2-00026 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;105&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Ozark Gas Transmission System; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 3, 1994 Ozark Gas Transmission System (Ozark) tendered for filing as part of its FERC Gas
Tariff, First Revised Volume No. 1 the following tariff sheet, with a proposed effective date of February 2, 1994:

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Seventh Revised Tariff Sheet No. 4. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Ozark states that the filing is a general rate case submitted principally to comply with the terms of Ozark's settlement
in Docket No. RP84&hyph;53. The filing reflects a base period encompassing the twelve months ending October 31, 1993,
adjusted for known and measurable changes through the nine month period ending July 31, 1994. Ozark states that the
filing utilizes straight fixed-variable rate design, the Ozark method of calculating an equity only rate base, and
projected ITS throughput of 10,000 Dth. The proposed changes would decrease Ozark's cost of service by approximately
$65,856 compared to the cost of service approved by the Commission in Docket No. RS92&hyph;72.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Ozark states that copies of the filing were served upon Ozark's jurisdictional customers and interested state regulatory
agencies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or to protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules of Practice and Procedure. All such motions and protests should be filed on or
before January 13, 1994. Protests will be considered by the Commission in determining the appropriate action to be
taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file
a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection
in the public reference room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;730 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00033 </DOCNO>
<PARENT> FR940112-2-00027 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP94&hyph;106&hyph;000]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Pacific Gas Transmission Co.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on January 3, 1994 Pacific Gas Transmission Company (PGT) tendered for filing Original Sheet No.
6B to its FERC Gas Tariff, First Revised Volume No. 1&hyph;A, to set forth the amount to be refunded as a result of the
closeout of its Account No. 191.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PGT states that in conjunction with the implementation of restructured services on its system on November 1, 1993,
sales to its sales customer, Pacific Gas and Electric Company (PG&amp;E), as well as its Purchased Gas Adjustment
mechanism terminated. Paragraph 31 of PGT's Transportation General Terms and Conditions governs the disposition
of the balance of PGT's Account No. 191 as is existed on the day before the implementation of restructured service.
As of October 1, 1993, the balance of its Account No. 191 was a credit balance of $2,158,042.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PGT states that Paragraph 31.5(f) requires it to refund to PG&amp;E the credit balance of its Account No. 191 and to
submit an accounting of the costs involved in support of this refund within 60 days of the implementation of restructured
service. PGT states that it will refund the credit balance on December 30, 1993 and is submitting the required accounting
as part of the instant filing in support of this refund.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
PGT further states that a copy of its filing is being serviced on the affected customer and interested state regulatory
agencies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Any person desiring to be heard or protest said filing should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed on or
before January 13, 1994. Protests will be considered by the Commission in determining the appropriate action to be
taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file
a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection
in the public reference room. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;731 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00034 </DOCNO>
<PARENT> FR940112-2-00028 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket Nos. RP93&hyph;173&hyph;001, TM94&hyph;2&hyph;86&hyph;001, TM94&hyph;2&hyph;86&hyph;002 &amp;
RP94&hyph;88&hyph;001]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Pacific Gas Transmission Co.; Change in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 28, 1993, Pacific Gas Transmission Company (PGT) tendered for filing and acceptance
proposed tariff sheets to be a part of its FERC Gas Tariffs, First Revised Volume No. 1&hyph;A and Second Revised Volume
No. 1. The purpose of this filing is to correct minor technical and pagination errors made in previous filings.
<!-- PJG 0012 frnewline -->
Take notice that on December 29, 1993, Pacific Gas Transmission Company (PGT) tendered for filing a correction to
the Substitute Seventh Revised Sheet No. 5 to its FERC Gas Tariff, Second Revised Volume No. 1.
<!-- PJG 0012 frnewline -->
A copy of these filings have been served on interested state commissions and the parties of record.
<!-- PJG 0012 frnewline -->
Any person desiring to be heard or protest said filings should file a motion to intervene or protest with the Federal
Energy Regulatory Commission, 825 North Capitol Street, NE., Washington, DC 20426, in accordance with &sect;&sect;385.214
and 385.211 of the Commission's Rules of Practice and Procedure. All such motions or protests should be filed on or
before January 13, 1994. Protests will be considered by the Commission in determining the appropriate action to be
taken, but will not serve to make protestants parties to the proceeding. Any person wishing to become a party must file
a motion to intervene. Copies of this filing are on file with the Commission and are available for public inspection
in the Public Reference Room.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;732 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00035 </DOCNO>
<PARENT> FR940112-2-00029 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP93&hyph;204&hyph;002]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Texas Eastern Transmission Corp.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 30, 1993, Texas Eastern Transmission Corporation (Texas Eastern), submitted for filing
as part of its FERC Gas Tariff, Sixth Revised Volume No. 1, the following tariff sheets:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Sub First Revised Sheet No. 165
<!-- PJG 0012 frnewline -->
Sub First Revised Sheet No. 166
<!-- PJG 0012 frnewline -->
Sub First Revised Sheet No. 167
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed effective date of the filing is October 31, 1993. 
<!-- PJG 0012 frnewline -->
Texas Eastern states that this filing is in compliance with ordering paragraph (C) of the Commission's October 29,
1993 Order in Docket No. RP93&hyph;204&hyph;000 (October 29 Order) and with the Commission's December 17, 1993 Order
in Docket Nos. RS92&hyph;11&hyph;000, et al. (December 17 Order).
<!-- PJG 0012 frnewline -->
Texas Eastern states that the October 29 Order accepted tariff sheets filed on September 30, 1993 by Texas Eastern
to recover Stranded Costs which allocated such costs on the basis of MDQs for customers under Rate Schedules CDS, FT&hyph;1,
and SCT with an adjustment to reflect Peak Day or MDQ billing determinants for Rate Schedule SCT. Ordering paragraph
(C) of the October 29 Order directed Texas Eastern, ``to conform the subject filing to the Commission's action on Municipal
Defense Group's small customer mitigation alternative methodology in Docket No. RS92&hyph;11&hyph;017 within
15 days of the date of the date of a Commission order therein.'' The Commission issued such an order on December 17, 1993.
The tariff sheets submitted herewith are being filed in compliance with the October 29 Order to recover Stranded Costs
using the allocation methodology accepted by the Commission in the December 17 Order.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Texas Eastern states that the October 29 Order authorized Texas Eastern to recover Stranded Costs totalling $3,696,950.41,
including carrying charges, incurred from June 1, 1993 through August 31, 1993.
<!-- PJG 0012 frnewline -->
Texas Eastern states that the customer detail on the tariff sheets and on Attachment B of the filing includes the correction
of a customer name from Equitrans, Inc. to Equitable Gas Company.
<!-- PJG 0012 frnewline -->
Texas Eastern states that copies of the filing were served on Texas Eastern's jurisdictional customers and interested
state commissions.
<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, NE., Washington, DC 20426, in accordance with Rule 211 of the Commission's Rules of Practice
and Procedure. All such protests should be filed on or before January 13, 1994. Protests will be considered by the Commission
in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding.
Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;733 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00036 </DOCNO>
<PARENT> FR940112-2-00030 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. RP93&hyph;204&hyph;003]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Texas Eastern Transmission Corp.; Proposed Changes in FERC Gas Tariff</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Take notice that on December 30, 1993, Texas Eastern Transmission Corporation (Texas Eastern) submitted for filing
as part of its FERC Gas Tariff, Sixth Revised Volume No. 1, the following tariff sheets:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Second Revised Sheet No. 165
<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 166
<!-- PJG 0012 frnewline -->
Second Revised Sheet No. 167
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed effective date of the tariff sheets is October 31, 1993.
<!-- PJG 0012 frnewline -->
Texas Eastern states that this filing is submitted pursuant to Section 15.2(D) of the General Terms and Conditions
of Texas Eastern's FERC Gas Tariff, Sixth Revised Volume No. 1.
<!-- PJG 0012 frnewline -->
Texas Eastern states that it filed tariff sheets on September 30, 1993 to recover Stranded Costs totalling $3,696,950.41.
In an order issued October 29, 1993, the Commission accepted the tariff sheets filed on September 30. Concurrent with
the filing being made herewith, and in compliance with the October 29 Order, Texas Eastern is filing substitute tariff
sheets to the September 30 filing which revise the allocation methodology for customers under Rate Schedule SCT.
On October 25, 1993, Texas Eastern received a rate refund from Columbia Gulf Docket Nos. RP91&hyph;160 and RP91&hyph;161,
et al., related to June, July, and August 1993 activity, for $72,662.08, including carrying charges. Section 15.2(D)
of the General Terms and Conditions states, ``Any refunds received by Pipeline of amounts direct billed hereunder
shall be flowed through to Customers in the proportion of each Customer's payment of such amounts, including carrying
charges calculated in accordance with &sect;154.305 of the Commission's Regulations from the date of payment by
the Customer to the refund date.'' The tariff sheets being filed herewith reflect a credit to the customers for the
Columbia Gulf refund and uses the allocation methodology in the compliance filing being made concurrently.
<!-- PJG 0012 frnewline -->
Texas Eastern states that copies of the filing were served on Texas Eastern's jurisdictional customers and interested
state commissions.
<!-- PJG 0012 frnewline -->
Any person desiring to protest said filing should file a protest with the Federal Energy Regulatory Commission, 825
North Capitol Street, NE., Washington, DC 20426, in accordance with Rule 211 of the Commission's Rules of Practice
and Procedure. All such protests should be filed on or before January 13, 1994. Protests will be considered by the Commission
in determining the appropriate action to be taken, but will not serve to make protestants parties to the proceeding.
Copies of this filing are on file with the Commission and are available for public inspection.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lois D. Cashell,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;734 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6717&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00037 </DOCNO>
<PARENT> FR940112-2-00031 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>ENVIRONMENTAL PROTECTION AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPPTS&hyph;00146; FRL&hyph;4754&hyph;7]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Guidance on Determining Environmentally Preferable Products and Services; Notice of Meeting </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Agency:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
Action:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 EPA is announcing a public meeting to solicit input from all interested parties on developing guidance that Executive
agencies can use in determining the preference and purchase of environmentally preferable products and services.
This meeting is part of a process that EPA has established to obtain public input. The draft guidance is being developed
to implement section 503 of Executive Order on Federal Acquisition, Recycling and Waste Prevention (Executive Order
12873). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The meeting will take place on February 7 and 8, 1994, starting at 9:30 a.m. on February 7, and 12:30 p.m. on February
8, and ending each day at 5 p.m. unless concluded earlier. Registration will occur one half hour before the meeting
is scheduled to begin on both days. The second day will only proceed if there are more confirmed presenters than can
be accommodated on the first day.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Requests to present oral testimony must be received on or before February 1, 1994, and will be scheduled on a first-come,
first-served basis. Written comments must be received on or before March 10, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The meeting will be held at: EPA Headquarters, Auditorium, 401 M St., SW., Washington, DC.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Written comments on the concept paper, discussed in Unit II. of this document, and other aspects of implementation
of section 503 should be sent to Eun-Sook Goidel (7409), Office of Pollution Prevention and Toxics, Environmental
Protection Agency, 401 M St., SW., Washington, DC 20460. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Claudia O'Brien (7406), Office of Pollution Prevention and Toxics, Environmental Protection Agency, 401 M St.,
SW., Washington, DC 20460; Telephone (202) 260&hyph;0688; Fax (202) 260&hyph;0981. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On October 20, 1993, President Clinton signed Executive Order 12873, entitled ``Federal Acquisition, Recycling
and Waste Prevention,'' (58 FR 5411, October 22, 1993). Section 503 of Executive Order 12873 requires EPA to ``issue
guidance that recommends principles that Executive agencies should use in making determinations for the preference
and purchase of environmentally preferable products.'' Draft guidance for implementing this provision is to be
published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 by EPA within 180 days from the effective date of the Executive Order (April 18, 1994). The Executive Order also allows
the Agency to issue additional guidance for public comment on how the principles can be applied to specific product
categories. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Process
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To implement section 503 of Executive Order 12873, the Agency is establishing a process whereby public input is solicited
from all interested persons and organizations. This process will include public meetings and discussions with stakeholders
where interested parties will be given an opportunity to comment on a concept paper. This concept paper will be available
in late January and will describe the Agency's preliminary proposal on guiding principles that Federal agencies
should use when making determinations for the preference and purchase of environmentally preferable products.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
To schedule oral testimony at the public meeting and to obtain a copy of the concept paper, contact EPA's Public Hearing
Hotline, 110 Hartwell Avenue, Lexington, MA 02173&hyph;3198; telephone (617) 674&hyph;7374. Callers will receive
mail confirmation of their scheduled testimony and logistical information. Persons who wish to make oral presentations
must restrict testimony to 7 minutes and are also expected to provide three written copies of their completed comments
for inclusion in the official record. If interested parties are unable to attend the public meetings, they are invited
to submit written comments to the Agency.
<!-- PJG 0012 frnewline -->
Finally, the Agency plans to hold a series of stakeholder meetings beginning in February, as time allows, at EPA Headquarters.
The Agency will accept requests for participation in stakeholder meetings on a first-come, first-served basis.
Persons or organizations wishing to sign up for stakeholder meetings with Agency representatives should contact
Claudia O'Brien at the telephone number listed under FOR FURTHER INFORMATION CONTACT. Due to the limited amount of
time available to develop the draft guidance, the Agency requests that organizations and companies with similar
interests arrange to meet with Agency representatives during the same time period. The Agency may also hold a limited
number of audio or video conferences for persons or organizations lacking travel funding. Interested persons should
contact Claudia O'Brien at the telephone number listed under FOR FURTHER INFORMATION CONTACT. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Approach
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Agency has been directed by Executive Order 12873 to develop an approach for Federal acquisition of environmentally
preferable products that not only minimizes environmental burden, but also provides incentives to industry to continuously
improve the environmental performance of products and services to the Federal government. Ideally, the approach
would guide Federal agencies in comparing environmental performance among competing products and services, so
that the environmental impact becomes a criterion like cost or performance against which Federal agencies may select
products or services. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
As currently envisioned, the Agency's guidance on acquisition of environmentally preferable products would include
three components: (1) General principles and procedures that apply across product categories and that Federal agencies
can use when implementing acquisition programs for the purchase of environmentally preferable products; (2) guidance
for applying these principles to specific products or product categories (to be developed as appropriate at a later
date); and (3) a code of practice that Federal agencies could use when judging the credibility of non-governmental
environmental certification or eco-labeling programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Lynn R. Goldman,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Administrator for Prevention, Pesticides and Toxic Substances.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;858 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00038 </DOCNO>
<PARENT> FR940112-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;4825&hyph;1]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Prevention of Significant Deterioration; Delegation of Authority; Maricopa County, AZ</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 U.S. Environmental Protection Agency (USEPA).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Delegation of authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Regional Administrator for EPA Region 9, San Francisco, has delegated full authority to Maricopa County to implement
and enforce the federal Prevention of Significant Deterioration (PSD) program.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The effective date of the delegation agreement is November 22, 1993.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Management and Transportation Agency, Maricopa County Division of Air Pollution Control, 2406 South
24th Street, suite E&hyph;214, Phoenix, AZ 85034.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Jessica Gaylord, Air and Toxics Division, U.S. Environmental Protection Agency, 75 Hawthorne Street (A&hyph;5&hyph;1),
San Francisco, CA 94105, (415) 744&hyph;1256.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The U.S. Environmental Protection Agency has delegated, under the provisions which are found in 40 CFR 52.21(u),
to Maricopa County: (a) The authority for all sources in that County subject to review for the prevention of significant
deterioration (PSD) of air quality, pursuant to Part C of Title I of the Clean Air Act, as amended August 7, 1977, and
the requirements promulgated in the July 1, 1992, edition of 40 CFR 52.21, as amended August 7, 1980, under authority
of sections 101, 110, and 160&hyph;169 of the Clean Air Act: and (b) the authority to review, administer, and enforce
throughout the County the PSD requirements imposed by the Clean Air Act sections 101, 110, and 160&hyph;169, and 40
CFR 52.21, as amended August 7, 1980.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following letter and attached agreement represent the terms and conditions of the amended delegation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The PSD Delegation of Authority is reviewable under section 307(b)(1) of the Clean Air Act only in the Ninth Circuit
Court of Appeals. A petition for review must be filed by March 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 13, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David P. Howekamp,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Air and Toxics Division, Region IX.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00039 </DOCNO>
<PARENT> FR940112-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
United States Environmental Protection Agency
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Region IX_75 Hawthorne Street, San Francisco, CA 94105&hyph;3901
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
December 16, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Karen J. Heidel, Ph.D., Environmental Management &amp; Transportation Agency, 2406 South 24th Street, Suite E&hyph;214,
Phoenix, AZ 85034.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
Re: PSD Delegation Agreement for Maricopa County
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dear Dr. Heidel: I am pleased to transmit to you two signed originals of the delegation agreement for the Prevention
of Significant Deterioration program. Please note that the delegation is effective on the date of the Regional Administrator's
signature. EPA will shortly publish a notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 announcing the delegation.
<!-- PJG 0012 frnewline -->
EPA will continue to provide any guidance or technical assistance that may be needed for Maricopa County's implementation
of this agreement. EPA is committed to including the Division of Air Pollution Control in decisions relating to determinations
of noncompliance with permits issued under this agreement, intended PSD enforcement actions, and in any intended
revocation proceedings related to this agreement. We are also committed to maintaining, as I know you are, unobstructed
channels of communication between our agencies. We look forward to a continuing partnership in the permitting program.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
&blank;&blank;Sincerely,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David P. Howekamp,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Air and Toxics Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00040 </DOCNO>
<PARENT> FR940112-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
Agreement for Delegation of Authority of the Regulations for Prevention of Significant Deterioration of Air Quality
(40 CFR 52.21) Between U.S. EPA and MC
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The undersigned, on behalf of the Maricopa County (MC) and the United States Environmental Protection Agency (U.S.
EPA), hereby agree to the delegation of authority for the administrative, technical and enforcement elements of
the source review provisions of 40 CFR 52.21, Prevention of Significant Deterioration (PSD), as they may be amended
and in accordance with the permit review requirements in 40 CFR part 124 subparts A and C, from U.S. EPA to MC, subject
to the terms and conditions below. This delegation is executed pursuant to 40 CFR 52.21(u), Delegation of Authority.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. General Delegation Conditions
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. Authority is delegated for all sources under the jurisdiction of MC that are subject to review for PSD. This includes
all source categories listed in 40 CFR 52.21 for each pollutant regulated by the Clean Air Act. 
<!-- PJG 0012 frnewline -->
B. This delegation may be amended at any time by the formal written agreement of both MC and U.S. EPA, including amendments
to add, change, or remove conditions or terms of this Agreement. 
<!-- PJG 0012 frnewline -->
C. If the Regional Administrator determines that the County is not implementing or enforcing the PSD program in accordance
with the terms and conditions of this delegation, the requirements of 40 CFR 52.21, 40 CFR 124, or the Clean Air Act,
this delegation, after consultation with MC, may be revoked in whole or in part. Any such revocation shall be effective
as of the date specified in a Notice of Revocation to the County. Nothing in this paragraph shall preclude U.S. EPA from
exercising its enforcement authority, as provided in paragraph V.B. below. 
<!-- PJG 0012 frnewline -->
D. The permit appeal provisions of 40 CFR 124.19 shall apply to all appeals to the Administrator on permits issued by
MC under this delegation. For purposes of implementing the federal permit appeal provisions under this delegation,
if there is a public comment requesting a change in a draft preliminary determination or draft permit conditions,
the final permit issued by MC is required to contain statements which indicate that for Federal PSD purposes and in
accordance with 40 CFR 124.15 and 124.19, (1) the effective date of the permit is 30 days after the final decision to
issue, modify, revoke and reissue the permit; and (2) if an appeal is made to the Administrator, the effective date
of the permit is suspended until such time as the appeal is resolved. MC shall inform U.S. EPA (Region IX) in accordance
with conditions of this delegation when there is public comment requesting a change in the preliminary determination
or in a draft permit condition. Failure by MC to comply with the terms of this paragraph shall render the subject permit
invalid for Federal PSD purposes. 
<!-- PJG 0012 frnewline -->
E. By this agreement, MC assumes authority for enforcement and permit modification/amendment for EPA issued NSR/PSD
permits. 
<!-- PJG 0012 frnewline -->
F. This delegation of authority becomes effective upon the date that both parties have signed the Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Communications Between U.S. EPA and MC 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MC and U.S. EPA will use the following communication procedures: 
<!-- PJG 0012 frnewline -->
A. MC shall report to U.S. EPA on a quarterly basis the compliance status of the sources that have received a PSD permit
from either MC or U.S. EPA. The Aerometric Information Retrieval System (AIRS) will be used for this purpose. Compliance
determinations will be made with respect to the conditions established in the PSD permits. 
<!-- PJG 0012 frnewline -->
B. MC shall forward to U.S. EPA, at the beginning of the public comment period for each PSD permit, a summary of (1) the
findings related to each PSD application, (2) the justification for MC's preliminary determination, and (3) a copy
of the draft permit. Should there be any comments or concerns about the pending PSD permit, U.S. EPA shall communicate
these comments and concerns to MC as soon as possible prior to the close of the public comment period. 
<!-- PJG 0012 frnewline -->
C. MC shall forward to EPA Region IX (attn: A&hyph;5&hyph;1) copies of the final action on the PSD permit applications
at the time of issuance, as well as copies of substantive public comments. MC must address any public comments not incorporated
into the permit, and shall provide a summary of the responses. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00041 </DOCNO>
<PARENT> FR940112-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
D. MC shall send U.S. EPA copies of preliminary determinations on PSD permit modifications and amendments at or prior
to the beginning of the public comment period. U.S. EPA will provide comments to MC prior to the close of the public comment
period.
<!-- PJG 0012 frnewline -->
E. MC shall send to EPA a copy of all applicability determinations and justifications made that would involve PSD exemptions
due to offsetting or netting (40 CFR 52.21(b)(3) and 52.21(b)(21).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Revisions to Title 40 CFR 52.21
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. This delegation covers any revisions that are promulgated for 40 CFR 52.21 and 40 CFR 124. The terms ``40 CFR 52.21''
and ``40 CFR 124'' as used in the delegation request and throughout this Agreement, include such regulations as are
in effect on the date this Agreement is executed and any revisions that are promulgated after that date.
<!-- PJG 0012 frnewline -->
B. In addition, the following U.S. EPA policies shall apply to PSD review:
<!-- PJG 0012 frnewline -->
1. U.S. EPA is responsible for the issuance of PSD permits on Indian Lands, under sections 110(c) and 301 of the Clean
Air Act. States (or their delegates) have no authority to establish air pollution control requirements on Indian
Reservations, unless requested to by the Tribal Governing Body. 
<!-- PJG 0012 frnewline -->
2. According to U.S. EPA guidance published on September 22, 1987 and supplemental guidance published on July 28,
1988, all delegated agencies must now consider pollutants not subject to the Clean Air Act in their Best Available
Control Technology (BACT) determinations. The BACT determinations must include a review of the toxic effects of
unregulated pollutants and the impact of the proposed BACT on the emissions of these pollutants.
<!-- PJG 0012 frnewline -->
3. MC shall consult with the appropriate Federal, State, and local land use agencies prior to issuance of preliminary
determinations on PSD permits. In particular, U.S. EPA requires that MC shall:
<!-- PJG 0012 frnewline -->
(a) Notify the Fish and Wildlife Service (FWS) and U.S. EPA when a PSD permit application has been received, in order
to assist U.S. EPA in carrying out its non-delegable responsibilities under section 7 of the Endangered Species Act
(PL 97&hyph;304).
<!-- PJG 0012 frnewline -->
(b) Notify potential applicants of the potential need for consultation between U.S. EPA and the FWS if an endangered
species may be affected by the project. U.S. EPA's data sheet may be used for this process (copy enclosed).
<!-- PJG 0012 frnewline -->
(c) Refrain from issuing a final PSD permit unless the FWS has determined that the proposed project will not adversely
affect any endangered species.
<!-- PJG 0012 frnewline -->
4. MC shall consider a dry scrubber for sulfur dioxide control, a baghouse or electrostatic precipitator for particulate
control, and efficient combustion techniques for carbon monoxide control in their BACT determinations for municipal
waste combustors pursuant to U.S. EPA guidance published on June 26, 1987.
<!-- PJG 0012 frnewline -->
5. MC shall begin any BACT determination with the most stringent control options available for that category, pursuant
to additional BACT guidance issued on December 1, 1987. U.S. EPA will consider as deficient any BACT determination
not complying with this ``top-down'' requirement.
<!-- PJG 0012 frnewline -->
6. Upon notification from EPA, MC shall implement such new regulations or directives pending revision of this Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Permits
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. In any matter involving interpretation of sections 160&hyph;169 of the Clean Air Act, or 40 CFR 52.21, and of 40 CFR
124 where guidance on the implementation, review, administration, or enforcement of these sections has not been
sent to MC, U.S. EPA will be contacted and requested to provide the appropriate guidance.
<!-- PJG 0012 frnewline -->
B. MC shall at no time grant any waiver to the PSD permit requirements.
<!-- PJG 0012 frnewline -->
C. Permits issued under this delegation shall contain language certifying that the Federal PSD requirements have
been satisfied.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00042 </DOCNO>
<PARENT> FR940112-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
D. Authorities to Construct must include appropriate provisions, as specified in Attachment A, to ensure permit
enforceability. Permit conditions shall, at a minimum, contain reporting requirements on initiation of construction,
startup, and where applicable, source testing and continuous emissions monitoring systems (CEMS). In all cases
where tests are required, the tests methods shall be specified. All cases where CEMS are required, appropriate testing
and reporting requirements shall be included. Upset/breakdown and malfunction conditions shall be included in
all permits. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
E. U.S. EPA will assist MC in the BACT determination for all PSD permit applications filed with MC, such that U.S. EPA
and MC jointly concur on each BACT determination. The signatures of U.S. EPA and MC on the final permit shall constitute
concurrence on the BACT determinations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
F. All modeling analyses for determination of increment consumption and compliance with the NAAQS will require the
joint concurrence of U.S. EPA and MC. The signatures of U.S. EPA and MC on the final permit shall constitute concurrence
on the modeling analyses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
G. Separate from conditions E and F and for a given time as specified in this subpart, U.S. EPA and MC shall jointly concur
on the entire analysis and permit conditions for each PSD permit issued. This requirement for dual concurrence shall
be waived beginning with the first application submitted and deemed complete two (2) years after the date of this agreement,
or after U.S. EPA concurs with MC on ten (10) final permits issued pursuant to this delegation agreement, whichever
occurs later. In any event, U.S. EPA shall provide written notice to MC when the requirement for dual concurrence no
longer applies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
H. MC shall conduct an annual review of the NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increment status for each Section 107 area designated as attainment over which it has jurisdiction and shall prepare
a summary report of the review. Such review shall be made in accordance with current U.S. EPA guidance as provided to
MC. Emissions from the following sources consume NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increment: (1) any new major stationary source or modification of a major stationary source on which construction
begins after February 8, 1988; and (2) minor, area, and mobile sources, after the minor source baseline date, as it
is defined by 40 CFR 52.21. The initial review of the NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increment status shall address the consumption of NO
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
2
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increment between February 8, 1988, and the effective date of this agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
I. MC shall conduct an annual review, similar to the one in preceeding subpart H, on the status of the PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increment. For that part of Maricopa County designated nonattainment for TSP, the requirement for tracking PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increment consumption becomes effective on the date of receipt of the first major source application deemed complete
after the June 3, 1994, implementation date for PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increments. For all other areas within Maricopa County, the minor source baseline date established for TSP remains
in effect, but PM
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=2 f=2 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 increments replace TSP increments as the particulate matter indicator. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
J. U.S. EPA shall retain the responsibility of issuing the PSD permit for Palo Verde Steel, but enforcement of the final
permit terms and conditions on the source shall be under local authority. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
V. Permit Enforcement 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A. The primary responsibility for enforcement of the PSD regulations as found in 40 CFR part 52 in Maricopa County will
rest with MC, except where responsibility is vested in the State of Arizona. Pursuant to A.R.S. 49&hyph;402, the State
of Arizona has original jurisdiction over the following sources in Maricopa County: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Smelting of metal ore. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Petroleum refineries. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Coal fired electrical generating stations. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Portland cement plants. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Air pollution generated by portable sources unless delegated to MC. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. Air pollution by mobile sources for the purpose of regulating those sources as prescribed by A.R.S. Title 49, Chapter
3, Articles 4 &amp; 5.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MC will enforce the provisions that pertain to the PSD program, except in those cases where the rules or policy of MC
are more stringent. In such cases, MC may elect to implement the more stringent requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
B. Nothing in this delegation agreement shall prohibit EPA from enforcing the PSD provisions of the Clean Air Act,
the PSD regulations or any PSD permit issued by MC pursuant to this Agreement. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
C. In the event that MC is unwilling or unable to enforce a provision of this delegation with respect to a source subject
to the PSD regulations, MC will immediately notify the Regional Administrator. Failure to notify the Regional Administrator
does not preclude U.S. EPA from exercising its enforcement authority.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 9, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
James D. Bruner,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chairman, Maricopa County Board of Supervisors.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: November 22, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John Wise,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting for
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Felicia A. Marcus,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Regional Administrator, U.S. EPA Region IX.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00043 </DOCNO>
<PARENT> FR940112-2-00032 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Attachment A
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All Authorities to Construct, where applicable, shall contain: 
<!-- PJG 0012 frnewline -->
1. Identification of all points of emission, both stack and fugitive. 
<!-- PJG 0012 frnewline -->
2. Specification of a numerical emission limitation for each point of emission in terms of mass rate and/or concentration
limitations. If emission testing based on a numerical emission limitation is infeasible, the permit may instead
prescribe a design, operational, or equipment standard. Any permits issued without numerical emission limitations
must contain conditions which assure that the design characteristics or equipment will be properly maintained or
that the operational conditions will be properly performed so as to continuously achieve the assumed degree of control.

<!-- PJG 0012 frnewline -->
3. Limitations or factors which were the basis for the air quality impact analysis must be specified (e.g. hours of
operation, stack height, materials processed which affect emissions). 
<!-- PJG 0012 frnewline -->
4. Methods and frequency of determining continued compliance for each point of emission (such as from the SIP or if
the source is subject to New Source Performance Standards [NSPS] or National Emission Standards for Hazardous Air
Pollutants [NESHAP] or explicitly identified if a reference method is not used. 
<!-- PJG 0012 frnewline -->
5. Recordkeeping requirements which enable the agency to ascertain continued compliance, especially where factors
such as hours of operation, throughput of materials, sulfur content of fuels, fuel usage, and type or quantity of materials
processed are conditions of the permit. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
6. A condition that the permit such that it will expire if construction is not commenced within eighteen (18) months
or a shorter period. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
7. A condition that the source is responsible for providing sampling and testing facilities at its own expense. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
8. A condition that continuous emission monitoring systems (CEMS) will be used for enforcement purposes. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
9. Reporting requirements which enable the agency to monitor the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) Progress of source construction including the date by which construction is completed; and 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(b) Compliance with (1) emission limitations, (2) operational limitations, (3) and work practice standards; the
reporting requirements should include excess emissions reports and source test results. 
<!-- PJG 0012 frnewline -->
10. Permits issued under this delegation should contain language certifying that the federal PSD requirements have
been satisfied. 
<!-- PJG 0012 frnewline -->
11. As a courtesy to sources exempted from PSD review due to federally enforceable operational or process restrictions,
or the use of controls more stringent than required by applicable SIP limits, the source shall be advised that any relaxation
of those limits may subject the entire source to full PSD review as if construction had not yet begun. Suggested language
is as follows:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
This source is exempt from PSD review because of *&blank;*&blank;* (state reason, for example, ``the requirement
that limits operation to eight hours per day''). Any relaxation in this limit which increases your potential to emit
above the applicable PSD threshold will require a full PSD review of the affected source as if construction had not
yet commenced.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;802 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00044 </DOCNO>
<PARENT> FR940112-2-00033 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[FRL&hyph;4825&hyph;2] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Prevention of Significant Deterioration; Rescission of Authority; 
<!-- PJG 0012 frnewline -->
Fresno County, CA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 U.S. Environmental Protection Agency (USEPA). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Rescission of local PSD permitting authority. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Director, Air &amp; Toxics Division, for EPA Region IX, San Francisco has rescinded local Prevention of Significant
Deterioration (PSD) permitting authority in Fresno County, California. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Rescission of local PSD permitting authority is effective April 9, 1993. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 David L. Crow, Executive Director/APCO, San Joaquin Valley Unified Air Pollution Control District, 1999 Tuolumne
Street, suite 200, Fresno, CA 93721. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Jessica Gaylord, Air and Toxics Division, U.S. Environmental Protection Agency, 75 Hawthorne Street (A&hyph;5&hyph;1),
San Francisco, CA 94105, (415) 744&hyph;1256. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->
In September 1991, the State of California passed legislation that effectively required the eight separate counties
of the San Joaquin Valley Air Basin to form a single air pollution control district (APCD). EPA had delegated PSD authority
to Fresno County APCD by an agreement dated December 23, 1985. Because the San Joaquin Valley Unified APCD has chosen
to defer to EPA the regulation of sources subject to PSD rules at 40 CFR 52.21, EPA is responding to their request to rescind
PSD authority previously delegated to Fresno County APCD. 
<!-- PJG 0012 frnewline -->
The following letter represents the terms and conditions of the rescission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The PSD Delegation of Authority is reviewable under section 307(b)(1) of the Clean Air Act only in the Ninth Circuit
Court of Appeals. A petition for review must be filed by March 14, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 10, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
David P. Howekamp, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Air and Toxics Division, 
<!-- PJG 0012 frnewline -->
Region IX. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00045 </DOCNO>
<PARENT> FR940112-2-00033 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=71 g=1 f=1 -->
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
April 9, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
David L. Crow, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=3 -->
Executive Director/APCO, 
<!-- PJG 0012 frnewline -->
San Joaquin Valley, Unified Air Pollution Control District, 
<!-- PJG 0012 frnewline -->
1999 Tuolumne Street, Suite 200, 
<!-- PJG 0012 frnewline -->
Fresno, CA 93721.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Dear Mr. Crow: This letter responds to your request to EPA to rescind Prevention of Significant Deterioration (PSD)
permitting authority in Fresno and Kern counties. We recognize that the request, dated March 16, 1993, and received
by this office on March 19, 1993, is consistent with ongoing efforts to attain a more coordinated approach to air quality
management in the San Joaquin Valley. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In September 1991, the State of California passed legislation that effectively required the formation of a single
air pollution control district in the Valley Air Basin. To that end, eight counties joined efforts in March 1992 to
form the San Joaquin Valley Unified Air Pollution Control District. The District comprises the counties of Fresno,
Kings, Madera, Merced, San Joaquin, Stanislaus, and Tulare counties, as well as that part of Kern County located in
the Valley Air Basin. By August 1992, the California Air Resources Board certified that the District met the requirements
stated in SB 124. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
EPA had specifically transferred PSD authority to Fresno County APCD by a delegation agreement, dated December 23,
1985. As mentioned in your letter, the District has chosen to defer to EPA the regulation of sources subject to PSD rules
at 40 CFR 52.21. Therefore, EPA hereby rescinds authority delegated to Fresno County APCD to regulate sources subject
to the federal PSD rules. Please note that no such agreement was made between EPA and Kern County, so that your request
to rescind PSD authority in that county requires no further action. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pursuant to grant conditions under &sect;105 (Program Objective 5), the District shall continue to provide to EPA
notification, as soon as possible and prior to deeming the application complete, of all new major stationary sources
and major modifications that may be subject to the federal PSD regulation. Specifically, this affects major stationary
sources and major modifications to existing sources, as defined under part 52.21(b), that are located in areas designated
as attainment within the San Joaquin Valley Unified APCD. The District should also provide notification to sources
potentially affected by the federal PSD requirements. These sources must submit PSD permit applications to EPA and
may be subject to enforcement action if construction commences before EPA issues a final PSD permit. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We look forward to continued cooperation with you and your staff, so that permits may be issued in a timely and effective
manner. If you have further questions regarding this matter, please contact Jessica Gaylord of my staff at (415) 744&hyph;1256.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=3 -->
&blank;&blank;Sincerely, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=3 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=06 g=1 f=1 -->
Carl C. Kohnert, Jr., 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting for David P. Howekamp, Director, Air &amp; Toxic Division. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;803 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00046 </DOCNO>
<PARENT> FR940112-2-00034 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;42024H; FRL&hyph;4743&hyph;5]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Notice of Approval of Amendment to Texas Plan for Certification of Applicators of Compound 1080 Livestock Protection
Collars </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of approval of amended certification plan.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On August 13, 1993, EPA announced its intention to approve an amendment to the Texas Plan for Certification of Applicators
of Compound 1080 Livestock Protection Collars (LPC's). Public comments were solicited on this amended plan. The
amended plan permits pooling of LPC's among certified LPC applicators. No comments were received and EPA therefore
approves the amended plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Jerry Oglesby, Pesticides and Toxic Substances Branch, Region VI, Environmental Protection Agency, 1445 Ross Ave.,
Dallas, TX 75202&hyph;2733, Telephone: 214&hyph;655&hyph;7563. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with the provision of section 11(a)(2) of the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA) and 40 CFR part 171, the Texas Department of Agriculture submitted to EPA for approval, revisions to its current
plan for certification of LPC applicators. The amendment to the Texas LPC certification plan permits the designation
of collar pool agents. Certified LPC applicators are permitted to participate in a collar pool administered by a collar
pool agent. The purpose of the collar pool is to reduce the number of LPC's in circulation by a pooling of LPC's. Certified
LPC applicators will check out the LPC's from the collar pool agent immediately prior to use. When no longer needed,
a LPC will be returned to the collar pool agent for distribution to another certified LPC applicator. All collar pool
agents are considered agents of the registrant and are required to keep the same records. Further, the collar pool
system will not affect the recordkeeping or reporting requirements of LPC users. EPA announced its intention to approve
the amended plan in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 of August 13, 1993 (58 FR 43115), and solicited comments. No comments were received and EPA therefore approves the
amended plan. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Copies of the amended plan are available for review at the following locations during normal business hours: 
<!-- PJG 0012 frnewline -->
1. Texas Department of Agriculture, Stephen F. Austin Building, Rm. 1034F, 17th St. and Congress Ave., Austin, TX
78711, Telephone 512&hyph;463&hyph;0013. 
<!-- PJG 0012 frnewline -->
2. Environmental Protection Agency, Region VI, 1445 Ross Ave., 12th Floor, Suite 1200, Dallas, TX 75202, Telephone:
214&hyph;655&hyph;7239. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 6, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Allyn M. Davis, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Administrator, Region VI. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;497 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00047 </DOCNO>
<PARENT> FR940112-2-00035 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[OPP&hyph;34050; FRL 4748&hyph;9] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Notice of Receipt of Requests for Amendments to Delete Uses in Certain Pesticide Registrations </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with section 6(f)(1) of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), as amended,
EPA is issuing a notice of receipt of request for amendment by registrants to delete uses in certain pesticide registrations.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Unless a request is withdrawn, the Agency will approve these use deletions and the deletions will become effective
on April 12, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: James A. Hollins, Office of Pesticide Programs (7502C), Environmental Protection Agency, 401 M Street,
SW., Washington, DC 20460. Office location for commercial courier delivery and telephone number: Room 216, Crystal
Mall No. 2, 1921 Jefferson Davis Highway, Arlington, VA 22202, (703) 305&hyph;5761. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Introduction 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 6(f)(1) of FIFRA provides that a registrant of a pesticide product may at any time request that any of its pesticide
registrations be amended to delete one or more uses. The Act further provides that, before acting on the request, EPA
must publish a notice of receipt of any such request in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Thereafter, the Administrator may approve such a request.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Intent to Delete Uses 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This notice announces receipt by the Agency of applications from registrants to delete uses in the 13 pesticide registrations
listed in the following Table 1. These registrations are listed by registration number, product names and the specific
uses deleted. Users of these products who desire continued use on crops or sites being deleted should contact the applicable
registrant before April 12, 1994 to discuss withdrawal of the applications for amendment. This 90-day period will
also permit interested members of the public to intercede with registrants prior to the Agency approval of the deletion.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,14,r60,r90  -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 1.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrations with Requests for Amendments to 
<!-- PJG 0012 frnewline -->
 Delete Uses in Certain Pesticide Registrations 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1EPA Registration No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Product Name 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Delete From Label 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000769&hyph;00221 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSuregard Grain Protectant Dust 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRice, grain sorghum and field or garden seed 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000769&hyph;00921
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lScience Benomyl 50W 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lRoses (field &amp; greenhouse), flowers, ornamentals (field &amp; greenhouse) 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000802&hyph;00460 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMiller's Malathion 5E
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lApples, pears, plums, prunes, interior 
<!-- PJG 0012 frnewline -->
buildings, meat processing establishments, stored grain, stored field and garden seeds
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005481&hyph;00218
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1-Naphthaleneacetic Acid Sodium Salt
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOrnamentals, cherries (sweet), citrus (oranges, tangelos, tangerines/mandarins, tangors), olives, quince

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005481&hyph;00219
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
l1-Naphthaleneacetic Acid 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lApples, cherries (sweet), pears, olives, quinces, citrus (oranges, tangelos, tangerines/mandarins, tangors)

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005481&hyph;00430
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTechnical Naphthaleneacetic Acid
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lApples, pears
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005481&hyph;00431
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTechnical 1-Naphthaleneacetamide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOlives
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005481&hyph;00432
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTechnical 1-Naphthaleneacetic Acid Sodium salt 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOlives 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005481&hyph;00433
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lTechnical 1-Naphthaleneacetic Acid Ethyl Ester 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lOlives 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005905&hyph;00112
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCythion ULV Concentrate Insecticide
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSafflower, soybeans, tomatoes, sugar beets 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005905&hyph;00293
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCythion 25 WP
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lCranberries, livestock, 
<!-- PJG 0012 frnewline -->
plums, apples, pears, alfalfa, clover, vetch, apricots, beans, broccoli, brussel sprouts, cauliflower, cabbage,
kale, mustard greens, turnips, celery, lettuce, spinach, cherries, citrus, cucumbers, melons, eggplant, grapes,
peaches, peas, peppers, potatoes, tomatoes, walnuts, prunes 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
008590&hyph;00228 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAgway Malathion Insect Spray 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAsparagus, dog &amp; cat, quarters, melons, 
<!-- PJG 0012 frnewline -->
pumpkins, watermelons 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
051036&hyph;00033 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMalathion 25W 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lEggplant, broccoli, turnips, endive, carrots, radishes, cabbage, collards, cauliflower, mustard, tomatoes,
strawberries, peppers, okra, beans, 
<!-- PJG 0012 frnewline -->
lettuce, cucumbers, citrus (oranges, limes, 
<!-- PJG 0012 frnewline -->
tangelos, lemons kumquats &amp; tangerines), 
<!-- PJG 0012 frnewline -->
peaches, peanuts, warehouse peanut spray 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->

<!-- PJG STAG 4706 -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The following Table 2, includes the names and addresses of record for all registrants of the products in Table 1, in
sequence by EPA company number. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 2,L2,i1,7,r150  -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Table 2.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=1 -->
 _ 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Registrants Requesting Amendments to Delete Uses in Certain Pesticide Registrations
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Company No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Company Name and Address 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000769 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lSureco, Inc., P.O. Box 938, 
<!-- PJG 0012 frnewline -->
 Fort Valley, GA 31030.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
000802 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lThe Chas. H. Lilly Co., 
<!-- PJG 0012 frnewline -->
 7737 NE Killingsworth, 
<!-- PJG 0012 frnewline -->
 Portland, OR 97218. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005481 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAmvac Chemical Corp., 
<!-- PJG 0012 frnewline -->
 4100 E. Washington Blvd., 
<!-- PJG 0012 frnewline -->
 Los Angeles, CA 90023. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
005905 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lHelena Chemical Co., 
<!-- PJG 0012 frnewline -->
 6075 Poplar Ave., 
<!-- PJG 0012 frnewline -->
 Suite 500, 
<!-- PJG 0012 frnewline -->
 Memphis, TN 38119.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
008590 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lAgway, Inc., 
<!-- PJG 0012 frnewline -->
 c/o Universal Cooperatives, Inc., 
<!-- PJG 0012 frnewline -->
 P.O. Box 460, 
<!-- PJG 0012 frnewline -->
 Minneapolis, MN 55440.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=01 g=1 f=4 -->
051036 
<!-- PJG 007 0104 intable -->

<!-- PJG 007 0170 intable -->
lMicro Flo Co., 
<!-- PJG 0012 frnewline -->
 P.O. Box 5498, 
<!-- PJG 0012 frnewline -->
 Lakeland, FL 33807. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=4 -->
III. Existing Stocks Provisions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
The Agency has authorized registrants to sell or distribute product under the previously approved labeling for a
period of 18 months after approval of the revision, unless other restrictions have been imposed, as in special review
actions. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=4 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Environmental protection, Pesticides and pests, Product registrations. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Dated: December 21, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=4 -->
Douglas D. Campt, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=4 -->
Director, Office of Pesticide Programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=4 -->
[FR Doc. 94&hyph;378 Filed 1&hyph;11&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=4 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00048 </DOCNO>
<PARENT> FR940112-2-00036 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=4 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=4 -->

<RINDOCK>[PP 1G3998/T653; FRL 4748&hyph;7] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=4 -->

<DOCTITLE>Iprodione; Establishment of a Temporary Tolerance </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 EPA has established a temporary tolerance for the combined residues of the fungicide Iprodione, its isomer and its
metabolite in or on the raw agricultural commodity cotton seed. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This temporary tolerance expires January 1, 1996. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: 
<!-- PJG 0012 frnewline -->
 Sidney C. Jackson, Acting, 
<!-- PJG 0012 frnewline -->
 Product Manager (PM) 21, 
<!-- PJG 0012 frnewline -->
 Registration Division (7505C), 
<!-- PJG 0012 frnewline -->
 Office of Pesticide Programs, 
<!-- PJG 0012 frnewline -->
 Environmental Protection Agency, 
<!-- PJG 0012 frnewline -->
 401 M St., SW., 
<!-- PJG 0012 frnewline -->
 Washington, DC 20460. 
<!-- PJG 0012 frnewline -->
 Office location and telephone number: 
<!-- PJG 0012 frnewline -->
 Rm. 227, CM#2, 
<!-- PJG 0012 frnewline -->
 1921 Jefferson Davis Highway, 
<!-- PJG 0012 frnewline -->
 Arlington, VA, 
<!-- PJG 0012 frnewline -->
 (703) 305&hyph;6900. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Rhone-Poulenc AG Company, P.O. Box 12014, 2 T.W. Alexander Drive, Research Triangle Park, NC 27709, has requested
in pesticide petition (PP) 1G3998, the establishment of a temporary tolerance for the combined residues of the fungicide
Iprodione [3-(3,5-dichlorophenyl)-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
-(methylethyl)-2,4-dioxo-1-imidazolidinecarboximide], its isomer [3-(1-methylethyl)-
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
N
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
-(3,5-dichlorophenyl)-2,4-dioxo-1-imidazolidinecarboximide], and its metabolite [3-(3,5-dichlorophenyl)-2,4-dioxo-1-imidazolidinecarboximide]
in or on the raw agricultural commodity cotton seed at 0.10 parts per million (ppm). This temporary tolerance will
permit the marketing of the above raw agricultural commodity when treated in accordance with the provisions of the
experimental use permit 264-EUP-91, which is being issued under the Federal Insecticide, Fungicide, and Rodenticide
Act (FIFRA), as amended (Pub. L. 95&hyph;396, 92 Stat. 819; 7 U.S.C. 136). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The scientific data reported and other relevant material were evaluated, and it was determined that establishment
of the temporary tolerance will protect the public health. Therefore, the temporary tolerance has been established
on the condition that the pesticide be used in accordance with the experimental use permit and with the following provisions:

<!-- PJG 0012 frnewline -->
1. The total amount of the active ingredient to be used must not exceed the quantity authorized by the experimental
use permit. 
<!-- PJG 0012 frnewline -->
2. Rhone-Poulenc AG Co., must immediately notify the EPA of any findings from the experimental use that have a bearing
on safety. The company must also keep records of production, distribution, and performance and on request make the
records available to any authorized officer or employee of the EPA or the Food and Drug Administration. 
<!-- PJG 0012 frnewline -->
This tolerance expires January 1, 1996. Residues not in excess of this amounts remaining in or on the raw agricultural
commodity after this expiration date will not be considered actionable if the pesticide is legally applied during
the term of, and in accordance with, the provisions of the experimental use permit and temporary tolerance. This tolerance
may be revoked if the experimental use permit is revoked or if any experience with or scientific data on this pesticide
indicate that such revocation is necessary to protect the public health. 
<!-- PJG 0012 frnewline -->
The Office of Management and Budget has exempted this notice from the requirement of section 3 of Executive Order 12291.

<!-- PJG 0012 frnewline -->
Pursuant to the requirements of the Regulatory Flexibility Act (Pub. L. 96&hyph;354, 94 Stat. 1164, 5 U.S.C. 601&hyph;612),
the Administrator has determined that regulations establishing new tolerances or raising tolerance levels or establishing
exemptions from tolerance requirements do not have a significant economic impact on a substantial number of small
entities. A certification statement to this effect was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of May 4, 1981 (46 FR 24950). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
21 U.S.C. 346a(j). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and
pests, Reporting and recordkeeping requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 21, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen L. Johnson, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Registration Division, 
<!-- PJG 0012 frnewline -->
Office of Pesticide Programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;376 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00049 </DOCNO>
<PARENT> FR940112-2-00037 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[PP 1G3997/T654; FRL 4748&hyph;8] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Rhone-Poulenc AG Company; Extension of Temporary Tolerance </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Environmental Protection Agency (EPA). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 EPA has extended a temporary tolerance for residues of the fungicide fosetyl-Al, aluminum tris (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
-ethylphosphonate) in or on the raw agricultural commodity cotton at 0.20 parts per million (ppm). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This temporary tolerance expires January 1, 1996. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 By mail: Cynthia Giles-Parker, Product Manager (PM) 22, Registration Division (7505C), Office of Pesticide Programs,
Environmental Protection Agency, 401 M St., SW., Washington, DC 20460. Office location and telephone number: Rm.
229, CM #2, 1921 Jefferson Davis Highway, Arlington, VA, (703) 305&hyph;5540. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
  EPA issued a notice, which was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 of May 6, 1992 (57 FR 19428), announcing the establishment of temporary tolerance for residues of the fungicide fosetyl-Al,
aluminum tris (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
O
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
-ethylphosphonate) in or on the raw agricultural commodity cotton at 0.20 parts per million (ppm). This tolerance
was issued in response to pesticide petition (PP) 1G3997, submitted by Rhone-Poulenc AG Company, P.O. Box 12014,
Research Triangle Park, NC 27709. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This temporary tolerance has been extended to permit the continued marketing of the raw agricultural commodity named
above when treated in accordance with the provisions of experimental use permit 264-EUP-91, which is being issued
under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) as amended (Pub. L. 95&hyph;396, 92 Stat.
819; 7 U.S.C. 136). 
<!-- PJG 0012 frnewline -->
The scientific data reported and other relevant material were evaluated, and it was determined that the extension
of this temporary tolerance will protect the public health. Therefore, the temporary tolerance has been extended
on the condition that the pesticide be used in accordance with the experimental use permit and with the following provisions:

<!-- PJG 0012 frnewline -->
1. The total amount of the active fungicide to be used must not exceed the quantity authorized by the experimental use
permit.
<!-- PJG 0012 frnewline -->
2. Rhone-Poulenc AG Company must immediately notify the EPA of any findings from the experimental use that have a bearing
on safety. The company must also keep records of production, distribution, and performance and on request make the
records available to any authorized officer or employee of the EPA or the Food and Drug Administration.
<!-- PJG 0012 frnewline -->
This tolerance expires January 1, 1996. Residues not in excess of this amount remaining in or on the raw agricultural
commodity after this expiration date will not be considered actionable if the pesticide is legally applied during
the term of, and in accordance with, the provisions of the experimental use permit and temporary tolerance. This tolerance
may be revoked if the experimental use permit is revoked or if any experience with or scientific data on this pesticide
indicate that such revocation is necessary to protect the public health. 
<!-- PJG 0012 frnewline -->
The Office of Management and Budget has exempted this notice from the requirements of section 3 of Executive Order
12291. 
<!-- PJG 0012 frnewline -->
Pursuant to the requirements of the Regulatory Flexibility Act (Pub. L. 96&hyph;354, 94 Stat. 1164, 5 U.S.C. 601&hyph;612),
the Administrator has determined that regulations establishing new tolerances or raising tolerance levels or establishing
exemptions from tolerance requirements do not have a significant economic impact on a substantial number of small
entities. A certification statement to this effect was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of May 4, 1981 (46 FR 24950).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 21 U.S.C. 346a(j). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=84 g=1 f=1 -->
List of Subjects 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Environmental protection, Administrative practice and procedure, Agricultural commodities, Pesticides and
pests, Reporting and recordkeeping requirements. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 21, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Stephen L. Johnson, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Registration Division, Office of Pesticide Programs. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;377 Filed 1&hyph;11&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6560&hyph;50&hyph;F 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00050 </DOCNO>
<PARENT> FR940112-2-00038 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL MARITIME COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Agreement(s) Filed</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Federal Maritime Commission hereby gives notice that the following agreement(s) has been filed with the Commission
pursuant to section 15 of the Shipping Act, 1916, and section 5 of the Shipping Act of 1984.
<!-- PJG 0012 frnewline -->
Interested parties may inspect and obtain a copy of each agreement at the Washington, DC Office of the Federal Maritime
Commission, 800 North Capitol Street NW., 9th Floor. Interested parties may submit protests or comments on each agreement
to the Secretary, Federal Maritime Commission, Washington, DC 20573, within 10 days after the date of the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in which this notice appears. The requirements for comments and protests are found in &sect;560.602 and/or &sect;572.603
of title 46 of the Code of Federal Regulations. Interested persons should consult this section before communicating
with the Commission regarding a pending agreement.
<!-- PJG 0012 frnewline -->
Any person filing a comment or protest with the Commission shall, at the same time, deliver a copy of that document to
the person filing the agreement at the address shown below.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Agreement No.: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
224&hyph;200818.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Port of Houston Authority/Schroder Marine Services, Inc. Guarantee Assignment for Manchester No. 2 Terminal Agreement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Parties: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Port of Houston Authority (``Port''), Schroder Marine Services, Inc. (``Schroder'').
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Filing Agent: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Martha T. Williams, Port of Houston Authority, P.O. Box 2562, Houston, TX 77252&hyph;2562.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Synopsis: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed Agreement would permit Schroder to perform freight handling services at the Port during the one year
term of the Agreement.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By Order of the Federal Maritime Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Joseph C. Polking,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;663 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6730&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00051 </DOCNO>
<PARENT> FR940112-2-00039 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93&hyph;19]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Cancellation of Tariffs for Failure To Comply With Automated Tariff Filing and Information System (``ATFI'') Filing
Requirements</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By Order published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (58 FR 50550) on September 28, 1993 (``September Order''), the Commission directed 103 carriers with tariffs on file
in the Worldwide, Asian and South Pacific trade areas to show cause by November 12, 1993, why their paper tariffs should
not be cancelled for failure to register and file a tariff in ATFI by the required date (i.e., June 4, 1993). This action
was taken pursuant to section 8 of the Shipping Act of 1984 (U.S.C. app. 1707), the Commission's regulations implementing
ATFI at 46 CFR part 514 and Supplemental Report Nos. 2, 3 and 4
<FOOTCITE>1</FOOTCITE>
 issued in Docket No. 90&hyph;23, Notice of Inquiry on Ocean Freight Tariffs in Foreign and Domestic Offshore Commerce
(Automated Tariff Filing and Information System). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Supplemental Report No. 2, served August 4, 1992, Supplemental Report No. 3 (57 FR 59999) and Supplemental Report
No. 4 (58 FR 31522) advised the public that failure to convert tariffs to ATFI format by scheduled filing dates would
subject entities to show cause proceedings for cancellation of tariffs. 
<!-- PJG 0012 frnewline -->
Sec. 502(b)(1) of Public Law 102&hyph;582 (``Pub. L. 102&hyph;582'') requires all tariffs and essential terms of
service contracts filed with the Commission to be in electronic format. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
World Tariff Services, Inc. (``WTS''), filed the only formal response to the September Order. It did so on behalf of
26 carriers named in the Order.
<FOOTCITE>2</FOOTCITE>
 Other carriers contacted the Commission informally by letter or telephone or filed their tariff in ATFI. The Commission
did not receive any response whatsoever from 42 of the respondents. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
ACB Ocean Line, Inc.; Alcar International Inc.; Aston International, Inc.; Breakbulk &amp; Consolidation Services
Pte Ltd.; Combitainer Ltd.; Enko International Ltd.; Fashion Distribution Services, Inc.; Firstair, Inc.; Freight
International Services, Ltd.; International Cargo Express, Ltd.; Master Air Cargo, Inc.; United Cargo Link Italia
Srl; Vantage International Forwarding Ltd.; W S A Lines Ltd.; American Freight Lines Ltd.; Amership, Inc.; LEP Freightways
International Limited; Polar Steamship and Commerce Company Inc.; Pro-Service Forwarding, Co., Inc.; Sea Lanes
Line Inc.; Americargo Lines, Inc.; Crystal Freight Services (HK) Ltd.; POL-Express, Inc.; DJ International Freight
Services, Inc.; Tigris International Corp.; and United Transport Associates Inc. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
WTS states that 14 of the carriers named in its response have satisfied the Commission's requirements and filed an
ATFI tariff, that three carriers have ceased doing business and have voluntarily cancelled their tariffs, and that
nine other carriers either have completed the ATFI registration process, are in the process of doing so, or recently
submitted the necessary information to WTS so that it may initiate ATFI registration. Two of those carriers have in
fact completed the registration process and filed an ATFI tariff.
<!-- PJG 0012 frnewline -->
The 42 carriers that did not respond to the September Order and have not registered in ATFI or filed an ATFI tariff will
have their tariffs or portions of tariffs currently on file with the Commission with Worldwide, Asian or South Pacific
scopes cancelled. Twenty-five carriers responded and/or registered for ATFI, but did not file the required tariff.
These carriers, which include seven of WTS's clients, have not provided sufficient grounds to justify their failure
to file. Accordingly, these carriers also will have their tariffs or applicable portions of their tariffs cancelled.
Carriers who have filed their tariffs in ATFI will be dismissed from the proceeding. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Therefore, it is ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
That the tariffs or portions of tariffs currently on file with the Commission with Worldwide, Asian or South Pacific
scope of the carriers identified in Appendix A to this Order are cancelled effective upon publication of the Order
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is further ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
That the parties listed in Appendix B to this Order are dismissed from this proceeding. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Joseph C. Polking,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00052 </DOCNO>
<PARENT> FR940112-2-00039 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Appendix A
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Air Sea Shipping, Inc.
<!-- PJG 0012 frnewline -->
Air-Mar Shipping, Inc.
<!-- PJG 0012 frnewline -->
Amadeus Transport, Inc.
<!-- PJG 0012 frnewline -->
America Niugini Shipping Co., Inc.
<!-- PJG 0012 frnewline -->
American Consolidated Container Line, Inc.
<!-- PJG 0012 frnewline -->
American Freight Lines, Ltd.
<!-- PJG 0012 frnewline -->
Americargo Lines, Inc.
<!-- PJG 0012 frnewline -->
Astro Air Express, Inc.
<!-- PJG 0012 frnewline -->
Aust-Asia Worldwide Shipping Pty. Ltd.
<!-- PJG 0012 frnewline -->
Australian Freight Services Ltd.
<FOOTCITE>1</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
This firm changed its name from McIlwaraith McEacharn Operations Limited.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Blue Horizon
<!-- PJG 0012 frnewline -->
Cargamericas Forwarding Services, Inc.
<!-- PJG 0012 frnewline -->
Cheung, Daniel H.
<!-- PJG 0012 frnewline -->
Clipper Shipping Lines Ltd.
<!-- PJG 0012 frnewline -->
CMB Transport NV
<!-- PJG 0012 frnewline -->
Compass International Forwarding, Inc.
<!-- PJG 0012 frnewline -->
Costa Rica Shipping Co. Inc.
<!-- PJG 0012 frnewline -->
Crusader Swire Container Service Limited
<!-- PJG 0012 frnewline -->
Crystal Freight Services (HK) Ltd.
<!-- PJG 0012 frnewline -->
Daher M.T.S. Multimodal Transport System
<!-- PJG 0012 frnewline -->
El Caribe Moving Van, Inc.
<!-- PJG 0012 frnewline -->
Fargo Shipping Co. Ltd.
<!-- PJG 0012 frnewline -->
Four Points Shipping &amp; Trading, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Freight Management Pte Ltd.
<!-- PJG 0012 frnewline -->
Hudson Container Line Ltd.
<!-- PJG 0012 frnewline -->
Interport Freight Systems, Inc.
<!-- PJG 0012 frnewline -->
Jetstream Freight Services International, Inc.
<!-- PJG 0012 frnewline -->
Jumbo Protectors Ltd.
<!-- PJG 0012 frnewline -->
Laser Freight Systems, Inc.
<!-- PJG 0012 frnewline -->
LCI Shipholdings, Inc.
<!-- PJG 0012 frnewline -->
LEP Freightways International Limited
<!-- PJG 0012 frnewline -->
Marimed Shipping Company Limited
<!-- PJG 0012 frnewline -->
Martin Bencher (U.K.) Ltd.
<!-- PJG 0012 frnewline -->
Myanmar Container Line
<!-- PJG 0012 frnewline -->
N.V. Sealift S.A.
<!-- PJG 0012 frnewline -->
Nichiro Corp.
<!-- PJG 0012 frnewline -->
Oceanbridge Shipping Ltd.
<!-- PJG 0012 frnewline -->
Overseas International Corporation
<!-- PJG 0012 frnewline -->
PBX Overseas Transport
<!-- PJG 0012 frnewline -->
Pearcy Marine, Inc.
<!-- PJG 0012 frnewline -->
Pearl Delta Shipping Co., Ltd.
<!-- PJG 0012 frnewline -->
Pentrans, Inc.
<!-- PJG 0012 frnewline -->
Polar Steamship and Commerce Company Inc.
<!-- PJG 0012 frnewline -->
Polish Travel Center
<FOOTCITE>2</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
This firm changed its name from Pol-Express, Inc.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
Pro-Service Forwarding Co., Inc.
<!-- PJG 0012 frnewline -->
R.C.T. Cargo Transport, Inc.
<!-- PJG 0012 frnewline -->
Rainbow Navigation, Inc.
<!-- PJG 0012 frnewline -->
Red Oak Industries, Inc.
<!-- PJG 0012 frnewline -->
Ren International Services, Inc.
<!-- PJG 0012 frnewline -->
Right-O-Way Ocean Transport International, Inc.
<!-- PJG 0012 frnewline -->
Rokuchu Marine Corporation
<!-- PJG 0012 frnewline -->
S.A. LD Seals N.V.
<!-- PJG 0012 frnewline -->
S.A. Louis Dreyfus Et Cie
<!-- PJG 0012 frnewline -->
Sanwa Sempaku Kabushiki Kaisha
<!-- PJG 0012 frnewline -->
Seaboard Trading and Shipping
<!-- PJG 0012 frnewline -->
Seacor Ocean Lines Inc.
<!-- PJG 0012 frnewline -->
Seafreight Container Line, Inc.
<!-- PJG 0012 frnewline -->
Sealift Services International Inc.
<!-- PJG 0012 frnewline -->
Shenk, David W.
<!-- PJG 0012 frnewline -->
Teeters Brothers Contracting Co.
<!-- PJG 0012 frnewline -->
Totalocean Line, Inc.
<!-- PJG 0012 frnewline -->
U.S. Trans-Link Inc.
<!-- PJG 0012 frnewline -->
UCB Freight Services (USA) Inc.
<!-- PJG 0012 frnewline -->
Van-Pax Global Consolidators, Inc.
<!-- PJG 0012 frnewline -->
Westwind Africa Line Limited
<!-- PJG 0012 frnewline -->
World Bridge Project Carriers, Ltd.
<!-- PJG 0012 frnewline -->
World Commerce Forwarding, Inc.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00053 </DOCNO>
<PARENT> FR940112-2-00039 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Appendix B
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
ACB Ocean Line, Inc.
<!-- PJG 0012 frnewline -->
Airport Brokers Corporation
<!-- PJG 0012 frnewline -->
Alcar International Inc.
<!-- PJG 0012 frnewline -->
Alliance Maritime Line, Inc.
<!-- PJG 0012 frnewline -->
Amership, Inc.
<!-- PJG 0012 frnewline -->
Aston International, Inc.
<!-- PJG 0012 frnewline -->
Breakbulk &amp; Consolidation Services PTE Ltd.
<!-- PJG 0012 frnewline -->
China Navigation Co., Ltd., The 
<!-- PJG 0012 frnewline -->
Combitainer Ltd.
<!-- PJG 0012 frnewline -->
Diamond Shipping Company
<!-- PJG 0012 frnewline -->
DJ International Freight Services Inc.
<!-- PJG 0012 frnewline -->
Eastar U.S.A. Inc.
<!-- PJG 0012 frnewline -->
ENKO International Ltd.
<!-- PJG 0012 frnewline -->
Fashion Distribution Services, Inc.
<!-- PJG 0012 frnewline -->
Firstair, Inc.
<!-- PJG 0012 frnewline -->
Freight International Services, Ltd.
<!-- PJG 0012 frnewline -->
International Cargo Express, Ltd.
<!-- PJG 0012 frnewline -->
Irish Warehousing &amp; Transport Company, Ltd.
<!-- PJG 0012 frnewline -->
Master Air Cargo, Inc.
<!-- PJG 0012 frnewline -->
Multiforwarding Belgium N.V.
<!-- PJG 0012 frnewline -->
Rex Air &amp; Ocean Freight, Inc.
<!-- PJG 0012 frnewline -->
Scan-Shipping, Inc.
<!-- PJG 0012 frnewline -->
Sea Lanes Line Inc.
<!-- PJG 0012 frnewline -->
Sealift Inc.
<!-- PJG 0012 frnewline -->
Simtex Ocean Services, Inc.
<!-- PJG 0012 frnewline -->
Skyway Systems
<!-- PJG 0012 frnewline -->
Societe Nationale Malgache De Transports Maritimes
<!-- PJG 0012 frnewline -->
Stalwart Shipping, Inc.
<!-- PJG 0012 frnewline -->
Tigris International Corp.
<!-- PJG 0012 frnewline -->
Trans America International Services, Inc.
<!-- PJG 0012 frnewline -->
Transport Systems Worldwide, Inc.
<!-- PJG 0012 frnewline -->
U.S. Express Inc.
<!-- PJG 0012 frnewline -->
United Cargo Link Italia SRL
<!-- PJG 0012 frnewline -->
United Transport Associates, Inc.
<!-- PJG 0012 frnewline -->
Vantage International Forwarding Ltd.
<!-- PJG 0012 frnewline -->
W S A Lines Ltd.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;664 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6730&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00054 </DOCNO>
<PARENT> FR940112-2-00040 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL RESERVE SYSTEM</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Bren-Mar Properties, Inc., et al.; Formations of; Acquisitions by; and Mergers of Bank Holding Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The companies listed in this notice have applied for the Board's approval under section 3 of the Bank Holding Company
Act (12 U.S.C. 1842) and  225.14 of the Board's Regulation Y (12 CFR 225.14) to become a bank holding company or to acquire
a bank or bank holding company. The factors that are considered in acting on the applications are set forth in section
3(c) of the Act (12 U.S.C. 1842(c)).
<!-- PJG 0012 frnewline -->
Each application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing to the Reserve Bank or to the offices of the Board of Governors.
Any comment on an application that requests a hearing must include a statement of why a written presentation would
not suffice in lieu of a hearing, identifying specifically any questions of fact that are in dispute and summarizing
the evidence that would be presented at a hearing.
<!-- PJG 0012 frnewline -->
Unless otherwise noted, comments regarding each of these applications must be received not later than February 4,
1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of St. Louis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Randall C. Sumner, Vice President) 411 Locust Street, St. Louis, Missouri 63166:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Bren-Mar Properties, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Columbia, Missouri; to acquire Jack's Fork Bancorporation, Inc., Columbia, Missouri, and thereby indirectly
acquire Texas County Bank, Houston, Missouri; Bank of Mountain View, Mountain View, Missouri; and Summersville
State Bank, Summersville, Missouri; and to acquire First Missouri Bancorporation, Inc., Columbia, Missouri, and
thereby indirectly acquire First National Bank and Trust Company, Columbia, Missouri; and First Heritage National
Bank, Davis, Oklahoma.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. Community First Financial Group, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, English, Indiana; to acquire at least 30.95 percent of the voting shares of Peoples Trust Bank Company, Corydon,
Indiana, a 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 bank.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
3. First United Bancshares, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, El Dorado, Arkansas; to merge with InvestArk Bankshares, Inc., Stuttgart, Arkansas, and thereby indirectly acquire
The Bank of North Arkansas, Melbourne, Arkansas, and First Stuttgart Bank &amp; Trust Company, Stuttgart, Arkansas.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
4. Murphy-Wall Bancorp
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Pinckneyville, Illinois; to become a bank holding company by acquiring 100 percent of the voting shares of Murphy-Wall
State Bank and Trust Company, Pinckneyville, Illinois.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
B. Federal Reserve Bank of Minneapolis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James M. Lyon, Vice President) 250 Marquette Avenue, Minneapolis, Minnesota 55480:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Aumanchester, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Rochester, Minnesota; to acquire 100 percent of the voting shares of Security State Bank of Hammond, Hammond, Minnesota.
In connection with this application, Rochester Bank and Trust Company, Rochester, Minnesota; has applied to become
a bank holding company by acquiring 100 percent of the voting shares of Security State Bank of Hammond, Hammond, Minnesota,
which will be merged into Rochester Bank and Trust Company. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. Brill Bancshares, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Owen, Wisconsin; to become a bank holding company by acquiring 89.9 percent of the voting shares of Brill State Bank,
Brill, Wisconsin.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
C. Federal Reserve Bank of Dallas
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Genie D. Short, Vice President) 2200 North Pearl Street, Dallas, Texas 75201-2272:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Limestone Bancshares, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Mexia, Texas; to become a bank holding company by acquiring 100 percent of the voting shares of First National Bank
of Mexia, Mexia, Texas.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. Western Commerce Bancshares of Carlsbad, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Carlsbad, New Mexico; to merge with Western Bancshares of Clovis, Inc., Carlsbad, New Mexico, and thereby indirectly
acquire Western Bank of Clovis, Clovis, New Mexico.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;649 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210-01-F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00055 </DOCNO>
<PARENT> FR940112-2-00041 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Crestar Financial Corporation; Acquisition of Company Engaged in Permissible Nonbanking Activities</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The organization listed in this notice has applied under  225.23(a)(2) or (f) of the Board's Regulation Y (12 CFR 225.23(a)(2)
or (f)) for the Board's approval under section 4(c)(8) of the Bank Holding Company Act (12 U.S.C. 1843(c)(8)) and  225.21(a)
of Regulation Y (12 CFR 225.21(a)) to acquire or control voting securities or assets of a company engaged in a nonbanking
activity that is listed in  225.25 of Regulation Y as closely related to banking and permissible for bank holding companies.
Unless otherwise noted, such activities will be conducted throughout the United States.
<!-- PJG 0012 frnewline -->
The application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing on the question whether consummation of the proposal can ``reasonably
be expected to produce benefits to the public, such as greater convenience, increased competition, or gains in efficiency,
that outweigh possible adverse effects, such as undue concentration of resources, decreased or unfair competition,
conflicts of interests, or unsound banking practices.'' Any request for a hearing on this question must be accompanied
by a statement of the reasons a written presentation would not suffice in lieu of a hearing, identifying specifically
any questions of fact that are in dispute, summarizing the evidence that would be presented at a hearing, and indicating
how the party commenting would be aggrieved by approval of the proposal.
<!-- PJG 0012 frnewline -->
Comments regarding the application must be received at the Reserve Bank indicated or the offices of the Board of Governors
not later than February 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Richmond
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Lloyd W. Bostian, Jr., Senior Vice President) 701 East Byrd Street, Richmond, Virginia 23261:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Crestar Financial Corporation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Richmond, Virginia; to acquire Annapolis Bancorp, Inc., Annapolis, Maryland, and its wholly-owned subsidiary,
Annapolis Federal Savings Bank, Annapolis, Maryland, and thereby engage in owning and operating a savings association
pursuant to &sect;225.25(b)(9) of the Board's Regulation Y.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;650 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00056 </DOCNO>
<PARENT> FR940112-2-00042 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>First National Sylacauga Corporation, et al.; Notice of Applications to Engage de novo in Permissible Nonbanking
Activities</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The companies listed in this notice have filed an application under &sect;225.23(a)(1) of the Board's Regulation
Y (12 CFR 225.23(a)(1)) for the Board's approval under section 4(c)(8) of the Bank Holding Company Act (12 U.S.C. 1843(c)(8))
and &sect;225.21(a) of Regulation Y (12 CFR 225.21(a)) to commence or to engage 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, either directly or through a subsidiary, in a nonbanking activity that is listed in &sect;225.25 of Regulation Y
as closely related to banking and permissible for bank holding companies. Unless otherwise noted, such activities
will be conducted throughout the United States.
<!-- PJG 0012 frnewline -->
Each application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing on the question whether consummation of the proposal can ``reasonably
be expected to produce benefits to the public, such as greater convenience, increased competition, or gains in efficiency,
that outweigh possible adverse effects, such as undue concentration of resources, decreased or unfair competition,
conflicts of interests, or unsound banking practices.'' Any request for a hearing on this question must be accompanied
by a statement of the reasons a written presentation would not suffice in lieu of a hearing, identifying specifically
any questions of fact that are in dispute, summarizing the evidence that would be presented at a hearing, and indicating
how the party commenting would be aggrieved by approval of the proposal.
<!-- PJG 0012 frnewline -->
Unless otherwise noted, comments regarding the applications must be received at the Reserve Bank indicated or the
offices of the Board of Governors not later than January 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Atlanta
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Zane R. Kelley, Vice President) 104 Marietta Street, N.W., Atlanta, Georgia 30303:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. First National Sylacauga Corporation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Sylacauga, Alabama; to engage 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 through its subsidiary, Frontier Financial Services, Inc., Sylacauga, Alabama, in making, acquiring, or servicing
loans or other extensions of credit pursuant to &sect;225.25(b)(1) of the Board's Regulation Y.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
B. Federal Reserve Bank of Minneapolis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James M. Lyon, Vice President) 250 Marquette Avenue, Minneapolis, Minnesota 55480:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. First Bank System, Inc.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Minneapolis, Minnesota; to engage 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in data processing and data transmission services through the ownership, installation, operation, and maintenance
of automatic teller machines at various retail store locations pursuant to &sect;225.25(b)(7) of the Board's Regulation
Y.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;651 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;F 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00057 </DOCNO>
<PARENT> FR940112-2-00043 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Firstbank of Illinois Co., et al.; Formation of, Acquisition by, or Merger of Bank Holding Companies; and Acquisition
of Nonbanking Company</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The company listed in this notice has applied under  225.14 of the Board's Regulation Y (12 CFR 225.14) for the Board's
approval under section 3 of the Bank Holding Company Act (12 U.S.C. 1842) to become a bank holding company or to acquire
voting securities of a bank or bank holding company. The listed company has also applied under  225.23(a)(2) of Regulation
Y (12 CFR 225.23(a)(2)) for the Board's approval under section 4(c)(8) of the Bank Holding Company Act (12 U.S.C. 1843(c)(8))
and  225.21(a) of Regulation Y (12 CFR 225.21(a)) to acquire or control voting securities or assets of a company engaged
in a nonbanking activity that is listed in  225.25 of Regulation Y as closely related to banking and permissible for
bank holding companies, or to engage in such an activity. Unless otherwise noted, these activities will be conducted
throughout the United States.
<!-- PJG 0012 frnewline -->
The application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing on the question whether consummation of the proposal can ``reasonably
be expected to produce benefits to the public, such as greater convenience, increased competition, or gains in efficiency,
that outweigh possible adverse effects, such as undue concentration of resources, decreased or unfair competition,
conflicts of interests, or unsound banking practices.'' Any request for a hearing on this question must be accompanied
by a statement of the reasons a written presentation would not suffice in lieu of a hearing, identifying specifically
any questions of fact that are in dispute, summarizing the evidence that would be presented at a hearing, and indicating
how the party commenting would be aggrieved by approval of the proposal.
<!-- PJG 0012 frnewline -->
Comments regarding the application must be received at the Reserve Bank indicated or the offices of the Board of Governors
not later than February 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Chicago
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James A. Bluemle, Vice President) 230 South LaSalle Street, Chicago, Illinois 60690:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Firstbank of Illinois Co.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Springfield, Illinois; to acquire 100 percent of the voting shares of Colonial Bancshares, Inc., Des Peres, Missouri,
and thereby indirectly acquire The Colonial Bank, Des Peres, Missouri, and The Village Bank of St. Louis County, Ballwin,
Missouri.
<!-- PJG 0012 frnewline -->
In connection with this application, Applicant also proposes to acquire Guido Insurance Agency, Des Peres, Missouri,
and thereby engage in the sale of credit-related insurance pursuant to &sect;225.25(b)(8)(i) of the Board's Regulation
Y.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;652 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;F 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00058 </DOCNO>
<PARENT> FR940112-2-00044 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Charles William Gerlach, et al.; Change in Bank Control Notices; Acquisitions of Shares of Banks or Bank Holding Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and  225.41 of the
Board's Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting
on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
<!-- PJG 0012 frnewline -->
The notices are available for immediate inspection at the Federal Reserve Bank indicated. Once the notices have been
accepted for processing, they will also be available for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board
of Governors. Comments must be received not later than January 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Atlanta
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Zane R. Kelley, Vice President) 104 Marietta Street, N.W., Atlanta, Georgia 30303:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Charles William Gerlach
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Palm Beach, Florida; to acquire 69.2 percent of the voting shares of White Eagle Financial Group, Inc., Boca Raton,
Florida, and thereby indirectly acquire Admiralty Bank, Palm Beach Gardens, Florida.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
B. Federal Reserve Bank of Minneapolis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James M. Lyon, Vice President) 250 Marquette Avenue, Minneapolis, Minnesota 55480:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Reuben A. Ellingson and Eunice R. Ellingson Family Revocable Trust
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Bottineau, North Dakota; to acquire 16.53 percent of the voting shares of State Bank of Bottineau Holding Company,
Bottineau, North Dakota, and thereby indirectly acquire State Bank of Bottineau, Bottineau, North Dakota.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
2. Kathleen A. Nesvig
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, to acquire 17.22 percent of the voting shares of Omega City Holding Company, La Moure, North Dakota, and thereby indirectly
acquire The First State Bank of La Moure, La Moure, North Dakota.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
C. Federal Reserve Bank of Kansas City
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (John E. Yorke, Senior Vice President) 925 Grand Avenue, Kansas City, Missouri 64198:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Don Bodard
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Shawnee, Oklahoma; to acquire 100 percent of the voting shares of First Medicine Lodge Bancshares, Inc., Medicine
Lodge, Kansas, and thereby indirectly acquire The First National Bank of Medicine Lodge, Medicine Lodge, Kansas.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;653 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00059 </DOCNO>
<PARENT> FR940112-2-00045 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Home Credit Corporation; Notice of Application to Engage de novo in Permissible Nonbanking Activities</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The company listed in this notice has filed an application under  225.23(a)(1) of the Board's Regulation Y (12 CFR 225.23(a)(1))
for the Board's approval under section 4(c)(8) of the Bank Holding Company Act (12 U.S.C. 1843(c)(8)) and  225.21(a)
of Regulation Y (12 CFR 225.21(a)) to commence or to engage 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, either directly or through a subsidiary, in a nonbanking activity that is listed in  225.25 of Regulation Y as closely
related to banking and permissible for bank holding companies. Unless otherwise noted, such activities will be conducted
throughout the United States.
<!-- PJG 0012 frnewline -->
The application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing on the question whether consummation of the proposal can ``reasonably
be expected to produce benefits to the public, such as greater convenience, increased competition, or gains in efficiency,
that outweigh possible adverse effects, such as undue concentration of resources, decreased or unfair competition,
conflicts of interests, or unsound banking practices.'' Any request for a hearing on this question must be accompanied
by a statement of the reasons a written presentation would not suffice in lieu of a hearing, identifying specifically
any questions of fact that are in dispute, summarizing the evidence that would be presented at a hearing, and indicating
how the party commenting would be aggrieved by approval of the proposal.
<!-- PJG 0012 frnewline -->
Comments regarding the application must be received at the Reserve Bank indicated or the offices of the Board of Governors
not later than February 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of San Francisco
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Kenneth R. Binning, Director, Bank Holding Company) 101 Market Street, San Francisco, California 94105:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Home Credit Corporation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Salt Lake City, Utah; to engage 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 in lending activities, which include, but are not limited to loan participations with Home Credit Bank, pursuant
to  225.25(b)(1) of the Board's Regulation Y.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;708 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00060 </DOCNO>
<PARENT> FR940112-2-00046 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Wachovia Corporation, et al.; Acquisition of Company Engaged in Permissible Nonbanking Activities</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The organization listed in this notice has applied under  225.23(a)(2) or (f) of the Board's Regulation Y (12 CFR 225.23(a)(2)
or (f)) for the Board's approval under section 4(c)(8) of the Bank Holding Company Act (12 U.S.C. 1843(c)(8)) and  225.21(a)
of Regulation Y (12 CFR 225.21(a)) to acquire or control voting securities or assets of a company engaged in a nonbanking
activity that is listed in  225.25 of Regulation Y as closely related to banking and permissible for bank holding companies.
Unless otherwise noted, such activities will be conducted throughout the United States.
<!-- PJG 0012 frnewline -->
The application is available for immediate inspection at the Federal Reserve Bank indicated. Once the application
has been accepted for processing, it will also be available for inspection at the offices of the Board of Governors.
Interested persons may express their views in writing on the question whether consummation of the proposal can ``reasonably
be expected to produce benefits to the public, such as greater convenience, increased competition, or gains in efficiency,
that outweigh possible adverse effects, such as undue concentration of resources, decreased or unfair competition,
conflicts of interests, or unsound banking practices.'' Any request for a hearing on this question must be accompanied
by a statement of the reasons a written presentation would not suffice in lieu of a hearing, identifying specifically
any questions of fact that are in dispute, summarizing the evidence that would be presented at a hearing, and indicating
how the party commenting would be aggrieved by approval of the proposal.
<!-- PJG 0012 frnewline -->
Comments regarding the application must be received at the Reserve Bank indicated or the offices of the Board of Governors
not later than January 25, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Richmond
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (Lloyd W. Bostian, Jr., Senior Vice President) 701 East Byrd Street, Richmond, Virginia 23261:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Wachovia Corporation
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Winston-Salem, North Carolina; to acquire shares of Southeast Switch, Inc., Maitland, Florida, and thereby engage
in providing data processing and transmission services to federally insured depository institutions who participate
in Company's neutral shared electronic funds transfer (EFT) network and providing related services, including
the administration and promotion of the network; providing data processing transmission and related services to
other EFT networks; and providing bank management consulting advice to depository institutions pursuant to  225.25(b)(7)
and (b)(11) of the Board's Regulation Y.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;654 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00061 </DOCNO>
<PARENT> FR940112-2-00047 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Ronald L. Wohlwend, et al.; Change in Bank Control Notices; Acquisitions of Shares of Banks or Bank Holding Companies</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and  225.41 of the
Board's Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting
on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)).
<!-- PJG 0012 frnewline -->
The notices are available for immediate inspection at the Federal Reserve Bank indicated. Once the notices have been
accepted for processing, they will also be available for inspection at the offices of the Board of Governors. Interested
persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board
of Governors. Comments must be received not later than February 1, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
A. Federal Reserve Bank of Chicago
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James A. Bluemle, Vice President) 230 South LaSalle Street, Chicago, Illinois 60690:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Ronald L. Wohlwend
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, to acquire 25.03 percent of the voting shares of Illinois Valley Bancorp, Inc., Morris, Illinois, and thereby indirectly
acquire Grundy County National Bank, Morris, Illinois.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
B. Federal Reserve Bank of Minneapolis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (James M. Lyon, Vice President) 250 Marquette Avenue, Minneapolis, Minnesota 55480:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
1. Wishek Grandchildren Voting Trust Agreement
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Ashley, North Dakota; to acquire an additional 0.31 percent of the voting shares of McIntosh County Bank Holding
Company, Inc., Ashley, North Dakota, for a total of 44.97 percent, and thereby indirectly acquire McIntosh County
Bank, Ashley, North Dakota.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Board of Governors of the Federal Reserve System, January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jennifer J. Johnson,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Secretary of the Board.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;709 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6210&hyph;01&hyph;F
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00062 </DOCNO>
<PARENT> FR940112-2-00048 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>FEDERAL TRADE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Granting of Request for Early Termination of the Waiting Period Under the Premerger Notification Rules</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 7A of the Clayton Act, 15 U.S.C. 18a, as added by Title II of the Hart-Scott-Rodino Antitrust Improvements
Act of 1976, requires persons contemplating certain mergers or acquisitions to give the Federal Trade Commission
and the Assistant Attorney General advance notice and to wait designated periods before consummation of such plans.
Section 7A(b)(2) of the Act permits the agencies, in individual cases, to terminate this waiting period prior to its
expiration and requires that notice of this action be published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
.
<!-- PJG 0012 frnewline -->
The following transactions were granted early termination of the waiting period provided by law and the premerger
notification rules. The grants were made by the Federal Trade Commission and the Assistant Attorney for the Antitrust
Division of the Department of Justice. Neither agency intends to take any action with respect to these proposed acquisitions
during the application waiting period.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00063 </DOCNO>
<PARENT> FR940112-2-00048 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<TABLE>

<!-- PJG tableformat 3,L2,i1,s150,10,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=95 g=1 f=4 -->
Transactions Granted Early Termination Between: 12/13/93 and 12/23/93
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Name of acquiring person, name of acquired person, name of acquired entity
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1PMN No.
<!-- PJG 007 0150 intable -->
1Date terminated
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=4 -->
American Oil and Gas Corporation, American Central Gas Companies, Inc., American Central Gas Companies, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0302
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Westfield Holdings Limited, The Prudential Insurance Company of America, CenterMark Properties, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0354
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Grupo Iusacell S.A. de S.V., BellSouth Corporation, Mexican Cellular Investments, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0374
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Ramsay-HMO, Inc., Dr. Luis Cruz, Miami Dade Health Plan, Inc., Miami Dade Medical Center
<!-- PJG 007 0104 intable -->
94&hyph;0382
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
MLP Holdings L.P., Ralph J. Roberts, Comcast Sound Communications, Inc., et al._see attached
<!-- PJG 007 0104 intable -->
94&hyph;0386
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Whitehall Street Real Estate Limited Partnership III, The Prudential Insurance Company of America, CenterMark
Properties, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0390
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
AGCO Corporation, AGCO Corporation, AGCO Acceptance Company
<!-- PJG 007 0104 intable -->
94&hyph;0393
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Norwest Corporation, APV plc, APV Douglas Machine Corporation
<!-- PJG 007 0104 intable -->
94&hyph;0396
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
AGCO Corporation, Varity Corporation, Agricredit Acceptance Company
<!-- PJG 007 0104 intable -->
94&hyph;0398
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Kawasaki Heavy Industries, Ltd., International Business Machines Corporation, Altium
<!-- PJG 007 0104 intable -->
94&hyph;0401
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Continental Bank Corporation, Custom Industries, Inc., Custom Industries, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0402
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Heidelberger Zement AG, J. Thomas Holton, Sherman International Corp
<!-- PJG 007 0104 intable -->
94&hyph;0403
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
DM Holdings, Inc., Fingerhut Companies, Inc., FDC, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0410
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Whitehall Street Real Estate, Pacific Mutual Life Insurance Company, Pacific Mutual Life Insurance Company
<!-- PJG 007 0104 intable -->
94&hyph;0411
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Nova University, Inc., Southeastern University of the Health Sciences, Inc., Southeastern University of the Health
Sciences, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0414
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Weiner Staedtische Wechseiseitige VV, Folksam General Mutual Insurance, Folksamerica Holding Company, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0417
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Societe Centrale Union des Assurances de Paris, Compagnie de Suez, Vinci BV
<!-- PJG 007 0104 intable -->
94&hyph;0418
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Kvaerner a.s., Armco Inc., National-Oilwell
<!-- PJG 007 0104 intable -->
94&hyph;0422
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Neil M. Chur, Beverly Enterprises, Inc., Beverly Enterprises_Texas, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0423
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Kvaerner a.s., USX Corporation, National-Oilwell
<!-- PJG 007 0104 intable -->
94&hyph;0424
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Transit Communications Atlanta L.P., Hancock Venture Partners III L.P., Transit Communications Investors, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0431
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
U S West, Inc., Russian Telecommunications Development Corporation, Russian Telecommunications Development
Corporation
<!-- PJG 007 0104 intable -->
94&hyph;0445
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
Raymond J. Noorda and Lewena Noorda, Systems Industries, Inc., Systems Industries, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0451
<!-- PJG 007 0104 intable -->
12/13/93
<!-- PJG 0012 frnewline -->
First Financial Management Corporation, Wilson T. Gildee, VIPS, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0368
<!-- PJG 007 0104 intable -->
12/14/93
<!-- PJG 0012 frnewline -->
SCEcorp, Muskegon Development Company, M3 Limited Partnership
<!-- PJG 007 0104 intable -->
94&hyph;0370
<!-- PJG 007 0104 intable -->
12/14/93
<!-- PJG 0012 frnewline -->
Fuji Photo Film Co., Ltd., BASF AG, B&amp;F Microdisks Partnership
<!-- PJG 007 0104 intable -->
94&hyph;0394
<!-- PJG 007 0104 intable -->
12/14/93
<!-- PJG 0012 frnewline -->
Fuji Photo Film Co., Ltd., Fuji Photo Film Co., Ltd., B&amp;F Microdisks Partnership
<!-- PJG 007 0104 intable -->
94&hyph;0413
<!-- PJG 007 0104 intable -->
12/14/93
<!-- PJG 0012 frnewline -->
Gebr. Otto KG, Browning-Ferris Industries, Inc., Browning-Ferris Industries, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0432
<!-- PJG 007 0104 intable -->
12/14/93
<!-- PJG 0012 frnewline -->
H Group Holding, Inc., PS Group, Inc., USTravel Systems, Inc., USTS Northeast, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0435
<!-- PJG 007 0104 intable -->
12/14/93
<!-- PJG 0012 frnewline -->
Madison Dearborn Capital Partners, L.P., Eli Jacobs, Milnot Company
<!-- PJG 007 0104 intable -->
94&hyph;0443
<!-- PJG 007 0104 intable -->
12/14/93
<!-- PJG 0012 frnewline -->
First Tennessee National Corporation, SNMC Management Corporation, SNMC Management Corporation
<!-- PJG 007 0104 intable -->
94&hyph;0373
<!-- PJG 007 0104 intable -->
12/15/93
<!-- PJG 0012 frnewline -->
Whitman Corporation, PepsiCo, Inc., MBA Waterloo
<!-- PJG 007 0104 intable -->
94&hyph;0433
<!-- PJG 007 0104 intable -->
12/15/93
<!-- PJG 0012 frnewline -->
Motorola, Inc., Western Digital Corporation, Western Digital Corporation
<!-- PJG 007 0104 intable -->
94&hyph;0307
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
National Medical Enterprises, Inc., Doctors Hospital of Jefferson, Inc., Doctors Hospital of Jefferson, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0337
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Williams Holdings plc, The Black &amp; Decker Corporation, Corbin &amp; Russwin Division of Emhart Industries,
Inc
<!-- PJG 007 0104 intable -->
94&hyph;0356
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Cardinal Distribution, Inc., Frederick L. Erlich, PRN Services, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0365
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Cardinal Distribution, Inc., Fredrick Kamienny, PRN Services, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0366
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
New Heritage USA Corporation, Forte plc, Forte Hotels, Inc. and Travel Beverages, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0421
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Adler Properties Limited Partnership, The Metropolitan Life Insurance Company, MICC Venture
<!-- PJG 007 0104 intable -->
94&hyph;0425
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Adler Properties Limited Partnership, Adler Properties Limited Partnership, MICC Venture
<!-- PJG 007 0104 intable -->
94&hyph;0426
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Forest Oil Corporation, Jack E. Brown, Wagner &amp; Brown, Ltd
<!-- PJG 007 0104 intable -->
94&hyph;0429
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Forest Oil Corporation, Cyril Wagner, Jr., Wagner &amp; Brown, Ltd
<!-- PJG 007 0104 intable -->
94&hyph;0430
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Kidd Kamm Equity Partners, L.P., New Action Corp. (joint venture), New Action Corp
<!-- PJG 007 0104 intable -->
94&hyph;0437
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
GFC Financial Corporation, Fleet Financial Group, Inc., Fleet Factors Corp
<!-- PJG 007 0104 intable -->
94&hyph;0440
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
The Western Company of North America, Simon Engineering plc, Unichem International Incorporated
<!-- PJG 007 0104 intable -->
94&hyph;0442
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Caisse Centrale des Mutuelles Agricoles, La Mutuelle du Mans Assurances, i.a.r.d., LeMans Reinsurance Company,
U.S.A
<!-- PJG 007 0104 intable -->
94&hyph;0456
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Code, Hennessy &amp; Simmons Limited Partnership, Mr. Frank J. St. Romain, South Central Pool Supply, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0460
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
The St. Paul Companies, Inc., SCEcorp, Mission_CCH I, L.P
<!-- PJG 007 0104 intable -->
94&hyph;0461
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Norcen Energy Resources Limited, Torchmark Corporation, 1993 Offshore Limited Partnership
<!-- PJG 007 0104 intable -->
94&hyph;0478
<!-- PJG 007 0104 intable -->
12/17/93
<!-- PJG 0012 frnewline -->
Horace Mann Educators Corporation, CIGNA Corporation, Allegiance Insurance Company
<!-- PJG 007 0104 intable -->
94&hyph;0395
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
Jefferson-Pilot Corporation, Randall T. Odeneal, IntraCoastal Broadcasting, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0405
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
Jefferson-Pilot Corporation, Scott R. McQueen, IntraCoastal Broadcasting, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0406
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
Associated Insurance Companies, Inc., Kemper Corporation, Federal Kemper Insurance Company
<!-- PJG 007 0104 intable -->
94&hyph;0408
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
Compagnie Generale des Communications (France Telecom), Infonet Services Corporation, Infonet Services Corporation
<!-- PJG 007 0104 intable -->
94&hyph;0438
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
MCI Communications Corporation, British Telecommunications plc, Transco
<!-- PJG 007 0104 intable -->
94&hyph;0452
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
V. Prem Watsa, D.T. Chase Enterprises, Inc., Ranger Insurance Company
<!-- PJG 007 0104 intable -->
94&hyph;0458
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
J.R. Simplot Company, Metropolitan Life Insurance Company, Metropolitan Life Insurance Company
<!-- PJG 007 0104 intable -->
94&hyph;0468
<!-- PJG 007 0104 intable -->
12/20/93
<!-- PJG 0012 frnewline -->
BTR plc, Rexnord Corporation, Rexnord Corporation
<!-- PJG 007 0104 intable -->
94&hyph;0441
<!-- PJG 007 0104 intable -->
12/21/93
<!-- PJG 0012 frnewline -->
Gary Joseph Chouest, Royal Dutch Petroleum Company, Shell Offshore Inc
<!-- PJG 007 0104 intable -->
94&hyph;0450
<!-- PJG 007 0104 intable -->
12/21/93
<!-- PJG 0012 frnewline -->
Stephens Group, Inc., SD Investments, Inc., SD Investments, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0475
<!-- PJG 007 0104 intable -->
12/21/93
<!-- PJG 0012 frnewline -->
Blue Cross of California, UniCARE Financial Corp., UniCARE Financial Corp
<!-- PJG 007 0104 intable -->
94&hyph;0481
<!-- PJG 007 0104 intable -->
12/21/93
<!-- PJG 0012 frnewline -->
John W. Kluge, c/o Metromedia Company, Steven E. Pearson, Beef Specialists of Iowa, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0381
<!-- PJG 007 0104 intable -->
12/22/93
<!-- PJG 0012 frnewline -->
Don Tyson, Matt F. Gorges, Gorges Foodservice, Inc
<!-- PJG 007 0104 intable -->
94&hyph;0434
<!-- PJG 007 0104 intable -->
12/22/93
<!-- PJG 0012 frnewline -->
Dr. Rajendra Singh, Telcom Ventures, L.L.C., Telcom Ventures, L.L.C
<!-- PJG 007 0104 intable -->
94&hyph;0470
<!-- PJG 007 0104 intable -->
12/23/93
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FORTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Sandra M. Peay, or Renee A. Horton, Contact Representatives, Federal Trade Commission, Premerger Notification
Office, Bureau of Competition, room 303, Washington, DC 20580, (202) 326&hyph;3100.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By Direction of the Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;749 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00064 </DOCNO>
<PARENT> FR940112-2-00049 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket C&hyph;2858]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>California and Hawaiian Sugar Co.</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of period for public comment on petition to modify or vacate consent order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
California and Hawaiian Sugar Company (``C&amp;H''), a respondent in Docket No. C&hyph;2858, is subject to an order
prohibiting it from representing that its granulated sugar is different or superior unless (a) such difference or
superiority relates to a consumer use of such sugar which is specified in the advertisement; (b) such difference or
superiority is substantiated; and (c) such substantiation includes competent and reliable evidence that the difference
or superiority is discernible to or of benefit to the class of consumers to whom the representation is directed. C&amp;H
filed a petition on December 16, 1993, requesting that the Commission reopen and modify the order to allow C&amp;H
to advertise all truthful, nondeceptive differences between its sugar and competing sugar that are substantiated
by competent and reliable evidence. In the alternative, C&amp;H requests that the Commission vacate the order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This document announces the public comment period on this petition.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The deadline for filing comments in this matter is January 24, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Comments should be sent to the Office of the Secretary, Federal Trade Commission, 6th Street and Pennsylvania Avenue
NW., Washington, DC 20580. Requests for copies of the petition should be sent to Public Reference Branch, room 130.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Robert M. Frisby, Enforcement Division, Bureau of Consumer Protection, Federal Trade Commission, Washington,
DC 20580, (202) 326&hyph;2098.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The order in Docket No. C&hyph;2858 was published at 42 FR 6800 on February 4, 1977, reported at 89 F.T.C. 15. C&amp;H
argues that significant changes in constitutional law and Commission policy since 1976 justify reopening the docket
and modifying the order. C&amp;H maintains that the U.S. Supreme Court has extended First Amendment protection to
purely commercial speech and views as particularly suspect prohibitions on expression such as those in the order.
C&amp;H also contends that the burden of proof in restricting commercial speech lies with the party seeking to restrict
it and that the Commission has provided no evidence that the order directly advances its interests in a reasonable
manner. In addition, C&amp;H argues that since 1976 the Commission altered its position concerning truthful comparative
advertising and now actively encourages such advertising. C&amp;H notes that since 1976 the Commission has adopted
a ``reasonable consumer'' standard. C&amp;H also contends that the public interest justifies reopening and setting
aside the order because consumers have a constitutional right to receive uncensored distribution of truthful information.
Furthermore, C&amp;H maintains that market efficiency requires that consumers be given access to truthful information
and that the order improperly discriminates among competitors. The petition was placed on the public record on December
23, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;751 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00065 </DOCNO>
<PARENT> FR940112-2-00050 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Dkt. C&hyph;3473]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Imperial Chemical Industries PLC, et al.; Prohibited Trade Practices, and Affirmative Corrective Actions</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Trade Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Consent order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition,
this consent order allows, among other things, the respondents to proceed with the proposed acquisition of certain
DuPont assets, but it requires the respondents to divest, within 15 months, a predetermined acrylic-plastic manufacturing
capacity by selling one of their U.S. plants to a Commission-approved purchaser, and to provide the buyer with technical
assistance for 18 months, if necessary. In addition, if the divestiture is not accomplished in the specified time-frame,
the respondents agree to a Commission-appointed trustee to complete the transaction.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Complaint and Order issued November 29, 1993.
<FOOTCITE>1</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Copies of the Complaint, the Decision and Order, and Commissioner Owen's statement are available from the Commission's
Public Reference Branch, H&hyph;130, 6th Street &amp; Pennsylvania Avenue NW., Washington, DC 20580.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
</FOOTNOTE>
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Rhett Krulla, FTC/S&hyph;3302, Washington, DC 20580, (202) 326&hyph;2608.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On Wednesday, July 14, 1993, there was published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, 58 FR 37944, a proposed consent agreement with analysis In the Matter of Imperial Chemical Industrial PLC, et al.,
for the purpose of soliciting public comment. Interested parties were given sixty (60) days in which to submit comments,
suggestions or objections regarding the proposed form of the order.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Comments were filed and considered by the Commission. The Commission has ordered the issuance of the complaint, made
its jurisdictional findings and entered an order to divest, in disposition of this proceeding.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Sec. 6, 38 Stat. 721; 15 U.S.C. 46. Interpret or apply sec. 5, 38 Stat. 719, as amended; sec. 7, 38 Stat. 731, as amended;
15 U.S.C. 45, 18)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donald S. Clark,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;750 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6750&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00066 </DOCNO>
<PARENT> FR940112-2-00051 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Centers for Disease Control and Prevention</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
National Committee on Vital and Health Statistics (NCVHS): Meetings
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Public Law 92&hyph;463, the National Center for Health Statistics (NCHS), Centers for Disease Control
and Prevention (CDC), announces the following meetings.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 NCVHS Subcommittee on Medical Classification Systems.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 9 a.m.&hyph;12 noon, February 2, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Room 703A, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The subcommittee will discuss follow on activities from its subcommittee report recommending a single procedure
classification system and will review its workplan for 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Joint meeting of NCVHS Subcommittees on Ambulatory and Hospital Care Statistics and Medical Classification Systems.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 1 p.m.&hyph;5 p.m., February 2, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: Room 703A, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The subcommittees will receive briefings on the International Classification of Primary Care (ICPC) and Systematized
Nomenclature of Medicine (SNOMED).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 NCVHS Subcommittee on Ambulatory and Hospital Care Statistics.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 9 a.m.&hyph;5 p.m., February 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
: Room 703A, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 The subcommittee will receive testimony and review comments regarding a uniform core data set that will meet current
and future needs for information on ambulatory care encounters.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Contact Person for More Information:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Substantive program information as well as summaries of the meetings and a roster of committee members may be obtained
from Gail F. Fisher, Ph.D., Executive Secretary, NCVHS, NCHS, room 1100, Presidential Building, 6525 Belcrest Road,
Hyattsville, Maryland 20782, telephone 301/436&hyph;7050.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Elvin Hilyer,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;698 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;18&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00067 </DOCNO>
<PARENT> FR940112-2-00052 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>National Committee on Vital and Health Statistics (NCVHS); Meetings</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to Public Law 92&hyph;463, the National Center for Health Statistics (NCHS), Centers for Disease Control
and Prevention (CDC), announces the following meetings.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
NCVHS Subcommittee on Long-Term Care Statistics.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
9 a.m.&hyph;2 p.m., February 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Room 703A, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington DC 20201.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The subcommittee will work on its report and revise its charge. Afterward, members will receive a briefing on disability-related
risk adjusters and long-term care data needs for health care reform.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Joint meeting of NCVHS Subcommittees on State and Community Health Statistics and Long-Term Care Statistics.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
2 p.m.&hyph;5 p.m., February 8, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Room 703A, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The subcommittees will meet jointly to discuss issues related to State and local long-term care data.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
NCVHS Subcommittee on State and Community Health Statistics.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time and Date: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
9 a.m.&hyph;5 p.m., February 9, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Room 703A, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC 20201.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Open.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The subcommittee will meet to discuss issues related to State and community health statistics and to develop a work
plan for the coming year.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Contact Person for More Information: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Substantive program information as well as summaries of the meetings and a roster of committee members may be obtained
from Gail F. Fisher, Ph.D., Executive Secretary, NCVHS, NCHS, room 1100, Presidential Building, 6525 Belcrest Road,
Hyattsville, Maryland 20782, telephone 301/436&hyph;7050.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Elvin Hilyer,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director for Policy Coordination, Centers for Disease Control and Prevention (CDC).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;699 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;18&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00068 </DOCNO>
<PARENT> FR940112-2-00053 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Administration for Children and Families</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Agency Information Collection Under OMB Review</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the provisions of the Federal Paperwork Reduction Act (44 U.S.C. chapter 35), the Administration for Children
and Families (ACF) has submitted to the Office of Management and Budget (OMB) a request for the reinstatement of a previously
approved information collection titled: ``State Plan for Child Support Collection and Establishment of Paternity
under Title IV&hyph;D of the Social Security Act, Form OCSE&hyph;100.'' The previously approved information collection
was approved for use through November 1993 under OMB Control Number 0970&hyph;0017.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Copies of this information collection request may be obtained from Stephen R. Smith of the Office of Information Systems
Management, ACF, by calling 401&hyph;6964.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Written comments and questions regarding the requested approval for information collection should be sent directly
to: Laura Oliven, OMB Desk Office for ACF, OMB Reports Management Branch, New Executive Office Building, room 3002,
725&hyph;17th Street NW., Washington, DC 20503, (202) 395&hyph;7316.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Information of Document
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Title: State Plan for Child Support Collection and Establishment of Paternity under Title IV&hyph;D of the Social
Security Act, Form OCSE&hyph;100.
<!-- PJG 0012 frnewline -->
OMB No.:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 0970&hyph;0017.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This information collection is required by Title IV&hyph;D of the Social Security Act, Federal regulations and issuances
made by the Secretary of the Department of Health and Human Service for the purpose of enforcing the support obligations
owed by absent parents to their children and the spouse (or former spouse) with whom such children are living, locating
absent parents, establishing paternity, obtaining child and spousal support, and assuring that assistance in obtaining
support will be available to all children.
<!-- PJG 0012 frnewline -->
The Secretary of the Department of Health and Human Services has designated the Director of the Office of Child Support
Enforcement at the Administration for Children and Families, among other things, to establish such standards for
State programs for locating absent parents, establishing paternity, and obtaining child support and support for
the spouse (or former spouse), and to review and approve State plans for such programs. A State must submit a State plan
for a program of support collection and establishment of paternity under Title IV&hyph;D of the Social Security Act.
The information obtained on the State plan preprint will serve as a contract between the Office of Child Support Enforcement
(OCSE) and any State specifying activities the State must perform as required by law and other Federal requirements
as a condition for Federal financial participation.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=38 g=1 f=1 -->
Annual Number of Respondents 
<!-- PJG 0114 ellipses -->
54
<!-- PJG 0012 frnewline -->
Frequency 
<!-- PJG 0114 ellipses -->
9
<!-- PJG 0012 frnewline -->
Average Burden Hours Per Response 
<!-- PJG 0114 ellipses -->
43
<!-- PJG 0012 frnewline -->
Total Burden Hours 
<!-- PJG 0114 ellipses -->
348.3
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ADDRESS>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Larry Guerrero,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Director, Office of Information Systems Management.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;793 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4184&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00069 </DOCNO>
<PARENT> FR940112-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Health Resources and Services Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Program Announcement for the Disadvantaged Health Professions </DOCTITLE>
<!-- PJG 0012 frnewline -->
Faculty Loan Repayment Program 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Health Resources and Services Administration (HRSA) announces that 
<!-- PJG 0012 frnewline -->
applications for fiscal year (FY) 1994, for the Disadvantaged Health Professions Faculty Loan Repayment Program
(FLRP) are now being accepted under section 738 (a) of the Public Health Service Act (The Act), as amended by the Health
Professions Education Extension Amendments of 1992, Public Law 102&hyph;408, dated October 13, 1992. 
<!-- PJG 0012 frnewline -->
In FY 1994, approximately $800,000 is available for competing applications for the Disadvantaged Health Professions
Faculty Loan Repayment Program. It is expected that 26 awards averaging $30,000 ($15,000 per year for two years) will
be supported with these funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Previous Funding Experience 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Previous funding experience information is provided to assist potential applicants to make better informed decisions
regarding submission of an application for this program. In fiscal years 1991, 1992 and 1993, a total of 91 awards,
averaging $24,000 ($12,000 per year for 2 years) were made. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Purpose 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The purpose of the Disadvantaged Health Professions Faculty Loan Repayment Program (FLRP) is to attract disadvantaged
health professions faculty members for accredited health professions schools. The program provides a financial
incentive for degree-trained health professions personnel from disadvantaged backgrounds who will serve as members
of the faculties of those schools. The FLRP is directed at those individuals available to serve immediately or within
a short time as ``new'' full-time faculty members. 
<!-- PJG 0012 frnewline -->
Loan repayment may be provided only for an individual who has 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
not 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
been a member of the faculty of any school at any time during the 18-month period preceding the date on which the Secretary
receives the request of the individual for a repayment contract (i.e., ``new'' faculty). 
<!-- PJG 0012 frnewline -->
Section 738(b) makes available grants and contracts with schools of medicine, osteopathic medicine, dentistry,
veterinary medicine, optometry, podiatric medicine, pharmacy, public health, health administration, clinical
psychology and other public or private nonprofit health or educational entities to assist in increasing the number
of underrepresented minority faculty. Section 738(b) will be implemented as a separate program. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Eligible Individuals 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individuals from disadvantaged backgrounds are eligible to compete for participation in the FLRP if they: 
<!-- PJG 0012 frnewline -->
1. Have a degree in medicine, osteopathic medicine, dentistry, 
<!-- PJG 0012 frnewline -->
nursing, pharmacy, podiatric medicine, optometry, veterinary 
<!-- PJG 0012 frnewline -->
medicine, public health or clinical psychology; or 
<!-- PJG 0012 frnewline -->
2. Are enrolled in an approved graduate training program in one 
<!-- PJG 0012 frnewline -->
of the health professions listed above; or 
<!-- PJG 0012 frnewline -->
3. Are enrolled as a full-time student in the final year of health 
<!-- PJG 0012 frnewline -->
professions training, leading to a degree from an eligible school. 
<!-- PJG 0012 frnewline -->
Established faculty members are not eligible to apply for funds under the FLRP. Only individuals that have not taught
in the last 18 (eighteen) months prior to application to the program will be considered. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Statutory Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Prior to submitting an application, eligible individuals must sign a contract, as prescribed by the Secretary, setting
forth the terms and conditions of the FLRP. This contract requires the individual to have entered into a contract with
an eligible school to serve as a full-time member of the faculty, as determined by the school, for not less than 2 years,
whereby the school agrees to pay, for each year, a sum (in addition to faculty salary) equal to that paid by the Secretary
towards the repayment of principal due on the applicant's health professions educational loans. Additionally,
the individual involved may not have been a member of the faculty of any school at any time during the last 18 months prior
to application to the program. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Eligible Schools 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Eligible health professions schools are public or nonprofit private accredited schools of medicine, osteopathic
medicine, dentistry, pharmacy, podiatric medicine, optometry, veterinary medicine or public health, or schools
that offer graduate programs in clinical psychology and which are located in States as provided in section 799 of the
Act. Schools of nursing are also eligible, as defined in section 853 of the Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Provisions of the Loan Repayment Program 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 738 (a) authorizes repayment, for any year for which repayments are made, not to exceed 20 percent of the outstanding
principal and interest on the individual's educational loans. Of the repayment, the Secretary pays half, up to $20,000.
The school pays an equal amount, unless the Secretary determines that the repayment will impose an undue financial
hardship on the school in which case, the Secretary may pay up to the entire 20 percent. 
<!-- PJG 0012 frnewline -->
The school is required, for each such year, to make payments of principal and interest in an amount equal to the amount
of payment made by the Secretary for that year. These payments must be in addition to the faculty salary the participant
otherwise would receive. 
<!-- PJG 0012 frnewline -->
Allowable educational loan repayment expenses include the following: 
<!-- PJG 0012 frnewline -->
1. Tuition expenses; 
<!-- PJG 0012 frnewline -->
2. All other reasonable educational expenses such as fees, books, 
<!-- PJG 0012 frnewline -->
supplies, educational equipment and materials required by the school, and incurred by the applicant; 
<!-- PJG 0012 frnewline -->
3. Reasonable living expenses, as determined by the Secretary; and 
<!-- PJG 0012 frnewline -->
4. Partial payments of the increased Federal income tax liability 
<!-- PJG 0012 frnewline -->
caused by the FLRP's payments and considered to be ``other income,'' if the recipient requests such assistance. 
<!-- PJG 0012 frnewline -->
Prior to entering into an agreement for repayment of loans, the Secretary requires satisfactory evidence of the existence
and reasonableness of the individual's educational loans, including a copy of the original written loan agreement
establishing the outstanding educational loan. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Waiver Provision 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the event of undue financial hardship to a school, the school may obtain from the Secretary a waiver of its share of
payments while the participant is serving under the terms of the contract. For purposes of this program, ``undue financial
hardship'', as seen by the Secretary, is based on a school's particular financial status as influenced by such circumstances
as budget cutbacks. Decisions will be made on a case-by-case basis, and may 
<!-- PJG 0012 frnewline -->
be supported by the school's documentation of comparative yearly financial allocation of funds; or the most current
certified public accounting audit, including the Balance Sheet and Statement of Income and Expenses for the past
several years. 
<!-- PJG 0012 frnewline -->
If the Secretary waives the school's payment requirement, the amount of the Federal loan repayment may be up to the
full 20 percent described above (regardless of the ``equal amount'' provision described above), but cannot exceed
the $20,000 repayment limit. The participant must pay that portion of loan payment due which is not covered. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The following Definitions, Program Requirements, Review Criteria and Funding Preference were established in FY
1991 after public comment dated October 2, 1991, at 56 FR 49896, and the Secretary is extending them in FY 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00070 </DOCNO>
<PARENT> FR940112-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Definitions 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For purposes of the FLRP in FY 1994, an ``Individual from a Disadvantaged 
<!-- PJG 0012 frnewline -->
Background'' is defined as in 42 CFR 57.1804, as one who: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Comes from an environment that has inhibited the individual from obtaining the knowledge, skill, and abilities
required to enroll in and graduate from a health professions school, or from a program providing education or training
in an allied health profession; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Comes from a family with an annual income below a level based on low 
<!-- PJG 0012 frnewline -->
income thresholds according to a family size published by the U.S. Bureau of the Census, adjusted annually for changes
in the Consumer Price Index, and adjusted by the Secretary for use in health professions and nursing programs. The
Secretary will periodically publish these income levels in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The following income figures determine what constitutes a low income family for purposes of the Faculty Loan Repayment
Program for FY l994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 2,L2,tp0,i1,s50,8 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Size of parents' family&sect;1 
<!-- PJG 007 0150 intable -->
1Income level2
<!-- PJG 007 0152 intable -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
1 
<!-- PJG 007 0104 intable -->
$9,4l9 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2 
<!-- PJG 007 0104 intable -->
l2,202 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3 
<!-- PJG 007 0104 intable -->
l4,523 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4 
<!-- PJG 007 0104 intable -->
l8,596 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5 
<!-- PJG 007 0104 intable -->
2l,930 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6 or more 
<!-- PJG 007 0104 intable -->
24,648 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
1Includes only dependents listed on Federal income tax forms. 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0146 intable -->
2Adjusted gross income for calendar year 1993 rounded to $100.
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The term ``Living expenses'' means the costs of room and board, transportation and commuting costs, and other costs
incurred during an individual's attendance at a health professions school, as estimated each year by the school as
part of the school's standard student budget. (National Health Service Corps Loan Repayment Program, 42 CFR 62.22)

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The term ``Reasonable educational expenses and living expenses'' means the costs of those educational and living
expenses which are equal to or less than the sum of the school's estimated standard student budgets for educational
and living expenses for the degree program and for the year(s) during which the Program participant is/was enrolled
in the school. (National Health Service Corps Loan Repayment Program, 42 CFR 62.22) 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The term ``Unserved Obligation Penalty'' means the amount equal to the number of months of obligated service that
were not completed by an individual, multiplied by $1,000, except that in any case in which the individual fails to
serve 1 year, the unserved obligation penalty shall be equal to the full period of obligated service multiplied by
$1,000. (Section 
<!-- PJG 0012 frnewline -->
338E of the Act) See ``Breach of Contract'' section below. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Program Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following requirements will be applied to the applicant and to the school. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00071 </DOCNO>
<PARENT> FR940112-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The Applicant 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant will be required to do the following: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Submit a completed application, including the applicant's contract with an eligible school to serve as a full-time
faculty member for not less than 2 years;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Provide evidence that the applicant has completely satisfied any other obligation for health professional service
which is owed under an agreement with the Federal Government, State Government, or other entity prior to beginning
the period of service under this program;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Certify that the applicant is not delinquent on any amounts which are owed to the Federal Government; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. Provide documentation to evidence the educational loans and to verify their status.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
The School
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The participating school will be required to do the following:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Enter into a contractual agreement with the applicant whereby the school is required, for each year for which the
participant serves as a faculty member, to make payments of principal and interest in an amount equal to the amount
of such quarterly payments made by the Secretary. These payments must be in addition to the faculty salary the participant
otherwise would receive.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Verify the participant's continuous employment at intervals as prescribed by the Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
If the school is unable to meet the requirement of the FLRP for payment of principal and interest due because the requirement
would impose undue financial hardship on the school, the school may request a waiver of this obligation from the Secretary.
If the school's proportionate share of loan repayment amounts is waived, the Federal Government agrees to make payments
of not more than $20,000 of principal and interest for a year, which includes the amount granted as a waiver to the school.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Secretary will pay participants in equal quarterly payments during the period of service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Effective Date of Contract
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
After an applicant has been approved for participation in the FLRP, the Director, Division of Disadvantaged Assistance
(DDA), will send the applicant a contract with the Secretary. The effective date is either the date work begins at the
school as a faculty member or the date the Director, DDA, signs the FLRP contract, whichever is later. Service should
begin no later than September 30, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Breach of Contract
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The following areas under Breach of Contract are addressed in the appended 
<!-- PJG 0012 frnewline -->
contract:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. If the participant fails to serve his or her period of obligated faculty service (minimum of 2 years) as contracted
with the school, he/she is then in breach of contract, and neither the Secretary nor the school is obligated to continue
loan repayments as stated in the contract. The participant must then reimburse the Secretary and the participating
school for all sums of principal and interest paid on his/her behalf as stated in the contract in addition to any income
tax assistance he/she may have received.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. Regardless of the length of the agreed period of obligated service (2, 3, or more years), a participant who serves
less than the time period specified in his/her contract is liable for monetary damages to the United States amounting
to the sum of the total of the amounts the Program paid him/her, plus an ``unserved obligation penalty'' of $1,000 for
each month unserved.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Any amount which the United States is entitled to recover because of a breach of the FLRP contract must be paid within
1 year from the day the Secretary determines that the participant is in breach of contract. If payment is not received
by the payment date, additional interest, penalties and administrative charges will be assessed in accordance with
Federal Law (45 CFR 30.13).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Review Criteria
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The HRSA will review fiscal year 1994 applications taking into consideration the following criteria:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00072 </DOCNO>
<PARENT> FR940112-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. The extent to which the applicant meets the requirements of section 
<!-- PJG 0012 frnewline -->
738 of the Act;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. The completeness, accuracy, and validity of the applicant's responses 
<!-- PJG 0012 frnewline -->
to application requirements;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The submission of the signed contract with the school;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. An applicant's earliest available date to begin service as a faculty member provided funding is available for that
year; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. An applicant's availability to enter into a service contract for a longer period than the mandatory 2-year minimum.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Factors to assure equitable distribution (e.g. geographic, discipline) will be considered in determining the funding
of completed applications.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
National Health Objectives for the Year 2000
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives
of Healthy People 2000, a PHS-led national activity for setting priority areas. The Disadvantaged Health Professions
Faculty Loan Repayment Program is related to the priority area of Educational and Community-Based Programs. Potential
applicants may obtain a copy of Healthy People 2000 (Full Report; Stock No. 017&hyph;001&hyph;00474&hyph;0) or
Healthy People 2000 (Summary Report; Stock No. 017&hyph;001&hyph;00473&hyph;1) through the Superintendent of
Documents, Government Printing Office, Washington, D.C. 20402&hyph;9325 (Telephone (202) 783&hyph;3238).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Application Requests
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Requests for application materials and questions regarding program information and business should be directed
to: Norman Roskos, Chief, Analysis and Evaluation Branch, Division of Disadvantaged Assistance, Bureau of Health
Professions, Health Resources and Services Administration, 5600 Fishers Lane, Room 8A&hyph;09, Rockville, Maryland
20857, Telephone: (301) 443&hyph;3680, FAX: (301) 443&hyph;5242.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Completed applications should be returned to the address listed above. The application deadline date is June 30,
1994. Applications shall be considered to be ``on time'' if they are either:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) Received on or before the established deadline date, or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) Sent on or before the established deadline date and received in time for orderly processing. (Applicants should
request a legibly dated U.S. Postal Service postmark or obtain a legibly dated receipt from a commercial carrier or
U.S. Postal Service. Private metered postmarks shall not be acceptable as proof of timely mailing.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Late applications not accepted for processing will be returned to the applicant.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The application form and instructions for this program have been approved by the Office of Management and Budget (OMB)
under the Paperwork Reduction Act. The OMB clearance number is 0915&hyph;0150.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Disadvantaged Health Professions Faculty Loan Repayment Program is listed at 93.923 in the Catalog of Federal
Domestic Assistance. It is not subject to the provisions of Executive Order 12372, Intergovernmental Review of Federal
Programs (as implemented through 45 CFR part 100).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This program is not subject to the Public Health System Reporting Requirements.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 9, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John H. Kelso,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00073 </DOCNO>
<PARENT> FR940112-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Contract for the Disadvantaged Health Professions Faculty Loan Repayment Program With U.S. Department of Health
and Human Services, Public Health Service, Health Resources and Services Administration, and Bureau of Health Professions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Section 738 of the Public Health Service Act (``Act'') [42 United States Code 293 et seq.], as added by Pub. L. 102&hyph;408,
authorizes the Secretary of Health and Human Services (``Secretary'') to repay the educational loans of applicants
from disadvantaged backgrounds selected to be participants in the Loan Repayment Program Regarding Service on Faculties
of Certain Health Professions Schools (``Faculty Loan Repayment Program''). In return for these loan repayments,
applicants must agree to provide teaching faculty services at an approved accredited health professions school
determined by the Secretary for a designated period of obligated service pursuant to section 738 of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sections 738(a) (5) and (7) of the Act require applicants to submit with their applications a signed contract with
an accredited health professions school and a signed contract which states the terms and conditions of participation
in the Faculty Loan Repayment Program. The Secretary shall sign only those contracts submitted by applicants who
are selected for participation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The terms and conditions of participating in the Faculty Loan Repayment Program are set forth below:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section A_Obligations of the Secretary
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Subject to the availability of funds appropriated by the Congress of the United States for the Faculty Loan Repayment
Program, the Secretary agrees to:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
1. Pay, in the amount provided in paragraph 2 of this section, the undersigned applicant's qualifying educational
loans. Qualifying educational loans consist of the principal and interest on educational loans received by the applicant
for the following expenses of enrollment:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. tuition expenses:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. all other reasonable educational expenses such as fees, books, supplies, educational equipment and materials
required by the school, and incurred by the applicant; or
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. reasonable living expenses as determined by the Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. If the applicant agrees to serve 2 or more years:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Except as provided in subparagraph b. of this paragraph, pay up to $20,000 of the outstanding principal and interest
of a participant's nondelinquent educational loans, but not more than half of the 20 percent of the qualified outstanding
educational loans for such year for each year of eligible faculty service; or 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. The Secretary's liability will not exceed a cap of $20,000 of principal and interest annually. This would include
the 10 percent waived under Sec. 738(a) of the Act for the school's proportionate share of the loan repayment amounts.
The applicant must pay that portion not covered.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. Make loan repayments for a year of obligated service no later than the end of the fiscal year in which the applicant
completes such year of service.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. The effective date of the Contract will be the date it is signed by the Director, Division of Disadvantaged Assistance
or the date employment begins as a faculty member at the contracting school whichever is later.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Section B_Obligations of the Participant
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
1. The applicant agrees to:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Continue loan repayments to lenders for the first quarter after which the Secretary will make delayed quarterly
payments to applicant for the years stated in paragraph c. of this section. Applicant must pay lender(s) these payments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. Serve his or her period of obligated faculty service as contracted with the school and as determined by the Secretary
to be acceptable.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. Serve in accordance with paragraph b. of this section for 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 years at 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=7 f=2 -->
XXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. The applicant must serve a minimum of two years.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00074 </DOCNO>
<PARENT> FR940112-2-00054 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2. If the applicant's eligibility to participate in the Faculty Loan Repayment Program is based on section 738(a)(2)
of the Act (i.e. based on his or her enrollment in an accredited health professions school), he or she also agrees to:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Maintain full-time enrollment, (as determined by the School), in good academic standing as determined by the School,
in the final year of the course of study leading to a degree in medicine, osteopathic medicine, dentistry, pharmacy,
podiatric medicine, optometry, veterinary medicine, nursing, or public health, or schools offering graduate programs
in clinical psychology in which the applicant is currently enrolled, until completion of such course of study;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
b. Enter into a contract with an accredited school described in subsection (a) of Section 738 to serve as a ``new'' member
of the faculty of the school for not less than 2 years according to the requirements described in subsection (a)(5)
of section 738.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
c. Begin service obligations as contracted.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section C_Breach of Written Loan Repayment Contract
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
1. If the participant fails to comply with section B.1.c. of this contract or is dismissed for disciplinary reasons
or voluntarily terminates the contracts, neither the Secretary nor the School is obligated to continue loan repayments
as stated in Sec. A of this Contract. The participant shall be liable to the United States and the School for the amounts
specified in paragraph 2 of this section.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
2. If the applicant agrees to serve as a full-time faculty member for two years or more and fails to serve the 2-year minimum
requirement, he or she is liable to pay monetary damages to the United States amounting to the sum of (a) the total amounts
specified in Section A.2 of this contract plus (b) an ``unserved obligation penalty'' of $1,000 for each month unserved
as set forth in paragraph 3 of this section plus (c) any tax assistance paid plus (d) interest, penalties and administrative
charges for past due payments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. The ``Unserved Obligation Penalty'' means the amount equal to the number of months of obligated services that were
not completed by an individual, multiplied by $1,000 except that in any case in which the individual fails to serve
1 year, the unserved obligation penalty shall be equal to the full period of obligated service multiplied by $1,000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. If the applicant agrees to serve more than the 2-year minimum service obligations and has completed the 2-year minimum
he or she will be liable for such sums paid for any months that are not a full year beyond the 2-year minimum requirement
as agreed to in Section B.1.c of this contract, plus an ``unserved obligation penalty'' of $1,000 for each month unserved.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. Any amount the United States is entitled to recover shall be paid within one year of the date the Secretary determines
that the applicant is in breach of this written contract. Failure to pay by the due date will incur delinquent charges
provided by Federal Law. (45 CFR 30.13).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Section D_Cancellation, Suspension, &amp; Waiver of Obligation
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any service or payment obligation may be canceled, suspended, or waived under certain circumstances described below:
(1) In the event of death or permanent and total disability, the Secretary will cancel obligations under this contract.
To receive cancellation in the event of death, the executor of the estate must submit an official death certificate
to the Secretary. To receive cancellation for permanent and total disability, applicant or his/her representative
must apply to the Secretary, submitting medical evidence of my condition, and the Secretary may cancel this obligation
in accordance with applicable Federal statutes and regulations; (2) Upon receipt of supporting documentation the
Secretary may waive or suspend service or payment obligation under this contract if the Secretary determines that:
(a) meeting the terms and conditions of the contract is impossible or would involve extreme hardship; and (b) enforcement
of the obligations would be unconscionable. (3) Deferment will be granted in the event of long term illness. Supporting
documentation should be sent to: Division of Disadvantaged Assistance, Room 8A&hyph;09 Parklawn Building, 5600
Fishers Lane, Rockville, MD 20857.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Secretary or his/her authorized representative must sign this contract before it becomes effective.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Applicant Name (Please Print)
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=7 f=2 -->
XXXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Applicant Signature*
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=7 f=2 -->
XXXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
*
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Before signing, be sure you have completed section B.1.c. on page 1 of this contract indicating the number of years
of service you agree to perform.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Date
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=7 f=2 -->
XXXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Secretary of Health and Human Services or Designee
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=7 f=2 -->
XXXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Date
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=7 f=2 -->
XXXXXXXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;669 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;15&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00075 </DOCNO>
<PARENT> FR940112-2-00055 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Advisory Council; Meeting </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92&hyph;463), announcement
is made of the following National Advisory bodies scheduled to meet during the month of February 1994:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Council on Graduate Medical Education. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Time: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
February 2&hyph;3, 1994, 8:30 a.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Conference Rooms G &amp; H on 2/2 and Rooms D &amp; E on 2/3, Parklawn Building, 5600 Fishers Lane, Rockville, MD 20857.
Open for entire meeting. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Provides advice and recommendations to the Secretary and to the Committees on Labor and Human Resources, and Finance
of the Senate and the Committees on Energy and Commerce and Ways and Means of the House of Representatives, with respect
to (A) the supply and distribution of physicians in the United States; (B) current and future shortages of physicians
in medical and surgical specialties and subspecialties; (C) issues relating to foreign medical graduates; (D) appropriate
Federal policies regarding (A), (B), and (C) above; (E) appropriate efforts to be carried out by medical and osteopathic
schools, public and private hospitals and accrediting bodies regarding matters in (A), (B), and (C) above; (F) deficiencies
in the needs for improvements in, existing data bases concerning supply and distribution of, and training programs
for physicians in the United States. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Agenda: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
There will be presentations and discussions regarding Recommendations from COGME Work Groups, Assessing the Impact
of Physician Assistants on Physician Workforce Requirements; Implications of Managed Care for Workforce Requirements
and the Training Environment; and Women in Medicine. A presentation on Communication from the National Advisory
Council on Nurse Education and Practice: Update on Nurse Practitioner/Certified Nurse Midwife Work Group. 
<!-- PJG 0012 frnewline -->
Anyone requiring information regarding the subject Council should contact Marc L. Rivo, M.D., M.P.H.. Executive
Secretary, telephone (301) 443&hyph;6190; or F. Lawrence Clare, M.D., M.P.H., Deputy Executive Secretary, telephone
(301) 443&hyph;6326, Council on Graduate Medical Education, Division of Medicine, Bureau of Health Professions,
Health Resources and Services Administration, room 4C&hyph;25, Parklawn Building, 5600 Fishers Lane, Rockville,
Maryland 20857. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Name: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
National Advisory Committee on Rural Health. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Date and Time: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
February 7&hyph;9, 1994; 8:30 a.m. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Place: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Washington Marriott, 22nd and M Streets, NW., Washington, DC 20037, (202) 872&hyph;1500. The meeting is open to the
public. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Purpose: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The Committee provides advice and recommendations to the Secretary with respect to the delivery, financing, research,
development and administration of health care services in rural areas. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Agenda: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Plenary session on Monday, February 7, will be devoted to the theme: ``The Health Security Act and Health Care Reform
in Rural Areas.'' The theme will include discussions and presentations on the changes which have occurred since the
last meeting regarding general infrastructure development, network development, and implications for states.
In addition, a presentation regarding the difficulties of obtaining public health services in minority rural communities
will be provided. 
<!-- PJG 0012 frnewline -->
Monday afternoon and all day Tuesday, the Health Care Financing Work Group and the Education and Health Services Work
Group will continue to study specific areas of the Health Security Act and its effect on services and financing in rural
health delivery systems. 
<!-- PJG 0012 frnewline -->
The meeting will end on Wednesday, February 9, with reports from the two Work Groups. The entire meeting is open to the
public. 
<!-- PJG 0012 frnewline -->
Anyone requiring information regarding the subject Council should contact Jeffery Human, Executive Secretary,
National Advisory Committee on Rural Health, Health Resources and Services Administration, room 9&hyph;05, Parklawn
Building, 5600 Fishers Lane, Rockville, Maryland 20857, Telephone (301) 443&hyph;0835, FAX (301) 443&hyph;2803.

<!-- PJG 0012 frnewline -->
Persons interested in attending any portion of the meeting should contact Ms. Arlene Granderson, Director of Operations,
Office of Rural Health Policy, Health Resources and Services Administration, Telephone (301) 443&hyph;0835. 
<!-- PJG 0012 frnewline -->
Agenda Items are subject to change as priorities dictate.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jackie E. Baum, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Advisory Committee Management Officer, HRSA. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;707 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;15&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00076 </DOCNO>
<PARENT> FR940112-2-00056 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Public Health Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Centers for Disease Control and Prevention; Statement of Organization, Functions, and Delegations of Authority</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Part H, Public Health Service (PHS), Chapter HC (Centers for Disease Control and Prevention), of the Statement of
Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (45 FR 67772&hyph;67776,
dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 58 FR 59052&hyph;59054,
November 5, 1993) is amended to reflect the following organizational changes within the National Center for Health
Statistics: (1) Modify the functional statement for the Office of Planning and Extramural Programs, and (2) retitle
the Office of Analysis and Epidemiology and modify the functional statement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Following the title Office of Planning and Extramural Programs (HCS14), delete the functional statement in its entirety
and insert the following: (1) Participates in the development of policy, long-range plans, and programs of the Center;
(2) develops proposed policies for the coordination of NCHS programs with external agencies, both public and private;
(3) serves as the focal point for coordination of health statistical activities within NCHS and for developing and
coordinating the collaborative statistical activities of NCHS with other organizations and agencies; 
<!-- PJG 0012 frnewline -->
 (4) provides a focus within NCHS for statistical program planning, evaluation, and legislative affairs; 
<!-- PJG 0012 frnewline -->
 (5) evaluates or arranges for the evaluation of the adequacy, completeness, and responsiveness of Center programs
both nationally and internationally to the NCHS mission and user needs for data; 
<!-- PJG 0012 frnewline -->
 (6) directs the definition, development, and coordination of cooperative programs in health statistics, working
with Regional Offices, State and local governments, and other organizations including the private and academic
sectors in the development and strengthening of subnational statistical systems; 
<!-- PJG 0012 frnewline -->
 (7) conducts research, analyses, and demonstrations related to the subnational systems; 
<!-- PJG 0012 frnewline -->
 (8) develops, pilots, and implements new programs through direct activities and through grants and contracts; 
<!-- PJG 0012 frnewline -->
 (9) provides Executive Secretariat and related services to the National Committee on Vital and Health Statistics;
<!-- PJG 0012 frnewline -->
 (10) provides program leadership and coordination for the NCHS Reimbursable Work Program; 
<!-- PJG 0012 frnewline -->
 (11) provides guidance and staff support for major Center conferences and committee meetings; 
<!-- PJG 0012 frnewline -->
 (12) provides advice and assistance to outside agencies and organizations in the conduct of statistical training
activities; 
<!-- PJG 0012 frnewline -->
 (13) participates with appropriate agencies and organizations to improve the quality, comparability, and timeliness
of standard health data sets and to promote and disseminate their use; maintains current information concerning
Federal and non-Federal health statistics systems; 
<!-- PJG 0012 frnewline -->
 (14) serves as principal advisor in areas of financial management activities and manages a system of budgetary and
expenditure controls; 
<!-- PJG 0012 frnewline -->
 (15) coordinates required clearances of Reimbursable Work Program and Human Subjects Review projects.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Delete in its entirety the title and functional statement for the Office of Analysis and Epidemiology (HCS4) and insert
the following:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Office of Analysis, Epidemiology, and Health Promotion (HCS4). (1) Participates in the development of policy, long-range
plans, and programs of the Center; (2) plans, directs, and coordinates the Analysis, Epidemiology, and Health Promotion
Program of the Center; (3) develops policy for the Analysis, Epidemiology, and Health Promotion Program of the Center;
(4) provides operating liaison with other programs of the Center and other public and private health agencies on activities
related to analysis, epidemiology and health promotion; (5) provides consultation and technical assistance to
Federal agencies, States, and other public and private sector institutions in epidemiologic investigations, in
the analysis and interpretation of national health statistics, and in health promotion activities; (6) conducts
developmental and evaluation research and analysis in the fields of epidemiology, health status, health services
utilization, health promotion, and health economics; (7) augments the policy analysis activities of CDC; (8) coordinates
NCHS health statistics activities with CDC, PHS, and other Federal agencies in the areas of environmental health,
injury, minority health, and HIV; (9) conducts environmental health research using national statistical data and
evaluates the utility of environmental health statistics for health program planning, policy analysis, and program
direction; (10) coordinates CDC activities to sustain and enhance State and local statistical capacity; (11) collects
and disseminates sources of current information on the conceptualization and measurement of health status, including
maintenance of a Clearinghouse on Health Indexes.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 17, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Walter R. Dowdle,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, Centers for Disease Control and Prevention.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;746 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4160&hyph;18&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00077 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Social Security Administration</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Social Security Ruling SSR 94&hyph;1c; Supplemental Security Income_Disability_Illegal Activity as Substantial
Gainful Activity </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Social Security Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Social Security ruling. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with 20 CFR 422.406(b)(1), the Commissioner of Social Security gives notice of Social Security Ruling
94&hyph;1c. This Ruling is based on the decision of the U.S. Court of Appeals for the Seventh Circuit in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Dotson 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Shalala, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
which affirmed the U.S. district court decision upholding the decision of the Secretary of Health and Human Services
denying the claimant's application for disability benefits under the supplemental security income program. Among
other things, the court of appeals determined that the decision of the Secretary that the illegal activity in which
the claimant engaged to support a drug addiction constituted substantial gainful activity (SGA) was consistent
with the Social Security Act and the Secretary's regulations and supported by substantial evidence, and that in determining
whether such activity was SGA, the cost of the claimant's narcotics could not be deducted from the claimant's income
as an impairment-related work expense. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 January 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 </DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Joanne K. Castello, Office of Regulations, Social Security Administration, 6401 Security Boulevard, Baltimore,
MD 21235, (410) 965&hyph;1711. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Although we are not required to do so pursuant to 5 U.S.C. 552(a)(1) and (a)(2), we are publishing this Social Security
Ruling in accordance with 20 CFR 422.406(b)(1). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Social Security Rulings make available to the public precedential decisions relating to the Federal old-age, survivors,
disability, supplemental security income, and black lung benefits programs. Social Security Rulings may be based
on case decisions made at all administrative levels of adjudication, Federal court decisions, Commissioner's decisions,
opinions of the Office of the General Counsel, and other policy interpretations of the law and regulations. 
<!-- PJG 0012 frnewline -->
Although Social Security Rulings do not have the force and effect of the law or regulations, they are binding on all
components of the Social Security Administration, in accordance with 20 CFR 422.406(b)(1), and are to be relied upon
as precedents in adjudicating other cases. 
<!-- PJG 0012 frnewline -->
If this Social Security Ruling is later superseded, modified, or rescinded, we will publish a notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to that effect. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance Program No. 93.807 Supplemental Security Income)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 21, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Shirley S. Chater, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Commissioner of Social Security. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00078 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Sections 1611 and 1614(a) of the Social Security Act (42 U.S.C. 1382 and 1382c(a)) Supplemental Security Income_Disability_Illegal
Activity as Substantial Gainful Activity 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=25 g=1 f=1 -->
20 CFR 416.910, 416.920(a)&hyph;(b), 416.971, 416.972(a)&hyph;(c), 416.973(a)&hyph;(b), 416.974 (a)(1), (b)(2)(vii)
and (b)(3)(vii), and 416.976 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Dotson 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=3 -->
Shalala, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1 F.3d 571 (7th Cir. 1993) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The claimant applied for disability benefits under the supplemental security income program, alleging that he was
disabled due to asthma, multiple allergies, and past drug abuse. His application was denied initially and upon reconsideration
and he requested a hearing before an administrative law judge (ALJ). At the hearing, the claimant testified that he
currently used $200&hyph;$300 worth of narcotics each day and that he supported his drug habit through stealing and
panhandling. Based on the claimant's testimony, the ALJ concluded that the claimant's stealing and panhandling
constituted substantial gainful activity (SGA) worth an average of approximately $5,600 per month. Specifically,
the ALJ found that due to the poor area in which the claimant panhandled, the bulk of his income must be derived from stealing,
which the ALJ determined involved significant physical and mental activities. The ALJ concluded that because the
claimant was engaging in SGA, he was not disabled and, therefore, not eligible for disability benefits. The Appeals
Council declined to review the ALJ's decision which became the final decision of the Secretary. The claimant sought
judicial review in Federal district court. The district court upheld the Secretary's decision and the claimant appealed
to the Court of Appeals for the Seventh Circuit. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
On appeal, the claimant argued that illegal activity undertaken to support a drug addiction cannot constitute SGA;
that assuming such activity can constitute SGA, the Secretary's finding of SGA in his case was unsupported by substantial
evidence; and that if illegal activity to support a drug habit can be considered SGA, then the Secretary, in determining
SGA, was required to deduct the cost of the narcotics from the claimant's income as an impairment-related work expense.
Additionally, the claimant contended that using illegal activity as a basis for finding SGA denied him due process
and equal protection of the law. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The court of appeals found nothing in the Social Security Act (the Act) or the Secretary's implementing regulations
which requires SGA to be lawful. The court noted that under the regulations, work activity is substantial if it ``involves
doing significant physical or mental activity'' and is gainful if it is ``the kind of work usually done for pay or profit,
whether or not a profit is realized.'' The court stated that these considerations ``apply with almost equal ease irrespective
of the legality of the activities involved,'' and that, therefore, ``[w]hether legally or illegally employed, the
regulations direct an ALJ to focus on whether the claimant is performing significant physical or mental activities,
and doing so with the intent of earning money or making a profit.'' Finding that neither the Act nor the regulations
recognizes a distinction between lawful and unlawful activity for purposes of determining SGA, the court of appeals
concluded that illegal activity can constitute SGA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The court also determined that the claimant's uncontradicted testimony regarding the thievery in which he engaged
to support his $200&hyph;$300 per day drug habit provided substantial evidence to support the ALJ's finding that
the claimant was engaged in SGA. The court rejected the claimant's contention that the cost of narcotics must be deducted
from his income as an impairment-related work expense. The court noted that to be considered an impairment-related
work expense under the Secretary's regulations, a drug must ``reduce or eliminate'' the symptoms of a claimant's
impairment, or ``slow down its progression.'' Contrary to these criteria, the court found that in this case the claimant's
use of drugs was the basis of his alleged disability, and that his continued usage of drugs only exacerbated his medical
condition. The court also found the claimant's due process and equal protection arguments to be without merit. Accordingly,
the court of appeals affirmed the decision of the district court upholding the Secretary's decision denying the claimant's
application for disability benefits. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Engel, Senior Circuit Judge
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=5 f=1 -->
*
<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
*
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Sitting by designation. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Harold Wayne Dotson, a Supplemental Security Income claimant, appeals the district court's grant of summary judgment
in favor of Donna E. Shalala, Secretary of the Department of Health and Human Services. In granting summary judgment,
the district court upheld an administrative law judge's finding that Dotson was engaging in substantial gainful
activity by supporting a $200- to $300-per-day heroin and cocaine habit through illegal means. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dotson 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
813 F. Supp. 651 (C.D. Ill. 1992). Because we agree that illegal activity can constitute substantial gainful activity,
we affirm.
<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00079 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Background
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson applied for Supplemental Security Income benefits on September 25, 1989, alleging disability since 1968
due to asthma, multiple allergies, and past drug abuse. The Social Security Administration denied his application
on January 10, 1990, and again upon reconsideration on May 21, 1990. Dotson then requested and received a hearing before
an administrative law judge (``ALJ''). At the administrative hearing, Dotson testified that he uses $200 to $300
worth of heroin and cocaine each day. Additionally, he testified that he supports his drug habit by hustling. When
asked to define hustling, Dotson replied: ``steal, beg, whatever, you know.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
With regard to his begging, Dotson stated that he usually panhandles at the Warner Homes, which are located in a poor
neighborhood in Peoria, Illinois. As to Dotson's thievery, the following colloquy occurred during the administrative
hearing: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. [By ALJ] Where do you steal at? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. [By Dotson] You can do that anywhere. Wherever we can find a place to. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Give me an idea. Give me some examples. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. The mall, downtown, wherever. You just ride and look and, you know. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. How long do you spend riding and looking until you find a place to steal? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. As long as you have to. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Like how long? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Sometime_ 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. All day long? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Sometimes it takes all day. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. What kinds of things have you stolen this month? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. This month? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Uh huh. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. I, well, I like to, I try to concentrate on saws. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. On what? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Saws. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Saws? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. You know, the chainsaws, the little bitty chainsaws? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Where do you find those at? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Everywhere, everywhere. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. And once you get them, what do you do with them? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. You sell them. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. To who? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. A lot of people buy. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Well, where do you find_I wouldn't imagine there would be a lot of demand for them in Warner homes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. No. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Where do you go to sell the chainsaws? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Different businesses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Like what? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Small businesses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Give me some examples. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Like small stores or cleaners, different places like that. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. Do you have to travel around to these places? How long does it take you to find somebody to buy a saw? 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. Usually, they already, you have been_you kind of already know they probably want one. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Q. So you have already canvassed these places earlier? You have gone out and_ 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
A. No, you have probably sold them stuff and they can give you kind of an idea about what else they might like, you know.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Based on Dotson's testimony, the ALJ found that Dotson's stealing and panhandling constituted substantial gainful
activity (``SGA'') worth an average of approximately $5,600 per month and, accordingly, denied his claim for SSI
benefits. Specifically, the ALJ found that, due to the poor area in which Dotson panhandles, the bulk of his income
must come from illegal means. As to the nature of Dotson's criminal endeavors, the ALJ concluded: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
In order to steal he must ``case'' the area in which he has determined to steal the property. He must then plan on how he
is going to steal the property and then actually steal it. During the month in which the hearing was held the claimant
was stealing chainsaws. Lifting and carrying the chainsaws would also be significant 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
physical
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 activity. The planning and execution of the larceny entails significant 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
mental
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 activity. From these activities the claimant earns enough money to support his cocaine habit and provide him with
other money in substantial amounts exceeding $200 to $300 a day. [Emphasis in original.] 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On July 9, 1991, the Appeals Council declined to review the ALJ's decision. Dotson then filed the instant action against
the Secretary of the Department of Health and Human Services (``Secretary'') in federal court. On July 1, 1992, with
cross-motions for summary judgment before it, the district court granted the Secretary's motion for summary affirmance
and entered a separate judgment against Dotson and in favor of the Secretary. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dotson 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
813 F. Supp. 651 (C.D. Ill. 1992). This appeal followed.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00080 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Discussion 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson essentially raises four arguments. First, he believes that illegal activities undertaken solely to satisfy
a drug addiction cannot constitute SGA. Second, assuming that illegal activity can constitute SGA, Dotson claims
that the ALJ's finding of SGA in his case is unsupported by substantial evidence. Third, Dotson contends that if illegal
activity undertaken to support a drug habit can constitute SGA, then the Secretary is required to deduct the cost of
the narcotics from the claimant's income as an impairment-related work expense. Fourth and finally, Dotson believes
that using illegal activities to furnish the basis for finding SGA denies him due process and equal protection of the
laws under the United States Constitution. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
A. Overview 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Social Security Act (``Act''), as amended, 42 U.S.C. 301 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 provides for the payment of benefits to disabled persons. Title II of the Act governs the payment of Old-Age, Survivors,
and Disability Insurance (``OASDI'') benefits to disabled persons who have contributed to the Social Security program.
42 U.S.C. 401 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Title XVI of the Act, the title under which Dotson filed his application for benefits, provides for the payment of Supplemental
Security Income (``SSI'') benefits to disabled persons who are indigent. 42 U.S.C. 1382 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
; see generally 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bowen
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Yuckert,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 482 U.S. 137, 140 (1987). Both Titles II and XVI define disability as an ``inability to engage in any substantial gainful
activity by reason of any medically determinable physical or mental impairment which can be expected to result in
death or which has lasted or can be expected to last for a continuous period of not less than twelve months *
<!-- PJG 0060 hspace -->
&blank;9*
<!-- PJG 0060 hspace -->
&blank;9*.'' 42 U.S.C. 423(d)(1)(A), 1382c(a)(3)(A). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 Pursuant to statutory authority, the Secretary has promulgated regulations establishing a five-step sequential
analysis for determining whether an SSI claimant is disabled. See 20 CFR 416.920; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Zebley,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 493 U.S. 521, 525 (1990).
<FOOTCITE>1</FOOTCITE>
 The first step of the process, and the only one relevant for purposes of this appeal, requires the Secretary to determine
whether the claimant is engaging in SGA. See 20 CFR 416.920(a). A finding of SGA means that the claimant is ineligible
for SSI benefits. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 at &sect;416.920(b); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Yuckert,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 482 U.S. at 140. In this case, because the ALJ found that Dotson's stealing and panhandling constituted SGA, he denied
Dotson's claim for benefits without moving to the next step in the sequential analysis.
<FOOTCITE>2</FOOTCITE>
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For other, more generalized, SSI eligibility requirements, see 20 CFR 416.202. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The parties have devoted some attention to the issue of whether panhandling, or the income therefrom, can cause a person
to become ineligible for SSI benefits. We decline to reach this issue. As noted above, the ALJ determined that, due
to the poor area in which Dotson panhandles, the bulk of his income comes from illegal activities. We believe the ALJ's
finding to be supported by substantial evidence and, therefore, leave the panhandling issue to a court with the question
properly before it. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 </FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Illegal Activity as SGA 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Our research reveals that we are the first appellate court to address the issue of whether illegal activity can support
a finding of SGA. The handful of federal trial courts faced with this question, including the district court below,
have answered unanimously in the affirmative.
<FOOTCITE>3</FOOTCITE>
 Because the ALJ and district court's determination that illegal activity can constitute SGA is a construction of
the Secretary's regulations, we review this decision of law 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
de novo.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Johnson
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 922 F.2d 346, 356 (7th Cir. 1990). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Bell
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 817 F. Supp. 719 (N.D. Ill. 1993) (Marovich, J.); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Jones
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 804 F. Supp. 1045 (N.D. Ill. 1992) (Holderman, J.); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Curtis
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 764 F. Supp. 119 (N.D. Ill. 1991) (Bua, J.); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Moore
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 No. 91 C 20369, 1992 WL 199257 (N.D. Ill. Aug. 4, 1992) (Reinhard, J.; unpublished); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Love
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 No. 91 C 7863, 1992 WL 86193 (N.D. Ill. Apr. 22, 1992) (Conlon, J.; unpublished); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Dugan
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Bowen,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 No. 87&hyph;3713, 1989 WL 281911 (S.D. Ill. Nov. 8, 1989) (unpublished), 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
rev'd on other grounds sub nom. Dugan 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 957 F.2d 1384 (7th Cir. 1992); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Hart
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 F. Supp. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
, No. C&hyph;92&hyph;1172 SBA, 1992 WL 496646 (N.D. Cal. Dec. 30, 1992). 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Cf. Hammonds
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Celebrezze,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 260 F. Supp. 992 (N.D. Ala. 1965) (claimant's illegal manufacture of whiskey not conclusive evidence of SGA absent
evidence of earnings). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 </FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
As the definition of disability quoted above indicates, the inability to engage in SGA is a statutory prerequisite
to obtaining either SSI or OASDI benefits. Nonetheless, Congress delegated to the Secretary the responsibility
for defining SGA. 42 U.S.C. 1382c(a)(3)(D) (Title XVI). In response to the Act's mandate, and as the components of
the term suggest, the Secretary has defined SGA as ``work activity that is both substantial and gainful.'' See 20 CFR
416.972. Work activity is substantial if it ``involves doing significant physical or mental activities.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 at &sect;416.972(a). Work activity is gainful if it is ``the kind of work usually done for pay or profit, whether or
not a profit is realized.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 at &sect;416.972(b); see generally 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Callaghan
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Shalala,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 992 F.2d 692 (7th Cir. 1993) (discussing elements of SGA).
<FOOTCITE>4</FOOTCITE>
 Activities such as taking care of one's self, performing household tasks, engaging in hobbies or therapy, and attending
school, clubs, or social programs generally do not constitute SGA. 20 CFR 416.972(c). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For a reconstituted formulation of the above definition, see 20 CFR 416.910, which provides: ``Substantial gainful
activity means work that_(a) Involves doing significant and productive physical or mental duties; and (b) Is done
(or intended) for pay or profit.'' 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00081 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The foregoing framework underscores the dual nature of an ALJ's inquiry into whether a claimant is engaging in SGA.
Under the substantiality prong of the analysis, an ALJ considers the nature of the undertakings comprising the claimant's
work activity. Thus, the degree to which a claimant's work requires the use of ``expertise, skills, supervision and
responsibilities'' becomes relevant in determining whether that work constitutes SGA. See 20 CFR 416.973(a). Additionally,
an ALJ will consider how well a claimant performs his or her work activities:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=21 g=1 f=1 -->
If you do your work satisfactorily, this may show that you are working at the substantial gainful activity level. If
you are unable, because of your impairments, to do ordinary or simple tasks satisfactorily without more supervision
or assistance than is usually given other people doing similar work, this may show that you are not working at the substantial
gainful activity level. If you are doing work that involves minimal duties that make little or no demands on you and
that are of little or no use to your employer, or to the operation of a business if you are self-employed, this does not
show that you are working at the substantial gainful activity level.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 at &sect;416.973(b). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In evaluating the gainfulness of a claimant's work, an ALJ's inquiry is more circumscribed. Here, as noted above,
the claimant's undertakings need be only of the type that normally result in pay or profit. In other words, a claimant
can be found to be engaging in SGA without earning any income. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Callaghan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 992 F.2d at 695&hyph;96 (unprofitable business owner was engaging in SGA).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
5
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This is not to say that a claimant's earnings are irrelevant for purposes of determining whether he or she is engaging
in SGA. See, e.g., 20 CFR 416.974(a)(1). To the contrary, a claimant who earns on average less than $300 per month is
presumed not to be engaging in SGA, while a claimant who makes more than an average of $500 per month is presumptively
ineligible for SSI benefits. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 at &sect;&sect;416.974(b)(3)(vii), (b)(2)(vii).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
6
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 As with most legal presumptions, however, these income guidelines are rebuttable and ``do not relieve an ALJ of the
duty to develop the record fully and fairly.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dugan
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 957 F.2d 1384, 1390 (7th Cir. 1992) (citations and internal quotations omitted). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Accordingly, substantial but non-remunerative volunteer work would fall short of SGA because people normally do
not volunteer their services for pay or profit. See Social Security Law and Practice &sect;37:4 at 8 (Timothy E. Travers
et al. eds., 1987). Evidence of such volunteer work, however, could be used to deny a claimant benefits at a later stage
in the sequential evaluation process. See 20 CFR 416.971. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
In contrast to the OASDI provisions of the Act, the SSI program is particularly concerned with a claimant's financial
situation: 
<!-- PJG 0012 frnewline -->
The basic purpose underlying the supplemental security income program is to assure a minimum level of income for people
who are age 65 or over, or who are blind or disabled and who do not have sufficient income and resources to maintain a standard
of living at the established Federal minimum income level. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 20 CFR 416.110 (emphasis added); see also 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
id
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
. at &sect;416.1100 (``the amount of income you have is a major factor in deciding whether you are eligible for SSI benefits'').
Thus, a claimant not engaging in SGA and otherwise eligible for the SSI program will be denied benefits if he or she has
too much income or too many resources. See 42 U.S.C. 1382(a); generally 20 CFR subpts. K, &sect;416.1100 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
se seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 (income) and L, &sect;416.1201 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 (resources). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 </FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Against this background, Dotson concedes_as he must_that in at least some instances illegal activity can be substantial
gainful activity. Dotson continues, however, that the context in which his thievery occurs precludes its use in determining
whether he has been engaging in SGA. In his own words:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=21 g=1 f=1 -->
A drastic distinction exists between a person who is engaged in illegal activity for effectively the equivalent of
a legal career such as being a drug dealer, illegal drug importer or other illegal activity which has counterparts
in lawful activities such as business managers, business owners and the like, and a thief who steals merely to feed
the cravings of unquenchable drug addiction.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG ITAG l=10 g=1 f=1 -->
Aplnt's. Br. at 18. Considering Dotson's claim under the scheme set forth above, we conclude that he forwards a distinction
without a difference. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00082 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Admittedly, even a cursory examination of the regulations reveals that the Secretary envisioned their application
within a traditional employment context. Importantly, however, nothing in the Act or its regulations specifically
requires SGA to be lawful. This silence, we believe, suggests that illegal activities can constitute SGA. The inference
is strengthened, moreover, when considering that the relevant considerations noted above apply with almost equal
ease irrespective of the legality of the activities involved. Thus, one can envision a number of illegal activities
that might not rise to the level of SGA.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
7
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Whether legally or illegally employed, the regulations direct an ALJ to focus on whether the claimant is performing
significant physical or mental activities, and doing so with the intent of earning money or making a profit. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For example, acting as a lookout at a drug house might constitute a gainful yet insubstantial activity, whereas someone
who chronically engages in acts of vandalism may be substantially, but not gainfully, occupied. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Moreover, it must be remembered that an ALJ performs the SGA analysis as one of five steps used to determine whether
a person is disabled and, consequently, unable to function within our economy. A claimant who can manage through illegal
means is just as undeserving of benefits as a claimant who can survive without violating the law. For this reason, there
is no difference between the addict who spends all of his lawfully derived earnings on narcotics and the one who illegally
obtains, and then exhausts, her income. Both are fueled, to quote Dotson, by the ``cravings of unquenchable drug addiction.''
The only real distinction between the two_the lawfulness of their income_finds no cognizance under the Act and its
interpretive regulations.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
8
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Indeed, were we to hold otherwise, the court would be creating the perverse incentive_although admittedly only at
the margins_for both SSI claimants and recipients to engage in illegal activity because the income therefrom would
be ignored. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Finally, our conclusion that illegal activity can constitute SGA derives substantial support from the well-established
tax principle that unlawful earnings come within the meaning of the term ``gross income'' and are thus taxable. See,

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g., James 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 366 U.S. 213, 218 (1961) (plurality opinion of Warren, C.J.), 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
overruling Commissioner 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Wilcox,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 327 U.S. 404 (1946); 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 274 U.S. 259, 263 (1927). Notably, the Act has adopted the tax code's definition of gross income for purposes of determining
whether a SSI claimant's income is sufficiently high so as to render him or her ineligible for benefits. 42 U.S.C. 1382(d);
see also 20 CFR 416.1110(b).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
9
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Indeed, one of the concerns motivating the plurality in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
James, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
``to remove the incongruity of having the gains of the honest laborer taxed and the gains of the dishonest immune,''
366 U.S. at 218, provides the crux of our reasoning in this case. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Again, however, the resources and income analysis implicated here and discussed at note 6, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
is different from the ALJ's responsibility to determine whether a claimant is engaging in SGA. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Sufficiency of the Evidence 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Having concluded that illegal activity can constitute SGA, we must next determine whether the ALJ properly applied
the legal standard in Dotson's case. Our inquiry is a limited one. We will not decide facts anew, reweigh evidence,
or substitute our judgment for the Secretary's. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Schroeter 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
977 F.2d 391, 394 (7th Cir. 1992). Rather, we look to see whether ``substantial evidence'' supports the ALJ's findings.
See 42 U.S.C. 1383(c)(3) (citing 42 U.S.C. 405(g)). Substantial evidence is ``such relevant evidence as a reasonable
mind might accept as adequate to support a conclusion.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Richardson 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Perales,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 402 U.S. 389, 402 (1977). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Dotson first contends that the ALJ had before him no evidence of specific illegal acts which could support a finding
of SGA. Secondly, he believes the ALJ erroneously assumed that he paid full street-value for the narcotics he used
and, thus, overestimated the amount of income needed to support his drug habit. We address each claim in order.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Dotson also argues that the ALJ erred by underestimating the amount of money he earned through panhandling. As we discussed
at note 2, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
the ALJ's decision to discount Dotson's panhandling income_because of the poor area in which he begs_is supported
by substantial evidence. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson's first claim, that the record lacks any evidence of illegal activities, is belied by his own testimony and
by the reasonable inferences drawn therefrom by the ALJ. For example, when the ALJ asked Dotson to describe what types
of items he had stolen in the month during which the administrative hearing was held, Dotson replied: ``I try to concentrate
on saws.&blank; *&blank;*&blank;*&blank; You know, the chainsaws, the little bitty chainsaws.'' Dotson then went
on to explain, in some detail, how he would sell the stolen items. Additionally, the ALJ made at least one specific inquiry
into the substantiality of Dotson's activities, asking him how long it takes him to find a place to steal. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
We grant to Dotson his point that the record contains no evidence concerning any specific act of thievery. Also, we
agree with him that the ALJ could have more fully developed the record as to the nature of his criminal undertakings.
Nevertheless, we cannot say that the record before us contains less than substantial evidence that Dotson's thievery
required the significant use of his physical and mental skills, and that those skills were applied within a context
designed to produce pay or profit. See 20 CFR 416.972 (a), (b). In short, Dotson's testimony allowed the ALJ to reasonably
conclude that the effort required to steal the chainsaws with regularity constituted SGA, and we therefore uphold
this aspect of the ALJ's decision. A more exacting inquiry, while desirable, was not required. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00083 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson's second argument, that the ALJ overestimated the cost of the narcotics, is also unpersuasive. As an initial
matter, this claim suffers from the same weakness that proved fatal to his first argument, that is, Dotson testified
without contradiction to using $200 to $300 worth of heroin and cocaine daily.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
11
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 If Dotson actually paid less for his narcotics, one would have expected him to testify accordingly. Furthermore,
this case is unlike 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Curtis 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 764 F. Supp. 119 (N.D. Ill. 1991), where the ALJ simply imputed to the claimant an income sufficient to satisfy his addiction.
In that case, the ALJ concluded, in the absence of evidence as to legal or illegal employment, that the claimant had
to be engaging in SGA in order to support his expensive drug habit. Here, on the other hand, Dotson's testimony as to
his thievery filled the gap. From this, the ALJ was justified in finding that Dotson's earnings surpassed $500 per
month, thereby rendering him presumptively ineligible for SSI benefits. See 20 CFR 416.974(b)(2)(vii). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Moreover, this is not an instance where the claimant's testimony was of such dubious veracity that the ALJ should have
discredited it. Dotson's claim to spending $200 to $300 per day on heroin and cocaine, while on the high side, is certainly
within the realm of possibility. See, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
e.g., Hart 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Sullivan,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 F. Supp. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=7 f=2 -->
XXX
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
, No. C&hyph;92&hyph;1172 SBA, 1992 WL 496646 (N.D. Cal. Dec. 30, 1992) (claimant ``presently consumes seven or eight
twenty-dollar bags of heroin daily *&blank;*&blank;*, uses crack every night *&blank;*&blank;*, and drinks approximately
eight half-pints of hard liquor daily''). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
We agree with the court in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Curtis 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
that simply because a claimant has a severe and expensive drug habit does not mean that the person is engaging in SGA
to support it. 764 F. Supp. at 120&hyph;21. The record must contain substantial evidence, of the type outlined in Section
II(B), 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, that the claimant is engaging in legal or illegal activities that are substantial and gainful. Because we have held
that the ALJ's decision in this case comports with those requirements, we reject Dotson's challenge to the evidence
supporting the Secretary's decision. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
D. Narcotics as an Impairment-Related Work Expense 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson next raises the interesting yet ultimately unavailing argument that, if illegal activities undertaken to
maintain a drug habit can constitute SGA, then the cost of the narcotics must be deducted from income as an impairment-related
work expense (``IRWE'') under 42 U.S.C. 1382a(b)(4)(B)(ii) and its interpretive regulations, 20 CFR 416.976. As
we discuss below, Dotson misapprehends the nature of IRWEs. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
42 U.S.C. 1382a(b)(4)(B)(ii), enacted as part of the Social Security Disability Amendments of 1980, Public Law No.
96&hyph;265, 94 Stat. 441 (1980), provides: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
In determining the income of an individual (and his eligible spouse) there shall be excluded *&blank;*&blank;* if
such individual (or such spouse) is disabled but not blind (and has not attained age 65, or received benefits under
this subchapter (or aid under a State plan approved under section 1352 or 1382 of this title) for the month before the
month in which he attained age 65) *&blank;*&blank;* such additional amounts of earned income of such individual,
if such individual's disability is sufficiently severe to result in a functional limitation requiring assistance
in order for him to work, as may be necessary to pay the costs (to such individual) of attendant care services, medical
devices, equipment, prostheses, and similar items and services (not including routine drugs or routine medical
services unless such drugs or services are necessary for the control of the disabling condition) which are necessary
(as determined by the Secretary in regulations) for that purpose, whether or not such assistance is also needed to
enable him to carry out his normal daily functions, except that the amounts to be excluded shall be subject to such reasonable
limits as the Secretary may prescribe. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
See also 42 U.S.C. 1382c(a)(3)(D) (restating same). In 1983, the Department of Health and Human Services promulgated
20 CFR 416.976. See 48 FR 21940 (1983). These regulations established a five-part test for determining the deductibility
of an IRWE: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
We will deduct impairment-related work expenses if_
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) You are otherwise disabled&blank;*&blank;*&blank;*; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) The severity of your impairment(s) requires you to purchase (or rent) certain items and services in order to work;

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(3) You pay the cost of the item or service&blank;*&blank;*&blank;*; 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(4) You pay for the item or service in accordance with paragraph (d) of this section; and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(5) Your payment is in cash (including checks and other forms of money). Payment in kind is not deductible. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
20 CFR 416.976(b). With respect to the deductibility of drugs as an IRWE, the regulations provide:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
If you must use drugs *&blank;*&blank;* to control your impairment(s), the payments you make for them may be deducted.
The drugs or services must be prescribed (or utilized) to reduce or eliminate the symptoms of your impairment(s) or
to slow down its progression. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=37 g=1 f=1 -->
* * * * *
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Examples of deductible drugs *&blank;*&blank;* are anticonvulsant drugs to control epilepsy *&blank;*&blank;*;
antidepressant medication for mental disorders; medication used to allay the side effects of certain treatments;*&blank;*&blank;*
and immunosuppressive medications that kidney transplant patients regularly take to protect against graft rejection.

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=1 -->
20 CFR 416.976(c)(5)(i), (ii). Consistent with the Act's objective, use of the drugs must be necessary to allow the
person to perform work. See Soc. Sec. R. 84&hyph;26 at 18 (1984) (``Routine drugs *&blank;*&blank;* are `needed'
when they are required to control the disabling condition, thereby enabling the individual to function at work.'').

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00084 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson argues that, due to the severity of his drug addiction, he needs the cocaine and heroin in order for him to steal
and panhandle. (Of course, he steals and panhandles so that he can purchase more cocaine and heroin, so that he can continue
to steal and panhandle_and thus the cycle of addiction continues.) Because he needs the narcotics in order to engage
in SGA, Dotson continues, he believes that the cost of the cocaine and heroin should be deducted from his earnings as
an IRWE.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Sadly, we have no reason to disbelieve Dotson's self-characterization. Unfortunately for him, however, the regulations
comprehend more than mere addiction to a substance before the cost of that substance will be considered an IRWE. As
the statute and regulations reveal, a number of obstacles lie in the path of Dotson's argument. We content ourselves,
however, to focus upon the requirement that in order to be an IRWE a drug must ``reduce or eliminate'' the symptoms of
a claimant's impairment, or ``slow down its progression.'' 20 CFR 416.976(c)(5)(i). In the face of Dotson's claim
that his disability stems from drug abuse, he cannot hope to maintain the argument that his continued use of heroin
and cocaine reduces or eliminates the symptoms of his impairment. Rather, Dotson's use of drugs serves as the basis
of his alleged disability. And far from slowing Dotson's dependency upon narcotics, his continued use of heroin and
cocaine only exacerbates his disability. With these considerations in mind, we must reject Dotson's claim for an
IRWE. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
E. The Constitutional Claims
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson lastly argues that using illegal activity to constitute SGA violates his rights to due process and equal protection
of the laws under the United States Constitution, although he has encountered some difficulty in articulating the
precise nature of his constitutional complaints. It would seem that his due process argument_one which might be more
properly construed as an administrative challenge to the regulations_reduces to the theory that the ALJ's decision
in this case attempts to override Congress' intent to provide SSI benefits to substance abusers and, therefore, is
void for want of a rational basis. His equal protection claim, on the other hand, appears based on the assertion that,
under the Secretary's position, rich drug addicts will be treated preferentially to the disadvantage of poor ones.
We briefly address each of his arguments. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Due Process
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
To establish a due process violation, Dotson faces the well-settled and formidable burden of proving that the Secretary's
regulations, as we have interpreted them, lack a rational basis. See, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g., Weinberger 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Salfi, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
422 U.S. 749, 768 (1975) (``the Due Process Clause can be thought to interpose a bar only if the statute [or, as here,
a regulation] manifests a patently arbitrary classification, utterly lacking in rational justification [citation
omitted]''). Moreover, that rational basis need not be expressed explicitly by Congress or the administrative agency;
``any state of facts reasonably may be conceived to justify it.'' 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dandridge 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Williams, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
397 U.S. 471, 485 (1970) (citation omitted).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Initially, we note that interpreting the Secretary's regulations as allowing illegal activity to constitute SGA
does not interfere with Congress' intent, assuming there is one, to provide disability benefits to substance abusers.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Rather, such an interpretation prevents only those substance abusers who are engaging in SGA, whether legally or
illegally employed, from receiving SSI benefits reserved for disabled persons who are also poor. See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Bowen 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Yuckert, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
482 U.S. 137, 140 (1987) (``Title XVI of the Act provides for the payment of disability benefits to indigent persons
*&blank;*&blank;*.'' [Emphasis added.]) Thus, the Secretary's regulations coincide with the SSI program's underlying
purpose.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
We are inclined to agree with Dotson that Congress has envisioned the application of the Act to substance abusers.
See, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
e.g., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
42 U.S.C. 1382(e)(3)(A) (requiring SSI recipients who are alcoholics or drug addicts to undergo treatment as a condition
of receiving disability benefits); 42 U.S.C. 1383(a)(2)(A)(ii) (providing for payment of SSI benefits to alcoholics
and drug addicts through representative payees).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Moving to the next level, Dotson's myopic view of Congress' intent in the statutory context serves to highlight the
flaw in his constitutional argument. Simply put, we cannot say that regulations which preclude the disbursement
of federal disability benefits to persons who are engaging in substantial and gainful activity, regardless of the
activity's legality, constitutes a ``patently arbitrary classification'' warranting judicial intervention.
To the contrary, working within a system where the limited supply of federal funds will never satisfy the deserving
demand, we are hard pressed to think of a better dividing line than the one drawn by the Secretary. Having said this much,
we must reject Dotson's due process claim.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Equal Protection
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson faces an equally difficult burden when arguing to this court that the Secretary's regulations violate the
equal protection component of the Fifth Amendment. Because a statute's or regulation's differential impact upon
the poor versus the wealthy, by itself, does not subject that distinction to strict judicial scrutiny, see, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g., Kadrmas 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Dickinson Public Schools, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
487 U.S. 450, 458 (1988), Dotson must prove that the classification drawn by the Secretary's regulations fails to
rationally further a legitimate interest, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Zobel 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Williams, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
457 U.S. 55, 60 (1982). Under such a standard, Dotson's constitutional claim again must fail.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00085 </DOCNO>
<PARENT> FR940112-2-00057 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Dotson argues that the Secretary's position, if implemented, will hurt only poor drug abusers because rich ones,
who presumably will have paid into the Social Security system, will be eligible to receive OASDI benefits under Title
II of the Act. This argument misses the mark for the simple reason that OASDI claimants, just like SSI claimants, must
navigate the same five-step administrative process, the first of which requires that the claimant not be engaging
in SGA. Compare 42 U.S.C. 423(d)(1)(A) and 20 CFR &sect;404.1520(a) (Title II) with 42 U.S.C. 1382c(a)(3)(A) and
20 CFR &sect;416.920(a) (title XVI).
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Even if Dotson could maintain such an argument, we would be inclined to reject it because the Secretary's classification
seems rationally to further the legitimate interest of rewarding those persons with a prior attachment to the work
force who have contributed to the Social Security system.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Dotson's argument would become relevant in two situations, the first of which is beyond the court's powers generally
and the second of which is not implicated in this appeal. The first scenario involves a wealthy addict who is able to
satisfy his or her addiction without resort to the welfare system. Such a person, of course, is better off than Dotson,
but this disparity yields him no cause of action. In the second scenario, a wealthy addict who is not engaging in SGA,
but who has paid into the Social Security system, applies for and receives OASDI benefits. This person, again undoubtedly
better off than Dotson, presumably would be ineligible for SSI benefits due to an excess of resources and income. See
generally note 6, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
Importantly, however, Dotson is not in a position to make this argument because the ALJ below did not deny him benefits
based on his income or resources, but rather based on the fact that Dotson was engaging in SGA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The judgment of the district court is affirmed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;657 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4190&hyph;29&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00086 </DOCNO>
<PARENT> FR940112-2-00058 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Agreement on Social Security Between the United States and Luxembourg; Entry Into Force </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commissioner of Social Security gives notice that an agreement coordinating the United States (U.S.) and Luxembourg
social security systems entered into force on November 1, 1993. The agreement with Luxembourg, which was signed on
February 12, 1992, is similar to U.S. social security agreements already in force with fifteen other countries_Austria,
Belgium, Canada, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Sweden,
Switzerland, and the United Kingdom. Agreements of this type are authorized by section 233 of the Social Security
Act. 
<!-- PJG 0012 frnewline -->
Like the other agreements, the U.S.-Luxembourg agreement eliminates dual social security coverage_the situation
that occurs when a person from one country works in the other country and is required, along with his employer, to pay
social security taxes to both countries on the same earnings. Under the U.S.-Luxembourg agreement, a worker who is
sent by an employer in the U.S. to work in Luxembourg for 5 years or less remains covered only by the U.S. system. The agreement
includes additional rules that eliminate dual U.S. and Luxembourg coverage in other work situations. 
<!-- PJG 0012 frnewline -->
The agreement also helps eliminate situations where workers suffer a loss of benefit rights because they have divided
their careers between the two countries. Under the agreement, workers may qualify for partial U.S. or Luxembourg
benefits based on combined (totalized) work credits from both countries. 
<!-- PJG 0012 frnewline -->
Individuals who wish to obtain copies of the agreement or want more information about its provisions may write to the
Social Security Administration, Office of International Policy, Post Office Box 17741, Baltimore, Maryland 21235.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 25, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Shirley S. Chater,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Commissioner of Social Security.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;735 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4190&hyph;29&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00087 </DOCNO>
<PARENT> FR940112-2-00059 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Social Security Ruling SSR 94&hyph;2p; Title XVI: Workers' Compensation (WC) Payments </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Social Security Administration, HHS.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of social security ruling.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with 20 CFR 422.406(b)(1), the Commissioner of Social Security gives notice of Social Security Ruling
94&hyph;2p. This Policy Interpretation Ruling clarifies the Social Security Administration's (SSA) longstanding
policy that, under the supplemental security income program, any portion of a workers' compensation (WC) payment
designated by the authorizing or paying agency for medical expenses, or for legal or other expenses attributable
to obtaining the WC award is not income. These expenses may be past, current, or future.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 January 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Joanne K. Castello, Office of Regulations, Social Security Administration, 6401 Security Boulevard, Baltimore,
MD 21235, (410) 965&hyph;1711.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Although we are not required to do so pursuant to 5 U.S.C. 552 (a)(1) and (a)(2), we are publishing this Social Security
Ruling in accordance with 20 CFR 422.406(b)(1).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Social Security Rulings make available to the public precedential decisions relating to the Federal old-age, survivors,
disability, supplemental security income, and black lung benefits programs. Social Security Rulings may be based
on case decisions made at all administrative levels of adjudication, Federal court decisions, Commissioner's decisions,
opinions of the Office of the General Counsel, and other policy interpretations of the law and regulations.
<!-- PJG 0012 frnewline -->
Although Social Security Rulings do not have the force and effect of the law or regulations, they are binding on all
components of the Social Security Administration, in accordance with 20 CFR 422.406(b)(1), and are to be relied upon
as precedents in adjudicating other cases. 
<!-- PJG 0012 frnewline -->
If this Social Security Ruling is later superseded, modified, or rescinded, we will publish a notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to that effect.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Catalog of Federal Domestic Assistance Program No. 93.807 Supplemental Security Income)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Shirley S. Chater,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Commissioner of Social Security.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Policy Interpretation Ruling
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Title XVI: Workers' Compensation (WC) Payments 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Purpose:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To clarify that, under the supplemental security income (SSI) program, any portion of a WC payment designated for
medical expenses, or for legal or other expenses attributable to obtaining the WC award is not income. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Citations (Authority):
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Section 1612(a)(2)(B) of the Social Security Act (SSACT), as amended; Regulations No. 16, sections 416.1103(a),
416.1121(a), and 416.1123(b)(3) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Pertinent History: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
WC is awarded to an injured employee or to the survivor(s) of an employee under Federal and State WC programs and the
Longshoremen and Harbor Workers' Act. It may be paid by a Federal or State agency, an insurance company, or an employer.
Payments may include amounts for medical expenses, or for legal or other expenses attributable to obtaining the WC
award. These expenses may be past, current, or future and may be lump-sum or periodic in nature.
<!-- PJG 0012 frnewline -->
The SSACT at section 1612(a)(2)(B), and regulations at 
<!-- PJG 0012 frnewline -->
20 CFR 416.1121(a) provide that WC is unearned income for SSI purposes. Regulations at 20 CFR 416.1123(b)(3) provide
for counting less than the amount actually received when part of the amount received is for an expense of obtaining
the income. Regulations at 20 CFR 416.1103(a) provide that reimbursement for certain medical expenses is not income.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Policy Interpretation:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 If the Federal or State agency, insurance company, or employer that authorizes or makes a WC payment designates any
portion of it for medical expenses, or for legal or other expenses attributable to obtaining the WC award, such portion
is not income for SSI purposes. The expenses may be past, current, or future. Any portion of a WC award or payment not
designated for such expenses is unearned income. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Effective Date:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 This Ruling merely clarifies longstanding SSI policy on the treatment of WC payments designated for certain types
of expenses. If a case comes to SSA's attention where SSA did not apply this policy, SSA will reopen and revise the earliest
determination possible under the rules of administrative finality. SSA will use the 2-year reopening rule, treating
the determination as an error on the face of the evidence.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Cross-Reference:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Program Operations Manual System, Part 5, Chapter 008, Subchapter 30, Section SI 00830.235.
<!-- PJG /ITAG -->

<!-- PJG QTAG 03 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;658 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4190&hyph;29&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00088 </DOCNO>
<PARENT> FR940112-2-00060 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;93&hyph;3699]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Notice of Submission of Proposed Information Collection to OMB</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of Administration, HUD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The proposed information collection requirement described below has been submitted to the Office of Management
and Budget (OMB) for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments
on the subject proposal.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal
by name and should be sent to: Joseph F. Lackey, Jr., OMB Desk Officer, Office of Management and Budget, New Executive
Office Building, Washington, DC 20503.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Kay F. Weaver, Reports Management Officer, Department of Housing and Urban Development, 451 7th Street, Southwest,
Washington, DC 20410, telephone (202) 708&hyph;0050. This is not a toll-free number. Copies of the proposed forms
and other available documents submitted to OMB may be obtained from Ms. Weaver.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Department has submitted the proposal for the collection of information, as described below, to OMB for review,
as required by the Paperwork Reduction Act (44 U.S.C. chapter 35).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Notice lists the following information: (1) The title of the information collection proposal; (2) the office
of the agency to collect the information; (3) the description of the need for the information and its proposed use;
(4) the agency form number, if applicable; (5) what members of the public will be affected by the proposal; (6) how frequently
information submissions will be required; (7) an estimate of the total number of hours needed to prepare the information
submission including number of respondents, frequency of response, and hours of response; (8) whether the proposal
is new or an extension, reinstatement, or revision of an information collection requirement; and (9) the names and
telephone numbers of an agency official familiar with the proposal and of the OMB Desk Officer for the Department.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Section 3507 of the Paperwork Reduction Act, 44 U.S.C. 3507; Section 7(d) of the Department of Housing and Urban Development
Act, 42 U.S.C. 3535(d).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 14, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Kay Weaver,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Director, IRM Policy and Management Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice of Submission of Proposed Information Collection to OMB
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Proposal:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Notice of Fund Availability for HOPE for Public and Indian Housing Homeownership Program (HOPE 1) (FR&hyph;3501).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Public and Indian Housing.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of the need for the information and its proposed use:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The purpose of this information collection is to provide grants to Resident Councils, Resident Management Corporations,
Public Housing Authorities, and Indian Housing Agencies. They will use the grants to plan and implement the conversion
of public housing to public housing resident and low income homeownership.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form number:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 None.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 State or local Governments, businesses or other for-profit, and non-profit institutions.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of submission:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Semi-annually and recordkeeping.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reporting burden:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 8,L1,tp0,i1,s175,12,xls10,12,xls10,10,xls10,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank; 
<!-- PJG 007 0150 intable -->
1Number of respondents 
<!-- PJG 007 0150 intable -->
1&times; 
<!-- PJG 007 0150 intable -->
1Frequency of response 
<!-- PJG 007 0150 intable -->
1&times; 
<!-- PJG 007 0150 intable -->
1Hours per response 
<!-- PJG 007 0150 intable -->
1= 
<!-- PJG 007 0150 intable -->
1Burden hours
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Information Collection 
<!-- PJG 007 0104 intable -->
100 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
91 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
9,100
<!-- PJG 0012 frnewline -->
Recordkeeping 
<!-- PJG 007 0104 intable -->
100 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
40 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
4,000
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Total estimated burden hours:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 13,100.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Status:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Reinstatement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Gary Van Buskirk, HUD, (202) 708&hyph;4233; Joseph F. Lackey, Jr., OMB, (202) 395&hyph;7316.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 14, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;689 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00089 </DOCNO>
<PARENT> FR940112-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;93&hyph;3700]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Notices of Submission of Proposed Information Collections to OMB</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of Administration, HUD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notices.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The proposed information collection requirements described below have been submitted to the Office of Management
and Budget (OMB) for review, as required by the Paperwork Reduction Act. The Department is soliciting public comment
on the subject proposals.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested persons are invited to submit comment regarding these proposals. Comments should refer to the proposal
by name and should be sent to: Joseph F. Lackey, Jr., OMB Desk Officer, Office of Management and Budget, New Executive
Office Building, Washington, DC 20503.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Kay F. Weaver, Reports Management Office, Department of Housing and Urban Development, 451 7th Street, Southwest,
Washington, DC 20410, telephone (202) 708&hyph;0050. This is not a toll-free number. Copies of the proposed forms
and other available documents submitted to OMB may be obtained from Ms. Weaver.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Department has submitted the proposals for the collections of information, as described below, to OMB for review,
as required by the Paperwork, Reduction Act (44 U.S.C. chapter 35).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Notices list the following information: (1) The title of the information collection proposal; (2) the office
of the agency to collect the information; (3) the description of the need for the information and its proposed use;
(4) the agency form number, if applicable; (5) what members of the public will be affected by the proposal; (6) how frequently
information submissions will be required; (7) an estimate of the total number of hours needed to prepare the information
submission including number of respondents, frequency of response, and hours of response; (8) whether the proposal
is new or an extension, reinstatement, or revision of an information collection requirement; and (9) the names and
telephone numbers of an agency official familiar with the proposal and of the OMB Desk Officer for the Department.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Section 3507 of the Paperwork Reduction Act, 44 U.S.C. 3507; Section 7(d) of the Department of Housing and Urban Development
Act, 42 U.S.C. 3535(d).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 27, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John T. Murphy,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, IRM Policy and Management Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00090 </DOCNO>
<PARENT> FR940112-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Notice of Submission of Proposed Information Collection to OMB 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Proposal: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Technical Suitability of Products Program, Section 521 of the National Housing Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Housing. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of the need for the information and its proposed use: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
This information is needed under HUD's Technical Suitability of Products Program to determine the acceptance of
materials and products to be used in structures approved for mortgages insured under the National Housing Act. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
Form number: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
None. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Businesses or other for-profit. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of submission: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On occasion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reporting burden: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 8,L1,tp0,i1,s175,12,xls10,12,xls10,10,xls10,10 -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1
<!-- PJG 0012 frnewline -->
Number of respondents
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Frequency of response 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Hours per response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1=
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Burden hours 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Information Collection 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
50
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
41
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
2,050
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Recordkeeping 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
50
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
1
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
3
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0104 intable -->
150
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Total estimated burden hours: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
2,200. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Extension. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Contact: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Donald R. Fairman, HUD, (202) 708&hyph;7440; Joseph F. Lackey, Jr., OMB, (202) 395&hyph;6880. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 14, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00091 </DOCNO>
<PARENT> FR940112-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice of Submission of Proposed Information Collection to OMB 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Proposal: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Cooperative Membership Exhibit.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Housing.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of the need for the information and its proposed use: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The form is used to provide HUD with a listing of prospective cooperative members totaling not less than the percentage
of cooperative subscribers necessary to validate the presale requirement.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form number: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD&hyph;93203.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individuals or households.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of submission: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On occasion.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reporting burden: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 8,L1,tp0,i1,s175,12,xls10,12,xls10,10,xls10,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=3 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank; 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Number of respondents
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Frequency of response 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Hours per response 
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1=
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Burden hours
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
HUD&hyph;93203 
<!-- PJG 007 0104 intable -->
300 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
.5 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
150
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG 0012 frnewline -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Total estimated burden hours: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
150.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Extension.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Contact: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Kerry J. Mulholland, HUD, (202) 708&hyph;0283 Joseph F. Lackey, Jr., OMB, (202) 395&hyph;7316.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 27, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00092 </DOCNO>
<PARENT> FR940112-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice of Submission of Proposed Information Collection to OMB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Proposal: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Application for HUD/FHA Insured Mortgage.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Housing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of the need for the information and its proposed use: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Form HUD&hyph;92900A and the related documents will determine the eligibility of the borrower and the proposed request
for HUD/FHA mortgage insurance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form number: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD&hyph;92900A, 92561, 92544, and 92900&hyph;WS.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Individuals or households and businesses or other for-profit.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of submission: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On occasion.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reporting burden: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 8,L1,tp0,i1,s175,12,xls10,12,xls10,10,xls10,10 -->

<!-- PJG ITAG l=95 g=1 f=3 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank; 
<!-- PJG 007 0150 intable -->
1Number of respondents 
<!-- PJG 007 0150 intable -->
1&times; 
<!-- PJG 007 0150 intable -->
1Frequency of response 
<!-- PJG 007 0150 intable -->
1&times; 
<!-- PJG 007 0150 intable -->
1Hours per response 
<!-- PJG 007 0150 intable -->
1= 
<!-- PJG 007 0150 intable -->
1Burden hours
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=3 -->
HUD&hyph;92900A and Related Exhibits 
<!-- PJG 007 0104 intable -->
1,000,000 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
.210 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
210,000
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Computations of Buydowns 
<!-- PJG 007 0104 intable -->
20,000 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
.250 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
5,000
<!-- PJG 0012 frnewline -->
Mortgagor Notice of Intent to Satisfy Occupancy 
<!-- PJG 007 0104 intable -->
5,000 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
.005 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
25
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Total estimated burden hours: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
215,025.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Extension.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Contact: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Susan Hoyer, HUD, (202) 708&hyph;2700; Joseph F. Lackey, Jr., OMB, (202) 395&hyph;6880.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 8, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00093 </DOCNO>
<PARENT> FR940112-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice of Submission of Proposed Information Collection to OMB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Proposal: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Mortgagor's Certificate of Actual Cost.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Housing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of the need for the information and its proposed use: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The mortgagor submits this report certifying actual development cost so that HUD can make a determination of mortgage
insurance acceptability and prevent windfall profits. It is also used to provide a base for evaluating housing programs,
labor costs, and physical improvements in connection with construction of multifamily housing.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form number: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
HUD&hyph;92330.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Businesses or other for-profit and non-profit institutions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of submission: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On occasion.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reporting burden: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 8,L1,tp0,i1,s175,12,xls10,12,xls10,10,xls10,10  -->

<!-- PJG ITAG l=95 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank; 
<!-- PJG 007 0150 intable -->
1Number of respondents
<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 007 0150 intable -->
1Frequency of response
<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 007 0150 intable -->
1Hours per response
<!-- PJG 007 0150 intable -->
1=
<!-- PJG 007 0150 intable -->
1Burden hours 
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
HUD&hyph;92330 
<!-- PJG 007 0104 intable -->
500 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
8 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
4,000 
<!-- PJG /ITAG -->

</TABLE>
 
<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Total estimated burden hours: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
4,000.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Status: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Reinstatement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Contact: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Genevieve A. Tucker, HUD, (202) 708&hyph;0283; Joseph F. Lackey, Jr., OMB, (202) 395&hyph;7316.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 22, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00094 </DOCNO>
<PARENT> FR940112-2-00061 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Notice of Submission of Proposed Information Collection to OMB
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Proposal:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Tenant/Homebuyer Data Summary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Office:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Public and Indian Housing.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Description of the need for the information and its proposed use:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The consolidated form HUD&hyph;50058, Tenant/Homebuyer Data Summary, reflects an effort to upgrade and expand
the quality of data received from PHAs, IHAs, and organizations administering the Section 8 Certificate, Voucher
and Moderate Rehabilitation Programs. Based on experience in obtaining tenant data summary information, the form
has been reformatted and data elements significantly modified to more accurately assess the demographic, ethnic
and economic character of assisted housing residents.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Form number:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 HUD&hyph;50058.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Respondents:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 State or local Governments.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Frequency of submission:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Monthly.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Reporting burden:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<TABLE>

<!-- PJG tableformat 8,L1,tp0,i1,s175,12,xls10,12,xls10,10,xls10,10 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=95 g=1 f=1 -->
&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&blank;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Number of respondents
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Frequency of response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1&times;
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Hours per response
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1=
<!-- PJG 0012 frnewline -->

<!-- PJG 007 0150 intable -->
1Burden hours
<!-- PJG 007 0152 intable -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Form HUD&hyph;50058 
<!-- PJG 007 0104 intable -->
4,500 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
916.5 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
1 
<!-- PJG 007 0104 intable -->
&blank; 
<!-- PJG 007 0104 intable -->
4,124,250
<!-- PJG /ITAG -->

</TABLE>

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Total estimated burden hours:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 4,124,250.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Status:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Revision.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Earl Simons, HUD, (202) 708&hyph;0744; Joseph F. Lackey, Jr., OMB, (202) 395&hyph;7316.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 21, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;690 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00095 </DOCNO>
<PARENT> FR940112-2-00062 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Assistant Secretary for Fair Housing and Equal Opportunity</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;93&hyph;3691; FR&hyph;3348&hyph;N&hyph;07] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
State and Local Fair Housing Laws: Initial Determination Concerning Substantial Equivalency of Fair Housing Law
of the State of Arizona 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of the Assistant Secretary for Fair Housing and Equal Opportunity, HUD. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice and request for comments. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 In accordance with 24 CFR 115.6(c) of the Department's regulations, this notice announces the Department's determination
that the fair housing law of the State of Arizona is substantially equivalent, on its face, to the Fair Housing Act.
This notice solicits comments from the public on this determination, and on the proposed determination that the present
practices and past performance of the agency enforcing the fair housing law of the State of Arizona demonstrate that,
in operation, the law provides rights and remedies that are substantially equivalent to those available under the
Fair Housing Act. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comment Due Date: February 11, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Interested persons are invited to submit comments regarding this notice to the Office of General Counsel, Rules Docket
Clerk, room 10276, Department of Housing and Urban Development, 451 Seventh Street, SW., Washington, DC 20410. Communications
should refer to the above docket number and title. A copy of each communication submitted will be available for public
inspection and copying on weekdays between 7:30 a.m. and 5:30 p.m. at the above address. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Marcella O. Brown, Director, Funded Programs Division, Office of Fair Housing and Equal Opportunity, Department
of Housing and Urban Development, 451 Seventh Street, SW., room 5234, Washington, DC 20410, telephone (202) 708&hyph;0455.
(This is not a toll-free number.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG 0012 frnewline -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Under the Fair Housing Act (42 U.S.C. 3600&hyph;3619), the Department is authorized to investigate complaints alleging
discrimination in housing. (Title VIII of the Civil Rights Act of 1968 as amended by the Fair Housing Amendments Act
of 1988 is cited as the ``Fair Housing Act.'') Section 810(f) of the Fair Housing Act requires the Department to refer
complaints to State and local agencies that have ``substantially equivalent'' fair housing standards, as determined
and certified by the Department. The 
<!-- PJG 0012 frnewline -->
standards and procedures for certifying State and local fair housing laws that provide substantive rights and remedies
for alleged discriminatory housing practices that are substantially equivalent to those provided in the Fair Housing
Act are set forth in 24 CFR part 115. 
<!-- PJG 0012 frnewline -->
On July 23, 1993 (58 FR 39561), the Department published the annual notice required by 24 CFR 115.6, which announced,
among other things, the updated, consolidated list of all certified agencies, and a list of agencies with which an
agreement for interim referrals or other utilization of services had been entered into under 24 CFR 115.11. In the
July 23, 1993 notice, the Department listed thirty-four jurisdictions, of which the State of Arizona was one, which
had entered into an agreement with the Department, subsequent to September 12, 1988, for interim referrals, and were
considered to have interim certification in accordance with section 810(f)(4) of the Fair Housing Amendments Act
of 1988 (hereafter ``Act''). (The Fair Housing Amendments Act of 1988 was enacted on September 13, 1988.) 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Notice Announcements and Solicitation of Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In accordance with 24 CFR 115.6(c)(1), this notice announces that the fair housing law of the State of Arizona has been
determined by the Assistant Secretary of Fair Housing and Equal Opportunity to be substantially equivalent, on its
face, to the Fair Housing Act. The Assistant Secretary has determined, after 
<!-- PJG 0012 frnewline -->
application of the criteria set forth in 24 CFR 115.3 and 115.4, that the fair housing law of the State of Arizona provides,
on its face, substantive rights and remedies for alleged discriminatory housing practices that are substantially
equivalent to those provided in the Fair Housing Act. 
<!-- PJG 0012 frnewline -->
Following a review of performance standards and other materials pertaining to the fair housing law of the State of
Arizona, and its enforcement by the State of Arizona, the Department expects to make a final determination that the
law, in operation, provides rights and remedies that are substantially equivalent to those available under the Fair
Housing Act. The Department intends to execute a Memorandum of Understanding with the agency charged with enforcement
of the fair housing law of the State of Arizona in accordance with &sect;115.6(c). 
<!-- PJG 0012 frnewline -->
In accordance with 24 CFR 115.6(b), the public is invited to submit written comments on this notice. Specifically,
the Department requests written comments on the proposed determination that the current practices and past performance
of the agency of the State of Arizona charged with administration and enforcement of the State's fair housing law demonstrate
that, in operation, the State law provides substantive rights and remedies that are substantially equivalent to
the Fair Housing Act. This notice also 
<!-- PJG 0012 frnewline -->
invites comments from the public on the Department's determination that the fair housing law of the State of Arizona
is substantially equivalent, on its face, to the Fair Housing Act. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->
Dated: December 23, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=2 -->
Roberta Achtenberg, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=2 -->
Assistant Secretary for Fair Housing and Equal Opportunity. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=2 -->
[FR Doc. 94&hyph;692 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=2 -->
BILLING CODE 4210&hyph;28&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00096 </DOCNO>
<PARENT> FR940112-2-00063 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=2 -->

<USBUREAU>Office of the Secretary_Office of Lead-Based Paint Abatement and Poisoning Prevention</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=2 -->

<RINDOCK>[Docket No. N&hyph;93&hyph;3701; FR&hyph;3633&hyph;N&hyph;01]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=2 -->
Task Force on Lead-Based Paint Hazard Reduction and Financing; Open Meeting
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of Lead-Based Paint Abatement and Poisoning Prevention, HUD.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of open meetings.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Task Force was established by the Secretary pursuant to section 1015 of the Residential Lead-Based Paint Hazard
Reduction Act of 1992. The charter of the Task Force was approved July 14, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Task Force includes individuals representing the Department of Housing and Urban Development; the Farmers Home
Administration; the Department of Veterans Affairs; the Federal Home Loan Mortgage Corporation; the Federal National
Mortgage Association; the Environmental Protection Agency; employee organizations in the building and construction
trades industry; landlords; tenants; primary lending institutions; private mortgage insurers; single-family
and multifamily real estate interests; nonprofit housing developers; property liability insurers; public housing
agencies; low-income housing advocacy organizations; national, State, and local lead-poisoning prevention advocates
and experts; and community-based organizations located in areas with substantial rental housing. These members
were selected on the basis of personal experience and expert knowledge. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The meetings will be held on February 9, 1994 (9 to 5:30), and February 10th, 1994 (9 to 1), (EST), at the Holiday Inn Capitol,
550 ``C'' St, SW. (corner of 6th &amp; C Streets), Washington, DC 20024.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Members of the public are invited to provide written material to: Ruth Wright, Task Force Staff Director, Department
of Housing and Urban Development, 451 7th Street SW., room B&hyph;133, Washington, DC 20410. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Ruth Wright, Task Force Staff Director, Department of Housing and Urban Development, 451 7th Street SW., room B&hyph;133,
Washington, DC 20410; telephone (202) 755&hyph;1805. The TTD numbers are (202) 708&hyph;9300 or 1&hyph;800&hyph;877&hyph;8339.
(Except for the ``800'' number, these are not toll-free numbers.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The first meeting of the Task Force was on November 8, 1993, in Washington, DC. An announcement will be published in
the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 at least 15 days before each meeting. All meetings will be open to the public, with limited seating available on a first-come,
first-served basis. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The mandate of the Task Force is to make recommendations to the Secretary of HUD and the Administrator of the Environmental
Protection Agency (EPA) concerning: 
<!-- PJG 0012 frnewline -->
(1) Incorporating the need to finance lead-based paint hazard reduction into underwriting standards;
<!-- PJG 0012 frnewline -->
(2) Developing new loan products and procedures for financing lead-based paint hazard evaluation and reduction
activities; 
<!-- PJG 0012 frnewline -->
(3) Adjusting appraisal guidelines to address lead safety; 
<!-- PJG 0012 frnewline -->
(4) Incorporating risk assessments or inspections for lead-based paint as a routine procedure in the origination
of new residential mortgages; 
<!-- PJG 0012 frnewline -->
(5) Revising guidelines, regulations, and educational pamphlets issued by the Department of Housing and Urban Development
and other Federal agencies relating to lead-based paint poisoning prevention; 
<!-- PJG 0012 frnewline -->
(6) Reducing the current uncertainties of liability related to lead-based paint in rental housing, by clarifying
standards of care for landlords and lenders and by exploring the ``safe harbor'' concept; 
<!-- PJG 0012 frnewline -->
(7) Increasing the availability of liability insurance for owners of rental housing and certified contractors and
establishing alternative systems to compensate victims of lead-based paint poisoning; and 
<!-- PJG 0012 frnewline -->
(8) Evaluating the utility and appropriateness of requiring both risk assessments or inspections and notification
to prospective lessees of rental housing. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
42 U.S.C. 4852a, 4852b. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 20, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Arthur S. Newburg, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Director, Office of Lead-Based Paint Abatement and Poisoning Prevention.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;694 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00097 </DOCNO>
<PARENT> FR940112-2-00064 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF THE INTERIOR</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Bureau of Land Management</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK></RINDOCK>
<!-- PJG 0012 frnewline -->
[CO&hyph;920&hyph;94&hyph;4120&hyph;03; COC 55135]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Colorado; Notice of Invitation for Coal Exploration License Application, Basin Resources, Inc. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Pursuant to the Mineral Leasing Act of February 25, 1920, as amended, and to Title 43, Code of Federal Regulations,
Subpart 3410, members of the public are hereby invited to participate with Basin Resources, Inc., in a program for
the exploration of unleased coal deposits owned by the United States of America in the following described lands located
in Las Animas County, Colorado: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
T. 32 S., R. 67 W., 6th P.M. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sec. 31, E1/2SE1/4;
<!-- PJG 0012 frnewline -->
Sec. 32, SW1/4.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
T. 33 S., R. 67 W., 6th P.M. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sec. 6, lots 2 to 7, inclusive, E1/2SW1/4;
<!-- PJG 0012 frnewline -->
Sec. 7, lot 2. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
T. 33 S., R. 68 W., 6th P.M. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sec. 1, lots 1, 2, S1/2NE1/4, and E1/2SE1/4;
<!-- PJG 0012 frnewline -->
Sec. 2, S1/2NE1/4; 
<!-- PJG 0012 frnewline -->
Sec. 12, E1/2NE1/4.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The area described contains approximately 975.75 acres. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The application for coal exploration license is available for public inspection during normal business hours under
serial number COC 55135 at the Bureau of Land Management (BLM) Colorado State Office, 2850 Youngfield Street, Lakewood,
Colorado 80215, and at the Canon City District Office, 3170 East Main Street, Canon City, Colorado 81212. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Written Notice of Intent to Participate should be addressed to the attention of the following persons and must be received
by them within 30 days after publication of the Notice of Invitation in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->
Richard D. Tate, Chief, Mining Law and Solid Minerals Adjudication Section, Colorado State Office, Bureau of Land
Management, 2850 Youngfield Street, Lakewood, Colorado 80215
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
&blank;&blank;and 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=15 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Ronald G. Thompson, Senior Mine Engineer, Basin Resources, Inc., 14300 Highway 12, Weston, Colorado 81091. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Any party electing to participate in this program must share all costs on a pro rata basis with the applicant and with
any other party or parties who elect to participate. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 3, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Richard D. Tate, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Mining Law and Solid Minerals Adjudication Section. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;794 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;JB&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00098 </DOCNO>
<PARENT> FR940112-2-00065 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[UT&hyph;040&hyph;04&hyph;4320&hyph;01; 4&hyph;00152]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Availability of Environmental Assessment for Animal Damage Control Activities</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bureau of Land Management, Interior.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of availability of Environmental Assessment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice is hereby given that the Cedar City District, Bureau of Land Management has prepared an environmental assessment
and decision for authorization of animal damage control activities by the Animal Plant Health and Inspection Service
(APHIS) in the Cedar City District. Within 30 days of the printing of this notice, the public has the right of appeal
to the Interior Board of Land Appeals, Office of the Secretary, in accordance with the regulations at 43 CFR 4.4.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
District Manager Gordon R. Staker, Cedar City District Office, 176 East D.L. Sargent Drive, Cedar City, Utah 84720.
Telephone: 801-586-2401.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 3, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Gordon R. Staker,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
District Manager.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;795 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;DQ&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00099 </DOCNO>
<PARENT> FR940112-2-00066 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[CO&hyph;920&hyph;94&hyph;4110&hyph;03; COC25040] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Colorado; Proposed Reinstatement of Terminated Oil and Gas Lease </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Under the provisions of Public Law 97&hyph;451, a petition for reinstatement of oil and gas lease COC25040, Mesa County,
Colorado, was timely filed and was accompanied by all required rentals and royalties accruing from April 1, 1993,
the date of termination. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
No valid lease has been issued affecting the lands. The lessees have agreed to new lease terms for rentals and royalties
at rates of $5 per acre and 162/3 percent, respectively. The lessees have paid the required $500 administrative fee
for the lease and have reimbursed the Bureau of Land Management for the cost of this 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 notice. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Having met all the requirements for reinstatement of the lease as set out in sections 31 (d) and (e) of the Mineral Leasing
Act of 1920, as amended, (30 U.S.C. 188 (d) and (e)), the Bureau of Land Management is proposing to reinstate the lease
effective April 1, 1993, subject to the original terms and conditions of the lease and the increased rental and royalty
rates cited above. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Questions concerning this notice may be directed to Bill Norton of the Colorado State Office at (303) 239&hyph;3779.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 3, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Janet M. Budzilek, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Fluid Minerals Adjudication Section. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;796 Filed 1&hyph;11&hyph;94; 8:45 a.m.] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;JB&hyph;M 
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00100 </DOCNO>
<PARENT> FR940112-2-00067 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[CACA 33632]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Proposed Withdrawal and Opportunity for Public Meeting; California</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agency:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Bureau of Land Management, Interior.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
action:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
summary:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The United States Department of Agriculture, Forest Service, has filed an application to withdraw 20 acres of National
Forest System land for protection of the historic Harlow Cabin and the surrounding lands. This site is on the National
Register of Historic Places. This notice closes the land for up to 2 years from location and entry under the United States
mining laws. The land will remain open to all other uses which may be made of National Forest System lands.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
dates:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments and requests for meeting should be received on or before April 12, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
addresses:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Comments and meeting requests should be sent to the California State Director, BLM, 2800 Cottage Way, room E&hyph;2845,
Sacramento, California 95825.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
for further information contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Marcia Sieckman, BLM California State Office, 916&hyph;978&hyph;4820.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
supplementary information:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 On November 19, 1993, the United States Department of Agriculture filed an application to withdraw the following
described National Forest System land from location and entry under the United States mining laws, subject to valid
existing rights:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Mount Diablo Meridian
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=1 -->
Rogue River National Forest
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=1 -->
T. 48 N., R. 11 W., 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=1 -->
Sec. 14, Tract 49.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
The area described contains 20 acres in Siskiyou County.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For a period of 90 days from the date of publication of this notice, all persons who wish to submit comments, suggestions,
or objections in connection with the proposed withdrawal may present their views in writing to the California State
Director of the Bureau of Land Management. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Notice is hereby given that an opportunity for a public meeting is afforded in connection with the proposed withdrawal.
All interested persons who desire a public meeting for the purpose of being heard on the proposed withdrawal must submit
a written request to the California State Director within 90 days from the date of publication of this notice. Upon
determination by the authorized officer that a public meeting will be held, a notice of time and place with be published
in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 at least 30 days before the scheduled date of the meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The application will be processed in accordance with the regulations set forth in 43 CFR part 2300.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For a period of 2 years from the date of publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, the lands will be segregated as specified above unless the application is denied or canceled or the withdrawal is
approved prior to that date. The temporary uses which will be permitted during this segregative period are land uses
permitted by the Forest Service under existing laws and regulations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 21, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Nancy J. Alex,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Lands Section.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;716 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3410&hyph;11&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00101 </DOCNO>
<PARENT> FR940112-2-00068 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Fish and Wildlife Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Aquatic Nuisance Species Task Force Risk Identification and Assessment Committee Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Department of the Interior, Fish and Wildlife Service.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice announces a meeting of the Risk Identification and Assessment Committee (Committee), a committee of
the Aquatic Nuisance Species Task Force. The Committee meeting will focus on evaluating potential pathways of nonindigenous
species introduction using the pathway evaluation process developed at the previous meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Risk Identification and Assessment Committee will meet from 9 a.m. to 3 p.m. on Wednesday, January 26, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Risk Identification and Assessment Committee meeting will be held at the U.S. Fish and Wildlife Service Building,
room 500, 4401 N. Fairfax Drive, Arlington, Virginia 22203.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Richard Orr, Risk Identification and Assessment Committee Chairman, U.S. Dept. of Agriculture, Animal and Plant
Health Inspection Service, 6505 Belcrest Rd., room 810, Hyattsville, MD (301) 436&hyph;8939.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Pursuant to Section 10(a)(2) of the Federal Advisory Committee Act (5 U.S.C. App. I), this notice announces a meeting
of the Aquatic Nuisance Species Task Force Risk Identification and Assessment Committee established under the authority
of the Nonindigenous Aquatic Nuisance Prevention and Control Act of 1990 (Pub. L. 101&hyph;646, 104 Stat. 4761, 16
U.S.C. 4701 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
et seq.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
, November 29, 1990). Minutes of the meetings will be maintained by the Coordinator, Aquatic Nuisance Species Task
Force, room 840, 4401 North Fairfax Drive, Arlington, Virginia 22203 and the Risk Identification and Assessment
Committee Chairman, U.S. Dept. of Agriculture, Animal and Plant Health Inspection Service, 6505 Belcrest Rd., room
810, Hyattsville, MD 20782 and will be available for public inspection during regular business hours, Monday through
Friday within 30 days following the meeting.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: 5 January 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Gary Edwards,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Co-Chair, Aquatic Nuisance Species Task Force Assistant Director_Fisheries.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;656 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;55&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00102 </DOCNO>
<PARENT> FR940112-2-00069 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Park Service</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Cape Cod National Seashore, South Wellfleet, MA; Cape Cod National Seashore Advisory Commission; Meeting </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given in accordance with the Federal Advisory Committee Act (Pub. L. 92&hyph;463, 86 Stat. 770, 5
U.S.C. app 1, section 10), that a meeting of the Cape Cod National Seashore Advisory Commission will be held on Friday,
January 28, 1994. 
<!-- PJG 0012 frnewline -->
The Commission was reestablished pursuant to Public Law 99&hyph;349, Amendment 24. The purpose of the Commission
is to consult with the Secretary of the Interior, or his designee, with respect to matters relating to the development
of the Cape Cod National Seashore, and with respect to carrying out the provisions of sections 4 and 5 of the Act establishing
the Seashore. 
<!-- PJG 0012 frnewline -->
The Commission members will meet at 1 p.m. at Park Headquarters, Marconi Station, for their regular business meeting
which will be held for the following reasons: 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=15 g=1 f=1 -->
1. Adoption of Agenda 
<!-- PJG 0012 frnewline -->
2. Approval of Minutes of Previous Meeting 
<!-- PJG 0012 frnewline -->
3. Reports of Officers 
<!-- PJG 0012 frnewline -->
4. Old Business 
<!-- PJG 0012 frnewline -->
5. Superintendent's Report 
<!-- PJG 0012 frnewline -->
6. Mission and Vision Statements 
<!-- PJG 0012 frnewline -->
7. Nauset Light Relocation 
<!-- PJG 0012 frnewline -->
8. Transportation Issues 
<!-- PJG 0012 frnewline -->
9. New Business 
<!-- PJG 0012 frnewline -->
10. Agenda for next meeting 
<!-- PJG 0012 frnewline -->
11. Date for next meeting 
<!-- PJG 0012 frnewline -->
12. Communications/Public Comment 
<!-- PJG 0012 frnewline -->
13. Adjournment 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The meeting is open to the public. It is expected that 15 persons will be able to attend the meeting in addition to the
Commission members. 
<!-- PJG 0012 frnewline -->
Interested persons may make oral/written presentations to the Commission during the business meeting or file written
statements. Such requests should be made to the park superintendent at least seven days prior to the meeting. Further
information concerning the meeting may be obtained from the Superintendent, Cape Cod National Seashore, So. Wellfleet,
MA 02663. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 29, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John C. Reed, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Director. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;756 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;70&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00103 </DOCNO>
<PARENT> FR940112-2-00070 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Sudbury, Assabet and Concord Rivers Wild and Scenic Study, MA; Sudbury, Assabet and Concord Rivers Study Committee;
Meeting </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given in accordance with the Federal Advisory Committee Act (Pub. L. 92&hyph;463, 86 Stat. 770, 5
U.S.C. app. 1 10), that there will be a meeting of the Sudbury, Assabet and Concord Rivers Study Committee on Thursday,
January 27, 1994. 
<!-- PJG 0012 frnewline -->
The Committee was established pursuant to Public Law 101&hyph;628. The purpose of the Committee is to consult with
the Secretary of the Interior and to advise the Secretary in conducting the study of the Sudbury, Assabet and Concord
River segments specified in Section 5 (a) (110) of the Wild and Scenic Rivers Act. The Committee shall also advise the
Secretary concerning management alternatives, should some or all of the river segments studied be found eligible
for inclusion in the National Wild and Scenic Rivers System. 
<!-- PJG 0012 frnewline -->
The meeting will be held at 7:30 p.m., Thursday, January 27, 1994, at the Bedford Town Hall, Mudge Way, Bedford, MA.
Directions: Bedford Town Hall is located on the left, along Mudge Way, off the south side of Great Road (where Rtes.
4/225 and 62 converge) in Bedford Center. From Rte. 128, take exit for Rtes. 4/225 West and travel approx. 2.3 miles.
Turn left on Mudge Way. From west, travel approx. 0.3 miles from the intersection of Rtes. 4/225 and 62. Turn right at
Mudge Way. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The agenda is as follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=16 g=1 f=1 -->
I. Welcome and introductions, approval of minutes from 12/2/93 meeting.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
II. Brief questions and comments from public 
<!-- PJG 0012 frnewline -->
III. Subcommittee Reports_Subcommittee Chairs 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
A. Water Resources Subcommittee: Water Resources Study and Recreation Task Force 
<!-- PJG 0012 frnewline -->
B. River Conservation Planning Subcommittee 
<!-- PJG 0012 frnewline -->
C. Public Participation Subcommittee 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=16 g=1 f=1 -->
V. Issues of Local Concern 
<!-- PJG 0012 frnewline -->
VI. Opportunity for public questions and comments 
<!-- PJG 0012 frnewline -->
VII. Other Business 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=14 g=1 f=1 -->
A. Next meeting dates and locations
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 29, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John C. Reed, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Acting Regional Director.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;755 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4310&hyph;70&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00104 </DOCNO>
<PARENT> FR940112-2-00071 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>INTERNATIONAL TRADE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Investigation No. 332&hyph;351] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Monitoring of U.S. Imports of Peppers </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 United States International Trade Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of institution of investigation.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 December 30, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The North American Free Trade Agreement Implementation Act, P.L. 103&hyph;182, directs the Commission to monitor
imports of fresh or chilled peppers, other than chili peppers (HTS subheading 0709.60.00), until January 1, 2009,
as if a proper request for such monitoring had been made under section 202(d) of the Trade Act of 1974 (19 U.S.C. 2252(d)),
for purposes of expediting an investigation concerning provisional relief under section 202 of the Trade Act of 1974.
As a result, the Commission instituted investigation No. 332&hyph;351, under section 332(g) of the Tariff Act of
1930 (19 U.S.C. 1332(g)), for the purpose of monitoring imports of fresh or chilled peppers. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the course of the investigation, the Commission will monitor U.S. imports of fresh or chilled peppers from all foreign
suppliers. In addition, the Commission will investigate and gather data, to the extent possible, on U.S. growers
in such areas as shipments, prices, market share, employment levels, profit-or-loss, and efforts to compete. Wherever
possible, the Commission will rely on existing data from other government agencies. 
<!-- PJG 0012 frnewline -->
Although section 316 does not require that the Commission publish reports summarizing the information obtained
as a result of such monitoring, the Commission plans to publish statistical annual reports of certain trade data through
the year 2008.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Timothy McCarty (202&hyph;205&hyph;3324) or 
<!-- PJG 0012 frnewline -->
Lowell Grant (202&hyph;205&hyph;3312), Agriculture Division, Office of Industries, or William Gearhart (202&hyph;205&hyph;3091),
Office of the General Counsel, U.S. International Trade Commission. Hearing impaired persons can obtain information
on this study by contacting the Commission's TDD terminal on (202) 205&hyph;1810.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
WRITTEN SUBMISSIONS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested persons are invited to submit written statements at any time during the investigation. Commercial or
financial information which a submitter desires the Commission to treat as confidential must be submitted on separate
sheets of paper, each clearly marked ``Confidential Business Information'' at the top. All submissions requesting
confidential treatment must conform with the requirement of section 201.6 of the Commission's 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=3 -->
Rules of Practice and Procedure 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
(19 CFR 201.6). All written submissions, except for confidential business information, will be made available for
inspection by interested persons. All submission should be addressed to the Secretary at the Commission's office
in Washington, DC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: January 4, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koehnke, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;770 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00105 </DOCNO>
<PARENT> FR940112-2-00072 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Investigations Nos. 731&hyph;TA&hyph;675 and 676 (Preliminary)] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Saccharin From China and Korea </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Determinations 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On the basis of the record
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
1
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 developed in the subject investigations, the Commission unanimously determines, pursuant to section 733(a) of
the Tariff Act of 1930 (19 U.S.C. 1673b(a)), that there is a reasonable indication that an industry in the United States
is materially injured by reason of imports from China and Korea of saccharin, provided for in subheading 2925.11.00
of the Harmonized Tariff Schedule of the United States, that are alleged to be sold in the United States at less than
fair value (LTFV). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The record is defined in sec. 207.2(f) of the Commission's Rules of Practice and Procedure (19 CFR 207.2(f)). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Background 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On November 18, 1993, a petition was filed with the Commission and the Department of Commerce by PMC Specialties Group,
Cincinnati, OH, alleging that an industry in the United States is materially injured by reason of LTFV imports of saccharin
from China and Korea. Accordingly, effective November 18, 1993, the Commission instituted antidumping investigations
Nos. 731&hyph;TA&hyph;675 and 676 (Preliminary). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Notice of the institution of the Commission's investigations and of a public conference to be held in connection therewith
was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington,
DC, and by publishing the notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 of November 29, 1993 (58 FR 62682). The conference was held in Washington, DC, on December 9, 1993, and all persons who
requested the opportunity were permitted to appear in person or by counsel.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission transmitted its determinations in these investigations to the Secretary of Commerce on January 3,
1994. The views of the Commission are contained in USITC Publication 2716 (January 1994), entitled ``Saccharin from
China and Korea: Investigations Nos. 675 and 676 (Preliminary).'' 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: January 3, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koehnke, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;772 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00106 </DOCNO>
<PARENT> FR940112-2-00073 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Investigation No. 337&hyph;TA&hyph;354]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Certain Tape Dispensers; Decision Not To Review an Initial Determination Granting Motion To Amend Notice of Investigation
To Clarify Identity of One Respondent and To Delete Another Respondent </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 U.S. International Trade Commission. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice is hereby given that the U.S. International Trade Commission has determined not to review the presiding administrative
law judge's (ALJ) initial determination (ID) in the above-captioned investigation granting complainant Minnesota
Mining and Manufacturing, Inc.'s (``3M'') motion to amend the notice of investigation to correct the identification
of one respondent and to delete another respondent. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 James M. Lyons, Esq., Office of the General Counsel, U.S. International Trade Commission, 500 E Street, SW., Washington,
DC 20436. Telephone: (202) 205&hyph;3094. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Commission instituted this investigation, which concerns allegations of violations of section 337 of the Tariff
Act of 1930 in the importation and sale of certain tape dispensers, on July 15, 1993. Complainant 3M alleges infringement
of U.S. Letters Patent Des. 289,180. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On November 29, 1993, complainant filed a second motion to amend the notice of investigation to clarify the identity
of the named respondents. Complainant moved to delete one respondent, Shiang Shin Trading Co., and to change the identification
of another respondent, Safina Office Products, to Shiang Shin International, Inc., d/b/a Safina Office Products.
In requesting this action, 3M stated that an affidavit received from one of the respondents had revealed that Safina
Office Products is merely the assumed name for Shiang Shin International, Inc. and that Shiang Shin Trading Co. is
an unrelated company that is not involved in the importation or sale of the subject tape dispensers. The Commission
investigative attorney supported the motion. On December 13, 1993, the ALJ issued an ID (Order No. 4) granting complainant's
motion. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
This action is taken under the authority of section 337 of the Tariff Act of 1930, 19 U.S.C. 1337, and Commission interim
rule 210.53(h), 19 CFR 210.53(h). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Copies of the ID and all other nonconfidential documents filed in connection with this investigation are available
for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International
Trade Commission, 500 E Street, SW., Washington, DC 20436, telephone 202&hyph;205&hyph;2000. Hearing-impaired
individuals are advised that information on this matter can be obtained by contacting the Commission's TDD terminal
at (202) 205&hyph;1810. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: January 7, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koehnke, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;773 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00107 </DOCNO>
<PARENT> FR940112-2-00074 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Investigation No. 332&hyph;350]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Monitoring of U.S. Imports of Tomatoes </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
United States International Trade Commission. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of institution of investigation. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
EFFECTIVE DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
December 30, 1993.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The North American Free Trade Agreement Implementation Act, Public Law 103&hyph;182, directs the Commission to
monitor imports of fresh or chilled tomatoes (HTS heading 0702.00), until January 1, 2009, as if a proper request for
such monitoring had been made under section 202(d) of the Trade Act of 1974 (19 U.S.C. 2252(d)), for purposes of expediting
an investigation concerning provisional relief under section 202 of the Trade Act of 1974. As a result, the Commission
instituted investigation No. 332&hyph;350, under section 332(g) of the Tariff Act of 1930 (19 U.S.C. 1332(g)), for
the purpose of monitoring imports of fresh or chilled tomatoes. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the course of the investigation, the Commission will monitor U.S. imports of fresh or chilled tomatoes from all
foreign suppliers. In addition, the Commission will investigate and gather data, to the extent possible, on U.S.
growers in such areas as shipments, prices, market share, employment levels, profit-or-loss, and efforts to compete.
Wherever possible, the Commission will rely on existing data from other government agencies. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Although section 316 does not require that the Commission publish reports summarizing the information obtained
as a result of such monitoring, the Commission plans to publish annual statistical reports of certain trade data through
the year 2008. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Timothy McCarty (202&hyph;205&hyph;3324) or Lowell Grant (202&hyph;205&hyph;3312), Agriculture Division,
Office of Industries, or William Gearhart (202&hyph;205&hyph;3091), Office of the General Counsel, U.S. International
Trade Commission. Hearing impaired persons can obtain information on this study by contacting the Commission's
TDD terminal on (202) 205&hyph;1810. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
WRITTEN SUBMISSION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Interested persons are invited to submit written statements at any time during the investigation. Commercial or
financial information which a submitter desires the Commission to treat as confidential must be submitted on separate
sheets of paper, each clearly marked ``Confidential Business Information'' at the top. All submissions requesting
confidential treatment must conform with the requirement of section 210.6 of the Commission's Rules of Practice
and Procedure (19 CFR 201.6). All written submissions, except for confidential business information, will be made
available for inspection by interested persons. All submission should be addressed to the Secretary at the Commission's
office in Washington, DC. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued: January 4, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By order of the Commission. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Donna R. Koeknke, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;771 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7020&hyph;02&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00108 </DOCNO>
<PARENT> FR940112-2-00075 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>INTERSTATE COMMERCE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Availability of Environmental Assessments </DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to 42 U.S.C. 4332, the Commission has prepared and made available environmental assessments for the proceedings
listed below. Dates environmental assessments are available are listed below for each individual proceeding. 
<!-- PJG 0012 frnewline -->
To obtain copies of these environmental assessments contact Ms. Tawanna Glover-Sanders or Ms. Johnnie Davis, Interstate
Commerce Commission, Section of Energy and Environment, room 3219, Washington, DC 20423, (202) 927&hyph;6212 or
(202) 927&hyph;6245. 
<!-- PJG 0012 frnewline -->
Comments on the following assessment are due 15 days after the date of availability: 
<!-- PJG 0012 frnewline -->
AB&hyph;167 (SUB-NO. 1132X), Consolidated Rail Corporation Abandonment Exemption_In Washington County, Pa and
Brooke County, WV. EA available 1/4/94. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AB&hyph;52 (SUB-NO. 76X), The Atchison Topeka and Santa Fe Railway Company Exempt Abandonment of 1.84 miles of right-of-way
at or near Harper, Harper County, Kansas. EA available 1/7/94. 
<!-- PJG 0012 frnewline -->
AB&hyph;32 (SUB-NO. 58X) and AB&hyph;355 (SUB-NO. 10X), Boston and Maine Corp. and Springfield Terminal Railway
Co._abandonment and discontinuance of service_Waterbury Industrial Track, in New Haven County, Ct. EA available

<!-- PJG 0034 unknown -->
&blank;&blank;1/7/94.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
AB&hyph;32 (SUB-NO. 61X) and AB&hyph;355 (SUB-NO. 13X), Boston and Maine Corp. and Springfield Terminal Railway
Co._abandonment and discontinuance of service_Dublin Street Track, in New Haven County, Ct. EA available 1/7/94.
<!-- PJG 0012 frnewline -->
Comments on the following assessment are due 30 days after the date of availability: None. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sidney L. Strickland, Jr., 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;766 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7035&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00109 </DOCNO>
<PARENT> FR940112-2-00076 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Finance Docket No. 32427] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>City of Los Angeles and City of Long Beach_Acquisition Exemption_Rail Lines of the Atchison, Topeka and Santa Fe Railway
Co., Southern Pacific Transportation Co., and Union Pacific Railroad Co.; Notice of Exemption</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The City of Los Angeles, acting by and through the Board of Harbor Commissioners of the Port of Los Angeles, and the City
of Long Beach, acting by and through its Board of Harbor Commissioners (collectively referred to as the Cities), have
jointly filed a notice of exemption to acquire from The Atchison, Topeka and Santa Fe Railway Company (Santa Fe), Southern
Pacific Transportation Company (SPT), and Union Pacific Railroad Company (UP) certain interest in property described
below to construct a railroad corridor that will permit consolidation of Santa Fe's, SPT's, and UP's overhead rail
service to and from the ports to a point in central Los Angeles. The exemption became effective on December 24, 1993.

<!-- PJG 0012 frnewline -->
The lines being acquired, by subdivision, include the following: (a) Santa Fe's line on the Los Angeles Harbor Subdivision
between milepost 27.6 and milepost 28.3 in the County of Los Angeles; and the connection track between SPT's San Pedro
Branch and Santa Fe's Watson Yard; (b) SPT's line from the connection with UP switch at the east side of Santa Fe Avenue
easterly of ``J'' Yard, milepost BG 486.17 (San Pedro Branch) southeasterly through ``J'' Yard and a portion of the
SPT's Santa Monica Branch to a point of connection with the San Pedro Branch milepost BBM 484.99 (Wilmington Branch)
then southerly paralleling Alameda Street to a crossing of the Wilmington Branch at Dominguez Junction milepost
BG 496.50 (San Pedro Branch) crossing over to the Wilmington Branch southerly to a point southerly of Sepulveda Boulevard
and merging into the San Pedro Branch with the Wilmington Branch terminating at the Santa Fe's Harbor Subdivision
Thernard Crossing milepost BBM 501.20 (Wilmington Branch) and milepost BG 501.4 (San Pedro Branch) and the San Pedro
Branch continuing southerly and southeasterly through the Port of Los Angeles to approximately 22nd Street in San
Pedro and also including to the legs of the West Wye and the Long Beach Branch from the San Pedro Branch into the Port of
Long Beach and terminating south of the 8th Street Yard milepost BH 503.73 (Long Beach Branch); and (c) UP's line from
a connection with SPT's ``J'' Yard at the east side of Santa Fe Avenue in Los Angeles milepost 1.8 via Redondo Jct. and
Bridge Jct. to a connection with the East Bank main line at Ninth St. Jct. milepost 0.97; from Bridge Jct. on the aforesaid
line milepost 1.30 to Soto St. Jct. milepost 2.08 (a distance of approximately 500 feet); from Soto St. Jct. milepost
2.08 to Downey Road milepost 2.88; and from milepost 2.84 near Downey Road to Hobart Junction milepost 3.08 on the San
Pedro Branch north of Santa Fe's at-grade crossing; and the San Pedro Branch from milepost 21.71 to milepost 23.73
in the County of Los Angeles. 
<!-- PJG 0012 frnewline -->
Santa Fe, SPT, and UP are to retain trackage rights and/or permanent easements over those portions of property on which
they currently conduct rail operations so as to continue rail freight service. 
<!-- PJG 0012 frnewline -->
According to the Cities, their acquisition of the described property interests from Santa Fe, SPT, and UP will not
confer common carrier status on the Cities, and the Cities reserve their right to file a motion to dismiss this notice
or subsequently to seek revocation of the exemption. If we subsequently find that we lack jurisdiction over these
transactions, we will enter a supplemental order vacating this exemption.
<!-- PJG 0012 frnewline -->
Any comments must be filed with the Commission and served on: Samuel M. Sipe, Jr., Steptoe &amp; Johnson, 1330 Connecticut
Ave., NW., Washington, DC 20036. 
<!-- PJG 0012 frnewline -->
This notice is filed under 49 CFR 1150.31. If the notice contains false or misleading information, the exemption is
void 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
ab initio
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Petitions to revoke the exemption under 49 U.S.C. 10505(d) may be filed at any time. The filing of a petition to revoke
will not automatically stay the transaction.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Decided: January 5, 1994. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
By the Commission, David M. Konschnik, Director, Office of Proceedings. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Sidney L. Strickland, Jr., 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;769 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7035&hyph;01&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00110 </DOCNO>
<PARENT> FR940112-2-00077 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF JUSTICE</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Lodging of Consent Decrees</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with 42 U.S.C. 9622(d)(2) and 28 CFR 50.7, notice is hereby given that two proposed consent decrees in

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
DiBiase Salem Realty Trust, et al., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Civil Action No. 91&hyph;11028&hyph;MA, were lodged on December 30, 1993 with the United States District Court of
Massachusetts. The Consent Decrees resolve certain claims of the United States against defendant South Essex Sewerage
District (``SESD'') and Massachusetts Electric Company (``Massachusetts Electric'') under Sections 106 and 107
of the Comprehensive Environmental Response, Compensation, and Liability Act, 42 U.S.C. 9606, 9607, in connection
with the Salem Acres Superfund Site, a 234.5-acre parcel located approximately one quarter mile west of Route 107
in Salem, Massachusetts. Under the settlement reflected in the Consent Decree with SESD, SESD will pay the United
States $460,948 in remedial costs incurred prior to March 31, 1993, and will perform the remedial cleanup of the sludge
lagoons and certain other areas of the Site. Through the second Consent Decree, Massachusetts Electric will pay the
United States $93,237 in remedial costs incurred prior to March 31, 1993, and will perform the remedial cleanup of
the flyash pile on the Site. Both SESD and Massachusetts Electric agree through the settlements to pay certain future
remedial costs incurred by the United States that are not inconsistent with the NCP.
<!-- PJG 0012 frnewline -->
The Department of Justice will receive comments relating to the proposed Consent Decree for 30 days following the
publication of this Notice. Comments should be addressed to the Assistant Attorney General of the Environment and
Natural Resources Division, Department of Justice, Washington, DC 20530, and should refer to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
DiBiase Salem Reality Trust, et al., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
D.J. Ref. No. 90&hyph;11&hyph;3&hyph;744. The proposed Consent Decrees may be examined at the Office of the United
States Attorney for the District of Massachusetts, 1107 John W. McCormack Federal Bldg., U.S. P.O. &amp; Courthouse,
Boston, Massachusetts 02109, the Region I Office of the United States Environmental Protection Agency, Office of
Regional Counsel, 1 Congress Street, 10th Floor, Boston, Massachusetts and at the Consent Decree Library, 1120 G
Street, NW., 4th Floor, Washington, DC 20005 (202&hyph;624&hyph;0892). A copy of the proposed consent decrees may
be obtained in person or by mail from the Consent Decree Library, 1120 G Street, NW., 4th Floor, Washington, DC 20005.
In requesting a copy, please enclose a check in the amount of $23.50 for each Consent Decree (25 cents per page for reproduction
costs, exclusive of the costs of the appendices), payable to the Consent Decree Library.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John C. Cruden,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Environmental Enforcement Section, Environment and Natural Resources Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;797 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->
 
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00111 </DOCNO>
<PARENT> FR940112-2-00078 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Lodging of Consent Decree; Salt Pond Associates</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In keeping with Departmental policy, 28 CFR 50.7, notice is hereby given that a consent decree in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Salt Pond Associates
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States Army Corps of Engineers, et al.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Civ. No. 92&hyph;597&hyph;LON (D. Del.), was lodged with the United States District Court for the District of Delaware
on or about January 10, 1994. This consent decree concerns counterclaims filed in the above-entitled action by the
United States pursuant to the Clean Water Act and the Rivers and Harbors Act of 1899. The counterclaims seek a permanent
injunction and civil penalties for plaintiff Salt Pond Associates' alleged violations of section 301(a) of the Clean
Water Act, 33 U.S.C 1311(a), and section 10 of the Rivers and Harbors Act of 1899, 33 U.S.C. 403. The consent decree allows
certain work conducted in wetlands and other waters of the United States to remain in place subject to Salt Pond Associates'
compliance with restoration and mitigation requirements, and imposes a civil penalty of two hundred thousand dollars
($200,000) on Salt Pond Associates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Pursuant to 28 CFR 50.7, the Department of Justice will accept written comments on the consent decree for a period of
thirty (30) days after the date of publication of this Notice in the Federal Register. Comments should be addressed
as follows: Assistant Attorney General/Environment and Natural Resources Division/United States Department
of Justice/Attention: Timothy Burns/Environmental Defense Section/P.O. Box 23986/Washington, DC 20026&hyph;3986.
Comments should reference 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Salt Pond Associates
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States Army Corps of Engineers, et al.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 No. 90&hyph;5&hyph;1&hyph;6&hyph;498.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The consent decree may be examined at the Clerk's Office/United States District Court/District of Delaware/844
King Street/Wilmington, Delaware (contact the Clerk at (302) 573&hyph;6170). It may also be examined at the United
States Department of Justice/Environmental Defense Section/10th Street and Pennsylvania Avenue, NW./Washington,
DC (contact Kevin Christof at (202) 514&hyph;0985).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Timothy Burns,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Trial Attorney, Environmental Defense Section, Environment &amp; Natural Resources Division, United States Department
of Justice.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;655 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00112 </DOCNO>
<PARENT> FR940112-2-00079 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Lodging of Consent Decree Pursuant to Clean Air Act</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with Department policy, 28 CFR 50.7, notice is hereby given that on December 28, 1993, a proposed Consent
Decree in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 Superior Contract Maintenance, Inc.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Civil Action No. 1:93CV2754, was lodged in the United States District Court for the Northern District of Ohio. The
Complaint filed by the United States alleged violations of the Clean Air Act, the National Emission Standards for
Hazardous Air Pollutants (NESHAP) for Asbestos, 40 CFR part 61, subpart M, by Superior Contract Maintenance, Inc.
(SCM), Superior Demolition and Excavating, Inc. (SDE), and Market Plaza Properties Limited Partnership. The Consent
Decree requires the defendants to pay a total civil penalty of $27,500 in full settlement of the claims set forth in
the Complaint filed by the United States. The Consent Decree also requires the defendants to ensure that their employees
have the required inspector and asbestos abatement worker training before those employees can inspect or work in
facilities where asbestos containing material (ACM) or suspect ACM would be removed. Additionally, the compliance
section requires SCM, SDE, and Market Plaza to provide written instructions to their employees not to handle, move,
or otherwise disturb ACM or suspect ACM unless specially trained, licensed or authorized to do so, to comply with the
asbestos NESHAP, and to provide EPA with notice before removing any asbestos in the future.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Department of Justice will receive for a period of thirty (30) days from the date of this publication comments concerning
the proposed Consent Decree. Comments should be addressed to the Assistant Attorney General, Environment and Natural
Resources Division, U.S. Department of Justice, P.O. Box 7611, Ben Franklin Station, Washington, DC 20044, and should
refer to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
 Superior Contract Maintenance, Inc.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 D.J. Ref. No. 90&hyph;5&hyph;2&hyph;1&hyph;1739.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed Consent Decree may be examined at any of the following offices: (1) The United States Attorney for the
Northern District of Ohio, United States Courthouse, Room 208, 2 South Main Street, Akron, Ohio 44308 (contact Assistant
United States Attorney James L. Bickett); (2) the U.S. Environmental Protection Agency, Region 5, 77 West Jackson
Boulevard, Chicago, Illinois 60604&hyph;3590 (contact Assistant Regional Counsel Padmavati G. Klejwa); and (3)
the Environmental Enforcement Section, Environment and Natural Resources Division, U.S. Department of Justice,
Consent Decree Library, 1120 G Street, NW., 4th Floor, Washington, DC 20005 (202&hyph;624&hyph;0892). A copy of
the proposed consent decree may be obtained in person or by mail from the Consent Decree Library, 1120 G Street, NW.,
4th Floor, Washington, DC 20005. For a copy of the Consent Decree please enclose a check in the amount of $5.50 (25 cents
per page for reproduction costs, exclusive of the costs of the appendices), payable to the Consent Decree Library.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John C. Cruden,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Environmental Enforcement Section, Environment and Natural Resources Division.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;798 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00113 </DOCNO>
<PARENT> FR940112-2-00080 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Lodging of Consent Decree Pursuant to the Clean Air Act</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In accordance with Departmental policy, 28 CFR 50.7, notice is hereby given that a proposed Consent Decree in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tropicana Energy Company, et al.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Civil Action No. 3:92&hyph;CV&hyph;0668&hyph;P, was lodged on December 21, 1993 with the United States District
Court for the Northern District of Texas. The Consent Decree resolves an action for civil penalties and injunctive
relief brought under section 211(c) of the Clean Air Act, 42 U.S.C. 7545(c), and the regulations promulgated thereunder
at 40 CFR part 80, for violations of the applicable gasoline volatility standards, which occurred in the States of
Texas, Illinois, and Tennessee. Under the Consent Decree, defendant Tropicana Energy Company has agreed to pay a
civil penalty in the amount of $1,000,000 to the United States. In addition, defendants Tropicana Investments Partnership,
Linda Pescosolido (as personal representative of the estate of Carl A. Pescosolido, Jr.), and J. Kent Burt have agreed
to pay a combined civil penalty in the amount of $100,000 to the United States. The Consent Decree also enjoins defendant
J. Kent Burt and any corporation, partnership or association that he has an ownership interest in or substantially
supervises or controls from violating section 211(c) of the Clean Air Act and its implementing regulations set forth
at 40 CFR part 80.
<!-- PJG 0012 frnewline -->
The Department of Justice will receive, for a period of thirty (30) days from the date of this publication, comments
relating to the proposed consent decree. Comments should be addressed to the Assistant Attorney General for the Environment
and Natural Resources Division, Department of Justice, Washington, DC 20530, and should refer to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Tropicana Energy Company, et al.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 DOJ Ref. #90&hyph;5&hyph;2&hyph;1&hyph;1214A.
<!-- PJG 0012 frnewline -->
The proposed consent decree may be examined at the office of the United States Attorney, U.S. Federal Building and
Courthouse, 1100 Commerce Street, room 16G28, Dallas, Texas 75242; the Office of Air and Radiation, United States
Environmental Protection Agency 401 M Street, SW., Washington, DC 20460; and at the Consent Decree Library, 1120
G Street, NW., 4th Floor, Washington, DC 20005, (202) 624&hyph;0892. A copy of the proposed consent decree may be obtained
in person or by mail from the Consent Decree Library, 1120 G Street, NW., 4th Floor, Washington, DC 20005. In requesting
a copy please refer to the referenced case and enclose a check in the amount of $4.00 (25 cents per page reproduction
costs), payable to the Consent Decree Library.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John C. Cruden,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Environment and Natural Resources Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;799 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00114 </DOCNO>
<PARENT> FR940112-2-00081 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Lodging of Consent Decree</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice is hereby given that a proposed Consent Decree and Insurance Agreement in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Uniroyal, Inc., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No. 3:93CV0883RM (N.D. Ind.) entered into by the United States, the States of Indiana and Wisconsin, Uniroyal, Inc.,
CDU Holding, Inc., Uniroyal Holding Inc., CDU Holding, Inc. Liquidating Trust, and Uniroyal Technology Corporation
(which is a signatory to the Insurance Agreement only) were lodged on December 27, 1993 with the United States District
Court for the Northern District of Indiana. The proposed Consent Decree and Insurance Agreement resolve certain
claims of the United States and the States of Indiana and Wisconsin under Sections 106 and 107 of the Comprehensive
Environmental Response Compensation and Liability Act (``CERCLA''), 42 U.S.C. 9606, 9607, Section 7003 of the Resource
Conservation and Recovery Act (``RCRA''), 42 U.S.C. 6973, and certain state environmental statutes with respect
to the following seventeen CERCLA sites: The Alburn Incinerator/American Chemical Services Site in Chicago, Illinois;
the American Chemical Service Site in Griffith, Indiana; the Calumet Container Site in Hammond, Indiana; the Cam-Or/Westville
Oil Site in Westville, Indiana; the Douglass Road Landfill Site in Mishawaka, Indiana; the Dunn Landfill/City Disposal
Sanitary Landfill Site in Dunn, Wisconsin; the Envirochem Site in Zionsville, Indiana; the Hagen Farm Site in Stoughton,
Wisconsin; the I. Jones Site in Ft. Wayne, Indiana; the Midco I and Midco II Sites in Gary, Indiana; the Ninth Avenue
Site in Gary, Indiana; the Northside Sanitary Landfill Site in Zionsville, Indiana; the Stoughton City Landfill
Site in Stoughton, Wisconsin; the Thermo-Chem Site in Muskegon, Michigan; the Verona Wellfield/Thomas Solvent
Site in Battle Creek, Michigan; and the Wayne Waste Oil/Wayne Reclamation Site in Columbia City, Indiana. Under the
Consent Decree, Uniroyal, Inc. and the other parties will pay the United States, the States of Indiana and Wisconsin,
and certain potentially responsible parties implementing remedial action $4,075,286. The Insurance Agreement
also provides for some additional recovery from insurance proceeds under policies issued to Uniroyal, Inc. and United
States Rubber Company.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Department of Justice will receive comments relating to the proposed Consent Decree and Insurance Agreement
for 30 days following the publication of this Notice. Comments should be addressed to the Assistant Attorney General
of the Environment and Natural Resources Division, Department of Justice, Washington, DC 20503, and should refer
to 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
United States 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
v. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Uniroyal, Inc., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
D.J. Ref. No. 90&hyph;11&hyph;2&hyph;784B. The proposed Consent Decree and Insurance Agreement may be examined
at the Office of the United States Attorney for the Northern District of Indiana, MO&hyph;1 Federal Bldg., 204 S. Main
St., South Bend, Indiana 46601; the Region V Office of the United States Environmental Protection Agency, 77 West
Jackson Street, Chicago, Illinois 60604; and at the Consent Decree Library, 1120 G Street, NW., 4th Floor, Washington,
DC 20005 (202&hyph;624&hyph;0892). A copy of the proposed Consent Decree and Insurance Agreement may be obtained
in person or by mail from the Consent Decree Library, 1120 G Street, NW., 4th Floor, Washington, DC 20005. In requesting
a copy, please enclose a check in the amount of $22.00 (25 cents per page for reproduction costs), payable to the Consent
Decree Library.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
John C. Cruden,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Environmental Enforcement Section, Environment and Natural Resources Division.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;800 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4410&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00115 </DOCNO>
<PARENT> FR940112-2-00082 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NATIONAL SCIENCE FOUNDATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Antarctic Conservation Act of 1978; Notice of Permit Modification</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agency:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 National Science Foundation.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
summary:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Foundation modified a permit to conduct activities regulated under the Antarctic Conservation Act of 1978 (Pub.
L. 95&hyph;541; Code of Federal Regulations title 45, part 670).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
for further information contact:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Guy G. Guthridge, (703) 306&hyph;1031. Permit Office, Office of Polar Programs, room 755, National Science Foundation,
Arlington, Virginia 22230.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
applicant:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 John L. Bengtson, National Marine Mammal Laboratory, National Oceanic and Atmospheric Administration, Seattle,
Washington 98115.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
description of permit and modification:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 The Foundation issued a permit to Dr. Bengtson, a marine mammals specialist, on 25 November 1992 after posting a notice
in the 26 October 1992 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
. Public comments were not received. The permit allows capture, handling, and release of six species of antarctic
seals as part of a study, supported by NSF and NOAA, of the ecology, abundance, and distribution of pack ice seals.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The modification, issued on 30 December 1993 and good until the permit expires on 31 December 1994, allows Dr. Bengtson's
project to inject stable isotopes before taking blood samples (a procedure that enables estimates of body composition);
to collect tissue biopsies for study of genetics, contaminants, and diet; and to fly as low as 200 feet for aerial surveys
when called for by conditions of survey design or human safety.
<!-- PJG 0012 frnewline -->
NSF review supports the applicant's statement that the requested modifications will not increase jeopardy to seals
or other wildlife and that the information obtained will be valuable in determining the role of seals in the marine
ecosystem.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
location:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Antarctic waters.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
dates:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 January 1, 1993&hyph;December 31, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Guy G. Guthridge,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Permit Office, Office of Polar Programs.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;662 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7555&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00116 </DOCNO>
<PARENT> FR940112-2-00083 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>NUCLEAR REGULATORY COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Third Meeting of the CONTAIN Peer Review Committee</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Nuclear Regulatory Commission.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of meeting.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The CONTAIN Peer Review Committee will meet to review the technical adequacy of the CONTAIN code.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
January 19&hyph;21, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
8:30 am each day.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Energy Research, Inc. 6290 Montrose Road, Rockville, Maryland.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
A. Notafrancesco, Office of Nuclear Regulatory Research, U.S. Nuclear Regulatory Commission, Washington, DC 20555,
Telephone (301) 492&hyph;3537.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The objective of this effort is to organize and conduct a peer review of the CONTAIN code, light water reactor version.
The peer review is to provide an independent assessment of the modeling capabilities and limitations, and adequacy
of the CONTAIN code. The results of the peer review are to be documented in a summary report that describes the results
of the independent assessment by the peer review participants and the technical acceptability of the code.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A peer review committee has been organized using recognized experts from the national laboratories, universities,
CONTAIN user community and independent contractors. Meetings are held to discuss and evaluate the applicability
and state of validation of the various CONTAIN phenomenological models. The meeting scheduled for January 19&hyph;21,
1994, is the third meeting of the CONTAIN Peer Review Committee. The Committee will (1) present preliminary review
findings, (2) review code sensitivity studies, and (3) receive briefings from the code development staff about the
integrated code and the detailed models in the code.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated at Rockville, Maryland, this 3rd day of January, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the U.S. Nuclear Regulatory Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Farouk Eltawila, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Accident Evaluation Branch, Division of Systems Research, Office of Nuclear Regulatory Research.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;703 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00117 </DOCNO>
<PARENT> FR940112-2-00084 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 72&hyph;4]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Duke Power Co.; Issuance of Amendment to Materials License SNM&hyph;2503</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The U.S. Nuclear Regulatory Commission (the Commission) has issued Amendment No. 4 to Material License No. SNM&hyph;2503
held by Duke Power Company for the receipt and storage of spent fuel at the Oconee Independent Spent Fuel Storage Installation
(ISFSI), located on the Oconee Nuclear Station site, Oconee County, South Carolina. This amendment is effective
as of the date of issuance.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The amendment revises section 5.4.1 of the Technical Specification regarding the concrete density of Horizontal
Storage Module (HSM) from ``a minimum of 145 pounds per cubic foot'' to ``a minimum of 140 pounds per cubic foot.'' This
amendment does not affect fuel receipt, handling, and storage safety.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The application for this amendment complies with the standards and requirements of the Atomic Energy Act of 1954,
as amended (the Act), and the Commission's rules and regulations. The Commission has made appropriate findings as
required by the Act and the Commission's rules and regulations in 10 CFR Chapter I, which are set forth in the license
amendment. Prior public notice of the amendment was not required since the amendment does not involve a significant
hazards consideration.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission has determined that the issuance of the amendment will not result in any significant environmental
impact and that, pursuant to 10 CFR 51.22(c)(11), an environmental assessment need not be prepared in connection
with issuance of the amendment.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
For further details with respect to this action, see (1) the application for amendment dated March 9, 1993, as supplemented
by letter dated November 16, 1993; (2) Amendment No. 4 to Materials license No. SNM&hyph;2503; and (3) the Commission's
letter to the licensee dated January 5, 1994. All of these items are available for public inspection at the Commission's
Public Document Room, The Gelman Building, Lower Level, 2120 L Street, NW., Washington, DC, and the Oconee County
Library, 501 W. South Broad Street, Walhalla, SC 29691.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Dated at Rockville, Maryland, this 5th day of January 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
For the U.S. Nuclear Regulatory Commission.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Charles J. Haughney,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Chief, Storage and Transport Systems Branch, Division of Industrial and Medical Nuclear Safety, Office of Nuclear
Material Safety and Safeguards.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;705 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00118 </DOCNO>
<PARENT> FR940112-2-00085 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>OFFICE OF MANAGEMENT AND BUDGET</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of Federal Procurement Policy</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Procurement Regulatory Activity Report, No. 9; Availability
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Office of Management and Budget, Office of Federal Procurement Policy.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice of availability of the Procurement Regulatory Activity Report, Number 9.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Subsections 25(g) (1) and (2) of the Office of Federal Procurement Policy (OFPP) Act, as amended by Public Law 100&hyph;679,
codified at 41 U.S.C. 421(g), require the Administrator for Federal Procurement Policy to publish a report within
six months after the date of enactment and every six months thereafter relating to the development of procurement
regulations.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Accordingly, OFPP has prepared the ninth Procurement Regulatory Activity Report. This report is designed to satisfy
all aspects of subsections 25(g) (1) and (2) of the OFPP Act, and includes information on the status of each regulation;
a description of those regulations required by statute; a description of the methods by which public comment was sought;
regulations, policies, procedures, and forms under review by the OFPP; whether the regulations have paperwork requirements;
the progress made in promulgating and implementing the Federal Acquisition Regulation; and such other matters as
the Administrator determines to be useful.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Those persons interested in obtaining a copy of the Procurement Regulatory Activity Report may contact the Executive
Office of the President Publications Service, room 2200, 725 17th Street, NW., Washington, DC 20503, or phone (202)
395&hyph;7332.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
FOR ADDITIONAL INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
For additional information write or call the Office of Federal Procurement Policy, 725 17 St., NW., Washington, DC
20503, (202) 395&hyph;6803.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ADDRESS>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Steven Kelman,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Administrator.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;745 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3110&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00119 </DOCNO>
<PARENT> FR940112-2-00086 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>SECURITIES AND EXCHANGE COMMISSION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33413; File No. SR&hyph;DGOC&hyph;91&hyph;01]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Self-Regulatory Organizations; Delta Government Options Corp.; Order Approving a Proposed Rule Change Relating
to Permissible Forms of Margin Deposits 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 4, 1994. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On February 12, 1991, Delta Government Options Corp. (``Delta'') filed with the Securities and Exchange Commission
(``Commission'') a proposed rule change pursuant to section 19(b)(1) of the Securities Exchange Act of 1934 (``Act'')
<FOOTCITE>1</FOOTCITE>
 relating to the acceptance of U.S. Treasury bills, notes, and bonds as margin. On March 23, 1991, the Commission published
notice of the proposed rule change in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 to solicit comments from interested persons.
<FOOTCITE>2</FOOTCITE>
 One comment letter was received in response to which 
<!-- PJG 0012 frnewline -->
Delta amended its proposal on April 25, 1991.
<FOOTCITE>3</FOOTCITE>
 On September 8, 1993, Delta submitted a second amendment concerning the participation of registered investment
companies.
<FOOTCITE>4</FOOTCITE>
 As discussed below, the Commission is approving Delta's proposal as amended. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 28983 (March 18, 1991), 56 FR 12572. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The one comment letter, submitted by The First Boston Corporation (``First Boston''), generally supported Delta's
proposal because it believed the acceptance of Treasury bills as margin would increase the competitiveness and usefulness
of Delta and would not infuse any additional credit risk into the settlement system. First Boston noted, however,
that pursuant to Delta's original proposal (1) deposits of Treasury bills as margin would have to be made in principal
amounts of $500,000 and integral multiples thereof and (2) where the margin was deposited in the form of Treasury bills,
excess margin of less than $500,000 would not be automatically returned to participants. First Boston stated that
these $500,000 minimums were unreasonably high and would reduce needlessly the utility of using Treasury bills as
margin. Letter from Scott H. Rockoff, Vice President, Regulatory Reporting and Analysis, First Boston, to Jonathan
G. Katz, Secretary, Commission (April 15, 1991). In response, Delta amended its proposal so that the deposit and automatic
return minimums are $50,000. Delta also added a provision to the proposal whereby participants can waive their rights
to receive on a daily basis excess margin. Participants have an unqualified right to withdraw such a waiver at any time
during business hours. Letter from Robert C. Mendelson, Morgan, Lewis and Bockius (Counsel for Delta), to Ross Pazzol,
Esq., Division of Market Regulation (``Division''), Commission (April 24, 1991) and letter from David J. Maloy,
President, Delta, to Sonia Burnett, Esq., Division, Commission (December 3, 1993). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
When Delta filed the original proposal, its rules permitted investment companies registered under the Investment
Company Act of 1940 (``1940 Act''), 15 U.S.C. 80a (1990), to be participants. Accordingly, the original proposal
would have allowed investment companies to deposit with their custodian banks that hold margin for the benefit of
Delta Treasury bills, notes, and bonds as margin. Staff of the Commission's Division of Investment Management (``IM'')
raised concerns relating to Delta's custody and control of investment companies' securities deposited as margin.
In response, Delta amended the proposal to prohibit participation in Delta by registered investment companies.
Delta intends to remove the participation prohibition at such time as Delta and Commission staff determine the conditions
under which investment companies may become participants. Letter from David J. Maloy, President, Delta, to Julia
Ulstrup, Senior Counsel, IM, Commission (September 8, 1993). 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Delta's proposal expands the permissible forms of margin by permitting participants to deposit not only Fed Funds
<FOOTCITE>5</FOOTCITE>
 but also U.S. Treasury bills with a remaining term to maturity of 365 days or less and Treasury securities which would
be deliverable by a participant if an option contract written by the participant was exercised and assigned to the
participant (i.e., ``cover).
<FOOTCITE>6</FOOTCITE>
 Treasury bills deposited as margin will be valued for purposes of determining the amount of margin on deposit with
Delta as 100% of the lesser of their par value or their market value. Deposits of Treasury bills as margin must be made
in principal amounts of $50,000 and integral multiples thereof. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Under Delta's previous rules, Delta accepted as margin only ``Fed Funds.'' Fed Funds is now defined in Delta's rules
as cash balances available for immediate withdrawal in accounts maintained at banks that are members of the Federal
Reserve System. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Delta issues and clears put and call options on Treasury bills, notes, and bonds written or purchased by participants;
therefore, cover can consist of Treasury bills, notes, or bonds. 
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
In the event that Treasury bills deposited as margin mature while on deposit with Delta, Delta will hold the cash proceeds
as margin and will invest them in accordance with its rules governing the investment of cash margin deposits.
<FOOTCITE>7</FOOTCITE>
 If a participant that is an employee benefit plan (i.e., pension plan) subject to the Employee Retirement Income Security
Act of 1974 (``ERISA'')
<FOOTCITE>8</FOOTCITE>
 deposits Treasury bills as margin, Delta will monitor the maturity date of such Treasury bills and will require the
pension plan to substitute collateral prior to the maturity of the Treasury bills.
<FOOTCITE>9</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Letter from Robert C. Mendelson, Morgan, Lewis &amp; Bockius (Counsel for Delta), to Ross Pazzol, Esq., Division,
Commission (April 24, 1991).
<!-- PJG 0012 frnewline -->
Pursant to Delta's procedures, margin deposited in the form of Fed Funds (i.e., cash) can be invested in overnight
repurchase agreements that require as collateral the delivery of Treasury bills with maturities not to exceed 180
days from the date of the repurchase agreement. Delta Procedures, Article VI, Section 601. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Public Law 93&hyph;406. 88 Stat. 829 (1974) (codified at 29 U.S.C. 1001&hyph;1461). 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Letter from Robert C. Mendelson, Esq., Morgan, Lewis &amp; Bockius (Counsel for Delta), to Ross Pazzol, Esq., Division,
Commission (April 24, 1991). Under section 1002(21) of ERISA, a person that exercises discretionary authority or
control over the assets of an employee benefit plan is deemed to be a plan fiduciary and is required to act solely in the
interest of the plan's participants and beneficiaries and exclusively to provide benefits to these participants
and beneficiaries. Because such fiduciary responsibilities may interfere and potentially conflict with Delta's
obligations to its participants as a registered clearing agency, Delta is implementing a special procedure for handling
margin deposited by pension plans to avoid this potential ERISA problem. Furthermore, as explained in greater detail
in Section II of this order, the Pension and Welfare Benefits Administration of the Department of Labor has granted
an exemption for certain transactions involving Delta that facilitates the participation of employee benefit plans
in Delta. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00120 </DOCNO>
<PARENT> FR940112-2-00086 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
II. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes Delta's proposal is consistent with the Act and particularly with sections 17A(b)(3) (A)
and (F) of the Act.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
10
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Those sections require that a clearing agency be organized and its rules be designed to promote the prompt and accurate
clearance and settlement of securities transactions and to assure the safeguarding of securities and funds which
are in its custody or control or for which it is responsible.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(b)(3) (A) and (F) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Delta's proposal will provide flexibility to its participants by expanding the types of assets eligible to be deposited
as margin without exposing Delta to undue credit risk, market risk, or liquidation risk.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
11
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Because Treasury securities are backed by the full faith and credit of the United States, Delta is not subject to the
credit risk of the obligor.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
12
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To reduce its exposure to market risk and liquidation risk, Delta will mark Treasury bills to market on a daily basis
and will value them at the lower of par or fair market value. Furthermore, because the market for Treasury bills is extremely
large and relatively liquid, Delta's liquidation risk is minimal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Credit risk is the risk that the counterparty to a transaction will not fulfill its obligation. Market risk is the risk
associated with adverse changes in the market price of a security. Liquidation risk is the risk that the full value
of collateral will not be realized upon liquidation of such collateral.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Of course, Delta remains subject to the credit risk of its participants.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission also believes that Delta's proposal to accept cover as margin for short call option positions is appropriate.
As an initial matter, the Commission notes that The Options Clearing Corporation (``OCC''), another registered
clearing agency, accepts deposits of the security underlying a call option written by a participant in lieu of margin.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
13
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The deposit of cover protects Delta to the maximum extent possible by fully collateralizing a participant's obligations
to Delta and by eliminating Delta's credit risk with respect to the depositing participant's short position. Accordingly,
the Commission believes that Delta's proposal to accept Treasury bills and cover as margin is consistent with its
obligation to safeguard the securities and funds for which it is responsible.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
OCC Rule 610.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission also believes that the special procedures for handling margin deposited by ERISA pension plan participants
is both necessary and appropriate. Until now, Delta's procedures for investing margin deposits and certain aspects
of ERISA have made participation in Delta impracticable for such plans. Under Delta's rules, Delta may invest the
cash margin received from participants in overnight repurchase agreements and pass the profits earned on such investments
back to participants.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
14
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Under section 1002(21) of ERISA, a person could be deemed to be a plan fiduciary to the extent that such person exercises
discretionary authority over the assets of a plan.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
15
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Accordingly, if Delta were to follow its usual investment procedures with respect to pension plan assets, Delta might
be deemed to be a plan fiduciary under ERISA. In light of these provisions, Delta has not permitted pension plans to
participate in its system.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
16
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
14
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Delta Procedures, Article VI, Rule 601.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
15
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
See 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 10.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
16
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Section 17A of the Act enumerates the types of entities that may participate in registered clearing agencies. That
section neither expressly permits nor precludes participation in a registered clearing agency by pension plans.
Section 17A provides that the rules of a clearing agency must permit any 
<!-- PJG 0012 frnewline -->
(1) registered broker-dealer, 
<!-- PJG 0012 frnewline -->
(2) bank, 
<!-- PJG 0012 frnewline -->
(3) insurance company, 
<!-- PJG 0012 frnewline -->
(4) registered clearing agency, or 
<!-- PJG 0012 frnewline -->
(5) registered investment company to become a participant in a registered clearing agency. 15 U.S.C. 78q&hyph;1(b)(3)(B).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
On March 15, 1991, the Pension and Welfare Benefits Administration of the Department of Labor (``DOL'') granted an
exemption that permits ERISA pension plans to participate in Delta without Delta becoming a plan fiduciary provided
neither Delta nor any of its affiliates exercise discretionary authority or control with respect to the investment
of plan assets.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
17
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To comply with the DOL exemption, Delta is implementing a procedure whereby pension plans will deposit substitute
collateral upon the maturity of Treasury bills deposited as margin in order that Delta is not viewed as exercising
discretionary authority or control with respect to the investment of any funds that are deemed to be plan assets.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
18
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Delta's proposal appears to provide a reasonable method of permitting employee benefit plans that are subject to
ERISA to participate in Delta's system and thereby promotes the prompt and accurate clearance and settlement of securities
transactions without exposing Delta to potential ERISA liability.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
17
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
DOL, Prohibited Transaction Exemption 91&hyph;19, Exemption Application No. D&hyph;8492, 56 FR 12396 (March 25,
1991) (``DOL Exemption'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
18
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Because the plan will have no right to the Treasury bills it deposits with Delta as margin (unless the market has moved
in its favor or it has closed out its positions), such Treasury bills will not be ``plan assets'' under ERISA.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission notes that under the DOL exemption, Delta is permitted to liquidate certain assets of a defaulting
plan without being deemed to be exercising discretionary authority.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=5 f=1 -->
19
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Delta's risk exposure is reduced to the extent that it has the authority to liquidate such assets free of ERISA constraints.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
19
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Specifically, Delta may draw on a letter of credit or a surety bond that has been issued to Delta on behalf of such participant.
DOL Exemption, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
supra
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
 note 17 at 12397.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
III. Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
For the reasons stated above, the Commission finds that the proposed rule change (File No. SR&hyph;DGOC&hyph;91&hyph;01)
is consistent with section 17A of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
It is therefore ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to section 19(b)(2) of the Act, that the proposed rule change (SR&hyph;DGOC&hyph;91&hyph;01) be, and hereby
is, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=5 f=1 -->
20
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=5 f=1 -->
20
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1990).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;739 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00121 </DOCNO>
<PARENT> FR940112-2-00087 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33412; File No. SR&hyph;DTC&hyph;93&hyph;9]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; The Depository Trust Co.; Order Approving a Proposed Rule Change Relating to Implementation
of a Deposit Automated Management Service</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On August 16, 1993, The Depository Trust Company (``DTC'') filed with the Securities and Exchange Commission (``Commission'')
under section 19(b)(1) of the Securities Exchange Act of 1934 (``Act'')
<FOOTCITE>1</FOOTCITE>
 a proposed rule change (File No. SR&hyph;DTC&hyph;93&hyph;9) to implement its Deposit Automated Management (``DAM'')
service. The Commission published notice of this proposed rule change in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
on October 1, 1993.
<FOOTCITE>2</FOOTCITE>
 No public comments were received. For the reasons discussed below, the Commission is approving the proposed rule
change.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 32957 (September 24, 1993), 58 FR 51395.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change establishes procedures for implementation of DTC's DAM service.
<FOOTCITE>3</FOOTCITE>
 DAM is an enhanced automated deposit service that enables DTC participants to send details of deposits to DTC in advance
of forwarding physical certificates.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The proposal will neither add new rules to nor amend any existing rules in DTC's Rules Manual. Telephone conversation
between Jack R. Wiener, Associate Counsel, and Cheryl Lambert, Group Director, DTC, and Richard C. Strasser, Attorney,
Division of Market Regulation (``Division''), Commission (September 7, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Using DAM, a DTC participant will send to DTC advance Computer-to-Computer Facility (CCF/CCF II) or PTS transmissions
with details regarding securities that the participant plans to deposit. DTC then will determine whether the proposed
deposit is acceptable by reviewing for such things as ineligible issues, chilled issues, and incorrect CUSIPs. At
this point, DTC will send to the participant a PTS transmission which will flag rejected items (i.e., securities which
are unacceptable for deposit), items with record dates that affect DTC's processing,
<FOOTCITE>4</FOOTCITE>
 and other special processing items. The participant then will direct the printing of a special bar-coded deposit
ticket for all accepted items on a thermal bar-code printer.
<FOOTCITE>5</FOOTCITE>
 One bar-coded ticket will be printed for each CUSIP.
<FOOTCITE>6</FOOTCITE>
 Each bar-coded ticket will contain information such as the identity of the transfer agent, the nature of the deposit
(e.g., whether the deposit is made pursuant to a special corporate event or whether the shares are those of a limited
partnership), and other information that is required for DTC's internal processing of the deposit. After the participant
presents the physical certificates and the bar-coded deposit ticket to DTC, DTC will scan the bar-coded deposit ticket,
and the information contained therein immediately will update DTC's mainframe computer. This process eliminates
the need to enter data by keystroke.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
DTC will not flag the record date of every corporate event. Letter from Jack R. Wiener, Associate Counsel, DTC, to Richard
C. Strasser, Attorney, Division, Commission (September 29, 1993). For instance, DTC will not notate the record date
of corporate events such as holiday parties.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
If a participant chooses not to acquire a bar-code printer (which costs between $2,000 and $8,000 depending on printer
speed), the participant will print a deposit ticket that does not have a bar-code using the information and deposit
control number received from DTC. When the participant presents the securities and the deposit tickets without bar-codes
to DTC, DTC will use the deposit control numbers on the deposit tickets to print bar-coded deposit tickets on a printer
located at DTC.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
If a CUSIP is eligible for deposit, the ticket will so signify. If a CUSIP is ineligible for deposit, the ticket will
state ``reject'' and will give the reason for the rejection. Telephone conversation between Cheryl Lambert, Group
Director, DTC, and Jerry W. Carpenter, Branch Chief, Division, Commission (December 17, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Among other benefits, DAM will provide an opportunity for participants to consolidate deposits in the same issue
(whether or not the advanced deposit notifications are transmitted to DTC together) and will enable DTC to produce
a single deposit ticket for the total quantity of an issue deposited on a particular day.
<FOOTCITE>7</FOOTCITE>
 By providing a unique deposit control number that will be printed on the deposit ticket for each deposit, the service
will speed research, when needed, on the deposited item. DAM also will permit participants to suspend deposits for
up to ten business days in the event of an emergency, transportation delay, or error.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Participants can realize cost savings by avoiding separate fees for multiple deposits made in the same issue on the
same day. For instance, throughout a given day a participant repeatedly may notify DTC that it plans to deposit a certain
number of shares of IBM common stock. Assume a participant announces in its first transmission that it will deliver
100 shares of IBM common stock, in its second transmission that it will deliver 200 more shares of IBM, and in its third
transmission that it will deposit yet another 300 shares of IBM for a total of 600 shares for the day. DTC will sum the
three deposits for the day, and the bar-coded deposit ticket will reflect an intended deposit of 600 shares of IBM common
stock.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00122 </DOCNO>
<PARENT> FR940112-2-00087 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Participants that have a low volume of deposits and that do not want to purchase a bar-coded printer will be able to use
the PTS Deposit Automation Management Participant (``DAMP'') function to enter details of their intended deposits.
<FOOTCITE>8</FOOTCITE>
 The PTS DAMP function also can be used by CCF users to modify or delete deposit data already transmitted to DTC as well
as to enter additional deposit data.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
The DAMP function is part of the DAM service that allows participants to enter data, to correct data previously entered,
to make inquiries, or to print bar-code tickets. Telephone conversation between Cheryl Lambert, Group Director,
DTC, and Richard C. Strasser, Attorney, Division, Commission (December 22, 1993). For instance, if a participant
had notified DTC that it planned to deliver 1,000 shares of stock in ABC Corporation when in fact the participant intended
to deliver 1,100 shares, the participant could use the DAMP function to make the necessary correction in the number
of shares it intended to deliver.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
By year-end 1993, DTC expects to have processed more than 4.5 million deposits comprised of approximately 17.5 million
certificates. The automation features of DAM will reduce DTC's costs and enhance DTC's efficiency in handling these
deposits. DTC will pass the savings that it will realize from DAM directly to participants by lowering deposit fees
as follows: (a) For deposits made under DAM, DTC will reduce the deposit charge by 40
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=8 f=1 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (29
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=8 f=1 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 for legal deposits) from the applicable zone deposit charge for participants that print bar-coded tickets in their
office and (b) by 29
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=8 f=1 -->
&cent;
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (for deposits other than legal deposits) from the applicable zone deposit charge for participants that ask DTC to
print the bar-coded tickets. In addition, because DTC will prescreen the issues of securities that participants
intend to deposit, the new service will help participants save money by minimizing costly deposit rejects.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes that DTC's proposal is consistent with the Act and in particular with sections 17A (a)(1)(C)
and (b)(3)(F) thereunder.
<FOOTCITE>9</FOOTCITE>
 In section 17A(a)(1)(C) of the Act, Congress expressed its finding that new communications and data processing techniques
create the opportunity for more efficient, effective, and safe procedures for clearance and settlement. In this
regard, the Commission believes that DTC's DAM service facilitates the efficient, effective, and safe procedures
for the clearance and settlement of securities transactions by employing the electronic communication of information
between DTC and its participants.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1 (a)(1)(C) and (b)(3)(F) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Section 17A(b)(3)(F) of the Act requires that the rules of a clearing agency be designed to promote the prompt and accurate
clearance and settlement of securities transactions and to ensure the safeguarding of securities and funds that
are in the clearing agency's custody or control or for which it is responsible. The Commission believes that by enabling
DTC to review proposed deposits before securities are delivered, the DAM service helps to promote the prompt and accurate
clearance and settlement of securities transactions in accordance with DTC's requirements under the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Moreover, DTC's current safeguards will remain in place with the implementation of the DAM service. These safeguards
require DTC participants to take steps necessary to assure that the certificates presented to DTC are in good deliverable
and transferable form. As with current procedures, after the certificates are presented to DTC, DTC will send them
to the transfer agent who will reregister them in DTC's nominee name, Cede &amp; Co. The certificates typically then
will be returned to DTC for safekeeping in its vault. On occasion, however, the transfer agent will reject a certificate
for reregistration.
<FOOTCITE>10</FOOTCITE>
 If a certificate is rejected, DTC will debit the depositing participant's securities account to the extent it was
credited when the securities were delivered to DTC. If the debit results in a short position, DTC will impose a charge
of 130% of market value until the short position is resolved.
<FOOTCITE>11</FOOTCITE>
 These safeguards, as they have in the past, will help to ensure that suspect securities or those with transfer restrictions
are excluded from DTC's system. Because the implementation of the DAM service will incorporate DTC's current safeguards,
the Commission believes the proposal is consistent with DTC's requirements under the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Transfer agents may reject a certificate for a number of reasons including improper or missing endorsements, missing
stock or bond powers, stops, called bonds, certificates reported as lost or stolen, or restrictions on the transfer
of the security.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
11
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Letter from Richard B. Nesson, Executive Vice President and General Counsel, DTC, to Judith Poppalardo, Assistant
Director, Division, Commission (December 3, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On the basis of the foregoing, the Commission finds that the proposed rule change is consistent with the Act and in particular
with section 17A thereunder.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is therefore ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to section 19(b)(2) of the Act,
<FOOTCITE>12</FOOTCITE>
 that the proposed rule change (File No. SR&hyph;DTC&hyph;93&hyph;9) be, and hereby is, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
12
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(2) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>13</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
13
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;740 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00123 </DOCNO>
<PARENT> FR940112-2-00088 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33414; File No. SR&hyph;MCC&hyph;92&hyph;06]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Midwest Clearing Corp.; Order Approving Proposed Rule Change to Reduce the Time
Frames for Processing Dividend Settlement Service Claims</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On June 15, 1992, the Midwest Clearing Corporation (``MCC'') submitted a proposed rule change (File No. SR&hyph;MCC&hyph;92&hyph;06)
to the Securities and Exchange Commission (``Commission'') pursuant to section 19(b) of the Securities Exchange
Act of 1934 (``Act'').
<FOOTCITE>1</FOOTCITE>
 Notice of the proposal appeared in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on September 17, 1992, to solicit comment from interested persons.
<FOOTCITE>2</FOOTCITE>
 No comments were received by the Commission. This order approves the proposal.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 31170 (September 10, 1992), 57 FR 43040.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description of the Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The purpose of the rule change is to expedite the settlement of claims for dividends or for registered bond interest
by shortening the time frames during which MCC requires delivery of Claim Forms by participants who are filing claims
against other participants. Under MCC's Dividend Settlement Service (``DSS''), MCC processes participants' claims
for dividends and registered bond interest. DDS procedures require that before a participant can submit a claim against
another participant, it must deliver to MCC a Notice of Intent. The Notice of Intent must include either documents
which establish the basis for the claim or a written explanation of the basis for the claim.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
MCC rules require the claiming participant to deliver two copies of a Claim Form to the participant against whom the
claim is made. The Claim Form must now be delivered within five business days, previously within ten business days,
after delivering the Notice of Intent to MCC.
<FOOTCITE>3</FOOTCITE>
 Where the Notice of Intent is delivered six months or more after the record date of the dividend or interest claimed,
the Claim Form must now be delivered within ten business days, previously within twenty business days, after the delivery
of the Notice of Intent to MCC.
<FOOTCITE>4</FOOTCITE>
 Both the Notice of Intent and Claim Form must be delivered through the facilities of MCC.
<FOOTCITE>5</FOOTCITE>
 Once MCC receives the Notice of Intent and Claim Form, MCC distributes them to the participant against whom the claim
is made on the same day the Claim Form is received.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
MCC Rules, Art. V, R. 7, Section 4.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
Id.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
MCC Rules, Art. V, R. 7, Sections 3 and 4.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
MCC's rules require the participant receiving the Claim Form to respond by the Charge Date, which appears on the Claim
Form. A participant who receives a Claim Form may honor it, may file an Intent Rejection with MCC, or may take no action.
If an Intent Rejection is filed, the participants may settle the matter themselves or may submit the matter to arbitration.
If the participant receiving the Claim Form honors the claim or fails to respond, MCC will debit that participant's
account and will credit the account of the claiming participant.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes that the proposal is consistent with the Act and particularly with section 17A of the Act.
<FOOTCITE>6</FOOTCITE>
 Section 17A(b)(3)(F) of the Act requires that the rules of clearing agencies be designed to promote the prompt and
accurate clearance and settlement of securities transactions.
<FOOTCITE>7</FOOTCITE>
 Moreover, in section 17A(a)(1) of the Act,
<FOOTCITE>8</FOOTCITE>
 Congress encourages the use of efficient and effective safe procedures for securities clearance and settlement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1 (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(b)(3)(F) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(a)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes that shortening the time frames for filing claim forms, from ten business days to five business
days and from twenty business days to ten business days, should result in more efficient and effective claim processing
at MCC. Shortening the time frames also should encourage participants to settle their claims and disputes involving
dividends and interest in a more prompt manner.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For the reasons discussed above, the Commission believes that the proposal is consistent with the requirements of
the Act, particularly section 17A of the Act, and the rules and regulations thereunder.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is therefore ordered,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Pursuant to section 19(b)(2) of the Act,
<FOOTCITE>9</FOOTCITE>
 that the above-mentioned proposed rule change (File No. SR&hyph;MCC&hyph;92&hyph;06) be, and hereby is, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(2) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>10</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1991).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;741 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00124 </DOCNO>
<PARENT> FR940112-2-00089 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33440; File No. SR&hyph;NASD&hyph;93&hyph;52]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; National Association of Securities Dealers, Inc.; Order Approving Proposed Rule
Change Relating to the Pricing of Open Orders</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On September 23, 1993, the National Association of Securities Dealers, Inc. (``NASD'' or ``Association'') filed
with the Securities and Exchange Commission (``SEC'' or ``Commission'')
<FOOTCITE>1</FOOTCITE>
 a proposed rule change pursuant to section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''),
<FOOTCITE>2</FOOTCITE>
 and Rule 19b&hyph;4 thereunder.
<FOOTCITE>3</FOOTCITE>
 The proposal amends the NASD Rules of Fair Practice by requiring members holding open orders of securities quoted
ex-dividend, ex-rights, ex-distribution or ex-interest to adjust the price and, if necessary, the size of the order
by the amount of any dividend, payment or distribution on the day that the security is quoted ex-dividend, ex-rights,
ex-distribution or ex-interest.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
On November 24, 1993, the NASD filed Amendment No. 1 with the Commission. Amendment No. 1 reports the result of an NASD
member vote on the proposed rule change, which was published for member vote in NASD Notice to Members 93&hyph;61 (September
1993). The results of the member vote are as follows: 1,682 voting in favor, 232 opposed, and 11 not voting, out of 1,925
ballots received.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 240.19b&hyph;4 (1993).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice of the proposed rule change, together with the substance of the proposal, was provided by issuance of a Commission
release (Securities Exchange Act Release No. 33000, October 1, 1993) and by publication in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 (58 FR 53600, October 15, 1993). No comment letters were received. This order approves the proposed rule change.
<!-- PJG 0012 frnewline -->
The rule change approved herein amends Article III of the Rules of Fair Practice to require members holding open orders
of securities quoted ex-dividend, ex-rights, ex-distribution or ex-interest to adjust the price and, if necessary,
the size of the order by the amount of any dividend, payment or distribution on the day that the security is quoted ex-dividend,
ex-rights, ex-distribution or ex-interest. The rule change exempts from its scope: (1) Open orders subject to the
rules of a registered national securities exchange, (2) open stop orders to buy, and (3) open sell orders, as well as
orders marked ``do not reduce'' or ``do not increase.''
<!-- PJG 0012 frnewline -->
The NASD does not currently require its members to adjust open orders of securities quoted ex-dividend, ex-rights,
ex-distribution or ex-interest. An open order is an order to buy or sell which remains in effect until it is executed
or cancelled, or expires. Such orders are also known as ``good 'til cancelled,'' ``limit,'' or ``stop limit.''
<FOOTCITE>4</FOOTCITE>
 The NASD believes it is important to adopt a standard for business practices and ethics in dealing with customer open
orders. Because there is currently no NASD rule governing open orders, members adjust them according to their own
procedures unless the rules of another self-regulatory organization apply to the transaction (
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
e.g.,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 New York Stock Exchange Rule 118). These procedures can vary from automatic adjustment, automatic withdrawal, reconfirmation
of the order with the customer, or no action. Further, the procedures may vary among orders entered at the same firm
because the orders are routed to different firms for execution. As a result, investors may find that their open orders
are executed without adjustment after the ex-date at a higher cost per share than they intended based on their valuation
of the security. For example, an investor entering a limit order for a security at $10 per share prior to the dividend
date may have based his pricing judgment on the impending dividend declaration. If his order remains open after the
ex-dividend date, he may find his order in the money and executed at the dividend-assuming price even though he would
not be entitled to the dividend.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
A ``good 'til cancelled'' order is an order to buy which remains in effect until it is either executed or cancelled.
A ``limit order'' is an order to buy a stated amount of a security at a specified price, or at a better price, if obtainable
after the order is given. A ``stop limit'' order to buy becomes a limit order executable at the limit price, or at a better
price, if obtainable, when a transaction in the security occurs at or above the stop price after the order is given.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Moreover, the NASD believes the fact that some members adjust open orders on ex-dates while others do not, creates
confusion for customers. The NASD believes that the rule change sets forth a uniform and predictable method for adjusting
open orders, eliminates the potential unfairness associated with the failure to adjust these orders, and provides
consistency in the adjustment of open orders for NASD members that are also members of the New York Stock Exchange and
American Stock Exchange.
<!-- PJG 0012 frnewline -->
Subsection (a) of the new Rule of Fair Practice requires a member holding an open order from a customer or broker-dealer,
prior to executing or permitting the order to be executed, to adjust the price of the order by the amount of any dividend,
payment or other distribution on the ex-date.
<!-- PJG 0012 frnewline -->
Subsection (b) requires the member to reconfirm an open order prior to execution if the value of the distribution cannot
be determined. Subsection (c) requires open orders to be cancelled where the security is the subject of a reverse split.
Subsection (d) defines the term ``open order'' as an order to buy which remains in effect for a definite or indefinite
period of time until it is either executed, cancelled, or expires, including, but not limited to, orders marked ``good
'til cancelled,'' ``limit'' or ``stop limit.''
<!-- PJG 0012 frnewline -->
Finally, subsection (e) exempts: (1) Open orders subject to the rules of a registered national securities exchange,
(2) open stop orders to buy, and (3) open sell orders, as well as orders marked ``do not reduce'' or ``do not increase.''
Open stop orders to buy and open sell orders are exempted because the assumptions underlying such an order may not include
the value of an upcoming dividend; the combination of stop and limit prices in such an order makes the effect of repricing
unpredictable. Orders marked ``do not reduce'' or ``do not increase'' are the method for the customer to state that
he is aware of the implications of not adjusting the order on the ex-date.
<!-- PJG 0012 frnewline -->
The Commission finds that the proposed rule change is consistent with the requirements of the Act and the rules and
regulations thereunder applicable to the NASD and, in particular, the requirements of section 15A(b)(6) of the Act.
<FOOTCITE>5</FOOTCITE>
 Section 15A(b)(6) requires, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
inter alia,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 that the NASD's rules be designed to prevent fraudulent and manipulative acts, promote just and equitable principles
of trade, and protect investors and the public interest. The Commission believes that the creation of a single method
of handling the adjustment of open orders after the ex-date will serve the interest of investor protection. For this
reason, and for the reasons stated above, the Commission believes that the proposed rule change satisfies the requirements
of section 15A(b)(6) of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C.&sect;78
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=3 -->
o
<!-- PJG /ITAG -->

<!-- PJG ITAG l=28 g=1 f=1 -->
&hyph;3.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is therefore ordered,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 pursuant to section 19(b)(2) of the Act, that the instant rule change be, and hereby is, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority, 17 CFR 200.30&hyph;3(a)(12).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;688 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00125 </DOCNO>
<PARENT> FR940112-2-00090 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33433; File No. SR&hyph;NASD&hyph;93&hyph;56]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; National Association of Securities Dealers, Inc.; Order Approving Proposed Rule
Change Relating to the Codification of Basic Requirements Respecting Access to and Use of the OTC Bulletin Board Service</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On October 12, 1993, the National Association of Securities Dealers, Inc. (``NASD'' or ``Association'') filed with
the Securities and Exchange Commission (``SEC'' or ``Commission'') a proposed rule change pursuant to section 19(b)(1)
of the Securities Exchange Act of 1934 (``Act'')
<FOOTCITE>1</FOOTCITE>
 and Rule 19b&hyph;4 thereunder.
<FOOTCITE>2</FOOTCITE>
 The proposal codifies the existing requirements respecting access to and use of the OTC Bulletin Board Service (``OTCBB'').
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(1) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 240.19b&hyph;4 (1992).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Notice of the proposed rule change, together with its terms of substance, appeared in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on October 21, 1993.
<FOOTCITE>3</FOOTCITE>
 No comments were received on the proposal. This order approves the rule change.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 33052 (October 15, 1993), 58 FR 54389 (October 21, 1993).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposal codifies, without substantive change, various requirements that the NASD has implemented, pursuant
to Commission approval, since the OTCBB was launched as a pilot program on June 1, 1990. Specifically, these requirements
are included in the following Rule 19b&hyph;4 NASD filings approved by the Commission: (1) File No. SR&hyph;NASD&hyph;88&hyph;19
(as amended), detailing the basic operational requirements for the OTCBB;
<FOOTCITE>4</FOOTCITE>
 (2) File No. SR&hyph;NASD&hyph;90&hyph;37, expanding by one-half hour the quotation-update period applicable
to market makers in foreign/ADR issues;
<FOOTCITE>5</FOOTCITE>
 (3) File No. SR&hyph;NASD&hyph;91&hyph;12, establishing a firm quote requirement for all priced bids/offers in
domestic equity securities; and (4) File No. SR&hyph;NASD&hyph;91&hyph;38, establishing the parameters for an
inside bid-ask calculation.
<FOOTCITE>6</FOOTCITE>
 Additionally, the codification references two recently approved regulatory initiatives affecting the OTCBB and
participating member firms: (1) File No. SR&hyph;NASD&hyph;92&hyph;48, concerning real-time trade reporting
requirements for OTC equity securities;
<FOOTCITE>7</FOOTCITE>
 and (2) File No. SR&hyph;NASD&hyph;93&hyph;17, revising the minimum quotation size requirements for OTCBB market
makers.
<FOOTCITE>8</FOOTCITE>
 The present proposal provides that these initiatives will be published, respectively, in Part XIII of Schedule D
to the NASD By-Laws and Section 5 of Schedule H to the NASD By-Laws.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 27975 (May 30, 1990), 55 FR 23161 (June 6, 1990).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 28404 (August 31, 1990), 55 FR 37791 (September 3, 1990). The codification provides
that, with respect to a priced bid and/or offer entered into OTCBB for a foreign equity security or an ADR, a market maker
may update quotation entries twice daily (once between 8:30 a.m. and 9:30 a.m. ET, and once between noon and 21:30 p.m.
ET).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
For any equity security quoted in the OTCBB, an inside bid-ask calculation (i.e., the highest bid and lowest offer
being displayed by market makers registered in a particular security) is available only if the security has at least
two registered market makers, each displaying a priced bid and offer. If additional market makers are displaying
either one or two-sided quotations, those entries also are factored into the inside calculation. On the other hand,
if the basic requirement of two market makers is not satisfied, an indication is generated denoting that no inside
calculation is available.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 32647 (July 16, 1993), 58 FR 39262 (July 22, 1993). The NASD has announced that
real-time trade reporting requirements for OTC equity securities would begin on December 20, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
8
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 32570 (July 1, 1993), 58 FR 36725 (July 8, 1993). File No. SR&hyph;NASD&hyph;93&hyph;17,
approved by the Commission, replaced the previous 100-share minimum quote size requirement for OTCBB with a tiered
structure for mandatory minimum quote size based on the price of the bid or offer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II. Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes that the proposed rule change is consistent with sections 15A(b) (6) and (11) of the Act. Section
15A(b)(6) requires, in pertinent part, that NASD rules be designed to prevent fraudulent and manipulative acts or
practices, to promote just and equitable principles of trade, to foster cooperation and coordination with persons
engaged in regulating, clearing, settling, processing information with respect to, and facilitating transactions
in securities, and in general to protect investors and the public interest. Section 15A(b)(11) requires that the
rules of the NASD include provisions governing the form and content of quotations relating to securities sold otherwise
than on a national securities exchange and that those rules, among other things, be designed to promote orderly procedures
for collecting, distributing, and publishing quotations.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The Commission believes that, because the proposal embodies existing operational requirements that have been in
place but, until now, have not been codified as NASD rules, the proposal should facilitate NASD members' efforts to
research pertinent requirements by referencing a discrete section of the NASD Manual. Thus, the codification should
facilitate members' ability to comply with the requirements since they will be in a readily accessible form. Moreover,
the codification should promote orderly procedures for collecting, distributing, and publishing OTCBB quotations
since those procedures now will be found in the NASD Manual. In sum, the Commission believes the proposed codification
should facilitate the NASD's administration of and member firms' compliance with the operational requirements
that are unique to the OTCBB, thereby furthering the purposes of sections 15A(b) (6) and (11) and the Act in general.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is therefore ordered, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to section 19(b)(2) of the Act,
<FOOTCITE>9</FOOTCITE>
 that the proposed rule change (SR&hyph;NASD&hyph;93&hyph;56) is approved.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
9
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(2) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>10</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
10
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1991).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;742 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00126 </DOCNO>
<PARENT> FR940112-2-00091 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33437; File No. SR&hyph;NYSE&hyph;93&hyph;37]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Self-Regulatory Organizations; Filing of Proposed Rule Change by the New York Stock Exchange, Inc. Relating to Amendments
to Rules 450 (``Restrictions on Giving of Proxies''), 451 (``Transmission of Proxy Material''), 452 (``Giving of
Proxies by Member Organizations'') and 465 (``Transmission of Interim Reports and Other Material'')</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 5, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Pursuant to section 19(b)(1) of the Securities Exchange Act of 1934 (``Act''), 15 U.S.C. 78s(b)(1), notice is hereby
given that on October 22, 1993, the New York Stock Exchange, Inc. (``NYSE'' or ``Exchange'') filed with the Securities
and Exchange Commission (``Commission'') the proposed rule change as described in Items I, II and III below, which
Items have been prepared by the self-regulatory organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=1 -->
I. Self-Regulatory Organization's Statement of the Terms of Substance of the Proposed Rule Change
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
The NYSE is herewith filing proposed amendments to NYSE Rules 450, 451, 452 and 465 which will allow designated registered
investment advisers to vote proxies and receive proxy and related issuer material in lieu of beneficial owners. The
text of these rules follows:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=3 -->
Italics
<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
 reflect additions
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Proxies
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
(Rules and Policies Administered by Marketing Division.)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
Applicability of proxy rules_Rules 450 to 460 [&para;2450&hyph;2460], inclusive, apply to both listed and unlisted
securities, unless the context otherwise limits application.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The term ``unregistered company'' as used in Rule 456 to 459 [&para;2456&hyph;2459] means a company not required
to conform to the proxy rules of the Securities and Exchange Commission in the solicitation of proxies with respect
to its securities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The term ``member'' as used in connection with Rules 456 to 459 [&para;2456&hyph;2459] includes a member, allied
member, member firm, member corporation and employee thereof.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
The term ``investment adviser'' as used in Rules 450, 451, 452 and 465 [&para;2450, 2451, 2452, 2465] may include a
registered broker-dealer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=3 -->
Restriction on Giving of Proxies
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
Rule 450. No member organization shall give or authorize the giving of a proxy to vote stock registered in its name,
or in the name of its nominee, except as required or permitted under the provisions of Rule 452 [&para;2452], unless
such member organization is the beneficial owner of such stock. Notwithstanding the foregoing,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Any member organization designated by a named fiduciary as the investment manager of stock held as assets of an ERISA
Plan that expressly grants discretion to the investment manager to manage, acquire, or dispose of any plan asset and
which has not expressly reserved the proxy voting right for the named fiduciary may vote the proxies in accordance
with its ERISA Plan fiduciary responsibilities; 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) any person registered as an investment adviser under the Investment Advisers Act of 1940 who exercises investment
discretion pursuant to an advisory contract for the beneficial owner and has been designated in writing by the beneficial
owner to vote the proxies for stock which is in the possession or control of the member organization, may vote such proxies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=3 -->
Transmission of Proxy Material
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->

<!-- PJG 0012 frnewline -->
Rule 451.(a) Whenever a person soliciting proxies shall furnish a member organization:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) copies of all soliciting material which such person is sending to registered holders and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(2) satisfactory assurance that he will reimburse such member organization for all out-of-pocket expenses, including
reasonable clerical expenses, incurred by such member organization in connection with such solicitation, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=20 g=1 f=3 -->
Such member organization shall transmit to each beneficial owner of stock which is in its possession or control or
to an investment adviser registered under the Investment Advisers Act of 1940 who exercises investment discretion
pursuant to an advisory contract for the beneficial owner and has been designated in writing by the beneficial owner
of such stock to receive soliciting material in lieu of the beneficial owner, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=20 g=1 f=1 -->
the material furnished; and
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG 0012 frnewline -->
(b) such member organization shall transmit with such material either:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(1) a request for voting instructions and, as to matters which may be voted without instructions under Rule 452 [&para;2452],
a statement to the effect that, if such instructions are not received by the tenth day before the meeting, the proxy
may be given at discretion by the owner of record of the stock; provided, however, that such statement may be made only
when the proxy soliciting material is transmitted to the beneficial owner of the stock 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
or to the beneficial owner's designated investment adviser registered under the Investment Advisers Act of 1940
who exercises investment discretion pursuant to an advisory contract for such beneficial owner, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
at least fifteen days before the meeting. When the proxy soliciting material is transmitted to the beneficial owner
of the stock 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
or to the beneficial owner's designated investment adviser registered under the Investment Advisers Act of 1940

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
twenty-five days or more before the meeting, the statement accompanying such material shall be to the effect that
the proxy may be given fifteen days before the meeting at the discretion of the owner of record of the stock; or 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00127 </DOCNO>
<PARENT> FR940112-2-00091 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=21 g=1 f=1 -->
(2) a signed proxy indicating the number of shares held for such beneficial owner and bearing a symbol identifying
the proxy records of such member organization, and also a letter informing the beneficial owner 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
or the beneficial owner's designated investment adviser registered under the Investment Advisers Act of 1940 who
exercises investment discretion pursuant to an advisory contract for such beneficial owner,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 of the necessity for completing the proxy form and forwarding it to the person soliciting proxies in order that the
shares may be represented at the meeting. 
<!-- PJG 0012 frnewline -->
This rule shall not apply to beneficial owners outside the United States. 
<!-- PJG 0012 frnewline -->
.&blank;.&blank;.&blank;Supplementary Material: 
<!-- PJG 0012 frnewline -->
.10 Annual reports to be transmitted._The annual report shall be transmitted to beneficial owners 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
or to beneficial owners' designated investment advisers registered under the Investment Advisers Act of 1940 who
exercise investment discretion pursuant to an advisory contract for such beneficial owners
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 under the same conditions as those applying to proxy soliciting material under Rule 451 even though it is not proxy-soliciting
material under the proxy rules of the Securities and Exchange Commission. 
<!-- PJG 0012 frnewline -->
.60 Duty to transmit even when requested not to._The proxy material must be sent to a beneficial owner even though such
owner has instructed the member organization not to do so, 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
unless the beneficial owner has instructed the member organization in writing to send such material to a designated
investment adviser registered under the Investment Advisers Act of 1940 who exercises investment discretion pursuant
to an advisory contract for such beneficial owner. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=3 -->
Rule 452 Giving Proxies by Member Organization 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=71 g=1 f=3 -->
Voting procedure without instructions 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
A member organization which has transmitted proxy soliciting material to the beneficial owner of stock or to an investment
adviser registered under the Investment Adviser Act of 1940 who exercises investment discretion pursuant to an advisory
contract for the beneficial owner and has been designated in writing by the beneficial owner of such stock to receive
soliciting material in lieu of the beneficial owner
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 and solicited voting instructions in accordance with the provisions of Rule 451 [&para;2451], and which has not received
instructions from the beneficial owner 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
or from such designated registered investment adviser
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 by the date specified in the statement accompanying such material, may give or authorize the giving of a proxy to vote
such stock, provided the person in the member organization giving or authorizing the giving of the proxy has no knowledge
of any contest as to the action to be taken at the meeting and provided such action is adequately disclosed to stockholders
and does not include authorization for a merger, consolidation or any other matter which may affect substantially
the rights or privileges of such stock. 
<!-- PJG 0012 frnewline -->
.&blank;.&blank;.&blank;Supplementary Material: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Giving a Proxy To Vote Stock 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
.10 When member organization may vote without customer instructions._Rule 452, above, provides that a member organization
may give a proxy to vote stock provided that: 
<!-- PJG 0012 frnewline -->
(1) It has transmitted proxy soliciting material to the beneficial owner of stock 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
or to an investment adviser registered under the Investment Advisers Act of 1940 who exercises investment discretion
pursuant to an advisory contract for the beneficial owner and has been designated by the beneficial owner to receive
such material
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 in accordance with Rule 451 [&para;2451], and 
<!-- PJG 0012 frnewline -->
(2) it has not received voting instructions from the beneficial owner 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
or from the beneficial owner's designated investment adviser registered under the Investment Advisers Act of 1940
who exercises investment discretion pursuant to an advisory contract for such beneficial owner,
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 by the date specified in the statement accompanying such material, and 
<!-- PJG 0012 frnewline -->
(3) [No change in text] 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=1 -->
Transmission of Interim Reports and Other Material 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Rule 465. A member organization, when so requested by a company, and upon being furnished with: 
<!-- PJG 0012 frnewline -->
(1) copies of interim reports of earnings or other material being sent to stockholders, and 
<!-- PJG 0012 frnewline -->
(2) satisfactory assurance that it will be reimbursed by such company for all out-of-pocket expenses, including
reasonable clerical expenses, shall transmit such reports or material to each beneficial owner of stock of such company
held by such member organization and registered in the name other than the name of the beneficial owner 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
unless the beneficial owner has instructed the member organization in writing to transmit such reports or material
to a designated investment adviser registered under the Investment Advisers Act of 1940 who exercises investment
discretion pursuant to an advisory contract for such beneficial owner. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=85 g=1 f=3 -->
II. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
In its filing with the Commission, the self-regulatory organization included statements concerning the purpose
of, and basis for, the proposed rule change and discussed any comments it received on the proposed rule change. The
text of these statements may be examined at the places specified in Item IV below. The self-regulatory organization
has prepared summaries, set forth in Sections A, B, and C below, of the most significant aspects of such statements.

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=3 -->
A. Self-Regulatory Organization's Statement of the Purpose of, and Statutory Basis for, the Proposed Rule Change

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=3 -->
1. Purpose 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
The purpose of the proposed rule amendments is to provide beneficial owners of stock with the ability to have investment
advisers registered under the Investment Advisers Act of 1940 who exercise investment discretion for their account(s)
pursuant to an advisory contract and who have been designated in writing by the beneficial owners to receive proxy
materials and to vote proxies on behalf of such beneficial owners. The proposed rule amendments will also allow the
designated registered investment advisers to receive annual reports and other related material. This would include
both member organizations of the NYSE and other entities registered as investment advisers. 
<!-- PJG 0012 frnewline -->
Currently, Exchange rules prohibit a member organization from voting proxies, on a discretionary basis, on securities
held in its custody unless the securities are beneficially owned by the member organization, the beneficial owner
has failed to provide the member organization with voting instructions and the subject of the vote is nonsubstantive,
or the member organization is the investment manager for an ERISA account. 
<!-- PJG 0012 frnewline -->
Further, Exchange rules require transmission of proxy and related issuer materials, as well as proxy voting instructions,
to each beneficial owner of stock held in the member organization's possession and control. Rule 451.60 explicitly
requires that proxy material be sent to a beneficial owner even though such owner has instructed the member organization
not to do so. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00128 </DOCNO>
<PARENT> FR940112-2-00091 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=3 -->
A number of member organizations and the Investment Adviser Committee of the Securities Industry Association (``SIA'')
represented to the Exchange that many of their customers who have their accounts managed by investment advisers do
not want to receive proxy related information and annual reports or vote the proxy. These member organizations have
indicated that their customers would rather have the professionals, whom they pay to manage their accounts, represent
their interests relative to the companies in which they own stock because the professionals are better qualified.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Also, banks, investment advisers and broker/dealers who are not subject to Exchange rules may receive proxy material
and vote proxies on behalf of their customers in accordance with fiduciary obligations set forth by contractual arrangement.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The amendments to Exchange Rules 450, 451, 452 and 465 will permit investment advisers who exercise investment discretion
pursuant to an advisory contract and who have been designated in writing by the beneficial owner, to receive proxy
soliciting materials, annual reports and other related material and to vote proxies in lieu of the beneficial owners
of securities. The term investment adviser is defiend to include a registered broker-dealer (e.g., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
a member organization).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The proposed rule change will not diminish a beneficial owner's rights to receive proxy related materials and to vote
proxies. Rather, it will give beneficial owners the option to designate their investment adviser as the person to
receive such materials and to vote proxies. In addition, it will enable member organizations to comply with customer
desires concerning transmission of proxy materials and voting proxies.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Statutory Basis
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposed rule change is consistent with Section 6(b)(5) of the Securities Exchange Act of 1934 which requires
that the rules of the Exchange be designed to prevent fraudulent and manipulative acts, to promote just and equitable
principles of trade, to remove impediments to and perfect the mechanism of a free and open market and, in general, to
protect the investing public, in that it establishes standards for investment advisers to receive proxy and related
material and to vote proxies, thereby meeting customer needs while providing appropriate regulatory safeguards.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
B. Self-Regulatory Organization's Statement on Burden on Competition
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange does not believe that the proposed rule change will result in any burden on competition that is not necessary
or appropriate in furtherance of the purposes of the Act.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
C. Self-Regulatory Organization's Statement on Comments on the Proposed Rule Change Received From Members, Participants
or Others
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Exchange has neither solicited, and does not intend to solicit, comments regarding this proposed rule change.
The Exchange has not received any unsolicited written comments from members or other interested parties.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00129 </DOCNO>
<PARENT> FR940112-2-00091 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=85 g=1 f=1 -->
III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Within 35 days of the publication of this notice in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 or within such other period (i) as the Commission may designate up to 90 days of such date if it finds such longer period
to be appropriate and publishes its reasons for so finding or (ii) as to which the self-regulatory organization consents,
the Commission will: 
<!-- PJG 0012 frnewline -->
(A) by order approve the proposed rule change, or 
<!-- PJG 0012 frnewline -->
(B) institute proceedings to determine whether the proposed rule change should be disapproved. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
IV. Solicitation of Comments 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Interested persons are invited to submit written data, views and arguments concerning the foregoing. Persons making
written submissions should file six copies thereof with the Secretary, Securities and Exchange Commission, 450
Fifth Street, NW., Washington, DC 20549. Copies of the submission, all subsequent amendments, all written statements
with respect to the proposed rule change that are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person, other than those that may be withheld from the public
in accordance with the provisions of 5 U.S.C. 552, will be available for inspection and copying at the Commission's
Public Reference Section, 450 Fifth Street, NW., Washington, DC 20549. Copies of such filing will also be available
for inspection and copying at the principal office of the NYSE. All submissions should refer to File No. SR&hyph;NYSE&hyph;93&hyph;37
and should be submitted by February 2, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission, by the Division of Market Regulation, pursuant to delegated authority. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland, 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;687 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00130 </DOCNO>
<PARENT> FR940112-2-00092 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Release No. 34&hyph;33411; International Series Release No. 627; File No. SR&hyph;OCC&hyph;92&hyph;29]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>Self&hyph;Regulatory Organizations; the Options Clearing Corp.; Order Approving a Proposed Rule Change Relating
to Delivery-Versus-Payment Settlement Procedures</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=44 g=1 f=1 -->
January 4, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
On September 17, 1992, The Options Clearing Corporation (``OCC'') submitted a proposed rule change (File No. SR&hyph;OCC&hyph;92&hyph;29)
to the Securities and Exchange Commission (``Commission'') pursuant to section 19(b) of the Securities Exchange
Act of 1934 (``Act'')
<FOOTCITE>1</FOOTCITE>
 concerning delivery-versus-payment (``DVP'') settlement procedures. Notice of the proposal appeared in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 on December 14, 1992, to solicit comment from interested persons.
<FOOTCITE>2</FOOTCITE>
 No comments were received by the Commission. This order approves the proposal.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
1
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b) (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
2
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
Securities Exchange Act Release No. 31566 (December 4, 1992), 57 FR 59190.
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
I. Description of the Proposal
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
OCC is amending its Rule 1606A to modify its DVP settlement procedures. First, the proposal clarifies that a clearing
member that elects to settle using DVP procedures in Rule 1606A is not discharged from its obligation to U.S. dollars
or to deliver foreign currency in settlement of the exercise of foreign currency options until the earlier of the time
when (i) the clearing member's agent bank irrevocably pays U.S. dollars or delivers foreign currency to OCC's correspondent
bank on behalf of the clearing member of (ii) OCC's correspondent bank irrevocably credits OCC's account with the
U.S. dollars or the foreign currency deliverable by the clearing member's agent bank whether or not the clearing member's
agent bank has paid U.S. dollars or delivered foreign currency to OCC's correspondent bank. Second, the proposal
emphasizes the conditional nature of OCC's obligation in the DVP settlement process. OCC is obligated to cause its
correspondent bank to deliver the quantity of U.S. dollars or foreign currency payable by OCC only against receipt
from the agent bank of the quantity of U.S. dollars or foreign currency payable to OCC. Finally, the proposal clarifies
that OCC's delivery obligation is to the party designated in the DVP authorization, which may or may not be the clearing
member's agent bank.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
II Discussion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Commission believes that the proposal is consistent with the Act and in particular section 17A of the Act.
<FOOTCITE>3</FOOTCITE>
 Sections 17A(b)(3) (A) and (F) of the Act
<FOOTCITE>4</FOOTCITE>
 require that a clearing agency be organized and its rules designed to promote the prompt and accurate clearance and
settlement of securities transactions and to assure the safeguarding of funds in the custody or control of the clearing
agency or for which it is responsible.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
3
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1 (1988).
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FOOTNOTE>

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
4
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1(b)(3) (A) and (F) (1988).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The proposal clarifies certain DVP settlement procedures and describes with more precision when a clearing member
is discharged from its delivery and payment obligations in foreign currency options. It also clarifies OCC's payment
and delivery obligations in connection with DVP settlement. In particular, the proposal clarifies that OCC's obligation
arises only after the clearing member's agent bank fulfills its obligation to OCC's correspondent bank. The Commission
believes that this effort by OCC to clarify the terms of DVP settlement should add certainty to the settlement process
and should provide an added measure of protection for OCC. Because the rule change should further enable OCC to comply
with its statutory obligations to provide prompt and accurate clearance and settlement of securities transactions
and to assure the safeguarding of securities and funds, the Commission believes that approval of the rule change is
warranted.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
III. Conclusion
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
For the reasons discussed above, the Commission believes that the proposal is consistent with the requirements of
the Act, particularly with section 17A of the Act,
<FOOTCITE>5</FOOTCITE>
 and the rules and regulations thereunder.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
5
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78q&hyph;1 (1988).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
It is therefore ordered
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
, Pursuant to section 19(b)(2) of the Act,
<FOOTCITE>6</FOOTCITE>
 that the above-mentioned proposed rule change (File No. SR&hyph;OCC&hyph;92&hyph;29) be, and hereby is, approved.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
6
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
15 U.S.C. 78s(b)(2) (1988).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
For the Commission by the Division of Market Regulation, pursuant to delegated authority.
<FOOTCITE>7</FOOTCITE>

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<FOOTNOTE>
<FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
7
<!-- PJG /ITAG -->

</FOOTNAME>
<!-- PJG ITAG l=28 g=1 f=1 -->
17 CFR 200.30&hyph;3(a)(12) (1991).
<!-- PJG 0012 frnewline -->
</FOOTNOTE>

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Margaret H. McFarland,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Deputy Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;743 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8010&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00131 </DOCNO>
<PARENT> FR940112-2-00093 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>DEPARTMENT OF TRANSPORTATION</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Federal Aviation Administration</USBUREAU>
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Research, Engineering and Development Advisory Committee Flight Service Technology Subcommittee Notice of Meeting;
Correction
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Federal Aviation Administration, USDOT.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Correction.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
On page 59 FR 646 in the issue of Wednesday, January 5, 1994, make the following correction: The time published for the
January 28 Research, Engineering and Development Advisory Committee, Flight Service Technology Subcommittee
meeting was 10 a.m. This should be changed to read 9:30 a.m.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUMMARY>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Martin T. Pozesky,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Executive Director, Research, Engineering and Development Advisory Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;774 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00132 </DOCNO>
<PARENT> FR940112-2-00094 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<DOCTITLE>Research, Engineering and Development Advisory Committee</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Pursuant to section 10(A)(2) of the Federal Advisory Committee Act (Pub. L. 92&hyph;362; 5 U.S.C. app. I), notice
is hereby given of a meeting of the Federal Aviation Administration (FAA) Research, Engineering and Development
(R,E&amp;D) Advisory Committee to be held Friday, February 4, 1994, at 10 a.m. The meeting will take place at the Federal
Aviation Administration, 800 Independence Avenue SW., Washington, DC, in the Round Room on the tenth floor.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The agenda for this meeting will include subcommittee reports on: Global Navigation Satellite System Technology;
Open Systems Architecture; Synthetic Vision; and Security R&amp;D. Time permitting, brief updates on subgroup
activities concerning Flight Service Technology, Airport Investment Criteria, Compatible Land Use, and Aircraft
Safety will also be provided.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Attendance is open to the interested public but limited to space available. With the approval of the Committee Chairman,
members of the public may present oral statements at the meeting. Persons wishing to present oral statements, obtain
information, or plan to access the building to attend the meeting should contact Ms. Jan Peters, ASE&hyph;3, at (202)
287&hyph;8543, in the Office of the Associate Administrator for System Engineering and Development, 800 Independence
Avenue, SW., Washington, DC 20591. Members of the public may present a written statement to the Committee at any time.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Issued in Washington, DC, on January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Martin T. Pozesky,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Executive Director, Research, Engineering and Development Advisory Committee.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;775 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4910&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00133 </DOCNO>
<PARENT> FR940112-2-00095 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=50 g=1 f=1 -->


<USDEPT>UNITED STATES INFORMATION AGENCY</USDEPT>

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->

<DOCTITLE>U.S. Advisory Commission on Public Diplomacy Meeting</DOCTITLE>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
agency: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
United States Information Agency.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
action: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
summary: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
A meeting of the U.S. Advisory Commission on Public Diplomacy will be held on January 12 in room 600, 301 4th Street SW.,
Washington, DC from 10:30 a.m. to 12 p.m.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
At 10:30 a.m. the Commission will meet with Mr. Stanley Silverman, Comptroller, USIA, to discuss the Agency's budget.
At 11:15 a.m. the Commission will meet with Mr. Robert Powers, Acting Associate Director, Bureau of Policy and Programs,
to discuss proposals to create a new Bureau of Information within USIA. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
for further information contact: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Please call Gloria Kalamets, (202) 619&hyph;4468, if you are interested in attending the meeting. Space is limited
and entrance to the building is controlled.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Rose Royal,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Management Analyst, Federal Register Liaison.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;693 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 8230&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00134 </DOCNO>
<PARENT> FR940112-2-00096 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4718 -->

<!-- PJG STAG 4718 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Sunshine Act Meetings
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Vol. 59, No. 8
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
Wednesday, January 12, 1994
<!-- PJG /ITAG -->

<!-- PJG ITAG l=94 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=10 g=1 f=2 -->
FEDERAL MINE SAFETY AND HEALTH REVIEW COMMISSION
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
10:00 a.m., Wednesday, January 5, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Room 600, 1730 K Street, NW., Washington, DC.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Open.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Commission will consider and act upon the following:
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=3 -->
Consolidation Coal Co., 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Docket No. WEVA 92&hyph;922. (Issues include whether the judge erred in finding that Consolidation violated 30 U.S.C.
&sect;813(f) because it refused to allow a miners' walkaround representative to enter an area of its mine which it
believed was too dangerous to be inspected.)
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any person attending this meeting who requires special accessibility features and/or auxiliary aids, such as sign
language interpreters, must inform the Commission in advance of those needs. Subject to 29 CFR 2706.150(a)(3) and
2706.160(e).
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFO: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Jean Ellen (202) 653&hyph;5629/(202) 708&hyph;9300 for TDD Relay/1&hyph;800&hyph;877&hyph;8339 for toll free.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 23, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Jean H. Ellen,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Agenda Clerk.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;914 Filed 1&hyph;10&hyph;94; 3:55 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 6735&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00135 </DOCNO>
<PARENT> FR940112-2-00097 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
NATIONAL TRANSPORTATION SAFETY BOARD
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
TIME AND DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
9:30 a.m., Wednesday, January 19, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The Board Room, 5th floor, 490 L'Enfant Plaza, SW., Washington, DC. 20594.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Open.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=26 g=1 f=1 -->
6241&blank;Safety Study: A Review of Flightcrew-Involved Major U.S. Air Carriers Accidents
<!-- PJG 0012 frnewline -->
6249&blank;Aviation Accident Summary Report: GP Express Airlines, Inc., Beech C&hyph;99, N115GP, Shelton, Nebraska,
April 28, 1993.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
NEWS MEDIA CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Telephone (202) 382&hyph;0660.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
FOR MORE INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Bea Hardesty, (202) 382&hyph;6525.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Bea Hardesty,
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Federal Register Liaison Officer.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;852 Filed 1&hyph;10&hyph;94; 11:21 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7533&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00136 </DOCNO>
<PARENT> FR940112-2-00098 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=69 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=2 -->
NUCLEAR REGULATORY COMMISSION 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Weeks of January 10, 17, 24, and 31, 1994.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
PLACE: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Commissioners' Conference Room, 11555 Rockville Pike, Rockville, Maryland. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
STATUS: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Public and Closed.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
MATTERS TO BE CONSIDERED:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Week of January 10
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Monday, January 10
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
10:30 a.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on Status of NRC's Agreement States Program (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(Contact: Richard Bangart, 301&hyph;504&hyph;3340)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
2:00 p.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on NRC Research Program on Low Level Waste (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(Contact: Nick Costanzi, 301&hyph;492&hyph;3760)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
3:30 p.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Affirmation/Discussion and Vote (Public Meeting) (if needed)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Week of January 17_Tentative
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Wednesday, January 19
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
11:30 a.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Affirmation/Discussion and Vote (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
a. Final Amendments to 10 CFR Part 55 on Renewal of Licenses and Requalification Requirements for Licensed Operators
(Tentative)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(Contact: Anthony DiPalo, 301&hyph;492&hyph;3784 or Frank Collins, 301&hyph;504&hyph;3173)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Week of January 24_Tentative
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Monday, January 24
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
9:30 a.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on Final Report of Regulatory Review Task Force: (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(Contact: Frank Gillespie, 301&hyph;504&hyph;1275)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
2:00 p.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on Options for Agreement States Compatibility Policy (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(Contact: Cardelia Maupin, 301&hyph;504&hyph;2312)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Tuesday, January 25
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
10:00 a.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on Status of TVA Nuclear Programs (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
1:30 p.m. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on Activities of the Center for Nuclear Waste Regulatory Analyses (CNWRA) (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(Contact: Malcolm Knapp, 301&hyph;504&hyph;3324)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00137 </DOCNO>
<PARENT> FR940112-2-00098 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Wednesday, January 26
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
10:00 a.m.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing by GE on Status of ABWR Application for Design Certification (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
11:30 a.m.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Affirmation/Discussion and Vote (Public Meeting) (if needed)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
2:00 p.m.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing by NARUC Nuclear Waste Program Office (Public Meeting)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Thursday, January 27
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
1:30 p.m.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Periodic Briefing on Operating Reactors and Fuel Facilities (Public Meeting)
<!-- PJG 0012 frnewline -->
(Contact: Bill Bateman, 301&hyph;504&hyph;1711)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Friday, January 28
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
10:00 a.m.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on Progress of Design Certification Review and Implementation (Public Meeting)
<!-- PJG 0012 frnewline -->
(Contact: Dennis Crutchfield, 301&hyph;504&hyph;1199 or Richard Borchardt, 301&hyph;504&hyph;1118)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=74 g=1 f=2 -->
Week of January 31_Tentative
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=73 g=1 f=2 -->
Monday, January 31
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
10:00 a.m.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Briefing on Plan for Implementation of PRA Working Group Report (Public Meeting)
<!-- PJG 0012 frnewline -->
(Contact: Joe Murphy, 301&hyph;492&hyph;3980)
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=26 g=1 f=2 -->
3:30 p.m.
<!-- PJG /ITAG -->

<!-- PJG ITAG l=24 g=1 f=2 -->
Affirmation/Discussion and Vote (Public Meeting) (if needed)
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=2 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Note: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Affirmation sessions are initially scheduled and announced to the public on a time-reserved basis. Supplementary
notice is provided in accordance with the Sunshine Act as specific items are identified and added to the meeting agenda.
If there is no specific subject listed for affirmation, this means that no item has as yet been identified as requiring
any Commission vote on this date.
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The schedule for Commission meetings is subject to change on short notice. To verify the status of meetings call (Recording)_(301)
504&hyph;1292.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=10 g=1 f=2 -->
CONTACT PERSON FOR MORE INFORMATION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
William Hill (301) 504&hyph;1661.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 7, 1994.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
William M. Hill, Jr.,
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
SECY Tracking Officer, Office of the Secretary.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;810 Filed 1&hyph;7&hyph;94; 4:43 pm]
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 7590&hyph;01&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00138 </DOCNO>
<PARENT> FR940112-2-00099 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part VI
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of Housing and Urban Development
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Office of the Assistant Secretary for Community Planning and Development
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Funding Availability for Historically Black Colleges and Universities Program; Notice
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT </USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>Office of the Assistant Secretary for Community Planning and Development</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. N&hyph;93&hyph;3682; FR&hyph;3615&hyph;N&hyph;01] </RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=56 g=1 f=1 -->
Notice of Funding Availability for Historically Black Colleges and Universities Program 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Office of the Assistant Secretary for Community Planning and Development, HUD. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Notice of Funding Availability (NOFA) for Fiscal Year (FY) 1994 and notice of additional funding and extension of
application due date under FY 1993 NOFA. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 This NOFA announces $6.5 million of FY 1994 funding for the Historically Black Colleges and Universities (HBCU) Program
plus an additional $2 million of FY 1993 funding. The total amount of FY 1993 and FY 1994 funding, $13 million, is combined
into a single competition and the application due date of the FY 1993 NOFA is extended to run concurrently with this
FY 1994 NOFA. 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 No applications for the FY 1993 and FY 1994 HBCU NOFAs will be accepted after 4:30 pm on February 11, 1994. This application
deadline is firm as to date and hour. In the interest of fairness to all competing applicants, the Department will treat
as ineligible for consideration any application that is received after the deadline. Applicants should take this
practice into account and make early submission of their materials to avoid any risk of loss of eligibility brought
about by unanticipated delays or other delivery-related problems. A ``FAX'' will not constitute delivery.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</DATE>
<ADDRESS>
<!-- PJG ITAG l=10 g=1 f=2 -->
ADDRESSES:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 For an application kit contact: Sylvester C. Angel, Processing and Control Branch, Office of Community Planning
and Development, Department of Housing and Urban Development, 451 7th Street SW., room 7255, Washington, DC 20410&hyph;3500.
Requests must be in writing and may be sent to this address or may be made by facsimile machine to the following number:
(202) 708&hyph;3363. The TDD number for the hearing impaired is (202) 708&hyph;2565. (This is not a toll-free number.)
When requesting an application kit, please refer to document FR&hyph;3615, and provide your name, address (including
zip code), and telephone number (including area code). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</ADDRESS>
<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 Dr. James Turk, Office of Technical Assistance, Department of Housing and Urban Development, 451 7th Street SW.,
room 7253, Washington, DC 20410. Telephone Number: (202) 708&hyph;3176. The TDD number for the hearing impaired
is (202) 708&hyph;2565. (These are not toll-free numbers.) 
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUPPLEMENTARY INFORMATION:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
 A Notice of Funding Availability (NOFA) announcing HUD's 
<!-- PJG 0012 frnewline -->
FY 1993 funding of $4.5 million for the Historically Black Colleges and Universities (HBCU) Program was published
on September 17, 1993 (58 FR 48716). A technical correction to the FY 1993 NOFA, which clarified that the application
due date was December 1, 1993, was published on October 4, 1993 (58 FR 51647). 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00139 </DOCNO>
<PARENT> FR940112-2-00099 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Departments of Veterans Affairs and Housing and Urban Development, and Independent Agencies Appropriations
Act 1994, (approved October 28, 1993, Public Law 103&hyph;124) (94 App. Act) made $6.5 million available for the HBCU
Program in FY 1994. The Department is also making an additional $2 million of FY 1993 HBCU funds eligible for program
applicants. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Because of the large number of applications anticipated for funding under the FY 1993 NOFA, and to make the FY 1994 funds
available as soon as possible, the Department is combining the FY 1993 and 1994 funds into a single competition under
this Notice. All of the applications received for the FY 1993 NOFA will be considered for funding from this combined
pool of $13,000,000. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
In addition, the Department is extending the application due date to 4:30 p.m. on February 11, 1994, to give additional
applicants an opportunity to apply for funding under this program. However, applicants who have already submitted
an application may not submit an additional application. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
The total of $13,000,000 announced as available in this Notice will be awarded under the same terms set forth in the
FY 1993 NOFA, cited above (September 17, 1993, 58 FR 48716). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=4 -->
Authority:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=21 g=1 f=1 -->
 Title I, Housing and Community Development Act of 
<!-- PJG 0012 frnewline -->
1974 (42 U.S.C. 5301&hyph;5320); sec. 7(d), Department of Housing and Urban Development Act (42 U.S.C. 3535(d);
24 CFR 570.404). 
<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: December 14, 1993. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Andrew Cuomo, 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Assistant Secretary for Community Planning and Development. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;737 Filed 1&hyph;11&hyph;94; 8:45 am]
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 4210&hyph;29&hyph;P
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00140 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG FTAG 4717 -->

<!-- PJG STAG 4717 -->

<!-- PJG ITAG l=01 g=1 f=1 -->
Wednesday
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=02 g=1 f=1 -->
January 12, 1994
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=03 g=1 f=1 -->
Part VII
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=04 g=1 f=1 -->
Department of Commerce
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
National Institute of Standards and Technology
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=09 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=05 g=1 f=1 -->
Manufacturing Extension Partnership Program; Notice
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->

<!-- PJG /FTAG -->

<!-- PJG FTAG 4701 -->

<!-- PJG STAG 4701 -->

<!-- PJG ITAG l=90 g=1 f=1 -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=90 g=1 f=1 -->
&blank;/&blank;Vol. 59, No. 8&blank;/&blank;Wednesday, January 12, 1994&blank;/&blank;Notices
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->

<USDEPT>DEPARTMENT OF COMMERCE</USDEPT>

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=18 g=1 f=1 -->

<USBUREAU>National Institute of Standards and Technology</USBUREAU>
<!-- PJG /ITAG -->

<!-- PJG ITAG l=41 g=1 f=1 -->

<RINDOCK>[Docket No. 93110&hyph;3310]</RINDOCK>
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=52 g=1 f=1 -->
Manufacturing Extension Partnership Program
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<AGENCY>
<!-- PJG ITAG l=10 g=1 f=2 -->
AGENCY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
National Institute of Standards and Technology (NIST), Technology Administration, Commerce.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</AGENCY>
<ACTION>
<!-- PJG ITAG l=10 g=1 f=2 -->
ACTION: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
Notice. (This information is provided for planning purposes only, and is not a solicitation for proposals)
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=59 g=1 f=1 -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</ACTION>
<SUMMARY>
<!-- PJG ITAG l=10 g=1 f=2 -->
SUMMARY: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
This notice describes three projects to be conducted by the National Institute of Standards and Technology (NIST)
in FY94, under its Manufacturing Extension Partnership (MEP) program, to provide planning and initial implementation
assistance for manufacturing extension programs. These projects correspond to the State Technology Extension
Program (STEP) component of MEP, and are intended to help states improve the planning, coordination, and implementation
of their technology extension activities. In conjunction with this notice, the MEP program office will conduct workshops
and make MEP staff available to describe fully the projects in advance of a formal solicitation for proposals.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The three projects are:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Program Planning:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To support the creation of a program plan for a state-wide, coordinated technology extension system to enhance the
competitiveness of small and medium-sized manufacturers through the application of technology.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Program Implementation:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To support the initial implementation of a comprehensive state-wide industrial extension program or the pilot testing
of new program and service concepts to help small and medium-sized manufacturers improve productivity and competitiveness.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Regional Linkages:
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 To support inter-state or multi-state efforts to expand the scope and enhance the effectiveness of technical assistance
services available regionally to small and medium-sized manufacturers.
<!-- PJG 0012 frnewline -->
Program Planning projects are open to all states, regardless of state size, industrial density/sparseness, or number
of existing industrial assistance programs.
<!-- PJG 0012 frnewline -->
For Program Implementation and Regional Linkages projects, NIST plans to give priority consideration to projects
having the best potential to benefit areas with relatively sparse distribution of industry, or low industry density
areas that do not lend themselves to large extension centers as a method of service delivery.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
</SUMMARY>
<DATE>
<!-- PJG ITAG l=10 g=1 f=2 -->
DATES: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
The following schedule is anticipated but is subject to change:
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
* January 12, 1994_Program announcement published in the 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. All potential applicants will have an opportunity for dialogue with NIST MEP staff and questions will be accepted
prior to notice requesting proposals.
<!-- PJG 0012 frnewline -->
* January 31, 1994_Informational workshop at NIST to address questions about the MEP program. MEP staff will be available
to meet with representatives from individual states.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</DATE>
<!-- PJG /STAG -->

<!-- PJG /FTAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00141 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
*February 28, 1994_Notice requesting proposals published in 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=4 -->
Federal Register
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
. Dialogue with MEP staff regarding notice restricted. 
<!-- PJG 0012 frnewline -->
*March 31, 1994_Deadline for submission of proposals.
<!-- PJG 0012 frnewline -->
*May 13, 1994_Award announcements.
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<FURTHER>
<!-- PJG ITAG l=10 g=1 f=2 -->
FOR FURTHER INFORMATION CONTACT: 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=10 g=1 f=1 -->
For information regarding this announcement, contact Ms. Gale Morse at (301) 975&hyph;3944, or at: Manufacturing
Extension Partnership, Polymers Building (Bldg. 224), room B115, National Institute of Standards and Technology,
Gaithersburg, Maryland 20899. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FURTHER>
<SUPPLEM>
<!-- PJG ITAG l=84 g=1 f=2 -->
SUPPLEMENTARY INFORMATION: 
<!-- PJG 0012 frnewline -->
Background
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
In accordance with the provisions of the National Institute of Standards and Technology Act (15 U.S.C. 2781), as amended,
NIST will provide assistance in FY94 to help states develop manufacturing assistance programs aimed at small- and
medium-sized manufacturers and help bring those state programs to a level of performance where they can provide the
full range of manufacturing extension services required by their manufacturers. Under the NIST Manufacturing Extension
Partnership (MEP), a cooperative effort to link and strengthen the nation's manufacturing extension programs and
activities, NIST will make merit-based awards to states to help improve their planning, coordination, and implementation
of their technology extension activities. This funding will also be available to multi-state partnerships which
seek to expand the scope of technology assistance related services regionally available to small- and medium-sized
manufacturers. MEP assumes a broad definition of manufacturing, and recognizes a wide range of technology and concepts,
including durable goods production; chemical, biotechnology and other materials processing; chemical, biotechnology
and other materials processing; electronic component and system fabrication; and engineering services associated
with manufacturing, as lying within the definition of manufacturing. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Funding Available 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Approximately, $2,500,000 will be available to support cooperative agreements on a matching funds basis under this
program. Funding size will vary according to the project category and scope of work. For example, program planning
projects have typically averaged less than $100,000 in past years. Program Planning projects that include pilot
testing of the proposed extension plan will be eligible for NIST funding up to $150,000. For Program Implementation
projects and Regional Linkage projects, awards will also vary, but NIST funds may not exceed $250,000 per project.
States will be able to submit proposals for each of the three project categories. 
<!-- PJG 0012 frnewline -->
The cooperative agreements entered into under this program will be available for one year. NIST will have no obligation
to provide any additional future funding to applicants selected for funding under these projects. Renewal of an award
to increase funding or extend the period of performance will be at the local discretion of NIST. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=2 -->
Projects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=2 -->
Program Planning Projects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=2 -->
Project Objective 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
The purpose of Program Planning projects will be to create plans for state-wide, coordinated, technology extension
programs in order to enhance the competitiveness of small- and medium-sized manufacturers. These projects will
plan for the development and coordination of existing and/or newly formed services, such as state industrial assistance
programs; workforce training; university-based industrial assistance programs; and management assistance programs;
into a unified state-wide program. Plans will include providing access to a wide range of technology and services,
such as technology deployment, worker skills development, technology transfer and commercialization, or export
and market development. 
<!-- PJG 0012 frnewline -->
Applicants may conduct planning activities on a regional basis within a state, when regions are defined by the state.
Regions should be clearly defined by the proposing organizations and it must be clear why the program is regionally
oriented, versus state-wide, and how the regions will be integrated into a state-wide plan or interact such that state-wide
coverage is achieved. 
<!-- PJG 0012 frnewline -->
Applicants may include pilot testing activities as part of their planning process. If pilot testing of the proposed
extension plan is included in the project, it should include methods of evaluating the pilot's success in implementing
the proposed extension plan. Any proposed pilot activity must be consistent with the program plan developed for the
state. 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=2 -->
Program Planning Projects Evaluation Criteria 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=2 -->
Proposals from applicants will be evaluated and rated on the basis of the following criteria by an impartial competitive
review panel. Each proposal should address all five selection criteria and selection criteria 1&hyph;3 will be weighted
more heavily than criteria 4&hyph;5. Selection will be based upon total evaluation score as well as geographic distribution.

<!-- PJG 0012 frnewline -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Target population (25 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Potential applicants should specify a methodology for identifying a population of beneficiary companies (the target
population) and their technology assistance-related needs. Factors that will be considered include: 
<!-- PJG 0012 frnewline -->
(a) Methodology for defining the size and demographic characteristics of the target population to be served by the
program plan. 
<!-- PJG 0012 frnewline -->
(b) Methodology for determining the target population's assistance needs, e.g. technology, training, information,
quality improvement, management, etc. 
<!-- PJG 0012 frnewline -->
(c) Methodology to ensure that the plan is appropriate for addressing identified industry needs. 
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Resource identification and assessment (20 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants should describe the methodology for collecting information about the number, size, technical sophistication,
type, and relevance of industrial assistance activities that will be part of the coordination effort. Factors that
will be considered include: 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SUPPLEM>
<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00142 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) Methodology for identifying relevant assistance programs and other sources of expertise outside applicant's
organization.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Methodology for assessing relevance and effectiveness of resources in addressing identified industry needs.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Coordination with existing resources (25 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants should set forth a plan for interacting or coordinating with appropriate existing and/or newly-formed
state and local technology-industrial assistance services, potential industry partners, and appropriate federal
services, to develop a coordinated state-wide delivery system. Factors that will be considered include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Methodology and adequacy of plans for forming effective linkages and partnerships necessary to plan for and provide
a coordinated range of services to meet the needs of the target population.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Safeguards to ensure that planned activity does not duplicate existing services or resources.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Management (15 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants should specify plans for proper organization, staffing, and management of the planning process. Factors
that will be considered include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Appropriateness and authority of the governing or managing organization to conduct a state-wide (or regional)
planning process.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Qualifications of the project team and its leadership to conduct a state-wide (or regional) planning process.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Appropriateness of the organizational approach for carrying out the planning activity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Evidence of significant involvement and support by the state and by private industry. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Financial plan (15 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants should show the relevance and cost effectiveness of the financial plan for meeting the objectives of the
project; the firmness and level of the applicant's total financial support for the project; and the plan to maintain
the program after the cooperative agreement has expired. Factors that will be considered include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Cost effectiveness of the budget.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Strength of commitment of proposer's cost share.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Effectiveness of management plans for control of budget. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Appropriateness of matching contribution. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Plan for maintaining the program after the cooperative agreement has expired. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Selection Procedures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Director of NIST will appoint an impartial evaluation panel to review and evaluate all qualified proposals in
accordance with the evaluation criteria and values set forth in this notice. From the qualified proposals a group
of finalists will be selected based on this review. This review process should take approximately 30 days. The Director
of NIST, or her designee, shall select awardees based on the rank order of total evaluation scores, geographic distribution,
and the availability of funds.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Eligibility
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Eligible applicants for these projects are state technology extension programs operated by state governments,
or on behalf of state governments by private or public non-profit organizations. All states will be eligible, regardless
of state size, industrial density/sparseness, or number of existing industrial assistance programs. States that
have received previous planning grants remain eligible for additional Program Planning projects. Applicants will
be able to propose conducting the planning activities themselves or arranging for some or all of the planning activities
to be carried out by a second party. One proposal for Program Planning will be accepted per state. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Financial Information
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A matching contribution from each applicant is required. NIST may provide financial support up to 50% of the total
budget for the project, however, the federal share may not exceed $150,000. The applicant's share of the budget may
include dollar contributions from state, county, industrial or other non-federal sources and in-kind contributions
necessary and reasonable for proper accomplishment of project objectives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Required Letters
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A letter will be required from the Governor indicating that the eligible applicant is the lead organization in that
state for Program Planning activities, and acknowledging that there is only one proposal from that state for a Program
Planning project. Where more than one such otherwise qualified Program Planning proposal per state is submitted,
all such proposals from that state may be disqualified.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00143 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Program Implementation Projects
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Project Objective
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The purpose of Program Implementation projects is to support the implementation of comprehensive, state-wide industrial
extension programs and/or pilot testing of new program and service concepts, such as pilot outreach centers and other
extension activities, to help small and medium-sized manufacturers improve productivity and competitiveness.
<!-- PJG 0012 frnewline -->
For projects that support the implementation of a comprehensive state-wide industrial extension system, activities
must build upon existing services and be consistent with comprehensive state plans, if such plans exist. Extension
programs should provide access to a range of services, including but not limited to: technical extension, training,
management assistance, and quality improvement.
<!-- PJG 0012 frnewline -->
Pilot testing of new services and activities will be permitted on a limited scale where there is an intent to replicate
these services on a larger scale or to move toward full-scale implementation. Accordingly, pilot testing must include
evaluation, analysis and documentation, and may include some planning activities as necessary.
<!-- PJG 0012 frnewline -->
NIST plans to give priority consideration to projects having the best potential to benefit areas with relatively
sparse distribution of industry, or low density industry areas that do not lend themselves to large extension centers
as a method of service delivery.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Program Implementation Projects Evaluation Criteria
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Proposals from applicants will be evaluated and rated on the basis of the following criteria by an impartial competitive
review panel. Each proposal should address all six selection criteria and selection criteria 1&hyph;4 will be weighted
more heavily than criteria 5&hyph;6. Selection will be based upon total evaluation score as well as geographic distribution.
<!-- PJG 0012 frnewline -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Target population (20 points):
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Potential applicants will be required to identify a population of beneficiary companies (the target population)
and their technology-related assistance needs in the proposed service area. Factors that will be considered include:
<!-- PJG 0012 frnewline -->
(a) A clear definition of the target population, its size and demographic characteristics.
<!-- PJG 0012 frnewline -->
(b) Demonstrated understanding of the target population's assistance needs, e.g., technology, training, information,
quality improvement, management, etc.
<!-- PJG 0012 frnewline -->
(c) Appropriateness of the size of the target population and the anticipated impact for the proposed expenditure.
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Delivery mechanisms (20 points):
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Applicants will need to specify the mechanism for delivery of services to the population of beneficiary companies
(the target population). Factors that will be considered include:
<!-- PJG 0012 frnewline -->
(a) Appropriateness and effectiveness of proposed delivery mechanism for meeting the identified needs of the target
population.
<!-- PJG 0012 frnewline -->
(b) Demonstration of capacity to form effective linkages and partnerships with other appropriate service providers.
<!-- PJG 0012 frnewline -->
(c) Technical quality of the proposed approach, including knowledge and use of best industrial modernization practices.
<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Coordination with existing resources (20 points):
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Applicants will need to describe how they will coordinate with existing or newly formed state or local technology/industrial
assistance services, and federal services, to allow for increased economies of scale and to avoid duplication of
services in providing assistance to small and medium-sized manufacturers. For a comprehensive, state-wide industrial
extension program, the applicant must show the degree to which activities integrate with and enhance existing or
newly formed state, local, and appropriate federal technology assistance and industrial modernization activities
to present a unified program of assistance. Factors that will be considered include:
<!-- PJG 0012 frnewline -->
(a) Demonstrated understanding of existing organizations and resources relevant for providing technology assistance
related services to the target population.
<!-- PJG 0012 frnewline -->
(b) Adequate linkages and partnerships with existing organizations and clear definition of those organizations'
roles in the proposed activities.
<!-- PJG 0012 frnewline -->
(c) Proposed activity does not duplicate existing services or resources.
<!-- PJG 0012 frnewline -->
(d) Consistency with comprehensive state plans if such plans exist.
<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Program evaluation (20 points):
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 The applicant should specify plans for evaluation of the effectiveness of the proposed program and for ensuring continuous
improvement of program activities. Factors that will be considered include:
<!-- PJG 0012 frnewline -->
(a) Thoroughness of evaluation plans, including internal evaluation for management control, external evaluation
for assessing outcomes of the activity, and ``customer satisfaction'' measures of performance.
<!-- PJG 0012 frnewline -->
(b) In the case of pilot projects, the proposer's plan must include documentation, analysis of the results, and must
show how the results can be used in program development.
<!-- PJG 0012 frnewline -->
5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Financial plan (10 points):
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Applicants should show the relevance and cost effectiveness of the financial plan for meeting the objectives of the
project; the firmness and level of the applicant's total financial support for the project; and a plan to maintain
the program after the cooperative agreement has expired. Factors that will be considered include:
<!-- PJG 0012 frnewline -->
(a) Reasonableness of the budget, both in income and expenses.
<!-- PJG 0012 frnewline -->
(b) Strength of commitment of the proposer's cost share.
<!-- PJG 0012 frnewline -->
(c) Effectiveness of management plans for control of budget.
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00144 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(d) Appropriateness of matching contributions.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Plan for maintaining the program after the cooperative agreement has expired.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Management (10 points):
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
 Applicants should specify plans for proper organization, staffing, and management of the implementation process.
Factors that will be considered include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Appropriateness and authority of the governing or managing organization to conduct the proposed activities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Qualifications of the project team and its leadership to conduct the proposed activity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Soundness of staffing plans, including recruitment, selection, training, and continuing professional development.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Appropriateness of the organizational approach for carrying out the proposed activity.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Evidence of significant involvement and support by private industry.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Selection Procedures
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Director of NIST will appoint an impartial evaluation panel to review and evaluate all qualified proposals in
accordance with the evaluation criteria and values set forth in this notice. From the qualified proposals a group
of finalists will be selected based on this review. This review process should take approximately 30 days. The Director
of NIST, or her designee, shall select awardees based on the rank order of total evaluation scores, geographic distribution,
and the availability of funds.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Eligibility
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Eligible applicants for these projects are state technology extension programs operated by state governments,
or on behalf of state governments by private or public non-profit organizations. States that have received previous
implementation grants remain eligible for additional Program Implementation projects. Applicants will be able
to propose providing services directly or arranging for the provision of some or all of the proposed services by a second
party. More than one proposal may be accepted from each state.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Financial Information
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A matching contribution from each applicant will be required. NIST may provide financial support up to 50 percent
of the total budget for the project; however, the federal share may not exceed $250,000. One half of the applicant's
required match (i.e. 25% of the total) must be non-federal cash. Cash may include dollar contributions from state,
county, industrial or other non-federal sources. The applicant's share of the budget may include in-kind contributions
necessary and reasonable for proper accomplishment of project objectives.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Required Letters
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All proposals for Program Implementation projects must contain a letter from the Governor indicating that the applicant
is the lead organization in that state for conducting the proposed activities.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
Where linkages to other organizations are proposed, applicants are advised to include a letter of support and commitment
from the linking organization.
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00145 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Regional Linkages Projects
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Project Objective
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The purpose of Regional Linkage projects is to support inter-state or multi-state partnerships that will expand
the scope and enhance the effectiveness of technical assistance services regionally available to small and medium-sized
manufacturers. Project may be assistance service-led, or industry-led partnerships to provide assistance services
that cross institutional and political boundaries. Assistance service-led partnerships, for example, can include
shared assistance services that cross state boundaries, or electronic networking. Industry-led partnerships
can include linkage activities between original equipment manufacturers (OEMs) and suppliers, creating a multi-state
network of suppliers, program planning for multi-state assistance delivery, or other activities that improve the
interactions between manufacturers.
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Regional Projects Evaluation Criteria
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Proposals from applicants will be evaluated and rated on the basis of the following criteria by an impartial competitive
review panel. Each proposal should address all six selection criteria and selection criteria 1&hyph;4 will be weighted
more heavily than criteria 5&hyph;6. Selection will be based upon total evaluation score as well as geographical
distribution.
<!-- PJG 0012 frnewline -->
1. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Target population (20 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Potential applicants will be required to identify a population of beneficiary companies (the target population)
and their technology-related assistance needs in the proposed service area. Factors that will be considered include:
<!-- PJG /ITAG -->

<!-- PJG QTAG 02 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) A clear definition of the target population, its size and demographic characteristics.
<!-- PJG 0012 frnewline -->
(b) Demonstrated understanding of the target population's assistance needs, eg. technology, training, information,
quality improvement, management, etc.
<!-- PJG 0012 frnewline -->
(c) Appropriateness of the size of the target population and the anticipated impact for the proposed expenditures.
<!-- PJG 0012 frnewline -->
2. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Delivery mechanisms (20 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants will need to specify the mechanism for delivery of services to the population of beneficiary companies
(the target population). Facts that will be considered include:
<!-- PJG 0012 frnewline -->
(a) Appropriateness and effectiveness of proposed delivery mechanism for meeting the identified needs of the target
population.
<!-- PJG 0012 frnewline -->
(b) Demonstration of capacity to form effective linkages and partnerships with other appropriate service providers.
<!-- PJG 0012 frnewline -->
(c) Technical quality of the proposed approach, including knowledge and use of best industrial modernization practices.
<!-- PJG 0012 frnewline -->
3. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Coordination with existing resources (20 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants will need to describe how they will coordinate with existing or newly-formed technology/industrial
assistance services and resources that will allow for increased economies of scale and complementary capabilities,
and will avoid duplication of efforts in providing assistance to small and medium-sized manufacturers. It will be
important to show how the proposed approach can reach across political or institutional boundaries to provide access
to services. Factors that will be considered include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Demonstrated understanding of existing organizations and resources relevant for providing technology assistance
related services to the target population.
<!-- PJG 0012 frnewline -->
(b) Strength of plans to establish and maintain linkages and partnerships with existing organizations (particularly
across state boundaries), and a clear definition of those organizations' roles in the proposed activities.
<!-- PJG 0012 frnewline -->
(c) Proposed activity does not duplicate existing services or resources.
<!-- PJG 0012 frnewline -->
(d) Consistency with comprehensive state plans if such plans exist.
<!-- PJG 0012 frnewline -->
4. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Program evaluation (20 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The applicant should specify plans for evaluation of the effectiveness of the proposed program and for ensuring continuous
improvement of program activities. Factors that will be considered include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Thoroughness of evaluation plans, including internal evaluation for management control, external evaluation
for assessing outcomes of the activity, and ``customer satisfaction'' measures of performance.
<!-- PJG 0012 frnewline -->
(b) Plans for the documentation, analysis for the results, and how the results can be used in program development.
<!-- PJG 0012 frnewline -->
5. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Financial plan (10 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants should show that relevance and cost effectiveness of the financial plan for meeting the objectives of
the project; the firmness and level of the applicant's total financial support for the project; and the plan to maintain
the program after the cooperative agreement has expired. Factors that will be considered include:
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00146 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=11 g=1 f=1 -->
(a) Reasonableness of the budget, both in income and expenses. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Strength of commitment of the proposer's cost share. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Effectiveness of management plans for control of the budget. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Appropriateness of matching contributions. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Plan for maintaining the program after the cooperative agreement has expired. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
6. 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=3 -->
Management (10 points): 
<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Applicants should specify plans for proper organization, staffing, and management of the implementation process.
Factors that will be considered include: 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(a) Appropriateness and authority of the governing or managing organization to conduct the proposed inter-state
or multi-state activities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(b) Qualifications of the project team and its leadership to conduct the proposed activity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(c) Soundness of staffing plans, including recruitment, selection, training, and continuing professional development.

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(d) Appropriateness of the organizational approach for carrying out the proposed activity. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->
(e) Evidence of significant involvement and support by private industry. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Selection Procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Director of NIST will appoint an impartial evaluation panel to review and evaluate all qualified proposals in
accordance with the evaluation criteria and values set forth in this notice. From the qualified proposals a group
of finalists will be selected based on this review. This review process should take approximately 30 days. The Director
of NIST, or her designee, shall select awardees based on the rank order of total evaluation scores, geographic distribution,
and the availability of funds. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Eligibility 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Eligible applicants for these projects will be state and local governments, representing either themselves or a
consortium of states, and appropriate private or public non-profit organizations, operating on behalf of a consortium
of states or as a representative of states. Applicants will be able to propose providing services directly or arranging
for the provision of any or all of the proposed services by a second party. At least one state represented in the partnership
or consortium must be characterized by relatively sparse distribution of industry or as having lower industrial
densities. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
Financial Information 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A matching contribution from each applicant will be required. NIST may provide financial support up to 50% of the total
budget for the project, however, the federal share may not exceed $250,000. The applicant's share of the budget may
include dollar contributions from state, county, industrial or other non-federal sources and in-kind contributions
necessary and reasonable for proper accomplishment of project objectives. 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=84 g=1 f=1 -->
Additional Requirements 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Federal Policies and Procedures 
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Recipients and subrecipients are subject to all Federal laws and Federal and DOC policies, regulations, and procedures
applicable to Federal financial assistance awards. 
<!-- PJG /ITAG -->

<!-- PJG /STAG -->
</TEXT>
</DOC>



<DOC>
<DOCNO> FR940112-2-00147 </DOCNO>
<PARENT> FR940112-2-00100 </PARENT>
<TEXT>
 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG STAG 4703 -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Past Performance 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Unsatisfactory performance under prior Federal awards may result in an application not being considered for funding.

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Preaward Activities 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
If applicants incur any cost prior to an award being made, they do so solely at their own risk of not being reimbursed
by the Government. Notwithstanding any verbal assurance that may have been received, there is no obligation on the
part of DOC to cover pre-award costs. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Delinquent Federal Debts 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
No award of Federal funds shall be made to an applicant who has an outstanding delinquent Federal debt until either:

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
1. The delinquent account is paid in full; 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
2. A negotiated repayment schedule is established and at least one payment is received; or 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->
3. Other arrangements satisfactory to DOC are made. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Name Check Review 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All non-profit and for-profit applicants are subject to a name check review process. Name checks are intended to reveal
if any key individuals associated with the applicant have been convicted of or are presently facing criminal charges
such as fraud, theft, perjury, or other matters which significantly reflect on the applicant's management honesty
or financial integrity. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Primary Applicant Certification 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
All primary applicants must submit a completed Form CD&hyph;511, ``Certifications Regarding Debarment, Suspension
and Other Responsibility Matters; Drug-Free Workplace Requirements and Lobbying,'' and the following explanations
are hereby provided. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
1. Nonprocurement Debarment and Suspension 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Prospective participants (as defined at 15 CFR part 26, section 105) are subject to 15 CFR part 26, ``Nonprocurement
Debarment and Suspension'' and the related section of the certification form prescribed above applies;
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
2. Drug Free Workplace 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Grantees (as defined at 15 CFR part 26, section 605) are subject to 15 CFR part 26, subpart F, ``Governmentwide Requirements
for Drug-Free Workplace (Grants)'' and the related section of the certification form prescribed above applies;

<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
3. Anti-Lobbying 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Persons (as defined at 15 CFR part 28, section 105) are subject to the lobbying provisions of 31 U.S.C. 1352, ``Limitation
on use of appropriated funds to influence certain Federal contracting and financial transactions,'' and the lobbying
section of the certification form prescribed above applies to applications/bids for grants, cooperative agreements,
and contracts for more than $100,000, and loans and loan guarantees for more than $150,000, or the single family maximum
mortgage limit for affected programs, whichever is greater; and 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=81 g=1 f=1 -->
4. Anti-Lobbying Disclosures 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Any applicant that has paid or will pay for lobbying using any funds must submit an SF&hyph;LLL, ``Disclosure of Lobbying
Activities,'' as required under 15 CFR part 28, appendix B. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Lower Tier Certifications 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Recipients shall require applicants/bidders for subgrants, contracts, subcontracts, or other lower tier covered
transaction at any tier under the award to submit, if applicable, a complete Form CD&hyph;512, ``Certification Regarding
Debarment, Suspension, Ineligibility and Voluntary Exclusion_Lower Tier Covered Transactions and Lobbying''
and disclosure form, SF&hyph;LLL, ``Disclosure of Lobbying Activities;'' Form CD&hyph;512 is intended for the
use of recipients and should not be transmitted to DOC. SF&hyph;LLL submitted by any tier recipient or subrecipient
should be submitted to DOC in accordance with the instructions contained in the award document. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
False Statements 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
A false statement on an application is grounds for denial or termination of funds and grounds for possible punishment
by a fine or imprisonment as provided in 18 U.S.C. 1001. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Catalog of Federal Domestic Assistance 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The catalog number for the award of State Technology Extension Program funds in the Catalog of Federal Domestic Assistance
is 11613. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Executive Order 12372 ``Intergovernmental Review of Federal Programs.''
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
Is applicable to the extent permitted by law. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=83 g=1 f=1 -->
Classification 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG ITAG l=11 g=1 f=1 -->
The Manufacturing Extension Partnership is being carried out under the authority of the Omnibus Trade and Competitiveness
Act of 1988, as amended 15 U.S.C. 2781. This notice relating to public property, loans, grants, benefits, or contracts
is exempt from all requirements of section 553 of the Administrative Procedure Act (5 U.S.C. 553(a)(2)) including
notice and opportunity for comment. Therefore, a Regulatory Flexibility Analysis is not required and was not prepared
for this notice for purposes of the Regulatory Flexibility Act (5) U.S.C. 603 and 604). The program is not a major Federal
action requiring an environmental assessment under the National Environmental Policy Act. This notice does not
contain policies with Federalism implications sufficient to warrant preparation of a Federalism assessment under
Executive Order 12612. This notice contains collection of information requirements subject to the Paperwork Reduction
Act which have been approved by the Office of Management and Budget (OMB Control Number 0693&hyph;0010).
<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<!-- PJG QTAG 04 -->
<!-- PJG /QTAG -->

<!-- PJG 0012 frnewline -->

<!-- PJG 0012 frnewline -->

<!-- PJG ITAG l=21 g=1 f=1 -->
Dated: January 6, 1994. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->

<SIGNER>
<!-- PJG ITAG l=06 g=1 f=1 -->
Samuel Kramer, 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNER>
<SIGNJOB>
<!-- PJG ITAG l=04 g=1 f=1 -->
Associate Director. 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</SIGNJOB>
<FRFILING>
<!-- PJG ITAG l=40 g=1 f=1 -->
[FR Doc. 94&hyph;647 Filed 1&hyph;11&hyph;94; 8:45 am] 
<!-- PJG 0012 frnewline -->
 
<!-- PJG 0012 frnewline -->

<!-- PJG /ITAG -->
</FRFILING>
<BILLING>
<!-- PJG ITAG l=68 g=1 f=1 -->
BILLING CODE 3510&hyph;13&hyph;M
<!-- PJG /ITAG -->
</BILLING>

<!-- PJG /STAG -->
</TEXT>
</DOC>



